data_6ap5_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6ap5 _Structure_validation_residue.Date_analyzed 2017-10-20 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.2 p . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.824 0.345 . . . . 73.230000000000004 111.112 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.2 t -147.09 145.4 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 75.219999999999999 111.086 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.8 t -77.7 127.93 33.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 73.519999999999996 111.109 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.9 t -97.66 120.79 47.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 75.140000000000001 111.11 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.92 173.58 0.59 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 64.140000000000001 111.185 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -77.87 -41.64 36.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 75.450000000000003 110.878 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.3 m -69.6 -33.73 73.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 71.530000000000001 110.881 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.2 t -85.55 -18.19 34.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 74.349999999999994 111.178 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -51.05 -52.68 40.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 75.219999999999999 110.886 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.412 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -64.6 -14.67 58.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 74.099999999999994 110.864 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.6 m -92.99 -33.17 14.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.294 -0.412 . . . . 74.129999999999995 111.16 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -96.96 -71.56 0.67 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 64.310000000000002 110.878 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.4 t -51.48 -71.81 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 72.109999999999999 111.117 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.412 ' HB2' ' HA ' ' A' ' 21' ' ' LYS . 12.1 mt -41.71 -58.95 1.8 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 65.109999999999999 110.921 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -49.71 -64.81 0.7 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 73.430000000000007 110.857 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.6 t -55.49 145.88 21.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 71.420000000000002 110.848 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -107.36 35.92 2.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.487 . . . . 71.349999999999994 110.858 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.25 160.3 38.07 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 121.571 0.7 . . . . 75.310000000000002 111.123 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 106.42 1.67 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.695 2.263 . . . . 74.430000000000007 112.343 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 70.5 t -87.64 118.28 33.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 71.140000000000001 111.135 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.84 99.52 11.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.477 . . . . 73.310000000000002 110.919 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.6 p -100.16 138.99 22.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 74.200000000000003 111.116 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -125.3 121.83 35.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 61.539999999999999 110.851 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -101.1 89.83 3.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 74.510000000000005 110.845 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -133.3 -167.73 1.97 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.132 -0.486 . . . . 74.540000000000006 110.945 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.05 -166.32 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 65.25 111.069 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.445 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 3.6 m-20 -78.89 12.63 2.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 72.420000000000002 110.919 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.457 ' N ' ' CD1' ' A' ' 39' ' ' TRP . 1.4 m0 77.01 94.62 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 74.340000000000003 110.895 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -174.69 -57.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 54.149999999999999 110.84 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.09 -70.06 1.36 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.788 -0.72 . . . . 72.329999999999998 112.488 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 -44.01 2.31 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.681 2.254 . . . . 72.530000000000001 112.29 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 42.4 t -52.08 -34.73 45.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.433 . . . . 74.349999999999994 110.894 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.6 -34.14 77.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 73.219999999999999 110.845 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 11.3 mtt -85.25 -38.34 19.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 71.510000000000005 110.88 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.0 t -94.1 21.48 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 71.230000000000004 111.141 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.47 ' N ' ' HD2' ' A' ' 48' ' ' PRO . . . -77.18 -60.84 0.73 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.579 0.704 . . . . 74.409999999999997 111.112 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 47' ' ' ALA . 53.7 Cg_endo -69.71 -49.65 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.681 2.254 . . . . 72.319999999999993 112.38 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.4 m -50.49 -30.16 7.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 74.120000000000005 111.127 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.4 tt -84.01 -39.69 19.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.202 -0.454 . . . . 74.340000000000003 110.91 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -61.43 -35.57 77.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 74.329999999999998 110.879 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -55.1 -60.56 3.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 74.439999999999998 110.936 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 mt -51.43 -38.18 20.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 74.430000000000007 111.13 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 74.340000000000003 111.123 179.806 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.42 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.898 0.38 . . . . 73.540000000000006 110.902 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -128.96 141.97 51.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 72.540000000000006 110.884 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.82 112.93 42.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 73.120000000000005 111.16 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -105.55 147.26 28.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 74.340000000000003 111.112 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.41 156.62 46.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.436 . . . . 75.450000000000003 110.896 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.42 137.62 27.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.452 . . . . 73.129999999999995 110.927 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.58 106.92 13.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.45 . . . . 73.549999999999997 110.87 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 78.8 t -55.54 -39.11 52.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 75.129999999999995 111.16 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.02 -36.02 62.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 74.450000000000003 110.849 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.8 -35.46 14.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 74.010000000000005 111.15 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -117.87 68.04 6.23 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.627 0.727 . . . . 74.25 110.894 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -33.3 16.86 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.684 2.256 . . . . 65.349999999999994 112.29 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -62.42 -36.8 83.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 72.109999999999999 110.877 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.15 -34.99 79.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 64.439999999999998 111.051 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.88 -67.52 0.36 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 63.32 111.088 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -53.41 -38.73 63.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 74.299999999999997 110.895 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -51.41 -37.82 50.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 74.019999999999996 110.919 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -110.08 29.93 7.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 74.439999999999998 110.845 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 49.35 82.02 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 75.010000000000005 110.924 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.4 t -126.89 103.35 10.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 74.030000000000001 111.138 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 60.3 t -98.29 -34.49 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 63.509999999999998 111.143 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.5 m -97.61 151.67 19.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 72.439999999999998 110.855 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.514 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.1 mt -66.66 -57.76 11.31 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.565 0.697 . . . . 73.219999999999999 111.148 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.4 Cg_endo -69.77 70.17 1.6 Allowed 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.694 2.263 . . . . 63.329999999999998 112.332 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 59.1 m -110.49 148.09 32.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 73.120000000000005 111.115 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 5.3 ttp -147.89 147.61 29.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 73.310000000000002 110.883 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 10.5 mt -133.43 115.32 22.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 74.099999999999994 111.15 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.9 tp -81.3 101.78 9.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 73.430000000000007 110.875 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -89.98 170.33 10.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 74.400000000000006 110.874 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -164.91 96.31 0.72 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 73.209999999999994 110.919 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.97 35.87 23.32 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.763 -0.732 . . . . 64.409999999999997 112.469 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.23 40.89 60.63 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.731 -0.747 . . . . 73.400000000000006 112.499 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.6 m -160.65 133.46 4.56 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.596 0.712 . . . . 74.430000000000007 111.158 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 87.76 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.67 2.247 . . . . 64.129999999999995 112.318 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 26.9 m -78.54 -34.96 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 73.209999999999994 111.097 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.43 163.71 32.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 73.530000000000001 110.904 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.54 133.47 16.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 75.549999999999997 110.858 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.3 mp -137.19 135.44 47.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 73.109999999999999 111.139 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -135.32 139.64 46.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 71.200000000000003 111.149 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 129.02 134.49 3.8 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.767 -0.73 . . . . 51.43 112.454 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.34 86.38 7.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.833 0.349 . . . . 53.329999999999998 111.116 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.41 172.46 9.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 74.200000000000003 110.847 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.26 171.0 8.42 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.739 -0.743 . . . . 74.400000000000006 112.448 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.06 -43.59 86.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.791 0.329 . . . . 74.5 110.916 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.96 -65.39 0.59 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 71.019999999999996 111.093 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.89 -56.91 13.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 73.129999999999995 111.084 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.82 -36.27 25.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 74.319999999999993 110.918 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.3 tt -70.15 -37.41 75.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 75.140000000000001 110.925 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 10.0 mtp85 -66.71 -41.52 87.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 75.019999999999996 110.845 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -52.19 -25.46 9.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 73.400000000000006 110.905 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.3 mt -84.82 -67.99 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 74.519999999999996 111.155 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -52.4 -48.8 65.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 73.340000000000003 110.913 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -58.0 -34.79 70.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.496 . . . . 63.32 110.886 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.81 -35.04 57.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 73.030000000000001 111.129 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.1 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 75.409999999999997 110.923 -179.984 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.6 p . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.789 0.328 . . . . 72.010000000000005 111.131 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.06 150.09 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 75.319999999999993 111.143 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.4 t -72.71 131.1 41.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 72.340000000000003 111.143 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.4 t -92.56 121.21 42.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 75.299999999999997 111.148 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.89 163.67 4.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.122 -0.49 . . . . 71.120000000000005 111.113 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -67.02 -39.86 87.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 74.400000000000006 110.82 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.7 t -75.86 -57.67 3.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 75.120000000000005 110.898 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.5 t -55.79 -24.22 34.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 75.319999999999993 111.144 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -51.71 -30.88 23.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 73.140000000000001 110.837 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.434 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -71.45 -33.37 69.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 71.099999999999994 110.9 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.9 m -92.69 -17.67 23.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 75.310000000000002 111.151 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -93.57 -72.05 0.63 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 64.519999999999996 110.849 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.2 t -69.4 -71.29 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 73.409999999999997 111.106 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.434 ' HB2' ' HA ' ' A' ' 21' ' ' LYS . 12.5 mt -40.18 -60.31 1.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 74.349999999999994 110.861 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -50.31 -56.62 10.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.242 -0.435 . . . . 73.129999999999995 110.863 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.1 t -51.84 158.47 1.0 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 64.109999999999999 110.859 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -119.44 35.76 4.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 71.549999999999997 110.844 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.4 159.96 70.13 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.523 0.678 . . . . 74.150000000000006 111.175 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 122.14 8.83 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.682 2.254 . . . . 73.120000000000005 112.344 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.1 t -100.93 122.93 53.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.449 . . . . 73.439999999999998 111.121 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -94.86 99.93 11.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 75.530000000000001 110.901 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.9 p -100.38 142.62 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 73.409999999999997 111.17 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -135.75 119.84 17.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 74.120000000000005 110.895 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -99.74 93.5 5.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 74.129999999999995 110.936 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -136.77 -167.72 2.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.126 -0.488 . . . . 72.200000000000003 110.958 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.57 -165.22 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.433 . . . . 73.010000000000005 111.085 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.446 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 34.7 p-10 -77.69 12.07 1.83 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 73.400000000000006 110.844 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.479 ' N ' ' CD1' ' A' ' 39' ' ' TRP . 1.7 m0 77.62 92.91 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.158 -0.474 . . . . 74.219999999999999 110.908 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -175.89 -53.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 62.409999999999997 110.881 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.26 -70.99 1.3 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.74 -0.743 . . . . 62.210000000000001 112.509 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -32.62 18.17 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.646 2.23 . . . . 72.430000000000007 112.351 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -59.42 -33.45 71.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 72.230000000000004 110.884 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.53 -28.81 70.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 74.319999999999993 110.898 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 4.6 mmt -87.21 -41.55 13.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 65.140000000000001 110.867 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.9 t -94.13 22.16 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 74.540000000000006 111.115 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.455 ' N ' ' HD2' ' A' ' 48' ' ' PRO . . . -76.75 -61.08 0.77 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.561 0.696 . . . . 70.310000000000002 111.08 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 47' ' ' ALA . 53.9 Cg_endo -69.76 -49.91 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.711 2.274 . . . . 73.319999999999993 112.326 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.3 m -51.02 -30.42 9.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 72.25 111.112 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.3 tt -82.95 -36.83 24.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.16 -0.473 . . . . 72.439999999999998 110.945 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -58.9 -35.29 72.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 74.439999999999998 110.907 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -61.82 -67.88 0.37 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 74.099999999999994 110.891 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 mt -51.38 -37.32 18.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 74.010000000000005 111.12 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 72.120000000000005 111.072 179.809 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.8 pp . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.862 0.363 . . . . 73.340000000000003 110.951 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 32.0 mttp -85.63 124.71 32.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 71.230000000000004 110.938 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.3 t -131.74 105.35 9.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 74.450000000000003 111.134 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -118.04 139.19 51.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 64.5 111.112 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -134.94 158.75 43.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 75.319999999999993 110.912 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -139.71 142.66 36.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.435 . . . . 72.150000000000006 110.974 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.88 107.28 19.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.201 -0.454 . . . . 51.25 110.871 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 69.4 t -57.47 -36.01 51.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 74.120000000000005 111.162 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.87 -36.38 48.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 71.319999999999993 110.908 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.29 -35.18 10.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 73.140000000000001 111.081 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -115.72 73.59 4.46 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.63 0.728 . . . . 62.439999999999998 110.89 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -30.87 21.41 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.672 2.248 . . . . 62.039999999999999 112.319 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -64.9 -38.96 92.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.429 . . . . 73.510000000000005 110.898 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.48 -48.88 71.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.492 . . . . 63.210000000000001 111.094 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.37 -64.05 0.95 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 73.239999999999995 111.102 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.5 ttp180 -51.23 -34.01 30.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 74.349999999999994 110.899 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -51.73 -40.04 59.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 74.420000000000002 110.892 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -106.65 28.45 7.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 73.030000000000001 110.891 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 50.33 52.88 13.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 74.329999999999998 110.877 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.7 t -89.63 109.19 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 60.409999999999997 111.135 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.9 t -96.18 -35.74 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 74.099999999999994 111.112 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.5 t -103.12 146.0 29.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 70.010000000000005 110.838 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.529 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 1.1 mp -56.9 -57.43 24.37 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.594 0.711 . . . . 72.010000000000005 111.136 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.7 Cg_endo -69.76 78.34 1.01 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.668 2.245 . . . . 73.519999999999996 112.329 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 77.0 m -116.72 111.64 20.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.26 -0.427 . . . . 73.549999999999997 111.138 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 10.4 ttp -113.48 122.96 48.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 71.140000000000001 110.896 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 20.9 mt -115.53 122.22 68.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 73.340000000000003 111.114 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 16.3 tp -88.16 105.7 17.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.485 . . . . 74.549999999999997 110.895 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -90.18 170.33 10.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 72.450000000000003 110.871 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -168.46 94.64 0.36 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.484 . . . . 73.329999999999998 110.88 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.89 35.85 10.91 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.775 -0.726 . . . . 53.310000000000002 112.48 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.84 37.94 65.76 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.75 -0.738 . . . . 55.450000000000003 112.494 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 85.1 m -161.13 134.16 4.63 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.572 0.701 . . . . 74.420000000000002 111.133 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 82.56 0.74 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.646 2.231 . . . . 74.120000000000005 112.37 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.7 m -64.76 -35.02 73.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 71.439999999999998 111.092 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.95 170.02 16.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 73.099999999999994 110.927 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -158.31 125.5 4.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 74.120000000000005 110.839 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.8 mp -134.12 125.41 48.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 74.230000000000004 111.12 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.6 m -132.77 150.96 33.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 71.129999999999995 111.096 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 140.99 -29.81 2.3 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.711 -0.757 . . . . 72.0 112.491 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 63.27 73.73 0.44 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.841 0.353 . . . . 72.540000000000006 111.07 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.41 -177.23 3.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 74.129999999999995 110.873 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.65 166.74 9.13 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.786 -0.721 . . . . 72.040000000000006 112.495 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.5 ptmt -55.71 -46.43 77.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.796 0.332 . . . . 70.239999999999995 110.93 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.23 -62.24 1.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 75.150000000000006 111.088 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.69 -56.57 18.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 71.349999999999994 111.108 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.14 -41.97 60.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 74.299999999999997 110.912 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.4 tt -63.98 -59.34 4.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 75.120000000000005 110.881 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -53.0 -38.77 62.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 74.510000000000005 110.865 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -51.1 -27.03 7.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 74.019999999999996 110.906 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.4 mt -82.87 -68.31 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 75.120000000000005 111.12 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -51.96 -47.86 64.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 50.100000000000001 110.866 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -57.81 -34.97 70.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.474 . . . . 73.310000000000002 110.837 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.36 -35.68 58.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 65.209999999999994 111.112 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.2 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 74.420000000000002 110.895 -179.931 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.7 p . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.82 0.343 . . . . 71.439999999999998 111.133 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.1 t -147.18 146.41 18.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 73.230000000000004 111.138 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.4 t -73.88 152.52 40.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.167 -0.47 . . . . 55.25 111.178 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.3 p -112.38 147.82 15.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 74.409999999999997 111.099 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.74 158.94 9.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 62.109999999999999 111.148 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.96 -50.48 16.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 74.099999999999994 110.861 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.8 t -58.96 -36.08 74.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 73.340000000000003 110.873 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.1 t -85.42 -18.25 34.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 72.439999999999998 111.133 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -50.41 -31.78 15.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 74.340000000000003 110.857 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.1 -33.59 70.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 63.520000000000003 110.876 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.1 m -91.18 -15.95 28.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.237 -0.438 . . . . 73.200000000000003 111.145 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -93.18 -70.86 0.68 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.233 -0.44 . . . . 65.030000000000001 110.861 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.6 t -71.14 -70.49 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 75.019999999999996 111.113 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.1 mt -40.54 -60.08 1.2 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.122 -0.49 . . . . 74.120000000000005 110.877 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -50.44 -59.39 4.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 73.510000000000005 110.848 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.8 t -51.78 149.06 5.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 74.319999999999993 110.84 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -111.66 35.31 3.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 70.030000000000001 110.885 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.19 160.41 50.07 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.544 0.688 . . . . 61.299999999999997 111.144 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 124.67 11.3 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.679 2.253 . . . . 71.200000000000003 112.339 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 95.0 t -103.57 122.37 56.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 63.119999999999997 111.137 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -93.72 100.08 12.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 72.439999999999998 110.87 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.1 p -99.63 145.27 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 51.509999999999998 111.135 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.51 118.57 19.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 74.400000000000006 110.808 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -103.08 97.49 7.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 73.409999999999997 110.916 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -148.32 -167.83 2.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.146 -0.479 . . . . 71.409999999999997 110.902 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.09 -166.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 60.409999999999997 111.097 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.432 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 18.0 t0 -78.51 12.46 1.99 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.434 . . . . 61.420000000000002 110.823 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.463 ' CD1' ' N ' ' A' ' 39' ' ' TRP . 1.6 m0 77.27 94.04 0.06 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.243 -0.435 . . . . 73.219999999999999 110.867 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 2.4 t -167.34 -54.18 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 74.319999999999993 110.872 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.01 -69.88 1.37 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.778 -0.725 . . . . 74.340000000000003 112.439 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -32.94 17.83 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.67 2.246 . . . . 74.5 112.355 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 45.5 t -52.02 -34.71 44.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 75.540000000000006 110.895 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -64.63 -34.63 78.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 75.140000000000001 110.883 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 42.1 mtt -84.11 -38.84 20.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.271 -0.422 . . . . 65.219999999999999 110.854 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.0 t -94.41 21.76 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.434 . . . . 74.209999999999994 111.108 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.471 ' N ' ' HD2' ' A' ' 48' ' ' PRO . . . -76.89 -60.83 0.77 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.634 0.731 . . . . 75.340000000000003 111.073 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 47' ' ' ALA . 53.7 Cg_endo -69.72 -49.58 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.697 2.265 . . . . 75.510000000000005 112.341 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.4 m -51.04 -30.23 9.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 75.340000000000003 111.132 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.4 mt -69.67 -38.2 76.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.123 -0.489 . . . . 75.230000000000004 110.934 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -71.93 -35.07 69.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 74.549999999999997 110.889 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -51.27 -66.42 0.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.495 . . . . 74.430000000000007 110.849 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.5 mp -51.23 -33.11 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 73.340000000000003 111.13 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 74.319999999999993 111.127 179.812 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.5 pp . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.947 0.403 . . . . 72.010000000000005 110.911 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.4 tptt -95.5 149.47 21.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.475 . . . . 74.209999999999994 110.914 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.4 t -126.93 106.96 16.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 75.349999999999994 111.165 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -118.13 126.61 52.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 74.239999999999995 111.088 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -110.4 159.29 17.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 74.340000000000003 110.93 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 11.1 tp -137.1 145.92 44.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.434 . . . . 71.409999999999997 110.891 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -97.6 119.62 36.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 71.540000000000006 110.846 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.8 m -61.5 -35.18 65.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 74.400000000000006 111.138 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.13 -35.28 47.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 74.409999999999997 110.843 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.47 -35.24 11.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 74.239999999999995 111.078 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -118.36 68.2 7.36 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.57 0.7 . . . . 71.030000000000001 110.868 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 -33.43 16.67 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.666 2.244 . . . . 64.299999999999997 112.38 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -68.28 -36.26 79.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 73.430000000000007 110.928 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.59 -47.45 79.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 74.510000000000005 111.09 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.31 -56.37 21.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 71.25 111.1 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -51.27 -34.19 31.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 74.239999999999995 110.854 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -58.05 -35.92 72.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 61.009999999999998 110.869 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -102.29 26.39 7.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 74.329999999999998 110.883 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 50.1 36.43 12.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 73.010000000000005 110.905 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 97.6 t -68.87 103.43 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 72.230000000000004 111.143 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 67.1 t -92.18 -35.04 6.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 75.400000000000006 111.174 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 t -105.61 151.76 23.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.481 . . . . 72.519999999999996 110.849 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.523 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.4 mt -60.58 -57.69 24.71 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.658 0.742 . . . . 73.239999999999995 111.139 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 54.1 Cg_endo -69.78 74.1 1.33 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.651 2.234 . . . . 73.540000000000006 112.347 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 84.0 m -108.99 137.99 46.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.223 -0.444 . . . . 73.319999999999993 111.178 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 10.2 ttm -135.17 145.91 48.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 74.519999999999996 110.878 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 28.6 mt -143.07 128.85 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 74.549999999999997 111.138 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -95.2 107.94 20.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 74.120000000000005 110.906 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -92.06 170.29 9.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 73.420000000000002 110.909 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -162.49 106.24 1.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.479 . . . . 74.040000000000006 110.872 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.68 34.28 56.86 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.782 -0.723 . . . . 74.120000000000005 112.489 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.08 40.22 51.46 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.778 -0.725 . . . . 73.430000000000007 112.489 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 86.0 m -160.91 133.8 4.59 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.539 0.685 . . . . 64.200000000000003 111.149 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 84.77 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.698 2.265 . . . . 72.299999999999997 112.329 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.5 m -72.37 -35.11 50.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 75.230000000000004 111.117 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -136.32 170.05 16.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 75.219999999999999 110.937 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 20.2 ttt-85 -155.97 128.55 7.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 73.219999999999999 110.9 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.5 mp -138.05 111.67 7.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.462 . . . . 71.209999999999994 111.141 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 48.9 t -109.62 133.07 56.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 71.0 111.165 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 136.57 137.4 3.65 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.754 -0.736 . . . . 73.519999999999996 112.479 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.47 83.15 4.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.87 0.367 . . . . 74.129999999999995 111.054 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.03 174.07 6.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 65.349999999999994 110.931 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.87 171.89 5.68 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.719 -0.753 . . . . 74.409999999999997 112.463 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.66 -44.88 90.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.81 0.338 . . . . 73.120000000000005 110.923 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.64 -64.14 0.95 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 64.150000000000006 111.143 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.81 -58.34 7.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 71.349999999999994 111.142 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.67 -40.94 54.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 72.340000000000003 110.924 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.7 tp -64.7 -54.17 35.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 74.299999999999997 110.921 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -51.45 -43.06 61.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 61.549999999999997 110.86 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -51.12 -27.24 7.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 74.430000000000007 110.881 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.3 mt -83.08 -68.99 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 71.120000000000005 111.143 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -50.9 -48.78 60.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 73.239999999999995 110.884 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -52.79 -32.48 44.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.479 . . . . 74.049999999999997 110.9 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.59 -33.77 71.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 71.120000000000005 111.108 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 71.230000000000004 110.929 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 44.5 p . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.827 0.346 . . . . 72.400000000000006 111.165 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.7 t -145.95 146.15 19.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 72.239999999999995 111.123 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.0 m -75.75 125.82 29.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 73.129999999999995 111.159 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.5 t -89.93 127.11 42.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 74.540000000000006 111.156 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.13 177.22 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 75.209999999999994 111.151 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.1 -35.06 37.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.232 -0.44 . . . . 73.239999999999995 110.882 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.8 t -84.62 -51.73 6.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 64.310000000000002 110.85 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.2 t -58.43 -19.55 37.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 72.230000000000004 111.167 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -51.25 -30.27 17.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 73.019999999999996 110.872 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.47 -34.1 67.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 71.439999999999998 110.898 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.8 m -91.26 -15.99 28.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 72.219999999999999 111.145 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -93.55 -71.53 0.65 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 61.020000000000003 110.851 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.2 t -70.15 -70.65 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 74.310000000000002 111.156 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.9 mt -40.6 -60.3 1.16 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.113 -0.494 . . . . 73.329999999999998 110.936 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -50.27 -52.8 33.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 61.210000000000001 110.866 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.9 t -57.21 155.06 9.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 75.120000000000005 110.822 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -104.36 -44.27 4.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.483 . . . . 72.25 110.827 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -51.54 160.0 1.11 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.583 0.706 . . . . 75.109999999999999 111.114 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 126.83 13.72 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.63 2.22 . . . . 74.109999999999999 112.336 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 80.1 t -97.69 127.52 49.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 71.310000000000002 111.159 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.3 mp -103.22 100.11 10.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 71.209999999999994 110.924 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.6 p -102.82 138.46 27.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 74.439999999999998 111.092 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.96 118.43 22.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 73.019999999999996 110.906 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -96.16 90.38 5.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 74.519999999999996 110.893 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -135.6 -167.94 2.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.152 -0.476 . . . . 74.409999999999997 110.969 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.18 -166.34 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.432 . . . . 75.409999999999997 111.092 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.446 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 9.3 p-10 -78.2 12.45 1.87 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 63.219999999999999 110.863 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.462 ' N ' ' CD1' ' A' ' 39' ' ' TRP . 1.3 m0 76.98 92.95 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 74.219999999999999 110.912 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 36.4 t -170.72 -58.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.441 . . . . 74.099999999999994 110.879 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.8 -71.02 1.25 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.778 -0.725 . . . . 65.430000000000007 112.484 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 -32.2 18.79 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.694 2.263 . . . . 72.219999999999999 112.331 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 36.3 t -60.23 -32.37 71.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 74.329999999999998 110.867 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -30.21 71.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 72.019999999999996 110.938 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 7.3 mmm -88.44 -39.91 13.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 64.430000000000007 110.858 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.1 t -94.25 22.34 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 62.009999999999998 111.096 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.455 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . . . -76.04 -61.04 0.9 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.596 0.712 . . . . 74.129999999999995 111.113 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' A' ' 47' ' ' ALA . 53.6 Cg_endo -69.78 -50.1 0.49 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.739 2.293 . . . . 72.219999999999999 112.349 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.4 m -52.86 -31.02 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 74.099999999999994 111.172 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.7 tp -70.33 -41.22 73.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 74.109999999999999 110.914 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -69.81 -34.61 73.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 72.439999999999998 110.906 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -56.39 -63.17 1.28 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 70.200000000000003 110.886 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.8 mt -53.04 -45.09 52.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 73.150000000000006 111.106 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 75.450000000000003 111.113 179.776 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.6 pp . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.817 0.341 . . . . 75.329999999999998 110.963 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -79.78 119.11 22.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.192 -0.458 . . . . 74.219999999999999 110.856 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.6 t -118.93 100.89 10.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 71.519999999999996 111.132 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -126.22 132.16 51.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 62.420000000000002 111.105 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -129.36 160.02 34.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 72.230000000000004 110.855 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 18.9 tp -136.16 148.91 48.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 75.420000000000002 110.944 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.78 112.36 24.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.176 -0.465 . . . . 71.120000000000005 110.849 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.4 m -59.5 -35.6 59.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 74.230000000000004 111.144 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.55 -36.46 61.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 74.439999999999998 110.868 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.47 -35.22 13.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 72.299999999999997 111.091 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -117.27 68.79 5.23 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.62 0.724 . . . . 74.030000000000001 110.884 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 -32.65 18.39 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.725 2.283 . . . . 64.040000000000006 112.384 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -65.23 -36.28 83.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 74.230000000000004 110.891 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.17 -44.81 96.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 75.439999999999998 111.138 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.57 -61.55 2.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 73.439999999999998 111.087 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.5 ttp180 -50.97 -34.79 30.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 73.510000000000005 110.9 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -51.89 -35.92 46.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.486 . . . . 72.400000000000006 110.859 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -108.87 27.89 9.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.449 . . . . 73.129999999999995 110.882 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 50.59 55.76 9.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.495 . . . . 63.130000000000003 110.906 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 91.0 t -92.24 104.97 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 64.450000000000003 111.115 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 57.4 t -96.44 -35.06 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 74.230000000000004 111.124 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.8 m -102.84 146.64 27.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 73.140000000000001 110.89 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.515 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 5.1 mt -58.19 -57.57 25.1 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.621 0.724 . . . . 71.109999999999999 111.144 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.5 Cg_endo -69.78 76.39 1.15 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.65 2.233 . . . . 74.25 112.33 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 73.6 m -113.99 134.95 54.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 72.329999999999998 111.112 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 14.2 ttt -133.85 126.42 30.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 74.209999999999994 110.883 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.0 mt -116.97 115.19 48.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 72.239999999999995 111.152 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.11 106.31 13.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 75.530000000000001 110.92 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -93.34 170.05 9.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 73.310000000000002 110.932 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -165.74 91.43 0.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 75.340000000000003 110.878 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.82 36.91 8.19 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.715 -0.755 . . . . 63.009999999999998 112.497 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.64 39.3 86.52 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.773 -0.727 . . . . 72.540000000000006 112.488 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 88.6 m -160.53 133.99 4.86 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.58 0.705 . . . . 74.519999999999996 111.156 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 109.56 2.35 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.661 2.241 . . . . 72.450000000000003 112.374 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.3 m -101.6 -32.99 3.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.46 . . . . 70.439999999999998 111.138 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.73 164.63 26.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.483 . . . . 73.219999999999999 110.906 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.84 117.51 3.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 74.340000000000003 110.852 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.7 mp -132.56 130.91 59.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 74.439999999999998 111.126 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.1 m -138.16 145.39 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 74.549999999999997 111.129 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 146.39 -26.88 1.69 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.745 -0.74 . . . . 73.040000000000006 112.522 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 62.7 68.35 0.65 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.843 0.354 . . . . 74.549999999999997 111.09 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.2 169.1 9.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 74.409999999999997 110.897 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.77 150.16 39.48 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.744 -0.741 . . . . 65.340000000000003 112.47 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.39 -34.99 11.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.809 0.338 . . . . 73.310000000000002 110.88 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.16 -40.39 77.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 55.039999999999999 111.078 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.76 -49.8 6.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 63.5 111.131 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.7 -52.94 16.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 70.299999999999997 110.961 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.6 pp -48.12 -35.58 11.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.468 . . . . 71.450000000000003 110.911 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 46.1 mtp85 -74.25 -42.24 59.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 75.5 110.865 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -51.48 -25.0 5.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 62.43 110.926 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.4 mt -87.68 -69.29 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 71.219999999999999 111.167 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -51.11 -49.39 60.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 74.129999999999995 110.873 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -58.91 -34.13 71.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 63.32 110.84 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.09 -35.64 61.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 71.030000000000001 111.116 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.4 mt . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 64.409999999999997 110.971 179.954 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.4 p . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.863 0.363 . . . . 73.439999999999998 111.121 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 98.6 t -150.16 143.68 17.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.225 -0.443 . . . . 75.409999999999997 111.093 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.8 t -67.71 126.98 31.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 75.430000000000007 111.131 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 74.7 t -94.82 130.44 43.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 72.400000000000006 111.13 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.72 160.52 7.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 61.229999999999997 111.161 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -73.62 -41.52 62.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.255 -0.43 . . . . 74.040000000000006 110.846 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.6 m -70.39 -34.53 72.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 75.140000000000001 110.885 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.3 t -85.19 -17.97 35.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 74.299999999999997 111.108 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -50.64 -31.23 15.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 75.430000000000007 110.859 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.414 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -71.74 -33.48 68.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.149 -0.478 . . . . 72.150000000000006 110.885 179.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.6 m -91.7 -16.23 27.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 73.129999999999995 111.182 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -93.36 -71.42 0.65 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 63.119999999999997 110.888 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.9 t -70.39 -70.3 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 71.450000000000003 111.165 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.414 ' HB2' ' HA ' ' A' ' 21' ' ' LYS . 7.6 mt -40.7 -60.21 1.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 75.530000000000001 110.886 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -50.36 -58.73 5.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 74.230000000000004 110.876 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.3 t -54.02 171.33 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 74.5 110.876 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -117.73 -40.96 2.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 74.140000000000001 110.836 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -53.05 159.47 1.91 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.59 0.71 . . . . 71.519999999999996 111.128 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 131.08 20.57 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.715 2.276 . . . . 63.240000000000002 112.369 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 96.7 t -105.02 125.26 60.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 65.310000000000002 111.11 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.7 mt -102.23 100.65 10.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 72.430000000000007 110.887 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.3 p -98.55 133.57 40.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 72.439999999999998 111.172 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -115.49 99.55 7.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.225 -0.443 . . . . 75.019999999999996 110.839 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -90.47 89.39 7.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 73.549999999999997 110.887 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -145.87 -169.05 3.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.143 -0.48 . . . . 75.010000000000005 110.917 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.37 -156.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 73.319999999999993 111.099 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.476 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 5.3 m-20 -77.61 9.54 3.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.202 -0.453 . . . . 70.400000000000006 110.862 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.476 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 1.0 OUTLIER 41.87 71.08 0.23 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 74.409999999999997 110.935 -179.933 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 44.5 t -132.63 -45.51 0.89 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 73.420000000000002 110.915 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.75 -67.39 1.52 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.722 -0.751 . . . . 62.219999999999999 112.503 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -24.11 30.08 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.713 2.275 . . . . 72.409999999999997 112.326 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 11.9 p -51.92 -27.13 12.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 74.200000000000003 110.877 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? -61.52 -33.72 74.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 64.200000000000003 110.882 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 6.2 mtp -86.48 -36.52 18.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 73.329999999999998 110.889 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.9 t -94.04 21.2 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 74.329999999999998 111.126 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.472 ' N ' ' HD2' ' A' ' 48' ' ' PRO . . . -76.79 -60.8 0.79 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.596 0.712 . . . . 74.239999999999995 111.051 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 47' ' ' ALA . 53.6 Cg_endo -69.73 -49.13 0.59 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.672 2.248 . . . . 75.230000000000004 112.335 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 m -51.44 -29.18 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 63.229999999999997 111.155 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.4 tp -84.1 -36.02 23.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 63.039999999999999 110.898 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -71.68 -31.98 67.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 74.439999999999998 110.911 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -49.87 -68.2 0.2 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 74.099999999999994 110.895 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.0 mp -51.45 -36.66 17.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.178 -0.465 . . . . 62.310000000000002 111.12 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 75.329999999999998 111.103 179.811 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.5 pp . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.855 0.359 . . . . 74.340000000000003 110.916 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.1 mtmp? -102.0 139.97 36.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.228 -0.442 . . . . 74.049999999999997 110.877 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.7 t -120.55 104.33 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 74.349999999999994 111.141 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -104.5 121.47 43.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 72.140000000000001 111.122 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.87 131.42 54.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 65.140000000000001 110.896 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 44.0 tp -123.83 155.47 37.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.227 -0.442 . . . . 74.329999999999998 110.952 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.45 114.85 27.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 74.450000000000003 110.856 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 79.5 t -61.38 -35.27 65.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 73.030000000000001 111.126 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -51.86 -36.88 49.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 74.349999999999994 110.887 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.93 -34.46 13.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 65.25 111.072 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -117.42 69.61 5.91 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.629 0.728 . . . . 72.150000000000006 110.892 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -32.31 18.81 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.744 2.296 . . . . 73.120000000000005 112.335 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -58.72 -37.58 76.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.438 . . . . 74.129999999999995 110.881 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.97 -47.88 67.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 75.25 111.065 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.02 -63.47 1.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 75.349999999999994 111.047 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.5 ttp85 -51.56 -33.18 31.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 72.409999999999997 110.868 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -50.99 -39.98 56.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 65.310000000000002 110.873 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -104.39 24.15 12.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 72.329999999999998 110.905 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 47.85 66.55 1.01 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 61.549999999999997 110.911 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 95.9 t -87.58 106.8 16.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 75.430000000000007 111.136 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.6 t -80.26 -58.39 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 72.409999999999997 111.139 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.3 m -91.65 163.28 14.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.468 . . . . 72.439999999999998 110.835 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.516 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 1.7 mp -65.3 -58.17 12.97 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.639 0.733 . . . . 65.310000000000002 111.133 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.7 Cg_endo -69.75 74.86 1.25 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.658 2.238 . . . . 72.420000000000002 112.374 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 99.7 m -113.87 106.0 13.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 74.230000000000004 111.119 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 9.4 ttp -116.16 121.84 43.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 75.510000000000005 110.865 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.0 mp -104.69 119.04 53.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 75.030000000000001 111.102 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.17 104.56 10.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 72.519999999999996 110.857 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -89.77 169.86 10.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 75.340000000000003 110.9 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -167.71 93.67 0.4 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 75.319999999999993 110.908 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.42 38.77 8.73 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.758 -0.734 . . . . 62.399999999999999 112.5 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.37 37.21 79.49 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.783 -0.722 . . . . 74.019999999999996 112.46 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 85.0 m -160.72 133.78 4.67 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.554 0.692 . . . . 74.540000000000006 111.138 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 83.01 0.71 Allowed 'Trans proline' 0 C--N 1.34 0.126 0 C-N-CA 122.703 2.269 . . . . 64.219999999999999 112.292 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.8 m -64.98 -33.88 66.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 73.329999999999998 111.133 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.66 170.22 16.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 73.230000000000004 110.91 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -153.35 127.44 9.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 74.129999999999995 110.881 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.3 mp -131.0 143.19 41.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.193 -0.458 . . . . 73.319999999999993 111.144 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -142.13 141.05 29.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 72.140000000000001 111.164 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 119.08 145.59 7.7 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.767 -0.73 . . . . 44.539999999999999 112.549 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -100.89 89.1 3.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.893 0.378 . . . . 72.209999999999994 111.109 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.55 179.87 4.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 74.340000000000003 110.866 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.8 175.26 13.07 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.735 -0.745 . . . . 73.120000000000005 112.525 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -58.18 -47.78 82.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.768 0.318 . . . . 73.049999999999997 110.894 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -53.48 -65.83 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.449 . . . . 72.439999999999998 111.093 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.97 -57.66 8.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 63.109999999999999 111.116 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.82 -34.97 29.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 73.439999999999998 110.938 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.1 tt -69.42 -60.34 2.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 72.519999999999996 110.927 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 45.1 mtp85 -54.47 -34.35 61.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 73.209999999999994 110.87 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -49.35 -26.74 3.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 64.450000000000003 110.868 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.3 mt -84.12 -69.73 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 73.150000000000006 111.121 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -52.75 -50.06 64.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 74.120000000000005 110.895 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -55.92 -34.61 65.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.116 -0.493 . . . . 71.25 110.884 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.1 -36.82 69.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 74.109999999999999 111.096 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 74.299999999999997 110.92 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.3 p . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.84 0.352 . . . . 62.450000000000003 111.152 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 65.5 t -148.63 142.19 18.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 72.219999999999999 111.13 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.3 t -77.04 128.7 34.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 71.310000000000002 111.14 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.6 t -91.36 126.59 44.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 75.140000000000001 111.109 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.65 165.99 2.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 71.209999999999994 111.182 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -68.37 -48.04 65.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 74.430000000000007 110.868 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.0 t -69.1 -52.93 23.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 65.25 110.87 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.4 t -59.36 -19.01 43.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 73.209999999999994 111.143 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -51.03 -30.74 16.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 72.420000000000002 110.84 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.402 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -72.07 -34.13 68.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 73.439999999999998 110.91 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.0 m -91.19 -16.0 28.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 72.340000000000003 111.178 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.39 -71.33 0.66 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 65.439999999999998 110.875 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.6 t -70.4 -70.47 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 72.129999999999995 111.149 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.402 ' HB2' ' HA ' ' A' ' 21' ' ' LYS . 7.4 mt -40.64 -60.49 1.13 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 61.229999999999997 110.869 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -50.32 -63.71 1.03 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 65.439999999999998 110.889 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.3 t -56.11 150.87 13.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 71.239999999999995 110.848 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -98.88 -36.45 9.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 75.040000000000006 110.814 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -52.67 159.84 1.6 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.567 0.699 . . . . 75.230000000000004 111.152 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.84 127.43 14.53 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.629 2.219 . . . . 74.310000000000002 112.355 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 99.4 t -102.18 124.4 56.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 75.319999999999993 111.157 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -91.41 123.44 34.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 64.439999999999998 110.908 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.9 t -118.6 139.54 45.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.206 -0.452 . . . . 73.329999999999998 111.132 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -131.4 99.83 4.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 74.299999999999997 110.893 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -91.05 89.54 7.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.462 . . . . 74.340000000000003 110.867 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -148.98 -169.27 3.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 73.019999999999996 110.923 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.08 -155.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.436 . . . . 64.200000000000003 111.103 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.473 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 18.7 p-10 -77.93 8.64 4.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 63.020000000000003 110.896 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.473 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 1.6 p-90 41.55 65.77 0.79 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.187 -0.46 . . . . 70.209999999999994 110.899 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 35.8 t -122.58 -46.38 2.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.233 -0.439 . . . . 72.200000000000003 110.875 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.7 -67.62 1.53 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.751 -0.738 . . . . 74.120000000000005 112.458 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -25.57 28.28 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.675 2.25 . . . . 74.230000000000004 112.359 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 28.9 t -51.49 -31.76 24.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 75.209999999999994 110.885 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.59 -33.5 71.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 74.329999999999998 110.895 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 7.0 mtt -88.13 -35.71 17.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 75.340000000000003 110.891 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.1 t -93.51 21.18 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 74.409999999999997 111.148 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.461 ' N ' ' HD2' ' A' ' 48' ' ' PRO . . . -80.14 -61.41 0.44 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.531 0.681 . . . . 74.530000000000001 111.062 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 47' ' ' ALA . 54.3 Cg_endo -69.69 -45.55 1.59 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.665 2.243 . . . . 75.299999999999997 112.375 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.4 m -49.37 -31.34 5.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 73.439999999999998 111.13 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.7 tt -88.25 -44.83 10.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 74.310000000000002 110.939 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -58.3 -33.8 69.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 73.439999999999998 110.911 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -63.17 -32.28 73.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.169 -0.469 . . . . 73.040000000000006 110.92 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.3 mm -64.92 -34.53 71.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 75.340000000000003 111.103 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 72.010000000000005 111.09 179.851 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.6 pp . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.901 0.382 . . . . 73.409999999999997 110.891 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.1 tptm -102.17 147.21 26.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 74.430000000000007 110.89 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.0 t -125.4 106.93 17.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 71.120000000000005 111.111 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -121.53 136.77 54.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 72.329999999999998 111.136 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -123.87 146.43 48.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 75.129999999999995 110.872 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 16.1 tp -127.03 152.09 47.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 75.420000000000002 110.918 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.29 121.23 42.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 70.310000000000002 110.885 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 33.1 m -62.24 -33.04 56.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 51.530000000000001 111.135 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -50.42 -35.77 30.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 70.540000000000006 110.926 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.26 -34.11 10.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 71.099999999999994 111.088 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.32 68.07 19.14 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.594 0.711 . . . . 73.129999999999995 110.857 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -33.88 15.69 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.677 2.251 . . . . 65.439999999999998 112.334 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -58.41 -43.57 88.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 63.350000000000001 110.904 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.0 -48.6 70.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 72.340000000000003 111.111 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.7 -68.17 0.19 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 65.230000000000004 111.092 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -50.97 -32.87 22.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 73.349999999999994 110.909 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -51.41 -34.54 35.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 74.430000000000007 110.847 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -112.03 26.08 10.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 73.439999999999998 110.865 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 69.9 mm-40 48.48 85.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 74.310000000000002 110.934 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 95.1 t -105.96 111.43 35.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 75.5 111.117 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 22.1 t -81.9 -59.86 2.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 73.420000000000002 111.145 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 m -91.34 156.25 17.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 74.200000000000003 110.834 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.521 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 4.7 mt -60.15 -58.01 22.51 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.606 0.717 . . . . 73.329999999999998 111.112 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.7 Cg_endo -69.75 69.77 1.61 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.689 2.259 . . . . 72.310000000000002 112.297 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 43.7 m -103.98 132.53 50.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 72.200000000000003 111.187 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 17.5 ttp -130.82 143.83 51.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 74.340000000000003 110.861 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 63.1 mt -128.98 117.99 45.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 75.030000000000001 111.138 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.9 tt -88.24 105.72 17.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.454 . . . . 75.25 110.943 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -90.02 170.14 10.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 74.140000000000001 110.868 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -165.53 92.29 0.54 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 73.230000000000004 110.862 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.15 41.36 7.09 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.731 -0.747 . . . . 54.109999999999999 112.487 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.89 35.96 85.72 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.709 -0.758 . . . . 42.140000000000001 112.506 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 86.2 m -161.0 133.86 4.57 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.633 0.73 . . . . 74.409999999999997 111.125 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 87.83 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.689 2.26 . . . . 74.329999999999998 112.336 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.8 m -70.49 -35.61 62.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 72.420000000000002 111.108 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.7 170.19 16.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 75.099999999999994 110.875 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -155.91 122.76 5.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 74.329999999999998 110.877 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.6 mp -124.93 132.64 71.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 74.439999999999998 111.146 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 98.0 t -131.74 136.6 56.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 70.329999999999998 111.137 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 127.13 138.66 4.79 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 74.340000000000003 112.476 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.21 84.88 4.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.88 0.371 . . . . 75.329999999999998 111.103 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.06 -179.62 3.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 74.329999999999998 110.895 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.49 -169.74 1.42 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.761 -0.733 . . . . 71.5 112.478 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -79.96 -41.74 25.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.776 0.322 . . . . 75.530000000000001 110.884 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.74 -31.95 72.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 71.230000000000004 111.103 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.412 ' HA ' ' HG2' ' A' ' 109' ' ' ARG . . . -84.07 -60.22 2.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 62.229999999999997 111.093 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.67 -34.59 27.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 73.239999999999995 110.913 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.8 tt -70.52 -60.51 2.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 70.109999999999999 110.947 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.412 ' HG2' ' HA ' ' A' ' 106' ' ' ALA . 12.6 ptp180 -54.9 -33.01 61.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 74.420000000000002 110.842 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -54.07 -24.54 17.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 73.310000000000002 110.859 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.6 mt -85.97 -68.19 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 73.439999999999998 111.138 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -51.75 -49.07 63.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 73.329999999999998 110.902 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -56.18 -34.84 66.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 74.439999999999998 110.817 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.57 -34.74 65.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 75.219999999999999 111.086 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.5 mt . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.218 -0.447 . . . . 65.340000000000003 110.861 -179.926 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.3 p . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.801 0.334 . . . . 65.530000000000001 111.165 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.3 t -146.24 148.26 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 72.219999999999999 111.115 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 t -73.05 127.51 32.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 73.239999999999995 111.124 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 90.7 t -91.84 143.79 10.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 73.420000000000002 111.124 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.64 171.73 0.82 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 64.430000000000007 111.065 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -80.79 -48.32 12.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 61.439999999999998 110.879 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.0 t -67.9 -53.98 22.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 72.099999999999994 110.886 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.0 t -58.83 -19.51 42.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.099 -0.501 . . . . 63.310000000000002 111.146 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -51.41 -30.85 20.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 73.230000000000004 110.868 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.415 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -71.88 -33.61 68.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.175 -0.466 . . . . 73.420000000000002 110.907 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.9 m -91.6 -16.17 27.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.169 -0.469 . . . . 75.349999999999994 111.12 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.9 -71.39 0.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 74.120000000000005 110.834 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.1 t -70.9 -70.11 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 73.109999999999999 111.152 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.415 ' HB2' ' HA ' ' A' ' 21' ' ' LYS . 6.9 mt -40.44 -60.02 1.2 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 74.200000000000003 110.915 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -51.24 -65.19 0.6 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.227 -0.442 . . . . 73.019999999999996 110.887 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 56.7 m -54.52 153.72 5.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 71.510000000000005 110.851 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -97.02 -34.92 11.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.489 . . . . 55.5 110.874 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.2 t -50.15 141.47 15.37 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.56 0.695 . . . . 75.25 111.15 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 125.86 12.67 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.685 2.257 . . . . 74.140000000000001 112.369 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.2 t -97.93 128.39 49.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 71.140000000000001 111.155 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.5 mp -102.4 108.11 19.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 72.329999999999998 110.905 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.4 p -97.13 145.44 9.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 74.140000000000001 111.121 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.57 112.19 13.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 64.349999999999994 110.838 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -97.6 97.8 9.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 74.319999999999993 110.872 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -150.78 -168.07 3.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 75.109999999999999 110.888 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.8 -164.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 74.140000000000001 111.106 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.444 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 1.8 m-20 -77.92 12.45 1.76 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.259 -0.428 . . . . 75.299999999999997 110.883 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.46 ' CD1' ' N ' ' A' ' 39' ' ' TRP . 1.6 m0 77.66 94.51 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.475 . . . . 74.319999999999993 110.928 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -167.94 -63.74 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 74.549999999999997 110.87 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.38 -70.51 1.33 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.748 -0.739 . . . . 63.140000000000001 112.522 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -8.07 22.67 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.661 2.241 . . . . 75.109999999999999 112.349 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 31.4 t -90.34 -26.84 19.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 74.030000000000001 110.914 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -60.54 -30.59 69.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 74.030000000000001 110.888 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 9.6 ptp -88.05 -39.93 14.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 74.310000000000002 110.908 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.5 t -93.81 23.12 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 64.099999999999994 111.111 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.461 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . . . -79.79 -61.38 0.46 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.576 0.703 . . . . 74.319999999999993 111.064 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.461 ' CD ' ' CB ' ' A' ' 47' ' ' ALA . 54.4 Cg_endo -69.69 -48.03 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.673 2.249 . . . . 63.229999999999997 112.366 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.6 m -49.78 -31.15 6.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 74.129999999999995 111.128 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.49 -40.27 80.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 74.340000000000003 110.906 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -64.33 -36.62 84.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.443 . . . . 71.430000000000007 110.927 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -59.9 -68.06 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 73.219999999999999 110.915 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.2 mt -50.44 -39.84 17.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 73.5 111.176 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 54.530000000000001 111.071 179.819 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.849 0.357 . . . . 73.450000000000003 110.921 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -99.97 141.74 32.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 74.109999999999999 110.868 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 37.7 t -146.43 131.54 11.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.257 -0.429 . . . . 62.32 111.144 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -152.91 138.05 17.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 75.129999999999995 111.146 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.3 mttp -114.08 159.93 19.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 71.239999999999995 110.903 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.85 141.03 44.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 73.5 110.918 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -93.95 113.46 25.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.472 . . . . 70.239999999999995 110.839 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.9 m -60.18 -35.12 59.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 75.299999999999997 111.149 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -53.97 -35.23 61.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 74.129999999999995 110.896 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.11 -35.55 10.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 73.400000000000006 111.095 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -117.94 68.33 6.52 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.607 0.718 . . . . 73.200000000000003 110.85 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -32.16 19.0 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.687 2.258 . . . . 73.349999999999994 112.309 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -65.99 -43.34 88.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.274 -0.421 . . . . 72.239999999999995 110.878 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.35 -54.57 25.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 54.399999999999999 111.086 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.88 -60.19 3.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 62.130000000000003 111.136 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -51.63 -34.56 38.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 75.310000000000002 110.897 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -55.44 -36.16 66.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 70.140000000000001 110.851 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -99.35 20.84 12.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 74.540000000000006 110.87 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 48.6 mm-40 48.78 80.51 0.06 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 72.329999999999998 110.931 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.7 p -105.44 144.02 15.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 74.219999999999999 111.118 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 66.1 t -108.82 -72.25 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 75.129999999999995 111.137 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.4 t -79.71 157.86 27.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 71.400000000000006 110.853 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.524 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 4.6 mt -59.91 -58.0 22.64 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.635 0.731 . . . . 71.140000000000001 111.099 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.4 Cg_endo -69.74 71.75 1.49 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.648 2.232 . . . . 74.239999999999995 112.374 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.5 m -110.44 126.62 54.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 65.150000000000006 111.125 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.0 mtm -122.56 158.18 30.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 74.209999999999994 110.838 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 34.0 mt -145.27 121.23 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 74.439999999999998 111.16 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.95 110.25 17.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 72.239999999999995 110.898 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -98.46 170.2 9.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 73.510000000000005 110.884 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -166.04 107.58 0.73 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 74.510000000000005 110.875 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.37 35.76 82.84 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.738 -0.744 . . . . 71.099999999999994 112.511 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.55 41.46 51.2 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.758 -0.734 . . . . 65.239999999999995 112.491 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 86.4 m -161.04 133.85 4.54 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.549 0.69 . . . . 74.230000000000004 111.182 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 103.05 1.1 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.722 2.281 . . . . 74.430000000000007 112.313 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.5 m -91.07 -32.58 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 72.409999999999997 111.147 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.6 mmtm -138.38 170.13 16.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 73.420000000000002 110.949 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.19 118.19 4.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 74.25 110.878 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.8 mp -125.5 137.63 57.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 73.299999999999997 111.119 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 66.8 t -147.81 136.15 15.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.472 . . . . 63.310000000000002 111.124 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 151.08 -27.58 1.0 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.734 -0.746 . . . . 72.340000000000003 112.475 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 63.46 72.68 0.47 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.849 0.357 . . . . 75.140000000000001 111.117 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.88 174.82 6.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 73.299999999999997 110.857 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.66 173.63 4.45 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.729 -0.748 . . . . 54.43 112.483 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.52 -44.13 75.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.791 0.329 . . . . 72.430000000000007 110.898 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.55 -30.2 65.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 74.150000000000006 111.107 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.34 -59.55 2.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.268 -0.424 . . . . 70.209999999999994 111.116 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.71 -44.16 37.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 74.150000000000006 110.891 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.8 tt -50.27 -43.63 53.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 74.230000000000004 110.91 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -72.46 -37.55 68.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 72.430000000000007 110.91 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -49.85 -25.87 3.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 75.209999999999994 110.873 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.8 mt -86.18 -69.61 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 75.430000000000007 111.102 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.5 -51.18 60.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 71.129999999999995 110.892 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -55.63 -33.87 64.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.157 -0.474 . . . . 61.049999999999997 110.815 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.9 -34.71 69.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 73.150000000000006 111.105 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 71.319999999999993 110.925 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.5 p . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.791 0.329 . . . . 74.109999999999999 111.141 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 96.1 t -150.08 144.18 17.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.428 . . . . 70.439999999999998 111.118 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 t -84.1 127.53 33.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.459 . . . . 64.430000000000007 111.097 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.6 t -94.88 126.0 47.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 74.319999999999993 111.109 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.5 166.44 2.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 73.510000000000005 111.13 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -68.52 -48.33 64.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 71.420000000000002 110.844 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.1 m -68.48 -52.98 26.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 73.329999999999998 110.879 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.8 t -59.66 -19.0 46.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.092 -0.504 . . . . 73.209999999999994 111.162 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -51.31 -30.8 19.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 75.150000000000006 110.878 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.447 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -72.69 -32.94 66.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 75.5 110.871 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.0 m -91.33 -17.1 26.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 74.109999999999999 111.098 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -93.63 -71.38 0.66 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 71.219999999999999 110.871 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.0 t -70.08 -70.78 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 63.340000000000003 111.136 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.447 ' HB2' ' HA ' ' A' ' 21' ' ' LYS . 10.6 mt -40.56 -59.8 1.27 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 73.109999999999999 110.933 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -50.86 -64.85 0.68 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 71.409999999999997 110.85 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.0 t -52.12 163.27 0.39 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 75.510000000000005 110.877 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -106.02 -40.85 5.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 73.400000000000006 110.838 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -51.79 159.69 1.28 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.581 0.705 . . . . 72.420000000000002 111.155 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 147.66 63.4 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.683 2.255 . . . . 75.129999999999995 112.372 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 97.0 t -123.14 115.5 45.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 62.299999999999997 111.149 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.5 mt -103.94 106.29 16.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 72.140000000000001 110.911 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 m -108.48 134.71 49.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 73.340000000000003 111.128 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -100.22 99.12 9.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 75.030000000000001 110.85 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -82.86 89.56 6.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 74.450000000000003 110.881 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -152.52 -169.19 3.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 74.310000000000002 110.915 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.44 -154.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 73.030000000000001 111.097 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.477 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 35.2 p-10 -77.44 8.94 3.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.434 . . . . 63.539999999999999 110.862 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.477 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 1.1 p-90 41.55 63.53 1.25 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 72.299999999999997 110.893 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 41.2 t -125.04 -45.89 1.84 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 63.200000000000003 110.891 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.59 -68.24 1.49 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.751 -0.738 . . . . 63.130000000000003 112.443 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -26.48 27.65 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.663 2.242 . . . . 75.5 112.317 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 34.8 t -50.49 -30.14 12.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 65.120000000000005 110.905 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.29 -30.3 17.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.148 -0.478 . . . . 73.510000000000005 110.861 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 16.4 mtt -88.75 -36.72 15.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 55.439999999999998 110.893 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.3 t -92.74 21.3 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 74.310000000000002 111.153 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.482 ' N ' ' HD2' ' A' ' 48' ' ' PRO . . . -68.95 -59.83 4.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.562 0.696 . . . . 71.319999999999993 111.113 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 47' ' ' ALA . 53.5 Cg_endo -69.75 -45.56 1.55 Allowed 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.705 2.27 . . . . 73.439999999999998 112.353 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.3 t -55.37 -50.63 63.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 73.310000000000002 111.113 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 50.5 tp -52.94 -32.03 43.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.195 -0.457 . . . . 74.439999999999998 110.921 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -83.89 -35.27 24.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 61.409999999999997 110.893 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -51.91 -61.41 2.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 72.099999999999994 110.939 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 mp -50.74 -32.83 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.478 . . . . 74.310000000000002 111.15 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.479 . . . . 72.540000000000006 111.048 179.888 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.3 pt? . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.853 0.359 . . . . 74.329999999999998 110.916 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.5 mttp -109.64 120.21 41.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 73.040000000000006 110.929 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.8 t -123.71 112.19 32.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 71.230000000000004 111.105 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -131.04 156.07 45.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 64.040000000000006 111.13 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.7 122.51 16.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 72.040000000000006 110.877 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 11.1 tp -103.28 155.46 18.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.246 -0.434 . . . . 72.120000000000005 110.897 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -112.54 103.14 11.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 72.129999999999995 110.874 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.7 m -51.11 -32.14 11.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 70.209999999999994 111.149 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.77 -35.58 23.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 75.329999999999998 110.862 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.17 -33.31 8.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.448 . . . . 74.439999999999998 111.097 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.91 71.75 21.26 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.6 0.714 . . . . 64.439999999999998 110.869 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -32.04 19.39 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.664 2.243 . . . . 73.409999999999997 112.341 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -51.71 -34.52 39.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 73.120000000000005 110.893 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.77 -46.47 68.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.479 . . . . 65.129999999999995 111.094 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.31 -65.93 0.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.437 . . . . 74.439999999999998 111.069 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -51.04 -32.72 22.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 71.319999999999993 110.886 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.62 -42.14 61.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 75.450000000000003 110.896 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -98.53 20.75 12.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 65.319999999999993 110.898 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 62.9 mm-40 47.41 79.55 0.06 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.474 . . . . 72.400000000000006 110.88 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.2 p -106.48 140.96 22.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 74.239999999999995 111.135 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.49 -35.49 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 75.510000000000005 111.135 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.7 t -105.85 151.88 23.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 71.219999999999999 110.885 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.519 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 5.3 mt -55.62 -58.04 17.86 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.64 0.733 . . . . 74.230000000000004 111.119 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.5 Cg_endo -69.76 99.17 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.667 2.245 . . . . 73.349999999999994 112.314 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 43.3 m -142.39 137.05 30.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 74.25 111.149 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 32.7 ttp -137.33 131.78 32.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 74.310000000000002 110.907 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 10.9 mm -108.2 110.93 33.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 75.310000000000002 111.1 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.59 100.27 7.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.178 -0.464 . . . . 75.420000000000002 110.896 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -89.58 170.32 10.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 75.230000000000004 110.904 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -166.33 89.59 0.4 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 64.329999999999998 110.902 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.86 39.41 8.7 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.758 -0.734 . . . . 62.450000000000003 112.499 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.72 41.63 82.69 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.74 -0.743 . . . . 72.140000000000001 112.484 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.7 m -161.79 131.31 3.25 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.558 0.694 . . . . 74.230000000000004 111.138 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 86.59 0.57 Allowed 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.675 2.25 . . . . 75.439999999999998 112.39 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.9 m -73.37 -32.24 36.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 71.120000000000005 111.116 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.9 mmtm -143.38 170.17 16.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 74.310000000000002 110.896 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -158.36 103.56 1.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 74.299999999999997 110.825 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.6 mp -113.75 132.71 61.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 74.349999999999994 111.113 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.0 m -128.06 141.6 46.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 74.140000000000001 111.141 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 128.06 142.35 5.44 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.741 -0.743 . . . . 74.319999999999993 112.532 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -96.25 89.2 5.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.873 0.368 . . . . 50.450000000000003 111.108 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.03 -175.39 3.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 71.340000000000003 110.959 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.23 -174.79 28.44 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.728 -0.748 . . . . 74.209999999999994 112.481 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.96 -46.47 62.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.761 0.315 . . . . 74.409999999999997 110.876 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.24 -22.24 65.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 73.239999999999995 111.08 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -91.28 -60.51 1.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 45.450000000000003 111.053 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.7 -31.28 47.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.248 -0.433 . . . . 74.319999999999993 110.883 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.7 tt -73.32 -59.64 2.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 73.209999999999994 110.9 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -52.85 -34.04 52.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 74.019999999999996 110.845 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -56.8 -25.0 54.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 74.209999999999994 110.847 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.2 mt -84.58 -65.81 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 74.310000000000002 111.129 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -53.12 -48.24 68.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.433 . . . . 72.430000000000007 110.871 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -54.56 -34.46 61.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.476 . . . . 73.150000000000006 110.86 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.07 -34.74 66.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 73.109999999999999 111.096 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.8 mt . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 75.299999999999997 110.865 -179.932 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.5 p . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.841 0.353 . . . . 75.510000000000005 111.117 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.4 m -152.13 163.57 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.251 -0.431 . . . . 74.209999999999994 111.124 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.8 t -75.66 127.62 33.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.16 -0.473 . . . . 74.519999999999996 111.172 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 99.8 t -93.18 136.63 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 74.239999999999995 111.146 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.03 176.05 0.35 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 72.219999999999999 111.127 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -81.06 -49.14 11.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 72.409999999999997 110.835 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.3 t -68.07 -54.27 19.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 64.219999999999999 110.872 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 t -58.24 -19.37 33.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.138 -0.483 . . . . 75.340000000000003 111.168 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -50.82 -31.19 16.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 74.409999999999997 110.889 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.54 -34.27 69.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.474 . . . . 74.049999999999997 110.898 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.2 m -91.04 -15.55 29.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 73.409999999999997 111.151 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -93.56 -71.1 0.67 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 74.400000000000006 110.855 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.9 t -71.04 -70.43 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 75.299999999999997 111.116 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.3 mt -40.55 -59.39 1.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 73.310000000000002 110.952 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -51.14 -62.41 1.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.476 . . . . 74.310000000000002 110.843 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.2 p -52.72 152.63 3.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 71.030000000000001 110.883 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -101.6 -37.79 8.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.112 -0.495 . . . . 64.25 110.829 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.94 159.69 1.76 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.589 0.709 . . . . 74.439999999999998 111.121 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 123.98 10.62 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.692 2.261 . . . . 70.430000000000007 112.335 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 97.8 t -97.39 123.87 50.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 73.430000000000007 111.112 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -103.5 100.0 9.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 73.239999999999995 110.899 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.1 p -95.18 135.09 30.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 75.310000000000002 111.137 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.13 99.72 7.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 75.230000000000004 110.876 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -91.41 89.84 7.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.458 . . . . 75.299999999999997 110.887 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -147.8 -169.65 3.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.165 -0.471 . . . . 74.430000000000007 110.919 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.72 -153.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 63.439999999999998 111.085 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.486 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 22.8 t0 -77.16 9.44 3.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 72.140000000000001 110.848 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.486 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 0.9 OUTLIER 42.01 67.02 0.62 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.166 -0.47 . . . . 71.540000000000006 110.911 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 46.8 t -127.74 -44.7 1.49 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.429 . . . . 71.209999999999994 110.935 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.92 -68.03 1.5 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.755 -0.736 . . . . 63.039999999999999 112.519 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -30.84 21.78 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.655 2.237 . . . . 74.349999999999994 112.312 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 42.8 t -56.08 -24.13 38.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.246 -0.434 . . . . 74.349999999999994 110.869 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 50.4 mttt -50.79 -39.5 52.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 75.230000000000004 110.906 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 12.2 ptm -90.12 -29.3 18.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 75.209999999999994 110.886 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.4 t -92.55 21.79 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 75.140000000000001 111.11 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.464 ' N ' ' HD2' ' A' ' 48' ' ' PRO . . . -80.01 -61.08 0.46 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.578 0.704 . . . . 75.530000000000001 111.116 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 47' ' ' ALA . 53.6 Cg_endo -69.76 -46.7 1.13 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.642 2.228 . . . . 71.099999999999994 112.321 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.3 m -50.5 -30.14 7.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 73.109999999999999 111.109 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.8 mt -69.23 -39.08 78.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 74.0 110.909 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -72.77 -32.45 65.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 74.319999999999993 110.858 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -49.74 -58.62 4.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 72.530000000000001 110.882 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 mp -50.38 -32.12 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 74.030000000000001 111.125 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 71.010000000000005 111.103 179.804 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.429 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.913 0.387 . . . . 74.019999999999996 110.901 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.69 148.68 46.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 75.129999999999995 110.933 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -125.49 102.06 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 74.019999999999996 111.17 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -99.98 138.42 37.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 72.340000000000003 111.084 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.1 pttp -135.64 111.2 9.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 74.239999999999995 110.914 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 27.9 tp -107.75 160.32 15.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 74.400000000000006 110.88 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.01 119.85 39.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 75.310000000000002 110.891 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.0 m -63.1 -33.49 61.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 71.329999999999998 111.129 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -50.59 -36.13 33.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 75.120000000000005 110.852 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.38 -35.39 10.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 74.239999999999995 111.086 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -120.39 67.6 13.42 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.579 0.704 . . . . 74.409999999999997 110.902 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -33.58 16.56 Favored 'Trans proline' 0 C--N 1.34 0.127 0 C-N-CA 122.687 2.258 . . . . 75.549999999999997 112.377 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -52.21 -52.06 54.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 72.299999999999997 110.877 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.44 -46.13 66.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 75.140000000000001 111.081 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.47 -70.48 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 60.140000000000001 111.115 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 -51.34 -32.11 24.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 74.0 110.863 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -51.69 -44.4 63.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 73.219999999999999 110.889 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -95.66 18.99 11.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 62.310000000000002 110.896 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 48.25 72.85 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 74.310000000000002 110.898 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.6 p -99.3 131.77 45.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 64.409999999999997 111.154 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.1 t -88.89 -74.03 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 75.340000000000003 111.112 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.86 158.75 29.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 71.0 110.828 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.504 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 1.3 mp -65.75 -58.37 11.62 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.635 0.731 . . . . 75.200000000000003 111.159 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.8 Cg_endo -69.77 71.33 1.53 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.709 2.273 . . . . 74.310000000000002 112.355 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 89.1 m -113.73 139.16 49.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 72.129999999999995 111.159 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 37.4 ttp -135.25 112.74 10.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 73.299999999999997 110.903 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.5 mt -90.04 128.08 42.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.429 . . . . 73.049999999999997 111.122 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.0 tp -92.27 105.78 17.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 63.219999999999999 110.97 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -91.86 170.98 9.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 74.239999999999995 110.834 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -165.67 91.9 0.51 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 73.319999999999993 110.915 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.34 36.14 8.32 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.749 -0.739 . . . . 62.210000000000001 112.53 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.48 38.59 79.73 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.752 -0.737 . . . . 63.140000000000001 112.452 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 86.4 m -161.12 133.91 4.53 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.592 0.71 . . . . 74.329999999999998 111.152 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 107.26 1.82 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.723 2.282 . . . . 72.150000000000006 112.322 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 16.5 m -94.13 -32.69 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 73.420000000000002 111.153 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.5 mmtm -152.61 170.38 20.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 73.439999999999998 110.92 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.29 131.72 11.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 73.420000000000002 110.843 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.1 mp -126.01 141.85 44.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 75.219999999999999 111.131 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.6 p -150.23 143.31 17.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 65.099999999999994 111.132 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.52 -27.32 1.35 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.765 -0.731 . . . . 63.32 112.518 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 61.82 72.5 0.5 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.817 0.341 . . . . 61.32 111.104 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.38 -179.2 3.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 75.430000000000007 110.873 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.72 178.84 2.3 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.724 -0.751 . . . . 72.439999999999998 112.515 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.64 -36.12 73.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.771 0.32 . . . . 71.200000000000003 110.887 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.61 -32.65 74.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 64.109999999999999 111.112 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.409 ' HA ' ' HG2' ' A' ' 109' ' ' ARG . . . -86.57 -56.38 3.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 74.420000000000002 111.113 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.24 -34.16 44.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 74.510000000000005 110.914 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.2 tt -70.05 -59.26 3.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.231 -0.441 . . . . 74.430000000000007 110.911 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.409 ' HG2' ' HA ' ' A' ' 106' ' ' ALA . 3.0 ptm180 -56.14 -34.5 66.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 73.409999999999997 110.888 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -52.8 -25.63 11.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 72.109999999999999 110.88 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.6 mt -84.72 -68.43 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.483 . . . . 72.25 111.143 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -51.93 -49.75 62.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 75.310000000000002 110.885 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -53.82 -35.01 60.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 71.409999999999997 110.851 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.98 -35.83 66.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 74.340000000000003 111.071 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.1 mt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 74.409999999999997 110.966 -179.988 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.8 p . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.862 0.363 . . . . 73.519999999999996 111.144 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 91.7 t -149.96 144.49 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 74.200000000000003 111.116 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 t -82.44 127.16 33.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 72.010000000000005 111.129 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.2 t -92.66 131.64 39.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 70.140000000000001 111.103 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.7 179.23 0.13 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.112 -0.495 . . . . 50.210000000000001 111.124 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.05 -49.8 10.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 75.120000000000005 110.934 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.0 m -69.3 -52.99 22.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 63.149999999999999 110.835 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.3 t -58.29 -19.5 35.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 75.099999999999994 111.147 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -51.22 -31.85 21.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 74.019999999999996 110.869 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.418 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -72.04 -32.82 67.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 72.329999999999998 110.876 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.4 m -90.94 -16.58 27.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 75.150000000000006 111.144 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -93.96 -70.76 0.69 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 64.030000000000001 110.879 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.8 t -70.2 -70.48 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 65.209999999999994 111.092 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.418 ' HB2' ' HA ' ' A' ' 21' ' ' LYS . 8.3 mt -41.09 -60.35 1.24 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 75.230000000000004 110.932 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -49.82 -63.05 1.23 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 73.409999999999997 110.864 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 59.6 m -48.85 -34.68 13.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 74.439999999999998 110.818 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.0 t0 59.51 30.88 20.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 54.299999999999997 110.897 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.24 160.62 36.75 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.552 0.692 . . . . 75.319999999999993 111.188 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 111.8 2.9 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.666 2.244 . . . . 71.319999999999993 112.349 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 89.7 t -102.88 117.42 48.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 73.540000000000006 111.087 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.1 mt -79.89 102.33 9.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 74.310000000000002 110.888 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 43.1 t -89.71 137.37 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 75.150000000000006 111.11 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -122.46 99.23 6.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.485 . . . . 74.129999999999995 110.892 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -96.72 89.82 5.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 75.129999999999995 110.885 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -151.18 -169.13 3.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.092 -0.504 . . . . 74.219999999999999 110.925 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.66 -154.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 53.009999999999998 111.1 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.477 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 23.9 t0 -77.33 8.74 3.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 73.219999999999999 110.909 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.477 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 1.3 p-90 41.5 64.87 0.94 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 73.239999999999995 110.949 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 4.0 p -124.87 -44.5 1.93 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.273 -0.421 . . . . 71.540000000000006 110.868 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.55 -69.33 1.4 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.755 -0.736 . . . . 72.510000000000005 112.473 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -26.33 27.67 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.697 2.265 . . . . 75.209999999999994 112.317 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 26.1 t -49.9 -31.09 11.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 72.439999999999998 110.889 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -51.94 -29.86 22.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 73.049999999999997 110.842 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 51.6 mmm -89.99 -38.2 13.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 73.310000000000002 110.863 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.3 t -92.44 22.72 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 74.349999999999994 111.129 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.468 ' N ' ' HD2' ' A' ' 48' ' ' PRO . . . -79.12 -60.92 0.52 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.584 0.707 . . . . 71.109999999999999 111.064 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 47' ' ' ALA . 53.7 Cg_endo -69.8 -48.45 0.71 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.701 2.268 . . . . 63.409999999999997 112.312 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.7 m -50.45 -29.91 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.433 . . . . 74.340000000000003 111.129 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.74 -39.59 73.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 72.349999999999994 110.951 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -70.99 -34.38 71.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 55.340000000000003 110.847 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -51.55 -68.76 0.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 74.5 110.873 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.7 mp -50.43 -34.42 11.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 70.439999999999998 111.131 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.176 -0.466 . . . . 43.32 111.124 179.784 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.7 pp . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.903 0.382 . . . . 70.140000000000001 110.873 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.0 tttp -93.34 146.87 23.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 74.349999999999994 110.893 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -141.26 123.76 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 74.109999999999999 111.129 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -134.89 140.56 45.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 71.319999999999993 111.121 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.71 140.61 51.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 74.25 110.878 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 tt -123.21 150.73 43.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 74.430000000000007 110.914 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.4 103.78 13.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 73.150000000000006 110.857 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.4 m -51.42 -33.33 14.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 73.239999999999995 111.104 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.85 -35.44 32.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 75.099999999999994 110.88 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -103.16 -34.26 8.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 64.430000000000007 111.088 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.92 67.35 8.05 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.657 0.742 . . . . 75.010000000000005 110.907 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -34.19 15.04 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.707 2.272 . . . . 74.409999999999997 112.285 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -52.01 -46.36 64.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 73.450000000000003 110.891 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.24 -42.58 86.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 73.310000000000002 111.122 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.52 -68.59 0.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 71.209999999999994 111.06 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -51.2 -31.76 21.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 73.120000000000005 110.854 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -51.08 -36.73 41.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 75.129999999999995 110.866 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -108.77 23.85 13.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 74.219999999999999 110.924 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 70.8 mm-40 48.2 67.65 0.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 74.010000000000005 110.871 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 99.4 t -87.5 113.34 24.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.478 . . . . 75.230000000000004 111.1 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.1 t -78.79 -66.88 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 74.519999999999996 111.12 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.45 162.58 17.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 74.329999999999998 110.845 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.521 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.4 mt -65.06 -58.12 13.59 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.636 0.731 . . . . 72.140000000000001 111.118 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.8 Cg_endo -69.8 70.28 1.61 Allowed 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.656 2.237 . . . . 71.439999999999998 112.316 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 99.2 m -108.13 100.02 9.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 53.229999999999997 111.125 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.5 ttt -99.75 118.31 35.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 71.450000000000003 110.856 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 51.4 mt -98.17 131.49 45.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 74.219999999999999 111.102 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.37 103.98 15.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 73.129999999999995 110.964 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -90.02 167.72 12.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 72.310000000000002 110.86 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -170.37 119.58 0.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 73.239999999999995 110.877 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.33 30.99 77.67 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.735 -0.745 . . . . 72.349999999999994 112.485 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.37 53.57 7.49 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.795 -0.717 . . . . 55.109999999999999 112.458 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 178.92 139.35 0.27 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.554 0.692 . . . . 74.519999999999996 111.143 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.84 84.88 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.676 2.251 . . . . 74.140000000000001 112.322 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.9 m -64.14 -33.84 65.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 73.010000000000005 111.138 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -152.84 170.28 20.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 72.319999999999993 110.907 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -151.68 130.86 12.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 70.310000000000002 110.926 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.08 135.75 60.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 72.510000000000005 111.16 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -125.29 140.6 47.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 75.420000000000002 111.125 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 127.98 131.05 3.4 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.751 -0.738 . . . . 75.540000000000006 112.478 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.09 70.92 10.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.835 0.35 . . . . 75.209999999999994 111.082 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.47 171.9 7.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 75.140000000000001 110.909 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.04 173.62 6.15 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.729 -0.748 . . . . 54.439999999999998 112.496 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.88 -44.93 91.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.766 0.317 . . . . 74.430000000000007 110.855 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.93 -64.11 0.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 63.32 111.124 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.44 -57.9 9.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 73.430000000000007 111.144 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.25 -42.49 61.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 75.430000000000007 110.955 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.1 tp -63.6 -55.42 23.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 63.009999999999998 110.879 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.7 mtm180 -51.71 -42.0 61.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 74.409999999999997 110.888 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -51.86 -26.09 9.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 62.219999999999999 110.9 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.9 mt -85.14 -68.65 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 74.340000000000003 111.084 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.53 -49.17 62.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 74.409999999999997 110.862 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -56.95 -34.92 68.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 55.219999999999999 110.884 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.22 -37.51 66.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 73.0 111.085 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.0 mt . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.437 . . . . 74.310000000000002 110.932 -179.956 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.2 p . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.83 0.347 . . . . 74.450000000000003 111.152 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.2 m -153.45 163.67 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 74.430000000000007 111.143 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 t -66.56 126.98 30.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 71.340000000000003 111.135 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.6 t -94.76 127.6 46.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.449 . . . . 73.450000000000003 111.106 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.51 179.08 0.12 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 73.530000000000001 111.119 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -79.98 -48.11 13.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 73.120000000000005 110.871 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.2 m -70.99 -51.56 24.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 74.310000000000002 110.867 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.9 t -59.57 -19.32 47.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.148 -0.478 . . . . 65.519999999999996 111.144 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -51.26 -30.8 18.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 74.519999999999996 110.86 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.1 -33.63 68.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.473 . . . . 74.120000000000005 110.907 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.2 m -91.43 -16.04 27.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 65.109999999999999 111.143 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -93.46 -71.24 0.66 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 63.039999999999999 110.835 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.6 t -70.47 -70.47 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 75.430000000000007 111.146 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.4 mt -40.66 -60.11 1.22 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 75.299999999999997 110.949 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -50.46 -57.43 8.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 74.299999999999997 110.848 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.8 t -51.84 153.15 2.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 74.340000000000003 110.868 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -102.17 -49.4 3.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 73.420000000000002 110.911 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -51.87 159.7 1.31 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 121.624 0.726 . . . . 74.420000000000002 111.094 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 120.08 6.93 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.695 2.263 . . . . 72.340000000000003 112.321 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 97.6 t -83.35 142.74 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 75.549999999999997 111.105 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -111.9 112.64 24.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.467 . . . . 72.200000000000003 110.934 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 70.8 t -100.61 142.78 15.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 75.549999999999997 111.158 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -133.84 99.79 4.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 71.310000000000002 110.826 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -91.72 89.77 7.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 71.439999999999998 110.892 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -141.66 -168.22 2.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 75.120000000000005 110.955 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.68 -164.76 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 63.240000000000002 111.091 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.456 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 1.5 t70 -77.67 11.98 1.86 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 71.519999999999996 110.87 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.482 ' N ' ' CD1' ' A' ' 39' ' ' TRP . 1.2 m0 76.35 94.76 0.07 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.194 -0.457 . . . . 74.319999999999993 110.886 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -169.68 -65.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 60.030000000000001 110.904 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -70.73 -70.28 1.22 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.761 -0.733 . . . . 73.140000000000001 112.491 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -41.37 4.27 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.73 2.287 . . . . 72.109999999999999 112.278 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 31.7 t -51.94 -32.57 33.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.445 . . . . 73.340000000000003 110.859 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 18.5 mtpt -62.4 -34.79 77.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 75.5 110.925 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 34.6 mtm -90.13 -36.13 15.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 75.329999999999998 110.893 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.2 t -94.35 23.11 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 63.100000000000001 111.1 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.473 ' N ' ' HD2' ' A' ' 48' ' ' PRO . . . -76.63 -60.62 0.85 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.603 0.716 . . . . 72.329999999999998 111.122 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 47' ' ' ALA . 53.9 Cg_endo -69.73 -48.7 0.67 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.696 2.264 . . . . 73.430000000000007 112.317 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.5 m -49.94 -30.2 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 75.430000000000007 111.143 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.13 -45.52 11.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 71.239999999999995 110.886 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -60.96 -32.45 71.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 74.349999999999994 110.846 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -51.31 -63.58 1.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 74.040000000000006 110.892 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.7 mp -50.75 -41.02 20.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 74.530000000000001 111.142 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 71.329999999999998 111.136 179.819 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.871 0.367 . . . . 71.129999999999995 110.938 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.8 tttp -111.95 148.98 32.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 71.340000000000003 110.867 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.3 t -124.2 104.5 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 74.25 111.126 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -108.59 109.75 21.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 55.43 111.071 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.98 160.68 19.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 72.510000000000005 110.892 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 50.1 tp -148.29 147.56 29.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.439 . . . . 73.239999999999995 110.936 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -79.4 120.99 24.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 74.140000000000001 110.878 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.1 m -48.71 -36.57 7.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 74.329999999999998 111.11 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.36 -32.88 57.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 75.450000000000003 110.838 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.02 -35.03 29.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 71.519999999999996 111.107 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -118.15 67.14 6.39 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.627 0.727 . . . . 73.409999999999997 110.888 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -32.43 18.33 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.706 2.271 . . . . 74.329999999999998 112.36 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -83.94 -40.8 18.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 62.420000000000002 110.907 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.06 -46.63 87.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 73.299999999999997 111.091 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.0 -63.24 1.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 75.400000000000006 111.141 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.7 ttp180 -51.25 -37.11 45.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 75.219999999999999 110.886 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -55.01 -36.17 65.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 70.120000000000005 110.857 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -98.35 21.77 10.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 75.120000000000005 110.874 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 50.23 80.22 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 71.439999999999998 110.926 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 96.5 t -108.55 97.17 5.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.148 -0.478 . . . . 70.310000000000002 111.099 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.4 t -99.57 34.21 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 73.209999999999994 111.102 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -176.04 140.28 0.41 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.467 . . . . 75.409999999999997 110.887 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.516 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 4.2 mt -57.84 -57.83 22.83 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.668 0.747 . . . . 74.200000000000003 111.09 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.6 Cg_endo -69.74 74.72 1.26 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.714 2.276 . . . . 71.049999999999997 112.359 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 53.6 m -109.26 143.35 38.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 60.450000000000003 111.142 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 10.9 ttp -141.3 128.79 21.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 75.150000000000006 110.9 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 17.2 mt -115.94 119.72 62.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 75.120000000000005 111.17 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.55 111.51 20.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 74.439999999999998 110.915 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -99.42 170.36 8.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 72.310000000000002 110.885 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -163.6 92.53 0.71 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.486 . . . . 74.409999999999997 110.872 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.45 32.21 28.58 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.745 -0.741 . . . . 31.239999999999998 112.503 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.12 38.93 24.88 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.757 -0.735 . . . . 73.230000000000004 112.498 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.1 m -160.32 132.39 4.24 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.589 0.709 . . . . 74.329999999999998 111.11 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 91.73 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.688 2.259 . . . . 64.430000000000007 112.361 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.9 m -70.95 -32.71 49.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 75.209999999999994 111.115 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.1 mmtm -155.25 170.07 22.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 75.439999999999998 110.918 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -148.01 128.01 13.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 73.400000000000006 110.896 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.0 mp -136.06 123.75 35.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 73.200000000000003 111.091 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.1 m -118.81 159.68 19.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 74.340000000000003 111.116 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 115.57 142.15 7.57 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.713 -0.756 . . . . 74.120000000000005 112.454 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.04 71.24 7.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.835 0.35 . . . . 61.539999999999999 111.12 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.1 164.98 11.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.19 -0.459 . . . . 71.329999999999998 110.909 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.78 -176.36 0.73 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.734 -0.746 . . . . 42.520000000000003 112.459 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.79 -43.77 65.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.737 0.303 . . . . 75.239999999999995 110.889 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.72 -26.14 66.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 70.439999999999998 111.099 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.55 -36.25 14.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 74.519999999999996 111.106 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -77.22 -36.13 55.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 73.409999999999997 110.896 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.2 pp -74.65 -39.05 62.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 75.319999999999993 110.906 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -66.88 -35.94 81.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 72.200000000000003 110.859 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -57.77 -23.1 50.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 62.020000000000003 110.887 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.1 mt -86.48 -66.23 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 72.450000000000003 111.108 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -52.59 -48.82 66.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 74.230000000000004 110.85 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -59.75 -33.76 72.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 74.219999999999999 110.907 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.0 -35.62 59.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 75.409999999999997 111.122 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.0 mt . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 72.439999999999998 110.874 -179.952 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.9 p . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.849 0.357 . . . . 72.409999999999997 111.121 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.1 m -153.76 173.19 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.475 . . . . 71.510000000000005 111.095 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.74 152.35 40.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 74.329999999999998 111.122 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.6 p -127.44 145.52 34.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 73.209999999999994 111.111 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.87 162.28 5.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 74.109999999999999 111.125 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.42 -50.28 13.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 75.239999999999995 110.881 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.1 m -59.69 -35.89 75.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.468 . . . . 63.420000000000002 110.821 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.3 t -85.43 -17.55 36.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 74.510000000000005 111.178 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -49.37 -31.86 10.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 61.43 110.856 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.09 -36.15 74.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.48 . . . . 75.109999999999999 110.918 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.8 m -89.94 -15.09 32.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.436 . . . . 73.120000000000005 111.135 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -92.92 -70.97 0.67 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 73.019999999999996 110.888 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.4 t -72.35 -70.31 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 75.420000000000002 111.142 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.1 mt -39.9 -56.22 1.84 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 75.120000000000005 110.947 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -55.67 -52.52 63.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 75.540000000000006 110.854 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.5 t -51.89 159.88 0.78 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 61.340000000000003 110.836 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -106.89 -44.76 4.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.143 -0.48 . . . . 73.340000000000003 110.867 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -54.49 159.49 3.28 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.601 0.715 . . . . 74.340000000000003 111.122 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 131.02 20.34 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.695 2.264 . . . . 73.349999999999994 112.322 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 88.2 t -102.25 129.45 53.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 75.109999999999999 111.159 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.7 mt -104.93 106.04 16.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 74.329999999999998 110.917 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.8 p -105.12 131.0 55.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 75.430000000000007 111.164 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -116.41 99.61 7.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 74.140000000000001 110.818 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -87.37 89.48 8.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 73.450000000000003 110.897 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -143.61 -169.4 3.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.486 . . . . 74.319999999999993 110.91 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.84 -157.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 73.099999999999994 111.093 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.476 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 15.3 t0 -76.85 9.39 2.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 75.239999999999995 110.876 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.476 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 1.2 p-90 41.69 67.51 0.55 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 72.219999999999999 110.91 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 18.1 t -127.09 -47.7 1.48 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.272 -0.422 . . . . 75.040000000000006 110.839 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.56 -67.91 1.51 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.712 -0.756 . . . . 75.329999999999998 112.525 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -24.82 29.39 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.696 2.264 . . . . 70.319999999999993 112.351 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 36.3 t -49.9 -31.5 12.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 33.130000000000003 110.903 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 11.7 mttp -52.27 -35.14 49.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 75.219999999999999 110.866 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 8.9 mtt -90.44 -32.46 16.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 73.340000000000003 110.875 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.468 ' HA ' ' CG1' ' A' ' 49' ' ' VAL . 3.0 t -92.85 22.89 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 74.219999999999999 111.113 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.466 ' N ' ' HD2' ' A' ' 48' ' ' PRO . . . -80.87 -60.67 0.43 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.559 0.695 . . . . 70.519999999999996 111.113 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 47' ' ' ALA . 53.9 Cg_endo -69.78 -56.72 0.13 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.702 2.268 . . . . 73.230000000000004 112.326 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.468 ' CG1' ' HA ' ' A' ' 46' ' ' VAL . 3.0 p -48.76 -33.93 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 71.140000000000001 111.119 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.3 tp -69.46 -41.44 76.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 74.209999999999994 110.915 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -73.29 -33.24 65.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.461 . . . . 70.540000000000006 110.881 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -50.33 -66.49 0.38 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 74.530000000000001 110.874 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.6 mt -50.07 -33.07 9.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 73.349999999999994 111.106 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 74.010000000000005 111.122 179.822 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.9 0.381 . . . . 74.239999999999995 110.868 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -97.96 140.55 32.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 74.519999999999996 110.903 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.2 t -141.95 118.15 6.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.253 -0.431 . . . . 73.439999999999998 111.138 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.48 147.09 41.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 74.430000000000007 111.09 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.2 pttp -138.97 131.38 28.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 75.310000000000002 110.892 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 32.1 tp -122.47 159.48 27.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 74.340000000000003 110.888 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -103.07 118.08 36.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 74.400000000000006 110.838 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 73.9 t -61.62 -35.7 68.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 73.409999999999997 111.141 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -51.41 -35.3 38.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 70.510000000000005 110.898 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.14 -35.06 11.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 64.219999999999999 111.055 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -117.79 72.5 8.29 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.619 0.723 . . . . 64.540000000000006 110.878 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -31.16 20.84 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.686 2.257 . . . . 72.109999999999999 112.343 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -61.34 -43.33 99.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.243 -0.435 . . . . 64.439999999999998 110.892 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.69 -48.08 83.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 75.340000000000003 111.079 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.16 -66.21 0.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 74.400000000000006 111.089 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.2 ttp85 -51.14 -33.15 25.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 72.209999999999994 110.895 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -51.28 -36.22 41.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 74.010000000000005 110.915 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -108.7 24.97 12.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 74.219999999999999 110.874 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 59.9 mm-40 48.2 67.1 0.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 74.329999999999998 110.858 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 98.9 t -91.2 106.2 17.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 72.519999999999996 111.113 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.5 t -80.12 -62.28 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 73.319999999999993 111.099 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 56.1 m -89.83 160.68 16.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.467 . . . . 71.409999999999997 110.858 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.519 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.8 mt -60.2 -58.18 21.27 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.624 0.726 . . . . 75.010000000000005 111.098 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.3 Cg_endo -69.79 77.43 1.08 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.683 2.255 . . . . 71.540000000000006 112.351 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 99.7 m -117.39 109.62 17.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.439 . . . . 64.430000000000007 111.116 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 31.0 ttp -113.77 145.95 40.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 74.010000000000005 110.891 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.6 mt -129.68 117.86 43.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 73.409999999999997 111.138 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.82 102.59 10.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 72.219999999999999 110.924 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -89.52 167.68 12.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 74.310000000000002 110.894 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -161.85 94.86 0.96 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 72.450000000000003 110.909 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.28 32.72 22.12 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.737 -0.744 . . . . 75.340000000000003 112.502 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.49 41.1 45.64 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.716 -0.754 . . . . 73.109999999999999 112.516 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 85.4 m -160.15 133.69 4.91 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.597 0.713 . . . . 73.430000000000007 111.143 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 93.78 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.692 2.261 . . . . 73.510000000000005 112.349 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.5 m -88.29 -32.37 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 71.310000000000002 111.133 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -132.12 166.22 22.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 72.439999999999998 110.911 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.4 ttp180 -160.09 116.74 2.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 75.140000000000001 110.867 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.95 139.6 48.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 72.409999999999997 111.128 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.8 m -132.26 154.82 40.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 72.140000000000001 111.107 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 115.34 137.92 6.4 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.719 -0.753 . . . . 74.040000000000006 112.503 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.43 77.11 6.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.883 0.373 . . . . 74.340000000000003 111.083 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.77 176.76 4.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 75.120000000000005 110.898 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -76.65 166.6 54.21 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.685 -0.769 . . . . 71.319999999999993 112.468 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.13 -41.01 82.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.755 0.312 . . . . 74.319999999999993 110.854 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.47 -32.19 66.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 73.5 111.1 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.53 -61.87 1.58 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 73.519999999999996 111.128 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -45.93 -43.1 13.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 63.450000000000003 110.942 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.3 tp -49.49 -47.87 48.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 73.310000000000002 110.937 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 50.7 mtm180 -65.7 -40.59 92.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 75.150000000000006 110.838 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -49.79 -25.15 2.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 71.519999999999996 110.896 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.2 mt -90.37 -70.09 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 71.25 111.15 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -51.86 -51.05 59.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 71.450000000000003 110.849 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -57.2 -34.22 68.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.47 . . . . 74.230000000000004 110.895 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.17 -34.02 65.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 71.129999999999995 111.081 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.5 mt . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 71.200000000000003 110.939 -179.984 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.6 p . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.788 0.328 . . . . 51.100000000000001 111.145 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.6 m -153.31 172.19 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 72.140000000000001 111.163 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.1 t -74.04 127.94 34.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 74.030000000000001 111.192 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.4 t -91.28 137.04 22.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 74.140000000000001 111.095 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.71 174.73 0.43 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.16 -0.473 . . . . 73.310000000000002 111.144 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -80.49 -48.97 12.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 61.219999999999999 110.888 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.6 m -68.07 -53.44 25.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 72.329999999999998 110.853 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.6 t -59.06 -19.28 42.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 73.219999999999999 111.158 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -51.08 -31.12 17.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 64.120000000000005 110.879 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.82 -33.45 68.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 74.019999999999996 110.902 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.6 m -91.51 -15.97 27.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.199 -0.455 . . . . 74.230000000000004 111.153 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -93.48 -71.23 0.66 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 74.120000000000005 110.888 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.1 t -70.5 -70.47 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 74.129999999999995 111.142 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.6 mt -40.72 -59.94 1.27 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 75.409999999999997 110.87 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -50.57 -60.68 2.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 73.540000000000006 110.868 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.0 t -51.32 162.06 0.38 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.45 . . . . 74.349999999999994 110.869 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -112.33 -40.28 4.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 74.540000000000006 110.828 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.94 158.88 1.56 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.563 0.697 . . . . 73.239999999999995 111.172 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 116.08 4.39 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.726 2.284 . . . . 73.450000000000003 112.323 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.0 t -82.35 141.53 14.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 74.540000000000006 111.111 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.1 mt -112.04 104.89 13.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 74.0 110.912 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.6 p -113.37 146.86 17.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 75.120000000000005 111.123 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -139.49 117.85 12.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 74.219999999999999 110.9 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -95.17 97.05 9.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 73.420000000000002 110.926 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -146.13 -167.32 2.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 73.329999999999998 110.935 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.09 -167.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 74.109999999999999 111.118 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.447 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 5.7 m-20 -78.77 12.69 1.99 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 73.450000000000003 110.855 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.449 ' CD1' ' N ' ' A' ' 39' ' ' TRP . 0.8 OUTLIER 75.37 85.57 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 75.25 110.91 -179.963 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 2.0 p -164.44 -47.08 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 65.129999999999995 110.88 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.88 -70.72 1.34 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.794 -0.717 . . . . 73.319999999999993 112.463 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -31.22 21.05 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.688 2.259 . . . . 65.120000000000005 112.339 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 43.7 t -51.24 -29.16 13.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 74.010000000000005 110.852 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -63.66 -49.34 73.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 74.409999999999997 110.902 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 10.9 ptp -77.54 -34.52 53.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 75.219999999999999 110.909 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.4 t -93.8 21.98 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 72.140000000000001 111.163 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.455 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . . . -76.52 -61.28 0.79 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.606 0.717 . . . . 73.549999999999997 111.142 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' A' ' 47' ' ' ALA . 53.3 Cg_endo -69.81 -49.83 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.651 2.234 . . . . 72.230000000000004 112.348 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.1 m -51.04 -30.35 9.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 73.099999999999994 111.144 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.2 tp -76.17 -41.51 49.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.121 -0.49 . . . . 73.519999999999996 110.911 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -71.12 -33.94 70.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 75.299999999999997 110.895 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -51.49 -69.53 0.11 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 72.420000000000002 110.864 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 mp -50.99 -37.29 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 74.219999999999999 111.14 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 73.310000000000002 111.108 179.806 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.426 ' N ' ' CD1' ' A' ' 61' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.868 0.366 . . . . 75.150000000000006 110.903 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -122.28 141.97 50.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 73.099999999999994 110.855 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 23.8 t -120.58 99.81 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 55.109999999999999 111.143 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -108.88 142.69 39.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 70.409999999999997 111.108 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.5 mtpt -130.93 159.51 37.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 75.5 110.91 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.4 tp -140.56 144.83 36.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 73.349999999999994 110.924 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.03 119.34 33.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 75.25 110.843 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.1 t -62.4 -34.58 65.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.486 . . . . 64.329999999999998 111.105 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.56 -35.54 41.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 71.540000000000006 110.867 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.36 -34.09 11.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 74.109999999999999 111.06 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -118.3 68.46 7.35 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.602 0.715 . . . . 75.349999999999994 110.878 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -32.81 17.8 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.692 2.261 . . . . 73.109999999999999 112.328 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -67.99 -35.19 77.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 73.230000000000004 110.859 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.96 -44.13 82.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 62.32 111.104 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.83 -64.38 0.97 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 70.129999999999995 111.097 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.6 ttp180 -50.51 -35.11 27.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 75.329999999999998 110.898 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.85 -35.79 64.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 71.140000000000001 110.835 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -107.6 28.7 7.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 73.510000000000005 110.896 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 50.96 84.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 75.439999999999998 110.942 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 96.9 t -120.78 140.06 46.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.443 . . . . 71.25 111.131 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.6 m -127.59 -37.69 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 73.530000000000001 111.154 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.2 t -100.96 148.28 25.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 74.5 110.871 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.52 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.1 mt -59.64 -57.69 24.97 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.599 0.714 . . . . 73.450000000000003 111.128 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.8 Cg_endo -69.76 71.56 1.51 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.687 2.258 . . . . 75.430000000000007 112.345 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 54.8 m -106.39 135.37 47.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 73.430000000000007 111.137 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 5.0 ttt -134.66 146.31 49.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 72.439999999999998 110.898 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 22.3 mt -141.86 118.03 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 75.420000000000002 111.156 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.39 101.42 9.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 73.540000000000006 110.948 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -89.91 170.92 9.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 62.299999999999997 110.865 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.74 119.11 0.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 74.0 110.901 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.37 34.41 88.14 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.707 -0.759 . . . . 64.430000000000007 112.501 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.56 42.34 55.5 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.714 -0.755 . . . . 65.25 112.538 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 84.9 m -161.05 133.94 4.57 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.613 0.721 . . . . 71.319999999999993 111.109 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 81.35 0.82 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.657 2.238 . . . . 74.219999999999999 112.345 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.3 m -68.2 -32.36 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 75.120000000000005 111.11 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.3 mmtm -142.75 160.19 40.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 75.239999999999995 110.879 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -149.37 124.63 10.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 75.439999999999998 110.871 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.6 mp -139.35 116.56 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 75.409999999999997 111.11 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 61.0 t -111.76 134.24 54.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 73.530000000000001 111.132 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 133.99 140.26 4.29 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.735 -0.745 . . . . 73.230000000000004 112.46 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.32 85.58 4.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.83 0.348 . . . . 74.140000000000001 111.139 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.36 165.92 15.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 72.340000000000003 110.908 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.22 149.76 49.65 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.755 -0.736 . . . . 71.219999999999999 112.523 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.17 -36.98 9.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.822 0.344 . . . . 73.439999999999998 110.869 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.82 -47.03 74.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 75.25 111.114 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -83.18 -49.6 9.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 73.340000000000003 111.094 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -47.87 -51.87 21.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.237 -0.438 . . . . 74.019999999999996 110.872 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.7 pp -50.69 -35.89 33.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 73.099999999999994 110.893 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -68.65 -44.69 73.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 74.0 110.898 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -51.4 -25.61 6.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.49 . . . . 73.120000000000005 110.909 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.7 mt -84.72 -68.08 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 71.409999999999997 111.167 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -52.32 -49.38 64.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 71.299999999999997 110.891 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -52.49 -33.82 46.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.481 . . . . 75.400000000000006 110.836 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.01 -34.68 73.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 74.109999999999999 111.081 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 75.519999999999996 110.919 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.3 p . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.856 0.36 . . . . 71.340000000000003 111.162 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.4 t -135.15 140.69 44.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 74.140000000000001 111.121 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 t -92.71 133.38 36.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 74.129999999999995 111.16 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.7 t -89.81 120.73 39.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 72.030000000000001 111.107 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.92 -179.52 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 75.329999999999998 111.144 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -79.71 -45.59 18.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 70.299999999999997 110.833 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.7 m -68.98 -54.86 13.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 52.130000000000003 110.864 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.3 t -57.74 -21.9 43.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 72.109999999999999 111.159 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -48.77 -30.5 5.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 73.439999999999998 110.913 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.422 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -67.61 -41.97 83.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 75.239999999999995 110.876 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.5 m -91.45 -9.69 43.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.228 -0.442 . . . . 74.349999999999994 111.153 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.57 -70.24 0.71 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 72.120000000000005 110.885 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.1 t -83.99 -66.87 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 74.5 111.145 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.422 ' HB2' ' HA ' ' A' ' 21' ' ' LYS . 77.8 mt -45.79 -32.77 2.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 75.129999999999995 110.898 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -48.8 -32.05 8.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.157 -0.474 . . . . 74.219999999999999 110.882 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.9 t 65.9 62.97 0.6 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 74.519999999999996 110.851 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -120.23 -32.38 4.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 73.120000000000005 110.886 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.16 159.67 30.97 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.557 0.694 . . . . 72.400000000000006 111.139 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 126.7 13.6 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.645 2.23 . . . . 72.319999999999993 112.356 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.6 t -98.18 119.17 45.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 71.230000000000004 111.113 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.0 mp -108.0 99.9 9.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 71.430000000000007 110.886 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.4 m -107.44 146.21 13.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 74.109999999999999 111.125 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -123.47 100.21 6.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 73.25 110.897 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -72.15 100.22 2.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 72.319999999999993 110.877 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -147.47 -168.3 3.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.153 -0.476 . . . . 70.549999999999997 110.908 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.47 -164.96 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 72.230000000000004 111.128 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.475 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 4.6 m-20 -79.25 13.66 1.8 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.446 . . . . 73.400000000000006 110.903 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.475 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 0.6 OUTLIER 75.19 94.76 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 75.230000000000004 110.925 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -172.13 -57.92 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.444 . . . . 70.239999999999995 110.91 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.26 -70.98 1.28 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.798 -0.715 . . . . 74.019999999999996 112.479 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 -31.04 21.65 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.693 2.262 . . . . 72.010000000000005 112.356 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 20.4 t -58.46 -35.4 72.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 74.319999999999993 110.87 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.5 ptmm? -65.02 -29.42 70.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 74.329999999999998 110.904 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 9.0 mtm -86.88 -41.54 13.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 75.25 110.883 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.1 t -94.24 22.3 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 72.409999999999997 111.176 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.452 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . . . -75.85 -61.1 0.93 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.512 0.672 . . . . 74.340000000000003 111.129 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.452 ' CD ' ' CB ' ' A' ' 47' ' ' ALA . 54.0 Cg_endo -69.72 -50.3 0.48 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.687 2.258 . . . . 72.0 112.354 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.2 m -52.66 -29.07 13.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 74.200000000000003 111.163 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.0 tp -86.16 -44.31 12.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.146 -0.479 . . . . 72.299999999999997 110.908 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -62.66 -34.4 77.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 72.530000000000001 110.899 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -51.76 -55.41 19.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 74.209999999999994 110.917 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 mt -50.57 -37.99 15.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.085 -0.507 . . . . 74.400000000000006 111.13 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 72.120000000000005 111.097 179.798 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.5 pp . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.847 0.356 . . . . 61.409999999999997 110.907 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.3 mttm -98.55 126.19 44.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.448 . . . . 73.200000000000003 110.891 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 44.5 t -100.34 101.53 12.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 74.239999999999995 111.137 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -117.01 152.45 34.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 62.130000000000003 111.104 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.26 136.88 42.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 74.239999999999995 110.923 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.5 tp -117.04 150.88 37.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 75.140000000000001 110.914 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -106.98 118.57 37.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 71.400000000000006 110.816 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 99.9 t -57.77 -40.35 75.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.469 . . . . 71.209999999999994 111.11 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -51.7 -36.19 45.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.142 -0.481 . . . . 73.120000000000005 110.869 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.34 -33.89 15.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 60.420000000000002 111.111 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -118.76 67.81 7.98 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.604 0.716 . . . . 74.140000000000001 110.866 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -33.58 16.32 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.64 2.227 . . . . 75.109999999999999 112.359 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -74.46 -36.7 63.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 64.319999999999993 110.895 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.26 -48.24 74.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 74.219999999999999 111.111 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.25 -61.41 2.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 71.140000000000001 111.12 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.58 -34.05 35.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 74.019999999999996 110.891 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.17 -34.69 73.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 74.540000000000006 110.873 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -103.88 26.91 8.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 74.099999999999994 110.853 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 49.85 82.5 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.485 . . . . 75.430000000000007 110.904 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 85.4 t -117.11 144.58 24.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.229 -0.442 . . . . 75.549999999999997 111.181 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.7 m -135.42 -40.22 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 74.299999999999997 111.096 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.2 m -97.65 146.71 25.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 73.129999999999995 110.861 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.527 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.9 mt -57.94 -57.75 23.52 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.586 0.707 . . . . 72.340000000000003 111.108 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 54.1 Cg_endo -69.79 74.94 1.26 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.696 2.264 . . . . 75.409999999999997 112.343 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 52.3 m -112.3 143.34 43.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 72.209999999999994 111.129 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 4.2 tmm? -140.34 139.1 35.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 74.540000000000006 110.843 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.1 mt -130.38 113.19 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 73.310000000000002 111.08 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.6 tt -80.53 111.32 16.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 75.5 110.93 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -98.91 168.75 9.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 75.049999999999997 110.88 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -170.68 93.33 0.19 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.171 -0.468 . . . . 73.140000000000001 110.915 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.77 44.66 6.32 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.727 -0.749 . . . . 73.319999999999993 112.449 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 63.71 38.41 96.17 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.739 -0.743 . . . . 73.329999999999998 112.5 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.5 m -162.93 128.62 2.22 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.573 0.701 . . . . 73.109999999999999 111.134 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 86.94 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.679 2.253 . . . . 75.120000000000005 112.384 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.5 m -57.56 -35.74 51.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.425 . . . . 64.310000000000002 111.146 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 45.8 mmtt -152.82 170.19 20.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 55.509999999999998 110.896 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 11.2 ttt180 -149.73 123.65 9.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 73.329999999999998 110.901 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.2 mp -127.11 128.97 70.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 74.25 111.131 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.8 m -124.55 160.22 29.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.467 . . . . 64.310000000000002 111.136 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 109.51 138.63 8.21 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.727 -0.749 . . . . 44.399999999999999 112.487 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -91.87 80.41 5.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.863 0.363 . . . . 74.430000000000007 111.139 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.84 178.58 4.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.435 . . . . 73.340000000000003 110.855 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.75 -169.71 1.07 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.783 -0.723 . . . . 64.0 112.47 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.17 -54.19 6.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.805 0.336 . . . . 65.409999999999997 110.905 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -53.63 -34.03 57.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 74.219999999999999 111.116 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.06 -64.4 1.17 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 72.230000000000004 111.094 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.27 -33.65 20.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 74.420000000000002 110.947 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.1 tt -71.71 -59.29 2.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 72.420000000000002 110.88 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.0 ptp180 -56.39 -31.74 64.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 74.299999999999997 110.875 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -51.75 -24.88 6.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.159 -0.473 . . . . 71.25 110.93 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.7 mt -86.0 -68.7 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.487 . . . . 73.400000000000006 111.123 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -52.42 -49.62 64.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 74.420000000000002 110.842 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -53.72 -35.2 60.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.146 -0.479 . . . . 71.200000000000003 110.888 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.19 -36.37 69.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 73.239999999999995 111.112 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.1 mt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 75.230000000000004 110.93 179.995 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.9 p . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.845 0.355 . . . . 74.140000000000001 111.133 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.8 m -152.43 160.97 3.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 75.439999999999998 111.125 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.7 t -68.52 157.17 36.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 72.25 111.17 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.3 p -124.16 155.01 31.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 71.519999999999996 111.127 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.57 167.79 1.87 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 75.109999999999999 111.146 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.3 -47.98 13.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.224 -0.444 . . . . 74.439999999999998 110.891 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.9 t -66.59 -53.29 36.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.202 -0.454 . . . . 74.329999999999998 110.901 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.8 t -61.51 -17.7 55.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 71.25 111.119 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -49.71 -32.45 13.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 73.329999999999998 110.907 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.42 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -70.69 -33.18 70.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 73.400000000000006 110.893 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.0 m -90.93 -16.47 28.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 75.319999999999993 111.133 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -93.16 -70.68 0.69 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.446 . . . . 63.450000000000003 110.86 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.0 t -71.48 -70.32 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.243 -0.435 . . . . 74.030000000000001 111.113 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.42 ' HB2' ' HA ' ' A' ' 21' ' ' LYS . 8.5 mt -40.46 -59.99 1.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 73.430000000000007 110.921 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -50.77 -62.11 1.8 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 74.129999999999995 110.874 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 86.2 p -51.79 137.65 25.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 72.319999999999993 110.858 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -88.49 -35.96 16.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.09 -0.505 . . . . 62.32 110.875 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -51.98 159.53 1.4 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.614 0.721 . . . . 74.0 111.174 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 126.5 13.35 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.676 2.25 . . . . 75.25 112.312 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 95.9 t -99.49 128.02 51.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 71.519999999999996 111.157 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.7 mp -99.8 121.65 41.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 74.329999999999998 110.938 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.6 p -127.43 126.15 66.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 75.420000000000002 111.105 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -110.76 100.07 8.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 71.439999999999998 110.874 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -84.29 89.42 7.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 74.319999999999993 110.914 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -147.83 -169.17 3.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.124 -0.489 . . . . 73.519999999999996 110.901 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.7 -154.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 72.319999999999993 111.114 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.475 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 14.2 p-10 -77.31 8.8 3.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 72.409999999999997 110.875 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.475 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 1.4 p-90 41.49 63.85 1.17 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 71.230000000000004 110.939 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 35.9 t -130.22 -45.94 1.11 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 74.420000000000002 110.924 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.74 -68.75 1.44 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.753 -0.736 . . . . 72.439999999999998 112.485 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -30.8 21.88 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.759 2.306 . . . . 71.319999999999993 112.335 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 53.3 t -58.18 -20.43 41.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.245 -0.434 . . . . 72.239999999999995 110.883 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -49.74 -36.24 24.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 73.030000000000001 110.868 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 6.5 ptp -90.83 -30.92 16.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 71.420000000000002 110.859 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.3 t -92.73 21.96 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.284 -0.416 . . . . 74.150000000000006 111.141 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.458 ' N ' ' HD2' ' A' ' 48' ' ' PRO . . . -79.07 -60.98 0.52 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.595 0.712 . . . . 72.109999999999999 111.084 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 47' ' ' ALA . 53.5 Cg_endo -69.75 -48.53 0.7 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.63 2.22 . . . . 73.230000000000004 112.38 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.6 m -50.01 -30.71 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 75.019999999999996 111.116 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.1 tt -71.57 -40.24 70.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 74.430000000000007 110.902 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -73.03 -33.5 65.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 72.140000000000001 110.87 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -52.22 -67.66 0.23 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 71.150000000000006 110.907 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 mt -51.28 -34.34 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 74.310000000000002 111.094 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 74.450000000000003 111.076 179.83 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.841 0.353 . . . . 74.420000000000002 110.964 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.02 138.77 35.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.435 . . . . 75.230000000000004 110.934 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.5 t -142.05 99.81 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.266 -0.425 . . . . 74.510000000000005 111.125 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.75 146.77 27.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 64.319999999999993 111.117 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.24 151.03 49.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 73.019999999999996 110.906 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.6 tp -139.94 150.57 44.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 75.319999999999993 110.931 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -103.08 115.45 30.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 72.109999999999999 110.897 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.0 m -57.89 -34.66 49.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.46 . . . . 74.239999999999995 111.107 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.48 -36.15 43.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 70.430000000000007 110.868 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.14 -34.62 11.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 73.319999999999993 111.126 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -118.82 70.18 9.58 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.625 0.726 . . . . 73.420000000000002 110.883 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.75 -32.65 18.21 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.718 2.278 . . . . 73.540000000000006 112.361 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -59.17 -44.6 92.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 71.340000000000003 110.898 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.07 -54.65 44.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 71.239999999999995 111.073 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.79 -60.3 3.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 74.349999999999994 111.148 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.85 -33.27 23.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 74.129999999999995 110.888 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -56.01 -38.77 70.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 73.200000000000003 110.881 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -94.63 19.22 10.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 74.299999999999997 110.884 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 47.76 77.84 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 72.150000000000006 110.903 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.6 p -120.04 142.47 35.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 70.25 111.121 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.5 m -119.58 -37.66 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 73.219999999999999 111.124 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 39.3 m -89.97 140.22 29.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 72.519999999999996 110.9 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.52 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.0 mt -55.82 -58.02 18.31 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.596 0.712 . . . . 71.319999999999993 111.09 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.5 Cg_endo -69.79 79.21 0.97 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.649 2.232 . . . . 74.409999999999997 112.342 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 85.6 m -123.37 108.05 12.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.226 -0.443 . . . . 64.340000000000003 111.147 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 18.8 ttp -109.97 142.1 41.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 63.409999999999997 110.903 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.2 mt -127.42 129.49 70.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 75.450000000000003 111.135 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.42 106.3 18.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 72.150000000000006 110.908 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -89.7 169.99 10.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 73.230000000000004 110.882 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -163.01 92.5 0.76 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 71.430000000000007 110.894 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.52 37.06 9.91 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.777 -0.725 . . . . 71.420000000000002 112.478 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.12 38.3 63.55 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.722 -0.752 . . . . 72.299999999999997 112.503 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 85.2 m -161.02 133.94 4.59 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.579 0.704 . . . . 75.439999999999998 111.171 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 107.32 1.82 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.706 2.271 . . . . 64.049999999999997 112.367 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.7 m -98.55 -33.17 4.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 73.099999999999994 111.118 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.9 mmtm -130.28 163.52 26.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 74.420000000000002 110.928 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.1 ttp180 -155.12 114.12 3.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 74.329999999999998 110.885 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.7 mp -129.83 129.88 66.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 75.400000000000006 111.134 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.2 m -128.49 141.69 45.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 72.329999999999998 111.135 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 132.59 130.92 3.15 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.765 -0.731 . . . . 73.150000000000006 112.482 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.37 59.1 3.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.845 0.355 . . . . 72.140000000000001 111.111 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.25 171.75 8.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 74.420000000000002 110.92 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -67.99 -178.67 14.62 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.771 -0.728 . . . . 74.409999999999997 112.492 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -44.14 72.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.821 0.343 . . . . 75.120000000000005 110.898 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.88 -34.46 65.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 73.209999999999994 111.058 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.408 ' HA ' ' HG2' ' A' ' 109' ' ' ARG . . . -87.97 -56.18 3.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 72.109999999999999 111.113 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -51.42 -35.19 38.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.448 . . . . 70.140000000000001 110.906 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.7 tt -68.98 -60.53 2.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 72.299999999999997 110.904 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.408 ' HG2' ' HA ' ' A' ' 106' ' ' ALA . 14.6 ptp180 -54.59 -35.12 63.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 73.150000000000006 110.864 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -53.24 -24.62 11.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 74.200000000000003 110.878 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.5 mt -84.75 -67.93 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 75.010000000000005 111.153 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.34 -46.86 66.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 73.120000000000005 110.892 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -55.42 -34.47 64.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 73.519999999999996 110.85 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.28 -37.1 69.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 71.319999999999993 111.122 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 73.409999999999997 110.905 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.9 p . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.804 0.335 . . . . 72.420000000000002 111.146 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 72.8 t -149.66 144.3 17.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.428 . . . . 74.109999999999999 111.124 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 t -69.13 127.24 32.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 74.319999999999993 111.162 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.9 t -92.9 132.41 37.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 64.109999999999999 111.126 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.72 177.71 0.2 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 72.109999999999999 111.141 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.53 -48.35 12.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 75.0 110.842 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.6 t -71.16 -52.05 21.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 72.349999999999994 110.865 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.8 t -58.54 -19.71 40.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 71.409999999999997 111.16 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -51.51 -30.71 21.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 75.219999999999999 110.855 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.33 -33.16 67.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 74.129999999999995 110.882 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.4 m -91.67 -16.09 27.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 74.040000000000006 111.162 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -93.48 -71.35 0.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 72.450000000000003 110.832 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.2 t -70.34 -70.42 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 72.239999999999995 111.114 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.6 mt -40.72 -60.42 1.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 75.510000000000005 110.919 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -50.05 -57.85 6.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 71.140000000000001 110.893 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.4 m -52.49 147.02 8.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 75.409999999999997 110.86 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -95.34 -45.67 7.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 75.230000000000004 110.839 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -51.11 160.56 0.84 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.53 0.681 . . . . 74.319999999999993 111.137 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 132.08 22.48 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.686 2.257 . . . . 74.420000000000002 112.318 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 62.8 t -102.3 134.24 43.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 74.409999999999997 111.107 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.77 116.41 32.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 70.030000000000001 110.948 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.4 t -94.07 143.51 11.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 74.420000000000002 111.115 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.76 99.85 5.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 64.319999999999993 110.881 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -100.96 95.88 6.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 73.310000000000002 110.867 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -152.05 -167.73 2.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.45 . . . . 73.230000000000004 110.92 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.13 -165.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 75.109999999999999 111.065 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.435 ' O ' ' CB ' ' A' ' 39' ' ' TRP . 4.9 m-20 -77.66 12.6 1.59 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.237 -0.438 . . . . 75.409999999999997 110.888 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.436 ' N ' ' CD1' ' A' ' 39' ' ' TRP . 1.9 m0 78.25 90.32 0.06 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 73.5 110.91 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -174.84 -56.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 72.340000000000003 110.878 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.05 -70.89 1.3 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.72 -0.752 . . . . 53.439999999999998 112.528 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.78 -29.18 24.2 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.714 2.276 . . . . 74.140000000000001 112.365 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -61.54 -32.17 72.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 72.430000000000007 110.899 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -63.74 -30.68 71.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 72.040000000000006 110.905 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 2.0 mtt -83.78 -43.29 15.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 70.219999999999999 110.836 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 t -93.93 22.49 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 74.430000000000007 111.121 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.472 ' N ' ' HD2' ' A' ' 48' ' ' PRO . . . -74.75 -60.73 1.21 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.617 0.723 . . . . 75.140000000000001 111.135 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 47' ' ' ALA . 53.4 Cg_endo -69.79 -49.99 0.5 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.677 2.251 . . . . 73.340000000000003 112.307 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.1 m -53.6 -29.68 17.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 73.319999999999993 111.128 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.9 tp -72.18 -42.07 66.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.476 . . . . 75.340000000000003 110.972 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -64.28 -36.38 83.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 74.420000000000002 110.898 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -55.82 -69.56 0.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 74.340000000000003 110.862 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.7 mt -54.83 -36.94 39.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 61.240000000000002 111.128 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 74.209999999999994 111.096 179.82 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.431 ' C ' ' CD2' ' A' ' 61' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.939 0.399 . . . . 73.549999999999997 110.87 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.15 122.27 46.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 74.219999999999999 110.928 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.9 t -121.6 112.57 35.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 74.349999999999994 111.147 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -121.94 129.88 52.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 72.200000000000003 111.095 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.78 154.55 26.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 72.420000000000002 110.937 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.7 tp -140.41 137.09 33.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 72.239999999999995 110.925 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.25 149.26 30.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 60.039999999999999 110.884 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.9 t -90.74 -36.17 7.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 75.010000000000005 111.117 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.1 -35.24 64.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 73.219999999999999 110.853 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.33 -32.56 13.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 75.209999999999994 111.116 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -117.01 68.36 4.5 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.611 0.72 . . . . 72.310000000000002 110.883 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -33.09 17.37 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.692 2.261 . . . . 71.209999999999994 112.348 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -67.37 -36.42 81.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 75.439999999999998 110.884 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.78 -49.58 76.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 64.040000000000006 111.078 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.62 -60.86 2.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 75.230000000000004 111.136 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 14.0 ttp85 -51.22 -34.71 33.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 74.230000000000004 110.828 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -51.93 -38.23 55.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.244 -0.435 . . . . 74.430000000000007 110.858 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -106.53 28.06 8.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 70.120000000000005 110.858 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 49.72 61.14 3.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 70.400000000000006 110.903 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 85.2 t -96.44 136.56 26.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 74.430000000000007 111.117 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.9 m -127.47 -36.48 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 54.439999999999998 111.137 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.7 t -97.06 143.84 27.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 75.129999999999995 110.825 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.519 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.9 mt -56.86 -57.59 23.18 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.624 0.726 . . . . 73.400000000000006 111.153 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 54.4 Cg_endo -69.71 76.88 1.09 Allowed 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.704 2.269 . . . . 72.329999999999998 112.35 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 68.8 m -116.67 127.59 54.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 73.340000000000003 111.11 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.3 tpp -128.35 140.73 51.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 71.310000000000002 110.838 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 19.2 mt -127.82 129.54 69.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 74.129999999999995 111.151 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.15 104.83 16.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 73.519999999999996 110.943 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -90.01 170.14 10.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 73.340000000000003 110.899 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -164.35 91.55 0.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 73.120000000000005 110.922 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.2 32.61 16.53 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.715 -0.755 . . . . 62.009999999999998 112.476 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.14 39.48 37.03 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.763 -0.732 . . . . 64.230000000000004 112.501 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.0 m -160.36 133.66 4.79 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.572 0.701 . . . . 71.129999999999995 111.118 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 94.52 0.53 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.721 2.28 . . . . 74.019999999999996 112.362 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.2 m -85.11 -30.32 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 74.450000000000003 111.083 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.91 164.43 30.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 75.219999999999999 110.886 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -159.29 118.26 2.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 75.450000000000003 110.907 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.5 mp -128.15 139.89 50.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 73.540000000000006 111.129 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.0 m -143.37 154.33 16.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 75.120000000000005 111.106 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 136.75 -30.04 2.7 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.743 -0.742 . . . . 43.149999999999999 112.457 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 63.59 83.04 0.17 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.863 0.363 . . . . 54.200000000000003 111.119 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.98 179.15 6.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 75.099999999999994 110.874 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.24 149.25 39.27 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.727 -0.749 . . . . 71.420000000000002 112.476 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.53 -42.73 44.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.775 0.322 . . . . 75.340000000000003 110.898 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.57 -38.5 72.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 55.450000000000003 111.131 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.93 -59.15 2.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 64.329999999999998 111.122 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -47.83 -41.01 22.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 74.299999999999997 110.881 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.4 tt -56.46 -41.99 77.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 71.519999999999996 110.872 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -63.75 -42.35 97.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 73.439999999999998 110.868 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -52.38 -25.15 9.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.19 -0.459 . . . . 62.409999999999997 110.887 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.7 mt -85.49 -67.87 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 74.040000000000006 111.112 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -52.3 -48.92 65.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 71.519999999999996 110.867 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -58.88 -33.71 70.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 70.409999999999997 110.871 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.76 -36.5 59.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 62.200000000000003 111.135 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 61.420000000000002 110.916 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.3 p . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.816 0.341 . . . . 74.349999999999994 111.125 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.1 p -160.23 155.59 3.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 74.329999999999998 111.122 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.5 t -68.29 156.9 36.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 73.400000000000006 111.154 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.9 t -118.99 127.48 75.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 75.140000000000001 111.155 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.23 162.88 4.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 74.230000000000004 111.201 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -72.93 -35.68 67.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 71.109999999999999 110.826 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.3 t -75.51 -34.42 60.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 73.530000000000001 110.87 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.6 t -86.52 -18.43 31.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.075 -0.512 . . . . 74.420000000000002 111.151 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -51.07 -30.68 16.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 75.510000000000005 110.858 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.413 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.8 OUTLIER -72.52 -34.02 67.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 74.209999999999994 110.89 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.1 m -91.51 -16.49 27.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 63.229999999999997 111.138 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.48 -71.33 0.66 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 64.340000000000003 110.845 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.9 t -70.26 -70.67 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 74.109999999999999 111.166 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.413 ' HB2' ' HA ' ' A' ' 21' ' ' LYS . 7.8 mt -40.55 -60.31 1.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 72.140000000000001 110.884 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -50.09 -57.87 6.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 62.229999999999997 110.87 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.8 m -53.33 156.83 2.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 64.209999999999994 110.836 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -98.73 -46.57 5.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.484 . . . . 73.310000000000002 110.861 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.8 159.83 9.28 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.593 0.711 . . . . 73.530000000000001 111.125 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 149.44 67.23 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.669 2.246 . . . . 73.329999999999998 112.332 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 84.1 t -112.65 127.63 69.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 71.219999999999999 111.149 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.7 mt -114.81 99.81 7.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 74.140000000000001 110.93 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.6 p -97.39 146.17 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 75.439999999999998 111.142 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -133.88 108.67 8.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.462 . . . . 73.310000000000002 110.86 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -92.11 94.84 9.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 73.510000000000005 110.868 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -138.18 -167.72 2.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.101 -0.5 . . . . 74.299999999999997 110.918 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.03 -166.62 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 44.240000000000002 111.101 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.444 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 9.6 p-10 -78.17 12.27 1.94 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.231 -0.441 . . . . 64.150000000000006 110.87 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.455 ' N ' ' CD1' ' A' ' 39' ' ' TRP . 1.6 m0 77.0 93.32 0.07 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.233 -0.44 . . . . 72.400000000000006 110.916 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 9.5 t -174.06 -56.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.432 . . . . 64.25 110.861 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.75 -69.29 1.41 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.787 -0.72 . . . . 75.129999999999995 112.499 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -43.58 2.57 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.717 2.278 . . . . 71.120000000000005 112.335 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 33.9 t -52.66 -34.63 52.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.44 . . . . 73.209999999999994 110.883 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -64.44 -35.2 80.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.452 . . . . 72.209999999999994 110.885 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 88.2 mmm -84.59 -36.66 21.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 73.349999999999994 110.867 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.3 t -95.29 21.33 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.243 -0.435 . . . . 73.140000000000001 111.15 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.463 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . . . -78.76 -61.39 0.52 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.6 0.715 . . . . 74.439999999999998 111.089 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.463 ' CD ' ' CB ' ' A' ' 47' ' ' ALA . 53.6 Cg_endo -69.74 -49.84 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.717 2.278 . . . . 75.120000000000005 112.307 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.4 m -52.23 -30.64 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.236 -0.438 . . . . 64.120000000000005 111.114 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.5 tt -84.29 -35.16 23.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 70.310000000000002 110.915 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -58.94 -35.47 73.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 74.230000000000004 110.9 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -51.28 -58.25 6.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 71.25 110.885 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.7 mp -51.56 -34.86 16.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 74.150000000000006 111.134 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 63.130000000000003 111.109 179.779 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.6 pp . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.885 0.374 . . . . 74.299999999999997 110.922 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -84.41 147.49 27.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 74.120000000000005 110.857 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.8 t -130.47 103.41 8.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 75.230000000000004 111.088 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.6 129.76 50.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 54.210000000000001 111.112 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -129.87 142.49 50.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 74.420000000000002 110.915 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.7 tp -137.67 141.17 41.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 73.310000000000002 110.877 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.51 108.99 18.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 73.019999999999996 110.834 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 70.0 t -60.06 -35.78 63.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 54.219999999999999 111.145 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -51.36 -35.07 36.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 74.019999999999996 110.838 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.89 -35.2 10.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 61.439999999999998 111.07 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -116.09 70.56 4.0 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.667 0.746 . . . . 73.219999999999999 110.882 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -31.73 19.92 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.686 2.257 . . . . 73.129999999999995 112.33 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -64.1 -35.74 81.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 72.549999999999997 110.933 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.23 -48.8 77.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 55.539999999999999 111.135 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.63 -61.16 2.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 73.340000000000003 111.084 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.7 ttp85 -51.3 -34.05 31.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 74.329999999999998 110.867 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -51.71 -39.65 58.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 64.209999999999994 110.867 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -104.29 26.43 8.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 74.010000000000005 110.892 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 51.0 mm-40 49.78 65.57 1.38 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 75.219999999999999 110.916 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 91.7 t -96.82 143.63 12.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.239 -0.437 . . . . 72.010000000000005 111.127 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.7 m -123.64 -38.71 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 73.230000000000004 111.066 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.72 156.82 17.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 73.109999999999999 110.866 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.518 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 2.3 mm -64.6 -57.84 15.48 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.588 0.709 . . . . 74.430000000000007 111.095 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.5 Cg_endo -69.78 70.6 1.58 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.673 2.249 . . . . 70.319999999999993 112.329 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 96.9 m -104.81 137.97 41.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.232 -0.44 . . . . 61.450000000000003 111.143 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -139.04 127.99 23.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 74.549999999999997 110.905 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.3 mp -114.36 112.76 41.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 63.350000000000001 111.122 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.53 105.71 11.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.47 . . . . 73.109999999999999 110.934 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -93.13 166.5 12.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 62.350000000000001 110.883 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -170.61 97.1 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 73.129999999999995 110.9 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.98 38.99 9.68 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.713 -0.756 . . . . 75.120000000000005 112.489 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.49 45.02 88.7 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.736 -0.745 . . . . 62.240000000000002 112.444 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.3 m -170.25 134.67 1.14 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.555 0.693 . . . . 74.019999999999996 111.161 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 82.49 0.75 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.667 2.245 . . . . 75.230000000000004 112.336 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.0 m -60.17 -34.08 55.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 74.219999999999999 111.141 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -147.87 170.1 18.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 74.319999999999993 110.911 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.37 123.77 6.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 75.239999999999995 110.847 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.26 128.84 64.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 74.120000000000005 111.118 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.4 p -128.42 141.74 45.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 74.049999999999997 111.163 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 122.64 140.23 5.7 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.749 -0.739 . . . . 53.039999999999999 112.502 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.53 93.9 9.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.811 0.339 . . . . 71.219999999999999 111.126 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.77 -176.05 2.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 75.420000000000002 110.859 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.18 163.62 54.52 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.739 -0.744 . . . . 63.439999999999998 112.489 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.79 -36.15 57.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.748 0.308 . . . . 73.530000000000001 110.897 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.5 -54.6 10.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 63.409999999999997 111.084 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.76 -53.99 49.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 71.310000000000002 111.125 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -50.78 -39.48 52.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 74.200000000000003 110.957 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.82 -52.77 39.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 74.129999999999995 110.883 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.51 -40.59 83.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 74.5 110.918 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -47.12 -28.65 1.86 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 73.019999999999996 110.933 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.6 mt -93.09 -69.52 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 74.120000000000005 111.163 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.07 -59.96 3.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 71.5 110.953 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -49.51 -35.9 21.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 72.420000000000002 110.835 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.56 -35.77 63.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 73.239999999999995 111.066 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 74.219999999999999 110.923 -179.964 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.1 p . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.81 0.338 . . . . 71.200000000000003 111.162 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 t -132.67 150.41 33.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 74.150000000000006 111.12 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.6 t -86.86 130.6 34.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 75.329999999999998 111.122 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.6 t -89.97 125.72 42.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 73.230000000000004 111.102 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.5 173.88 0.49 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 71.140000000000001 111.131 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -74.96 -47.39 29.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 72.109999999999999 110.848 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.1 m -71.62 -51.64 22.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 62.240000000000002 110.861 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.3 t -59.28 -19.12 43.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 74.340000000000003 111.18 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -51.24 -30.26 16.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 74.209999999999994 110.898 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.55 -33.65 66.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 74.340000000000003 110.869 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.0 m -91.56 -16.08 27.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.196 -0.456 . . . . 73.340000000000003 111.181 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.44 -71.32 0.66 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 72.340000000000003 110.864 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.4 t -70.39 -70.5 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.476 . . . . 73.420000000000002 111.109 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.6 mt -40.57 -59.99 1.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 70.430000000000007 110.925 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -50.57 -52.64 37.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.458 . . . . 75.450000000000003 110.853 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.1 t -65.31 148.61 51.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 73.519999999999996 110.839 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -102.32 -38.2 7.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.131 -0.486 . . . . 75.129999999999995 110.895 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -52.05 160.23 1.24 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.527 0.68 . . . . 74.329999999999998 111.143 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 127.46 14.62 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.651 2.234 . . . . 73.109999999999999 112.385 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 41.1 t -93.25 132.0 38.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 64.519999999999996 111.132 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -102.85 99.8 9.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 75.329999999999998 110.917 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.2 m -121.46 150.2 24.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 72.510000000000005 111.137 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.01 123.97 31.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 74.540000000000006 110.902 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -89.71 88.78 7.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 73.310000000000002 110.87 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -142.59 -169.19 2.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.477 . . . . 74.319999999999993 110.952 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.87 -163.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.43 . . . . 61.509999999999998 111.116 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.471 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 2.6 m-20 -77.88 12.88 1.55 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 75.230000000000004 110.877 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.497 ' N ' ' CD1' ' A' ' 39' ' ' TRP . 0.6 OUTLIER 74.95 96.18 0.07 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 71.530000000000001 110.954 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -170.1 -53.76 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 72.239999999999995 110.875 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.29 -70.72 1.32 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.762 -0.732 . . . . 74.209999999999994 112.474 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.67 -34.18 15.41 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.694 2.263 . . . . 74.519999999999996 112.347 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 38.4 t -51.8 -33.73 36.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 74.099999999999994 110.883 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.4 mtmt -65.43 -35.3 80.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 75.340000000000003 110.952 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 15.1 mtp -83.49 -39.95 19.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 74.310000000000002 110.883 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.9 t -94.54 22.93 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 70.129999999999995 111.152 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.456 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . . . -75.13 -61.16 1.05 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.558 0.694 . . . . 62.43 111.077 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.456 ' CD ' ' CB ' ' A' ' 47' ' ' ALA . 52.9 Cg_endo -69.8 -50.65 0.44 Allowed 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.671 2.248 . . . . 72.049999999999997 112.322 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.3 m -52.53 -30.04 14.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 74.329999999999998 111.141 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.0 tp -74.5 -42.57 58.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 72.530000000000001 110.881 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -57.8 -36.72 72.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 73.540000000000006 110.87 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -57.74 -67.79 0.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 52.350000000000001 110.884 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.7 mp -50.94 -34.84 14.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 73.400000000000006 111.118 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 74.209999999999994 111.119 179.831 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.1 pp . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.904 0.383 . . . . 75.019999999999996 110.895 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -79.9 118.96 22.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 75.439999999999998 110.924 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.6 t -111.9 107.16 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 72.439999999999998 111.108 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -126.65 170.9 11.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 65.299999999999997 111.093 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 31.1 mttt -145.29 148.13 33.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.448 . . . . 73.049999999999997 110.845 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 tp -125.62 140.55 52.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 73.319999999999993 110.879 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -87.79 119.76 28.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 74.150000000000006 110.831 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.71 -28.08 44.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 72.409999999999997 111.152 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -68.94 -34.98 76.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.178 -0.465 . . . . 74.329999999999998 110.875 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.32 -28.7 23.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 74.450000000000003 111.087 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -115.43 69.37 2.85 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.564 0.697 . . . . 71.510000000000005 110.896 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 -32.06 19.01 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.647 2.231 . . . . 73.439999999999998 112.331 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -74.83 -35.1 62.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 73.310000000000002 110.883 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.04 -40.87 91.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 74.010000000000005 111.111 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.96 -64.85 0.76 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 74.200000000000003 111.086 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -51.15 -34.88 33.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 75.510000000000005 110.879 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.82 -36.33 80.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 54.009999999999998 110.883 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -98.45 24.69 7.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 75.340000000000003 110.88 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 49.09 54.05 11.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 73.549999999999997 110.945 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 97.6 t -90.15 136.66 23.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 73.030000000000001 111.164 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.8 m -131.58 -39.07 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 74.239999999999995 111.132 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.1 t -97.04 155.16 16.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 75.129999999999995 110.888 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.509 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 2.3 mm -66.47 -57.96 11.28 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.601 0.715 . . . . 75.299999999999997 111.124 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.4 Cg_endo -69.71 70.07 1.58 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.669 2.246 . . . . 73.310000000000002 112.355 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 62.0 m -109.39 149.39 29.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 64.340000000000003 111.127 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 26.6 ttm -138.63 150.35 46.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 74.219999999999999 110.843 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.9 mt -142.76 109.92 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 73.420000000000002 111.139 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.68 105.85 11.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.47 . . . . 75.129999999999995 110.926 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -90.29 169.79 10.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 73.530000000000001 110.855 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -165.44 95.34 0.64 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 73.540000000000006 110.863 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.67 37.72 13.31 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.753 -0.737 . . . . 74.239999999999995 112.474 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.38 41.01 86.69 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.71 -0.757 . . . . 33.329999999999998 112.494 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 85.4 m -160.76 134.05 4.77 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.643 0.735 . . . . 74.420000000000002 111.088 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 86.94 0.57 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.703 2.269 . . . . 72.219999999999999 112.327 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.0 m -76.66 -34.58 23.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 75.450000000000003 111.173 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.92 164.12 26.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 75.340000000000003 110.897 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.61 119.83 4.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 74.219999999999999 110.895 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.8 mp -138.31 130.12 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 75.420000000000002 111.133 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.6 p -126.11 143.44 39.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 71.040000000000006 111.104 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 128.83 132.61 3.54 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.771 -0.728 . . . . 74.200000000000003 112.486 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.19 75.05 9.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.854 0.359 . . . . 74.409999999999997 111.138 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.39 171.63 7.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 71.329999999999998 110.896 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.57 171.6 5.45 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.696 -0.764 . . . . 72.239999999999995 112.496 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -60.1 -44.39 94.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.784 0.326 . . . . 74.150000000000006 110.888 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -52.49 -66.29 0.41 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 74.5 111.09 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.71 -59.36 4.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 71.209999999999994 111.095 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -47.31 -35.48 8.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 74.5 110.933 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.2 tp -71.19 -43.92 66.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 74.439999999999998 110.91 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 10.6 mtp85 -59.46 -41.82 90.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 75.409999999999997 110.876 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -53.03 -25.33 12.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 55.219999999999999 110.933 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.7 mt -86.04 -68.59 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 75.120000000000005 111.16 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -51.15 -49.57 60.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.151 -0.477 . . . . 71.219999999999999 110.894 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -58.53 -34.23 70.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 61.109999999999999 110.918 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.1 -36.33 61.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 63.399999999999999 111.124 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 mt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 74.209999999999994 110.902 -179.979 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.1 p . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.832 0.348 . . . . 73.319999999999993 111.112 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.3 m -153.14 174.78 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 72.150000000000006 111.147 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.1 t -75.69 127.21 32.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 72.109999999999999 111.174 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 49.1 t -94.77 125.91 47.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 74.430000000000007 111.136 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.27 174.0 0.44 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 62.439999999999998 111.152 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -75.1 -47.37 29.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 74.299999999999997 110.81 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.5 t -72.1 -51.52 21.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 75.310000000000002 110.847 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.8 t -59.12 -19.2 42.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.478 . . . . 74.329999999999998 111.124 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -50.88 -30.96 16.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 70.25 110.868 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.411 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -71.78 -34.13 69.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 72.299999999999997 110.92 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.0 m -91.13 -15.91 28.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 74.329999999999998 111.15 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.34 -71.41 0.65 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.441 . . . . 65.230000000000004 110.907 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.3 t -70.71 -70.34 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.239 -0.437 . . . . 75.150000000000006 111.127 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 21' ' ' LYS . 7.4 mt -40.55 -60.31 1.15 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 64.030000000000001 110.921 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -50.36 -61.21 2.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.439 . . . . 74.409999999999997 110.874 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.7 t -56.55 161.33 2.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 73.400000000000006 110.821 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -109.92 -35.98 6.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.104 -0.498 . . . . 71.120000000000005 110.884 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -53.44 158.88 2.57 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.585 0.707 . . . . 72.349999999999994 111.103 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 125.66 12.42 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.631 2.221 . . . . 72.150000000000006 112.387 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 94.6 t -102.1 115.88 44.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 73.239999999999995 111.148 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.9 mp -94.58 99.73 11.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 74.349999999999994 110.874 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.3 p -98.59 140.88 17.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.14 -0.482 . . . . 74.329999999999998 111.075 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -124.8 102.08 7.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 73.549999999999997 110.84 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -83.4 89.57 7.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 73.340000000000003 110.889 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -135.6 -168.58 2.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.148 -0.478 . . . . 72.209999999999994 110.903 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.54 -164.48 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 75.530000000000001 111.096 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.45 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 9.5 p-10 -78.68 12.71 1.94 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 75.340000000000003 110.861 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.476 ' N ' ' CD1' ' A' ' 39' ' ' TRP . 1.0 OUTLIER 76.03 95.15 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 71.540000000000006 110.935 -179.94 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 46.1 t -172.25 -56.22 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 73.420000000000002 110.849 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.51 -70.71 1.32 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.721 -0.752 . . . . 71.310000000000002 112.478 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -32.63 18.36 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.639 2.226 . . . . 73.530000000000001 112.324 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 35.8 t -54.74 -40.69 69.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.436 . . . . 74.239999999999995 110.907 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.8 pttp -64.34 -26.46 68.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 74.329999999999998 110.861 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 5.3 mtp -87.15 -42.85 12.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.276 -0.42 . . . . 74.439999999999998 110.871 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.1 t -94.31 21.44 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 75.049999999999997 111.147 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.463 ' N ' ' HD2' ' A' ' 48' ' ' PRO . . . -76.75 -61.17 0.76 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.562 0.696 . . . . 65.349999999999994 111.088 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 47' ' ' ALA . 53.7 Cg_endo -69.81 -49.77 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.678 2.252 . . . . 64.400000000000006 112.344 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.3 m -51.24 -30.85 10.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 75.400000000000006 111.105 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.4 tp -90.16 -35.89 15.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 72.299999999999997 110.886 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -68.26 -24.16 64.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 75.209999999999994 110.925 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -65.97 -60.71 2.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.478 . . . . 74.439999999999998 110.873 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.6 mp -61.52 -33.02 55.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 72.430000000000007 111.118 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 73.150000000000006 111.101 179.823 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.863 0.363 . . . . 72.310000000000002 110.918 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.4 ttpp -107.62 141.39 39.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 71.120000000000005 110.93 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 50.4 t -101.71 108.67 24.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.22 -0.446 . . . . 75.209999999999994 111.182 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -122.27 128.91 51.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 73.450000000000003 111.103 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.8 pttt -125.99 157.61 37.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 75.450000000000003 110.882 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 31.3 tp -147.95 146.45 28.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 71.239999999999995 110.882 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -82.96 119.88 24.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 75.0 110.925 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 84.7 t -48.14 -39.52 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 75.450000000000003 111.086 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.02 -33.31 56.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 72.230000000000004 110.862 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.82 -34.68 45.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 75.25 111.043 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -118.39 66.91 6.76 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.627 0.727 . . . . 74.209999999999994 110.874 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -32.85 17.52 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.686 2.257 . . . . 62.340000000000003 112.327 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -80.92 -38.65 27.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 64.510000000000005 110.925 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.99 -43.32 99.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 65.430000000000007 111.149 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.76 -67.27 0.27 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 74.409999999999997 111.136 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.1 ttm-85 -51.19 -34.07 30.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.259 -0.428 . . . . 73.420000000000002 110.886 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.43 -40.19 90.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 75.439999999999998 110.867 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -98.89 26.68 5.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 74.219999999999999 110.867 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 49.85 75.44 0.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 73.430000000000007 110.919 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 90.9 t -116.45 90.55 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 72.049999999999997 111.134 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 61.1 t -84.4 -42.61 17.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 63.030000000000001 111.111 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.6 m -96.75 152.73 18.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 75.040000000000006 110.866 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.514 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.3 mt -63.9 -57.64 17.94 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.598 0.713 . . . . 75.219999999999999 111.112 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 54.0 Cg_endo -69.74 75.43 1.21 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.743 2.295 . . . . 74.230000000000004 112.336 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 84.8 m -117.17 100.89 8.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 72.209999999999994 111.159 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 22.5 ttp -100.76 112.08 24.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 74.239999999999995 110.883 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 25.2 mt -101.33 118.0 47.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 71.349999999999994 111.165 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.9 tt -81.15 110.3 16.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 73.319999999999993 110.923 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -97.47 170.27 9.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.477 . . . . 74.230000000000004 110.88 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -167.3 97.95 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 75.329999999999998 110.903 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.68 38.43 10.63 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.719 -0.753 . . . . 75.299999999999997 112.509 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 65.76 37.12 93.13 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.702 -0.761 . . . . 65.209999999999994 112.458 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 86.6 m -158.43 133.89 5.85 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.584 0.707 . . . . 75.040000000000006 111.147 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 112.64 3.13 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.697 2.265 . . . . 75.099999999999994 112.322 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.6 m -99.63 -33.51 3.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.443 . . . . 75.310000000000002 111.115 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.5 mmtt -140.88 169.66 17.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 71.400000000000006 110.864 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -153.93 111.87 3.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 75.430000000000007 110.875 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.6 mp -112.75 127.95 69.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 75.129999999999995 111.164 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.0 p -141.69 144.7 25.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 73.299999999999997 111.155 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 139.58 -28.65 2.53 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.786 -0.721 . . . . 65.400000000000006 112.518 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 64.5 96.57 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.822 0.344 . . . . 71.530000000000001 111.101 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.15 -179.25 5.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 74.519999999999996 110.884 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.29 176.76 2.68 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.745 -0.74 . . . . 51.25 112.508 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.16 -44.57 71.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.799 0.333 . . . . 73.430000000000007 110.896 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.58 -32.9 70.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 72.030000000000001 111.12 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.417 ' HA ' ' HG2' ' A' ' 109' ' ' ARG . . . -85.43 -58.39 2.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 74.329999999999998 111.082 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.12 -35.51 35.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 71.219999999999999 110.93 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.7 tt -68.83 -59.44 3.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 73.030000000000001 110.91 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.417 ' HG2' ' HA ' ' A' ' 106' ' ' ALA . 15.8 ptm180 -56.91 -32.81 66.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 74.219999999999999 110.867 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -51.9 -25.46 8.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 72.530000000000001 110.878 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.8 mt -85.56 -69.03 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 74.400000000000006 111.148 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -51.56 -49.88 61.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 71.430000000000007 110.92 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -54.12 -34.68 60.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 72.230000000000004 110.84 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.17 -34.95 66.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 75.349999999999994 111.1 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.9 mt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 62.530000000000001 110.889 -179.951 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.2 p . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.836 0.35 . . . . 71.439999999999998 111.109 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.6 m -154.53 -179.85 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 75.140000000000001 111.16 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.3 t -72.64 151.16 42.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 63.450000000000003 111.149 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.1 p -119.26 151.87 21.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 75.540000000000006 111.144 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.37 162.06 13.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 73.010000000000005 111.109 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -77.4 -52.33 9.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 73.439999999999998 110.821 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.9 t -57.76 -36.37 72.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 64.329999999999998 110.859 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.0 t -84.65 -17.83 37.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 75.219999999999999 111.137 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -49.92 -31.49 12.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 75.540000000000006 110.924 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.95 -34.46 71.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 72.200000000000003 110.869 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.5 m -91.01 -15.2 30.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 75.209999999999994 111.157 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.42 -70.61 0.69 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.231 -0.441 . . . . 73.0 110.862 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.3 t -72.06 -70.38 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 75.099999999999994 111.137 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.5 mt -40.41 -57.7 1.72 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.156 -0.475 . . . . 71.239999999999995 110.911 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -51.28 -60.04 3.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 74.140000000000001 110.852 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 55.5 p -51.67 139.47 20.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 71.140000000000001 110.838 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -88.82 -41.77 12.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 73.129999999999995 110.872 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.54 158.76 1.39 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.582 0.706 . . . . 71.400000000000006 111.18 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 129.8 18.27 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.703 2.269 . . . . 72.230000000000004 112.324 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 92.4 t -97.1 126.6 49.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.437 . . . . 75.340000000000003 111.135 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.8 mp -110.12 121.07 44.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 74.409999999999997 110.937 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.7 m -132.81 149.9 32.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 75.540000000000006 111.104 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.28 99.63 5.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 75.510000000000005 110.832 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -73.59 96.81 2.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 65.400000000000006 110.893 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -142.83 -168.6 2.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.168 -0.469 . . . . 74.439999999999998 110.914 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.401 ' C ' ' H ' ' A' ' 39' ' ' TRP . . . -58.49 -162.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 54.240000000000002 111.133 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.484 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 4.1 t70 -77.96 13.72 1.32 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.268 -0.424 . . . . 62.039999999999999 110.876 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.484 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 0.5 OUTLIER 74.95 94.34 0.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.204 -0.453 . . . . 73.310000000000002 110.887 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 35.0 t -174.79 -50.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 72.349999999999994 110.885 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.24 -69.55 1.39 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.724 -0.75 . . . . 75.219999999999999 112.459 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 -28.47 24.96 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.684 2.256 . . . . 71.129999999999995 112.351 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.9 p -53.95 -25.53 21.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 75.450000000000003 110.95 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.2 pttt -77.96 -31.48 50.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 73.400000000000006 110.847 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 16.1 mtt -85.82 -35.4 20.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 74.549999999999997 110.886 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 t -100.36 22.07 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.246 -0.434 . . . . 75.129999999999995 111.122 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.458 ' N ' ' HD2' ' A' ' 48' ' ' PRO . . . -74.36 -61.21 1.23 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.556 0.693 . . . . 74.25 111.091 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 47' ' ' ALA . 53.7 Cg_endo -69.73 -50.66 0.45 Allowed 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.732 2.288 . . . . 73.120000000000005 112.359 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.1 m -52.09 -29.98 12.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.459 . . . . 74.230000000000004 111.132 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.6 tp -75.04 -41.96 58.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 73.420000000000002 110.888 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -67.45 -34.34 76.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 70.319999999999993 110.872 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -52.84 -62.09 1.87 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 74.120000000000005 110.876 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.1 mt -51.21 -39.51 20.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 74.049999999999997 111.118 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 74.319999999999993 111.116 179.771 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.3 pp . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.854 0.359 . . . . 75.299999999999997 110.945 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.8 tttp -86.78 147.64 25.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.443 . . . . 64.400000000000006 110.888 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.4 t -140.74 106.56 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.421 . . . . 71.540000000000006 111.124 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.62 110.08 19.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 64.340000000000003 111.07 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.0 pttm -97.23 128.98 44.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 73.099999999999994 110.911 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.2 tp -105.15 146.08 29.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 74.420000000000002 110.909 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.86 97.37 7.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 70.230000000000004 110.86 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.1 m -49.08 -32.2 4.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 44.100000000000001 111.155 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -50.14 -32.5 16.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 72.340000000000003 110.904 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.99 -28.5 10.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 64.349999999999994 111.098 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.82 72.22 2.02 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.631 0.729 . . . . 75.150000000000006 110.9 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -30.99 21.2 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.661 2.24 . . . . 74.409999999999997 112.337 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -70.6 -42.88 70.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 73.349999999999994 110.895 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.24 -48.35 62.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 75.040000000000006 111.081 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.76 -67.31 0.27 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 74.340000000000003 111.157 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.1 ttp85 -51.87 -31.4 27.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 72.209999999999994 110.868 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -51.64 -37.96 52.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 70.409999999999997 110.87 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -105.24 21.44 17.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 75.420000000000002 110.888 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 65.3 mm-40 46.61 82.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.115 -0.493 . . . . 73.409999999999997 110.917 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.0 p -122.09 132.77 70.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 75.230000000000004 111.149 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.8 t -120.46 45.81 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 74.230000000000004 111.13 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.05 144.91 1.03 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 73.450000000000003 110.847 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.514 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 4.3 mt -66.44 -58.04 11.16 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.571 0.7 . . . . 75.549999999999997 111.116 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.2 Cg_endo -69.79 73.96 1.34 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.699 2.266 . . . . 74.25 112.336 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 97.6 m -117.77 129.57 55.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 72.409999999999997 111.145 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -120.78 144.02 48.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.443 . . . . 71.120000000000005 110.874 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 17.5 mt -131.7 122.89 50.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 74.519999999999996 111.129 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.28 105.4 17.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.149 -0.478 . . . . 73.430000000000007 110.889 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -89.45 169.84 11.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 74.409999999999997 110.933 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.12 91.16 0.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 75.040000000000006 110.886 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.33 33.13 12.14 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.706 -0.759 . . . . 74.120000000000005 112.49 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.99 38.83 39.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.761 -0.733 . . . . 63.229999999999997 112.477 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 85.5 m -161.26 133.8 4.41 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.577 0.704 . . . . 65.219999999999999 111.128 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 98.13 0.67 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.651 2.234 . . . . 75.219999999999999 112.352 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.6 m -87.65 -31.8 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 73.530000000000001 111.131 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.9 mmtm -132.42 166.0 22.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 73.299999999999997 110.915 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -159.76 115.0 2.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 71.299999999999997 110.866 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.5 mp -125.36 118.01 51.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 74.120000000000005 111.105 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.2 p -128.18 145.14 35.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 73.150000000000006 111.146 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 136.68 -28.31 2.87 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.796 -0.716 . . . . 75.329999999999998 112.475 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 64.49 106.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.821 0.344 . . . . 73.329999999999998 111.075 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.46 175.61 10.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 74.420000000000002 110.901 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.51 166.66 8.88 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.735 -0.745 . . . . 75.519999999999996 112.538 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.68 -36.51 84.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.766 0.317 . . . . 74.540000000000006 110.932 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.34 -31.33 72.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 75.439999999999998 111.102 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.46 -58.84 2.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 72.409999999999997 111.105 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.22 -47.53 35.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 74.530000000000001 110.929 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.0 tt -47.98 -41.53 25.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 75.329999999999998 110.905 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 44.4 mtp180 -76.51 -35.8 58.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 73.430000000000007 110.878 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -51.02 -24.68 3.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.229 -0.441 . . . . 74.439999999999998 110.862 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.0 mt -87.78 -68.94 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 73.209999999999994 111.143 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.88 -52.92 58.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 74.439999999999998 110.885 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -54.14 -34.47 60.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 71.310000000000002 110.858 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.87 -34.67 71.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 75.420000000000002 111.066 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 74.219999999999999 110.951 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.2 ttm . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.777 0.322 . . . . 75.310000000000002 110.828 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.44 124.98 36.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 75.420000000000002 111.114 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -99.99 -65.9 0.94 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 75.530000000000001 110.831 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -52.06 149.44 5.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 61.520000000000003 110.864 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -143.26 165.93 26.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 73.150000000000006 110.866 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -119.99 30.76 6.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 74.099999999999994 110.859 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -95.64 -36.47 11.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 73.230000000000004 110.814 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -52.26 -36.06 51.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.253 -0.431 . . . . 72.209999999999994 110.9 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 13.3 mtt -52.19 -37.32 54.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 73.120000000000005 110.887 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.8 t -53.91 127.89 28.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.433 . . . . 74.129999999999995 110.897 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.08 -97.84 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.741 -0.742 . . . . 71.319999999999993 112.499 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.2 p -63.4 115.68 4.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.824 0.345 . . . . 73.230000000000004 111.112 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.2 t -147.09 145.4 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 75.219999999999999 111.086 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.8 t -77.7 127.93 33.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 73.519999999999996 111.109 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.9 t -97.66 120.79 47.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 75.140000000000001 111.11 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.92 173.58 0.59 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 64.140000000000001 111.185 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -77.87 -41.64 36.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 75.450000000000003 110.878 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.3 m -69.6 -33.73 73.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 71.530000000000001 110.881 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.2 t -85.55 -18.19 34.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 74.349999999999994 111.178 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -51.05 -52.68 40.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 75.219999999999999 110.886 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.412 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -64.6 -14.67 58.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 74.099999999999994 110.864 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.6 m -92.99 -33.17 14.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.294 -0.412 . . . . 74.129999999999995 111.16 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -96.96 -71.56 0.67 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 64.310000000000002 110.878 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.4 t -51.48 -71.81 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 72.109999999999999 111.117 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.412 ' HB2' ' HA ' ' A' ' 21' ' ' LYS . 12.1 mt -41.71 -58.95 1.8 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 65.109999999999999 110.921 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -49.71 -64.81 0.7 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 73.430000000000007 110.857 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.6 t -55.49 145.88 21.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 71.420000000000002 110.848 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -107.36 35.92 2.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.487 . . . . 71.349999999999994 110.858 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.25 160.3 38.07 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 121.571 0.7 . . . . 75.310000000000002 111.123 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 106.42 1.67 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.695 2.263 . . . . 74.430000000000007 112.343 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 70.5 t -87.64 118.28 33.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 71.140000000000001 111.135 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.84 99.52 11.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.477 . . . . 73.310000000000002 110.919 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.6 p -100.16 138.99 22.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 74.200000000000003 111.116 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -125.3 121.83 35.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 61.539999999999999 110.851 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -101.1 89.83 3.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 74.510000000000005 110.845 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -133.3 -167.73 1.97 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.132 -0.486 . . . . 74.540000000000006 110.945 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.05 -166.32 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 65.25 111.069 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.445 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 3.6 m-20 -78.89 12.63 2.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 72.420000000000002 110.919 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.457 ' N ' ' CD1' ' A' ' 39' ' ' TRP . 1.4 m0 77.01 94.62 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 74.340000000000003 110.895 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -174.69 -57.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 54.149999999999999 110.84 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.09 -70.06 1.36 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.788 -0.72 . . . . 72.329999999999998 112.488 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 -44.01 2.31 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.681 2.254 . . . . 72.530000000000001 112.29 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 42.4 t -52.08 -34.73 45.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.433 . . . . 74.349999999999994 110.894 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.6 -34.14 77.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 73.219999999999999 110.845 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 11.3 mtt -85.25 -38.34 19.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 71.510000000000005 110.88 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.0 t -94.1 21.48 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 71.230000000000004 111.141 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.47 ' N ' ' HD2' ' A' ' 48' ' ' PRO . . . -77.18 -60.84 0.73 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.579 0.704 . . . . 74.409999999999997 111.112 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 47' ' ' ALA . 53.7 Cg_endo -69.71 -49.65 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.681 2.254 . . . . 72.319999999999993 112.38 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.4 m -50.49 -30.16 7.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 74.120000000000005 111.127 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.4 tt -84.01 -39.69 19.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.202 -0.454 . . . . 74.340000000000003 110.91 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -61.43 -35.57 77.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 74.329999999999998 110.879 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -55.1 -60.56 3.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 74.439999999999998 110.936 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 mt -51.43 -38.18 20.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 74.430000000000007 111.13 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.33 -43.37 77.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 74.340000000000003 111.123 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -40.55 94.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 73.230000000000004 110.849 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -77.64 -37.21 50.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 73.230000000000004 110.846 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.2 mmmt -59.41 -75.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 72.450000000000003 110.898 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -178.13 177.41 1.02 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 61.310000000000002 110.825 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -113.22 34.03 5.27 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.692 -0.766 . . . . 71.519999999999996 112.478 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 70.4 p -122.03 -39.04 2.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.795 0.331 . . . . 60.399999999999999 111.13 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.42 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -51.13 169.25 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.203 -0.453 . . . . 73.540000000000006 110.902 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -128.96 141.97 51.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 72.540000000000006 110.884 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.82 112.93 42.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 73.120000000000005 111.16 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -105.55 147.26 28.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 74.340000000000003 111.112 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.41 156.62 46.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.436 . . . . 75.450000000000003 110.896 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.42 137.62 27.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.452 . . . . 73.129999999999995 110.927 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.58 106.92 13.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.45 . . . . 73.549999999999997 110.87 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 78.8 t -55.54 -39.11 52.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 75.129999999999995 111.16 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.02 -36.02 62.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 74.450000000000003 110.849 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.8 -35.46 14.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 74.010000000000005 111.15 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -117.87 68.04 6.23 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.627 0.727 . . . . 74.25 110.894 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -33.3 16.86 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.684 2.256 . . . . 65.349999999999994 112.29 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -62.42 -36.8 83.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 72.109999999999999 110.877 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.15 -34.99 79.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 64.439999999999998 111.051 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.88 -67.52 0.36 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 63.32 111.088 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -53.41 -38.73 63.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 74.299999999999997 110.895 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -51.41 -37.82 50.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 74.019999999999996 110.919 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -110.08 29.93 7.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 74.439999999999998 110.845 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 49.35 82.02 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 75.010000000000005 110.924 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.4 t -126.89 103.35 10.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 74.030000000000001 111.138 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 60.3 t -98.29 -34.49 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 63.509999999999998 111.143 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.5 m -97.61 151.67 19.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 72.439999999999998 110.855 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.514 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.1 mt -66.66 -57.76 11.31 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.565 0.697 . . . . 73.219999999999999 111.148 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.4 Cg_endo -69.77 70.17 1.6 Allowed 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.694 2.263 . . . . 63.329999999999998 112.332 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 59.1 m -110.49 148.09 32.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 73.120000000000005 111.115 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 5.3 ttp -147.89 147.61 29.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 73.310000000000002 110.883 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 10.5 mt -133.43 115.32 22.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 74.099999999999994 111.15 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.9 tp -81.3 101.78 9.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 73.430000000000007 110.875 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -89.98 170.33 10.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 74.400000000000006 110.874 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -164.91 96.31 0.72 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 73.209999999999994 110.919 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.97 35.87 23.32 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.763 -0.732 . . . . 64.409999999999997 112.469 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.23 40.89 60.63 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.731 -0.747 . . . . 73.400000000000006 112.499 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.6 m -160.65 133.46 4.56 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.596 0.712 . . . . 74.430000000000007 111.158 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 87.76 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.67 2.247 . . . . 64.129999999999995 112.318 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 26.9 m -78.54 -34.96 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 73.209999999999994 111.097 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.43 163.71 32.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 73.530000000000001 110.904 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.54 133.47 16.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 75.549999999999997 110.858 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.3 mp -137.19 135.44 47.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 73.109999999999999 111.139 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -135.32 139.64 46.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 71.200000000000003 111.149 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 129.02 134.49 3.8 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.767 -0.73 . . . . 51.43 112.454 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.34 86.38 7.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.833 0.349 . . . . 53.329999999999998 111.116 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.41 172.46 9.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 74.200000000000003 110.847 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.26 171.0 8.42 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.739 -0.743 . . . . 74.400000000000006 112.448 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.06 -43.59 86.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.791 0.329 . . . . 74.5 110.916 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.96 -65.39 0.59 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 71.019999999999996 111.093 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.89 -56.91 13.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 73.129999999999995 111.084 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.82 -36.27 25.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 74.319999999999993 110.918 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.3 tt -70.15 -37.41 75.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 75.140000000000001 110.925 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 10.0 mtp85 -66.71 -41.52 87.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 75.019999999999996 110.845 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -52.19 -25.46 9.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 73.400000000000006 110.905 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.3 mt -84.82 -67.99 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 74.519999999999996 111.155 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -52.4 -48.8 65.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 73.340000000000003 110.913 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -58.0 -34.79 70.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.496 . . . . 63.32 110.886 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.81 -35.04 57.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 73.030000000000001 111.129 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.1 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 75.409999999999997 110.923 -179.984 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 mmt . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.743 0.306 . . . . 72.329999999999998 110.926 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.23 173.31 11.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 72.519999999999996 111.088 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -50.21 -51.94 39.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.203 -0.453 . . . . 74.340000000000003 110.843 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 59.6 m170 49.79 34.63 7.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 73.530000000000001 110.89 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -56.61 167.45 0.73 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 73.209999999999994 110.838 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -119.75 30.85 6.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 73.219999999999999 110.887 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 41.5 t60 -68.34 -36.12 78.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 73.109999999999999 110.896 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -58.57 -42.75 88.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.45 . . . . 73.329999999999998 110.921 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 32.1 mtt -69.3 -36.09 76.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 63.0 110.883 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.6 t -70.21 120.13 15.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 72.310000000000002 110.834 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -93.84 -91.06 1.61 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.763 -0.732 . . . . 62.450000000000003 112.475 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.6 p -67.78 118.51 11.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.789 0.328 . . . . 72.010000000000005 111.131 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.06 150.09 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 75.319999999999993 111.143 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.4 t -72.71 131.1 41.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 72.340000000000003 111.143 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.4 t -92.56 121.21 42.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 75.299999999999997 111.148 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.89 163.67 4.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.122 -0.49 . . . . 71.120000000000005 111.113 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -67.02 -39.86 87.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 74.400000000000006 110.82 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.7 t -75.86 -57.67 3.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 75.120000000000005 110.898 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.5 t -55.79 -24.22 34.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 75.319999999999993 111.144 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -51.71 -30.88 23.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 73.140000000000001 110.837 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.434 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -71.45 -33.37 69.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 71.099999999999994 110.9 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.9 m -92.69 -17.67 23.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 75.310000000000002 111.151 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -93.57 -72.05 0.63 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 64.519999999999996 110.849 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.2 t -69.4 -71.29 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 73.409999999999997 111.106 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.434 ' HB2' ' HA ' ' A' ' 21' ' ' LYS . 12.5 mt -40.18 -60.31 1.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 74.349999999999994 110.861 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -50.31 -56.62 10.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.242 -0.435 . . . . 73.129999999999995 110.863 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.1 t -51.84 158.47 1.0 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 64.109999999999999 110.859 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -119.44 35.76 4.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 71.549999999999997 110.844 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.4 159.96 70.13 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.523 0.678 . . . . 74.150000000000006 111.175 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 122.14 8.83 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.682 2.254 . . . . 73.120000000000005 112.344 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.1 t -100.93 122.93 53.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.449 . . . . 73.439999999999998 111.121 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -94.86 99.93 11.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 75.530000000000001 110.901 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.9 p -100.38 142.62 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 73.409999999999997 111.17 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -135.75 119.84 17.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 74.120000000000005 110.895 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -99.74 93.5 5.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 74.129999999999995 110.936 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -136.77 -167.72 2.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.126 -0.488 . . . . 72.200000000000003 110.958 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.57 -165.22 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.433 . . . . 73.010000000000005 111.085 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.446 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 34.7 p-10 -77.69 12.07 1.83 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 73.400000000000006 110.844 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.479 ' N ' ' CD1' ' A' ' 39' ' ' TRP . 1.7 m0 77.62 92.91 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.158 -0.474 . . . . 74.219999999999999 110.908 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -175.89 -53.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 62.409999999999997 110.881 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.26 -70.99 1.3 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.74 -0.743 . . . . 62.210000000000001 112.509 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -32.62 18.17 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.646 2.23 . . . . 72.430000000000007 112.351 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -59.42 -33.45 71.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 72.230000000000004 110.884 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.53 -28.81 70.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 74.319999999999993 110.898 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 4.6 mmt -87.21 -41.55 13.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 65.140000000000001 110.867 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.9 t -94.13 22.16 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 74.540000000000006 111.115 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.455 ' N ' ' HD2' ' A' ' 48' ' ' PRO . . . -76.75 -61.08 0.77 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.561 0.696 . . . . 70.310000000000002 111.08 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 47' ' ' ALA . 53.9 Cg_endo -69.76 -49.91 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.711 2.274 . . . . 73.319999999999993 112.326 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.3 m -51.02 -30.42 9.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 72.25 111.112 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.3 tt -82.95 -36.83 24.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.16 -0.473 . . . . 72.439999999999998 110.945 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -58.9 -35.29 72.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 74.439999999999998 110.907 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -61.82 -67.88 0.37 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 74.099999999999994 110.891 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 mt -51.38 -37.32 18.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 74.010000000000005 111.12 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.82 -41.38 87.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 72.120000000000005 111.072 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.97 -47.24 78.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 72.409999999999997 110.896 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -69.99 -37.37 75.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 75.019999999999996 110.874 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.0 mmtt -55.6 -66.5 0.41 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 73.340000000000003 110.899 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.26 173.9 15.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 64.540000000000006 110.808 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.94 -41.19 41.75 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.74 -0.743 . . . . 44.0 112.52 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.6 p -149.81 53.86 0.93 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.791 0.329 . . . . 54.240000000000002 111.155 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.8 pp -58.33 -175.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 73.340000000000003 110.951 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 32.0 mttp -85.63 124.71 32.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 71.230000000000004 110.938 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.3 t -131.74 105.35 9.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 74.450000000000003 111.134 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -118.04 139.19 51.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 64.5 111.112 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -134.94 158.75 43.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 75.319999999999993 110.912 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -139.71 142.66 36.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.435 . . . . 72.150000000000006 110.974 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.88 107.28 19.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.201 -0.454 . . . . 51.25 110.871 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 69.4 t -57.47 -36.01 51.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 74.120000000000005 111.162 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.87 -36.38 48.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 71.319999999999993 110.908 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.29 -35.18 10.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 73.140000000000001 111.081 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -115.72 73.59 4.46 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.63 0.728 . . . . 62.439999999999998 110.89 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -30.87 21.41 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.672 2.248 . . . . 62.039999999999999 112.319 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -64.9 -38.96 92.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.429 . . . . 73.510000000000005 110.898 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.48 -48.88 71.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.492 . . . . 63.210000000000001 111.094 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.37 -64.05 0.95 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 73.239999999999995 111.102 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.5 ttp180 -51.23 -34.01 30.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 74.349999999999994 110.899 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -51.73 -40.04 59.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 74.420000000000002 110.892 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -106.65 28.45 7.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 73.030000000000001 110.891 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 50.33 52.88 13.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 74.329999999999998 110.877 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.7 t -89.63 109.19 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 60.409999999999997 111.135 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.9 t -96.18 -35.74 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 74.099999999999994 111.112 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.5 t -103.12 146.0 29.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 70.010000000000005 110.838 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.529 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 1.1 mp -56.9 -57.43 24.37 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.594 0.711 . . . . 72.010000000000005 111.136 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.7 Cg_endo -69.76 78.34 1.01 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.668 2.245 . . . . 73.519999999999996 112.329 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 77.0 m -116.72 111.64 20.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.26 -0.427 . . . . 73.549999999999997 111.138 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 10.4 ttp -113.48 122.96 48.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 71.140000000000001 110.896 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 20.9 mt -115.53 122.22 68.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 73.340000000000003 111.114 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 16.3 tp -88.16 105.7 17.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.485 . . . . 74.549999999999997 110.895 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -90.18 170.33 10.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 72.450000000000003 110.871 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -168.46 94.64 0.36 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.484 . . . . 73.329999999999998 110.88 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.89 35.85 10.91 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.775 -0.726 . . . . 53.310000000000002 112.48 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.84 37.94 65.76 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.75 -0.738 . . . . 55.450000000000003 112.494 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 85.1 m -161.13 134.16 4.63 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.572 0.701 . . . . 74.420000000000002 111.133 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 82.56 0.74 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.646 2.231 . . . . 74.120000000000005 112.37 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.7 m -64.76 -35.02 73.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 71.439999999999998 111.092 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.95 170.02 16.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 73.099999999999994 110.927 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -158.31 125.5 4.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 74.120000000000005 110.839 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.8 mp -134.12 125.41 48.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 74.230000000000004 111.12 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.6 m -132.77 150.96 33.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 71.129999999999995 111.096 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 140.99 -29.81 2.3 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.711 -0.757 . . . . 72.0 112.491 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 63.27 73.73 0.44 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.841 0.353 . . . . 72.540000000000006 111.07 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.41 -177.23 3.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 74.129999999999995 110.873 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.65 166.74 9.13 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.786 -0.721 . . . . 72.040000000000006 112.495 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.5 ptmt -55.71 -46.43 77.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.796 0.332 . . . . 70.239999999999995 110.93 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.23 -62.24 1.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 75.150000000000006 111.088 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.69 -56.57 18.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 71.349999999999994 111.108 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.14 -41.97 60.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 74.299999999999997 110.912 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.4 tt -63.98 -59.34 4.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 75.120000000000005 110.881 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -53.0 -38.77 62.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 74.510000000000005 110.865 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -51.1 -27.03 7.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 74.019999999999996 110.906 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.4 mt -82.87 -68.31 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 75.120000000000005 111.12 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -51.96 -47.86 64.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 50.100000000000001 110.866 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -57.81 -34.97 70.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.474 . . . . 73.310000000000002 110.837 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.36 -35.68 58.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 65.209999999999994 111.112 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.2 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 74.420000000000002 110.895 -179.931 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.1 ptm . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.79 0.328 . . . . 71.109999999999999 110.884 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.95 93.86 4.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 64.219999999999999 111.112 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -98.29 -45.52 6.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.45 . . . . 74.5 110.86 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 43.9 t-80 -68.16 132.85 47.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 75.230000000000004 110.87 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -98.03 170.01 9.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 73.150000000000006 110.854 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 29.6 p80 -119.55 30.75 6.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 65.120000000000005 110.86 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -74.4 -36.15 63.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 74.340000000000003 110.815 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -95.97 11.25 34.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 75.420000000000002 110.867 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 5.5 ttt -53.81 -36.63 62.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 73.340000000000003 110.861 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.7 t -52.53 117.53 2.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.247 -0.433 . . . . 71.230000000000004 110.86 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 123.17 169.85 13.35 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.758 -0.734 . . . . 61.039999999999999 112.486 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.7 p -61.71 100.02 0.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.82 0.343 . . . . 71.439999999999998 111.133 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.1 t -147.18 146.41 18.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 73.230000000000004 111.138 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.4 t -73.88 152.52 40.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.167 -0.47 . . . . 55.25 111.178 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.3 p -112.38 147.82 15.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 74.409999999999997 111.099 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.74 158.94 9.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 62.109999999999999 111.148 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.96 -50.48 16.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 74.099999999999994 110.861 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.8 t -58.96 -36.08 74.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 73.340000000000003 110.873 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.1 t -85.42 -18.25 34.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 72.439999999999998 111.133 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -50.41 -31.78 15.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 74.340000000000003 110.857 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.1 -33.59 70.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 63.520000000000003 110.876 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.1 m -91.18 -15.95 28.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.237 -0.438 . . . . 73.200000000000003 111.145 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -93.18 -70.86 0.68 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.233 -0.44 . . . . 65.030000000000001 110.861 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.6 t -71.14 -70.49 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 75.019999999999996 111.113 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.1 mt -40.54 -60.08 1.2 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.122 -0.49 . . . . 74.120000000000005 110.877 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -50.44 -59.39 4.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 73.510000000000005 110.848 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.8 t -51.78 149.06 5.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 74.319999999999993 110.84 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -111.66 35.31 3.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 70.030000000000001 110.885 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.19 160.41 50.07 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.544 0.688 . . . . 61.299999999999997 111.144 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 124.67 11.3 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.679 2.253 . . . . 71.200000000000003 112.339 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 95.0 t -103.57 122.37 56.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 63.119999999999997 111.137 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -93.72 100.08 12.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 72.439999999999998 110.87 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.1 p -99.63 145.27 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 51.509999999999998 111.135 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.51 118.57 19.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 74.400000000000006 110.808 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -103.08 97.49 7.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 73.409999999999997 110.916 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -148.32 -167.83 2.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.146 -0.479 . . . . 71.409999999999997 110.902 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.09 -166.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 60.409999999999997 111.097 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.432 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 18.0 t0 -78.51 12.46 1.99 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.434 . . . . 61.420000000000002 110.823 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.463 ' CD1' ' N ' ' A' ' 39' ' ' TRP . 1.6 m0 77.27 94.04 0.06 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.243 -0.435 . . . . 73.219999999999999 110.867 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 2.4 t -167.34 -54.18 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 74.319999999999993 110.872 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.01 -69.88 1.37 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.778 -0.725 . . . . 74.340000000000003 112.439 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -32.94 17.83 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.67 2.246 . . . . 74.5 112.355 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 45.5 t -52.02 -34.71 44.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 75.540000000000006 110.895 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -64.63 -34.63 78.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 75.140000000000001 110.883 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 42.1 mtt -84.11 -38.84 20.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.271 -0.422 . . . . 65.219999999999999 110.854 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.0 t -94.41 21.76 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.434 . . . . 74.209999999999994 111.108 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.471 ' N ' ' HD2' ' A' ' 48' ' ' PRO . . . -76.89 -60.83 0.77 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.634 0.731 . . . . 75.340000000000003 111.073 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 47' ' ' ALA . 53.7 Cg_endo -69.72 -49.58 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.697 2.265 . . . . 75.510000000000005 112.341 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.4 m -51.04 -30.23 9.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 75.340000000000003 111.132 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.4 mt -69.67 -38.2 76.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.123 -0.489 . . . . 75.230000000000004 110.934 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -71.93 -35.07 69.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 74.549999999999997 110.889 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -51.27 -66.42 0.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.495 . . . . 74.430000000000007 110.849 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.5 mp -51.23 -33.11 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 73.340000000000003 111.13 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.19 -52.38 62.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 74.319999999999993 111.127 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.81 -35.58 81.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 73.319999999999993 110.846 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -67.92 -36.0 79.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 73.120000000000005 110.908 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -70.02 -69.81 0.33 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 75.120000000000005 110.905 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.0 t 63.23 40.04 9.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 54.530000000000001 110.877 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -122.81 42.16 1.67 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.768 -0.729 . . . . 70.439999999999998 112.468 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.4 p 46.27 48.87 13.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.803 0.335 . . . . 62.340000000000003 111.163 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.5 pp -87.59 141.81 28.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 72.010000000000005 110.911 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.4 tptt -95.5 149.47 21.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.475 . . . . 74.209999999999994 110.914 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.4 t -126.93 106.96 16.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 75.349999999999994 111.165 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -118.13 126.61 52.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 74.239999999999995 111.088 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -110.4 159.29 17.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 74.340000000000003 110.93 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 11.1 tp -137.1 145.92 44.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.434 . . . . 71.409999999999997 110.891 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -97.6 119.62 36.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 71.540000000000006 110.846 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.8 m -61.5 -35.18 65.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 74.400000000000006 111.138 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.13 -35.28 47.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 74.409999999999997 110.843 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.47 -35.24 11.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 74.239999999999995 111.078 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -118.36 68.2 7.36 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.57 0.7 . . . . 71.030000000000001 110.868 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 -33.43 16.67 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.666 2.244 . . . . 64.299999999999997 112.38 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -68.28 -36.26 79.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 73.430000000000007 110.928 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.59 -47.45 79.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 74.510000000000005 111.09 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.31 -56.37 21.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 71.25 111.1 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -51.27 -34.19 31.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 74.239999999999995 110.854 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -58.05 -35.92 72.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 61.009999999999998 110.869 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -102.29 26.39 7.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 74.329999999999998 110.883 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 50.1 36.43 12.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 73.010000000000005 110.905 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 97.6 t -68.87 103.43 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 72.230000000000004 111.143 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 67.1 t -92.18 -35.04 6.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 75.400000000000006 111.174 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 t -105.61 151.76 23.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.481 . . . . 72.519999999999996 110.849 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.523 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.4 mt -60.58 -57.69 24.71 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.658 0.742 . . . . 73.239999999999995 111.139 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 54.1 Cg_endo -69.78 74.1 1.33 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.651 2.234 . . . . 73.540000000000006 112.347 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 84.0 m -108.99 137.99 46.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.223 -0.444 . . . . 73.319999999999993 111.178 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 10.2 ttm -135.17 145.91 48.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 74.519999999999996 110.878 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 28.6 mt -143.07 128.85 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 74.549999999999997 111.138 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -95.2 107.94 20.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 74.120000000000005 110.906 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -92.06 170.29 9.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 73.420000000000002 110.909 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -162.49 106.24 1.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.479 . . . . 74.040000000000006 110.872 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.68 34.28 56.86 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.782 -0.723 . . . . 74.120000000000005 112.489 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.08 40.22 51.46 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.778 -0.725 . . . . 73.430000000000007 112.489 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 86.0 m -160.91 133.8 4.59 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.539 0.685 . . . . 64.200000000000003 111.149 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 84.77 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.698 2.265 . . . . 72.299999999999997 112.329 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.5 m -72.37 -35.11 50.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 75.230000000000004 111.117 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -136.32 170.05 16.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 75.219999999999999 110.937 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 20.2 ttt-85 -155.97 128.55 7.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 73.219999999999999 110.9 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.5 mp -138.05 111.67 7.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.462 . . . . 71.209999999999994 111.141 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 48.9 t -109.62 133.07 56.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 71.0 111.165 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 136.57 137.4 3.65 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.754 -0.736 . . . . 73.519999999999996 112.479 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.47 83.15 4.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.87 0.367 . . . . 74.129999999999995 111.054 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.03 174.07 6.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 65.349999999999994 110.931 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.87 171.89 5.68 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.719 -0.753 . . . . 74.409999999999997 112.463 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.66 -44.88 90.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.81 0.338 . . . . 73.120000000000005 110.923 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.64 -64.14 0.95 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 64.150000000000006 111.143 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.81 -58.34 7.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 71.349999999999994 111.142 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.67 -40.94 54.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 72.340000000000003 110.924 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.7 tp -64.7 -54.17 35.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 74.299999999999997 110.921 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -51.45 -43.06 61.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 61.549999999999997 110.86 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -51.12 -27.24 7.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 74.430000000000007 110.881 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.3 mt -83.08 -68.99 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 71.120000000000005 111.143 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -50.9 -48.78 60.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 73.239999999999995 110.884 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -52.79 -32.48 44.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.479 . . . . 74.049999999999997 110.9 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.59 -33.77 71.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 71.120000000000005 111.108 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 71.230000000000004 110.929 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.798 0.332 . . . . 75.129999999999995 110.889 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.24 64.03 5.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 72.230000000000004 111.089 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -95.32 -43.41 8.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 72.219999999999999 110.825 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -81.39 171.22 15.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 71.230000000000004 110.864 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -145.39 155.65 43.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 75.319999999999993 110.841 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -119.71 -40.42 2.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 71.540000000000006 110.851 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 39.6 p-80 -52.02 -36.27 49.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 72.530000000000001 110.846 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -54.5 -47.86 72.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 62.530000000000001 110.824 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -51.99 -36.22 49.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 55.340000000000003 110.853 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.0 t -52.28 129.7 28.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 72.219999999999999 110.846 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.31 171.61 47.43 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.715 -0.755 . . . . 71.230000000000004 112.464 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 44.5 p -61.27 110.73 1.49 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.827 0.346 . . . . 72.400000000000006 111.165 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.7 t -145.95 146.15 19.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 72.239999999999995 111.123 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.0 m -75.75 125.82 29.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 73.129999999999995 111.159 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.5 t -89.93 127.11 42.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 74.540000000000006 111.156 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.13 177.22 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 75.209999999999994 111.151 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.1 -35.06 37.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.232 -0.44 . . . . 73.239999999999995 110.882 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.8 t -84.62 -51.73 6.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 64.310000000000002 110.85 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.2 t -58.43 -19.55 37.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 72.230000000000004 111.167 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -51.25 -30.27 17.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 73.019999999999996 110.872 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.47 -34.1 67.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 71.439999999999998 110.898 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.8 m -91.26 -15.99 28.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 72.219999999999999 111.145 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -93.55 -71.53 0.65 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 61.020000000000003 110.851 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.2 t -70.15 -70.65 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 74.310000000000002 111.156 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.9 mt -40.6 -60.3 1.16 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.113 -0.494 . . . . 73.329999999999998 110.936 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -50.27 -52.8 33.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 61.210000000000001 110.866 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.9 t -57.21 155.06 9.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 75.120000000000005 110.822 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -104.36 -44.27 4.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.483 . . . . 72.25 110.827 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -51.54 160.0 1.11 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.583 0.706 . . . . 75.109999999999999 111.114 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 126.83 13.72 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.63 2.22 . . . . 74.109999999999999 112.336 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 80.1 t -97.69 127.52 49.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 71.310000000000002 111.159 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.3 mp -103.22 100.11 10.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 71.209999999999994 110.924 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.6 p -102.82 138.46 27.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 74.439999999999998 111.092 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.96 118.43 22.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 73.019999999999996 110.906 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -96.16 90.38 5.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 74.519999999999996 110.893 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -135.6 -167.94 2.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.152 -0.476 . . . . 74.409999999999997 110.969 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.18 -166.34 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.432 . . . . 75.409999999999997 111.092 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.446 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 9.3 p-10 -78.2 12.45 1.87 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 63.219999999999999 110.863 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.462 ' N ' ' CD1' ' A' ' 39' ' ' TRP . 1.3 m0 76.98 92.95 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 74.219999999999999 110.912 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 36.4 t -170.72 -58.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.441 . . . . 74.099999999999994 110.879 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.8 -71.02 1.25 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.778 -0.725 . . . . 65.430000000000007 112.484 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 -32.2 18.79 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.694 2.263 . . . . 72.219999999999999 112.331 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 36.3 t -60.23 -32.37 71.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 74.329999999999998 110.867 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -30.21 71.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 72.019999999999996 110.938 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 7.3 mmm -88.44 -39.91 13.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 64.430000000000007 110.858 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.1 t -94.25 22.34 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 62.009999999999998 111.096 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.455 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . . . -76.04 -61.04 0.9 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.596 0.712 . . . . 74.129999999999995 111.113 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' A' ' 47' ' ' ALA . 53.6 Cg_endo -69.78 -50.1 0.49 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.739 2.293 . . . . 72.219999999999999 112.349 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.4 m -52.86 -31.02 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 74.099999999999994 111.172 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.7 tp -70.33 -41.22 73.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 74.109999999999999 110.914 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -69.81 -34.61 73.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 72.439999999999998 110.906 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -56.39 -63.17 1.28 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 70.200000000000003 110.886 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.8 mt -53.04 -45.09 52.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 73.150000000000006 111.106 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.41 -23.35 65.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 75.450000000000003 111.113 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.34 -45.38 19.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 73.400000000000006 110.888 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -74.31 -45.51 47.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 73.430000000000007 110.919 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -51.52 -73.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 75.340000000000003 110.918 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.46 -168.81 2.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 74.420000000000002 110.879 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -109.32 116.88 4.71 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.734 -0.746 . . . . 72.0 112.464 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.8 p 49.83 44.28 25.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.833 0.349 . . . . 74.019999999999996 111.107 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.6 pp -58.16 -176.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.257 -0.429 . . . . 75.329999999999998 110.963 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -79.78 119.11 22.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.192 -0.458 . . . . 74.219999999999999 110.856 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.6 t -118.93 100.89 10.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 71.519999999999996 111.132 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -126.22 132.16 51.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 62.420000000000002 111.105 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -129.36 160.02 34.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 72.230000000000004 110.855 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 18.9 tp -136.16 148.91 48.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 75.420000000000002 110.944 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.78 112.36 24.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.176 -0.465 . . . . 71.120000000000005 110.849 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.4 m -59.5 -35.6 59.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 74.230000000000004 111.144 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.55 -36.46 61.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 74.439999999999998 110.868 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.47 -35.22 13.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 72.299999999999997 111.091 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -117.27 68.79 5.23 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.62 0.724 . . . . 74.030000000000001 110.884 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 -32.65 18.39 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.725 2.283 . . . . 64.040000000000006 112.384 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -65.23 -36.28 83.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 74.230000000000004 110.891 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.17 -44.81 96.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 75.439999999999998 111.138 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.57 -61.55 2.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 73.439999999999998 111.087 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.5 ttp180 -50.97 -34.79 30.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 73.510000000000005 110.9 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -51.89 -35.92 46.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.486 . . . . 72.400000000000006 110.859 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -108.87 27.89 9.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.449 . . . . 73.129999999999995 110.882 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 50.59 55.76 9.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.495 . . . . 63.130000000000003 110.906 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 91.0 t -92.24 104.97 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 64.450000000000003 111.115 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 57.4 t -96.44 -35.06 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 74.230000000000004 111.124 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.8 m -102.84 146.64 27.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 73.140000000000001 110.89 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.515 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 5.1 mt -58.19 -57.57 25.1 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.621 0.724 . . . . 71.109999999999999 111.144 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.5 Cg_endo -69.78 76.39 1.15 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.65 2.233 . . . . 74.25 112.33 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 73.6 m -113.99 134.95 54.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 72.329999999999998 111.112 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 14.2 ttt -133.85 126.42 30.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 74.209999999999994 110.883 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.0 mt -116.97 115.19 48.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 72.239999999999995 111.152 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.11 106.31 13.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 75.530000000000001 110.92 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -93.34 170.05 9.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 73.310000000000002 110.932 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -165.74 91.43 0.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 75.340000000000003 110.878 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.82 36.91 8.19 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.715 -0.755 . . . . 63.009999999999998 112.497 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.64 39.3 86.52 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.773 -0.727 . . . . 72.540000000000006 112.488 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 88.6 m -160.53 133.99 4.86 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.58 0.705 . . . . 74.519999999999996 111.156 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 109.56 2.35 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.661 2.241 . . . . 72.450000000000003 112.374 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.3 m -101.6 -32.99 3.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.46 . . . . 70.439999999999998 111.138 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.73 164.63 26.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.483 . . . . 73.219999999999999 110.906 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.84 117.51 3.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 74.340000000000003 110.852 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.7 mp -132.56 130.91 59.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 74.439999999999998 111.126 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.1 m -138.16 145.39 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 74.549999999999997 111.129 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 146.39 -26.88 1.69 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.745 -0.74 . . . . 73.040000000000006 112.522 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 62.7 68.35 0.65 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.843 0.354 . . . . 74.549999999999997 111.09 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.2 169.1 9.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 74.409999999999997 110.897 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.77 150.16 39.48 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.744 -0.741 . . . . 65.340000000000003 112.47 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.39 -34.99 11.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.809 0.338 . . . . 73.310000000000002 110.88 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.16 -40.39 77.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 55.039999999999999 111.078 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.76 -49.8 6.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 63.5 111.131 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.7 -52.94 16.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 70.299999999999997 110.961 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.6 pp -48.12 -35.58 11.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.468 . . . . 71.450000000000003 110.911 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 46.1 mtp85 -74.25 -42.24 59.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 75.5 110.865 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -51.48 -25.0 5.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 62.43 110.926 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.4 mt -87.68 -69.29 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 71.219999999999999 111.167 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -51.11 -49.39 60.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 74.129999999999995 110.873 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -58.91 -34.13 71.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 63.32 110.84 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.09 -35.64 61.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 71.030000000000001 111.116 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.4 mt . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 64.409999999999997 110.971 179.954 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.2 ptm . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.777 0.322 . . . . 73.349999999999994 110.897 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.93 91.84 6.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 74.430000000000007 111.107 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.5 t60 -95.43 -40.5 9.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 75.049999999999997 110.889 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -118.24 144.01 46.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 75.140000000000001 110.829 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -58.84 163.3 3.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 74.109999999999999 110.857 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 61.6 m80 -106.46 -38.1 6.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 73.209999999999994 110.854 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -82.36 -36.21 27.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.436 . . . . 74.430000000000007 110.838 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -70.7 -39.46 73.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 74.209999999999994 110.87 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 28.8 mtp -100.04 30.84 3.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 74.150000000000006 110.867 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.5 m -60.26 121.12 11.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.28 -0.418 . . . . 73.200000000000003 110.856 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.52 174.71 38.09 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.773 -0.727 . . . . 75.209999999999994 112.523 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.4 p -74.11 99.77 3.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.863 0.363 . . . . 73.439999999999998 111.121 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 98.6 t -150.16 143.68 17.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.225 -0.443 . . . . 75.409999999999997 111.093 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.8 t -67.71 126.98 31.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 75.430000000000007 111.131 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 74.7 t -94.82 130.44 43.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 72.400000000000006 111.13 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.72 160.52 7.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 61.229999999999997 111.161 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -73.62 -41.52 62.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.255 -0.43 . . . . 74.040000000000006 110.846 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.6 m -70.39 -34.53 72.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 75.140000000000001 110.885 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.3 t -85.19 -17.97 35.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 74.299999999999997 111.108 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -50.64 -31.23 15.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 75.430000000000007 110.859 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.414 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -71.74 -33.48 68.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.149 -0.478 . . . . 72.150000000000006 110.885 179.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.6 m -91.7 -16.23 27.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 73.129999999999995 111.182 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -93.36 -71.42 0.65 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 63.119999999999997 110.888 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.9 t -70.39 -70.3 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 71.450000000000003 111.165 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.414 ' HB2' ' HA ' ' A' ' 21' ' ' LYS . 7.6 mt -40.7 -60.21 1.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 75.530000000000001 110.886 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -50.36 -58.73 5.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 74.230000000000004 110.876 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.3 t -54.02 171.33 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 74.5 110.876 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -117.73 -40.96 2.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 74.140000000000001 110.836 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -53.05 159.47 1.91 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.59 0.71 . . . . 71.519999999999996 111.128 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.7 131.08 20.57 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.715 2.276 . . . . 63.240000000000002 112.369 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 96.7 t -105.02 125.26 60.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 65.310000000000002 111.11 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.7 mt -102.23 100.65 10.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 72.430000000000007 110.887 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.3 p -98.55 133.57 40.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 72.439999999999998 111.172 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -115.49 99.55 7.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.225 -0.443 . . . . 75.019999999999996 110.839 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -90.47 89.39 7.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 73.549999999999997 110.887 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -145.87 -169.05 3.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.143 -0.48 . . . . 75.010000000000005 110.917 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.37 -156.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 73.319999999999993 111.099 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.476 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 5.3 m-20 -77.61 9.54 3.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.202 -0.453 . . . . 70.400000000000006 110.862 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.476 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 1.0 OUTLIER 41.87 71.08 0.23 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 74.409999999999997 110.935 -179.933 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 44.5 t -132.63 -45.51 0.89 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 73.420000000000002 110.915 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.75 -67.39 1.52 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.722 -0.751 . . . . 62.219999999999999 112.503 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -24.11 30.08 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.713 2.275 . . . . 72.409999999999997 112.326 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 11.9 p -51.92 -27.13 12.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 74.200000000000003 110.877 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? -61.52 -33.72 74.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 64.200000000000003 110.882 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 6.2 mtp -86.48 -36.52 18.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 73.329999999999998 110.889 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.9 t -94.04 21.2 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 74.329999999999998 111.126 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.472 ' N ' ' HD2' ' A' ' 48' ' ' PRO . . . -76.79 -60.8 0.79 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.596 0.712 . . . . 74.239999999999995 111.051 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 47' ' ' ALA . 53.6 Cg_endo -69.73 -49.13 0.59 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.672 2.248 . . . . 75.230000000000004 112.335 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.0 m -51.44 -29.18 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 63.229999999999997 111.155 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.4 tp -84.1 -36.02 23.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 63.039999999999999 110.898 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -71.68 -31.98 67.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 74.439999999999998 110.911 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -49.87 -68.2 0.2 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 74.099999999999994 110.895 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.0 mp -51.45 -36.66 17.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.178 -0.465 . . . . 62.310000000000002 111.12 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.05 -40.25 97.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 75.329999999999998 111.103 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -77.77 -39.26 44.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 73.219999999999999 110.871 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -58.95 -41.19 86.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 73.439999999999998 110.921 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.2 mmtp -69.97 -70.33 0.3 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.475 . . . . 75.030000000000001 110.889 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.3 t 62.85 40.29 9.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 62.32 110.829 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -120.17 53.81 0.67 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.722 -0.752 . . . . 72.140000000000001 112.499 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.5 p 49.82 41.86 23.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.859 0.361 . . . . 71.510000000000005 111.163 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.5 pp -81.99 136.98 35.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 74.340000000000003 110.916 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.1 mtmp? -102.0 139.97 36.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.228 -0.442 . . . . 74.049999999999997 110.877 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.7 t -120.55 104.33 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 74.349999999999994 111.141 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -104.5 121.47 43.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 72.140000000000001 111.122 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.87 131.42 54.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 65.140000000000001 110.896 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 44.0 tp -123.83 155.47 37.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.227 -0.442 . . . . 74.329999999999998 110.952 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.45 114.85 27.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 74.450000000000003 110.856 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 79.5 t -61.38 -35.27 65.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 73.030000000000001 111.126 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -51.86 -36.88 49.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 74.349999999999994 110.887 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.93 -34.46 13.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 65.25 111.072 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -117.42 69.61 5.91 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.629 0.728 . . . . 72.150000000000006 110.892 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -32.31 18.81 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.744 2.296 . . . . 73.120000000000005 112.335 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -58.72 -37.58 76.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.438 . . . . 74.129999999999995 110.881 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.97 -47.88 67.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 75.25 111.065 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.02 -63.47 1.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 75.349999999999994 111.047 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.5 ttp85 -51.56 -33.18 31.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 72.409999999999997 110.868 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -50.99 -39.98 56.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 65.310000000000002 110.873 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -104.39 24.15 12.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 72.329999999999998 110.905 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 47.85 66.55 1.01 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 61.549999999999997 110.911 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 95.9 t -87.58 106.8 16.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 75.430000000000007 111.136 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.6 t -80.26 -58.39 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 72.409999999999997 111.139 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.3 m -91.65 163.28 14.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.468 . . . . 72.439999999999998 110.835 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.516 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 1.7 mp -65.3 -58.17 12.97 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.639 0.733 . . . . 65.310000000000002 111.133 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.7 Cg_endo -69.75 74.86 1.25 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.658 2.238 . . . . 72.420000000000002 112.374 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 99.7 m -113.87 106.0 13.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 74.230000000000004 111.119 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 9.4 ttp -116.16 121.84 43.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 75.510000000000005 110.865 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.0 mp -104.69 119.04 53.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 75.030000000000001 111.102 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.17 104.56 10.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 72.519999999999996 110.857 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -89.77 169.86 10.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 75.340000000000003 110.9 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -167.71 93.67 0.4 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 75.319999999999993 110.908 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.42 38.77 8.73 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.758 -0.734 . . . . 62.399999999999999 112.5 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.37 37.21 79.49 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.783 -0.722 . . . . 74.019999999999996 112.46 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 85.0 m -160.72 133.78 4.67 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.554 0.692 . . . . 74.540000000000006 111.138 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 83.01 0.71 Allowed 'Trans proline' 0 C--N 1.34 0.126 0 C-N-CA 122.703 2.269 . . . . 64.219999999999999 112.292 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.8 m -64.98 -33.88 66.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 73.329999999999998 111.133 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.66 170.22 16.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 73.230000000000004 110.91 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -153.35 127.44 9.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 74.129999999999995 110.881 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.3 mp -131.0 143.19 41.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.193 -0.458 . . . . 73.319999999999993 111.144 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -142.13 141.05 29.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 72.140000000000001 111.164 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 119.08 145.59 7.7 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.767 -0.73 . . . . 44.539999999999999 112.549 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -100.89 89.1 3.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.893 0.378 . . . . 72.209999999999994 111.109 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.55 179.87 4.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 74.340000000000003 110.866 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.8 175.26 13.07 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.735 -0.745 . . . . 73.120000000000005 112.525 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -58.18 -47.78 82.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.768 0.318 . . . . 73.049999999999997 110.894 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -53.48 -65.83 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.449 . . . . 72.439999999999998 111.093 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.97 -57.66 8.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 63.109999999999999 111.116 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.82 -34.97 29.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 73.439999999999998 110.938 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.1 tt -69.42 -60.34 2.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 72.519999999999996 110.927 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 45.1 mtp85 -54.47 -34.35 61.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 73.209999999999994 110.87 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -49.35 -26.74 3.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 64.450000000000003 110.868 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.3 mt -84.12 -69.73 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 73.150000000000006 111.121 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -52.75 -50.06 64.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 74.120000000000005 110.895 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -55.92 -34.61 65.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.116 -0.493 . . . . 71.25 110.884 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.1 -36.82 69.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 74.109999999999999 111.096 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 74.299999999999997 110.92 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.7 mtt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.781 0.324 . . . . 73.099999999999994 110.891 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.62 103.56 0.34 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 75.010000000000005 111.086 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -73.84 -42.06 61.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 61.549999999999997 110.872 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 -120.65 137.28 54.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 72.349999999999994 110.833 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.9 m80 -57.75 157.94 6.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 74.010000000000005 110.837 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -105.39 30.87 5.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 72.25 110.859 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -76.55 -41.0 48.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 73.040000000000006 110.867 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -69.47 -35.94 76.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 73.409999999999997 110.86 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -97.81 30.81 2.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 70.099999999999994 110.87 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.5 m -62.1 116.33 4.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 75.450000000000003 110.818 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.78 -176.25 33.67 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.734 . . . . 75.420000000000002 112.48 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.3 p -77.09 104.79 7.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.84 0.352 . . . . 62.450000000000003 111.152 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 65.5 t -148.63 142.19 18.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 72.219999999999999 111.13 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.3 t -77.04 128.7 34.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 71.310000000000002 111.14 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.6 t -91.36 126.59 44.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 75.140000000000001 111.109 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.65 165.99 2.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 71.209999999999994 111.182 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -68.37 -48.04 65.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 74.430000000000007 110.868 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.0 t -69.1 -52.93 23.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 65.25 110.87 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.4 t -59.36 -19.01 43.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 73.209999999999994 111.143 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -51.03 -30.74 16.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 72.420000000000002 110.84 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.402 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -72.07 -34.13 68.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 73.439999999999998 110.91 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.0 m -91.19 -16.0 28.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 72.340000000000003 111.178 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.39 -71.33 0.66 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 65.439999999999998 110.875 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.6 t -70.4 -70.47 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 72.129999999999995 111.149 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.402 ' HB2' ' HA ' ' A' ' 21' ' ' LYS . 7.4 mt -40.64 -60.49 1.13 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 61.229999999999997 110.869 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -50.32 -63.71 1.03 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 65.439999999999998 110.889 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.3 t -56.11 150.87 13.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 71.239999999999995 110.848 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -98.88 -36.45 9.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 75.040000000000006 110.814 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -52.67 159.84 1.6 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.567 0.699 . . . . 75.230000000000004 111.152 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.84 127.43 14.53 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.629 2.219 . . . . 74.310000000000002 112.355 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 99.4 t -102.18 124.4 56.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 75.319999999999993 111.157 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -91.41 123.44 34.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 64.439999999999998 110.908 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.9 t -118.6 139.54 45.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.206 -0.452 . . . . 73.329999999999998 111.132 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -131.4 99.83 4.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 74.299999999999997 110.893 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -91.05 89.54 7.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.462 . . . . 74.340000000000003 110.867 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -148.98 -169.27 3.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 73.019999999999996 110.923 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.08 -155.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.436 . . . . 64.200000000000003 111.103 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.473 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 18.7 p-10 -77.93 8.64 4.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 63.020000000000003 110.896 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.473 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 1.6 p-90 41.55 65.77 0.79 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.187 -0.46 . . . . 70.209999999999994 110.899 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 35.8 t -122.58 -46.38 2.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.233 -0.439 . . . . 72.200000000000003 110.875 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.7 -67.62 1.53 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.751 -0.738 . . . . 74.120000000000005 112.458 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -25.57 28.28 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.675 2.25 . . . . 74.230000000000004 112.359 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 28.9 t -51.49 -31.76 24.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 75.209999999999994 110.885 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.59 -33.5 71.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 74.329999999999998 110.895 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 7.0 mtt -88.13 -35.71 17.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 75.340000000000003 110.891 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.1 t -93.51 21.18 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 74.409999999999997 111.148 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.461 ' N ' ' HD2' ' A' ' 48' ' ' PRO . . . -80.14 -61.41 0.44 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.531 0.681 . . . . 74.530000000000001 111.062 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 47' ' ' ALA . 54.3 Cg_endo -69.69 -45.55 1.59 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.665 2.243 . . . . 75.299999999999997 112.375 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.4 m -49.37 -31.34 5.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 73.439999999999998 111.13 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.7 tt -88.25 -44.83 10.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 74.310000000000002 110.939 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -58.3 -33.8 69.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 73.439999999999998 110.911 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -63.17 -32.28 73.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.169 -0.469 . . . . 73.040000000000006 110.92 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.3 mm -64.92 -34.53 71.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 75.340000000000003 111.103 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.99 -43.03 84.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 72.010000000000005 111.09 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -35.7 78.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 72.299999999999997 110.886 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -70.65 -36.11 73.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.147 -0.479 . . . . 74.030000000000001 110.869 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.19 -71.13 0.53 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 71.319999999999993 110.864 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.4 t -173.14 156.05 3.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.428 . . . . 75.510000000000005 110.886 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -96.23 33.22 5.76 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.772 -0.728 . . . . 71.329999999999998 112.495 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.8 t -121.47 -33.15 3.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.85 0.357 . . . . 75.040000000000006 111.138 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.6 pp -51.15 159.41 0.63 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 73.409999999999997 110.891 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.1 tptm -102.17 147.21 26.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 74.430000000000007 110.89 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.0 t -125.4 106.93 17.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 71.120000000000005 111.111 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -121.53 136.77 54.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 72.329999999999998 111.136 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -123.87 146.43 48.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 75.129999999999995 110.872 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 16.1 tp -127.03 152.09 47.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 75.420000000000002 110.918 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.29 121.23 42.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 70.310000000000002 110.885 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 33.1 m -62.24 -33.04 56.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 51.530000000000001 111.135 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -50.42 -35.77 30.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 70.540000000000006 110.926 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -100.26 -34.11 10.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 71.099999999999994 111.088 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.32 68.07 19.14 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.594 0.711 . . . . 73.129999999999995 110.857 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -33.88 15.69 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.677 2.251 . . . . 65.439999999999998 112.334 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -58.41 -43.57 88.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 63.350000000000001 110.904 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.0 -48.6 70.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 72.340000000000003 111.111 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.7 -68.17 0.19 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 65.230000000000004 111.092 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -50.97 -32.87 22.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 73.349999999999994 110.909 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -51.41 -34.54 35.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 74.430000000000007 110.847 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -112.03 26.08 10.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 73.439999999999998 110.865 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 69.9 mm-40 48.48 85.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 74.310000000000002 110.934 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 95.1 t -105.96 111.43 35.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 75.5 111.117 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 22.1 t -81.9 -59.86 2.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 73.420000000000002 111.145 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 m -91.34 156.25 17.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 74.200000000000003 110.834 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.521 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 4.7 mt -60.15 -58.01 22.51 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.606 0.717 . . . . 73.329999999999998 111.112 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.7 Cg_endo -69.75 69.77 1.61 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.689 2.259 . . . . 72.310000000000002 112.297 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 43.7 m -103.98 132.53 50.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 72.200000000000003 111.187 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 17.5 ttp -130.82 143.83 51.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 74.340000000000003 110.861 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 63.1 mt -128.98 117.99 45.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 75.030000000000001 111.138 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.9 tt -88.24 105.72 17.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.454 . . . . 75.25 110.943 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -90.02 170.14 10.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 74.140000000000001 110.868 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -165.53 92.29 0.54 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 73.230000000000004 110.862 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.15 41.36 7.09 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.731 -0.747 . . . . 54.109999999999999 112.487 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.89 35.96 85.72 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.709 -0.758 . . . . 42.140000000000001 112.506 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 86.2 m -161.0 133.86 4.57 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.633 0.73 . . . . 74.409999999999997 111.125 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 87.83 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.689 2.26 . . . . 74.329999999999998 112.336 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.8 m -70.49 -35.61 62.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 72.420000000000002 111.108 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.7 170.19 16.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 75.099999999999994 110.875 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -155.91 122.76 5.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 74.329999999999998 110.877 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.6 mp -124.93 132.64 71.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 74.439999999999998 111.146 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 98.0 t -131.74 136.6 56.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 70.329999999999998 111.137 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 127.13 138.66 4.79 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 74.340000000000003 112.476 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.21 84.88 4.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.88 0.371 . . . . 75.329999999999998 111.103 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.06 -179.62 3.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 74.329999999999998 110.895 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.49 -169.74 1.42 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.761 -0.733 . . . . 71.5 112.478 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -79.96 -41.74 25.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.776 0.322 . . . . 75.530000000000001 110.884 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.74 -31.95 72.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 71.230000000000004 111.103 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.412 ' HA ' ' HG2' ' A' ' 109' ' ' ARG . . . -84.07 -60.22 2.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 62.229999999999997 111.093 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -50.67 -34.59 27.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 73.239999999999995 110.913 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.8 tt -70.52 -60.51 2.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 70.109999999999999 110.947 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.412 ' HG2' ' HA ' ' A' ' 106' ' ' ALA . 12.6 ptp180 -54.9 -33.01 61.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 74.420000000000002 110.842 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -54.07 -24.54 17.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 73.310000000000002 110.859 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.6 mt -85.97 -68.19 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 73.439999999999998 111.138 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -51.75 -49.07 63.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 73.329999999999998 110.902 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -56.18 -34.84 66.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 74.439999999999998 110.817 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.57 -34.74 65.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 75.219999999999999 111.086 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.5 mt . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.218 -0.447 . . . . 65.340000000000003 110.861 -179.926 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 tpt . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.824 0.345 . . . . 72.409999999999997 110.888 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.52 141.3 33.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 74.019999999999996 111.16 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -94.31 -43.95 8.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 71.540000000000006 110.852 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -88.08 139.22 30.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 74.310000000000002 110.891 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -167.4 146.56 5.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 70.409999999999997 110.836 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 -119.96 30.8 6.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 64.030000000000001 110.899 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -66.95 -36.25 81.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 75.120000000000005 110.855 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -52.34 -35.92 52.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 74.019999999999996 110.845 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.9 mmt -52.02 -37.23 52.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 75.120000000000005 110.891 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.1 m -58.77 127.11 30.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 54.409999999999997 110.859 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.1 -99.98 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.737 -0.744 . . . . 74.219999999999999 112.46 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.3 p -61.97 108.07 0.97 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.801 0.334 . . . . 65.530000000000001 111.165 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.3 t -146.24 148.26 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 72.219999999999999 111.115 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 t -73.05 127.51 32.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 73.239999999999995 111.124 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 90.7 t -91.84 143.79 10.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 73.420000000000002 111.124 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.64 171.73 0.82 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 64.430000000000007 111.065 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -80.79 -48.32 12.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 61.439999999999998 110.879 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.0 t -67.9 -53.98 22.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 72.099999999999994 110.886 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.0 t -58.83 -19.51 42.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.099 -0.501 . . . . 63.310000000000002 111.146 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -51.41 -30.85 20.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 73.230000000000004 110.868 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.415 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -71.88 -33.61 68.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.175 -0.466 . . . . 73.420000000000002 110.907 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.9 m -91.6 -16.17 27.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.169 -0.469 . . . . 75.349999999999994 111.12 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.9 -71.39 0.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 74.120000000000005 110.834 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.1 t -70.9 -70.11 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 73.109999999999999 111.152 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.415 ' HB2' ' HA ' ' A' ' 21' ' ' LYS . 6.9 mt -40.44 -60.02 1.2 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 74.200000000000003 110.915 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -51.24 -65.19 0.6 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.227 -0.442 . . . . 73.019999999999996 110.887 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 56.7 m -54.52 153.72 5.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 71.510000000000005 110.851 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -97.02 -34.92 11.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.489 . . . . 55.5 110.874 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.2 t -50.15 141.47 15.37 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.56 0.695 . . . . 75.25 111.15 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 125.86 12.67 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.685 2.257 . . . . 74.140000000000001 112.369 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.2 t -97.93 128.39 49.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 71.140000000000001 111.155 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.5 mp -102.4 108.11 19.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 72.329999999999998 110.905 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.4 p -97.13 145.44 9.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 74.140000000000001 111.121 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.57 112.19 13.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 64.349999999999994 110.838 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -97.6 97.8 9.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 74.319999999999993 110.872 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -150.78 -168.07 3.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 75.109999999999999 110.888 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.8 -164.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 74.140000000000001 111.106 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.444 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 1.8 m-20 -77.92 12.45 1.76 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.259 -0.428 . . . . 75.299999999999997 110.883 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.46 ' CD1' ' N ' ' A' ' 39' ' ' TRP . 1.6 m0 77.66 94.51 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.475 . . . . 74.319999999999993 110.928 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -167.94 -63.74 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 74.549999999999997 110.87 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.38 -70.51 1.33 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.748 -0.739 . . . . 63.140000000000001 112.522 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -8.07 22.67 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.661 2.241 . . . . 75.109999999999999 112.349 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 31.4 t -90.34 -26.84 19.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 74.030000000000001 110.914 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -60.54 -30.59 69.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 74.030000000000001 110.888 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 9.6 ptp -88.05 -39.93 14.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 74.310000000000002 110.908 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.5 t -93.81 23.12 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 64.099999999999994 111.111 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.461 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . . . -79.79 -61.38 0.46 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.576 0.703 . . . . 74.319999999999993 111.064 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.461 ' CD ' ' CB ' ' A' ' 47' ' ' ALA . 54.4 Cg_endo -69.69 -48.03 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.673 2.249 . . . . 63.229999999999997 112.366 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.6 m -49.78 -31.15 6.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 74.129999999999995 111.128 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.49 -40.27 80.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 74.340000000000003 110.906 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -64.33 -36.62 84.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.443 . . . . 71.430000000000007 110.927 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -59.9 -68.06 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 73.219999999999999 110.915 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.2 mt -50.44 -39.84 17.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 73.5 111.176 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -53.55 -39.15 64.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 54.530000000000001 111.071 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.9 -35.25 22.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 73.230000000000004 110.876 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -64.09 -36.73 84.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 74.319999999999993 110.937 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -67.59 -73.46 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 74.329999999999998 110.855 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.9 -175.59 4.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 70.420000000000002 110.866 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -89.52 -33.91 8.94 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.748 -0.739 . . . . 74.219999999999999 112.486 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 45.7 p -138.18 46.77 2.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.807 0.337 . . . . 72.430000000000007 111.133 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -63.62 175.76 1.01 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.453 . . . . 73.450000000000003 110.921 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -99.97 141.74 32.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 74.109999999999999 110.868 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 37.7 t -146.43 131.54 11.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.257 -0.429 . . . . 62.32 111.144 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -152.91 138.05 17.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 75.129999999999995 111.146 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.3 mttp -114.08 159.93 19.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 71.239999999999995 110.903 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.85 141.03 44.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 73.5 110.918 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -93.95 113.46 25.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.472 . . . . 70.239999999999995 110.839 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.9 m -60.18 -35.12 59.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 75.299999999999997 111.149 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -53.97 -35.23 61.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 74.129999999999995 110.896 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.11 -35.55 10.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 73.400000000000006 111.095 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -117.94 68.33 6.52 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.607 0.718 . . . . 73.200000000000003 110.85 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -32.16 19.0 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.687 2.258 . . . . 73.349999999999994 112.309 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -65.99 -43.34 88.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.274 -0.421 . . . . 72.239999999999995 110.878 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.35 -54.57 25.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 54.399999999999999 111.086 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.88 -60.19 3.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 62.130000000000003 111.136 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -51.63 -34.56 38.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 75.310000000000002 110.897 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -55.44 -36.16 66.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 70.140000000000001 110.851 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -99.35 20.84 12.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 74.540000000000006 110.87 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 48.6 mm-40 48.78 80.51 0.06 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 72.329999999999998 110.931 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.7 p -105.44 144.02 15.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 74.219999999999999 111.118 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 66.1 t -108.82 -72.25 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 75.129999999999995 111.137 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.4 t -79.71 157.86 27.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 71.400000000000006 110.853 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.524 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 4.6 mt -59.91 -58.0 22.64 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.635 0.731 . . . . 71.140000000000001 111.099 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.4 Cg_endo -69.74 71.75 1.49 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.648 2.232 . . . . 74.239999999999995 112.374 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.5 m -110.44 126.62 54.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 65.150000000000006 111.125 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.0 mtm -122.56 158.18 30.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 74.209999999999994 110.838 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 34.0 mt -145.27 121.23 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 74.439999999999998 111.16 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.95 110.25 17.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 72.239999999999995 110.898 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -98.46 170.2 9.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 73.510000000000005 110.884 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -166.04 107.58 0.73 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 74.510000000000005 110.875 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.37 35.76 82.84 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.738 -0.744 . . . . 71.099999999999994 112.511 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.55 41.46 51.2 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.758 -0.734 . . . . 65.239999999999995 112.491 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 86.4 m -161.04 133.85 4.54 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.549 0.69 . . . . 74.230000000000004 111.182 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.74 103.05 1.1 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.722 2.281 . . . . 74.430000000000007 112.313 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.5 m -91.07 -32.58 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 72.409999999999997 111.147 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.6 mmtm -138.38 170.13 16.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 73.420000000000002 110.949 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.19 118.19 4.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 74.25 110.878 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.8 mp -125.5 137.63 57.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 73.299999999999997 111.119 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 66.8 t -147.81 136.15 15.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.472 . . . . 63.310000000000002 111.124 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 151.08 -27.58 1.0 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.734 -0.746 . . . . 72.340000000000003 112.475 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 63.46 72.68 0.47 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.849 0.357 . . . . 75.140000000000001 111.117 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.88 174.82 6.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 73.299999999999997 110.857 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.66 173.63 4.45 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.729 -0.748 . . . . 54.43 112.483 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.52 -44.13 75.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.791 0.329 . . . . 72.430000000000007 110.898 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.55 -30.2 65.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 74.150000000000006 111.107 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.34 -59.55 2.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.268 -0.424 . . . . 70.209999999999994 111.116 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.71 -44.16 37.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 74.150000000000006 110.891 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 7.8 tt -50.27 -43.63 53.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 74.230000000000004 110.91 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -72.46 -37.55 68.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 72.430000000000007 110.91 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -49.85 -25.87 3.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 75.209999999999994 110.873 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.8 mt -86.18 -69.61 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 75.430000000000007 111.102 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.5 -51.18 60.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 71.129999999999995 110.892 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -55.63 -33.87 64.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.157 -0.474 . . . . 61.049999999999997 110.815 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.9 -34.71 69.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 73.150000000000006 111.105 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 71.319999999999993 110.925 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.778 0.323 . . . . 70.510000000000005 110.854 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.72 149.25 25.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 64.299999999999997 111.092 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -92.87 -46.58 7.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 74.319999999999993 110.878 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -110.53 145.39 37.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 75.099999999999994 110.837 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 42.7 p-80 -151.78 118.8 5.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 73.450000000000003 110.857 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -112.95 -36.91 4.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 63.409999999999997 110.891 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -52.02 -59.86 3.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 75.530000000000001 110.855 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -52.05 -35.87 48.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 73.340000000000003 110.844 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 13.1 ttm -51.97 -37.22 52.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 73.120000000000005 110.904 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.7 m -54.99 119.93 6.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 63.539999999999999 110.861 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.09 164.82 18.49 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.723 -0.751 . . . . 72.219999999999999 112.495 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.5 p -60.1 114.75 3.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.791 0.329 . . . . 74.109999999999999 111.141 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 96.1 t -150.08 144.18 17.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.428 . . . . 70.439999999999998 111.118 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 t -84.1 127.53 33.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.459 . . . . 64.430000000000007 111.097 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.6 t -94.88 126.0 47.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 74.319999999999993 111.109 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.5 166.44 2.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 73.510000000000005 111.13 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -68.52 -48.33 64.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 71.420000000000002 110.844 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.1 m -68.48 -52.98 26.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 73.329999999999998 110.879 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.8 t -59.66 -19.0 46.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.092 -0.504 . . . . 73.209999999999994 111.162 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -51.31 -30.8 19.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 75.150000000000006 110.878 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.447 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -72.69 -32.94 66.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 75.5 110.871 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.0 m -91.33 -17.1 26.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 74.109999999999999 111.098 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -93.63 -71.38 0.66 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 71.219999999999999 110.871 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.0 t -70.08 -70.78 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 63.340000000000003 111.136 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.447 ' HB2' ' HA ' ' A' ' 21' ' ' LYS . 10.6 mt -40.56 -59.8 1.27 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 73.109999999999999 110.933 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -50.86 -64.85 0.68 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 71.409999999999997 110.85 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.0 t -52.12 163.27 0.39 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 75.510000000000005 110.877 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -106.02 -40.85 5.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 73.400000000000006 110.838 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -51.79 159.69 1.28 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.581 0.705 . . . . 72.420000000000002 111.155 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 147.66 63.4 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.683 2.255 . . . . 75.129999999999995 112.372 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 97.0 t -123.14 115.5 45.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 62.299999999999997 111.149 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.5 mt -103.94 106.29 16.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 72.140000000000001 110.911 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 m -108.48 134.71 49.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 73.340000000000003 111.128 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -100.22 99.12 9.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 75.030000000000001 110.85 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -82.86 89.56 6.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 74.450000000000003 110.881 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -152.52 -169.19 3.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 74.310000000000002 110.915 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.44 -154.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 73.030000000000001 111.097 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.477 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 35.2 p-10 -77.44 8.94 3.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.434 . . . . 63.539999999999999 110.862 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.477 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 1.1 p-90 41.55 63.53 1.25 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 72.299999999999997 110.893 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 41.2 t -125.04 -45.89 1.84 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 63.200000000000003 110.891 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.59 -68.24 1.49 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.751 -0.738 . . . . 63.130000000000003 112.443 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -26.48 27.65 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.663 2.242 . . . . 75.5 112.317 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 34.8 t -50.49 -30.14 12.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 65.120000000000005 110.905 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.29 -30.3 17.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.148 -0.478 . . . . 73.510000000000005 110.861 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 16.4 mtt -88.75 -36.72 15.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 55.439999999999998 110.893 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.3 t -92.74 21.3 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 74.310000000000002 111.153 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.482 ' N ' ' HD2' ' A' ' 48' ' ' PRO . . . -68.95 -59.83 4.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.562 0.696 . . . . 71.319999999999993 111.113 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 47' ' ' ALA . 53.5 Cg_endo -69.75 -45.56 1.55 Allowed 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.705 2.27 . . . . 73.439999999999998 112.353 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.3 t -55.37 -50.63 63.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 73.310000000000002 111.113 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 50.5 tp -52.94 -32.03 43.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.195 -0.457 . . . . 74.439999999999998 110.921 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -83.89 -35.27 24.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 61.409999999999997 110.893 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -51.91 -61.41 2.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 72.099999999999994 110.939 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 mp -50.74 -32.83 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.478 . . . . 74.310000000000002 111.15 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.52 -40.74 97.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.479 . . . . 72.540000000000006 111.048 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.28 -35.44 35.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 75.200000000000003 110.887 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -62.46 -40.16 95.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 73.439999999999998 110.903 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.8 mmpt? -67.32 -72.08 0.18 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.111 -0.495 . . . . 74.349999999999994 110.895 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.4 t -145.25 -173.85 4.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 75.420000000000002 110.826 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.82 -34.98 6.0 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.737 -0.744 . . . . 44.130000000000003 112.473 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.1 t -123.97 35.15 4.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.831 0.348 . . . . 75.549999999999997 111.165 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -62.97 -171.95 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 74.329999999999998 110.916 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.5 mttp -109.64 120.21 41.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 73.040000000000006 110.929 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.8 t -123.71 112.19 32.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 71.230000000000004 111.105 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -131.04 156.07 45.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 64.040000000000006 111.13 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.7 122.51 16.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 72.040000000000006 110.877 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 11.1 tp -103.28 155.46 18.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.246 -0.434 . . . . 72.120000000000005 110.897 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -112.54 103.14 11.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 72.129999999999995 110.874 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.7 m -51.11 -32.14 11.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 70.209999999999994 111.149 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.77 -35.58 23.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 75.329999999999998 110.862 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.17 -33.31 8.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.448 . . . . 74.439999999999998 111.097 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.91 71.75 21.26 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.6 0.714 . . . . 64.439999999999998 110.869 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -32.04 19.39 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.664 2.243 . . . . 73.409999999999997 112.341 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -51.71 -34.52 39.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 73.120000000000005 110.893 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.77 -46.47 68.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.479 . . . . 65.129999999999995 111.094 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.31 -65.93 0.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.437 . . . . 74.439999999999998 111.069 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -51.04 -32.72 22.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 71.319999999999993 110.886 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.62 -42.14 61.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 75.450000000000003 110.896 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -98.53 20.75 12.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 65.319999999999993 110.898 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 62.9 mm-40 47.41 79.55 0.06 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.474 . . . . 72.400000000000006 110.88 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.2 p -106.48 140.96 22.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 74.239999999999995 111.135 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.49 -35.49 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 75.510000000000005 111.135 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.7 t -105.85 151.88 23.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 71.219999999999999 110.885 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.519 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 5.3 mt -55.62 -58.04 17.86 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.64 0.733 . . . . 74.230000000000004 111.119 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.5 Cg_endo -69.76 99.17 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.667 2.245 . . . . 73.349999999999994 112.314 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 43.3 m -142.39 137.05 30.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 74.25 111.149 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 32.7 ttp -137.33 131.78 32.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 74.310000000000002 110.907 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 10.9 mm -108.2 110.93 33.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 75.310000000000002 111.1 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.59 100.27 7.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.178 -0.464 . . . . 75.420000000000002 110.896 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -89.58 170.32 10.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 75.230000000000004 110.904 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -166.33 89.59 0.4 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 64.329999999999998 110.902 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.86 39.41 8.7 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.758 -0.734 . . . . 62.450000000000003 112.499 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.72 41.63 82.69 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.74 -0.743 . . . . 72.140000000000001 112.484 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.7 m -161.79 131.31 3.25 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.558 0.694 . . . . 74.230000000000004 111.138 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 86.59 0.57 Allowed 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.675 2.25 . . . . 75.439999999999998 112.39 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.9 m -73.37 -32.24 36.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 71.120000000000005 111.116 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.9 mmtm -143.38 170.17 16.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 74.310000000000002 110.896 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -158.36 103.56 1.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 74.299999999999997 110.825 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.6 mp -113.75 132.71 61.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 74.349999999999994 111.113 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.0 m -128.06 141.6 46.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 74.140000000000001 111.141 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 128.06 142.35 5.44 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.741 -0.743 . . . . 74.319999999999993 112.532 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -96.25 89.2 5.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.873 0.368 . . . . 50.450000000000003 111.108 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.03 -175.39 3.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 71.340000000000003 110.959 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.23 -174.79 28.44 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.728 -0.748 . . . . 74.209999999999994 112.481 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.96 -46.47 62.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.761 0.315 . . . . 74.409999999999997 110.876 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.24 -22.24 65.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 73.239999999999995 111.08 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -91.28 -60.51 1.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 45.450000000000003 111.053 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.7 -31.28 47.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.248 -0.433 . . . . 74.319999999999993 110.883 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.7 tt -73.32 -59.64 2.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 73.209999999999994 110.9 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -52.85 -34.04 52.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 74.019999999999996 110.845 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -56.8 -25.0 54.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 74.209999999999994 110.847 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.2 mt -84.58 -65.81 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 74.310000000000002 111.129 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -53.12 -48.24 68.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.433 . . . . 72.430000000000007 110.871 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -54.56 -34.46 61.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.476 . . . . 73.150000000000006 110.86 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.07 -34.74 66.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 73.109999999999999 111.096 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.8 mt . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 75.299999999999997 110.865 -179.932 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ttt . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.767 0.318 . . . . 75.219999999999999 110.853 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -127.5 97.56 4.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 75.319999999999993 111.114 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.9 m-70 -97.4 -50.37 4.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.449 . . . . 64.219999999999999 110.888 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.5 p80 -125.84 115.81 20.57 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.219 -0.446 . . . . 74.400000000000006 110.834 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -150.66 179.65 8.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 74.420000000000002 110.865 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -105.26 30.82 5.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 73.430000000000007 110.846 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -55.69 -36.22 66.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 75.540000000000006 110.85 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -62.81 -36.35 82.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 74.420000000000002 110.843 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 6.7 mmm -77.57 -38.93 47.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 72.099999999999994 110.858 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.9 p -55.08 127.54 29.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 65.209999999999994 110.867 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -89.77 -116.09 1.62 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.721 -0.752 . . . . 54.200000000000003 112.47 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.5 p -70.4 100.29 1.73 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.841 0.353 . . . . 75.510000000000005 111.117 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.4 m -152.13 163.57 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.251 -0.431 . . . . 74.209999999999994 111.124 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.8 t -75.66 127.62 33.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.16 -0.473 . . . . 74.519999999999996 111.172 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 99.8 t -93.18 136.63 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 74.239999999999995 111.146 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.03 176.05 0.35 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 72.219999999999999 111.127 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -81.06 -49.14 11.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 72.409999999999997 110.835 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.3 t -68.07 -54.27 19.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 64.219999999999999 110.872 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 t -58.24 -19.37 33.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.138 -0.483 . . . . 75.340000000000003 111.168 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -50.82 -31.19 16.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 74.409999999999997 110.889 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.54 -34.27 69.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.474 . . . . 74.049999999999997 110.898 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.2 m -91.04 -15.55 29.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 73.409999999999997 111.151 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -93.56 -71.1 0.67 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 74.400000000000006 110.855 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.9 t -71.04 -70.43 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 75.299999999999997 111.116 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.3 mt -40.55 -59.39 1.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 73.310000000000002 110.952 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -51.14 -62.41 1.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.476 . . . . 74.310000000000002 110.843 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.2 p -52.72 152.63 3.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 71.030000000000001 110.883 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -101.6 -37.79 8.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.112 -0.495 . . . . 64.25 110.829 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.94 159.69 1.76 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.589 0.709 . . . . 74.439999999999998 111.121 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 123.98 10.62 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.692 2.261 . . . . 70.430000000000007 112.335 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 97.8 t -97.39 123.87 50.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 73.430000000000007 111.112 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -103.5 100.0 9.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 73.239999999999995 110.899 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.1 p -95.18 135.09 30.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 75.310000000000002 111.137 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.13 99.72 7.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 75.230000000000004 110.876 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -91.41 89.84 7.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.458 . . . . 75.299999999999997 110.887 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -147.8 -169.65 3.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.165 -0.471 . . . . 74.430000000000007 110.919 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.72 -153.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 63.439999999999998 111.085 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.486 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 22.8 t0 -77.16 9.44 3.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 72.140000000000001 110.848 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.486 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 0.9 OUTLIER 42.01 67.02 0.62 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.166 -0.47 . . . . 71.540000000000006 110.911 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 46.8 t -127.74 -44.7 1.49 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.429 . . . . 71.209999999999994 110.935 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.92 -68.03 1.5 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.755 -0.736 . . . . 63.039999999999999 112.519 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -30.84 21.78 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.655 2.237 . . . . 74.349999999999994 112.312 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 42.8 t -56.08 -24.13 38.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.246 -0.434 . . . . 74.349999999999994 110.869 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 50.4 mttt -50.79 -39.5 52.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 75.230000000000004 110.906 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 12.2 ptm -90.12 -29.3 18.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 75.209999999999994 110.886 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.4 t -92.55 21.79 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 75.140000000000001 111.11 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.464 ' N ' ' HD2' ' A' ' 48' ' ' PRO . . . -80.01 -61.08 0.46 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.578 0.704 . . . . 75.530000000000001 111.116 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 47' ' ' ALA . 53.6 Cg_endo -69.76 -46.7 1.13 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.642 2.228 . . . . 71.099999999999994 112.321 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.3 m -50.5 -30.14 7.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 73.109999999999999 111.109 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.8 mt -69.23 -39.08 78.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 74.0 110.909 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -72.77 -32.45 65.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 74.319999999999993 110.858 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -49.74 -58.62 4.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 72.530000000000001 110.882 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 mp -50.38 -32.12 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 74.030000000000001 111.125 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.64 -53.04 60.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 71.010000000000005 111.103 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -65.71 -34.78 79.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.441 . . . . 75.209999999999994 110.893 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -63.53 -34.44 77.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 74.540000000000006 110.874 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -92.8 -74.56 0.52 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 75.030000000000001 110.882 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.0 t -174.48 179.59 1.74 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 65.219999999999999 110.846 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -105.51 34.44 5.77 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.747 -0.739 . . . . 73.200000000000003 112.465 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.3 p -118.65 -35.45 3.72 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.845 0.355 . . . . 75.439999999999998 111.144 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.429 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -51.31 169.38 0.05 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 74.019999999999996 110.901 179.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.69 148.68 46.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 75.129999999999995 110.933 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -125.49 102.06 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 74.019999999999996 111.17 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -99.98 138.42 37.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 72.340000000000003 111.084 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.1 pttp -135.64 111.2 9.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 74.239999999999995 110.914 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 27.9 tp -107.75 160.32 15.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 74.400000000000006 110.88 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.01 119.85 39.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 75.310000000000002 110.891 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.0 m -63.1 -33.49 61.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 71.329999999999998 111.129 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -50.59 -36.13 33.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 75.120000000000005 110.852 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.38 -35.39 10.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 74.239999999999995 111.086 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -120.39 67.6 13.42 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.579 0.704 . . . . 74.409999999999997 110.902 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -33.58 16.56 Favored 'Trans proline' 0 C--N 1.34 0.127 0 C-N-CA 122.687 2.258 . . . . 75.549999999999997 112.377 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -52.21 -52.06 54.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 72.299999999999997 110.877 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.44 -46.13 66.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 75.140000000000001 111.081 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.47 -70.48 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 60.140000000000001 111.115 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 -51.34 -32.11 24.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 74.0 110.863 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -51.69 -44.4 63.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 73.219999999999999 110.889 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -95.66 18.99 11.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 62.310000000000002 110.896 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 48.25 72.85 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 74.310000000000002 110.898 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.6 p -99.3 131.77 45.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 64.409999999999997 111.154 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.1 t -88.89 -74.03 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 75.340000000000003 111.112 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.86 158.75 29.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 71.0 110.828 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.504 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 1.3 mp -65.75 -58.37 11.62 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.635 0.731 . . . . 75.200000000000003 111.159 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.8 Cg_endo -69.77 71.33 1.53 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.709 2.273 . . . . 74.310000000000002 112.355 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 89.1 m -113.73 139.16 49.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 72.129999999999995 111.159 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 37.4 ttp -135.25 112.74 10.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 73.299999999999997 110.903 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.5 mt -90.04 128.08 42.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.429 . . . . 73.049999999999997 111.122 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.0 tp -92.27 105.78 17.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 63.219999999999999 110.97 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -91.86 170.98 9.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 74.239999999999995 110.834 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -165.67 91.9 0.51 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 73.319999999999993 110.915 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.34 36.14 8.32 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.749 -0.739 . . . . 62.210000000000001 112.53 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.48 38.59 79.73 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.752 -0.737 . . . . 63.140000000000001 112.452 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 86.4 m -161.12 133.91 4.53 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.592 0.71 . . . . 74.329999999999998 111.152 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 107.26 1.82 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.723 2.282 . . . . 72.150000000000006 112.322 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 16.5 m -94.13 -32.69 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 73.420000000000002 111.153 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.5 mmtm -152.61 170.38 20.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 73.439999999999998 110.92 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.29 131.72 11.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 73.420000000000002 110.843 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.1 mp -126.01 141.85 44.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 75.219999999999999 111.131 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.6 p -150.23 143.31 17.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 65.099999999999994 111.132 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.52 -27.32 1.35 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.765 -0.731 . . . . 63.32 112.518 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 61.82 72.5 0.5 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.817 0.341 . . . . 61.32 111.104 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.38 -179.2 3.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 75.430000000000007 110.873 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.72 178.84 2.3 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.724 -0.751 . . . . 72.439999999999998 112.515 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.64 -36.12 73.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.771 0.32 . . . . 71.200000000000003 110.887 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.61 -32.65 74.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 64.109999999999999 111.112 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.409 ' HA ' ' HG2' ' A' ' 109' ' ' ARG . . . -86.57 -56.38 3.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 74.420000000000002 111.113 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.24 -34.16 44.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 74.510000000000005 110.914 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.2 tt -70.05 -59.26 3.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.231 -0.441 . . . . 74.430000000000007 110.911 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.409 ' HG2' ' HA ' ' A' ' 106' ' ' ALA . 3.0 ptm180 -56.14 -34.5 66.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 73.409999999999997 110.888 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -52.8 -25.63 11.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 72.109999999999999 110.88 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.6 mt -84.72 -68.43 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.483 . . . . 72.25 111.143 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -51.93 -49.75 62.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 75.310000000000002 110.885 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -53.82 -35.01 60.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 71.409999999999997 110.851 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.98 -35.83 66.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 74.340000000000003 111.071 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.1 mt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 74.409999999999997 110.966 -179.988 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 mtm . . . . . 0 N--CA 1.458 -0.061 0 CA-C-O 120.769 0.319 . . . . 73.340000000000003 110.923 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -129.07 148.07 50.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 74.349999999999994 111.087 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -83.81 -60.25 2.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 73.340000000000003 110.855 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -59.04 104.75 0.26 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 71.310000000000002 110.85 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -157.23 166.19 33.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 75.109999999999999 110.882 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -111.65 30.84 6.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 70.129999999999995 110.889 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -92.99 11.33 27.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.136 -0.484 . . . . 70.310000000000002 110.886 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -79.36 -36.01 40.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 75.239999999999995 110.848 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -58.03 -36.95 73.45 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.207 -0.451 . . . . 72.319999999999993 110.849 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.5 m -52.51 131.42 33.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 72.230000000000004 110.902 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.7 -108.8 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.759 -0.734 . . . . 60.299999999999997 112.452 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.8 p -60.63 113.93 2.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.862 0.363 . . . . 73.519999999999996 111.144 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 91.7 t -149.96 144.49 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 74.200000000000003 111.116 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 t -82.44 127.16 33.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 72.010000000000005 111.129 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.2 t -92.66 131.64 39.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 70.140000000000001 111.103 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.7 179.23 0.13 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.112 -0.495 . . . . 50.210000000000001 111.124 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.05 -49.8 10.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 75.120000000000005 110.934 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.0 m -69.3 -52.99 22.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 63.149999999999999 110.835 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.3 t -58.29 -19.5 35.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 75.099999999999994 111.147 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -51.22 -31.85 21.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 74.019999999999996 110.869 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.418 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -72.04 -32.82 67.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 72.329999999999998 110.876 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.4 m -90.94 -16.58 27.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 75.150000000000006 111.144 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -93.96 -70.76 0.69 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 64.030000000000001 110.879 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.8 t -70.2 -70.48 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 65.209999999999994 111.092 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.418 ' HB2' ' HA ' ' A' ' 21' ' ' LYS . 8.3 mt -41.09 -60.35 1.24 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 75.230000000000004 110.932 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -49.82 -63.05 1.23 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 73.409999999999997 110.864 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 59.6 m -48.85 -34.68 13.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 74.439999999999998 110.818 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.0 t0 59.51 30.88 20.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 54.299999999999997 110.897 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.24 160.62 36.75 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.552 0.692 . . . . 75.319999999999993 111.188 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 111.8 2.9 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.666 2.244 . . . . 71.319999999999993 112.349 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 89.7 t -102.88 117.42 48.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 73.540000000000006 111.087 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.1 mt -79.89 102.33 9.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 74.310000000000002 110.888 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 43.1 t -89.71 137.37 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 75.150000000000006 111.11 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -122.46 99.23 6.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.485 . . . . 74.129999999999995 110.892 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -96.72 89.82 5.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 75.129999999999995 110.885 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -151.18 -169.13 3.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.092 -0.504 . . . . 74.219999999999999 110.925 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.66 -154.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 53.009999999999998 111.1 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.477 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 23.9 t0 -77.33 8.74 3.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 73.219999999999999 110.909 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.477 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 1.3 p-90 41.5 64.87 0.94 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 73.239999999999995 110.949 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 4.0 p -124.87 -44.5 1.93 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.273 -0.421 . . . . 71.540000000000006 110.868 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.55 -69.33 1.4 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.755 -0.736 . . . . 72.510000000000005 112.473 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -26.33 27.67 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.697 2.265 . . . . 75.209999999999994 112.317 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 26.1 t -49.9 -31.09 11.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 72.439999999999998 110.889 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -51.94 -29.86 22.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 73.049999999999997 110.842 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 51.6 mmm -89.99 -38.2 13.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 73.310000000000002 110.863 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.3 t -92.44 22.72 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 74.349999999999994 111.129 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.468 ' N ' ' HD2' ' A' ' 48' ' ' PRO . . . -79.12 -60.92 0.52 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.584 0.707 . . . . 71.109999999999999 111.064 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 47' ' ' ALA . 53.7 Cg_endo -69.8 -48.45 0.71 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.701 2.268 . . . . 63.409999999999997 112.312 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.7 m -50.45 -29.91 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.433 . . . . 74.340000000000003 111.129 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.74 -39.59 73.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 72.349999999999994 110.951 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -70.99 -34.38 71.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 55.340000000000003 110.847 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -51.55 -68.76 0.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 74.5 110.873 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.7 mp -50.43 -34.42 11.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 70.439999999999998 111.131 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.79 -38.58 85.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.176 -0.466 . . . . 43.32 111.124 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.88 -35.25 24.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 65.530000000000001 110.883 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -65.84 -47.05 76.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.476 . . . . 73.209999999999994 110.908 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 53.7 mmtt -62.6 -72.34 0.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 75.349999999999994 110.864 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -128.64 178.23 6.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 74.120000000000005 110.872 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.61 -52.4 20.99 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.794 -0.717 . . . . 62.350000000000001 112.517 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 60.5 p -143.67 56.98 1.36 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.821 0.343 . . . . 71.430000000000007 111.121 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.7 pp -57.94 -178.21 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.238 -0.437 . . . . 70.140000000000001 110.873 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.0 tttp -93.34 146.87 23.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 74.349999999999994 110.893 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -141.26 123.76 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 74.109999999999999 111.129 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -134.89 140.56 45.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 71.319999999999993 111.121 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.71 140.61 51.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 74.25 110.878 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 tt -123.21 150.73 43.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 74.430000000000007 110.914 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.4 103.78 13.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 73.150000000000006 110.857 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.4 m -51.42 -33.33 14.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 73.239999999999995 111.104 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.85 -35.44 32.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 75.099999999999994 110.88 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -103.16 -34.26 8.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 64.430000000000007 111.088 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -118.92 67.35 8.05 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.657 0.742 . . . . 75.010000000000005 110.907 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -34.19 15.04 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.707 2.272 . . . . 74.409999999999997 112.285 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -52.01 -46.36 64.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 73.450000000000003 110.891 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.24 -42.58 86.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 73.310000000000002 111.122 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -55.52 -68.59 0.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 71.209999999999994 111.06 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -51.2 -31.76 21.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 73.120000000000005 110.854 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -51.08 -36.73 41.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 75.129999999999995 110.866 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -108.77 23.85 13.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 74.219999999999999 110.924 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 70.8 mm-40 48.2 67.65 0.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 74.010000000000005 110.871 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 99.4 t -87.5 113.34 24.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.478 . . . . 75.230000000000004 111.1 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.1 t -78.79 -66.88 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 74.519999999999996 111.12 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.45 162.58 17.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 74.329999999999998 110.845 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.521 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.4 mt -65.06 -58.12 13.59 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.636 0.731 . . . . 72.140000000000001 111.118 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.8 Cg_endo -69.8 70.28 1.61 Allowed 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.656 2.237 . . . . 71.439999999999998 112.316 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 99.2 m -108.13 100.02 9.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 53.229999999999997 111.125 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.5 ttt -99.75 118.31 35.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 71.450000000000003 110.856 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 51.4 mt -98.17 131.49 45.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 74.219999999999999 111.102 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.37 103.98 15.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 73.129999999999995 110.964 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -90.02 167.72 12.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 72.310000000000002 110.86 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -170.37 119.58 0.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 73.239999999999995 110.877 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.33 30.99 77.67 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.735 -0.745 . . . . 72.349999999999994 112.485 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.37 53.57 7.49 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.795 -0.717 . . . . 55.109999999999999 112.458 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 178.92 139.35 0.27 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.554 0.692 . . . . 74.519999999999996 111.143 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.84 84.88 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.676 2.251 . . . . 74.140000000000001 112.322 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.9 m -64.14 -33.84 65.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 73.010000000000005 111.138 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -152.84 170.28 20.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 72.319999999999993 110.907 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -151.68 130.86 12.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 70.310000000000002 110.926 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.08 135.75 60.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 72.510000000000005 111.16 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -125.29 140.6 47.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 75.420000000000002 111.125 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 127.98 131.05 3.4 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.751 -0.738 . . . . 75.540000000000006 112.478 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.09 70.92 10.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.835 0.35 . . . . 75.209999999999994 111.082 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.47 171.9 7.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 75.140000000000001 110.909 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.04 173.62 6.15 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.729 -0.748 . . . . 54.439999999999998 112.496 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.88 -44.93 91.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.766 0.317 . . . . 74.430000000000007 110.855 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.93 -64.11 0.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 63.32 111.124 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.44 -57.9 9.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 73.430000000000007 111.144 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.25 -42.49 61.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 75.430000000000007 110.955 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.1 tp -63.6 -55.42 23.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 63.009999999999998 110.879 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.7 mtm180 -51.71 -42.0 61.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 74.409999999999997 110.888 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -51.86 -26.09 9.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 62.219999999999999 110.9 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.9 mt -85.14 -68.65 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 74.340000000000003 111.084 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.53 -49.17 62.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 74.409999999999997 110.862 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -56.95 -34.92 68.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 55.219999999999999 110.884 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.22 -37.51 66.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 73.0 111.085 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.0 mt . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.437 . . . . 74.310000000000002 110.932 -179.956 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 mmt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.761 0.315 . . . . 75.0 110.879 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.39 106.1 11.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 71.349999999999994 111.113 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -98.26 -40.42 8.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 75.340000000000003 110.857 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 24.2 t-80 -101.27 156.0 17.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 74.540000000000006 110.846 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -77.26 168.31 20.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 74.140000000000001 110.832 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 61.2 m-70 -118.4 -37.25 3.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 71.219999999999999 110.86 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -53.08 -36.23 60.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 75.200000000000003 110.826 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -54.83 -36.59 65.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 72.420000000000002 110.843 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 10.1 mtt -98.52 30.73 3.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 75.430000000000007 110.883 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.1 t -71.81 127.55 32.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 73.510000000000005 110.846 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 143.66 173.55 15.26 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.738 -0.744 . . . . 71.409999999999997 112.485 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.2 p -59.98 101.14 0.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.83 0.347 . . . . 74.450000000000003 111.152 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.2 m -153.45 163.67 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 74.430000000000007 111.143 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 t -66.56 126.98 30.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 71.340000000000003 111.135 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.6 t -94.76 127.6 46.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.449 . . . . 73.450000000000003 111.106 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.51 179.08 0.12 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 73.530000000000001 111.119 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -79.98 -48.11 13.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 73.120000000000005 110.871 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.2 m -70.99 -51.56 24.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 74.310000000000002 110.867 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.9 t -59.57 -19.32 47.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.148 -0.478 . . . . 65.519999999999996 111.144 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -51.26 -30.8 18.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 74.519999999999996 110.86 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.1 -33.63 68.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.473 . . . . 74.120000000000005 110.907 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.2 m -91.43 -16.04 27.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 65.109999999999999 111.143 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -93.46 -71.24 0.66 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 63.039999999999999 110.835 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.6 t -70.47 -70.47 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 75.430000000000007 111.146 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.4 mt -40.66 -60.11 1.22 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 75.299999999999997 110.949 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -50.46 -57.43 8.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 74.299999999999997 110.848 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.8 t -51.84 153.15 2.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 74.340000000000003 110.868 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -102.17 -49.4 3.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 73.420000000000002 110.911 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -51.87 159.7 1.31 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 121.624 0.726 . . . . 74.420000000000002 111.094 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 120.08 6.93 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.695 2.263 . . . . 72.340000000000003 112.321 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 97.6 t -83.35 142.74 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 75.549999999999997 111.105 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -111.9 112.64 24.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.467 . . . . 72.200000000000003 110.934 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 70.8 t -100.61 142.78 15.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 75.549999999999997 111.158 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -133.84 99.79 4.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 71.310000000000002 110.826 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -91.72 89.77 7.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 71.439999999999998 110.892 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -141.66 -168.22 2.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 75.120000000000005 110.955 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.68 -164.76 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 63.240000000000002 111.091 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.456 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 1.5 t70 -77.67 11.98 1.86 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 71.519999999999996 110.87 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.482 ' N ' ' CD1' ' A' ' 39' ' ' TRP . 1.2 m0 76.35 94.76 0.07 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.194 -0.457 . . . . 74.319999999999993 110.886 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -169.68 -65.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 60.030000000000001 110.904 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -70.73 -70.28 1.22 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.761 -0.733 . . . . 73.140000000000001 112.491 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -41.37 4.27 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.73 2.287 . . . . 72.109999999999999 112.278 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 31.7 t -51.94 -32.57 33.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.445 . . . . 73.340000000000003 110.859 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 18.5 mtpt -62.4 -34.79 77.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 75.5 110.925 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 34.6 mtm -90.13 -36.13 15.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 75.329999999999998 110.893 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.2 t -94.35 23.11 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 63.100000000000001 111.1 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.473 ' N ' ' HD2' ' A' ' 48' ' ' PRO . . . -76.63 -60.62 0.85 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.603 0.716 . . . . 72.329999999999998 111.122 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 47' ' ' ALA . 53.9 Cg_endo -69.73 -48.7 0.67 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.696 2.264 . . . . 73.430000000000007 112.317 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.5 m -49.94 -30.2 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 75.430000000000007 111.143 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.13 -45.52 11.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 71.239999999999995 110.886 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -60.96 -32.45 71.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 74.349999999999994 110.846 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -51.31 -63.58 1.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 74.040000000000006 110.892 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.7 mp -50.75 -41.02 20.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 74.530000000000001 111.142 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.22 -43.75 74.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 71.329999999999998 111.136 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.91 -36.22 42.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 70.129999999999995 110.884 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -60.64 -36.23 78.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 74.340000000000003 110.902 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.3 mmmt -75.64 -75.36 0.18 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.485 . . . . 74.450000000000003 110.951 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.36 -176.85 0.29 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.248 -0.433 . . . . 75.239999999999995 110.872 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.44 -39.88 55.81 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.769 -0.729 . . . . 75.040000000000006 112.473 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 34.6 p -52.84 -29.05 25.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.804 0.335 . . . . 60.32 111.132 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.01 123.88 7.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 71.129999999999995 110.938 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.8 tttp -111.95 148.98 32.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 71.340000000000003 110.867 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.3 t -124.2 104.5 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 74.25 111.126 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -108.59 109.75 21.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 55.43 111.071 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.98 160.68 19.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 72.510000000000005 110.892 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 50.1 tp -148.29 147.56 29.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.439 . . . . 73.239999999999995 110.936 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -79.4 120.99 24.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 74.140000000000001 110.878 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.1 m -48.71 -36.57 7.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 74.329999999999998 111.11 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.36 -32.88 57.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 75.450000000000003 110.838 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.02 -35.03 29.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 71.519999999999996 111.107 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -118.15 67.14 6.39 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.627 0.727 . . . . 73.409999999999997 110.888 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -32.43 18.33 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.706 2.271 . . . . 74.329999999999998 112.36 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -83.94 -40.8 18.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 62.420000000000002 110.907 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.06 -46.63 87.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 73.299999999999997 111.091 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.0 -63.24 1.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 75.400000000000006 111.141 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.7 ttp180 -51.25 -37.11 45.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 75.219999999999999 110.886 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -55.01 -36.17 65.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 70.120000000000005 110.857 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -98.35 21.77 10.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 75.120000000000005 110.874 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 50.23 80.22 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 71.439999999999998 110.926 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 96.5 t -108.55 97.17 5.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.148 -0.478 . . . . 70.310000000000002 111.099 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.4 t -99.57 34.21 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 73.209999999999994 111.102 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -176.04 140.28 0.41 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.467 . . . . 75.409999999999997 110.887 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.516 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 4.2 mt -57.84 -57.83 22.83 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.668 0.747 . . . . 74.200000000000003 111.09 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.6 Cg_endo -69.74 74.72 1.26 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.714 2.276 . . . . 71.049999999999997 112.359 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 53.6 m -109.26 143.35 38.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 60.450000000000003 111.142 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 10.9 ttp -141.3 128.79 21.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 75.150000000000006 110.9 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 17.2 mt -115.94 119.72 62.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 75.120000000000005 111.17 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.55 111.51 20.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 74.439999999999998 110.915 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -99.42 170.36 8.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 72.310000000000002 110.885 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -163.6 92.53 0.71 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.486 . . . . 74.409999999999997 110.872 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.45 32.21 28.58 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.745 -0.741 . . . . 31.239999999999998 112.503 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.12 38.93 24.88 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.757 -0.735 . . . . 73.230000000000004 112.498 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.1 m -160.32 132.39 4.24 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.589 0.709 . . . . 74.329999999999998 111.11 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 91.73 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.688 2.259 . . . . 64.430000000000007 112.361 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.9 m -70.95 -32.71 49.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 75.209999999999994 111.115 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.1 mmtm -155.25 170.07 22.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 75.439999999999998 110.918 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -148.01 128.01 13.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 73.400000000000006 110.896 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.0 mp -136.06 123.75 35.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 73.200000000000003 111.091 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.1 m -118.81 159.68 19.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 74.340000000000003 111.116 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 115.57 142.15 7.57 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.713 -0.756 . . . . 74.120000000000005 112.454 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.04 71.24 7.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.835 0.35 . . . . 61.539999999999999 111.12 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.1 164.98 11.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.19 -0.459 . . . . 71.329999999999998 110.909 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.78 -176.36 0.73 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.734 -0.746 . . . . 42.520000000000003 112.459 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.79 -43.77 65.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.737 0.303 . . . . 75.239999999999995 110.889 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.72 -26.14 66.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 70.439999999999998 111.099 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.55 -36.25 14.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 74.519999999999996 111.106 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -77.22 -36.13 55.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 73.409999999999997 110.896 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.2 pp -74.65 -39.05 62.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 75.319999999999993 110.906 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -66.88 -35.94 81.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 72.200000000000003 110.859 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -57.77 -23.1 50.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 62.020000000000003 110.887 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.1 mt -86.48 -66.23 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 72.450000000000003 111.108 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -52.59 -48.82 66.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 74.230000000000004 110.85 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -59.75 -33.76 72.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 74.219999999999999 110.907 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.0 -35.62 59.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 75.409999999999997 111.122 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.0 mt . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 72.439999999999998 110.874 -179.952 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.799 0.333 . . . . 73.519999999999996 110.888 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.09 106.19 4.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 71.219999999999999 111.097 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 45.1 p-80 -81.14 -36.13 30.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 73.049999999999997 110.889 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -120.93 175.62 5.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 75.120000000000005 110.861 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -114.98 146.23 41.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 75.439999999999998 110.862 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -115.72 30.79 7.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 64.549999999999997 110.875 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 26.3 t60 -88.95 -36.28 15.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 75.530000000000001 110.9 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 28.1 m170 -79.06 -39.92 32.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 72.409999999999997 110.854 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 36.5 mtm -96.01 30.8 2.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 74.319999999999993 110.87 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.9 t -59.15 113.14 1.98 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 63.140000000000001 110.841 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -160.59 173.47 37.14 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.722 -0.752 . . . . 71.430000000000007 112.502 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.9 p -82.79 99.79 9.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.849 0.357 . . . . 72.409999999999997 111.121 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.1 m -153.76 173.19 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.475 . . . . 71.510000000000005 111.095 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.74 152.35 40.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 74.329999999999998 111.122 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.6 p -127.44 145.52 34.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 73.209999999999994 111.111 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.87 162.28 5.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 74.109999999999999 111.125 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.42 -50.28 13.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 75.239999999999995 110.881 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.1 m -59.69 -35.89 75.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.468 . . . . 63.420000000000002 110.821 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.3 t -85.43 -17.55 36.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 74.510000000000005 111.178 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -49.37 -31.86 10.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 61.43 110.856 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.09 -36.15 74.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.48 . . . . 75.109999999999999 110.918 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.8 m -89.94 -15.09 32.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.436 . . . . 73.120000000000005 111.135 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -92.92 -70.97 0.67 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 73.019999999999996 110.888 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.4 t -72.35 -70.31 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 75.420000000000002 111.142 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.1 mt -39.9 -56.22 1.84 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 75.120000000000005 110.947 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -55.67 -52.52 63.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 75.540000000000006 110.854 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.5 t -51.89 159.88 0.78 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 61.340000000000003 110.836 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -106.89 -44.76 4.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.143 -0.48 . . . . 73.340000000000003 110.867 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -54.49 159.49 3.28 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.601 0.715 . . . . 74.340000000000003 111.122 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 131.02 20.34 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.695 2.264 . . . . 73.349999999999994 112.322 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 88.2 t -102.25 129.45 53.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 75.109999999999999 111.159 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.7 mt -104.93 106.04 16.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 74.329999999999998 110.917 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.8 p -105.12 131.0 55.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 75.430000000000007 111.164 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -116.41 99.61 7.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 74.140000000000001 110.818 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -87.37 89.48 8.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 73.450000000000003 110.897 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -143.61 -169.4 3.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.486 . . . . 74.319999999999993 110.91 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.84 -157.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 73.099999999999994 111.093 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.476 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 15.3 t0 -76.85 9.39 2.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 75.239999999999995 110.876 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.476 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 1.2 p-90 41.69 67.51 0.55 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 72.219999999999999 110.91 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 18.1 t -127.09 -47.7 1.48 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.272 -0.422 . . . . 75.040000000000006 110.839 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.56 -67.91 1.51 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.712 -0.756 . . . . 75.329999999999998 112.525 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -24.82 29.39 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.696 2.264 . . . . 70.319999999999993 112.351 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 36.3 t -49.9 -31.5 12.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 33.130000000000003 110.903 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 11.7 mttp -52.27 -35.14 49.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 75.219999999999999 110.866 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 8.9 mtt -90.44 -32.46 16.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 73.340000000000003 110.875 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.468 ' HA ' ' CG1' ' A' ' 49' ' ' VAL . 3.0 t -92.85 22.89 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 74.219999999999999 111.113 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.466 ' N ' ' HD2' ' A' ' 48' ' ' PRO . . . -80.87 -60.67 0.43 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.559 0.695 . . . . 70.519999999999996 111.113 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 47' ' ' ALA . 53.9 Cg_endo -69.78 -56.72 0.13 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.702 2.268 . . . . 73.230000000000004 112.326 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.468 ' CG1' ' HA ' ' A' ' 46' ' ' VAL . 3.0 p -48.76 -33.93 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 71.140000000000001 111.119 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.3 tp -69.46 -41.44 76.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 74.209999999999994 110.915 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -73.29 -33.24 65.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.461 . . . . 70.540000000000006 110.881 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -50.33 -66.49 0.38 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 74.530000000000001 110.874 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.6 mt -50.07 -33.07 9.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 73.349999999999994 111.106 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.81 -45.04 94.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 74.010000000000005 111.122 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.3 -35.27 66.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 75.530000000000001 110.893 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -71.04 -35.84 72.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 71.140000000000001 110.912 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.6 mmtt -61.88 -62.84 1.51 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 73.349999999999994 110.87 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 t -151.58 -169.04 3.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 75.530000000000001 110.854 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 60' ' ' THR . . . -92.05 123.53 7.27 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.762 -0.732 . . . . 73.439999999999998 112.491 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.406 ' C ' ' O ' ' A' ' 59' ' ' GLY . 9.9 t 37.57 43.41 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.785 0.326 . . . . 63.020000000000003 111.159 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.42 -174.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.264 -0.425 . . . . 74.239999999999995 110.868 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -97.96 140.55 32.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 74.519999999999996 110.903 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.2 t -141.95 118.15 6.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.253 -0.431 . . . . 73.439999999999998 111.138 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.48 147.09 41.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 74.430000000000007 111.09 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.2 pttp -138.97 131.38 28.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 75.310000000000002 110.892 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 32.1 tp -122.47 159.48 27.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 74.340000000000003 110.888 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -103.07 118.08 36.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 74.400000000000006 110.838 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 73.9 t -61.62 -35.7 68.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 73.409999999999997 111.141 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -51.41 -35.3 38.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 70.510000000000005 110.898 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.14 -35.06 11.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 64.219999999999999 111.055 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -117.79 72.5 8.29 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.619 0.723 . . . . 64.540000000000006 110.878 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -31.16 20.84 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.686 2.257 . . . . 72.109999999999999 112.343 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -61.34 -43.33 99.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.243 -0.435 . . . . 64.439999999999998 110.892 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.69 -48.08 83.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 75.340000000000003 111.079 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.16 -66.21 0.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 74.400000000000006 111.089 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.2 ttp85 -51.14 -33.15 25.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 72.209999999999994 110.895 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -51.28 -36.22 41.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 74.010000000000005 110.915 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -108.7 24.97 12.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 74.219999999999999 110.874 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 59.9 mm-40 48.2 67.1 0.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 74.329999999999998 110.858 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 98.9 t -91.2 106.2 17.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 72.519999999999996 111.113 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.5 t -80.12 -62.28 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 73.319999999999993 111.099 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 56.1 m -89.83 160.68 16.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.467 . . . . 71.409999999999997 110.858 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.519 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.8 mt -60.2 -58.18 21.27 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.624 0.726 . . . . 75.010000000000005 111.098 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.3 Cg_endo -69.79 77.43 1.08 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.683 2.255 . . . . 71.540000000000006 112.351 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 99.7 m -117.39 109.62 17.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.439 . . . . 64.430000000000007 111.116 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 31.0 ttp -113.77 145.95 40.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 74.010000000000005 110.891 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.6 mt -129.68 117.86 43.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 73.409999999999997 111.138 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.82 102.59 10.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 72.219999999999999 110.924 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -89.52 167.68 12.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 74.310000000000002 110.894 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -161.85 94.86 0.96 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 72.450000000000003 110.909 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.28 32.72 22.12 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.737 -0.744 . . . . 75.340000000000003 112.502 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.49 41.1 45.64 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.716 -0.754 . . . . 73.109999999999999 112.516 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 85.4 m -160.15 133.69 4.91 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.597 0.713 . . . . 73.430000000000007 111.143 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 93.78 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.692 2.261 . . . . 73.510000000000005 112.349 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.5 m -88.29 -32.37 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 71.310000000000002 111.133 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -132.12 166.22 22.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 72.439999999999998 110.911 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.4 ttp180 -160.09 116.74 2.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 75.140000000000001 110.867 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.0 mp -133.95 139.6 48.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 72.409999999999997 111.128 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.8 m -132.26 154.82 40.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 72.140000000000001 111.107 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 115.34 137.92 6.4 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.719 -0.753 . . . . 74.040000000000006 112.503 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.43 77.11 6.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.883 0.373 . . . . 74.340000000000003 111.083 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.77 176.76 4.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 75.120000000000005 110.898 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -76.65 166.6 54.21 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.685 -0.769 . . . . 71.319999999999993 112.468 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.13 -41.01 82.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.755 0.312 . . . . 74.319999999999993 110.854 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.47 -32.19 66.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 73.5 111.1 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.53 -61.87 1.58 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 73.519999999999996 111.128 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -45.93 -43.1 13.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 63.450000000000003 110.942 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.3 tp -49.49 -47.87 48.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 73.310000000000002 110.937 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 50.7 mtm180 -65.7 -40.59 92.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 75.150000000000006 110.838 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -49.79 -25.15 2.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 71.519999999999996 110.896 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.2 mt -90.37 -70.09 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 71.25 111.15 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -51.86 -51.05 59.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 71.450000000000003 110.849 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -57.2 -34.22 68.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.47 . . . . 74.230000000000004 110.895 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.17 -34.02 65.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 71.129999999999995 111.081 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.5 mt . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 71.200000000000003 110.939 -179.984 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.1 ptm . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.804 0.335 . . . . 74.099999999999994 110.916 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -113.67 85.45 2.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 74.430000000000007 111.067 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -85.64 -38.19 18.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.258 -0.428 . . . . 64.450000000000003 110.85 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -68.45 126.08 28.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 74.230000000000004 110.822 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -92.08 132.11 36.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 73.25 110.85 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -119.98 -36.95 3.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 73.209999999999994 110.855 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 21.4 m170 -98.83 -36.13 9.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 75.140000000000001 110.84 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -97.64 11.33 37.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 65.129999999999995 110.889 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 4.4 ptm -61.41 -40.53 94.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 75.310000000000002 110.876 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.9 t -54.58 113.62 1.37 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 75.209999999999994 110.851 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 133.93 155.03 7.49 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.804 -0.712 . . . . 72.349999999999994 112.523 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.6 p -60.74 105.09 0.41 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.788 0.328 . . . . 51.100000000000001 111.145 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.6 m -153.31 172.19 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 72.140000000000001 111.163 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.1 t -74.04 127.94 34.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 74.030000000000001 111.192 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.4 t -91.28 137.04 22.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 74.140000000000001 111.095 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.71 174.73 0.43 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.16 -0.473 . . . . 73.310000000000002 111.144 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -80.49 -48.97 12.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 61.219999999999999 110.888 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.6 m -68.07 -53.44 25.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 72.329999999999998 110.853 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.6 t -59.06 -19.28 42.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 73.219999999999999 111.158 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -51.08 -31.12 17.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 64.120000000000005 110.879 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.82 -33.45 68.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 74.019999999999996 110.902 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.6 m -91.51 -15.97 27.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.199 -0.455 . . . . 74.230000000000004 111.153 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -93.48 -71.23 0.66 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 74.120000000000005 110.888 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.1 t -70.5 -70.47 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 74.129999999999995 111.142 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.6 mt -40.72 -59.94 1.27 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 75.409999999999997 110.87 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -50.57 -60.68 2.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 73.540000000000006 110.868 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.0 t -51.32 162.06 0.38 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.45 . . . . 74.349999999999994 110.869 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -112.33 -40.28 4.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 74.540000000000006 110.828 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.94 158.88 1.56 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.563 0.697 . . . . 73.239999999999995 111.172 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 116.08 4.39 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.726 2.284 . . . . 73.450000000000003 112.323 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.0 t -82.35 141.53 14.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 74.540000000000006 111.111 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.1 mt -112.04 104.89 13.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 74.0 110.912 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.6 p -113.37 146.86 17.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 75.120000000000005 111.123 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -139.49 117.85 12.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 74.219999999999999 110.9 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -95.17 97.05 9.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 73.420000000000002 110.926 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -146.13 -167.32 2.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 73.329999999999998 110.935 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.09 -167.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 74.109999999999999 111.118 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.447 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 5.7 m-20 -78.77 12.69 1.99 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 73.450000000000003 110.855 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.449 ' CD1' ' N ' ' A' ' 39' ' ' TRP . 0.8 OUTLIER 75.37 85.57 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 75.25 110.91 -179.963 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 2.0 p -164.44 -47.08 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 65.129999999999995 110.88 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.88 -70.72 1.34 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.794 -0.717 . . . . 73.319999999999993 112.463 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -31.22 21.05 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.688 2.259 . . . . 65.120000000000005 112.339 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 43.7 t -51.24 -29.16 13.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 74.010000000000005 110.852 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -63.66 -49.34 73.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 74.409999999999997 110.902 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 10.9 ptp -77.54 -34.52 53.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 75.219999999999999 110.909 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.4 t -93.8 21.98 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 72.140000000000001 111.163 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.455 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . . . -76.52 -61.28 0.79 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.606 0.717 . . . . 73.549999999999997 111.142 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' A' ' 47' ' ' ALA . 53.3 Cg_endo -69.81 -49.83 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.651 2.234 . . . . 72.230000000000004 112.348 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.1 m -51.04 -30.35 9.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 73.099999999999994 111.144 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.2 tp -76.17 -41.51 49.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.121 -0.49 . . . . 73.519999999999996 110.911 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -71.12 -33.94 70.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 75.299999999999997 110.895 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -51.49 -69.53 0.11 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 72.420000000000002 110.864 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 mp -50.99 -37.29 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 74.219999999999999 111.14 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.75 -48.78 80.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 73.310000000000002 111.108 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.69 -35.99 75.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 71.540000000000006 110.863 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -66.01 -36.67 83.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 74.450000000000003 110.903 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.9 mmtt -75.97 -71.82 0.36 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 74.129999999999995 110.866 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -178.82 -169.03 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 74.239999999999995 110.817 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -113.3 -31.14 2.48 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.77 -0.728 . . . . 71.310000000000002 112.502 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 29.4 p -57.31 -32.54 66.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.842 0.353 . . . . 64.140000000000001 111.158 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.426 ' N ' ' CD1' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -50.71 168.8 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 75.150000000000006 110.903 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -122.28 141.97 50.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 73.099999999999994 110.855 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 23.8 t -120.58 99.81 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 55.109999999999999 111.143 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -108.88 142.69 39.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 70.409999999999997 111.108 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.5 mtpt -130.93 159.51 37.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 75.5 110.91 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.4 tp -140.56 144.83 36.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 73.349999999999994 110.924 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.03 119.34 33.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 75.25 110.843 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.1 t -62.4 -34.58 65.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.486 . . . . 64.329999999999998 111.105 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.56 -35.54 41.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 71.540000000000006 110.867 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.36 -34.09 11.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 74.109999999999999 111.06 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -118.3 68.46 7.35 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.602 0.715 . . . . 75.349999999999994 110.878 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -32.81 17.8 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.692 2.261 . . . . 73.109999999999999 112.328 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -67.99 -35.19 77.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 73.230000000000004 110.859 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.96 -44.13 82.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 62.32 111.104 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.83 -64.38 0.97 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 70.129999999999995 111.097 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.6 ttp180 -50.51 -35.11 27.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 75.329999999999998 110.898 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.85 -35.79 64.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 71.140000000000001 110.835 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -107.6 28.7 7.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 73.510000000000005 110.896 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 50.96 84.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 75.439999999999998 110.942 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 96.9 t -120.78 140.06 46.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.443 . . . . 71.25 111.131 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.6 m -127.59 -37.69 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 73.530000000000001 111.154 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.2 t -100.96 148.28 25.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 74.5 110.871 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.52 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.1 mt -59.64 -57.69 24.97 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.599 0.714 . . . . 73.450000000000003 111.128 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.8 Cg_endo -69.76 71.56 1.51 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.687 2.258 . . . . 75.430000000000007 112.345 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 54.8 m -106.39 135.37 47.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 73.430000000000007 111.137 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 5.0 ttt -134.66 146.31 49.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 72.439999999999998 110.898 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 22.3 mt -141.86 118.03 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 75.420000000000002 111.156 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.39 101.42 9.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 73.540000000000006 110.948 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -89.91 170.92 9.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 62.299999999999997 110.865 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.74 119.11 0.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 74.0 110.901 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.37 34.41 88.14 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.707 -0.759 . . . . 64.430000000000007 112.501 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.56 42.34 55.5 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.714 -0.755 . . . . 65.25 112.538 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 84.9 m -161.05 133.94 4.57 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.613 0.721 . . . . 71.319999999999993 111.109 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 81.35 0.82 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.657 2.238 . . . . 74.219999999999999 112.345 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.3 m -68.2 -32.36 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 75.120000000000005 111.11 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.3 mmtm -142.75 160.19 40.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 75.239999999999995 110.879 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -149.37 124.63 10.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 75.439999999999998 110.871 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.6 mp -139.35 116.56 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 75.409999999999997 111.11 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 61.0 t -111.76 134.24 54.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 73.530000000000001 111.132 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 133.99 140.26 4.29 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.735 -0.745 . . . . 73.230000000000004 112.46 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.32 85.58 4.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.83 0.348 . . . . 74.140000000000001 111.139 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.36 165.92 15.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 72.340000000000003 110.908 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.22 149.76 49.65 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.755 -0.736 . . . . 71.219999999999999 112.523 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.17 -36.98 9.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.822 0.344 . . . . 73.439999999999998 110.869 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.82 -47.03 74.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 75.25 111.114 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -83.18 -49.6 9.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 73.340000000000003 111.094 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -47.87 -51.87 21.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.237 -0.438 . . . . 74.019999999999996 110.872 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.7 pp -50.69 -35.89 33.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 73.099999999999994 110.893 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -68.65 -44.69 73.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 74.0 110.898 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -51.4 -25.61 6.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.49 . . . . 73.120000000000005 110.909 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.7 mt -84.72 -68.08 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 71.409999999999997 111.167 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -52.32 -49.38 64.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 71.299999999999997 110.891 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -52.49 -33.82 46.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.481 . . . . 75.400000000000006 110.836 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.01 -34.68 73.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 74.109999999999999 111.081 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 75.519999999999996 110.919 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.0 mtm . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.802 0.334 . . . . 63.439999999999998 110.895 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.59 -175.82 5.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.447 . . . . 70.439999999999998 111.06 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.7 m170 -77.68 -57.7 3.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.467 . . . . 74.409999999999997 110.847 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -105.65 -175.69 2.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 72.519999999999996 110.847 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.4 m-70 -146.03 120.1 9.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.442 . . . . 74.409999999999997 110.88 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 27.8 m170 -113.99 30.76 7.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 63.450000000000003 110.875 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -97.28 11.25 37.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 72.030000000000001 110.885 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.8 t-160 -62.22 -37.84 86.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 75.409999999999997 110.873 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 83.0 mtp -57.77 -44.64 86.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 75.209999999999994 110.888 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.1 m -57.57 124.79 20.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 75.439999999999998 110.884 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -55.9 -84.26 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.678 -0.773 . . . . 71.310000000000002 112.483 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.3 p -71.27 120.76 17.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.856 0.36 . . . . 71.340000000000003 111.162 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.4 t -135.15 140.69 44.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 74.140000000000001 111.121 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 t -92.71 133.38 36.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 74.129999999999995 111.16 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.7 t -89.81 120.73 39.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 72.030000000000001 111.107 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.92 -179.52 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 75.329999999999998 111.144 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -79.71 -45.59 18.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 70.299999999999997 110.833 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.7 m -68.98 -54.86 13.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 52.130000000000003 110.864 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.3 t -57.74 -21.9 43.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 72.109999999999999 111.159 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -48.77 -30.5 5.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 73.439999999999998 110.913 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.422 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -67.61 -41.97 83.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 75.239999999999995 110.876 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.5 m -91.45 -9.69 43.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.228 -0.442 . . . . 74.349999999999994 111.153 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.57 -70.24 0.71 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 72.120000000000005 110.885 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.1 t -83.99 -66.87 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 74.5 111.145 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.422 ' HB2' ' HA ' ' A' ' 21' ' ' LYS . 77.8 mt -45.79 -32.77 2.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 75.129999999999995 110.898 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -48.8 -32.05 8.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.157 -0.474 . . . . 74.219999999999999 110.882 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.9 t 65.9 62.97 0.6 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 74.519999999999996 110.851 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -120.23 -32.38 4.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 73.120000000000005 110.886 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.16 159.67 30.97 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.557 0.694 . . . . 72.400000000000006 111.139 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 126.7 13.6 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.645 2.23 . . . . 72.319999999999993 112.356 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.6 t -98.18 119.17 45.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 71.230000000000004 111.113 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.0 mp -108.0 99.9 9.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 71.430000000000007 110.886 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.4 m -107.44 146.21 13.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 74.109999999999999 111.125 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -123.47 100.21 6.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 73.25 110.897 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -72.15 100.22 2.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 72.319999999999993 110.877 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -147.47 -168.3 3.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.153 -0.476 . . . . 70.549999999999997 110.908 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.47 -164.96 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 72.230000000000004 111.128 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.475 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 4.6 m-20 -79.25 13.66 1.8 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.446 . . . . 73.400000000000006 110.903 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.475 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 0.6 OUTLIER 75.19 94.76 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 75.230000000000004 110.925 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -172.13 -57.92 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.444 . . . . 70.239999999999995 110.91 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.26 -70.98 1.28 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.798 -0.715 . . . . 74.019999999999996 112.479 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 -31.04 21.65 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.693 2.262 . . . . 72.010000000000005 112.356 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 20.4 t -58.46 -35.4 72.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 74.319999999999993 110.87 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.5 ptmm? -65.02 -29.42 70.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 74.329999999999998 110.904 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 9.0 mtm -86.88 -41.54 13.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 75.25 110.883 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.1 t -94.24 22.3 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 72.409999999999997 111.176 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.452 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . . . -75.85 -61.1 0.93 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.512 0.672 . . . . 74.340000000000003 111.129 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.452 ' CD ' ' CB ' ' A' ' 47' ' ' ALA . 54.0 Cg_endo -69.72 -50.3 0.48 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.687 2.258 . . . . 72.0 112.354 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.2 m -52.66 -29.07 13.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 74.200000000000003 111.163 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.0 tp -86.16 -44.31 12.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.146 -0.479 . . . . 72.299999999999997 110.908 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -62.66 -34.4 77.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 72.530000000000001 110.899 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -51.76 -55.41 19.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 74.209999999999994 110.917 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 mt -50.57 -37.99 15.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.085 -0.507 . . . . 74.400000000000006 111.13 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.43 -42.44 62.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 72.120000000000005 111.097 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.0 -40.92 97.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 52.409999999999997 110.881 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -73.57 -36.09 65.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 71.230000000000004 110.862 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.3 -69.36 0.2 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 74.209999999999994 110.901 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.3 t 63.04 39.1 10.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 75.310000000000002 110.826 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -111.06 -117.09 3.7 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.749 -0.739 . . . . 74.540000000000006 112.533 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.8 p -140.31 34.35 1.88 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.788 0.328 . . . . 75.340000000000003 111.152 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.5 pp -81.46 144.8 31.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 61.409999999999997 110.907 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.3 mttm -98.55 126.19 44.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.448 . . . . 73.200000000000003 110.891 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 44.5 t -100.34 101.53 12.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 74.239999999999995 111.137 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -117.01 152.45 34.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 62.130000000000003 111.104 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.26 136.88 42.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 74.239999999999995 110.923 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.5 tp -117.04 150.88 37.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 75.140000000000001 110.914 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -106.98 118.57 37.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 71.400000000000006 110.816 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 99.9 t -57.77 -40.35 75.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.469 . . . . 71.209999999999994 111.11 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -51.7 -36.19 45.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.142 -0.481 . . . . 73.120000000000005 110.869 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.34 -33.89 15.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 60.420000000000002 111.111 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -118.76 67.81 7.98 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.604 0.716 . . . . 74.140000000000001 110.866 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -33.58 16.32 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.64 2.227 . . . . 75.109999999999999 112.359 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -74.46 -36.7 63.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 64.319999999999993 110.895 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.26 -48.24 74.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 74.219999999999999 111.111 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.25 -61.41 2.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 71.140000000000001 111.12 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.58 -34.05 35.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 74.019999999999996 110.891 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.17 -34.69 73.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 74.540000000000006 110.873 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -103.88 26.91 8.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 74.099999999999994 110.853 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 49.85 82.5 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.485 . . . . 75.430000000000007 110.904 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 85.4 t -117.11 144.58 24.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.229 -0.442 . . . . 75.549999999999997 111.181 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.7 m -135.42 -40.22 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 74.299999999999997 111.096 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.2 m -97.65 146.71 25.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 73.129999999999995 110.861 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.527 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.9 mt -57.94 -57.75 23.52 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.586 0.707 . . . . 72.340000000000003 111.108 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 54.1 Cg_endo -69.79 74.94 1.26 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.696 2.264 . . . . 75.409999999999997 112.343 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 52.3 m -112.3 143.34 43.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 72.209999999999994 111.129 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 4.2 tmm? -140.34 139.1 35.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 74.540000000000006 110.843 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.1 mt -130.38 113.19 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 73.310000000000002 111.08 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.6 tt -80.53 111.32 16.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 75.5 110.93 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -98.91 168.75 9.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 75.049999999999997 110.88 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -170.68 93.33 0.19 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.171 -0.468 . . . . 73.140000000000001 110.915 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.77 44.66 6.32 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.727 -0.749 . . . . 73.319999999999993 112.449 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 63.71 38.41 96.17 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.739 -0.743 . . . . 73.329999999999998 112.5 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.5 m -162.93 128.62 2.22 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.573 0.701 . . . . 73.109999999999999 111.134 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 86.94 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.679 2.253 . . . . 75.120000000000005 112.384 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.5 m -57.56 -35.74 51.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.425 . . . . 64.310000000000002 111.146 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 45.8 mmtt -152.82 170.19 20.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 55.509999999999998 110.896 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 11.2 ttt180 -149.73 123.65 9.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 73.329999999999998 110.901 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.2 mp -127.11 128.97 70.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 74.25 111.131 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.8 m -124.55 160.22 29.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.467 . . . . 64.310000000000002 111.136 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 109.51 138.63 8.21 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.727 -0.749 . . . . 44.399999999999999 112.487 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -91.87 80.41 5.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.863 0.363 . . . . 74.430000000000007 111.139 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.84 178.58 4.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.435 . . . . 73.340000000000003 110.855 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.75 -169.71 1.07 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.783 -0.723 . . . . 64.0 112.47 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.17 -54.19 6.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.805 0.336 . . . . 65.409999999999997 110.905 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -53.63 -34.03 57.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 74.219999999999999 111.116 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.06 -64.4 1.17 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 72.230000000000004 111.094 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.27 -33.65 20.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 74.420000000000002 110.947 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.1 tt -71.71 -59.29 2.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 72.420000000000002 110.88 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.0 ptp180 -56.39 -31.74 64.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 74.299999999999997 110.875 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -51.75 -24.88 6.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.159 -0.473 . . . . 71.25 110.93 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.7 mt -86.0 -68.7 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.487 . . . . 73.400000000000006 111.123 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -52.42 -49.62 64.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 74.420000000000002 110.842 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -53.72 -35.2 60.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.146 -0.479 . . . . 71.200000000000003 110.888 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.19 -36.37 69.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 73.239999999999995 111.112 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.1 mt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 75.230000000000004 110.93 179.995 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.7 mtt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.709 0.29 . . . . 74.409999999999997 110.902 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.1 59.09 0.65 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.269 -0.423 . . . . 74.510000000000005 111.067 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 15.2 t60 -88.1 -44.65 10.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 72.099999999999994 110.856 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -79.07 -176.01 4.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 72.519999999999996 110.837 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -124.86 174.23 8.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 70.109999999999999 110.813 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 -100.28 30.85 3.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 75.549999999999997 110.871 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -93.62 11.32 29.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 74.349999999999994 110.841 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -108.15 -36.01 6.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 75.540000000000006 110.839 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 49.4 mtt -95.91 30.82 2.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 73.5 110.859 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.5 m -74.41 110.12 8.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.446 . . . . 64.219999999999999 110.803 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 157.72 175.97 29.25 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.751 -0.737 . . . . 71.299999999999997 112.495 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.9 p -74.48 100.33 3.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.845 0.355 . . . . 74.140000000000001 111.133 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.8 m -152.43 160.97 3.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 75.439999999999998 111.125 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.7 t -68.52 157.17 36.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 72.25 111.17 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.3 p -124.16 155.01 31.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 71.519999999999996 111.127 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.57 167.79 1.87 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 75.109999999999999 111.146 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.3 -47.98 13.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.224 -0.444 . . . . 74.439999999999998 110.891 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.9 t -66.59 -53.29 36.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.202 -0.454 . . . . 74.329999999999998 110.901 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.8 t -61.51 -17.7 55.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 71.25 111.119 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -49.71 -32.45 13.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 73.329999999999998 110.907 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.42 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -70.69 -33.18 70.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 73.400000000000006 110.893 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.0 m -90.93 -16.47 28.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 75.319999999999993 111.133 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -93.16 -70.68 0.69 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.446 . . . . 63.450000000000003 110.86 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.0 t -71.48 -70.32 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.243 -0.435 . . . . 74.030000000000001 111.113 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.42 ' HB2' ' HA ' ' A' ' 21' ' ' LYS . 8.5 mt -40.46 -59.99 1.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 73.430000000000007 110.921 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -50.77 -62.11 1.8 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 74.129999999999995 110.874 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 86.2 p -51.79 137.65 25.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 72.319999999999993 110.858 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -88.49 -35.96 16.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.09 -0.505 . . . . 62.32 110.875 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -51.98 159.53 1.4 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.614 0.721 . . . . 74.0 111.174 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 126.5 13.35 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.676 2.25 . . . . 75.25 112.312 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 95.9 t -99.49 128.02 51.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 71.519999999999996 111.157 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.7 mp -99.8 121.65 41.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 74.329999999999998 110.938 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.6 p -127.43 126.15 66.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 75.420000000000002 111.105 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -110.76 100.07 8.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 71.439999999999998 110.874 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -84.29 89.42 7.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 74.319999999999993 110.914 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -147.83 -169.17 3.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.124 -0.489 . . . . 73.519999999999996 110.901 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.7 -154.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 72.319999999999993 111.114 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.475 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 14.2 p-10 -77.31 8.8 3.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 72.409999999999997 110.875 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.475 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 1.4 p-90 41.49 63.85 1.17 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 71.230000000000004 110.939 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 35.9 t -130.22 -45.94 1.11 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 74.420000000000002 110.924 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.74 -68.75 1.44 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.753 -0.736 . . . . 72.439999999999998 112.485 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -30.8 21.88 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.759 2.306 . . . . 71.319999999999993 112.335 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 53.3 t -58.18 -20.43 41.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.245 -0.434 . . . . 72.239999999999995 110.883 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -49.74 -36.24 24.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 73.030000000000001 110.868 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 6.5 ptp -90.83 -30.92 16.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 71.420000000000002 110.859 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.3 t -92.73 21.96 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.284 -0.416 . . . . 74.150000000000006 111.141 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.458 ' N ' ' HD2' ' A' ' 48' ' ' PRO . . . -79.07 -60.98 0.52 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.595 0.712 . . . . 72.109999999999999 111.084 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 47' ' ' ALA . 53.5 Cg_endo -69.75 -48.53 0.7 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.63 2.22 . . . . 73.230000000000004 112.38 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.6 m -50.01 -30.71 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 75.019999999999996 111.116 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.1 tt -71.57 -40.24 70.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 74.430000000000007 110.902 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -73.03 -33.5 65.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 72.140000000000001 110.87 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -52.22 -67.66 0.23 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 71.150000000000006 110.907 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.8 mt -51.28 -34.34 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 74.310000000000002 111.094 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.3 -40.29 86.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 74.450000000000003 111.076 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.34 -47.61 75.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.443 . . . . 74.209999999999994 110.856 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -71.11 -36.18 72.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 72.239999999999995 110.892 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.74 -75.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 73.239999999999995 110.867 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.4 -38.49 0.84 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 63.039999999999999 110.891 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 100.28 -27.39 20.6 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.718 -0.754 . . . . 71.400000000000006 112.449 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 79.5 p -137.31 64.43 1.53 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.853 0.358 . . . . 75.329999999999998 111.139 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.13 -177.4 3.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 74.420000000000002 110.964 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.02 138.77 35.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.435 . . . . 75.230000000000004 110.934 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.5 t -142.05 99.81 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.266 -0.425 . . . . 74.510000000000005 111.125 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -101.75 146.77 27.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 64.319999999999993 111.117 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.24 151.03 49.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 73.019999999999996 110.906 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 13.6 tp -139.94 150.57 44.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 75.319999999999993 110.931 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -103.08 115.45 30.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 72.109999999999999 110.897 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.0 m -57.89 -34.66 49.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.46 . . . . 74.239999999999995 111.107 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.48 -36.15 43.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 70.430000000000007 110.868 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.14 -34.62 11.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 73.319999999999993 111.126 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -118.82 70.18 9.58 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.625 0.726 . . . . 73.420000000000002 110.883 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.75 -32.65 18.21 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.718 2.278 . . . . 73.540000000000006 112.361 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -59.17 -44.6 92.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 71.340000000000003 110.898 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.07 -54.65 44.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 71.239999999999995 111.073 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.79 -60.3 3.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 74.349999999999994 111.148 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.85 -33.27 23.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 74.129999999999995 110.888 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -56.01 -38.77 70.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 73.200000000000003 110.881 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -94.63 19.22 10.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 74.299999999999997 110.884 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 47.76 77.84 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 72.150000000000006 110.903 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.6 p -120.04 142.47 35.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 70.25 111.121 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.5 m -119.58 -37.66 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 73.219999999999999 111.124 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 39.3 m -89.97 140.22 29.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 72.519999999999996 110.9 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.52 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.0 mt -55.82 -58.02 18.31 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.596 0.712 . . . . 71.319999999999993 111.09 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.5 Cg_endo -69.79 79.21 0.97 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.649 2.232 . . . . 74.409999999999997 112.342 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 85.6 m -123.37 108.05 12.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.226 -0.443 . . . . 64.340000000000003 111.147 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 18.8 ttp -109.97 142.1 41.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 63.409999999999997 110.903 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.2 mt -127.42 129.49 70.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 75.450000000000003 111.135 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.42 106.3 18.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 72.150000000000006 110.908 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -89.7 169.99 10.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 73.230000000000004 110.882 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -163.01 92.5 0.76 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 71.430000000000007 110.894 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.52 37.06 9.91 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.777 -0.725 . . . . 71.420000000000002 112.478 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.12 38.3 63.55 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.722 -0.752 . . . . 72.299999999999997 112.503 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 85.2 m -161.02 133.94 4.59 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.579 0.704 . . . . 75.439999999999998 111.171 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 107.32 1.82 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.706 2.271 . . . . 64.049999999999997 112.367 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.7 m -98.55 -33.17 4.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 73.099999999999994 111.118 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.9 mmtm -130.28 163.52 26.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 74.420000000000002 110.928 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.1 ttp180 -155.12 114.12 3.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 74.329999999999998 110.885 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.7 mp -129.83 129.88 66.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 75.400000000000006 111.134 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.2 m -128.49 141.69 45.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 72.329999999999998 111.135 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 132.59 130.92 3.15 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.765 -0.731 . . . . 73.150000000000006 112.482 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.37 59.1 3.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.845 0.355 . . . . 72.140000000000001 111.111 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.25 171.75 8.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 74.420000000000002 110.92 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -67.99 -178.67 14.62 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.771 -0.728 . . . . 74.409999999999997 112.492 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -44.14 72.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.821 0.343 . . . . 75.120000000000005 110.898 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.88 -34.46 65.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 73.209999999999994 111.058 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.408 ' HA ' ' HG2' ' A' ' 109' ' ' ARG . . . -87.97 -56.18 3.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 72.109999999999999 111.113 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -51.42 -35.19 38.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.448 . . . . 70.140000000000001 110.906 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.7 tt -68.98 -60.53 2.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 72.299999999999997 110.904 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.408 ' HG2' ' HA ' ' A' ' 106' ' ' ALA . 14.6 ptp180 -54.59 -35.12 63.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 73.150000000000006 110.864 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -53.24 -24.62 11.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 74.200000000000003 110.878 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.5 mt -84.75 -67.93 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 75.010000000000005 111.153 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.34 -46.86 66.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 73.120000000000005 110.892 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -55.42 -34.47 64.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 73.519999999999996 110.85 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.28 -37.1 69.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 71.319999999999993 111.122 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 73.409999999999997 110.905 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.765 0.317 . . . . 75.400000000000006 110.885 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.07 109.05 4.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 63.350000000000001 111.1 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.6 m-70 -98.87 -59.87 1.65 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 71.150000000000006 110.827 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -172.27 -179.68 2.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 73.219999999999999 110.882 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 -62.72 168.19 3.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.449 . . . . 73.040000000000006 110.847 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 23.6 p80 -101.19 30.76 3.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 62.229999999999997 110.852 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -57.72 -36.1 71.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 73.209999999999994 110.866 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -96.83 -35.93 10.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.198 -0.456 . . . . 72.150000000000006 110.843 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 4.3 tpt -52.14 -36.07 50.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 75.140000000000001 110.921 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.3 t -58.33 114.41 2.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.437 . . . . 65.230000000000004 110.839 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 120.86 177.54 15.75 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 72.329999999999998 112.441 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.9 p -61.47 105.71 0.55 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.804 0.335 . . . . 72.420000000000002 111.146 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 72.8 t -149.66 144.3 17.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.428 . . . . 74.109999999999999 111.124 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 t -69.13 127.24 32.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 74.319999999999993 111.162 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.9 t -92.9 132.41 37.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 64.109999999999999 111.126 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.72 177.71 0.2 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 72.109999999999999 111.141 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.53 -48.35 12.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 75.0 110.842 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.6 t -71.16 -52.05 21.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 72.349999999999994 110.865 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.8 t -58.54 -19.71 40.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 71.409999999999997 111.16 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -51.51 -30.71 21.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 75.219999999999999 110.855 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.33 -33.16 67.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 74.129999999999995 110.882 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.4 m -91.67 -16.09 27.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 74.040000000000006 111.162 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -93.48 -71.35 0.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 72.450000000000003 110.832 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.2 t -70.34 -70.42 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 72.239999999999995 111.114 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.6 mt -40.72 -60.42 1.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 75.510000000000005 110.919 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -50.05 -57.85 6.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 71.140000000000001 110.893 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.4 m -52.49 147.02 8.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 75.409999999999997 110.86 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -95.34 -45.67 7.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 75.230000000000004 110.839 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -51.11 160.56 0.84 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.53 0.681 . . . . 74.319999999999993 111.137 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 132.08 22.48 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.686 2.257 . . . . 74.420000000000002 112.318 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 62.8 t -102.3 134.24 43.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 74.409999999999997 111.107 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.77 116.41 32.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 70.030000000000001 110.948 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.4 t -94.07 143.51 11.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 74.420000000000002 111.115 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.76 99.85 5.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 64.319999999999993 110.881 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -100.96 95.88 6.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 73.310000000000002 110.867 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -152.05 -167.73 2.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.45 . . . . 73.230000000000004 110.92 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.13 -165.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 75.109999999999999 111.065 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.435 ' O ' ' CB ' ' A' ' 39' ' ' TRP . 4.9 m-20 -77.66 12.6 1.59 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.237 -0.438 . . . . 75.409999999999997 110.888 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.436 ' N ' ' CD1' ' A' ' 39' ' ' TRP . 1.9 m0 78.25 90.32 0.06 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 73.5 110.91 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -174.84 -56.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 72.340000000000003 110.878 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.05 -70.89 1.3 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.72 -0.752 . . . . 53.439999999999998 112.528 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.78 -29.18 24.2 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.714 2.276 . . . . 74.140000000000001 112.365 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -61.54 -32.17 72.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 72.430000000000007 110.899 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -63.74 -30.68 71.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 72.040000000000006 110.905 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 2.0 mtt -83.78 -43.29 15.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 70.219999999999999 110.836 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 t -93.93 22.49 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 74.430000000000007 111.121 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.472 ' N ' ' HD2' ' A' ' 48' ' ' PRO . . . -74.75 -60.73 1.21 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.617 0.723 . . . . 75.140000000000001 111.135 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 47' ' ' ALA . 53.4 Cg_endo -69.79 -49.99 0.5 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.677 2.251 . . . . 73.340000000000003 112.307 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.1 m -53.6 -29.68 17.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 73.319999999999993 111.128 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.9 tp -72.18 -42.07 66.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.476 . . . . 75.340000000000003 110.972 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -64.28 -36.38 83.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 74.420000000000002 110.898 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -55.82 -69.56 0.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 74.340000000000003 110.862 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.7 mt -54.83 -36.94 39.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 61.240000000000002 111.128 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.74 -38.24 84.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 74.209999999999994 111.096 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -81.91 -40.5 22.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 54.43 110.908 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -63.66 -49.12 74.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 75.340000000000003 110.832 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.1 mmtp -55.05 -61.81 2.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 73.450000000000003 110.913 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -152.32 -179.65 7.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 63.530000000000001 110.859 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -114.28 -21.05 5.68 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.758 -0.734 . . . . 74.439999999999998 112.458 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.2 t -129.01 61.5 1.52 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.858 0.361 . . . . 74.319999999999993 111.161 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.431 ' C ' ' CD2' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -105.41 172.97 6.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 73.549999999999997 110.87 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.15 122.27 46.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 74.219999999999999 110.928 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.9 t -121.6 112.57 35.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 74.349999999999994 111.147 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -121.94 129.88 52.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 72.200000000000003 111.095 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.78 154.55 26.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 72.420000000000002 110.937 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.7 tp -140.41 137.09 33.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 72.239999999999995 110.925 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.25 149.26 30.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 60.039999999999999 110.884 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.9 t -90.74 -36.17 7.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 75.010000000000005 111.117 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.1 -35.24 64.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 73.219999999999999 110.853 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.33 -32.56 13.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 75.209999999999994 111.116 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -117.01 68.36 4.5 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.611 0.72 . . . . 72.310000000000002 110.883 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -33.09 17.37 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.692 2.261 . . . . 71.209999999999994 112.348 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -67.37 -36.42 81.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 75.439999999999998 110.884 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.78 -49.58 76.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 64.040000000000006 111.078 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.62 -60.86 2.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 75.230000000000004 111.136 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 14.0 ttp85 -51.22 -34.71 33.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 74.230000000000004 110.828 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -51.93 -38.23 55.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.244 -0.435 . . . . 74.430000000000007 110.858 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -106.53 28.06 8.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 70.120000000000005 110.858 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 49.72 61.14 3.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 70.400000000000006 110.903 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 85.2 t -96.44 136.56 26.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 74.430000000000007 111.117 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.9 m -127.47 -36.48 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 54.439999999999998 111.137 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.7 t -97.06 143.84 27.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 75.129999999999995 110.825 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.519 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.9 mt -56.86 -57.59 23.18 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.624 0.726 . . . . 73.400000000000006 111.153 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 54.4 Cg_endo -69.71 76.88 1.09 Allowed 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.704 2.269 . . . . 72.329999999999998 112.35 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 68.8 m -116.67 127.59 54.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 73.340000000000003 111.11 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.3 tpp -128.35 140.73 51.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 71.310000000000002 110.838 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 19.2 mt -127.82 129.54 69.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 74.129999999999995 111.151 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.15 104.83 16.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 73.519999999999996 110.943 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -90.01 170.14 10.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 73.340000000000003 110.899 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -164.35 91.55 0.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 73.120000000000005 110.922 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.2 32.61 16.53 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.715 -0.755 . . . . 62.009999999999998 112.476 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.14 39.48 37.03 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.763 -0.732 . . . . 64.230000000000004 112.501 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.0 m -160.36 133.66 4.79 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.572 0.701 . . . . 71.129999999999995 111.118 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 94.52 0.53 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.721 2.28 . . . . 74.019999999999996 112.362 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.2 m -85.11 -30.32 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 74.450000000000003 111.083 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.91 164.43 30.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 75.219999999999999 110.886 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -159.29 118.26 2.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 75.450000000000003 110.907 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.5 mp -128.15 139.89 50.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 73.540000000000006 111.129 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.0 m -143.37 154.33 16.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 75.120000000000005 111.106 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 136.75 -30.04 2.7 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.743 -0.742 . . . . 43.149999999999999 112.457 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 63.59 83.04 0.17 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.863 0.363 . . . . 54.200000000000003 111.119 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.98 179.15 6.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 75.099999999999994 110.874 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.24 149.25 39.27 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.727 -0.749 . . . . 71.420000000000002 112.476 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.53 -42.73 44.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.775 0.322 . . . . 75.340000000000003 110.898 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.57 -38.5 72.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 55.450000000000003 111.131 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.93 -59.15 2.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 64.329999999999998 111.122 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -47.83 -41.01 22.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 74.299999999999997 110.881 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.4 tt -56.46 -41.99 77.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 71.519999999999996 110.872 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -63.75 -42.35 97.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 73.439999999999998 110.868 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -52.38 -25.15 9.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.19 -0.459 . . . . 62.409999999999997 110.887 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.7 mt -85.49 -67.87 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 74.040000000000006 111.112 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -52.3 -48.92 65.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 71.519999999999996 110.867 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -58.88 -33.71 70.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 70.409999999999997 110.871 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.76 -36.5 59.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 62.200000000000003 111.135 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 61.420000000000002 110.916 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 ptm . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.825 0.345 . . . . 73.230000000000004 110.925 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -114.38 -177.14 3.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 72.439999999999998 111.131 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -88.67 -36.98 15.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 74.310000000000002 110.851 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -69.71 169.36 13.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 72.319999999999993 110.873 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 72.7 m-70 -82.59 165.61 19.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 75.420000000000002 110.835 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -119.34 31.06 6.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 74.230000000000004 110.848 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 8.7 m170 -93.1 -37.7 12.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 73.299999999999997 110.837 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -52.3 -39.32 60.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 55.32 110.897 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.0 mtt -95.99 30.88 2.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 73.540000000000006 110.899 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.9 m -58.68 128.66 38.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.242 -0.436 . . . . 71.25 110.863 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 154.32 -163.79 31.23 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.748 -0.739 . . . . 64.430000000000007 112.488 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.3 p -68.82 117.85 11.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.816 0.341 . . . . 74.349999999999994 111.125 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.1 p -160.23 155.59 3.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 74.329999999999998 111.122 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.5 t -68.29 156.9 36.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 73.400000000000006 111.154 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.9 t -118.99 127.48 75.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 75.140000000000001 111.155 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.23 162.88 4.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 74.230000000000004 111.201 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -72.93 -35.68 67.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 71.109999999999999 110.826 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.3 t -75.51 -34.42 60.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 73.530000000000001 110.87 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.6 t -86.52 -18.43 31.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.075 -0.512 . . . . 74.420000000000002 111.151 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -51.07 -30.68 16.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 75.510000000000005 110.858 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.413 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.8 OUTLIER -72.52 -34.02 67.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 74.209999999999994 110.89 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.1 m -91.51 -16.49 27.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 63.229999999999997 111.138 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.48 -71.33 0.66 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 64.340000000000003 110.845 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.9 t -70.26 -70.67 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 74.109999999999999 111.166 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.413 ' HB2' ' HA ' ' A' ' 21' ' ' LYS . 7.8 mt -40.55 -60.31 1.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 72.140000000000001 110.884 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -50.09 -57.87 6.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 62.229999999999997 110.87 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.8 m -53.33 156.83 2.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 64.209999999999994 110.836 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -98.73 -46.57 5.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.484 . . . . 73.310000000000002 110.861 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.8 159.83 9.28 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.593 0.711 . . . . 73.530000000000001 111.125 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 149.44 67.23 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.669 2.246 . . . . 73.329999999999998 112.332 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 84.1 t -112.65 127.63 69.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 71.219999999999999 111.149 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.7 mt -114.81 99.81 7.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 74.140000000000001 110.93 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.6 p -97.39 146.17 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 75.439999999999998 111.142 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -133.88 108.67 8.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.462 . . . . 73.310000000000002 110.86 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -92.11 94.84 9.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 73.510000000000005 110.868 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -138.18 -167.72 2.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.101 -0.5 . . . . 74.299999999999997 110.918 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.03 -166.62 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 44.240000000000002 111.101 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.444 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 9.6 p-10 -78.17 12.27 1.94 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.231 -0.441 . . . . 64.150000000000006 110.87 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.455 ' N ' ' CD1' ' A' ' 39' ' ' TRP . 1.6 m0 77.0 93.32 0.07 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.233 -0.44 . . . . 72.400000000000006 110.916 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 9.5 t -174.06 -56.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.432 . . . . 64.25 110.861 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.75 -69.29 1.41 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.787 -0.72 . . . . 75.129999999999995 112.499 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -43.58 2.57 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.717 2.278 . . . . 71.120000000000005 112.335 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 33.9 t -52.66 -34.63 52.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.44 . . . . 73.209999999999994 110.883 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -64.44 -35.2 80.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.452 . . . . 72.209999999999994 110.885 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 88.2 mmm -84.59 -36.66 21.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 73.349999999999994 110.867 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.3 t -95.29 21.33 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.243 -0.435 . . . . 73.140000000000001 111.15 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.463 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . . . -78.76 -61.39 0.52 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.6 0.715 . . . . 74.439999999999998 111.089 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.463 ' CD ' ' CB ' ' A' ' 47' ' ' ALA . 53.6 Cg_endo -69.74 -49.84 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.717 2.278 . . . . 75.120000000000005 112.307 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.4 m -52.23 -30.64 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.236 -0.438 . . . . 64.120000000000005 111.114 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.5 tt -84.29 -35.16 23.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 70.310000000000002 110.915 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -58.94 -35.47 73.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 74.230000000000004 110.9 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -51.28 -58.25 6.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 71.25 110.885 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.7 mp -51.56 -34.86 16.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 74.150000000000006 111.134 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.62 -39.92 66.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 63.130000000000003 111.109 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.97 -38.47 91.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 65.040000000000006 110.884 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -77.15 -36.46 55.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 74.430000000000007 110.861 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -74.22 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 75.230000000000004 110.868 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.9 t 62.41 35.59 14.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 75.530000000000001 110.824 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -119.77 50.87 0.79 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.759 -0.734 . . . . 70.450000000000003 112.521 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.7 t 37.49 43.18 0.4 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.827 0.346 . . . . 63.350000000000001 111.137 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.6 pp -69.69 139.94 53.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 74.299999999999997 110.922 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -84.41 147.49 27.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 74.120000000000005 110.857 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.8 t -130.47 103.41 8.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 75.230000000000004 111.088 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.6 129.76 50.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 54.210000000000001 111.112 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -129.87 142.49 50.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 74.420000000000002 110.915 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.7 tp -137.67 141.17 41.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 73.310000000000002 110.877 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.51 108.99 18.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 73.019999999999996 110.834 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 70.0 t -60.06 -35.78 63.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 54.219999999999999 111.145 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -51.36 -35.07 36.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 74.019999999999996 110.838 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.89 -35.2 10.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 61.439999999999998 111.07 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -116.09 70.56 4.0 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.667 0.746 . . . . 73.219999999999999 110.882 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -31.73 19.92 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.686 2.257 . . . . 73.129999999999995 112.33 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -64.1 -35.74 81.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 72.549999999999997 110.933 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.23 -48.8 77.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 55.539999999999999 111.135 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.63 -61.16 2.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 73.340000000000003 111.084 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.7 ttp85 -51.3 -34.05 31.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 74.329999999999998 110.867 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -51.71 -39.65 58.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 64.209999999999994 110.867 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -104.29 26.43 8.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 74.010000000000005 110.892 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 51.0 mm-40 49.78 65.57 1.38 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 75.219999999999999 110.916 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 91.7 t -96.82 143.63 12.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.239 -0.437 . . . . 72.010000000000005 111.127 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.7 m -123.64 -38.71 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 73.230000000000004 111.066 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.72 156.82 17.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 73.109999999999999 110.866 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.518 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 2.3 mm -64.6 -57.84 15.48 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.588 0.709 . . . . 74.430000000000007 111.095 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.5 Cg_endo -69.78 70.6 1.58 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.673 2.249 . . . . 70.319999999999993 112.329 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 96.9 m -104.81 137.97 41.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.232 -0.44 . . . . 61.450000000000003 111.143 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -139.04 127.99 23.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 74.549999999999997 110.905 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.3 mp -114.36 112.76 41.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 63.350000000000001 111.122 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.53 105.71 11.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.47 . . . . 73.109999999999999 110.934 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -93.13 166.5 12.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 62.350000000000001 110.883 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -170.61 97.1 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 73.129999999999995 110.9 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.98 38.99 9.68 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.713 -0.756 . . . . 75.120000000000005 112.489 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.49 45.02 88.7 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.736 -0.745 . . . . 62.240000000000002 112.444 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.3 m -170.25 134.67 1.14 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.555 0.693 . . . . 74.019999999999996 111.161 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 82.49 0.75 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.667 2.245 . . . . 75.230000000000004 112.336 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.0 m -60.17 -34.08 55.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 74.219999999999999 111.141 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -147.87 170.1 18.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 74.319999999999993 110.911 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.37 123.77 6.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 75.239999999999995 110.847 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.26 128.84 64.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 74.120000000000005 111.118 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.4 p -128.42 141.74 45.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 74.049999999999997 111.163 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 122.64 140.23 5.7 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.749 -0.739 . . . . 53.039999999999999 112.502 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.53 93.9 9.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.811 0.339 . . . . 71.219999999999999 111.126 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.77 -176.05 2.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 75.420000000000002 110.859 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.18 163.62 54.52 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.739 -0.744 . . . . 63.439999999999998 112.489 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.79 -36.15 57.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.748 0.308 . . . . 73.530000000000001 110.897 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.5 -54.6 10.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 63.409999999999997 111.084 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.76 -53.99 49.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 71.310000000000002 111.125 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -50.78 -39.48 52.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 74.200000000000003 110.957 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.82 -52.77 39.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 74.129999999999995 110.883 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.51 -40.59 83.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 74.5 110.918 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -47.12 -28.65 1.86 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 73.019999999999996 110.933 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.6 mt -93.09 -69.52 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 74.120000000000005 111.163 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.07 -59.96 3.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 71.5 110.953 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -49.51 -35.9 21.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 72.420000000000002 110.835 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.56 -35.77 63.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 73.239999999999995 111.066 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 74.219999999999999 110.923 -179.964 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 mtt . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.827 0.346 . . . . 73.340000000000003 110.907 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.02 -44.97 13.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 63.530000000000001 111.092 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -81.84 -36.13 28.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 72.299999999999997 110.834 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -91.13 149.22 21.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 74.430000000000007 110.821 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -145.43 154.65 42.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 75.340000000000003 110.86 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -119.97 30.78 6.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 74.109999999999999 110.862 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -68.22 -35.67 78.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 53.450000000000003 110.847 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 48.8 p-80 -88.43 -35.52 17.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 73.549999999999997 110.893 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 13.6 mmt -51.79 -35.61 44.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 65.209999999999994 110.872 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.3 t -51.73 110.18 0.44 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 54.409999999999997 110.857 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 129.11 -147.2 17.61 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.793 -0.718 . . . . 71.420000000000002 112.494 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.1 p -72.72 120.0 17.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.81 0.338 . . . . 71.200000000000003 111.162 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 t -132.67 150.41 33.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 74.150000000000006 111.12 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.6 t -86.86 130.6 34.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 75.329999999999998 111.122 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.6 t -89.97 125.72 42.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 73.230000000000004 111.102 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.5 173.88 0.49 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 71.140000000000001 111.131 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -74.96 -47.39 29.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 72.109999999999999 110.848 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.1 m -71.62 -51.64 22.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 62.240000000000002 110.861 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.3 t -59.28 -19.12 43.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 74.340000000000003 111.18 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -51.24 -30.26 16.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 74.209999999999994 110.898 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.55 -33.65 66.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 74.340000000000003 110.869 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.0 m -91.56 -16.08 27.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.196 -0.456 . . . . 73.340000000000003 111.181 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.44 -71.32 0.66 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 72.340000000000003 110.864 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.4 t -70.39 -70.5 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.476 . . . . 73.420000000000002 111.109 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.6 mt -40.57 -59.99 1.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 70.430000000000007 110.925 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -50.57 -52.64 37.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.458 . . . . 75.450000000000003 110.853 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.1 t -65.31 148.61 51.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 73.519999999999996 110.839 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -102.32 -38.2 7.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.131 -0.486 . . . . 75.129999999999995 110.895 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -52.05 160.23 1.24 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.527 0.68 . . . . 74.329999999999998 111.143 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 127.46 14.62 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.651 2.234 . . . . 73.109999999999999 112.385 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 41.1 t -93.25 132.0 38.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 64.519999999999996 111.132 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -102.85 99.8 9.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 75.329999999999998 110.917 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.2 m -121.46 150.2 24.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 72.510000000000005 111.137 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.01 123.97 31.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 74.540000000000006 110.902 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -89.71 88.78 7.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 73.310000000000002 110.87 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -142.59 -169.19 2.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.477 . . . . 74.319999999999993 110.952 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.87 -163.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.43 . . . . 61.509999999999998 111.116 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.471 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 2.6 m-20 -77.88 12.88 1.55 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 75.230000000000004 110.877 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.497 ' N ' ' CD1' ' A' ' 39' ' ' TRP . 0.6 OUTLIER 74.95 96.18 0.07 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 71.530000000000001 110.954 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -170.1 -53.76 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 72.239999999999995 110.875 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.29 -70.72 1.32 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.762 -0.732 . . . . 74.209999999999994 112.474 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.67 -34.18 15.41 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.694 2.263 . . . . 74.519999999999996 112.347 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 38.4 t -51.8 -33.73 36.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 74.099999999999994 110.883 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.4 mtmt -65.43 -35.3 80.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 75.340000000000003 110.952 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 15.1 mtp -83.49 -39.95 19.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 74.310000000000002 110.883 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.9 t -94.54 22.93 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 70.129999999999995 111.152 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.456 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . . . -75.13 -61.16 1.05 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.558 0.694 . . . . 62.43 111.077 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.456 ' CD ' ' CB ' ' A' ' 47' ' ' ALA . 52.9 Cg_endo -69.8 -50.65 0.44 Allowed 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.671 2.248 . . . . 72.049999999999997 112.322 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.3 m -52.53 -30.04 14.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 74.329999999999998 111.141 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.0 tp -74.5 -42.57 58.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 72.530000000000001 110.881 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -57.8 -36.72 72.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 73.540000000000006 110.87 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -57.74 -67.79 0.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 52.350000000000001 110.884 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.7 mp -50.94 -34.84 14.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 73.400000000000006 111.118 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.48 -34.55 72.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 74.209999999999994 111.119 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.28 -35.37 15.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 72.329999999999998 110.895 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -66.66 -48.5 69.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 74.319999999999993 110.875 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.2 mmpt? -50.68 -69.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 75.409999999999997 110.916 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -141.32 -178.08 5.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 71.299999999999997 110.889 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 60' ' ' THR . . . -81.44 115.78 4.08 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.748 -0.739 . . . . 71.230000000000004 112.466 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.41 ' C ' ' O ' ' A' ' 59' ' ' GLY . 9.8 t 36.95 45.32 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.817 0.341 . . . . 74.150000000000006 111.183 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.1 pp -56.46 -178.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 75.019999999999996 110.895 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -79.9 118.96 22.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 75.439999999999998 110.924 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.6 t -111.9 107.16 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 72.439999999999998 111.108 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -126.65 170.9 11.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 65.299999999999997 111.093 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 31.1 mttt -145.29 148.13 33.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.448 . . . . 73.049999999999997 110.845 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 tp -125.62 140.55 52.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 73.319999999999993 110.879 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -87.79 119.76 28.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 74.150000000000006 110.831 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.71 -28.08 44.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 72.409999999999997 111.152 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -68.94 -34.98 76.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.178 -0.465 . . . . 74.329999999999998 110.875 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.32 -28.7 23.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 74.450000000000003 111.087 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -115.43 69.37 2.85 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.564 0.697 . . . . 71.510000000000005 110.896 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 -32.06 19.01 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.647 2.231 . . . . 73.439999999999998 112.331 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -74.83 -35.1 62.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 73.310000000000002 110.883 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.04 -40.87 91.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 74.010000000000005 111.111 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.96 -64.85 0.76 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 74.200000000000003 111.086 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -51.15 -34.88 33.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 75.510000000000005 110.879 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.82 -36.33 80.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 54.009999999999998 110.883 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -98.45 24.69 7.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 75.340000000000003 110.88 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 49.09 54.05 11.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 73.549999999999997 110.945 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 97.6 t -90.15 136.66 23.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 73.030000000000001 111.164 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.8 m -131.58 -39.07 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 74.239999999999995 111.132 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.1 t -97.04 155.16 16.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 75.129999999999995 110.888 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.509 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 2.3 mm -66.47 -57.96 11.28 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.601 0.715 . . . . 75.299999999999997 111.124 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.4 Cg_endo -69.71 70.07 1.58 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.669 2.246 . . . . 73.310000000000002 112.355 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 62.0 m -109.39 149.39 29.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 64.340000000000003 111.127 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 26.6 ttm -138.63 150.35 46.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 74.219999999999999 110.843 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.9 mt -142.76 109.92 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 73.420000000000002 111.139 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.68 105.85 11.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.47 . . . . 75.129999999999995 110.926 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -90.29 169.79 10.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 73.530000000000001 110.855 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -165.44 95.34 0.64 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 73.540000000000006 110.863 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.67 37.72 13.31 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.753 -0.737 . . . . 74.239999999999995 112.474 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.38 41.01 86.69 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.71 -0.757 . . . . 33.329999999999998 112.494 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 85.4 m -160.76 134.05 4.77 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.643 0.735 . . . . 74.420000000000002 111.088 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 86.94 0.57 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.703 2.269 . . . . 72.219999999999999 112.327 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.0 m -76.66 -34.58 23.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 75.450000000000003 111.173 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.92 164.12 26.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 75.340000000000003 110.897 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.61 119.83 4.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 74.219999999999999 110.895 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.8 mp -138.31 130.12 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 75.420000000000002 111.133 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.6 p -126.11 143.44 39.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 71.040000000000006 111.104 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 128.83 132.61 3.54 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.771 -0.728 . . . . 74.200000000000003 112.486 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.19 75.05 9.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.854 0.359 . . . . 74.409999999999997 111.138 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.39 171.63 7.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 71.329999999999998 110.896 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.57 171.6 5.45 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.696 -0.764 . . . . 72.239999999999995 112.496 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -60.1 -44.39 94.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.784 0.326 . . . . 74.150000000000006 110.888 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -52.49 -66.29 0.41 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 74.5 111.09 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.71 -59.36 4.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 71.209999999999994 111.095 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -47.31 -35.48 8.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 74.5 110.933 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.2 tp -71.19 -43.92 66.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 74.439999999999998 110.91 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 10.6 mtp85 -59.46 -41.82 90.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 75.409999999999997 110.876 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -53.03 -25.33 12.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 55.219999999999999 110.933 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.7 mt -86.04 -68.59 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 75.120000000000005 111.16 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -51.15 -49.57 60.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.151 -0.477 . . . . 71.219999999999999 110.894 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -58.53 -34.23 70.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 61.109999999999999 110.918 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.1 -36.33 61.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 63.399999999999999 111.124 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 mt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 74.209999999999994 110.902 -179.979 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.5 mtt . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.785 0.326 . . . . 75.209999999999994 110.86 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.66 174.07 11.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 74.040000000000006 111.03 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -84.5 -51.17 7.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 74.420000000000002 110.862 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 56.54 54.01 7.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 73.230000000000004 110.865 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 62.0 m170 -77.58 137.46 38.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 71.409999999999997 110.882 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -119.85 30.77 6.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 73.519999999999996 110.887 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -76.6 -40.43 49.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 74.109999999999999 110.811 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 49.1 m-70 -74.28 -36.63 63.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 74.25 110.818 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 37.4 mtp -53.68 -40.52 66.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.444 . . . . 75.120000000000005 110.919 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.3 t -55.0 128.95 35.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 74.420000000000002 110.851 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 130.11 163.58 11.12 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.727 -0.749 . . . . 42.119999999999997 112.49 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.1 p -60.27 99.85 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.832 0.348 . . . . 73.319999999999993 111.112 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.3 m -153.14 174.78 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 72.150000000000006 111.147 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.1 t -75.69 127.21 32.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 72.109999999999999 111.174 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 49.1 t -94.77 125.91 47.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 74.430000000000007 111.136 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.27 174.0 0.44 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 62.439999999999998 111.152 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -75.1 -47.37 29.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 74.299999999999997 110.81 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.5 t -72.1 -51.52 21.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 75.310000000000002 110.847 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.8 t -59.12 -19.2 42.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.478 . . . . 74.329999999999998 111.124 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -50.88 -30.96 16.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 70.25 110.868 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.411 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -71.78 -34.13 69.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 72.299999999999997 110.92 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.0 m -91.13 -15.91 28.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 74.329999999999998 111.15 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.34 -71.41 0.65 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.441 . . . . 65.230000000000004 110.907 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.3 t -70.71 -70.34 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.239 -0.437 . . . . 75.150000000000006 111.127 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 21' ' ' LYS . 7.4 mt -40.55 -60.31 1.15 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 64.030000000000001 110.921 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -50.36 -61.21 2.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.439 . . . . 74.409999999999997 110.874 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.7 t -56.55 161.33 2.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 73.400000000000006 110.821 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -109.92 -35.98 6.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.104 -0.498 . . . . 71.120000000000005 110.884 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -53.44 158.88 2.57 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.585 0.707 . . . . 72.349999999999994 111.103 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 125.66 12.42 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.631 2.221 . . . . 72.150000000000006 112.387 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 94.6 t -102.1 115.88 44.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 73.239999999999995 111.148 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.9 mp -94.58 99.73 11.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 74.349999999999994 110.874 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.3 p -98.59 140.88 17.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.14 -0.482 . . . . 74.329999999999998 111.075 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -124.8 102.08 7.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 73.549999999999997 110.84 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -83.4 89.57 7.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 73.340000000000003 110.889 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -135.6 -168.58 2.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.148 -0.478 . . . . 72.209999999999994 110.903 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.54 -164.48 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 75.530000000000001 111.096 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.45 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 9.5 p-10 -78.68 12.71 1.94 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 75.340000000000003 110.861 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.476 ' N ' ' CD1' ' A' ' 39' ' ' TRP . 1.0 OUTLIER 76.03 95.15 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 71.540000000000006 110.935 -179.94 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 46.1 t -172.25 -56.22 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 73.420000000000002 110.849 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.51 -70.71 1.32 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.721 -0.752 . . . . 71.310000000000002 112.478 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -32.63 18.36 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.639 2.226 . . . . 73.530000000000001 112.324 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 35.8 t -54.74 -40.69 69.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.436 . . . . 74.239999999999995 110.907 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.8 pttp -64.34 -26.46 68.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 74.329999999999998 110.861 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 5.3 mtp -87.15 -42.85 12.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.276 -0.42 . . . . 74.439999999999998 110.871 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.1 t -94.31 21.44 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 75.049999999999997 111.147 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.463 ' N ' ' HD2' ' A' ' 48' ' ' PRO . . . -76.75 -61.17 0.76 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.562 0.696 . . . . 65.349999999999994 111.088 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 47' ' ' ALA . 53.7 Cg_endo -69.81 -49.77 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.678 2.252 . . . . 64.400000000000006 112.344 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.3 m -51.24 -30.85 10.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 75.400000000000006 111.105 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.4 tp -90.16 -35.89 15.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 72.299999999999997 110.886 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -68.26 -24.16 64.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 75.209999999999994 110.925 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -65.97 -60.71 2.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.478 . . . . 74.439999999999998 110.873 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.6 mp -61.52 -33.02 55.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 72.430000000000007 111.118 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.98 -20.04 50.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 73.150000000000006 111.101 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -41.01 92.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 73.409999999999997 110.873 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -91.08 -41.25 11.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 75.430000000000007 110.876 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.91 -27.83 69.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 75.239999999999995 110.91 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.8 t -42.91 135.42 3.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 64.439999999999998 110.899 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 127.08 -27.99 4.69 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.788 -0.72 . . . . 74.519999999999996 112.484 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -129.34 -37.39 1.64 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.863 0.363 . . . . 73.540000000000006 111.148 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.89 144.5 26.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 72.310000000000002 110.918 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.4 ttpp -107.62 141.39 39.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 71.120000000000005 110.93 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 50.4 t -101.71 108.67 24.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.22 -0.446 . . . . 75.209999999999994 111.182 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -122.27 128.91 51.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 73.450000000000003 111.103 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.8 pttt -125.99 157.61 37.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 75.450000000000003 110.882 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 31.3 tp -147.95 146.45 28.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 71.239999999999995 110.882 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -82.96 119.88 24.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 75.0 110.925 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 84.7 t -48.14 -39.52 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 75.450000000000003 111.086 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.02 -33.31 56.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 72.230000000000004 110.862 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.82 -34.68 45.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 75.25 111.043 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -118.39 66.91 6.76 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.627 0.727 . . . . 74.209999999999994 110.874 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -32.85 17.52 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.686 2.257 . . . . 62.340000000000003 112.327 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -80.92 -38.65 27.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 64.510000000000005 110.925 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.99 -43.32 99.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 65.430000000000007 111.149 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.76 -67.27 0.27 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 74.409999999999997 111.136 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.1 ttm-85 -51.19 -34.07 30.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.259 -0.428 . . . . 73.420000000000002 110.886 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.43 -40.19 90.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 75.439999999999998 110.867 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -98.89 26.68 5.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 74.219999999999999 110.867 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 49.85 75.44 0.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 73.430000000000007 110.919 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 90.9 t -116.45 90.55 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 72.049999999999997 111.134 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 61.1 t -84.4 -42.61 17.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 63.030000000000001 111.111 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.6 m -96.75 152.73 18.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 75.040000000000006 110.866 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.514 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.3 mt -63.9 -57.64 17.94 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.598 0.713 . . . . 75.219999999999999 111.112 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 54.0 Cg_endo -69.74 75.43 1.21 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.743 2.295 . . . . 74.230000000000004 112.336 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 84.8 m -117.17 100.89 8.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 72.209999999999994 111.159 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 22.5 ttp -100.76 112.08 24.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 74.239999999999995 110.883 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 25.2 mt -101.33 118.0 47.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 71.349999999999994 111.165 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.9 tt -81.15 110.3 16.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 73.319999999999993 110.923 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -97.47 170.27 9.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.477 . . . . 74.230000000000004 110.88 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -167.3 97.95 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 75.329999999999998 110.903 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.68 38.43 10.63 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.719 -0.753 . . . . 75.299999999999997 112.509 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 65.76 37.12 93.13 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.702 -0.761 . . . . 65.209999999999994 112.458 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 86.6 m -158.43 133.89 5.85 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.584 0.707 . . . . 75.040000000000006 111.147 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 112.64 3.13 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.697 2.265 . . . . 75.099999999999994 112.322 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.6 m -99.63 -33.51 3.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.443 . . . . 75.310000000000002 111.115 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.5 mmtt -140.88 169.66 17.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 71.400000000000006 110.864 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -153.93 111.87 3.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 75.430000000000007 110.875 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.6 mp -112.75 127.95 69.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 75.129999999999995 111.164 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.0 p -141.69 144.7 25.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 73.299999999999997 111.155 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 139.58 -28.65 2.53 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.786 -0.721 . . . . 65.400000000000006 112.518 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 64.5 96.57 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.822 0.344 . . . . 71.530000000000001 111.101 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.15 -179.25 5.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 74.519999999999996 110.884 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.29 176.76 2.68 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.745 -0.74 . . . . 51.25 112.508 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.16 -44.57 71.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.799 0.333 . . . . 73.430000000000007 110.896 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.58 -32.9 70.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 72.030000000000001 111.12 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.417 ' HA ' ' HG2' ' A' ' 109' ' ' ARG . . . -85.43 -58.39 2.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 74.329999999999998 111.082 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.12 -35.51 35.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 71.219999999999999 110.93 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 5.7 tt -68.83 -59.44 3.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 73.030000000000001 110.91 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.417 ' HG2' ' HA ' ' A' ' 106' ' ' ALA . 15.8 ptm180 -56.91 -32.81 66.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 74.219999999999999 110.867 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -51.9 -25.46 8.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 72.530000000000001 110.878 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.8 mt -85.56 -69.03 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 74.400000000000006 111.148 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -51.56 -49.88 61.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 71.430000000000007 110.92 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -54.12 -34.68 60.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 72.230000000000004 110.84 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.17 -34.95 66.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 75.349999999999994 111.1 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.9 mt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 62.530000000000001 110.889 -179.951 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 mmt . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.79 0.328 . . . . 75.310000000000002 110.906 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.24 81.32 1.93 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 74.519999999999996 111.133 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -99.88 -37.59 8.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 75.5 110.884 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.8 m170 -75.85 -179.84 5.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 74.439999999999998 110.827 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -116.91 167.02 11.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 71.299999999999997 110.888 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -119.71 30.84 6.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.456 . . . . 74.450000000000003 110.858 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -70.89 -63.8 1.03 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 73.420000000000002 110.82 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -52.17 -35.1 47.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.191 -0.459 . . . . 72.140000000000001 110.862 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 10.9 mtp -51.47 -34.89 37.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 75.530000000000001 110.883 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.6 p -51.62 129.88 26.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 74.329999999999998 110.847 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 135.97 152.92 6.47 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.745 -0.74 . . . . 72.409999999999997 112.495 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.2 p -73.94 99.55 3.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.836 0.35 . . . . 71.439999999999998 111.109 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.6 m -154.53 -179.85 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 75.140000000000001 111.16 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.3 t -72.64 151.16 42.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 63.450000000000003 111.149 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.1 p -119.26 151.87 21.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 75.540000000000006 111.144 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.37 162.06 13.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 73.010000000000005 111.109 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -77.4 -52.33 9.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 73.439999999999998 110.821 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.9 t -57.76 -36.37 72.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 64.329999999999998 110.859 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.0 t -84.65 -17.83 37.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 75.219999999999999 111.137 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -49.92 -31.49 12.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 75.540000000000006 110.924 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.95 -34.46 71.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 72.200000000000003 110.869 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.5 m -91.01 -15.2 30.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 75.209999999999994 111.157 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.42 -70.61 0.69 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.231 -0.441 . . . . 73.0 110.862 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.3 t -72.06 -70.38 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 75.099999999999994 111.137 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.5 mt -40.41 -57.7 1.72 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.156 -0.475 . . . . 71.239999999999995 110.911 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -51.28 -60.04 3.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 74.140000000000001 110.852 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 55.5 p -51.67 139.47 20.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 71.140000000000001 110.838 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -88.82 -41.77 12.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 73.129999999999995 110.872 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.54 158.76 1.39 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.582 0.706 . . . . 71.400000000000006 111.18 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 129.8 18.27 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.703 2.269 . . . . 72.230000000000004 112.324 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 92.4 t -97.1 126.6 49.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.437 . . . . 75.340000000000003 111.135 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.8 mp -110.12 121.07 44.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 74.409999999999997 110.937 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.7 m -132.81 149.9 32.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 75.540000000000006 111.104 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.28 99.63 5.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 75.510000000000005 110.832 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -73.59 96.81 2.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 65.400000000000006 110.893 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -142.83 -168.6 2.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.168 -0.469 . . . . 74.439999999999998 110.914 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.401 ' C ' ' H ' ' A' ' 39' ' ' TRP . . . -58.49 -162.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 54.240000000000002 111.133 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.484 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 4.1 t70 -77.96 13.72 1.32 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.268 -0.424 . . . . 62.039999999999999 110.876 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.484 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 0.5 OUTLIER 74.95 94.34 0.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.204 -0.453 . . . . 73.310000000000002 110.887 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 35.0 t -174.79 -50.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 72.349999999999994 110.885 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.24 -69.55 1.39 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.724 -0.75 . . . . 75.219999999999999 112.459 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 -28.47 24.96 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.684 2.256 . . . . 71.129999999999995 112.351 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 1.9 p -53.95 -25.53 21.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 75.450000000000003 110.95 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.2 pttt -77.96 -31.48 50.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 73.400000000000006 110.847 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 16.1 mtt -85.82 -35.4 20.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 74.549999999999997 110.886 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 t -100.36 22.07 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.246 -0.434 . . . . 75.129999999999995 111.122 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.458 ' N ' ' HD2' ' A' ' 48' ' ' PRO . . . -74.36 -61.21 1.23 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.556 0.693 . . . . 74.25 111.091 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 47' ' ' ALA . 53.7 Cg_endo -69.73 -50.66 0.45 Allowed 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.732 2.288 . . . . 73.120000000000005 112.359 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 4.1 m -52.09 -29.98 12.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.459 . . . . 74.230000000000004 111.132 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.6 tp -75.04 -41.96 58.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 73.420000000000002 110.888 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -67.45 -34.34 76.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 70.319999999999993 110.872 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -52.84 -62.09 1.87 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 74.120000000000005 110.876 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.1 mt -51.21 -39.51 20.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 74.049999999999997 111.118 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.87 -42.43 90.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 74.319999999999993 111.116 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -44.68 96.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 75.109999999999999 110.893 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.24 -35.53 66.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 73.0 110.828 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.2 mmtm -67.37 -74.63 0.11 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 73.049999999999997 110.872 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.04 -170.93 0.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 64.530000000000001 110.863 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -124.96 32.96 3.84 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.718 -0.753 . . . . 73.010000000000005 112.517 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.0 p -146.07 32.59 1.01 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.833 0.349 . . . . 65.299999999999997 111.154 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.3 pp -101.51 156.34 17.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 75.299999999999997 110.945 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.8 tttp -86.78 147.64 25.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.443 . . . . 64.400000000000006 110.888 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.4 t -140.74 106.56 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.421 . . . . 71.540000000000006 111.124 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -113.62 110.08 19.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 64.340000000000003 111.07 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.0 pttm -97.23 128.98 44.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 73.099999999999994 110.911 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.2 tp -105.15 146.08 29.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 74.420000000000002 110.909 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.86 97.37 7.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 70.230000000000004 110.86 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.1 m -49.08 -32.2 4.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 44.100000000000001 111.155 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -50.14 -32.5 16.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 72.340000000000003 110.904 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -105.99 -28.5 10.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 64.349999999999994 111.098 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.82 72.22 2.02 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.631 0.729 . . . . 75.150000000000006 110.9 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -30.99 21.2 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.661 2.24 . . . . 74.409999999999997 112.337 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -70.6 -42.88 70.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 73.349999999999994 110.895 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.24 -48.35 62.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 75.040000000000006 111.081 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.76 -67.31 0.27 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 74.340000000000003 111.157 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.1 ttp85 -51.87 -31.4 27.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 72.209999999999994 110.868 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -51.64 -37.96 52.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 70.409999999999997 110.87 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -105.24 21.44 17.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 75.420000000000002 110.888 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 65.3 mm-40 46.61 82.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.115 -0.493 . . . . 73.409999999999997 110.917 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.0 p -122.09 132.77 70.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 75.230000000000004 111.149 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.8 t -120.46 45.81 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 74.230000000000004 111.13 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.05 144.91 1.03 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 73.450000000000003 110.847 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.514 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 4.3 mt -66.44 -58.04 11.16 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.571 0.7 . . . . 75.549999999999997 111.116 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.2 Cg_endo -69.79 73.96 1.34 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.699 2.266 . . . . 74.25 112.336 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 97.6 m -117.77 129.57 55.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 72.409999999999997 111.145 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -120.78 144.02 48.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.443 . . . . 71.120000000000005 110.874 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 17.5 mt -131.7 122.89 50.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 74.519999999999996 111.129 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.28 105.4 17.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.149 -0.478 . . . . 73.430000000000007 110.889 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -89.45 169.84 11.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 74.409999999999997 110.933 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.12 91.16 0.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 75.040000000000006 110.886 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.33 33.13 12.14 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.706 -0.759 . . . . 74.120000000000005 112.49 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.99 38.83 39.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.761 -0.733 . . . . 63.229999999999997 112.477 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 85.5 m -161.26 133.8 4.41 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.577 0.704 . . . . 65.219999999999999 111.128 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 98.13 0.67 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.651 2.234 . . . . 75.219999999999999 112.352 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.6 m -87.65 -31.8 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 73.530000000000001 111.131 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.9 mmtm -132.42 166.0 22.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 73.299999999999997 110.915 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -159.76 115.0 2.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 71.299999999999997 110.866 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.5 mp -125.36 118.01 51.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 74.120000000000005 111.105 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.2 p -128.18 145.14 35.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 73.150000000000006 111.146 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 136.68 -28.31 2.87 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.796 -0.716 . . . . 75.329999999999998 112.475 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 64.49 106.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.821 0.344 . . . . 73.329999999999998 111.075 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.46 175.61 10.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 74.420000000000002 110.901 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.51 166.66 8.88 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.735 -0.745 . . . . 75.519999999999996 112.538 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.68 -36.51 84.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.766 0.317 . . . . 74.540000000000006 110.932 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.34 -31.33 72.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 75.439999999999998 111.102 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.46 -58.84 2.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 72.409999999999997 111.105 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -48.22 -47.53 35.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 74.530000000000001 110.929 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.0 tt -47.98 -41.53 25.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 75.329999999999998 110.905 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 44.4 mtp180 -76.51 -35.8 58.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 73.430000000000007 110.878 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -51.02 -24.68 3.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.229 -0.441 . . . . 74.439999999999998 110.862 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.0 mt -87.78 -68.94 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 73.209999999999994 111.143 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.88 -52.92 58.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 74.439999999999998 110.885 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -54.14 -34.47 60.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 71.310000000000002 110.858 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.87 -34.67 71.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 75.420000000000002 111.066 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 74.219999999999999 110.951 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.2 p . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.824 0.345 . . . . 73.230000000000004 111.112 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.2 t -147.09 145.4 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 75.219999999999999 111.086 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.8 t -77.7 127.93 33.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 71.450000000000003 111.109 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.537 ' CG1' HG23 ' A' ' 19' ' ' THR . 43.9 t -97.66 120.79 47.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 75.140000000000001 111.11 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.451 HG22 ' H ' ' A' ' 17' ' ' ASP . 0.2 OUTLIER -59.92 173.58 0.59 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 64.140000000000001 111.185 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.451 ' H ' HG22 ' A' ' 16' ' ' THR . 38.0 t0 -77.87 -41.64 36.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 74.099999999999994 110.878 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.3 m -69.6 -33.73 73.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 71.530000000000001 110.881 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.537 HG23 ' CG1' ' A' ' 15' ' ' VAL . 13.2 t -85.55 -18.19 34.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 74.349999999999994 111.178 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.804 ' CZ ' HG21 ' A' ' 24' ' ' VAL . 7.3 t80 -51.05 -52.68 40.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 73.120000000000005 110.886 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.719 ' CB ' HD12 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -64.6 -14.67 58.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 72.239999999999995 110.864 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.6 m -92.99 -33.17 14.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.294 -0.412 . . . . 73.400000000000006 111.16 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -96.96 -71.56 0.67 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 54.130000000000003 110.878 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.804 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 38.4 t -51.48 -71.81 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 55.450000000000003 111.117 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.719 HD12 ' CB ' ' A' ' 21' ' ' LYS . 12.1 mt -41.71 -58.95 1.8 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 65.109999999999999 110.921 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -49.71 -64.81 0.7 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 73.430000000000007 110.857 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.6 t -55.49 145.88 21.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 70.299999999999997 110.848 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -107.36 35.92 2.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.487 . . . . 71.349999999999994 110.858 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.25 160.3 38.07 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 121.571 0.7 . . . . 74.450000000000003 111.123 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 106.42 1.67 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.695 2.263 . . . . 74.430000000000007 112.343 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.747 HG21 HG13 ' A' ' 24' ' ' VAL . 70.5 t -87.64 118.28 33.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 60.140000000000001 111.135 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.84 99.52 11.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.477 . . . . 70.030000000000001 110.919 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 87' ' ' ILE . 5.6 p -100.16 138.99 22.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 74.200000000000003 111.116 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -125.3 121.83 35.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 61.539999999999999 110.851 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.613 ' CD2' HD22 ' A' ' 66' ' ' LEU . 35.6 m-85 -101.1 89.83 3.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 74.510000000000005 110.845 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -133.3 -167.73 1.97 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.132 -0.486 . . . . 72.219999999999999 110.945 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.05 -166.32 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 65.25 111.069 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.445 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 3.6 m-20 -78.89 12.63 2.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 72.420000000000002 110.919 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.457 ' N ' ' CD1' ' A' ' 39' ' ' TRP . 1.4 m0 77.01 94.62 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 74.340000000000003 110.895 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -174.69 -57.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 53.100000000000001 110.84 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.09 -70.06 1.36 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.788 -0.72 . . . . 72.329999999999998 112.488 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 -44.01 2.31 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.681 2.254 . . . . 63.030000000000001 112.29 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.536 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 42.4 t -52.08 -34.73 45.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.433 . . . . 74.349999999999994 110.894 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.6 -34.14 77.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 73.219999999999999 110.845 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 11.3 mtt -85.25 -38.34 19.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 71.510000000000005 110.88 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.506 ' HA ' HG22 ' A' ' 49' ' ' VAL . 3.0 t -94.1 21.48 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 62.240000000000002 111.141 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.786 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -77.18 -60.84 0.73 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.579 0.704 . . . . 70.400000000000006 111.112 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.786 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.7 Cg_endo -69.71 -49.65 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.681 2.254 . . . . 72.040000000000006 112.38 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.506 HG22 ' HA ' ' A' ' 46' ' ' VAL . 4.4 m -50.49 -30.16 7.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 61.340000000000003 111.127 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.4 tt -84.01 -39.69 19.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.202 -0.454 . . . . 72.439999999999998 110.91 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -61.43 -35.57 77.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 72.230000000000004 110.879 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -55.1 -60.56 3.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 74.439999999999998 110.936 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.432 HD12 ' O ' ' A' ' 49' ' ' VAL . 3.0 mt -51.43 -38.18 20.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 63.439999999999998 111.13 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 61.149999999999999 111.123 179.806 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.645 ' C ' HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.898 0.38 . . . . 73.540000000000006 110.902 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.538 ' N ' HD22 ' A' ' 61' ' ' LEU . 1.7 ttmp? -128.96 141.97 51.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 72.140000000000001 110.884 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.82 112.93 42.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 73.120000000000005 111.16 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -105.55 147.26 28.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 74.340000000000003 111.112 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.41 156.62 46.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.436 . . . . 72.129999999999995 110.896 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.681 HD21 ' HB2' ' A' ' 71' ' ' ASN . 0.4 OUTLIER -144.42 137.62 27.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.452 . . . . 65.319999999999993 110.927 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.58 106.92 13.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.45 . . . . 73.549999999999997 110.87 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 78.8 t -55.54 -39.11 52.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 62.109999999999999 111.16 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.02 -36.02 62.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 72.319999999999993 110.849 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.8 -35.46 14.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 74.010000000000005 111.15 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.681 ' HB2' HD21 ' A' ' 66' ' ' LEU . 1.7 m-80 -117.87 68.04 6.23 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.627 0.727 . . . . 71.439999999999998 110.894 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -33.3 16.86 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.684 2.256 . . . . 65.349999999999994 112.29 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -62.42 -36.8 83.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 72.109999999999999 110.877 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.15 -34.99 79.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 63.409999999999997 111.051 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.583 ' HB1' ' HB ' ' A' ' 80' ' ' VAL . . . -58.88 -67.52 0.36 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 63.32 111.088 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -53.41 -38.73 63.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 74.299999999999997 110.895 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -51.41 -37.82 50.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 74.019999999999996 110.919 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -110.08 29.93 7.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 74.439999999999998 110.845 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 49.35 82.02 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 71.439999999999998 110.924 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.583 ' HB ' ' HB1' ' A' ' 75' ' ' ALA . 87.4 t -126.89 103.35 10.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 70.209999999999994 111.138 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 60.3 t -98.29 -34.49 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 63.509999999999998 111.143 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.5 m -97.61 151.67 19.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 70.109999999999999 110.855 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.53 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.1 mt -66.66 -57.76 11.31 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.565 0.697 . . . . 73.219999999999999 111.148 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.4 Cg_endo -69.77 70.17 1.6 Allowed 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.694 2.263 . . . . 61.229999999999997 112.332 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 59.1 m -110.49 148.09 32.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 73.120000000000005 111.115 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 5.3 ttp -147.89 147.61 29.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 71.329999999999998 110.883 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.416 ' O ' HG12 ' A' ' 33' ' ' VAL . 10.5 mt -133.43 115.32 22.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 74.099999999999994 111.15 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.429 HD23 ' HB2' ' A' ' 96' ' ' LYS . 10.9 tp -81.3 101.78 9.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 73.430000000000007 110.875 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -89.98 170.33 10.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 73.209999999999994 110.874 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -164.91 96.31 0.72 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 70.439999999999998 110.919 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.97 35.87 23.32 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.763 -0.732 . . . . 52.450000000000003 112.469 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.652 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 71.23 40.89 60.63 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.731 -0.747 . . . . 73.400000000000006 112.499 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.419 HG23 ' HD2' ' A' ' 94' ' ' PRO . 46.6 m -160.65 133.46 4.56 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.596 0.712 . . . . 74.430000000000007 111.158 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.419 ' HD2' HG23 ' A' ' 93' ' ' THR . 53.2 Cg_endo -69.79 87.76 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.67 2.247 . . . . 64.129999999999995 112.318 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 26.9 m -78.54 -34.96 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 72.129999999999995 111.097 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.429 ' HB2' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -141.43 163.71 32.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 73.530000000000001 110.904 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.404 ' C ' HD12 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -150.54 133.47 16.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 75.549999999999997 110.858 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.44 HG23 ' HB3' ' A' ' 110' ' ' GLU . 5.3 mp -137.19 135.44 47.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 72.530000000000001 111.139 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -135.32 139.64 46.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 71.200000000000003 111.149 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 129.02 134.49 3.8 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.767 -0.73 . . . . 34.5 112.454 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.34 86.38 7.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.833 0.349 . . . . 53.329999999999998 111.116 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.529 ' HG2' HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -124.41 172.46 9.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 73.400000000000006 110.847 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.26 171.0 8.42 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.739 -0.743 . . . . 73.230000000000004 112.448 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.06 -43.59 86.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.791 0.329 . . . . 74.5 110.916 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.96 -65.39 0.59 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 54.43 111.093 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.89 -56.91 13.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 73.129999999999995 111.084 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.529 HD23 ' HG2' ' A' ' 102' ' ' LYS . 0.3 OUTLIER -49.82 -36.27 25.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 72.549999999999997 110.918 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.419 HD23 ' C ' ' A' ' 108' ' ' LEU . 10.3 tt -70.15 -37.41 75.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 75.140000000000001 110.925 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 10.0 mtp85 -66.71 -41.52 87.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 71.230000000000004 110.845 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.44 ' HB3' HG23 ' A' ' 98' ' ' ILE . 42.9 mm-40 -52.19 -25.46 9.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 73.400000000000006 110.905 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.3 mt -84.82 -67.99 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 65.340000000000003 111.155 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -52.4 -48.8 65.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 62.439999999999998 110.913 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -58.0 -34.79 70.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.496 . . . . 62.439999999999998 110.886 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.81 -35.04 57.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 73.030000000000001 111.129 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.1 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 62.020000000000003 110.923 -179.984 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.573 HG22 ' HB ' ' A' ' 63' ' ' VAL . 58.6 p . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.789 0.328 . . . . 62.240000000000002 111.131 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.06 150.09 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 75.319999999999993 111.143 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.4 t -72.71 131.1 41.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 53.409999999999997 111.143 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.4 t -92.56 121.21 42.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 72.140000000000001 111.148 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.577 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.89 163.67 4.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.122 -0.49 . . . . 61.130000000000003 111.113 -179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -67.02 -39.86 87.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 74.400000000000006 110.82 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.7 t -75.86 -57.67 3.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 75.120000000000005 110.898 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.577 HG22 ' HB ' ' A' ' 16' ' ' THR . 10.5 t -55.79 -24.22 34.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 75.319999999999993 111.144 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.538 ' CE2' HG21 ' A' ' 24' ' ' VAL . 16.6 t80 -51.71 -30.88 23.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 73.140000000000001 110.837 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.562 ' HA ' HD12 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -71.45 -33.37 69.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 71.099999999999994 110.9 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.9 m -92.69 -17.67 23.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 75.310000000000002 111.151 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -93.57 -72.05 0.63 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 64.519999999999996 110.849 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.538 HG21 ' CE2' ' A' ' 20' ' ' PHE . 58.2 t -69.4 -71.29 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 64.140000000000001 111.106 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.562 HD12 ' HA ' ' A' ' 21' ' ' LYS . 12.5 mt -40.18 -60.31 1.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 74.349999999999994 110.861 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -50.31 -56.62 10.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.242 -0.435 . . . . 73.129999999999995 110.863 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.1 t -51.84 158.47 1.0 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 64.109999999999999 110.859 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -119.44 35.76 4.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 71.549999999999997 110.844 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.452 HG22 ' HD2' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -132.4 159.96 70.13 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.523 0.678 . . . . 74.150000000000006 111.175 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.452 ' HD2' HG22 ' A' ' 29' ' ' THR . 53.4 Cg_endo -69.76 122.14 8.83 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.682 2.254 . . . . 53.119999999999997 112.344 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.503 HG22 ' HD2' ' A' ' 62' ' ' LYS . 90.1 t -100.93 122.93 53.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.449 . . . . 73.439999999999998 111.121 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -94.86 99.93 11.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 71.340000000000003 110.901 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 87' ' ' ILE . 7.9 p -100.38 142.62 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 63.229999999999997 111.17 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -135.75 119.84 17.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 74.120000000000005 110.895 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.6 ' HE2' ' HB1' ' A' ' 74' ' ' ALA . 47.1 m-85 -99.74 93.5 5.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 54.340000000000003 110.936 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -136.77 -167.72 2.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.126 -0.488 . . . . 72.200000000000003 110.958 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.57 -165.22 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.433 . . . . 73.010000000000005 111.085 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.446 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 34.7 p-10 -77.69 12.07 1.83 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 73.400000000000006 110.844 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.479 ' N ' ' CD1' ' A' ' 39' ' ' TRP . 1.7 m0 77.62 92.91 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.158 -0.474 . . . . 65.519999999999996 110.908 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -175.89 -53.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 62.409999999999997 110.881 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.26 -70.99 1.3 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.74 -0.743 . . . . 62.210000000000001 112.509 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -32.62 18.17 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.646 2.23 . . . . 71.010000000000005 112.351 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.534 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -59.42 -33.45 71.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 72.230000000000004 110.884 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.53 -28.81 70.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 64.319999999999993 110.898 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 4.6 mmt -87.21 -41.55 13.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 64.430000000000007 110.867 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.522 ' HA ' HG22 ' A' ' 49' ' ' VAL . 2.9 t -94.13 22.16 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 72.420000000000002 111.115 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.78 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -76.75 -61.08 0.77 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.561 0.696 . . . . 70.310000000000002 111.08 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.78 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.9 Cg_endo -69.76 -49.91 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.711 2.274 . . . . 63.329999999999998 112.326 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.612 ' O ' HD12 ' A' ' 53' ' ' ILE . 4.3 m -51.02 -30.42 9.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 72.25 111.112 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.555 HD23 ' O ' ' A' ' 50' ' ' LEU . 7.3 tt -82.95 -36.83 24.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.16 -0.473 . . . . 71.109999999999999 110.945 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -58.9 -35.29 72.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 74.439999999999998 110.907 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -61.82 -67.88 0.37 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 74.099999999999994 110.891 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.612 HD12 ' O ' ' A' ' 49' ' ' VAL . 3.0 mt -51.38 -37.32 18.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 72.439999999999998 111.12 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 61.049999999999997 111.072 179.809 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.8 pp . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.862 0.363 . . . . 73.010000000000005 110.951 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.503 ' HD2' HG22 ' A' ' 31' ' ' VAL . 32.0 mttp -85.63 124.71 32.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 71.230000000000004 110.938 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.573 ' HB ' HG22 ' A' ' 12' ' ' THR . 57.3 t -131.74 105.35 9.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 53.409999999999997 111.134 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -118.04 139.19 51.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 64.5 111.112 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -134.94 158.75 43.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 75.319999999999993 110.912 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.582 HD22 ' CD2' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -139.71 142.66 36.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.435 . . . . 70.329999999999998 110.974 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.88 107.28 19.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.201 -0.454 . . . . 44.009999999999998 110.871 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 69.4 t -57.47 -36.01 51.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 74.120000000000005 111.162 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.87 -36.38 48.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 71.319999999999993 110.908 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.29 -35.18 10.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 64.219999999999999 111.081 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.485 ' HB2' HD21 ' A' ' 66' ' ' LEU . 2.1 m-80 -115.72 73.59 4.46 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.63 0.728 . . . . 44.109999999999999 110.89 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -30.87 21.41 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.672 2.248 . . . . 44.350000000000001 112.319 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -64.9 -38.96 92.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.429 . . . . 73.120000000000005 110.898 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.6 ' HB1' ' HE2' ' A' ' 35' ' ' PHE . . . -54.48 -48.88 71.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.492 . . . . 63.210000000000001 111.094 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.615 ' HB1' ' HB ' ' A' ' 80' ' ' VAL . . . -53.37 -64.05 0.95 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 73.239999999999995 111.102 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.5 ttp180 -51.23 -34.01 30.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 73.230000000000004 110.899 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -51.73 -40.04 59.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 74.420000000000002 110.892 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -106.65 28.45 7.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 73.030000000000001 110.891 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 50.33 52.88 13.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 74.030000000000001 110.877 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.615 ' HB ' ' HB1' ' A' ' 75' ' ' ALA . 87.7 t -89.63 109.19 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 60.409999999999997 111.135 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.9 t -96.18 -35.74 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 74.099999999999994 111.112 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.5 t -103.12 146.0 29.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 70.010000000000005 110.838 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.54 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 1.1 mp -56.9 -57.43 24.37 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.594 0.711 . . . . 64.010000000000005 111.136 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.647 ' CB ' ' HB2' ' A' ' 101' ' ' ALA . 53.7 Cg_endo -69.76 78.34 1.01 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.668 2.245 . . . . 63.240000000000002 112.329 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.676 HG23 ' CG1' ' A' ' 99' ' ' VAL . 77.0 m -116.72 111.64 20.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.26 -0.427 . . . . 73.549999999999997 111.138 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 10.4 ttp -113.48 122.96 48.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 65.540000000000006 110.896 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.427 ' O ' HG12 ' A' ' 33' ' ' VAL . 20.9 mt -115.53 122.22 68.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 73.340000000000003 111.114 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 16.3 tp -88.16 105.7 17.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.485 . . . . 74.549999999999997 110.895 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -90.18 170.33 10.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 70.420000000000002 110.871 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -168.46 94.64 0.36 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.484 . . . . 63.049999999999997 110.88 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.89 35.85 10.91 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.775 -0.726 . . . . 31.399999999999999 112.48 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.402 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 70.84 37.94 65.76 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.75 -0.738 . . . . 43.420000000000002 112.494 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.459 HG23 ' HD2' ' A' ' 94' ' ' PRO . 85.1 m -161.13 134.16 4.63 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.572 0.701 . . . . 74.420000000000002 111.133 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.459 ' HD2' HG23 ' A' ' 93' ' ' THR . 54.0 Cg_endo -69.73 82.56 0.74 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.646 2.231 . . . . 70.430000000000007 112.37 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.7 m -64.76 -35.02 73.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 70.329999999999998 111.092 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.415 ' HE2' ' HB1' ' A' ' 114' ' ' ALA . 0.0 OUTLIER -140.95 170.02 16.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 73.099999999999994 110.927 179.919 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.476 ' C ' HD12 ' A' ' 98' ' ' ILE . 66.2 ttt180 -158.31 125.5 4.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 73.349999999999994 110.839 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.476 HD12 ' C ' ' A' ' 97' ' ' ARG . 4.8 mp -134.12 125.41 48.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 64.540000000000006 111.12 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.676 ' CG1' HG23 ' A' ' 85' ' ' THR . 10.6 m -132.77 150.96 33.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 71.129999999999995 111.096 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 140.99 -29.81 2.3 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.711 -0.757 . . . . 72.0 112.491 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.647 ' HB2' ' CB ' ' A' ' 84' ' ' PRO . . . 63.27 73.73 0.44 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.841 0.353 . . . . 72.540000000000006 111.07 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.41 -177.23 3.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 70.0 110.873 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.65 166.74 9.13 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.786 -0.721 . . . . 72.040000000000006 112.495 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.5 ptmt -55.71 -46.43 77.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.796 0.332 . . . . 55.509999999999998 110.93 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.23 -62.24 1.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 71.409999999999997 111.088 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.69 -56.57 18.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 70.340000000000003 111.108 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.547 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.8 OUTLIER -51.14 -41.97 60.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 73.510000000000005 110.912 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.437 HD23 ' C ' ' A' ' 108' ' ' LEU . 10.4 tt -63.98 -59.34 4.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 74.25 110.881 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -53.0 -38.77 62.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 73.540000000000006 110.865 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -51.1 -27.03 7.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 74.019999999999996 110.906 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.4 mt -82.87 -68.31 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 62.420000000000002 111.12 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -51.96 -47.86 64.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 45.450000000000003 110.866 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -57.81 -34.97 70.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.474 . . . . 73.310000000000002 110.837 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.415 ' HB1' ' HE2' ' A' ' 96' ' ' LYS . . . -76.36 -35.68 58.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 65.209999999999994 111.112 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.2 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 74.200000000000003 110.895 -179.931 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.532 HG22 ' HB ' ' A' ' 63' ' ' VAL . 81.7 p . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.82 0.343 . . . . 64.409999999999997 111.133 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.1 t -147.18 146.41 18.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 53.100000000000001 111.138 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.4 t -73.88 152.52 40.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.167 -0.47 . . . . 50.549999999999997 111.178 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.509 HG22 ' CG2' ' A' ' 19' ' ' THR . 5.3 p -112.38 147.82 15.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 61.130000000000003 111.099 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.55 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.74 158.94 9.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 55.100000000000001 111.148 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.96 -50.48 16.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 74.099999999999994 110.861 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.8 t -58.96 -36.08 74.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 73.340000000000003 110.873 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.55 HG22 ' HB ' ' A' ' 16' ' ' THR . 6.1 t -85.42 -18.25 34.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 72.439999999999998 111.133 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.721 ' CE2' HG21 ' A' ' 24' ' ' VAL . 23.5 t80 -50.41 -31.78 15.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 74.340000000000003 110.857 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.406 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -71.1 -33.59 70.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 61.149999999999999 110.876 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.1 m -91.18 -15.95 28.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.237 -0.438 . . . . 73.200000000000003 111.145 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -93.18 -70.86 0.68 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.233 -0.44 . . . . 65.030000000000001 110.861 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 1.029 HG13 HG21 ' A' ' 31' ' ' VAL . 15.6 t -71.14 -70.49 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 75.019999999999996 111.113 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.624 HD23 ' HA3' ' A' ' 92' ' ' GLY . 7.1 mt -40.54 -60.08 1.2 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.122 -0.49 . . . . 73.349999999999994 110.877 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -50.44 -59.39 4.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 73.510000000000005 110.848 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.8 t -51.78 149.06 5.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 62.409999999999997 110.84 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -111.66 35.31 3.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 70.030000000000001 110.885 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.426 HG22 ' HD2' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -123.19 160.41 50.07 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.544 0.688 . . . . 61.299999999999997 111.144 -179.839 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.426 ' HD2' HG22 ' A' ' 29' ' ' THR . 53.6 Cg_endo -69.78 124.67 11.3 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.679 2.253 . . . . 71.200000000000003 112.339 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 1.029 HG21 HG13 ' A' ' 24' ' ' VAL . 95.0 t -103.57 122.37 56.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 32.5 111.137 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.573 HD22 HD23 ' A' ' 88' ' ' LEU . 4.0 mm? -93.72 100.08 12.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 44.020000000000003 110.87 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 87' ' ' ILE . 7.1 p -99.63 145.27 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 51.039999999999999 111.135 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.51 118.57 19.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 74.400000000000006 110.808 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -103.08 97.49 7.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 73.409999999999997 110.916 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.5 ' HH2' HD11 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -148.32 -167.83 2.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.146 -0.479 . . . . 71.409999999999997 110.902 -179.914 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.572 ' HA ' HG22 ' A' ' 68' ' ' VAL . . . -56.09 -166.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 60.409999999999997 111.097 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.432 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 18.0 t0 -78.51 12.46 1.99 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.434 . . . . 61.420000000000002 110.823 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.463 ' CD1' ' N ' ' A' ' 39' ' ' TRP . 1.6 m0 77.27 94.04 0.06 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.243 -0.435 . . . . 71.0 110.867 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 2.4 t -167.34 -54.18 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 74.319999999999993 110.872 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.01 -69.88 1.37 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.778 -0.725 . . . . 74.340000000000003 112.439 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -32.94 17.83 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.67 2.246 . . . . 73.230000000000004 112.355 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.546 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 45.5 t -52.02 -34.71 44.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 72.209999999999994 110.895 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -64.63 -34.63 78.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 71.439999999999998 110.883 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 42.1 mtt -84.11 -38.84 20.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.271 -0.422 . . . . 65.219999999999999 110.854 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.521 ' HA ' HG22 ' A' ' 49' ' ' VAL . 3.0 t -94.41 21.76 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.434 . . . . 74.209999999999994 111.108 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.791 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -76.89 -60.83 0.77 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.634 0.731 . . . . 75.340000000000003 111.073 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.791 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.7 Cg_endo -69.72 -49.58 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.697 2.265 . . . . 42.32 112.341 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.618 ' O ' HD12 ' A' ' 53' ' ' ILE . 4.4 m -51.04 -30.23 9.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 75.340000000000003 111.132 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.515 ' HG ' HG12 ' A' ' 46' ' ' VAL . 4.4 mt -69.67 -38.2 76.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.123 -0.489 . . . . 34.539999999999999 110.934 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 8.3 mm-40 -71.93 -35.07 69.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 74.549999999999997 110.889 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -51.27 -66.42 0.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.495 . . . . 74.430000000000007 110.849 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.618 HD12 ' O ' ' A' ' 49' ' ' VAL . 2.5 mp -51.23 -33.11 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 73.340000000000003 111.13 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 51' ' ' GLU . . . . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 74.319999999999993 111.127 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.5 pp . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.947 0.403 . . . . 61.409999999999997 110.911 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.4 tptt -95.5 149.47 21.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.475 . . . . 74.209999999999994 110.914 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.532 ' HB ' HG22 ' A' ' 12' ' ' THR . 22.4 t -126.93 106.96 16.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 71.200000000000003 111.165 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -118.13 126.61 52.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 74.239999999999995 111.088 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -110.4 159.29 17.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 62.049999999999997 110.93 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.511 HD21 ' HB2' ' A' ' 71' ' ' ASN . 11.1 tp -137.1 145.92 44.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.434 . . . . 71.409999999999997 110.891 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -97.6 119.62 36.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 71.540000000000006 110.846 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.572 HG22 ' HA ' ' A' ' 37' ' ' ALA . 28.8 m -61.5 -35.18 65.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 74.400000000000006 111.138 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.13 -35.28 47.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 74.409999999999997 110.843 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.47 -35.24 11.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 44.229999999999997 111.078 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.511 ' HB2' HD21 ' A' ' 66' ' ' LEU . 1.4 m-80 -118.36 68.2 7.36 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.57 0.7 . . . . 65.219999999999999 110.868 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 -33.43 16.67 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.666 2.244 . . . . 54.329999999999998 112.38 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -68.28 -36.26 79.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 73.430000000000007 110.928 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.59 -47.45 79.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 74.510000000000005 111.09 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.666 ' HB1' ' HB ' ' A' ' 80' ' ' VAL . . . -56.31 -56.37 21.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 64.049999999999997 111.1 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -51.27 -34.19 31.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 54.140000000000001 110.854 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -58.05 -35.92 72.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 61.009999999999998 110.869 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -102.29 26.39 7.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 74.329999999999998 110.883 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 50.1 36.43 12.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 62.229999999999997 110.905 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.666 ' HB ' ' HB1' ' A' ' 75' ' ' ALA . 97.6 t -68.87 103.43 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 70.25 111.143 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 67.1 t -92.18 -35.04 6.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 75.400000000000006 111.174 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 t -105.61 151.76 23.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.481 . . . . 72.519999999999996 110.849 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.538 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.4 mt -60.58 -57.69 24.71 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.658 0.742 . . . . 73.239999999999995 111.139 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 54.1 Cg_endo -69.78 74.1 1.33 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.651 2.234 . . . . 71.230000000000004 112.347 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.985 HG23 HG22 ' A' ' 99' ' ' VAL . 84.0 m -108.99 137.99 46.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.223 -0.444 . . . . 73.319999999999993 111.178 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 10.2 ttm -135.17 145.91 48.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 70.109999999999999 110.878 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.48 ' O ' HG12 ' A' ' 33' ' ' VAL . 28.6 mt -143.07 128.85 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 72.310000000000002 111.138 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.573 HD23 HD22 ' A' ' 32' ' ' LEU . 2.2 tm? -95.2 107.94 20.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 74.120000000000005 110.906 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -92.06 170.29 9.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 73.420000000000002 110.909 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -162.49 106.24 1.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.479 . . . . 74.040000000000006 110.872 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.68 34.28 56.86 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.782 -0.723 . . . . 74.120000000000005 112.489 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.624 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 73.08 40.22 51.46 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.778 -0.725 . . . . 40.210000000000001 112.489 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.442 HG23 ' HD2' ' A' ' 94' ' ' PRO . 86.0 m -160.91 133.8 4.59 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.539 0.685 . . . . 53.420000000000002 111.149 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.442 ' HD2' HG23 ' A' ' 93' ' ' THR . 53.8 Cg_endo -69.77 84.77 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.698 2.265 . . . . 72.299999999999997 112.329 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.5 m -72.37 -35.11 50.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 75.230000000000004 111.117 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -136.32 170.05 16.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 64.409999999999997 110.937 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.554 ' C ' HD12 ' A' ' 98' ' ' ILE . 20.2 ttt-85 -155.97 128.55 7.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 61.039999999999999 110.9 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.554 HD12 ' C ' ' A' ' 97' ' ' ARG . 4.5 mp -138.05 111.67 7.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.462 . . . . 61.25 111.141 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.985 HG22 HG23 ' A' ' 85' ' ' THR . 48.9 t -109.62 133.07 56.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 71.0 111.165 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 136.57 137.4 3.65 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.754 -0.736 . . . . 73.519999999999996 112.479 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.47 83.15 4.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.87 0.367 . . . . 50.5 111.054 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.449 ' HG2' HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -120.03 174.07 6.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 65.349999999999994 110.931 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.87 171.89 5.68 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.719 -0.753 . . . . 74.409999999999997 112.463 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.66 -44.88 90.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.81 0.338 . . . . 51.520000000000003 110.923 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.64 -64.14 0.95 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 64.150000000000006 111.143 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.81 -58.34 7.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 71.349999999999994 111.142 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.49 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.2 OUTLIER -50.67 -40.94 54.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 61.100000000000001 110.924 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.509 ' O ' HD12 ' A' ' 108' ' ' LEU . 3.7 tp -64.7 -54.17 35.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 64.200000000000003 110.921 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -51.45 -43.06 61.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 53.210000000000001 110.86 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -51.12 -27.24 7.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 74.430000000000007 110.881 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.3 mt -83.08 -68.99 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 71.120000000000005 111.143 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.423 ' O ' HD23 ' A' ' 115' ' ' LEU . 9.0 pt-20 -50.9 -48.78 60.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 63.119999999999997 110.884 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -52.79 -32.48 44.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.479 . . . . 74.049999999999997 110.9 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.59 -33.77 71.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 71.120000000000005 111.108 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.423 HD23 ' O ' ' A' ' 112' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 71.230000000000004 110.929 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.422 HG22 ' HB ' ' A' ' 63' ' ' VAL . 44.5 p . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.827 0.346 . . . . 72.400000000000006 111.165 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.7 t -145.95 146.15 19.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 72.239999999999995 111.123 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.0 m -75.75 125.82 29.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 62.240000000000002 111.159 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.5 t -89.93 127.11 42.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 71.430000000000007 111.156 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.492 ' CB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.13 177.22 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 72.200000000000003 111.151 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.463 ' H ' HG22 ' A' ' 16' ' ' THR . 0.6 OUTLIER -80.1 -35.06 37.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.232 -0.44 . . . . 72.040000000000006 110.882 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.8 t -84.62 -51.73 6.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 64.129999999999995 110.85 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.492 HG22 ' CB ' ' A' ' 16' ' ' THR . 6.2 t -58.43 -19.55 37.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 72.230000000000004 111.167 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.72 ' CE2' HG21 ' A' ' 24' ' ' VAL . 25.1 t80 -51.25 -30.27 17.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 62.240000000000002 110.872 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.417 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -72.47 -34.1 67.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 64.239999999999995 110.898 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.8 m -91.26 -15.99 28.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 65.310000000000002 111.145 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -93.55 -71.53 0.65 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 61.020000000000003 110.851 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.916 HG13 HG21 ' A' ' 31' ' ' VAL . 21.2 t -70.15 -70.65 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 71.549999999999997 111.156 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.609 HD23 ' HA3' ' A' ' 92' ' ' GLY . 7.9 mt -40.6 -60.3 1.16 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.113 -0.494 . . . . 73.329999999999998 110.936 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -50.27 -52.8 33.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 61.210000000000001 110.866 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.9 t -57.21 155.06 9.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 74.200000000000003 110.822 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -104.36 -44.27 4.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.483 . . . . 72.25 110.827 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -51.54 160.0 1.11 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.583 0.706 . . . . 54.32 111.114 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 126.83 13.72 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.63 2.22 . . . . 74.109999999999999 112.336 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.916 HG21 HG13 ' A' ' 24' ' ' VAL . 80.1 t -97.69 127.52 49.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 71.310000000000002 111.159 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.47 HD11 HD11 ' A' ' 88' ' ' LEU . 6.3 mp -103.22 100.11 10.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 71.209999999999994 110.924 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.6 p -102.82 138.46 27.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 74.439999999999998 111.092 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.96 118.43 22.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 73.019999999999996 110.906 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -96.16 90.38 5.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 74.519999999999996 110.893 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -135.6 -167.94 2.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.152 -0.476 . . . . 73.549999999999997 110.969 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.42 ' HA ' HG22 ' A' ' 68' ' ' VAL . . . -56.18 -166.34 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.432 . . . . 60.130000000000003 111.092 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.446 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 9.3 p-10 -78.2 12.45 1.87 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 63.219999999999999 110.863 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.462 ' N ' ' CD1' ' A' ' 39' ' ' TRP . 1.3 m0 76.98 92.95 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 72.420000000000002 110.912 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 36.4 t -170.72 -58.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.441 . . . . 73.430000000000007 110.879 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.8 -71.02 1.25 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.778 -0.725 . . . . 65.430000000000007 112.484 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 -32.2 18.79 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.694 2.263 . . . . 72.219999999999999 112.331 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.536 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 36.3 t -60.23 -32.37 71.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 63.439999999999998 110.867 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -30.21 71.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 71.319999999999993 110.938 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 7.3 mmm -88.44 -39.91 13.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 55.109999999999999 110.858 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.564 ' HA ' HG22 ' A' ' 49' ' ' VAL . 3.1 t -94.25 22.34 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 42.310000000000002 111.096 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.803 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -76.04 -61.04 0.9 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.596 0.712 . . . . 73.019999999999996 111.113 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.803 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.6 Cg_endo -69.78 -50.1 0.49 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.739 2.293 . . . . 61.020000000000003 112.349 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.577 ' O ' HD12 ' A' ' 53' ' ' ILE . 4.4 m -52.86 -31.02 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 74.099999999999994 111.172 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.7 tp -70.33 -41.22 73.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 74.109999999999999 110.914 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -69.81 -34.61 73.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 64.239999999999995 110.906 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -56.39 -63.17 1.28 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 65.409999999999997 110.886 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.577 HD12 ' O ' ' A' ' 49' ' ' VAL . 3.8 mt -53.04 -45.09 52.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 73.150000000000006 111.106 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.462 ' HA ' HD21 ' A' ' 61' ' ' LEU . . . . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 75.450000000000003 111.113 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.462 HD21 ' HA ' ' A' ' 54' ' ' ALA . 3.6 pp . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.817 0.341 . . . . 75.329999999999998 110.963 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -79.78 119.11 22.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.192 -0.458 . . . . 62.299999999999997 110.856 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.422 ' HB ' HG22 ' A' ' 12' ' ' THR . 58.6 t -118.93 100.89 10.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 63.299999999999997 111.132 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -126.22 132.16 51.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 62.420000000000002 111.105 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -129.36 160.02 34.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 72.200000000000003 110.855 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.483 HD21 ' CB ' ' A' ' 71' ' ' ASN . 18.9 tp -136.16 148.91 48.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 75.420000000000002 110.944 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.78 112.36 24.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.176 -0.465 . . . . 71.120000000000005 110.849 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.42 HG22 ' HA ' ' A' ' 37' ' ' ALA . 27.4 m -59.5 -35.6 59.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 74.230000000000004 111.144 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.55 -36.46 61.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 74.439999999999998 110.868 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.47 -35.22 13.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 72.299999999999997 111.091 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.483 ' CB ' HD21 ' A' ' 66' ' ' LEU . 1.7 m-80 -117.27 68.79 5.23 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.62 0.724 . . . . 74.030000000000001 110.884 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 -32.65 18.39 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.725 2.283 . . . . 61.530000000000001 112.384 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -65.23 -36.28 83.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 74.230000000000004 110.891 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.17 -44.81 96.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 75.439999999999998 111.138 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.674 ' HB1' ' HB ' ' A' ' 80' ' ' VAL . . . -52.57 -61.55 2.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 61.25 111.087 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.5 ttp180 -50.97 -34.79 30.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 73.510000000000005 110.9 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -51.89 -35.92 46.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.486 . . . . 72.400000000000006 110.859 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -108.87 27.89 9.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.449 . . . . 73.129999999999995 110.882 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 50.59 55.76 9.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.495 . . . . 61.530000000000001 110.906 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.674 ' HB ' ' HB1' ' A' ' 75' ' ' ALA . 91.0 t -92.24 104.97 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 50.43 111.115 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 57.4 t -96.44 -35.06 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 63.009999999999998 111.124 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.8 m -102.84 146.64 27.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 73.140000000000001 110.89 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.531 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 5.1 mt -58.19 -57.57 25.1 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.621 0.724 . . . . 71.109999999999999 111.144 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.637 ' CB ' ' HB2' ' A' ' 101' ' ' ALA . 53.5 Cg_endo -69.78 76.39 1.15 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.65 2.233 . . . . 74.25 112.33 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.669 HG23 ' CG1' ' A' ' 99' ' ' VAL . 73.6 m -113.99 134.95 54.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 72.329999999999998 111.112 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 14.2 ttt -133.85 126.42 30.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 64.239999999999995 110.883 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.0 mt -116.97 115.19 48.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 72.239999999999995 111.152 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.47 HD11 HD11 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -81.11 106.31 13.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 75.530000000000001 110.92 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -93.34 170.05 9.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 72.439999999999998 110.932 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -165.74 91.43 0.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 73.530000000000001 110.878 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.82 36.91 8.19 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.715 -0.755 . . . . 61.439999999999998 112.497 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.609 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 68.64 39.3 86.52 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.773 -0.727 . . . . 70.430000000000007 112.488 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.456 HG23 ' HD2' ' A' ' 94' ' ' PRO . 88.6 m -160.53 133.99 4.86 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.58 0.705 . . . . 72.209999999999994 111.156 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.456 ' HD2' HG23 ' A' ' 93' ' ' THR . 53.7 Cg_endo -69.79 109.56 2.35 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.661 2.241 . . . . 64.310000000000002 112.374 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.3 m -101.6 -32.99 3.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.46 . . . . 70.439999999999998 111.138 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.464 ' HD2' ' HB3' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -132.73 164.63 26.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.483 . . . . 62.340000000000003 110.906 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.441 ' C ' HD12 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -155.84 117.51 3.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 64.099999999999994 110.852 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.441 ' N ' HD12 ' A' ' 98' ' ' ILE . 4.7 mp -132.56 130.91 59.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 74.439999999999998 111.126 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.669 ' CG1' HG23 ' A' ' 85' ' ' THR . 11.1 m -138.16 145.39 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 73.319999999999993 111.129 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 146.39 -26.88 1.69 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.745 -0.74 . . . . 73.040000000000006 112.522 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.637 ' HB2' ' CB ' ' A' ' 84' ' ' PRO . . . 62.7 68.35 0.65 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.843 0.354 . . . . 74.549999999999997 111.09 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.2 169.1 9.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 74.409999999999997 110.897 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.77 150.16 39.48 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.744 -0.741 . . . . 52.420000000000002 112.47 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.576 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -48.39 -34.99 11.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.809 0.338 . . . . 73.310000000000002 110.88 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.16 -40.39 77.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 42.020000000000003 111.078 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.76 -49.8 6.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 63.32 111.131 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.7 -52.94 16.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 62.520000000000003 110.961 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.576 HD23 ' O ' ' A' ' 104' ' ' LYS . 1.6 pp -48.12 -35.58 11.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.468 . . . . 71.109999999999999 110.911 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 46.1 mtp85 -74.25 -42.24 59.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 75.5 110.865 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -51.48 -25.0 5.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 62.43 110.926 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.4 mt -87.68 -69.29 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 53.539999999999999 111.167 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -51.11 -49.39 60.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 74.129999999999995 110.873 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -58.91 -34.13 71.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 63.32 110.84 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.464 ' HB3' ' HD2' ' A' ' 96' ' ' LYS . . . -75.09 -35.64 61.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 64.219999999999999 111.116 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.4 mt . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 64.409999999999997 110.971 179.954 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.625 HG22 ' HB ' ' A' ' 63' ' ' VAL . 82.4 p . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.863 0.363 . . . . 73.439999999999998 111.121 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 98.6 t -150.16 143.68 17.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.225 -0.443 . . . . 75.409999999999997 111.093 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.8 t -67.71 126.98 31.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 75.430000000000007 111.131 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 74.7 t -94.82 130.44 43.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 72.239999999999995 111.13 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.599 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.72 160.52 7.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 61.229999999999997 111.161 -179.952 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -73.62 -41.52 62.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.255 -0.43 . . . . 74.040000000000006 110.846 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.6 m -70.39 -34.53 72.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 70.319999999999993 110.885 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.599 HG22 ' HB ' ' A' ' 16' ' ' THR . 7.3 t -85.19 -17.97 35.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 72.030000000000001 111.108 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.724 ' CE2' HG21 ' A' ' 24' ' ' VAL . 24.2 t80 -50.64 -31.23 15.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 62.25 110.859 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.436 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -71.74 -33.48 68.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.149 -0.478 . . . . 72.150000000000006 110.885 179.923 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.6 m -91.7 -16.23 27.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 73.129999999999995 111.182 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -93.36 -71.42 0.65 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 63.119999999999997 110.888 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.842 HG13 HG21 ' A' ' 31' ' ' VAL . 17.9 t -70.39 -70.3 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 71.450000000000003 111.165 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.589 HD23 ' HA3' ' A' ' 92' ' ' GLY . 7.6 mt -40.7 -60.21 1.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 75.530000000000001 110.886 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -50.36 -58.73 5.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 74.230000000000004 110.876 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.3 t -54.02 171.33 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 73.219999999999999 110.876 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -117.73 -40.96 2.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 74.140000000000001 110.836 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.478 HG22 ' HD2' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -53.05 159.47 1.91 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.59 0.71 . . . . 65.299999999999997 111.128 -179.905 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.478 ' HD2' HG22 ' A' ' 29' ' ' THR . 54.4 Cg_endo -69.7 131.08 20.57 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.715 2.276 . . . . 63.210000000000001 112.369 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.842 HG21 HG13 ' A' ' 24' ' ' VAL . 96.7 t -105.02 125.26 60.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 53.43 111.11 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.694 ' CD1' HD13 ' A' ' 61' ' ' LEU . 4.7 mt -102.23 100.65 10.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 63.43 110.887 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.3 p -98.55 133.57 40.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 64.430000000000007 111.172 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -115.49 99.55 7.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.225 -0.443 . . . . 75.019999999999996 110.839 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -90.47 89.39 7.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 64.430000000000007 110.887 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -145.87 -169.05 3.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.143 -0.48 . . . . 75.010000000000005 110.917 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.37 -156.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 72.109999999999999 111.099 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.476 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 5.3 m-20 -77.61 9.54 3.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.202 -0.453 . . . . 70.400000000000006 110.862 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.476 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 1.0 OUTLIER 41.87 71.08 0.23 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 74.409999999999997 110.935 -179.933 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 44.5 t -132.63 -45.51 0.89 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 73.420000000000002 110.915 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.75 -67.39 1.52 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.722 -0.751 . . . . 62.219999999999999 112.503 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -24.11 30.08 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.713 2.275 . . . . 71.230000000000004 112.326 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 11.9 p -51.92 -27.13 12.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 74.200000000000003 110.877 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? -61.52 -33.72 74.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 63.310000000000002 110.882 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 6.2 mtp -86.48 -36.52 18.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 73.329999999999998 110.889 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.521 ' HA ' HG22 ' A' ' 49' ' ' VAL . 2.9 t -94.04 21.2 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 74.329999999999998 111.126 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.754 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -76.79 -60.8 0.79 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.596 0.712 . . . . 73.019999999999996 111.051 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.754 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.6 Cg_endo -69.73 -49.13 0.59 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.672 2.248 . . . . 72.230000000000004 112.335 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.717 HG12 ' HG3' ' A' ' 104' ' ' LYS . 4.0 m -51.44 -29.18 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 63.229999999999997 111.155 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.4 tp -84.1 -36.02 23.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 63.039999999999999 110.898 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -71.68 -31.98 67.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 74.439999999999998 110.911 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -49.87 -68.2 0.2 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 74.099999999999994 110.895 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.483 ' H ' HD12 ' A' ' 53' ' ' ILE . 4.0 mp -51.45 -36.66 17.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.178 -0.465 . . . . 62.310000000000002 111.12 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.602 ' HA ' HD21 ' A' ' 61' ' ' LEU . . . . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 75.329999999999998 111.103 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.694 HD13 ' CD1' ' A' ' 32' ' ' LEU . 2.5 pp . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.855 0.359 . . . . 74.340000000000003 110.916 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.1 mtmp? -102.0 139.97 36.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.228 -0.442 . . . . 73.319999999999993 110.877 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.625 ' HB ' HG22 ' A' ' 12' ' ' THR . 21.7 t -120.55 104.33 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 74.349999999999994 111.141 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -104.5 121.47 43.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 55.039999999999999 111.122 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.87 131.42 54.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 64.340000000000003 110.896 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.512 HD21 ' CG ' ' A' ' 71' ' ' ASN . 44.0 tp -123.83 155.47 37.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.227 -0.442 . . . . 74.329999999999998 110.952 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.45 114.85 27.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 74.450000000000003 110.856 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 79.5 t -61.38 -35.27 65.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 71.549999999999997 111.126 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -51.86 -36.88 49.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 74.349999999999994 110.887 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.93 -34.46 13.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 64.209999999999994 111.072 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.512 ' CG ' HD21 ' A' ' 66' ' ' LEU . 3.1 m120 -117.42 69.61 5.91 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.629 0.728 . . . . 72.150000000000006 110.892 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -32.31 18.81 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.744 2.296 . . . . 73.120000000000005 112.335 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -58.72 -37.58 76.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.438 . . . . 73.010000000000005 110.881 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.97 -47.88 67.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 53.109999999999999 111.065 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.56 ' O ' HG23 ' A' ' 80' ' ' VAL . . . -54.02 -63.47 1.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 75.349999999999994 111.047 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.5 ttp85 -51.56 -33.18 31.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 72.140000000000001 110.868 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -50.99 -39.98 56.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 43.399999999999999 110.873 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -104.39 24.15 12.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 64.040000000000006 110.905 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 47.85 66.55 1.01 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 61.549999999999997 110.911 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 75' ' ' ALA . 95.9 t -87.58 106.8 16.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 75.430000000000007 111.136 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.6 t -80.26 -58.39 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 64.230000000000004 111.139 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.3 m -91.65 163.28 14.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.468 . . . . 71.439999999999998 110.835 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.531 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 1.7 mp -65.3 -58.17 12.97 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.639 0.733 . . . . 54.43 111.133 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.7 Cg_endo -69.75 74.86 1.25 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.658 2.238 . . . . 72.420000000000002 112.374 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.507 ' OG1' HG13 ' A' ' 80' ' ' VAL . 99.7 m -113.87 106.0 13.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 74.230000000000004 111.119 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 9.4 ttp -116.16 121.84 43.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 74.310000000000002 110.865 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.0 mp -104.69 119.04 53.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 73.040000000000006 111.102 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.639 ' CD2' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -80.17 104.56 10.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 72.430000000000007 110.857 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -89.77 169.86 10.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 74.329999999999998 110.9 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -167.71 93.67 0.4 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 75.319999999999993 110.908 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.42 38.77 8.73 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.758 -0.734 . . . . 62.399999999999999 112.5 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.589 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 69.37 37.21 79.49 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.783 -0.722 . . . . 74.019999999999996 112.46 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.459 HG23 ' HD2' ' A' ' 94' ' ' PRO . 85.0 m -160.72 133.78 4.67 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.554 0.692 . . . . 74.140000000000001 111.138 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.459 ' HD2' HG23 ' A' ' 93' ' ' THR . 53.6 Cg_endo -69.74 83.01 0.71 Allowed 'Trans proline' 0 C--N 1.34 0.126 0 C-N-CA 122.703 2.269 . . . . 55.140000000000001 112.292 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.8 m -64.98 -33.88 66.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 73.329999999999998 111.133 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.66 170.22 16.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 63.299999999999997 110.91 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -153.35 127.44 9.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 62.210000000000001 110.881 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.472 HG23 ' HB3' ' A' ' 110' ' ' GLU . 5.3 mp -131.0 143.19 41.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.193 -0.458 . . . . 54.450000000000003 111.144 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -142.13 141.05 29.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 61.43 111.164 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 119.08 145.59 7.7 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.767 -0.73 . . . . 44.539999999999999 112.549 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -100.89 89.1 3.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.893 0.378 . . . . 61.25 111.109 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -120.55 179.87 4.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 74.340000000000003 110.866 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.8 175.26 13.07 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.735 -0.745 . . . . 72.310000000000002 112.525 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.717 ' HG3' HG12 ' A' ' 49' ' ' VAL . 1.6 mtpt -58.18 -47.78 82.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.768 0.318 . . . . 72.310000000000002 110.894 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -53.48 -65.83 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.449 . . . . 72.409999999999997 111.093 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.466 ' HB3' ' HB2' ' A' ' 102' ' ' LYS . . . -50.97 -57.66 8.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 61.030000000000001 111.116 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.572 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.4 OUTLIER -50.82 -34.97 29.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 63.530000000000001 110.938 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.455 HD23 ' C ' ' A' ' 108' ' ' LEU . 9.1 tt -69.42 -60.34 2.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 71.340000000000003 110.927 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 45.1 mtp85 -54.47 -34.35 61.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 73.209999999999994 110.87 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.472 ' HB3' HG23 ' A' ' 98' ' ' ILE . 14.0 mm-40 -49.35 -26.74 3.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 64.450000000000003 110.868 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.3 mt -84.12 -69.73 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 73.150000000000006 111.121 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.677 ' HA ' HD23 ' A' ' 115' ' ' LEU . 3.1 pt-20 -52.75 -50.06 64.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 73.099999999999994 110.895 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -55.92 -34.61 65.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.116 -0.493 . . . . 71.25 110.884 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.1 -36.82 69.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 74.109999999999999 111.096 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.677 HD23 ' HA ' ' A' ' 112' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 64.209999999999994 110.92 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.3 p . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.84 0.352 . . . . 53.340000000000003 111.152 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 65.5 t -148.63 142.19 18.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 72.219999999999999 111.13 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.3 t -77.04 128.7 34.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 71.310000000000002 111.14 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.423 ' CG1' HG23 ' A' ' 19' ' ' THR . 47.6 t -91.36 126.59 44.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 74.239999999999995 111.109 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.652 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.6 OUTLIER -59.65 165.99 2.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 63.43 111.182 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.41 ' H ' HG22 ' A' ' 16' ' ' THR . 25.1 t0 -68.37 -48.04 65.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 74.430000000000007 110.868 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.0 t -69.1 -52.93 23.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 65.25 110.87 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.652 HG22 ' HB ' ' A' ' 16' ' ' THR . 6.4 t -59.36 -19.01 43.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 62.539999999999999 111.143 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.711 ' CE2' HG21 ' A' ' 24' ' ' VAL . 24.6 t80 -51.03 -30.74 16.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 72.420000000000002 110.84 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.422 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -72.07 -34.13 68.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 65.299999999999997 110.91 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.0 m -91.19 -16.0 28.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 72.340000000000003 111.178 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.39 -71.33 0.66 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 61.219999999999999 110.875 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.711 HG21 ' CE2' ' A' ' 20' ' ' PHE . 18.6 t -70.4 -70.47 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 64.409999999999997 111.149 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.519 HD23 ' HA3' ' A' ' 92' ' ' GLY . 7.4 mt -40.64 -60.49 1.13 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 50.119999999999997 110.869 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -50.32 -63.71 1.03 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 65.439999999999998 110.889 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.3 t -56.11 150.87 13.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 71.239999999999995 110.848 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -98.88 -36.45 9.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 75.040000000000006 110.814 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -52.67 159.84 1.6 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.567 0.699 . . . . 64.109999999999999 111.152 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.84 127.43 14.53 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.629 2.219 . . . . 72.329999999999998 112.355 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.664 HG21 HG13 ' A' ' 24' ' ' VAL . 99.4 t -102.18 124.4 56.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 72.420000000000002 111.157 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.661 HD23 HD13 ' A' ' 61' ' ' LEU . 3.5 mm? -91.41 123.44 34.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 64.439999999999998 110.908 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.409 HG11 ' CE1' ' A' ' 35' ' ' PHE . 12.9 t -118.6 139.54 45.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.206 -0.452 . . . . 73.129999999999995 111.132 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.528 ' OD1' HD11 ' A' ' 50' ' ' LEU . 1.6 m-20 -131.4 99.83 4.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 74.299999999999997 110.893 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.541 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 32.1 m-85 -91.05 89.54 7.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.462 . . . . 74.340000000000003 110.867 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.437 ' O ' HG13 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -148.98 -169.27 3.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 72.519999999999996 110.923 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.594 ' HA ' HG22 ' A' ' 68' ' ' VAL . . . -60.08 -155.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.436 . . . . 64.200000000000003 111.103 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.473 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 18.7 p-10 -77.93 8.64 4.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 62.329999999999998 110.896 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.473 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 1.6 p-90 41.55 65.77 0.79 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.187 -0.46 . . . . 63.409999999999997 110.899 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 35.8 t -122.58 -46.38 2.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.233 -0.439 . . . . 70.140000000000001 110.875 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.7 -67.62 1.53 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.751 -0.738 . . . . 74.120000000000005 112.458 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -25.57 28.28 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.675 2.25 . . . . 64.25 112.359 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 28.9 t -51.49 -31.76 24.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 31.23 110.885 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.59 -33.5 71.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 54.009999999999998 110.895 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 7.0 mtt -88.13 -35.71 17.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 75.340000000000003 110.891 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.447 ' HA ' HG22 ' A' ' 49' ' ' VAL . 3.1 t -93.51 21.18 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 54.149999999999999 111.148 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.792 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -80.14 -61.41 0.44 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.531 0.681 . . . . 74.530000000000001 111.062 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.792 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 54.3 Cg_endo -69.69 -45.55 1.59 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.665 2.243 . . . . 73.219999999999999 112.375 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' A' ' 46' ' ' VAL . 4.4 m -49.37 -31.34 5.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 73.040000000000006 111.13 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.528 HD11 ' OD1' ' A' ' 34' ' ' ASP . 4.7 tt -88.25 -44.83 10.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 70.420000000000002 110.939 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -58.3 -33.8 69.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 73.439999999999998 110.911 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -63.17 -32.28 73.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.169 -0.469 . . . . 73.040000000000006 110.92 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.449 HD13 ' N ' ' A' ' 53' ' ' ILE . 4.3 mm -64.92 -34.53 71.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 75.340000000000003 111.103 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.422 ' HA ' HD21 ' A' ' 61' ' ' LEU . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 72.010000000000005 111.09 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.661 HD13 HD23 ' A' ' 32' ' ' LEU . 3.6 pp . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.901 0.382 . . . . 73.409999999999997 110.891 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.1 tptm -102.17 147.21 26.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 73.430000000000007 110.89 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.0 t -125.4 106.93 17.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 65.109999999999999 111.111 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -121.53 136.77 54.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 72.329999999999998 111.136 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -123.87 146.43 48.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 74.109999999999999 110.872 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.488 HD21 ' CB ' ' A' ' 71' ' ' ASN . 16.1 tp -127.03 152.09 47.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 63.25 110.918 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.588 ' OD2' ' HB3' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -103.29 121.23 42.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 70.310000000000002 110.885 179.85 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.594 HG22 ' HA ' ' A' ' 37' ' ' ALA . 33.1 m -62.24 -33.04 56.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 42.119999999999997 111.135 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -50.42 -35.77 30.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 60.219999999999999 110.926 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.588 ' HB3' ' OD2' ' A' ' 67' ' ' ASP . . . -100.26 -34.11 10.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 61.32 111.088 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.488 ' CB ' HD21 ' A' ' 66' ' ' LEU . 0.7 OUTLIER -121.32 68.07 19.14 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.594 0.711 . . . . 64.549999999999997 110.857 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -33.88 15.69 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.677 2.251 . . . . 63.530000000000001 112.334 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -58.41 -43.57 88.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 62.009999999999998 110.904 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.541 ' HB1' ' CE2' ' A' ' 35' ' ' PHE . . . -54.0 -48.6 70.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 72.340000000000003 111.111 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.568 ' O ' HG23 ' A' ' 80' ' ' VAL . . . -51.7 -68.17 0.19 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 65.230000000000004 111.092 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -50.97 -32.87 22.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 64.25 110.909 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -51.41 -34.54 35.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 74.430000000000007 110.847 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -112.03 26.08 10.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 73.439999999999998 110.865 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 69.9 mm-40 48.48 85.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 73.439999999999998 110.934 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.667 HG13 ' OG1' ' A' ' 85' ' ' THR . 95.1 t -105.96 111.43 35.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 75.5 111.117 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 22.1 t -81.9 -59.86 2.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 62.119999999999997 111.145 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 m -91.34 156.25 17.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 74.200000000000003 110.834 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.531 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 4.7 mt -60.15 -58.01 22.51 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.606 0.717 . . . . 73.329999999999998 111.112 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.7 Cg_endo -69.75 69.77 1.61 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.689 2.259 . . . . 52.399999999999999 112.297 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.742 HG23 HG22 ' A' ' 99' ' ' VAL . 43.7 m -103.98 132.53 50.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 72.200000000000003 111.187 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 17.5 ttp -130.82 143.83 51.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 72.519999999999996 110.861 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 63.1 mt -128.98 117.99 45.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 75.030000000000001 111.138 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.436 ' CD1' HG21 ' A' ' 111' ' ' ILE . 1.9 tt -88.24 105.72 17.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.454 . . . . 75.25 110.943 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -90.02 170.14 10.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 72.319999999999993 110.868 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.424 ' HB3' HG11 ' A' ' 95' ' ' VAL . 0.7 OUTLIER -165.53 92.29 0.54 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 62.32 110.862 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.15 41.36 7.09 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.731 -0.747 . . . . 54.109999999999999 112.487 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.519 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 67.89 35.96 85.72 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.709 -0.758 . . . . 42.140000000000001 112.506 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.457 HG23 ' HD2' ' A' ' 94' ' ' PRO . 86.2 m -161.0 133.86 4.57 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.633 0.73 . . . . 74.409999999999997 111.125 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.457 ' HD2' HG23 ' A' ' 93' ' ' THR . 53.9 Cg_endo -69.77 87.83 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.689 2.26 . . . . 74.329999999999998 112.336 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.424 HG11 ' HB3' ' A' ' 90' ' ' LYS . 28.8 m -70.49 -35.61 62.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 72.420000000000002 111.108 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.466 ' HE2' ' HB1' ' A' ' 114' ' ' ALA . 0.0 OUTLIER -140.7 170.19 16.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 75.099999999999994 110.875 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -155.91 122.76 5.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 72.540000000000006 110.877 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.435 ' N ' HD12 ' A' ' 98' ' ' ILE . 4.6 mp -124.93 132.64 71.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 63.030000000000001 111.146 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.742 HG22 HG23 ' A' ' 85' ' ' THR . 98.0 t -131.74 136.6 56.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 70.329999999999998 111.137 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 127.13 138.66 4.79 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 74.340000000000003 112.476 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.21 84.88 4.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.88 0.371 . . . . 75.329999999999998 111.103 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.06 -179.62 3.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 74.329999999999998 110.895 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.49 -169.74 1.42 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.761 -0.733 . . . . 71.5 112.478 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -79.96 -41.74 25.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.776 0.322 . . . . 75.329999999999998 110.884 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.74 -31.95 72.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 71.230000000000004 111.103 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.438 ' HA ' ' HG2' ' A' ' 109' ' ' ARG . . . -84.07 -60.22 2.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 34.530000000000001 111.093 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.657 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -50.67 -34.59 27.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 72.099999999999994 110.913 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.599 HD23 ' N ' ' A' ' 109' ' ' ARG . 5.8 tt -70.52 -60.51 2.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 62.340000000000003 110.947 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.599 ' N ' HD23 ' A' ' 108' ' ' LEU . 12.6 ptp180 -54.9 -33.01 61.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 74.420000000000002 110.842 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -54.07 -24.54 17.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 73.310000000000002 110.859 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.436 HG21 ' CD1' ' A' ' 88' ' ' LEU . 4.6 mt -85.97 -68.19 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 73.439999999999998 111.138 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -51.75 -49.07 63.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 61.109999999999999 110.902 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -56.18 -34.84 66.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 74.439999999999998 110.817 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.466 ' HB1' ' HE2' ' A' ' 96' ' ' LYS . . . -73.57 -34.74 65.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 61.210000000000001 111.086 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.5 mt . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.218 -0.447 . . . . 65.340000000000003 110.861 -179.926 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.3 p . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.801 0.334 . . . . 65.530000000000001 111.165 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.3 t -146.24 148.26 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 72.219999999999999 111.115 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 t -73.05 127.51 32.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 70.209999999999994 111.124 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 90.7 t -91.84 143.79 10.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 73.420000000000002 111.124 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.661 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.64 171.73 0.82 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 64.430000000000007 111.065 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.454 ' H ' HG22 ' A' ' 16' ' ' THR . 2.8 t70 -80.79 -48.32 12.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 61.439999999999998 110.879 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.0 t -67.9 -53.98 22.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 72.099999999999994 110.886 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.661 HG22 ' HB ' ' A' ' 16' ' ' THR . 5.0 t -58.83 -19.51 42.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.099 -0.501 . . . . 63.310000000000002 111.146 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.705 ' CE2' HG21 ' A' ' 24' ' ' VAL . 24.2 t80 -51.41 -30.85 20.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 73.230000000000004 110.868 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.432 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -71.88 -33.61 68.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.175 -0.466 . . . . 73.420000000000002 110.907 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.9 m -91.6 -16.17 27.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.169 -0.469 . . . . 75.349999999999994 111.12 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.9 -71.39 0.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 72.329999999999998 110.834 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.705 HG21 ' CE2' ' A' ' 20' ' ' PHE . 13.1 t -70.9 -70.11 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 73.109999999999999 111.152 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.666 HD23 ' O ' ' A' ' 91' ' ' GLY . 6.9 mt -40.44 -60.02 1.2 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 64.420000000000002 110.915 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -51.24 -65.19 0.6 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.227 -0.442 . . . . 73.019999999999996 110.887 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 56.7 m -54.52 153.72 5.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 71.510000000000005 110.851 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -97.02 -34.92 11.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.489 . . . . 54.119999999999997 110.874 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.2 t -50.15 141.47 15.37 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.56 0.695 . . . . 61.0 111.15 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 125.86 12.67 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.685 2.257 . . . . 54.240000000000002 112.369 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.538 HG22 ' HB3' ' A' ' 62' ' ' LYS . 91.2 t -97.93 128.39 49.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 60.149999999999999 111.155 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.437 HD11 HD11 ' A' ' 88' ' ' LEU . 6.5 mp -102.4 108.11 19.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 65.230000000000004 110.905 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.523 HG12 ' O ' ' A' ' 87' ' ' ILE . 7.4 p -97.13 145.44 9.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 53.329999999999998 111.121 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.57 112.19 13.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 64.349999999999994 110.838 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.681 ' CD2' HD22 ' A' ' 66' ' ' LEU . 75.5 m-85 -97.6 97.8 9.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 72.230000000000004 110.872 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -150.78 -168.07 3.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 75.109999999999999 110.888 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.8 -164.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 74.140000000000001 111.106 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.444 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 1.8 m-20 -77.92 12.45 1.76 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.259 -0.428 . . . . 75.299999999999997 110.883 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.46 ' CD1' ' N ' ' A' ' 39' ' ' TRP . 1.6 m0 77.66 94.51 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.475 . . . . 72.099999999999994 110.928 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -167.94 -63.74 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 74.549999999999997 110.87 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.38 -70.51 1.33 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.748 -0.739 . . . . 63.140000000000001 112.522 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -8.07 22.67 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.661 2.241 . . . . 73.120000000000005 112.349 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.503 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 31.4 t -90.34 -26.84 19.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 74.030000000000001 110.914 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -60.54 -30.59 69.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 71.129999999999995 110.888 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 9.6 ptp -88.05 -39.93 14.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 74.310000000000002 110.908 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.476 ' HA ' HG22 ' A' ' 49' ' ' VAL . 3.5 t -93.81 23.12 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 62.039999999999999 111.111 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.814 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -79.79 -61.38 0.46 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.576 0.703 . . . . 60.119999999999997 111.064 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.814 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 54.4 Cg_endo -69.69 -48.03 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.673 2.249 . . . . 63.229999999999997 112.366 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.666 ' O ' HD12 ' A' ' 53' ' ' ILE . 4.6 m -49.78 -31.15 6.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 74.129999999999995 111.128 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.49 -40.27 80.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 72.239999999999995 110.906 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -64.33 -36.62 84.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.443 . . . . 71.430000000000007 110.927 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -59.9 -68.06 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 73.219999999999999 110.915 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.666 HD12 ' O ' ' A' ' 49' ' ' VAL . 3.2 mt -50.44 -39.84 17.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 73.5 111.176 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.455 ' O ' HD22 ' A' ' 61' ' ' LEU . . . . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 53.43 111.071 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.455 HD22 ' O ' ' A' ' 54' ' ' ALA . 2.1 pt? . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.849 0.357 . . . . 62.210000000000001 110.921 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.538 ' HB3' HG22 ' A' ' 31' ' ' VAL . 24.0 tttp -99.97 141.74 32.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 71.310000000000002 110.868 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 37.7 t -146.43 131.54 11.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.257 -0.429 . . . . 23.449999999999999 111.144 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -152.91 138.05 17.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 74.219999999999999 111.146 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.3 mttp -114.08 159.93 19.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 61.409999999999997 110.903 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.681 HD22 ' CD2' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -135.85 141.03 44.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 63.43 110.918 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -93.95 113.46 25.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.472 . . . . 70.239999999999995 110.839 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.9 m -60.18 -35.12 59.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 75.299999999999997 111.149 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -53.97 -35.23 61.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 74.129999999999995 110.896 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.11 -35.55 10.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 73.400000000000006 111.095 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.524 ' HB2' HD21 ' A' ' 66' ' ' LEU . 1.4 m-80 -117.94 68.33 6.52 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.607 0.718 . . . . 63.329999999999998 110.85 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -32.16 19.0 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.687 2.258 . . . . 73.349999999999994 112.309 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -65.99 -43.34 88.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.274 -0.421 . . . . 72.239999999999995 110.878 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.35 -54.57 25.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 54.399999999999999 111.086 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.904 ' HB1' HG11 ' A' ' 80' ' ' VAL . . . -55.88 -60.19 3.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 62.130000000000003 111.136 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -51.63 -34.56 38.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 74.400000000000006 110.897 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -55.44 -36.16 66.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 70.140000000000001 110.851 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -99.35 20.84 12.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 74.540000000000006 110.87 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 48.6 mm-40 48.78 80.51 0.06 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 71.049999999999997 110.931 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.904 HG11 ' HB1' ' A' ' 75' ' ' ALA . 14.7 p -105.44 144.02 15.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 63.32 111.118 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 66.1 t -108.82 -72.25 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 61.020000000000003 111.137 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.4 t -79.71 157.86 27.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 71.400000000000006 110.853 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.534 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 4.6 mt -59.91 -58.0 22.64 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.635 0.731 . . . . 70.329999999999998 111.099 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.743 ' HB2' ' HB2' ' A' ' 101' ' ' ALA . 53.4 Cg_endo -69.74 71.75 1.49 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.648 2.232 . . . . 64.549999999999997 112.374 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.703 HG23 ' CG2' ' A' ' 99' ' ' VAL . 23.5 m -110.44 126.62 54.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 52.520000000000003 111.125 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.0 mtm -122.56 158.18 30.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 74.209999999999994 110.838 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.523 ' O ' HG12 ' A' ' 33' ' ' VAL . 34.0 mt -145.27 121.23 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 74.439999999999998 111.16 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.437 HD11 HD11 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -81.95 110.25 17.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 43.299999999999997 110.898 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -98.46 170.2 9.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 73.439999999999998 110.884 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -166.04 107.58 0.73 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 74.209999999999994 110.875 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.666 ' O ' HD23 ' A' ' 25' ' ' LEU . . . 68.37 35.76 82.84 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.738 -0.744 . . . . 71.099999999999994 112.511 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.646 ' H ' HG12 ' A' ' 24' ' ' VAL . . . 72.55 41.46 51.2 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.758 -0.734 . . . . 65.239999999999995 112.491 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.46 HG23 ' HD2' ' A' ' 94' ' ' PRO . 86.4 m -161.04 133.85 4.54 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.549 0.69 . . . . 74.230000000000004 111.182 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.46 ' HD2' HG23 ' A' ' 93' ' ' THR . 53.4 Cg_endo -69.74 103.05 1.1 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.722 2.281 . . . . 74.430000000000007 112.313 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.5 m -91.07 -32.58 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 72.409999999999997 111.147 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.417 ' HD2' ' HB3' ' A' ' 114' ' ' ALA . 1.6 mmtm -138.38 170.13 16.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 63.32 110.949 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.19 118.19 4.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 74.150000000000006 110.878 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.417 ' N ' HD12 ' A' ' 98' ' ' ILE . 4.8 mp -125.5 137.63 57.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 73.299999999999997 111.119 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.703 ' CG2' HG23 ' A' ' 85' ' ' THR . 66.8 t -147.81 136.15 15.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.472 . . . . 63.310000000000002 111.124 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 151.08 -27.58 1.0 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.734 -0.746 . . . . 72.340000000000003 112.475 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.743 ' HB2' ' HB2' ' A' ' 84' ' ' PRO . . . 63.46 72.68 0.47 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.849 0.357 . . . . 75.140000000000001 111.117 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.423 ' HG2' HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -118.88 174.82 6.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 71.140000000000001 110.857 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.66 173.63 4.45 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.729 -0.748 . . . . 54.43 112.483 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.52 -44.13 75.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.791 0.329 . . . . 70.040000000000006 110.898 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.55 -30.2 65.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 63.32 111.107 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.34 -59.55 2.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.268 -0.424 . . . . 61.219999999999999 111.116 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.468 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.3 OUTLIER -48.71 -44.16 37.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 64.140000000000001 110.891 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.456 HD23 ' C ' ' A' ' 108' ' ' LEU . 7.8 tt -50.27 -43.63 53.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 72.540000000000006 110.91 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -72.46 -37.55 68.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 61.299999999999997 110.91 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -49.85 -25.87 3.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 75.209999999999994 110.873 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.8 mt -86.18 -69.61 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 75.430000000000007 111.102 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.474 ' HA ' HD23 ' A' ' 115' ' ' LEU . 0.4 OUTLIER -52.5 -51.18 60.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 71.129999999999995 110.892 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -55.63 -33.87 64.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.157 -0.474 . . . . 61.049999999999997 110.815 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.417 ' HB3' ' HD2' ' A' ' 96' ' ' LYS . . . -71.9 -34.71 69.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 73.150000000000006 111.105 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' A' ' 112' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 63.299999999999997 110.925 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.5 p . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.791 0.329 . . . . 74.109999999999999 111.141 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 96.1 t -150.08 144.18 17.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.428 . . . . 65.019999999999996 111.118 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 t -84.1 127.53 33.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.459 . . . . 64.430000000000007 111.097 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.417 ' CG1' HG23 ' A' ' 19' ' ' THR . 47.6 t -94.88 126.0 47.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 73.030000000000001 111.109 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.659 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.6 OUTLIER -59.5 166.44 2.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 64.019999999999996 111.13 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.427 ' H ' HG22 ' A' ' 16' ' ' THR . 1.4 p30 -68.52 -48.33 64.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 71.420000000000002 110.844 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.1 m -68.48 -52.98 26.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 73.329999999999998 110.879 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.659 HG22 ' HB ' ' A' ' 16' ' ' THR . 6.8 t -59.66 -19.0 46.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.092 -0.504 . . . . 73.209999999999994 111.162 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.73 ' CE2' HG21 ' A' ' 24' ' ' VAL . 25.6 t80 -51.31 -30.8 19.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 75.150000000000006 110.878 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.462 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -72.69 -32.94 66.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 75.5 110.871 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.0 m -91.33 -17.1 26.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 74.109999999999999 111.098 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.405 ' HB3' HG11 ' A' ' 15' ' ' VAL . 7.6 t70 -93.63 -71.38 0.66 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 71.219999999999999 110.871 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.743 HG13 HG21 ' A' ' 31' ' ' VAL . 20.0 t -70.08 -70.78 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 35.119999999999997 111.136 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.637 HD23 ' HA3' ' A' ' 92' ' ' GLY . 10.6 mt -40.56 -59.8 1.27 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 73.109999999999999 110.933 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -50.86 -64.85 0.68 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 51.219999999999999 110.85 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.0 t -52.12 163.27 0.39 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 73.099999999999994 110.877 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -106.02 -40.85 5.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 70.409999999999997 110.838 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -51.79 159.69 1.28 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.581 0.705 . . . . 71.510000000000005 111.155 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 147.66 63.4 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.683 2.255 . . . . 62.100000000000001 112.372 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.743 HG21 HG13 ' A' ' 24' ' ' VAL . 97.0 t -123.14 115.5 45.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 51.530000000000001 111.149 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.699 HD22 ' HG ' ' A' ' 88' ' ' LEU . 7.5 mt -103.94 106.29 16.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 72.140000000000001 110.911 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 m -108.48 134.71 49.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 62.520000000000003 111.128 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.526 ' OD2' HD11 ' A' ' 50' ' ' LEU . 0.8 OUTLIER -100.22 99.12 9.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 63.329999999999998 110.85 179.915 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.711 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 5.5 m-85 -82.86 89.56 6.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 72.319999999999993 110.881 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -152.52 -169.19 3.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 74.310000000000002 110.915 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.44 -154.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 61.130000000000003 111.097 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.477 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 35.2 p-10 -77.44 8.94 3.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.434 . . . . 62.140000000000001 110.862 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.477 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 1.1 p-90 41.55 63.53 1.25 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 72.299999999999997 110.893 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 41.2 t -125.04 -45.89 1.84 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 63.200000000000003 110.891 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.59 -68.24 1.49 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.751 -0.738 . . . . 61.530000000000001 112.443 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -26.48 27.65 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.663 2.242 . . . . 74.420000000000002 112.317 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 34.8 t -50.49 -30.14 12.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 63.039999999999999 110.905 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.29 -30.3 17.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.148 -0.478 . . . . 73.510000000000005 110.861 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 16.4 mtt -88.75 -36.72 15.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 53.43 110.893 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.434 ' O ' HG12 ' A' ' 46' ' ' VAL . 3.3 t -92.74 21.3 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 64.329999999999998 111.153 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.779 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -68.95 -59.83 4.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.562 0.696 . . . . 71.319999999999993 111.113 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.779 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.5 Cg_endo -69.75 -45.56 1.55 Allowed 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.705 2.27 . . . . 73.439999999999998 112.353 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.82 HG13 ' HA ' ' A' ' 104' ' ' LYS . 26.3 t -55.37 -50.63 63.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 71.510000000000005 111.113 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.526 HD11 ' OD2' ' A' ' 34' ' ' ASP . 50.5 tp -52.94 -32.03 43.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.195 -0.457 . . . . 62.43 110.921 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.475 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 28.0 mm-40 -83.89 -35.27 24.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 61.409999999999997 110.893 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -51.91 -61.41 2.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 72.040000000000006 110.939 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.665 HD12 ' O ' ' A' ' 49' ' ' VAL . 3.0 mp -50.74 -32.83 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.478 . . . . 62.409999999999997 111.15 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.655 ' HA ' HD11 ' A' ' 61' ' ' LEU . . . . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.479 . . . . 72.540000000000006 111.048 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.655 HD11 ' HA ' ' A' ' 54' ' ' ALA . 2.3 pt? . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.853 0.359 . . . . 74.329999999999998 110.916 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.5 mttp -109.64 120.21 41.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 73.040000000000006 110.929 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.8 t -123.71 112.19 32.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 61.240000000000002 111.105 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -131.04 156.07 45.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 64.040000000000006 111.13 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.7 122.51 16.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 62.299999999999997 110.877 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.534 HD21 ' HB2' ' A' ' 71' ' ' ASN . 11.1 tp -103.28 155.46 18.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.246 -0.434 . . . . 72.120000000000005 110.897 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.414 ' OD1' ' HB3' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -112.54 103.14 11.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 72.129999999999995 110.874 179.824 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.702 HG12 ' HB2' ' A' ' 75' ' ' ALA . 30.7 m -51.11 -32.14 11.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 64.549999999999997 111.149 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.77 -35.58 23.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 75.329999999999998 110.862 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.414 ' HB3' ' OD1' ' A' ' 67' ' ' ASP . . . -105.17 -33.31 8.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.448 . . . . 65.310000000000002 111.097 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.534 ' HB2' HD21 ' A' ' 66' ' ' LEU . 0.4 OUTLIER -120.91 71.75 21.26 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.6 0.714 . . . . 64.109999999999999 110.869 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -32.04 19.39 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.664 2.243 . . . . 73.409999999999997 112.341 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -51.71 -34.52 39.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 73.120000000000005 110.893 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.711 ' HB1' ' CE2' ' A' ' 35' ' ' PHE . . . -68.77 -46.47 68.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.479 . . . . 65.129999999999995 111.094 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.838 ' HB1' HG11 ' A' ' 80' ' ' VAL . . . -55.31 -65.93 0.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.437 . . . . 74.439999999999998 111.069 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -51.04 -32.72 22.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 71.319999999999993 110.886 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.62 -42.14 61.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 75.450000000000003 110.896 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -98.53 20.75 12.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 54.030000000000001 110.898 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 62.9 mm-40 47.41 79.55 0.06 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.474 . . . . 72.400000000000006 110.88 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.838 HG11 ' HB1' ' A' ' 75' ' ' ALA . 14.2 p -106.48 140.96 22.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 74.239999999999995 111.135 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.49 -35.49 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 75.510000000000005 111.135 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.7 t -105.85 151.88 23.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 65.310000000000002 110.885 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.531 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 5.3 mt -55.62 -58.04 17.86 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.64 0.733 . . . . 73.349999999999994 111.119 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.5 Cg_endo -69.76 99.17 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.667 2.245 . . . . 73.349999999999994 112.314 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . 1.001 HG23 HG12 ' A' ' 99' ' ' VAL . 43.3 m -142.39 137.05 30.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 62.219999999999999 111.149 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 32.7 ttp -137.33 131.78 32.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 73.420000000000002 110.907 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 10.9 mm -108.2 110.93 33.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 72.340000000000003 111.1 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.699 ' HG ' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -79.59 100.27 7.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.178 -0.464 . . . . 65.420000000000002 110.896 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -89.58 170.32 10.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 75.230000000000004 110.904 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -166.33 89.59 0.4 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 64.230000000000004 110.902 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.86 39.41 8.7 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.758 -0.734 . . . . 62.450000000000003 112.499 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.637 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 68.72 41.63 82.69 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.74 -0.743 . . . . 71.109999999999999 112.484 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.7 m -161.79 131.31 3.25 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.558 0.694 . . . . 74.120000000000005 111.138 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 86.59 0.57 Allowed 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.675 2.25 . . . . 72.140000000000001 112.39 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.9 m -73.37 -32.24 36.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 60.030000000000001 111.116 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.49 ' HD2' ' HB3' ' A' ' 114' ' ' ALA . 10.9 mmtm -143.38 170.17 16.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 71.019999999999996 110.896 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -158.36 103.56 1.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 73.409999999999997 110.825 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.429 ' N ' HD12 ' A' ' 98' ' ' ILE . 4.6 mp -113.75 132.71 61.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 61.530000000000001 111.113 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 1.001 HG12 HG23 ' A' ' 85' ' ' THR . 3.0 m -128.06 141.6 46.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 74.140000000000001 111.141 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 128.06 142.35 5.44 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.741 -0.743 . . . . 73.519999999999996 112.532 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -96.25 89.2 5.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.873 0.368 . . . . 50.450000000000003 111.108 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.51 ' HB2' ' HB3' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -123.03 -175.39 3.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 62.43 110.959 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.23 -174.79 28.44 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.728 -0.748 . . . . 61.210000000000001 112.481 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.82 ' HA ' HG13 ' A' ' 49' ' ' VAL . 0.4 OUTLIER -70.96 -46.47 62.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.761 0.315 . . . . 72.019999999999996 110.876 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.24 -22.24 65.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 73.239999999999995 111.08 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.51 ' HB3' ' HB2' ' A' ' 102' ' ' LYS . . . -91.28 -60.51 1.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 40.25 111.053 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.478 HD23 ' HG2' ' A' ' 102' ' ' LYS . 0.2 OUTLIER -53.7 -31.28 47.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.248 -0.433 . . . . 74.319999999999993 110.883 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.594 HD23 ' N ' ' A' ' 109' ' ' ARG . 5.7 tt -73.32 -59.64 2.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 73.209999999999994 110.9 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.594 ' N ' HD23 ' A' ' 108' ' ' LEU . 15.6 ptm180 -52.85 -34.04 52.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 65.519999999999996 110.845 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.401 ' HG3' ' HE2' ' A' ' 102' ' ' LYS . 49.9 mm-40 -56.8 -25.0 54.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 63.420000000000002 110.847 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.2 mt -84.58 -65.81 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 62.509999999999998 111.129 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -53.12 -48.24 68.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.433 . . . . 70.329999999999998 110.871 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -54.56 -34.46 61.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.476 . . . . 72.409999999999997 110.86 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.49 ' HB3' ' HD2' ' A' ' 96' ' ' LYS . . . -73.07 -34.74 66.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 65.420000000000002 111.096 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.8 mt . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 75.299999999999997 110.865 -179.932 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.506 HG22 ' HB ' ' A' ' 63' ' ' VAL . 59.5 p . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.841 0.353 . . . . 75.510000000000005 111.117 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.4 m -152.13 163.57 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.251 -0.431 . . . . 74.209999999999994 111.124 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.475 ' OG1' HD13 ' A' ' 66' ' ' LEU . 9.8 t -75.66 127.62 33.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.16 -0.473 . . . . 74.519999999999996 111.172 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.479 HG21 ' OD1' ' A' ' 23' ' ' ASP . 99.8 t -93.18 136.63 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 74.239999999999995 111.146 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.565 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -60.03 176.05 0.35 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 64.129999999999995 111.127 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.42 ' H ' HG22 ' A' ' 16' ' ' THR . 3.8 p-10 -81.06 -49.14 11.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 71.430000000000007 110.835 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.3 t -68.07 -54.27 19.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 44.5 110.872 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.565 HG22 ' HB ' ' A' ' 16' ' ' THR . 5.7 t -58.24 -19.37 33.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.138 -0.483 . . . . 75.340000000000003 111.168 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.724 ' CE2' HG21 ' A' ' 24' ' ' VAL . 24.9 t80 -50.82 -31.19 16.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 74.409999999999997 110.889 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.413 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.7 OUTLIER -71.54 -34.27 69.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.474 . . . . 73.510000000000005 110.898 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.2 m -91.04 -15.55 29.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 72.420000000000002 111.151 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.479 ' OD1' HG21 ' A' ' 15' ' ' VAL . 29.5 t70 -93.56 -71.1 0.67 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 74.400000000000006 110.855 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.841 HG13 HG21 ' A' ' 31' ' ' VAL . 17.9 t -71.04 -70.43 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 53.140000000000001 111.116 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.58 HD23 ' HA3' ' A' ' 92' ' ' GLY . 7.3 mt -40.55 -59.39 1.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 73.209999999999994 110.952 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -51.14 -62.41 1.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.476 . . . . 74.209999999999994 110.843 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.2 p -52.72 152.63 3.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 71.030000000000001 110.883 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -101.6 -37.79 8.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.112 -0.495 . . . . 64.25 110.829 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.94 159.69 1.76 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.589 0.709 . . . . 62.439999999999998 111.121 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 123.98 10.62 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.692 2.261 . . . . 62.109999999999999 112.335 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.841 HG21 HG13 ' A' ' 24' ' ' VAL . 97.8 t -97.39 123.87 50.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 65.230000000000004 111.112 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.468 HD21 HD13 ' A' ' 88' ' ' LEU . 3.3 mm? -103.5 100.0 9.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 72.129999999999995 110.899 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.1 p -95.18 135.09 30.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 61.43 111.137 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.13 99.72 7.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 75.230000000000004 110.876 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -91.41 89.84 7.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.458 . . . . 63.140000000000001 110.887 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.52 ' HH2' HD11 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -147.8 -169.65 3.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.165 -0.471 . . . . 74.430000000000007 110.919 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.52 ' HA ' HG22 ' A' ' 68' ' ' VAL . . . -61.72 -153.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 53.299999999999997 111.085 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.486 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 22.8 t0 -77.16 9.44 3.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 70.329999999999998 110.848 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.486 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 0.9 OUTLIER 42.01 67.02 0.62 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.166 -0.47 . . . . 71.540000000000006 110.911 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 46.8 t -127.74 -44.7 1.49 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.429 . . . . 71.209999999999994 110.935 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.92 -68.03 1.5 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.755 -0.736 . . . . 42.329999999999998 112.519 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -30.84 21.78 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.655 2.237 . . . . 72.329999999999998 112.312 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 42.8 t -56.08 -24.13 38.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.246 -0.434 . . . . 35.310000000000002 110.869 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 50.4 mttt -50.79 -39.5 52.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 75.230000000000004 110.906 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.457 ' HG3' HG23 ' A' ' 46' ' ' VAL . 12.2 ptm -90.12 -29.3 18.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 75.209999999999994 110.886 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.474 ' HA ' HG22 ' A' ' 49' ' ' VAL . 3.4 t -92.55 21.79 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 71.340000000000003 111.11 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.783 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -80.01 -61.08 0.46 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.578 0.704 . . . . 75.530000000000001 111.116 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.783 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.6 Cg_endo -69.76 -46.7 1.13 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.642 2.228 . . . . 52.140000000000001 112.321 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.589 ' O ' HD12 ' A' ' 53' ' ' ILE . 4.3 m -50.5 -30.14 7.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 41.420000000000002 111.109 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.52 HD11 ' HH2' ' A' ' 36' ' ' TRP . 10.8 mt -69.23 -39.08 78.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 73.349999999999994 110.909 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.53 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 4.0 mm-40 -72.77 -32.45 65.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 74.319999999999993 110.858 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -49.74 -58.62 4.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 72.530000000000001 110.882 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.589 HD12 ' O ' ' A' ' 49' ' ' VAL . 3.0 mp -50.38 -32.12 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 74.030000000000001 111.125 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 51' ' ' GLU . . . . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 54.420000000000002 111.103 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.647 ' C ' HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.913 0.387 . . . . 73.040000000000006 110.901 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.551 ' N ' HD22 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -123.69 148.68 46.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 63.420000000000002 110.933 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.506 ' HB ' HG22 ' A' ' 12' ' ' THR . 21.5 t -125.49 102.06 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 64.209999999999994 111.17 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -99.98 138.42 37.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 72.340000000000003 111.084 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.1 pttp -135.64 111.2 9.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 71.129999999999995 110.914 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.475 HD13 ' OG1' ' A' ' 14' ' ' THR . 27.9 tp -107.75 160.32 15.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 70.140000000000001 110.88 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.613 ' OD2' ' HB3' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -104.01 119.85 39.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 75.310000000000002 110.891 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.52 HG22 ' HA ' ' A' ' 37' ' ' ALA . 27.0 m -63.1 -33.49 61.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 63.310000000000002 111.129 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -50.59 -36.13 33.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 62.420000000000002 110.852 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.613 ' HB3' ' OD2' ' A' ' 67' ' ' ASP . . . -98.38 -35.39 10.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 72.439999999999998 111.086 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -120.39 67.6 13.42 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.579 0.704 . . . . 74.409999999999997 110.902 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -33.58 16.56 Favored 'Trans proline' 0 C--N 1.34 0.127 0 C-N-CA 122.687 2.258 . . . . 65.120000000000005 112.377 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -52.21 -52.06 54.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 72.299999999999997 110.877 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.44 -46.13 66.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 75.140000000000001 111.081 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.68 ' HB1' HG11 ' A' ' 80' ' ' VAL . . . -51.47 -70.48 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 60.140000000000001 111.115 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 -51.34 -32.11 24.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 72.340000000000003 110.863 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -51.69 -44.4 63.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 73.219999999999999 110.889 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -95.66 18.99 11.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 62.310000000000002 110.896 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 48.25 72.85 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 65.140000000000001 110.898 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.68 HG11 ' HB1' ' A' ' 75' ' ' ALA . 14.6 p -99.3 131.77 45.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 62.119999999999997 111.154 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.1 t -88.89 -74.03 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 73.200000000000003 111.112 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.86 158.75 29.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 60.32 110.828 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.52 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 1.3 mp -65.75 -58.37 11.62 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.635 0.731 . . . . 73.129999999999995 111.159 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.8 Cg_endo -69.77 71.33 1.53 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.709 2.273 . . . . 55.340000000000003 112.355 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 89.1 m -113.73 139.16 49.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 72.129999999999995 111.159 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 37.4 ttp -135.25 112.74 10.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 73.299999999999997 110.903 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.5 mt -90.04 128.08 42.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.429 . . . . 71.230000000000004 111.122 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.468 HD13 HD21 ' A' ' 32' ' ' LEU . 10.0 tp -92.27 105.78 17.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 63.219999999999999 110.97 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -91.86 170.98 9.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 73.329999999999998 110.834 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -165.67 91.9 0.51 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 72.340000000000003 110.915 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.34 36.14 8.32 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.749 -0.739 . . . . 62.210000000000001 112.53 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.58 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 69.48 38.59 79.73 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.752 -0.737 . . . . 63.140000000000001 112.452 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.46 HG23 ' HD2' ' A' ' 94' ' ' PRO . 86.4 m -161.12 133.91 4.53 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.592 0.71 . . . . 73.140000000000001 111.152 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.46 ' HD2' HG23 ' A' ' 93' ' ' THR . 53.3 Cg_endo -69.79 107.26 1.82 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.723 2.282 . . . . 72.150000000000006 112.322 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 16.5 m -94.13 -32.69 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 73.420000000000002 111.153 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.509 ' HE3' ' HB1' ' A' ' 114' ' ' ALA . 23.5 mmtm -152.61 170.38 20.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 73.439999999999998 110.92 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.417 ' C ' HD12 ' A' ' 98' ' ' ILE . 0.2 OUTLIER -154.29 131.72 11.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 71.540000000000006 110.843 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.434 ' N ' HD12 ' A' ' 98' ' ' ILE . 4.1 mp -126.01 141.85 44.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 75.219999999999999 111.131 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.6 p -150.23 143.31 17.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 65.099999999999994 111.132 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.52 -27.32 1.35 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.765 -0.731 . . . . 63.32 112.518 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 61.82 72.5 0.5 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.817 0.341 . . . . 60.32 111.104 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.44 ' HB2' ' HB3' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -119.38 -179.2 3.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 75.230000000000004 110.873 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.72 178.84 2.3 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.724 -0.751 . . . . 52.030000000000001 112.515 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.64 -36.12 73.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.771 0.32 . . . . 63.020000000000003 110.887 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.61 -32.65 74.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 62.210000000000001 111.112 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.44 ' HB3' ' HB2' ' A' ' 102' ' ' LYS . . . -86.57 -56.38 3.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 64.109999999999999 111.113 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.579 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.4 OUTLIER -52.24 -34.16 44.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 74.510000000000005 110.914 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.601 HD23 ' N ' ' A' ' 109' ' ' ARG . 5.2 tt -70.05 -59.26 3.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.231 -0.441 . . . . 73.439999999999998 110.911 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.601 ' N ' HD23 ' A' ' 108' ' ' LEU . 3.0 ptm180 -56.14 -34.5 66.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 73.409999999999997 110.888 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -52.8 -25.63 11.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 72.109999999999999 110.88 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.6 mt -84.72 -68.43 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.483 . . . . 61.409999999999997 111.143 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -51.93 -49.75 62.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 75.310000000000002 110.885 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -53.82 -35.01 60.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 61.549999999999997 110.851 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.509 ' HB1' ' HE3' ' A' ' 96' ' ' LYS . . . -72.98 -35.83 66.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 74.340000000000003 111.071 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.1 mt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 63.420000000000002 110.966 -179.988 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.8 p . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.862 0.363 . . . . 73.519999999999996 111.144 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 91.7 t -149.96 144.49 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 64.299999999999997 111.116 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 t -82.44 127.16 33.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 72.010000000000005 111.129 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.2 t -92.66 131.64 39.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 63.450000000000003 111.103 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.484 ' CB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.7 179.23 0.13 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.112 -0.495 . . . . 45.450000000000003 111.124 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.441 ' H ' HG22 ' A' ' 16' ' ' THR . 1.1 m-20 -81.05 -49.8 10.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 75.120000000000005 110.934 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.0 m -69.3 -52.99 22.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 63.149999999999999 110.835 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.484 HG22 ' CB ' ' A' ' 16' ' ' THR . 5.3 t -58.29 -19.5 35.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 75.099999999999994 111.147 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.724 ' CE2' HG21 ' A' ' 24' ' ' VAL . 27.3 t80 -51.22 -31.85 21.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 74.019999999999996 110.869 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.432 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -72.04 -32.82 67.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 54.399999999999999 110.876 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.4 m -90.94 -16.58 27.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 75.150000000000006 111.144 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -93.96 -70.76 0.69 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 64.030000000000001 110.879 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.724 HG21 ' CE2' ' A' ' 20' ' ' PHE . 18.8 t -70.2 -70.48 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 65.209999999999994 111.092 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.45 HD23 ' O ' ' A' ' 91' ' ' GLY . 8.3 mt -41.09 -60.35 1.24 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 62.119999999999997 110.932 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -49.82 -63.05 1.23 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 73.409999999999997 110.864 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 59.6 m -48.85 -34.68 13.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 72.530000000000001 110.818 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.0 t0 59.51 30.88 20.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 54.299999999999997 110.897 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.24 160.62 36.75 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.552 0.692 . . . . 73.519999999999996 111.188 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 111.8 2.9 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.666 2.244 . . . . 44.149999999999999 112.349 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.404 HG22 ' HB3' ' A' ' 62' ' ' LYS . 89.7 t -102.88 117.42 48.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 62.229999999999997 111.087 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.1 mt -79.89 102.33 9.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 74.310000000000002 110.888 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.509 HG11 ' CE1' ' A' ' 35' ' ' PHE . 43.1 t -89.71 137.37 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 75.150000000000006 111.11 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -122.46 99.23 6.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.485 . . . . 74.129999999999995 110.892 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.509 ' CE1' HG11 ' A' ' 33' ' ' VAL . 15.1 m-85 -96.72 89.82 5.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 71.340000000000003 110.885 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -151.18 -169.13 3.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.092 -0.504 . . . . 74.219999999999999 110.925 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.66 -154.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 53.009999999999998 111.1 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.477 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 23.9 t0 -77.33 8.74 3.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 70.209999999999994 110.909 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.477 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 1.3 p-90 41.5 64.87 0.94 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 44.340000000000003 110.949 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 4.0 p -124.87 -44.5 1.93 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.273 -0.421 . . . . 71.540000000000006 110.868 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.55 -69.33 1.4 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.755 -0.736 . . . . 72.510000000000005 112.473 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -26.33 27.67 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.697 2.265 . . . . 75.209999999999994 112.317 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 26.1 t -49.9 -31.09 11.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 53.340000000000003 110.889 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -51.94 -29.86 22.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 73.049999999999997 110.842 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 51.6 mmm -89.99 -38.2 13.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 62.450000000000003 110.863 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 1.014 HG12 HD23 ' A' ' 50' ' ' LEU . 3.3 t -92.44 22.72 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 74.349999999999994 111.129 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.772 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -79.12 -60.92 0.52 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.584 0.707 . . . . 54.310000000000002 111.064 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.772 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.7 Cg_endo -69.8 -48.45 0.71 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.701 2.268 . . . . 55.439999999999998 112.312 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.676 ' O ' HD12 ' A' ' 53' ' ' ILE . 4.7 m -50.45 -29.91 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.433 . . . . 74.219999999999999 111.129 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.014 HD23 HG12 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -70.74 -39.59 73.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 72.349999999999994 110.951 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -70.99 -34.38 71.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 54.520000000000003 110.847 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -51.55 -68.76 0.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 60.5 110.873 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.676 HD12 ' O ' ' A' ' 49' ' ' VAL . 2.7 mp -50.43 -34.42 11.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 55.049999999999997 111.131 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.795 ' HA ' HD21 ' A' ' 61' ' ' LEU . . . . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.176 -0.466 . . . . 34.539999999999999 111.124 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.795 HD21 ' HA ' ' A' ' 54' ' ' ALA . 3.7 pp . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.903 0.382 . . . . 70.140000000000001 110.873 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.404 ' HB3' HG22 ' A' ' 31' ' ' VAL . 14.0 tttp -93.34 146.87 23.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 64.219999999999999 110.893 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -141.26 123.76 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 70.540000000000006 111.129 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -134.89 140.56 45.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 71.140000000000001 111.121 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.71 140.61 51.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 72.129999999999995 110.878 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.583 HD21 ' HB2' ' A' ' 71' ' ' ASN . 4.0 tt -123.21 150.73 43.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 64.409999999999997 110.914 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.658 ' OD2' ' HB3' ' A' ' 70' ' ' ALA . 0.5 OUTLIER -105.4 103.78 13.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 73.150000000000006 110.857 179.88 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.65 HG12 ' HB2' ' A' ' 75' ' ' ALA . 13.4 m -51.42 -33.33 14.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 73.209999999999994 111.104 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.85 -35.44 32.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 75.099999999999994 110.88 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.658 ' HB3' ' OD2' ' A' ' 67' ' ' ASP . . . -103.16 -34.26 8.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 64.430000000000007 111.088 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.583 ' HB2' HD21 ' A' ' 66' ' ' LEU . 1.0 OUTLIER -118.92 67.35 8.05 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.657 0.742 . . . . 75.010000000000005 110.907 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -34.19 15.04 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.707 2.272 . . . . 64.120000000000005 112.285 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -52.01 -46.36 64.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 73.409999999999997 110.891 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.24 -42.58 86.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 72.420000000000002 111.122 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.65 ' HB2' HG12 ' A' ' 68' ' ' VAL . . . -55.52 -68.59 0.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 62.140000000000001 111.06 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -51.2 -31.76 21.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 72.030000000000001 110.854 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -51.08 -36.73 41.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 74.519999999999996 110.866 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -108.77 23.85 13.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 74.219999999999999 110.924 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 70.8 mm-40 48.2 67.65 0.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 72.349999999999994 110.871 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 75' ' ' ALA . 99.4 t -87.5 113.34 24.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.478 . . . . 75.230000000000004 111.1 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.1 t -78.79 -66.88 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 74.519999999999996 111.12 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.45 162.58 17.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 74.329999999999998 110.845 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.53 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.4 mt -65.06 -58.12 13.59 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.636 0.731 . . . . 72.140000000000001 111.118 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.8 Cg_endo -69.8 70.28 1.61 Allowed 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.656 2.237 . . . . 61.310000000000002 112.316 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.499 ' OG1' HG13 ' A' ' 80' ' ' VAL . 99.2 m -108.13 100.02 9.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 53.229999999999997 111.125 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.5 ttt -99.75 118.31 35.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 64.510000000000005 110.856 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.462 HD12 ' CD1' ' A' ' 35' ' ' PHE . 51.4 mt -98.17 131.49 45.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 53.130000000000003 111.102 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.629 HD12 HG21 ' A' ' 111' ' ' ILE . 0.4 OUTLIER -96.37 103.98 15.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 61.109999999999999 110.964 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -90.02 167.72 12.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 71.120000000000005 110.86 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -170.37 119.58 0.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 73.239999999999995 110.877 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.45 ' O ' HD23 ' A' ' 25' ' ' LEU . . . 66.33 30.99 77.67 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.735 -0.745 . . . . 64.120000000000005 112.485 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.411 ' H ' HG12 ' A' ' 24' ' ' VAL . . . 73.37 53.57 7.49 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.795 -0.717 . . . . 52.5 112.458 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 178.92 139.35 0.27 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.554 0.692 . . . . 74.519999999999996 111.143 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.84 84.88 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.676 2.251 . . . . 64.450000000000003 112.322 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.9 m -64.14 -33.84 65.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 73.010000000000005 111.138 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -152.84 170.28 20.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 64.0 110.907 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.44 ' C ' HD12 ' A' ' 98' ' ' ILE . 27.4 ttt180 -151.68 130.86 12.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 70.310000000000002 110.926 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.44 HD12 ' C ' ' A' ' 97' ' ' ARG . 4.5 mp -130.08 135.75 60.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 72.510000000000005 111.16 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -125.29 140.6 47.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 73.209999999999994 111.125 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 127.98 131.05 3.4 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.751 -0.738 . . . . 72.420000000000002 112.478 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.09 70.92 10.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.835 0.35 . . . . 71.239999999999995 111.082 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.439 ' HG2' HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -107.47 171.9 7.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 75.140000000000001 110.909 179.945 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.04 173.62 6.15 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.729 -0.748 . . . . 51.119999999999997 112.496 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.88 -44.93 91.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.766 0.317 . . . . 72.030000000000001 110.855 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.93 -64.11 0.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 61.43 111.124 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.44 -57.9 9.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 73.430000000000007 111.144 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.466 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.2 OUTLIER -51.25 -42.49 61.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 72.310000000000002 110.955 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.478 ' O ' HD12 ' A' ' 108' ' ' LEU . 4.1 tp -63.6 -55.42 23.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 50.409999999999997 110.879 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.7 mtm180 -51.71 -42.0 61.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 73.319999999999993 110.888 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -51.86 -26.09 9.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 62.219999999999999 110.9 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.629 HG21 HD12 ' A' ' 88' ' ' LEU . 2.9 mt -85.14 -68.65 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 55.229999999999997 111.084 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.53 -49.17 62.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 74.409999999999997 110.862 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -56.95 -34.92 68.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 51.149999999999999 110.884 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.22 -37.51 66.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 73.0 111.085 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.0 mt . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.437 . . . . 74.310000000000002 110.932 -179.956 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.2 p . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.83 0.347 . . . . 63.020000000000003 111.152 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.2 m -153.45 163.67 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 74.430000000000007 111.143 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 t -66.56 126.98 30.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 62.420000000000002 111.135 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.43 HG23 ' CB ' ' A' ' 64' ' ' ALA . 60.6 t -94.76 127.6 46.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.449 . . . . 73.450000000000003 111.106 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.49 ' CB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.51 179.08 0.12 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 73.129999999999995 111.119 -179.927 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.461 ' H ' HG22 ' A' ' 16' ' ' THR . 1.3 p30 -79.98 -48.11 13.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 73.120000000000005 110.871 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.2 m -70.99 -51.56 24.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 73.519999999999996 110.867 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.49 HG22 ' CB ' ' A' ' 16' ' ' THR . 5.9 t -59.57 -19.32 47.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.148 -0.478 . . . . 63.329999999999998 111.144 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.729 ' CE2' HG21 ' A' ' 24' ' ' VAL . 25.1 t80 -51.26 -30.8 18.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 74.519999999999996 110.86 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.41 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -72.1 -33.63 68.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.473 . . . . 74.120000000000005 110.907 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.2 m -91.43 -16.04 27.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 65.109999999999999 111.143 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -93.46 -71.24 0.66 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 63.039999999999999 110.835 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.74 HG13 HG21 ' A' ' 31' ' ' VAL . 18.6 t -70.47 -70.47 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 75.430000000000007 111.146 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.41 ' HB2' ' HA ' ' A' ' 21' ' ' LYS . 7.4 mt -40.66 -60.11 1.22 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 75.299999999999997 110.949 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -50.46 -57.43 8.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 74.299999999999997 110.848 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.8 t -51.84 153.15 2.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 74.340000000000003 110.868 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -102.17 -49.4 3.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 55.539999999999999 110.911 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -51.87 159.7 1.31 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 121.624 0.726 . . . . 73.409999999999997 111.094 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 120.08 6.93 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.695 2.263 . . . . 64.540000000000006 112.321 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.74 HG21 HG13 ' A' ' 24' ' ' VAL . 97.6 t -83.35 142.74 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 75.549999999999997 111.105 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.468 HD23 HD11 ' A' ' 61' ' ' LEU . 3.8 mm? -111.9 112.64 24.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.467 . . . . 72.200000000000003 110.934 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.46 HG11 ' CE1' ' A' ' 35' ' ' PHE . 70.8 t -100.61 142.78 15.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 71.519999999999996 111.158 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -133.84 99.79 4.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 71.310000000000002 110.826 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.46 ' CE1' HG11 ' A' ' 33' ' ' VAL . 21.0 m-85 -91.72 89.77 7.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 65.400000000000006 110.892 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -141.66 -168.22 2.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 74.140000000000001 110.955 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.68 -164.76 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 63.240000000000002 111.091 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.456 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 1.5 t70 -77.67 11.98 1.86 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 71.519999999999996 110.87 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.482 ' N ' ' CD1' ' A' ' 39' ' ' TRP . 1.2 m0 76.35 94.76 0.07 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.194 -0.457 . . . . 74.319999999999993 110.886 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -169.68 -65.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 60.030000000000001 110.904 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -70.73 -70.28 1.22 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.761 -0.733 . . . . 73.140000000000001 112.491 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.47 ' O ' HG23 ' A' ' 46' ' ' VAL . 53.2 Cg_endo -69.81 -41.37 4.27 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.73 2.287 . . . . 70.549999999999997 112.278 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.55 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 31.7 t -51.94 -32.57 33.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.445 . . . . 53.350000000000001 110.859 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 18.5 mtpt -62.4 -34.79 77.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 75.5 110.925 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 34.6 mtm -90.13 -36.13 15.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 75.329999999999998 110.893 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.489 ' HA ' HG22 ' A' ' 49' ' ' VAL . 2.2 t -94.35 23.11 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 62.219999999999999 111.1 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.781 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -76.63 -60.62 0.85 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.603 0.716 . . . . 70.150000000000006 111.122 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.781 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.9 Cg_endo -69.73 -48.7 0.67 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.696 2.264 . . . . 73.430000000000007 112.317 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.489 HG22 ' HA ' ' A' ' 46' ' ' VAL . 4.5 m -49.94 -30.2 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 72.409999999999997 111.143 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.458 ' O ' HD13 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -86.13 -45.52 11.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 71.239999999999995 110.886 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -60.96 -32.45 71.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 74.349999999999994 110.846 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -51.31 -63.58 1.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 74.040000000000006 110.892 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.402 HD12 ' O ' ' A' ' 49' ' ' VAL . 2.7 mp -50.75 -41.02 20.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 71.140000000000001 111.142 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 71.329999999999998 111.136 179.819 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.468 HD11 HD23 ' A' ' 32' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.871 0.367 . . . . 60.109999999999999 110.938 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.8 tttp -111.95 148.98 32.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 61.420000000000002 110.867 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.3 t -124.2 104.5 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 62.530000000000001 111.126 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.43 ' CB ' HG23 ' A' ' 15' ' ' VAL . . . -108.59 109.75 21.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 55.43 111.071 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.98 160.68 19.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 72.510000000000005 110.892 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 50.1 tp -148.29 147.56 29.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.439 . . . . 73.239999999999995 110.936 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -79.4 120.99 24.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 61.530000000000001 110.878 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.1 m -48.71 -36.57 7.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 74.329999999999998 111.11 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.36 -32.88 57.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 74.319999999999993 110.838 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.02 -35.03 29.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 70.040000000000006 111.107 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.686 ' HB2' ' HB3' ' A' ' 74' ' ' ALA . 4.5 p30 -118.15 67.14 6.39 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.627 0.727 . . . . 73.409999999999997 110.888 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -32.43 18.33 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.706 2.271 . . . . 62.399999999999999 112.36 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -83.94 -40.8 18.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 42.200000000000003 110.907 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.686 ' HB3' ' HB2' ' A' ' 71' ' ' ASN . . . -59.06 -46.63 87.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 62.039999999999999 111.091 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.497 ' O ' HG23 ' A' ' 80' ' ' VAL . . . -51.0 -63.24 1.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 74.150000000000006 111.141 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.7 ttp180 -51.25 -37.11 45.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 73.310000000000002 110.886 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -55.01 -36.17 65.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 70.120000000000005 110.857 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -98.35 21.77 10.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 75.120000000000005 110.874 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 50.23 80.22 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 63.340000000000003 110.926 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 75' ' ' ALA . 96.5 t -108.55 97.17 5.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.148 -0.478 . . . . 70.310000000000002 111.099 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 81' ' ' VAL . 3.4 t -99.57 34.21 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 72.340000000000003 111.102 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -176.04 140.28 0.41 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.467 . . . . 75.409999999999997 110.887 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.523 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 4.2 mt -57.84 -57.83 22.83 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.668 0.747 . . . . 74.200000000000003 111.09 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.6 Cg_endo -69.74 74.72 1.26 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.714 2.276 . . . . 70.349999999999994 112.359 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.846 HG23 HG12 ' A' ' 99' ' ' VAL . 53.6 m -109.26 143.35 38.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 60.450000000000003 111.142 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 10.9 ttp -141.3 128.79 21.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 75.150000000000006 110.9 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 17.2 mt -115.94 119.72 62.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 65.030000000000001 111.17 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.802 HD12 HG21 ' A' ' 111' ' ' ILE . 0.5 OUTLIER -86.55 111.51 20.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 71.010000000000005 110.915 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -99.42 170.36 8.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 72.140000000000001 110.885 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -163.6 92.53 0.71 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.486 . . . . 74.409999999999997 110.872 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.45 32.21 28.58 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.745 -0.741 . . . . 31.239999999999998 112.503 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.401 ' H ' HG12 ' A' ' 24' ' ' VAL . . . 78.12 38.93 24.88 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.757 -0.735 . . . . 73.230000000000004 112.498 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.1 m -160.32 132.39 4.24 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.589 0.709 . . . . 72.120000000000005 111.11 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 91.73 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.688 2.259 . . . . 62.539999999999999 112.361 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.9 m -70.95 -32.71 49.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 75.209999999999994 111.115 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.1 mmtm -155.25 170.07 22.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 75.109999999999999 110.918 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.614 ' C ' HD12 ' A' ' 98' ' ' ILE . 0.9 OUTLIER -148.01 128.01 13.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 72.219999999999999 110.896 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.614 HD12 ' C ' ' A' ' 97' ' ' ARG . 4.0 mp -136.06 123.75 35.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 63.119999999999997 111.091 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.846 HG12 HG23 ' A' ' 85' ' ' THR . 7.1 m -118.81 159.68 19.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 74.340000000000003 111.116 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 115.57 142.15 7.57 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.713 -0.756 . . . . 74.120000000000005 112.454 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.04 71.24 7.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.835 0.35 . . . . 34.100000000000001 111.12 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.523 ' HB2' ' HB3' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -107.1 164.98 11.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.19 -0.459 . . . . 55.340000000000003 110.909 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.78 -176.36 0.73 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.734 -0.746 . . . . 33.130000000000003 112.459 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.79 -43.77 65.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.737 0.303 . . . . 75.239999999999995 110.889 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.72 -26.14 66.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 33.329999999999998 111.099 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.523 ' HB3' ' HB2' ' A' ' 102' ' ' LYS . . . -90.55 -36.25 14.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 74.519999999999996 111.106 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.688 HD13 ' O ' ' A' ' 107' ' ' LEU . 2.5 tm? -77.22 -36.13 55.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 73.409999999999997 110.896 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.628 ' C ' HD12 ' A' ' 108' ' ' LEU . 1.2 pp -74.65 -39.05 62.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 75.319999999999993 110.906 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.465 ' N ' HD12 ' A' ' 108' ' ' LEU . 16.0 ptm180 -66.88 -35.94 81.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 53.32 110.859 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -57.77 -23.1 50.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 54.32 110.887 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.802 HG21 HD12 ' A' ' 88' ' ' LEU . 3.1 mt -86.48 -66.23 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 72.450000000000003 111.108 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.476 ' HA ' HD12 ' A' ' 115' ' ' LEU . 9.9 pt-20 -52.59 -48.82 66.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 74.230000000000004 110.85 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -59.75 -33.76 72.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 74.219999999999999 110.907 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.0 -35.62 59.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 75.409999999999997 111.122 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.476 HD12 ' HA ' ' A' ' 112' ' ' GLU . 10.0 mt . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 72.439999999999998 110.874 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.9 p . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.849 0.357 . . . . 72.409999999999997 111.121 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.1 m -153.76 173.19 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.475 . . . . 64.129999999999995 111.095 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.473 ' HA ' ' HB1' ' A' ' 64' ' ' ALA . 0.2 OUTLIER -73.74 152.35 40.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 74.329999999999998 111.122 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.494 HG22 HG23 ' A' ' 19' ' ' THR . 8.6 p -127.44 145.52 34.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 71.329999999999998 111.111 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.649 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.87 162.28 5.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 74.109999999999999 111.125 -179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.42 -50.28 13.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 65.0 110.881 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.1 m -59.69 -35.89 75.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.468 . . . . 53.140000000000001 110.821 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.649 HG22 ' HB ' ' A' ' 16' ' ' THR . 5.3 t -85.43 -17.55 36.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 74.510000000000005 111.178 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.71 ' CE2' HG21 ' A' ' 24' ' ' VAL . 24.7 t80 -49.37 -31.86 10.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 53.340000000000003 110.856 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.411 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -70.09 -36.15 74.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.48 . . . . 72.329999999999998 110.918 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.8 m -89.94 -15.09 32.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.436 . . . . 64.040000000000006 111.135 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -92.92 -70.97 0.67 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 73.019999999999996 110.888 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 1.046 HG13 HG21 ' A' ' 31' ' ' VAL . 16.4 t -72.35 -70.31 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 75.420000000000002 111.142 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.639 HD23 ' HA3' ' A' ' 92' ' ' GLY . 7.1 mt -39.9 -56.22 1.84 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 75.120000000000005 110.947 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -55.67 -52.52 63.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 75.540000000000006 110.854 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.5 t -51.89 159.88 0.78 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 61.340000000000003 110.836 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -106.89 -44.76 4.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.143 -0.48 . . . . 73.340000000000003 110.867 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -54.49 159.49 3.28 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.601 0.715 . . . . 74.340000000000003 111.122 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 131.02 20.34 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.695 2.264 . . . . 72.530000000000001 112.322 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 1.046 HG21 HG13 ' A' ' 24' ' ' VAL . 88.2 t -102.25 129.45 53.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 75.109999999999999 111.159 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.813 HD11 HD11 ' A' ' 61' ' ' LEU . 10.7 mt -104.93 106.04 16.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 70.019999999999996 110.917 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.442 HG21 ' CE1' ' A' ' 35' ' ' PHE . 3.8 p -105.12 131.0 55.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 75.430000000000007 111.164 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -116.41 99.61 7.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 74.140000000000001 110.818 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.442 ' CE1' HG21 ' A' ' 33' ' ' VAL . 23.0 m-85 -87.37 89.48 8.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 65.040000000000006 110.897 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.458 ' HZ3' HG11 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -143.61 -169.4 3.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.486 . . . . 74.209999999999994 110.91 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.84 -157.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 73.099999999999994 111.093 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.476 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 15.3 t0 -76.85 9.39 2.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 72.219999999999999 110.876 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.476 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 1.2 p-90 41.69 67.51 0.55 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 72.219999999999999 110.91 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 18.1 t -127.09 -47.7 1.48 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.272 -0.422 . . . . 73.310000000000002 110.839 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.56 -67.91 1.51 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.712 -0.756 . . . . 72.319999999999993 112.525 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -24.82 29.39 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.696 2.264 . . . . 70.319999999999993 112.351 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 36.3 t -49.9 -31.5 12.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 21.129999999999999 110.903 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 11.7 mttp -52.27 -35.14 49.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 72.219999999999999 110.866 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 8.9 mtt -90.44 -32.46 16.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 64.310000000000002 110.875 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.472 ' HA ' ' CG1' ' A' ' 49' ' ' VAL . 3.0 t -92.85 22.89 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 74.219999999999999 111.113 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.79 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -80.87 -60.67 0.43 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.559 0.695 . . . . 62.219999999999999 111.113 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.79 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.9 Cg_endo -69.78 -56.72 0.13 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.702 2.268 . . . . 73.230000000000004 112.326 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.81 HG23 ' HA ' ' A' ' 104' ' ' LYS . 3.0 p -48.76 -33.93 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 62.32 111.119 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.3 tp -69.46 -41.44 76.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 74.209999999999994 110.915 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.466 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 6.4 mm-40 -73.29 -33.24 65.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.461 . . . . 64.439999999999998 110.881 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -50.33 -66.49 0.38 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 74.329999999999998 110.874 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.595 HD12 ' O ' ' A' ' 49' ' ' VAL . 2.6 mt -50.07 -33.07 9.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 62.310000000000002 111.106 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.689 ' HB1' HD21 ' A' ' 61' ' ' LEU . . . . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 72.319999999999993 111.122 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.813 HD11 HD11 ' A' ' 32' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.9 0.381 . . . . 74.129999999999995 110.868 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -97.96 140.55 32.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 55.539999999999999 110.903 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.2 t -141.95 118.15 6.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.253 -0.431 . . . . 73.400000000000006 111.138 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.473 ' HB1' ' HA ' ' A' ' 14' ' ' THR . . . -115.48 147.09 41.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 60.450000000000003 111.09 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.2 pttp -138.97 131.38 28.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 75.310000000000002 110.892 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.429 HD21 ' CG ' ' A' ' 71' ' ' ASN . 32.1 tp -122.47 159.48 27.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 74.340000000000003 110.888 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -103.07 118.08 36.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 74.400000000000006 110.838 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.418 HG22 ' HB2' ' A' ' 75' ' ' ALA . 73.9 t -61.62 -35.7 68.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 73.409999999999997 111.141 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -51.41 -35.3 38.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 63.240000000000002 110.898 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.14 -35.06 11.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 64.219999999999999 111.055 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.429 ' CG ' HD21 ' A' ' 66' ' ' LEU . 2.7 m120 -117.79 72.5 8.29 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.619 0.723 . . . . 51.25 110.878 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -31.16 20.84 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.686 2.257 . . . . 72.109999999999999 112.343 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -61.34 -43.33 99.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.243 -0.435 . . . . 64.129999999999995 110.892 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.417 ' HB1' ' CE2' ' A' ' 35' ' ' PHE . . . -60.69 -48.08 83.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 61.030000000000001 111.079 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.548 ' O ' HG23 ' A' ' 80' ' ' VAL . . . -52.16 -66.21 0.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 74.400000000000006 111.089 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.2 ttp85 -51.14 -33.15 25.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 60.299999999999997 110.895 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -51.28 -36.22 41.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 74.010000000000005 110.915 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -108.7 24.97 12.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 74.219999999999999 110.874 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 59.9 mm-40 48.2 67.1 0.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 74.329999999999998 110.858 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 75' ' ' ALA . 98.9 t -91.2 106.2 17.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 72.519999999999996 111.113 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.5 t -80.12 -62.28 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 73.319999999999993 111.099 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 56.1 m -89.83 160.68 16.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.467 . . . . 71.409999999999997 110.858 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.53 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.8 mt -60.2 -58.18 21.27 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.624 0.726 . . . . 60.219999999999999 111.098 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.3 Cg_endo -69.79 77.43 1.08 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.683 2.255 . . . . 71.540000000000006 112.351 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.57 ' HA ' HG12 ' A' ' 99' ' ' VAL . 99.7 m -117.39 109.62 17.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.439 . . . . 43.200000000000003 111.116 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 31.0 ttp -113.77 145.95 40.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 72.219999999999999 110.891 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.6 mt -129.68 117.86 43.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 71.239999999999995 111.138 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.468 ' HG ' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -80.82 102.59 10.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 72.219999999999999 110.924 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -89.52 167.68 12.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 73.219999999999999 110.894 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -161.85 94.86 0.96 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 54.539999999999999 110.909 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.28 32.72 22.12 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.737 -0.744 . . . . 71.209999999999994 112.502 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.639 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 73.49 41.1 45.64 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.716 -0.754 . . . . 73.109999999999999 112.516 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.451 HG23 ' HD2' ' A' ' 94' ' ' PRO . 85.4 m -160.15 133.69 4.91 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.597 0.713 . . . . 73.430000000000007 111.143 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.451 ' HD2' HG23 ' A' ' 93' ' ' THR . 53.8 Cg_endo -69.76 93.78 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.692 2.261 . . . . 71.409999999999997 112.349 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.5 m -88.29 -32.37 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 71.030000000000001 111.133 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -132.12 166.22 22.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 71.450000000000003 110.911 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.408 ' C ' HD12 ' A' ' 98' ' ' ILE . 6.4 ttp180 -160.09 116.74 2.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 73.239999999999995 110.867 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.411 ' N ' HD12 ' A' ' 98' ' ' ILE . 5.0 mp -133.95 139.6 48.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 61.219999999999999 111.128 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.57 HG12 ' HA ' ' A' ' 85' ' ' THR . 4.8 m -132.26 154.82 40.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 72.140000000000001 111.107 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 115.34 137.92 6.4 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.719 -0.753 . . . . 73.129999999999995 112.503 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.43 77.11 6.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.883 0.373 . . . . 62.509999999999998 111.083 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.77 176.76 4.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 75.120000000000005 110.898 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -76.65 166.6 54.21 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.685 -0.769 . . . . 71.319999999999993 112.468 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.81 ' HA ' HG23 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -58.13 -41.01 82.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.755 0.312 . . . . 63.100000000000001 110.854 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.47 -32.19 66.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 64.340000000000003 111.1 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.53 -61.87 1.58 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 72.200000000000003 111.128 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.512 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.3 OUTLIER -45.93 -43.1 13.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 63.240000000000002 110.942 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.581 ' O ' HD12 ' A' ' 108' ' ' LEU . 4.3 tp -49.49 -47.87 48.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 73.310000000000002 110.937 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 50.7 mtm180 -65.7 -40.59 92.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 75.150000000000006 110.838 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -49.79 -25.15 2.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 71.430000000000007 110.896 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.414 ' CD1' HG21 ' A' ' 53' ' ' ILE . 4.2 mt -90.37 -70.09 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 65.230000000000004 111.15 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -51.86 -51.05 59.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 71.450000000000003 110.849 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -57.2 -34.22 68.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.47 . . . . 74.230000000000004 110.895 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.17 -34.02 65.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 43.020000000000003 111.081 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 115' ' ' LEU . 8.5 mt . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 71.200000000000003 110.939 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.6 p . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.788 0.328 . . . . 50.119999999999997 111.145 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.6 m -153.31 172.19 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 72.140000000000001 111.163 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.1 t -74.04 127.94 34.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 74.030000000000001 111.192 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.4 t -91.28 137.04 22.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 74.140000000000001 111.095 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.605 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.71 174.73 0.43 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.16 -0.473 . . . . 73.310000000000002 111.144 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.453 ' H ' HG22 ' A' ' 16' ' ' THR . 10.1 t0 -80.49 -48.97 12.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 61.219999999999999 110.888 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.6 m -68.07 -53.44 25.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 72.329999999999998 110.853 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.605 HG22 ' HB ' ' A' ' 16' ' ' THR . 5.6 t -59.06 -19.28 42.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 73.219999999999999 111.158 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.719 ' CE2' HG21 ' A' ' 24' ' ' VAL . 25.0 t80 -51.08 -31.12 17.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 62.210000000000001 110.879 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.402 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -71.82 -33.45 68.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 74.019999999999996 110.902 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.6 m -91.51 -15.97 27.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.199 -0.455 . . . . 60.420000000000002 111.153 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -93.48 -71.23 0.66 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 72.409999999999997 110.888 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 1.005 HG13 HG21 ' A' ' 31' ' ' VAL . 19.1 t -70.5 -70.47 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 71.099999999999994 111.142 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.623 HD23 ' HA3' ' A' ' 92' ' ' GLY . 7.6 mt -40.72 -59.94 1.27 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 75.409999999999997 110.87 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -50.57 -60.68 2.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 73.540000000000006 110.868 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.0 t -51.32 162.06 0.38 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.45 . . . . 74.349999999999994 110.869 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -112.33 -40.28 4.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 74.540000000000006 110.828 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.452 HG22 ' HD2' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -51.94 158.88 1.56 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.563 0.697 . . . . 73.239999999999995 111.172 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.452 ' HD2' HG22 ' A' ' 29' ' ' THR . 53.7 Cg_endo -69.74 116.08 4.39 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.726 2.284 . . . . 73.450000000000003 112.323 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 1.005 HG21 HG13 ' A' ' 24' ' ' VAL . 98.0 t -82.35 141.53 14.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 72.409999999999997 111.111 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.1 mt -112.04 104.89 13.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 74.0 110.912 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 87' ' ' ILE . 8.6 p -113.37 146.86 17.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 75.120000000000005 111.123 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -139.49 117.85 12.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 74.219999999999999 110.9 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.557 ' HE2' ' HB1' ' A' ' 74' ' ' ALA . 20.2 m-85 -95.17 97.05 9.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 73.420000000000002 110.926 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.621 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -146.13 -167.32 2.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 73.329999999999998 110.935 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.09 -167.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 63.130000000000003 111.118 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.447 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 5.7 m-20 -78.77 12.69 1.99 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 73.450000000000003 110.855 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.449 ' CD1' ' N ' ' A' ' 39' ' ' TRP . 0.8 OUTLIER 75.37 85.57 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 75.25 110.91 -179.963 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 2.0 p -164.44 -47.08 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 63.310000000000002 110.88 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.88 -70.72 1.34 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.794 -0.717 . . . . 73.319999999999993 112.463 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -31.22 21.05 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.688 2.259 . . . . 65.120000000000005 112.339 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.548 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 43.7 t -51.24 -29.16 13.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 54.210000000000001 110.852 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -63.66 -49.34 73.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 74.409999999999997 110.902 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.547 ' HG3' HG23 ' A' ' 46' ' ' VAL . 10.9 ptp -77.54 -34.52 53.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 75.219999999999999 110.909 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.547 HG23 ' HG3' ' A' ' 45' ' ' MET . 3.4 t -93.8 21.98 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 72.140000000000001 111.163 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.812 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -76.52 -61.28 0.79 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.606 0.717 . . . . 73.549999999999997 111.142 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.812 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.3 Cg_endo -69.81 -49.83 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.651 2.234 . . . . 64.239999999999995 112.348 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.684 ' O ' HD12 ' A' ' 53' ' ' ILE . 4.1 m -51.04 -30.35 9.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 71.549999999999997 111.144 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.2 tp -76.17 -41.51 49.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.121 -0.49 . . . . 73.510000000000005 110.911 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -71.12 -33.94 70.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 75.299999999999997 110.895 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -51.49 -69.53 0.11 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 63.409999999999997 110.864 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.684 HD12 ' O ' ' A' ' 49' ' ' VAL . 2.8 mp -50.99 -37.29 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 62.520000000000003 111.14 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 73.310000000000002 111.108 179.806 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.661 ' C ' HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.868 0.366 . . . . 75.150000000000006 110.903 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.546 ' N ' HD22 ' A' ' 61' ' ' LEU . 1.3 mptm? -122.28 141.97 50.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 72.519999999999996 110.855 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 23.8 t -120.58 99.81 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 24.23 111.143 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -108.88 142.69 39.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 64.310000000000002 111.108 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.5 mtpt -130.93 159.51 37.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 62.009999999999998 110.91 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.526 HD21 ' CB ' ' A' ' 71' ' ' ASN . 10.4 tp -140.56 144.83 36.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 63.140000000000001 110.924 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.03 119.34 33.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 75.25 110.843 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 36' ' ' TRP . 21.1 t -62.4 -34.58 65.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.486 . . . . 62.340000000000003 111.105 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.56 -35.54 41.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 71.540000000000006 110.867 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.36 -34.09 11.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 51.200000000000003 111.06 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.526 ' CB ' HD21 ' A' ' 66' ' ' LEU . 1.8 m-80 -118.3 68.46 7.35 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.602 0.715 . . . . 75.349999999999994 110.878 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -32.81 17.8 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.692 2.261 . . . . 64.109999999999999 112.328 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -67.99 -35.19 77.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 73.230000000000004 110.859 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.557 ' HB1' ' HE2' ' A' ' 35' ' ' PHE . . . -56.96 -44.13 82.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 55.039999999999999 111.104 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.52 ' O ' HG23 ' A' ' 80' ' ' VAL . . . -59.83 -64.38 0.97 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 70.129999999999995 111.097 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.6 ttp180 -50.51 -35.11 27.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 74.010000000000005 110.898 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.85 -35.79 64.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 71.140000000000001 110.835 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -107.6 28.7 7.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 72.239999999999995 110.896 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 50.96 84.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 75.439999999999998 110.942 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 75' ' ' ALA . 96.9 t -120.78 140.06 46.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.443 . . . . 65.129999999999995 111.131 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.6 m -127.59 -37.69 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 73.340000000000003 111.154 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.2 t -100.96 148.28 25.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 74.5 110.871 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.535 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.1 mt -59.64 -57.69 24.97 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.599 0.714 . . . . 71.010000000000005 111.128 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.8 Cg_endo -69.76 71.56 1.51 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.687 2.258 . . . . 75.430000000000007 112.345 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.982 HG23 HG22 ' A' ' 99' ' ' VAL . 54.8 m -106.39 135.37 47.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 73.430000000000007 111.137 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 5.0 ttt -134.66 146.31 49.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 65.439999999999998 110.898 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.423 ' O ' HG12 ' A' ' 33' ' ' VAL . 22.3 mt -141.86 118.03 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 75.420000000000002 111.156 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.39 101.42 9.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 71.409999999999997 110.948 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -89.91 170.92 9.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 62.299999999999997 110.865 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.74 119.11 0.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 70.439999999999998 110.901 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.37 34.41 88.14 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.707 -0.759 . . . . 61.43 112.501 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.623 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 71.56 42.34 55.5 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.714 -0.755 . . . . 65.25 112.538 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.448 HG23 ' HD2' ' A' ' 94' ' ' PRO . 84.9 m -161.05 133.94 4.57 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.613 0.721 . . . . 51.329999999999998 111.109 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.448 ' HD2' HG23 ' A' ' 93' ' ' THR . 54.0 Cg_endo -69.75 81.35 0.82 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.657 2.238 . . . . 74.219999999999999 112.345 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.3 m -68.2 -32.36 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 52.140000000000001 111.11 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.3 mmtm -142.75 160.19 40.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 75.239999999999995 110.879 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.59 ' C ' HD12 ' A' ' 98' ' ' ILE . 2.4 tmt_? -149.37 124.63 10.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 75.439999999999998 110.871 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.59 HD12 ' C ' ' A' ' 97' ' ' ARG . 4.6 mp -139.35 116.56 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 75.0 111.11 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.982 HG22 HG23 ' A' ' 85' ' ' THR . 61.0 t -111.76 134.24 54.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 73.109999999999999 111.132 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 133.99 140.26 4.29 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.735 -0.745 . . . . 52.149999999999999 112.46 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.32 85.58 4.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.83 0.348 . . . . 44.329999999999998 111.139 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.36 165.92 15.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 63.130000000000003 110.908 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.22 149.76 49.65 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.755 -0.736 . . . . 71.219999999999999 112.523 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.475 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -47.17 -36.98 9.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.822 0.344 . . . . 73.439999999999998 110.869 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.82 -47.03 74.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 75.25 111.114 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -83.18 -49.6 9.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 64.510000000000005 111.094 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.428 ' C ' HD13 ' A' ' 107' ' ' LEU . 2.0 tm? -47.87 -51.87 21.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.237 -0.438 . . . . 64.439999999999998 110.872 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.475 HD23 ' O ' ' A' ' 104' ' ' LYS . 1.7 pp -50.69 -35.89 33.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 73.099999999999994 110.893 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -68.65 -44.69 73.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 60.329999999999998 110.898 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -51.4 -25.61 6.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.49 . . . . 70.129999999999995 110.909 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.401 ' HA ' HD11 ' A' ' 98' ' ' ILE . 3.7 mt -84.72 -68.08 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 71.409999999999997 111.167 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.43 ' O ' HD23 ' A' ' 115' ' ' LEU . 10.1 pt-20 -52.32 -49.38 64.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 70.420000000000002 110.891 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -52.49 -33.82 46.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.481 . . . . 75.400000000000006 110.836 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.01 -34.68 73.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 74.109999999999999 111.081 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.43 HD23 ' O ' ' A' ' 112' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 75.099999999999994 110.919 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.3 p . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.856 0.36 . . . . 71.340000000000003 111.162 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.4 t -135.15 140.69 44.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 74.140000000000001 111.121 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 t -92.71 133.38 36.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 74.129999999999995 111.16 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.7 t -89.81 120.73 39.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 72.030000000000001 111.107 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.528 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.92 -179.52 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 62.229999999999997 111.144 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.42 ' H ' HG22 ' A' ' 16' ' ' THR . 4.4 m-20 -79.71 -45.59 18.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 63.409999999999997 110.833 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.7 m -68.98 -54.86 13.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 35.140000000000001 110.864 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.528 HG22 ' HB ' ' A' ' 16' ' ' THR . 10.3 t -57.74 -21.9 43.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 62.240000000000002 111.159 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.629 ' CE2' HG21 ' A' ' 24' ' ' VAL . 20.6 t80 -48.77 -30.5 5.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 73.439999999999998 110.913 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.523 ' HA ' HD12 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -67.61 -41.97 83.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 75.239999999999995 110.876 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.426 HG22 ' O ' ' A' ' 22' ' ' THR . 25.5 m -91.45 -9.69 43.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.228 -0.442 . . . . 63.420000000000002 111.153 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.57 -70.24 0.71 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 52.130000000000003 110.885 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.772 HG22 HG21 ' A' ' 31' ' ' VAL . 11.1 t -83.99 -66.87 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 62.539999999999999 111.145 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.681 HD23 ' HA3' ' A' ' 92' ' ' GLY . 77.8 mt -45.79 -32.77 2.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 71.319999999999993 110.898 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -48.8 -32.05 8.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.157 -0.474 . . . . 74.219999999999999 110.882 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.9 t 65.9 62.97 0.6 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 52.340000000000003 110.851 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -120.23 -32.38 4.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 73.120000000000005 110.886 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.403 HG22 ' HD2' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -157.16 159.67 30.97 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.557 0.694 . . . . 63.439999999999998 111.139 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.403 ' HD2' HG22 ' A' ' 29' ' ' THR . 53.3 Cg_endo -69.77 126.7 13.6 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.645 2.23 . . . . 72.319999999999993 112.356 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.772 HG21 HG22 ' A' ' 24' ' ' VAL . 91.6 t -98.18 119.17 45.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 53.420000000000002 111.113 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.0 mp -108.0 99.9 9.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 64.230000000000004 110.886 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.4 m -107.44 146.21 13.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 74.109999999999999 111.125 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -123.47 100.21 6.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 73.25 110.897 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -72.15 100.22 2.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 72.319999999999993 110.877 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.467 ' HH2' HD22 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -147.47 -168.3 3.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.153 -0.476 . . . . 64.430000000000007 110.908 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.47 -164.96 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 64.439999999999998 111.128 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.475 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 4.6 m-20 -79.25 13.66 1.8 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.446 . . . . 73.400000000000006 110.903 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.475 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 0.6 OUTLIER 75.19 94.76 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 72.019999999999996 110.925 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -172.13 -57.92 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.444 . . . . 62.439999999999998 110.91 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.26 -70.98 1.28 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.798 -0.715 . . . . 73.430000000000007 112.479 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.404 ' HG3' HG21 ' A' ' 83' ' ' ILE . 54.3 Cg_endo -69.68 -31.04 21.65 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.693 2.262 . . . . 53.520000000000003 112.356 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.556 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 20.4 t -58.46 -35.4 72.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 74.319999999999993 110.87 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.5 ptmm? -65.02 -29.42 70.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 53.409999999999997 110.904 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 9.0 mtm -86.88 -41.54 13.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 74.519999999999996 110.883 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.54 ' HA ' HG22 ' A' ' 49' ' ' VAL . 3.1 t -94.24 22.3 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 51.229999999999997 111.176 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.796 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -75.85 -61.1 0.93 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.512 0.672 . . . . 72.519999999999996 111.129 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.796 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 54.0 Cg_endo -69.72 -50.3 0.48 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.687 2.258 . . . . 72.0 112.354 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.54 HG22 ' HA ' ' A' ' 46' ' ' VAL . 4.2 m -52.66 -29.07 13.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 70.239999999999995 111.163 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.467 HD22 ' HH2' ' A' ' 36' ' ' TRP . 14.0 tp -86.16 -44.31 12.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.146 -0.479 . . . . 72.299999999999997 110.908 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -62.66 -34.4 77.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 72.530000000000001 110.899 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -51.76 -55.41 19.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 74.209999999999994 110.917 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 mt -50.57 -37.99 15.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.085 -0.507 . . . . 74.400000000000006 111.13 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 72.120000000000005 111.097 179.798 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.5 pp . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.847 0.356 . . . . 43.450000000000003 110.907 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.3 mttm -98.55 126.19 44.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.448 . . . . 71.25 110.891 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 44.5 t -100.34 101.53 12.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 74.239999999999995 111.137 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -117.01 152.45 34.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 60.409999999999997 111.104 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.26 136.88 42.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 72.109999999999999 110.923 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.5 tp -117.04 150.88 37.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 75.140000000000001 110.914 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -106.98 118.57 37.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 71.400000000000006 110.816 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 99.9 t -57.77 -40.35 75.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.469 . . . . 65.409999999999997 111.11 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -51.7 -36.19 45.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.142 -0.481 . . . . 64.420000000000002 110.869 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.34 -33.89 15.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 60.420000000000002 111.111 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -118.76 67.81 7.98 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.604 0.716 . . . . 74.140000000000001 110.866 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -33.58 16.32 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.64 2.227 . . . . 75.109999999999999 112.359 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -74.46 -36.7 63.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 64.319999999999993 110.895 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.26 -48.24 74.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 74.219999999999999 111.111 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.537 ' O ' HG23 ' A' ' 80' ' ' VAL . . . -56.25 -61.41 2.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 71.140000000000001 111.12 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.58 -34.05 35.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 72.549999999999997 110.891 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.17 -34.69 73.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 64.019999999999996 110.873 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -103.88 26.91 8.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 54.219999999999999 110.853 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 49.85 82.5 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.485 . . . . 75.430000000000007 110.904 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 75' ' ' ALA . 85.4 t -117.11 144.58 24.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.229 -0.442 . . . . 75.549999999999997 111.181 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.7 m -135.42 -40.22 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 74.299999999999997 111.096 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.2 m -97.65 146.71 25.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 72.230000000000004 110.861 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.541 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.9 mt -57.94 -57.75 23.52 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.586 0.707 . . . . 72.340000000000003 111.108 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 54.1 Cg_endo -69.79 74.94 1.26 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.696 2.264 . . . . 74.049999999999997 112.343 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.757 HG23 HG12 ' A' ' 99' ' ' VAL . 52.3 m -112.3 143.34 43.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 72.209999999999994 111.129 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 4.2 tmm? -140.34 139.1 35.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 74.319999999999993 110.843 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.1 mt -130.38 113.19 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 73.310000000000002 111.08 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.459 HD12 HD13 ' A' ' 111' ' ' ILE . 1.6 tt -80.53 111.32 16.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 65.030000000000001 110.93 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -98.91 168.75 9.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 74.150000000000006 110.88 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -170.68 93.33 0.19 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.171 -0.468 . . . . 73.140000000000001 110.915 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.77 44.66 6.32 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.727 -0.749 . . . . 73.319999999999993 112.449 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.681 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 63.71 38.41 96.17 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.739 -0.743 . . . . 52.350000000000001 112.5 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.5 m -162.93 128.62 2.22 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.573 0.701 . . . . 60.229999999999997 111.134 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 86.94 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.679 2.253 . . . . 43.530000000000001 112.384 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.5 m -57.56 -35.74 51.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.425 . . . . 63.109999999999999 111.146 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 45.8 mmtt -152.82 170.19 20.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 45.130000000000003 110.896 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.452 ' C ' HD12 ' A' ' 98' ' ' ILE . 11.2 ttt180 -149.73 123.65 9.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 73.329999999999998 110.901 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.452 HD12 ' C ' ' A' ' 97' ' ' ARG . 4.2 mp -127.11 128.97 70.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 74.25 111.131 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.757 HG12 HG23 ' A' ' 85' ' ' THR . 4.8 m -124.55 160.22 29.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.467 . . . . 64.310000000000002 111.136 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 109.51 138.63 8.21 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.727 -0.749 . . . . 41.43 112.487 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -91.87 80.41 5.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.863 0.363 . . . . 74.430000000000007 111.139 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.401 ' HG2' HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -110.84 178.58 4.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.435 . . . . 63.210000000000001 110.855 -179.958 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.75 -169.71 1.07 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.783 -0.723 . . . . 64.0 112.47 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.17 -54.19 6.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.805 0.336 . . . . 54.100000000000001 110.905 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -53.63 -34.03 57.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 74.219999999999999 111.116 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.06 -64.4 1.17 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 54.43 111.094 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.647 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.7 OUTLIER -50.27 -33.65 20.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 73.239999999999995 110.947 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.658 HD23 ' N ' ' A' ' 109' ' ' ARG . 4.1 tt -71.71 -59.29 2.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 53.210000000000001 110.88 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.658 ' N ' HD23 ' A' ' 108' ' ' LEU . 13.0 ptp180 -56.39 -31.74 64.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 63.32 110.875 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -51.75 -24.88 6.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.159 -0.473 . . . . 71.25 110.93 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.459 HD13 HD12 ' A' ' 88' ' ' LEU . 4.7 mt -86.0 -68.7 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.487 . . . . 73.010000000000005 111.123 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -52.42 -49.62 64.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 74.420000000000002 110.842 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -53.72 -35.2 60.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.146 -0.479 . . . . 71.200000000000003 110.888 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.19 -36.37 69.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 71.420000000000002 111.112 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.1 mt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 75.230000000000004 110.93 179.995 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.9 p . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.845 0.355 . . . . 73.0 111.133 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.8 m -152.43 160.97 3.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 72.450000000000003 111.125 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.61 ' HA ' ' HB1' ' A' ' 64' ' ' ALA . 8.7 t -68.52 157.17 36.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 72.25 111.17 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.461 HG22 ' CG2' ' A' ' 19' ' ' THR . 8.3 p -124.16 155.01 31.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 71.519999999999996 111.127 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.686 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.57 167.79 1.87 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 53.229999999999997 111.146 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.3 -47.98 13.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.224 -0.444 . . . . 74.439999999999998 110.891 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.9 t -66.59 -53.29 36.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.202 -0.454 . . . . 71.349999999999994 110.901 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.686 HG22 ' HB ' ' A' ' 16' ' ' THR . 3.8 t -61.51 -17.7 55.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 71.25 111.119 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.698 ' CE2' HG21 ' A' ' 24' ' ' VAL . 25.5 t80 -49.71 -32.45 13.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 73.109999999999999 110.907 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.441 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -70.69 -33.18 70.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 72.230000000000004 110.893 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.0 m -90.93 -16.47 28.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 72.030000000000001 111.133 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -93.16 -70.68 0.69 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.446 . . . . 63.450000000000003 110.86 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 1.111 HG13 HG21 ' A' ' 31' ' ' VAL . 17.0 t -71.48 -70.32 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.243 -0.435 . . . . 65.409999999999997 111.113 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.705 HD23 ' HA3' ' A' ' 92' ' ' GLY . 8.5 mt -40.46 -59.99 1.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 73.430000000000007 110.921 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -50.77 -62.11 1.8 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 50.340000000000003 110.874 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 86.2 p -51.79 137.65 25.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 72.319999999999993 110.858 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -88.49 -35.96 16.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.09 -0.505 . . . . 62.32 110.875 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -51.98 159.53 1.4 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.614 0.721 . . . . 74.0 111.174 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 126.5 13.35 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.676 2.25 . . . . 71.340000000000003 112.312 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 1.111 HG21 HG13 ' A' ' 24' ' ' VAL . 95.9 t -99.49 128.02 51.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 71.519999999999996 111.157 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.457 HD11 HD11 ' A' ' 88' ' ' LEU . 7.7 mp -99.8 121.65 41.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 74.329999999999998 110.938 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.6 p -127.43 126.15 66.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 71.129999999999995 111.105 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -110.76 100.07 8.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 64.420000000000002 110.874 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.441 ' HE2' ' HB1' ' A' ' 74' ' ' ALA . 25.8 m-85 -84.29 89.42 7.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 74.209999999999994 110.914 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.402 ' HH2' HD12 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -147.83 -169.17 3.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.124 -0.489 . . . . 73.519999999999996 110.901 -179.933 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.469 ' HA ' HG22 ' A' ' 68' ' ' VAL . . . -60.7 -154.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 60.43 111.114 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.475 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 14.2 p-10 -77.31 8.8 3.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 72.409999999999997 110.875 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.475 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 1.4 p-90 41.49 63.85 1.17 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 71.230000000000004 110.939 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 35.9 t -130.22 -45.94 1.11 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 74.420000000000002 110.924 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.74 -68.75 1.44 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.753 -0.736 . . . . 72.439999999999998 112.485 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -30.8 21.88 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.759 2.306 . . . . 62.140000000000001 112.335 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 53.3 t -58.18 -20.43 41.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.245 -0.434 . . . . 71.329999999999998 110.883 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -49.74 -36.24 24.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 73.030000000000001 110.868 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.496 ' HG3' HG23 ' A' ' 46' ' ' VAL . 6.5 ptp -90.83 -30.92 16.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 71.129999999999995 110.859 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.496 HG23 ' HG3' ' A' ' 45' ' ' MET . 3.3 t -92.73 21.96 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.284 -0.416 . . . . 74.030000000000001 111.141 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.783 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -79.07 -60.98 0.52 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.595 0.712 . . . . 72.109999999999999 111.084 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.783 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.5 Cg_endo -69.75 -48.53 0.7 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.63 2.22 . . . . 64.200000000000003 112.38 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.627 ' O ' HD12 ' A' ' 53' ' ' ILE . 4.6 m -50.01 -30.71 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 75.019999999999996 111.116 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.402 HD12 ' HH2' ' A' ' 36' ' ' TRP . 6.1 tt -71.57 -40.24 70.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 74.430000000000007 110.902 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -73.03 -33.5 65.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 72.140000000000001 110.87 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -52.22 -67.66 0.23 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 71.150000000000006 110.907 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.627 HD12 ' O ' ' A' ' 49' ' ' VAL . 2.8 mt -51.28 -34.34 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 74.310000000000002 111.094 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 70.209999999999994 111.076 179.83 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.608 HD13 ' N ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.841 0.353 . . . . 64.239999999999995 110.964 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.02 138.77 35.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.435 . . . . 74.019999999999996 110.934 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.427 HG23 HD23 ' A' ' 61' ' ' LEU . 48.5 t -142.05 99.81 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.266 -0.425 . . . . 63.32 111.125 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.61 ' HB1' ' HA ' ' A' ' 14' ' ' THR . . . -101.75 146.77 27.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 62.340000000000003 111.117 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.24 151.03 49.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 73.019999999999996 110.906 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.49 HD21 ' HB2' ' A' ' 71' ' ' ASN . 13.6 tp -139.94 150.57 44.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 71.400000000000006 110.931 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -103.08 115.45 30.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 62.109999999999999 110.897 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.594 HG12 ' HB2' ' A' ' 75' ' ' ALA . 27.0 m -57.89 -34.66 49.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.46 . . . . 74.239999999999995 111.107 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.48 -36.15 43.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 62.340000000000003 110.868 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.14 -34.62 11.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 73.319999999999993 111.126 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.49 ' HB2' HD21 ' A' ' 66' ' ' LEU . 0.9 OUTLIER -118.82 70.18 9.58 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.625 0.726 . . . . 73.420000000000002 110.883 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.75 -32.65 18.21 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.718 2.278 . . . . 73.540000000000006 112.361 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -59.17 -44.6 92.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 55.109999999999999 110.898 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.441 ' HB1' ' HE2' ' A' ' 35' ' ' PHE . . . -57.07 -54.65 44.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 42.039999999999999 111.073 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.827 ' HB1' HG11 ' A' ' 80' ' ' VAL . . . -54.79 -60.3 3.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 74.349999999999994 111.148 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.85 -33.27 23.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 65.530000000000001 110.888 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -56.01 -38.77 70.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 72.120000000000005 110.881 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -94.63 19.22 10.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 74.299999999999997 110.884 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 47.76 77.84 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 72.150000000000006 110.903 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.827 HG11 ' HB1' ' A' ' 75' ' ' ALA . 6.6 p -120.04 142.47 35.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 70.25 111.121 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.5 m -119.58 -37.66 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 73.219999999999999 111.124 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 39.3 m -89.97 140.22 29.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 71.230000000000004 110.9 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.532 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.0 mt -55.82 -58.02 18.31 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.596 0.712 . . . . 63.520000000000003 111.09 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.5 Cg_endo -69.79 79.21 0.97 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.649 2.232 . . . . 74.409999999999997 112.342 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.714 HG23 HG12 ' A' ' 99' ' ' VAL . 85.6 m -123.37 108.05 12.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.226 -0.443 . . . . 64.340000000000003 111.147 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 18.8 ttp -109.97 142.1 41.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 63.25 110.903 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.2 mt -127.42 129.49 70.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 75.450000000000003 111.135 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.457 HD11 HD11 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -94.42 106.3 18.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 52.310000000000002 110.908 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -89.7 169.99 10.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 72.120000000000005 110.882 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -163.01 92.5 0.76 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 61.149999999999999 110.894 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.52 37.06 9.91 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.777 -0.725 . . . . 71.420000000000002 112.478 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.705 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 71.12 38.3 63.55 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.722 -0.752 . . . . 33.200000000000003 112.503 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.462 HG23 ' HD2' ' A' ' 94' ' ' PRO . 85.2 m -161.02 133.94 4.59 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.579 0.704 . . . . 75.439999999999998 111.171 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.462 ' HD2' HG23 ' A' ' 93' ' ' THR . 54.2 Cg_endo -69.72 107.32 1.82 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.706 2.271 . . . . 64.049999999999997 112.367 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.7 m -98.55 -33.17 4.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 73.099999999999994 111.118 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.9 mmtm -130.28 163.52 26.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 63.409999999999997 110.928 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.417 ' C ' HD12 ' A' ' 98' ' ' ILE . 9.1 ttp180 -155.12 114.12 3.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 73.409999999999997 110.885 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.443 ' N ' HD12 ' A' ' 98' ' ' ILE . 4.7 mp -129.83 129.88 66.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 75.400000000000006 111.134 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.714 HG12 HG23 ' A' ' 85' ' ' THR . 4.2 m -128.49 141.69 45.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 51.340000000000003 111.135 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 132.59 130.92 3.15 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.765 -0.731 . . . . 65.239999999999995 112.482 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.37 59.1 3.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.845 0.355 . . . . 64.400000000000006 111.111 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.25 171.75 8.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 72.209999999999994 110.92 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -67.99 -178.67 14.62 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.771 -0.728 . . . . 74.409999999999997 112.492 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -44.14 72.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.821 0.343 . . . . 75.120000000000005 110.898 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.88 -34.46 65.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 73.209999999999994 111.058 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.437 ' HA ' ' HG2' ' A' ' 109' ' ' ARG . . . -87.97 -56.18 3.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 72.109999999999999 111.113 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.664 HD13 ' O ' ' A' ' 107' ' ' LEU . 1.0 OUTLIER -51.42 -35.19 38.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.448 . . . . 62.43 110.906 -179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.561 HD23 ' N ' ' A' ' 109' ' ' ARG . 6.7 tt -68.98 -60.53 2.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 63.350000000000001 110.904 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.561 ' N ' HD23 ' A' ' 108' ' ' LEU . 14.6 ptp180 -54.59 -35.12 63.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 71.040000000000006 110.864 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -53.24 -24.62 11.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 74.200000000000003 110.878 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.5 mt -84.75 -67.93 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 74.230000000000004 111.153 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.687 ' HA ' HD23 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -52.34 -46.86 66.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 54.020000000000003 110.892 179.901 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -55.42 -34.47 64.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 73.519999999999996 110.85 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.28 -37.1 69.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 41.119999999999997 111.122 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.687 HD23 ' HA ' ' A' ' 112' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 72.340000000000003 110.905 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.463 HG22 ' HB ' ' A' ' 63' ' ' VAL . 20.9 p . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.804 0.335 . . . . 63.25 111.146 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 72.8 t -149.66 144.3 17.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.428 . . . . 65.349999999999994 111.124 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 t -69.13 127.24 32.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 71.430000000000007 111.162 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.9 t -92.9 132.41 37.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 61.140000000000001 111.126 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.499 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.72 177.71 0.2 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 72.109999999999999 111.141 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.455 ' H ' HG22 ' A' ' 16' ' ' THR . 0.6 OUTLIER -80.53 -48.35 12.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 70.120000000000005 110.842 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.6 t -71.16 -52.05 21.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 72.349999999999994 110.865 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.499 HG22 ' HB ' ' A' ' 16' ' ' THR . 4.8 t -58.54 -19.71 40.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 71.409999999999997 111.16 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.709 ' CE2' HG21 ' A' ' 24' ' ' VAL . 24.5 t80 -51.51 -30.71 21.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 74.150000000000006 110.855 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.415 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -72.33 -33.16 67.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 74.129999999999995 110.882 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.4 m -91.67 -16.09 27.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 74.040000000000006 111.162 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -93.48 -71.35 0.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 72.420000000000002 110.832 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.969 HG13 HG21 ' A' ' 31' ' ' VAL . 18.2 t -70.34 -70.42 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 72.239999999999995 111.114 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.617 HD23 ' HA3' ' A' ' 92' ' ' GLY . 7.6 mt -40.72 -60.42 1.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 74.140000000000001 110.919 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -50.05 -57.85 6.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 71.140000000000001 110.893 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.4 m -52.49 147.02 8.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 52.030000000000001 110.86 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -95.34 -45.67 7.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 75.230000000000004 110.839 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -51.11 160.56 0.84 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.53 0.681 . . . . 71.329999999999998 111.137 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 132.08 22.48 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.686 2.257 . . . . 71.409999999999997 112.318 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.969 HG21 HG13 ' A' ' 24' ' ' VAL . 62.8 t -102.3 134.24 43.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 74.409999999999997 111.107 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.851 HD23 HG22 ' A' ' 63' ' ' VAL . 0.3 OUTLIER -101.77 116.41 32.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 64.430000000000007 110.948 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.4 t -94.07 143.51 11.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 74.420000000000002 111.115 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.76 99.85 5.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 62.43 110.881 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -100.96 95.88 6.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 73.310000000000002 110.867 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.683 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -152.05 -167.73 2.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.45 . . . . 72.430000000000007 110.92 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.13 -165.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 52.109999999999999 111.065 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.435 ' O ' ' CB ' ' A' ' 39' ' ' TRP . 4.9 m-20 -77.66 12.6 1.59 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.237 -0.438 . . . . 75.409999999999997 110.888 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.436 ' N ' ' CD1' ' A' ' 39' ' ' TRP . 1.9 m0 78.25 90.32 0.06 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 73.5 110.91 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -174.84 -56.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 72.340000000000003 110.878 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.05 -70.89 1.3 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.72 -0.752 . . . . 52.310000000000002 112.528 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.78 -29.18 24.2 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.714 2.276 . . . . 74.140000000000001 112.365 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.535 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -61.54 -32.17 72.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 72.140000000000001 110.899 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -63.74 -30.68 71.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 72.040000000000006 110.905 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 2.0 mtt -83.78 -43.29 15.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 64.030000000000001 110.836 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.565 ' HA ' HG22 ' A' ' 49' ' ' VAL . 2.8 t -93.93 22.49 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 74.430000000000007 111.121 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.777 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -74.75 -60.73 1.21 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.617 0.723 . . . . 40.310000000000002 111.135 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.777 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.4 Cg_endo -69.79 -49.99 0.5 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.677 2.251 . . . . 73.340000000000003 112.307 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.68 ' O ' HD12 ' A' ' 53' ' ' ILE . 4.1 m -53.6 -29.68 17.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 73.319999999999993 111.128 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.9 tp -72.18 -42.07 66.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.476 . . . . 64.400000000000006 110.972 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -64.28 -36.38 83.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 74.420000000000002 110.898 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -55.82 -69.56 0.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 74.340000000000003 110.862 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.68 HD12 ' O ' ' A' ' 49' ' ' VAL . 2.7 mt -54.83 -36.94 39.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 35.030000000000001 111.128 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 54.409999999999997 111.096 179.82 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.53 HD23 HG23 ' A' ' 63' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.939 0.399 . . . . 73.549999999999997 110.87 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.15 122.27 46.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 74.219999999999999 110.928 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.851 HG22 HD23 ' A' ' 32' ' ' LEU . 21.9 t -121.6 112.57 35.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 63.350000000000001 111.147 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -121.94 129.88 52.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 72.200000000000003 111.095 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.78 154.55 26.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 72.200000000000003 110.937 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.451 HD11 ' CG ' ' A' ' 71' ' ' ASN . 4.7 tp -140.41 137.09 33.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 35.399999999999999 110.925 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.25 149.26 30.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 52.409999999999997 110.884 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 36' ' ' TRP . 6.9 t -90.74 -36.17 7.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 75.010000000000005 111.117 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.1 -35.24 64.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 45.119999999999997 110.853 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.33 -32.56 13.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 73.340000000000003 111.116 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.451 ' CG ' HD11 ' A' ' 66' ' ' LEU . 3.7 m-80 -117.01 68.36 4.5 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.611 0.72 . . . . 72.310000000000002 110.883 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -33.09 17.37 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.692 2.261 . . . . 61.399999999999999 112.348 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -67.37 -36.42 81.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 70.430000000000007 110.884 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.78 -49.58 76.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 64.040000000000006 111.078 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.652 ' HB1' ' HB ' ' A' ' 80' ' ' VAL . . . -53.62 -60.86 2.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 75.230000000000004 111.136 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 14.0 ttp85 -51.22 -34.71 33.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 72.430000000000007 110.828 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -51.93 -38.23 55.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.244 -0.435 . . . . 61.219999999999999 110.858 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -106.53 28.06 8.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 65.040000000000006 110.858 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 49.72 61.14 3.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 70.400000000000006 110.903 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.652 ' HB ' ' HB1' ' A' ' 75' ' ' ALA . 85.2 t -96.44 136.56 26.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 74.299999999999997 111.117 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.9 m -127.47 -36.48 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 54.439999999999998 111.137 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.7 t -97.06 143.84 27.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 75.129999999999995 110.825 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.527 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.9 mt -56.86 -57.59 23.18 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.624 0.726 . . . . 55.520000000000003 111.153 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.616 ' CB ' ' HB2' ' A' ' 101' ' ' ALA . 54.4 Cg_endo -69.71 76.88 1.09 Allowed 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.704 2.269 . . . . 64.310000000000002 112.35 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.666 HG23 ' CG1' ' A' ' 99' ' ' VAL . 68.8 m -116.67 127.59 54.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 72.109999999999999 111.11 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.3 tpp -128.35 140.73 51.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 71.310000000000002 110.838 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 19.2 mt -127.82 129.54 69.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 74.129999999999995 111.151 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.15 104.83 16.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 73.519999999999996 110.943 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -90.01 170.14 10.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 73.340000000000003 110.899 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -164.35 91.55 0.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 64.530000000000001 110.922 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.2 32.61 16.53 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.715 -0.755 . . . . 62.009999999999998 112.476 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.617 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 75.14 39.48 37.03 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.763 -0.732 . . . . 64.230000000000004 112.501 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.42 HG23 ' HD2' ' A' ' 94' ' ' PRO . 46.0 m -160.36 133.66 4.79 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.572 0.701 . . . . 71.129999999999995 111.118 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.42 ' HD2' HG23 ' A' ' 93' ' ' THR . 54.3 Cg_endo -69.7 94.52 0.53 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.721 2.28 . . . . 73.239999999999995 112.362 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.2 m -85.11 -30.32 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 63.32 111.083 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.91 164.43 30.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 72.430000000000007 110.886 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.409 ' C ' HD12 ' A' ' 98' ' ' ILE . 22.7 ttt180 -159.29 118.26 2.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 71.409999999999997 110.907 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.452 ' N ' HD12 ' A' ' 98' ' ' ILE . 4.5 mp -128.15 139.89 50.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 73.340000000000003 111.129 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.666 ' CG1' HG23 ' A' ' 85' ' ' THR . 10.0 m -143.37 154.33 16.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 75.120000000000005 111.106 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 136.75 -30.04 2.7 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.743 -0.742 . . . . 33.210000000000001 112.457 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.616 ' HB2' ' CB ' ' A' ' 84' ' ' PRO . . . 63.59 83.04 0.17 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.863 0.363 . . . . 40.409999999999997 111.119 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.98 179.15 6.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 75.099999999999994 110.874 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.24 149.25 39.27 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.727 -0.749 . . . . 71.420000000000002 112.476 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.53 -42.73 44.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.775 0.322 . . . . 74.340000000000003 110.898 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.57 -38.5 72.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 54.420000000000002 111.131 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.93 -59.15 2.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 53.329999999999998 111.122 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.542 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.6 OUTLIER -47.83 -41.01 22.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 74.299999999999997 110.881 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.4 tt -56.46 -41.99 77.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 62.299999999999997 110.872 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -63.75 -42.35 97.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 71.430000000000007 110.868 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -52.38 -25.15 9.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.19 -0.459 . . . . 50.450000000000003 110.887 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.7 mt -85.49 -67.87 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 73.120000000000005 111.112 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.765 ' HA ' HD23 ' A' ' 115' ' ' LEU . 1.9 pp20? -52.3 -48.92 65.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 71.519999999999996 110.867 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -58.88 -33.71 70.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 64.340000000000003 110.871 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.76 -36.5 59.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 62.200000000000003 111.135 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.765 HD23 ' HA ' ' A' ' 112' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 61.420000000000002 110.916 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.514 HG22 ' HB ' ' A' ' 63' ' ' VAL . 21.3 p . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.816 0.341 . . . . 74.349999999999994 111.125 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.1 p -160.23 155.59 3.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 74.329999999999998 111.122 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.5 t -68.29 156.9 36.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 73.400000000000006 111.154 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.552 ' CG1' HG23 ' A' ' 19' ' ' THR . 41.9 t -118.99 127.48 75.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 73.239999999999995 111.155 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.485 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.23 162.88 4.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 73.140000000000001 111.201 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -72.93 -35.68 67.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 71.109999999999999 110.826 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.3 t -75.51 -34.42 60.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 44.530000000000001 110.87 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.552 HG23 ' CG1' ' A' ' 15' ' ' VAL . 7.6 t -86.52 -18.43 31.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.075 -0.512 . . . . 74.420000000000002 111.151 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.735 ' CE2' HG21 ' A' ' 24' ' ' VAL . 24.2 t80 -51.07 -30.68 16.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 75.510000000000005 110.858 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.428 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.8 OUTLIER -72.52 -34.02 67.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 73.400000000000006 110.89 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.1 m -91.51 -16.49 27.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 63.229999999999997 111.138 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.48 -71.33 0.66 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 64.340000000000003 110.845 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.806 HG13 HG21 ' A' ' 31' ' ' VAL . 24.9 t -70.26 -70.67 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 74.109999999999999 111.166 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.428 ' HB2' ' HA ' ' A' ' 21' ' ' LYS . 7.8 mt -40.55 -60.31 1.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 52.420000000000002 110.884 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -50.09 -57.87 6.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 62.229999999999997 110.87 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.8 m -53.33 156.83 2.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 64.209999999999994 110.836 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -98.73 -46.57 5.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.484 . . . . 73.310000000000002 110.861 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.8 159.83 9.28 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.593 0.711 . . . . 73.530000000000001 111.125 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 149.44 67.23 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.669 2.246 . . . . 73.329999999999998 112.332 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.806 HG21 HG13 ' A' ' 24' ' ' VAL . 84.1 t -112.65 127.63 69.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 71.219999999999999 111.149 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.712 HD22 ' CD2' ' A' ' 88' ' ' LEU . 3.7 mt -114.81 99.81 7.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 73.420000000000002 110.93 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 87' ' ' ILE . 8.6 p -97.39 146.17 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 75.439999999999998 111.142 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -133.88 108.67 8.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.462 . . . . 73.310000000000002 110.86 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.566 ' HE2' ' HB1' ' A' ' 74' ' ' ALA . 51.4 m-85 -92.11 94.84 9.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 73.420000000000002 110.868 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -138.18 -167.72 2.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.101 -0.5 . . . . 74.299999999999997 110.918 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.03 -166.62 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 24.34 111.101 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.444 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 9.6 p-10 -78.17 12.27 1.94 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.231 -0.441 . . . . 54.219999999999999 110.87 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.455 ' N ' ' CD1' ' A' ' 39' ' ' TRP . 1.6 m0 77.0 93.32 0.07 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.233 -0.44 . . . . 71.299999999999997 110.916 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 9.5 t -174.06 -56.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.432 . . . . 64.25 110.861 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.75 -69.29 1.41 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.787 -0.72 . . . . 75.129999999999995 112.499 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -43.58 2.57 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.717 2.278 . . . . 71.120000000000005 112.335 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.543 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 33.9 t -52.66 -34.63 52.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.44 . . . . 73.209999999999994 110.883 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -64.44 -35.2 80.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.452 . . . . 72.209999999999994 110.885 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 88.2 mmm -84.59 -36.66 21.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 64.239999999999995 110.867 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.545 ' HA ' HG22 ' A' ' 49' ' ' VAL . 3.3 t -95.29 21.33 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.243 -0.435 . . . . 72.120000000000005 111.15 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.795 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -78.76 -61.39 0.52 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.6 0.715 . . . . 42.030000000000001 111.089 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.795 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.6 Cg_endo -69.74 -49.84 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.717 2.278 . . . . 70.340000000000003 112.307 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.545 HG22 ' HA ' ' A' ' 46' ' ' VAL . 4.4 m -52.23 -30.64 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.236 -0.438 . . . . 63.520000000000003 111.114 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.528 HD23 ' O ' ' A' ' 50' ' ' LEU . 7.5 tt -84.29 -35.16 23.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 52.130000000000003 110.915 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -58.94 -35.47 73.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 74.230000000000004 110.9 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -51.28 -58.25 6.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 71.25 110.885 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.7 mp -51.56 -34.86 16.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 65.310000000000002 111.134 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 62.210000000000001 111.109 179.779 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.617 HD13 HD12 ' A' ' 32' ' ' LEU . 3.6 pp . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.885 0.374 . . . . 72.239999999999995 110.922 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -84.41 147.49 27.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 74.120000000000005 110.857 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.514 ' HB ' HG22 ' A' ' 12' ' ' THR . 19.8 t -130.47 103.41 8.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 75.230000000000004 111.088 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.6 129.76 50.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 54.210000000000001 111.112 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -129.87 142.49 50.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 71.510000000000005 110.915 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.617 HD21 ' HB2' ' A' ' 71' ' ' ASN . 7.7 tp -137.67 141.17 41.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 61.109999999999999 110.877 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.51 108.99 18.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 73.019999999999996 110.834 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 70.0 t -60.06 -35.78 63.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 41.329999999999998 111.145 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -51.36 -35.07 36.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 74.019999999999996 110.838 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.89 -35.2 10.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 61.439999999999998 111.07 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.617 ' HB2' HD21 ' A' ' 66' ' ' LEU . 1.8 m-80 -116.09 70.56 4.0 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.667 0.746 . . . . 73.219999999999999 110.882 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -31.73 19.92 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.686 2.257 . . . . 43.25 112.33 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -64.1 -35.74 81.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 72.549999999999997 110.933 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.566 ' HB1' ' HE2' ' A' ' 35' ' ' PHE . . . -57.23 -48.8 77.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 45.520000000000003 111.135 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.541 ' O ' HG23 ' A' ' 80' ' ' VAL . . . -53.63 -61.16 2.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 65.299999999999997 111.084 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.7 ttp85 -51.3 -34.05 31.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 62.229999999999997 110.867 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -51.71 -39.65 58.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 55.219999999999999 110.867 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -104.29 26.43 8.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 72.450000000000003 110.892 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 51.0 mm-40 49.78 65.57 1.38 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 74.540000000000006 110.916 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 75' ' ' ALA . 91.7 t -96.82 143.63 12.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.239 -0.437 . . . . 54.439999999999998 111.127 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.7 m -123.64 -38.71 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 73.230000000000004 111.066 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.72 156.82 17.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 63.200000000000003 110.866 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.527 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 2.3 mm -64.6 -57.84 15.48 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.588 0.709 . . . . 73.430000000000007 111.095 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.5 Cg_endo -69.78 70.6 1.58 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.673 2.249 . . . . 65.230000000000004 112.329 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.43 ' OG1' HG13 ' A' ' 80' ' ' VAL . 96.9 m -104.81 137.97 41.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.232 -0.44 . . . . 52.520000000000003 111.143 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -139.04 127.99 23.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 74.549999999999997 110.905 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.403 ' O ' HG12 ' A' ' 33' ' ' VAL . 2.3 mp -114.36 112.76 41.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 63.350000000000001 111.122 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.712 ' CD2' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -79.53 105.71 11.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.47 . . . . 70.200000000000003 110.934 179.891 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -93.13 166.5 12.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 62.350000000000001 110.883 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -170.61 97.1 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 65.340000000000003 110.9 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.98 38.99 9.68 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.713 -0.756 . . . . 70.299999999999997 112.489 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.49 45.02 88.7 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.736 -0.745 . . . . 62.240000000000002 112.444 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.3 m -170.25 134.67 1.14 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.555 0.693 . . . . 74.019999999999996 111.161 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 82.49 0.75 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.667 2.245 . . . . 75.230000000000004 112.336 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.0 m -60.17 -34.08 55.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 74.219999999999999 111.141 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -147.87 170.1 18.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 54.310000000000002 110.911 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.458 ' C ' HD12 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -154.37 123.77 6.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 75.239999999999995 110.847 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.458 HD12 ' C ' ' A' ' 97' ' ' ARG . 4.5 mp -130.26 128.84 64.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 65.230000000000004 111.118 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.4 p -128.42 141.74 45.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 71.409999999999997 111.163 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 122.64 140.23 5.7 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.749 -0.739 . . . . 53.039999999999999 112.502 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.53 93.9 9.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.811 0.339 . . . . 71.019999999999996 111.126 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.577 ' HB2' ' HB3' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -116.77 -176.05 2.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 73.040000000000006 110.859 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.18 163.62 54.52 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.739 -0.744 . . . . 63.43 112.489 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.79 -36.15 57.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.748 0.308 . . . . 73.530000000000001 110.897 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.5 -54.6 10.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 62.240000000000002 111.084 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.577 ' HB3' ' HB2' ' A' ' 102' ' ' LYS . . . -55.76 -53.99 49.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 71.310000000000002 111.125 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.61 HD13 ' O ' ' A' ' 107' ' ' LEU . 1.0 OUTLIER -50.78 -39.48 52.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 74.200000000000003 110.957 179.974 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.436 HD23 ' HG2' ' A' ' 112' ' ' GLU . 0.3 OUTLIER -66.82 -52.77 39.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 70.310000000000002 110.883 179.885 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.51 -40.59 83.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 74.310000000000002 110.918 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -47.12 -28.65 1.86 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 63.020000000000003 110.933 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.6 mt -93.09 -69.52 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 61.229999999999997 111.163 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.436 ' HG2' HD23 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -54.07 -59.96 3.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 63.509999999999998 110.953 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -49.51 -35.9 21.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 72.420000000000002 110.835 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.56 -35.77 63.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 70.450000000000003 111.066 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 74.219999999999999 110.923 -179.964 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.1 p . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.81 0.338 . . . . 71.200000000000003 111.162 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 t -132.67 150.41 33.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 74.150000000000006 111.12 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.6 t -86.86 130.6 34.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 75.329999999999998 111.122 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.6 t -89.97 125.72 42.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 73.230000000000004 111.102 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.545 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.5 173.88 0.49 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 55.0 111.131 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.466 ' H ' HG22 ' A' ' 16' ' ' THR . 11.3 t70 -74.96 -47.39 29.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 72.109999999999999 110.848 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.1 m -71.62 -51.64 22.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 62.240000000000002 110.861 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.545 HG22 ' HB ' ' A' ' 16' ' ' THR . 6.3 t -59.28 -19.12 43.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 64.200000000000003 111.18 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.711 ' CE2' HG21 ' A' ' 24' ' ' VAL . 25.2 t80 -51.24 -30.26 16.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 70.109999999999999 110.898 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.409 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -72.55 -33.65 66.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 74.340000000000003 110.869 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.0 m -91.56 -16.08 27.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.196 -0.456 . . . . 73.25 111.181 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.44 -71.32 0.66 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 72.340000000000003 110.864 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.869 HG13 HG21 ' A' ' 31' ' ' VAL . 20.4 t -70.39 -70.5 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.476 . . . . 73.420000000000002 111.109 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.571 HD23 ' HA3' ' A' ' 92' ' ' GLY . 7.6 mt -40.57 -59.99 1.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 70.430000000000007 110.925 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -50.57 -52.64 37.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.458 . . . . 61.100000000000001 110.853 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.1 t -65.31 148.61 51.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 73.519999999999996 110.839 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -102.32 -38.2 7.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.131 -0.486 . . . . 75.129999999999995 110.895 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -52.05 160.23 1.24 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.527 0.68 . . . . 74.329999999999998 111.143 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 127.46 14.62 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.651 2.234 . . . . 73.109999999999999 112.385 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.869 HG21 HG13 ' A' ' 24' ' ' VAL . 41.1 t -93.25 132.0 38.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 64.519999999999996 111.132 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.422 ' CD1' HD21 ' A' ' 88' ' ' LEU . 1.5 mm? -102.85 99.8 9.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 74.409999999999997 110.917 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.555 HG13 HG12 ' A' ' 31' ' ' VAL . 10.2 m -121.46 150.2 24.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 72.510000000000005 111.137 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.01 123.97 31.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 64.319999999999993 110.902 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -89.71 88.78 7.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 71.510000000000005 110.87 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -142.59 -169.19 2.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.477 . . . . 74.200000000000003 110.952 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.87 -163.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.43 . . . . 61.509999999999998 111.116 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.471 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 2.6 m-20 -77.88 12.88 1.55 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 71.25 110.877 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.497 ' N ' ' CD1' ' A' ' 39' ' ' TRP . 0.6 OUTLIER 74.95 96.18 0.07 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 64.400000000000006 110.954 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -170.1 -53.76 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 51.020000000000003 110.875 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.29 -70.72 1.32 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.762 -0.732 . . . . 74.209999999999994 112.474 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.67 -34.18 15.41 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.694 2.263 . . . . 74.519999999999996 112.347 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.562 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 38.4 t -51.8 -33.73 36.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 73.219999999999999 110.883 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.4 mtmt -65.43 -35.3 80.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 75.340000000000003 110.952 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 15.1 mtp -83.49 -39.95 19.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 72.530000000000001 110.883 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.564 ' HA ' HG22 ' A' ' 49' ' ' VAL . 2.9 t -94.54 22.93 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 70.129999999999995 111.152 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.808 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -75.13 -61.16 1.05 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.558 0.694 . . . . 50.43 111.077 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.808 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 52.9 Cg_endo -69.8 -50.65 0.44 Allowed 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.671 2.248 . . . . 42.439999999999998 112.322 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.679 ' O ' HD12 ' A' ' 53' ' ' ILE . 4.3 m -52.53 -30.04 14.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 73.010000000000005 111.141 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.0 tp -74.5 -42.57 58.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 72.530000000000001 110.881 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -57.8 -36.72 72.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 62.299999999999997 110.87 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -57.74 -67.79 0.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 51.210000000000001 110.884 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.679 HD12 ' O ' ' A' ' 49' ' ' VAL . 2.7 mp -50.94 -34.84 14.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 72.219999999999999 111.118 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 74.209999999999994 111.119 179.831 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.408 ' C ' HD12 ' A' ' 61' ' ' LEU . 4.1 pp . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.904 0.383 . . . . 75.019999999999996 110.895 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -79.9 118.96 22.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 71.239999999999995 110.924 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.6 t -111.9 107.16 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 53.340000000000003 111.108 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -126.65 170.9 11.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 61.43 111.093 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 31.1 mttt -145.29 148.13 33.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.448 . . . . 72.340000000000003 110.845 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.537 HD11 ' CG ' ' A' ' 71' ' ' ASN . 4.0 tp -125.62 140.55 52.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 73.319999999999993 110.879 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -87.79 119.76 28.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 74.150000000000006 110.831 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.71 -28.08 44.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 61.219999999999999 111.152 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -68.94 -34.98 76.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.178 -0.465 . . . . 74.329999999999998 110.875 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.32 -28.7 23.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 74.450000000000003 111.087 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.537 ' CG ' HD11 ' A' ' 66' ' ' LEU . 5.5 m-80 -115.43 69.37 2.85 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.564 0.697 . . . . 71.510000000000005 110.896 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 -32.06 19.01 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.647 2.231 . . . . 73.439999999999998 112.331 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -74.83 -35.1 62.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 73.310000000000002 110.883 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.04 -40.87 91.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 44.109999999999999 111.111 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.494 ' HB1' ' HB ' ' A' ' 80' ' ' VAL . . . -57.96 -64.85 0.76 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 62.210000000000001 111.086 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -51.15 -34.88 33.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 72.409999999999997 110.879 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.82 -36.33 80.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 44.420000000000002 110.883 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -98.45 24.69 7.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 75.340000000000003 110.88 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 49.09 54.05 11.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 73.549999999999997 110.945 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.494 ' HB ' ' HB1' ' A' ' 75' ' ' ALA . 97.6 t -90.15 136.66 23.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 64.450000000000003 111.164 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.8 m -131.58 -39.07 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 70.420000000000002 111.132 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.1 t -97.04 155.16 16.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 71.409999999999997 110.888 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.52 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 2.3 mm -66.47 -57.96 11.28 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.601 0.715 . . . . 73.439999999999998 111.124 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.4 Cg_endo -69.71 70.07 1.58 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.669 2.246 . . . . 44.520000000000003 112.355 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.645 HG23 ' HB ' ' A' ' 99' ' ' VAL . 62.0 m -109.39 149.39 29.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 64.340000000000003 111.127 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 26.6 ttm -138.63 150.35 46.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 64.109999999999999 110.843 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.9 mt -142.76 109.92 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 73.230000000000004 111.139 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.422 HD21 ' CD1' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -79.68 105.85 11.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.47 . . . . 75.129999999999995 110.926 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -90.29 169.79 10.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 61.32 110.855 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -165.44 95.34 0.64 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 73.540000000000006 110.863 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.67 37.72 13.31 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.753 -0.737 . . . . 74.239999999999995 112.474 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.571 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 68.38 41.01 86.69 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.71 -0.757 . . . . 33.329999999999998 112.494 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.446 HG23 ' HD2' ' A' ' 94' ' ' PRO . 85.4 m -160.76 134.05 4.77 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.643 0.735 . . . . 74.420000000000002 111.088 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.446 ' HD2' HG23 ' A' ' 93' ' ' THR . 53.7 Cg_endo -69.79 86.94 0.57 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.703 2.269 . . . . 71.340000000000003 112.327 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.0 m -76.66 -34.58 23.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 60.32 111.173 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.92 164.12 26.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 62.539999999999999 110.897 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.546 ' C ' HD12 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -155.61 119.83 4.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 74.219999999999999 110.895 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.546 HD12 ' C ' ' A' ' 97' ' ' ARG . 4.8 mp -138.31 130.12 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 75.420000000000002 111.133 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.645 ' HB ' HG23 ' A' ' 85' ' ' THR . 1.6 p -126.11 143.44 39.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 64.430000000000007 111.104 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 128.83 132.61 3.54 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.771 -0.728 . . . . 62.140000000000001 112.486 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.19 75.05 9.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.854 0.359 . . . . 74.140000000000001 111.138 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.432 ' HG2' HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -113.39 171.63 7.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 53.140000000000001 110.896 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.57 171.6 5.45 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.696 -0.764 . . . . 72.239999999999995 112.496 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -60.1 -44.39 94.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.784 0.326 . . . . 73.329999999999998 110.888 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -52.49 -66.29 0.41 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 74.5 111.09 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.71 -59.36 4.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 71.209999999999994 111.095 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.637 HD13 ' O ' ' A' ' 107' ' ' LEU . 1.0 OUTLIER -47.31 -35.48 8.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 73.030000000000001 110.933 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.598 ' O ' HD12 ' A' ' 108' ' ' LEU . 4.2 tp -71.19 -43.92 66.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 74.439999999999998 110.91 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 10.6 mtp85 -59.46 -41.82 90.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 74.400000000000006 110.876 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -53.03 -25.33 12.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 55.219999999999999 110.933 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.7 mt -86.04 -68.59 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 75.120000000000005 111.16 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -51.15 -49.57 60.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.151 -0.477 . . . . 71.219999999999999 110.894 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -58.53 -34.23 70.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 52.329999999999998 110.918 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.1 -36.33 61.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 53.25 111.124 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 mt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 71.430000000000007 110.902 -179.979 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.717 HG22 ' H ' ' A' ' 63' ' ' VAL . 37.1 p . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.832 0.348 . . . . 73.319999999999993 111.112 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.3 m -153.14 174.78 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 72.150000000000006 111.147 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.1 t -75.69 127.21 32.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 52.229999999999997 111.174 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 49.1 t -94.77 125.91 47.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 63.119999999999997 111.136 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.55 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.27 174.0 0.44 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 62.439999999999998 111.152 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.473 ' H ' HG22 ' A' ' 16' ' ' THR . 16.6 t0 -75.1 -47.37 29.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 74.299999999999997 110.81 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.5 t -72.1 -51.52 21.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 75.310000000000002 110.847 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.55 HG22 ' HB ' ' A' ' 16' ' ' THR . 5.8 t -59.12 -19.2 42.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.478 . . . . 73.409999999999997 111.124 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.718 ' CE2' HG21 ' A' ' 24' ' ' VAL . 24.9 t80 -50.88 -30.96 16.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 70.25 110.868 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.43 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -71.78 -34.13 69.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 63.119999999999997 110.92 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.0 m -91.13 -15.91 28.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 71.239999999999995 111.15 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.34 -71.41 0.65 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.441 . . . . 65.230000000000004 110.907 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.718 HG21 ' CE2' ' A' ' 20' ' ' PHE . 17.3 t -70.71 -70.34 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.239 -0.437 . . . . 75.150000000000006 111.127 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.508 HD23 ' HA3' ' A' ' 92' ' ' GLY . 7.4 mt -40.55 -60.31 1.15 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 64.030000000000001 110.921 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -50.36 -61.21 2.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.439 . . . . 74.409999999999997 110.874 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.7 t -56.55 161.33 2.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 73.400000000000006 110.821 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -109.92 -35.98 6.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.104 -0.498 . . . . 71.120000000000005 110.884 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -53.44 158.88 2.57 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.585 0.707 . . . . 72.349999999999994 111.103 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 125.66 12.42 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.631 2.221 . . . . 72.150000000000006 112.387 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.552 HG21 HG13 ' A' ' 24' ' ' VAL . 94.6 t -102.1 115.88 44.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 73.140000000000001 111.148 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.9 mp -94.58 99.73 11.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 73.310000000000002 110.874 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.3 p -98.59 140.88 17.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.14 -0.482 . . . . 70.230000000000004 111.075 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -124.8 102.08 7.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 73.549999999999997 110.84 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -83.4 89.57 7.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 73.340000000000003 110.889 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.739 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -135.6 -168.58 2.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.148 -0.478 . . . . 72.209999999999994 110.903 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.54 -164.48 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 75.530000000000001 111.096 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.45 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 9.5 p-10 -78.68 12.71 1.94 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 74.340000000000003 110.861 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.476 ' N ' ' CD1' ' A' ' 39' ' ' TRP . 1.0 OUTLIER 76.03 95.15 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 71.540000000000006 110.935 -179.94 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 46.1 t -172.25 -56.22 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 41.439999999999998 110.849 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.51 -70.71 1.32 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.721 -0.752 . . . . 71.310000000000002 112.478 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.449 ' HG3' HG21 ' A' ' 83' ' ' ILE . 53.7 Cg_endo -69.72 -32.63 18.36 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.639 2.226 . . . . 65.430000000000007 112.324 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.558 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 35.8 t -54.74 -40.69 69.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.436 . . . . 74.239999999999995 110.907 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.8 pttp -64.34 -26.46 68.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 60.350000000000001 110.861 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 5.3 mtp -87.15 -42.85 12.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.276 -0.42 . . . . 65.450000000000003 110.871 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.522 ' HA ' HG22 ' A' ' 49' ' ' VAL . 3.1 t -94.31 21.44 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 73.209999999999994 111.147 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.778 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -76.75 -61.17 0.76 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.562 0.696 . . . . 54.43 111.088 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.778 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.7 Cg_endo -69.81 -49.77 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.678 2.252 . . . . 63.149999999999999 112.344 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.596 ' O ' HD12 ' A' ' 53' ' ' ILE . 4.3 m -51.24 -30.85 10.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 71.450000000000003 111.105 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.4 tp -90.16 -35.89 15.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 62.140000000000001 110.886 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -68.26 -24.16 64.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 72.099999999999994 110.925 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -65.97 -60.71 2.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.478 . . . . 52.140000000000001 110.873 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.596 HD12 ' O ' ' A' ' 49' ' ' VAL . 2.6 mp -61.52 -33.02 55.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 64.299999999999997 111.118 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 73.150000000000006 111.101 179.823 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.486 HD12 ' N ' ' A' ' 62' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.863 0.363 . . . . 72.310000000000002 110.918 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.486 ' N ' HD12 ' A' ' 61' ' ' LEU . 12.4 ttpp -107.62 141.39 39.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 65.5 110.93 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.717 ' H ' HG22 ' A' ' 12' ' ' THR . 50.4 t -101.71 108.67 24.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.22 -0.446 . . . . 62.130000000000003 111.182 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -122.27 128.91 51.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 73.450000000000003 111.103 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.8 pttt -125.99 157.61 37.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 74.140000000000001 110.882 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 31.3 tp -147.95 146.45 28.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 54.25 110.882 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -82.96 119.88 24.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 62.340000000000003 110.925 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 36' ' ' TRP . 84.7 t -48.14 -39.52 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 75.450000000000003 111.086 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.02 -33.31 56.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 72.230000000000004 110.862 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.82 -34.68 45.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 75.25 111.043 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.601 ' HB2' ' HB3' ' A' ' 74' ' ' ALA . 5.2 p30 -118.39 66.91 6.76 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.627 0.727 . . . . 74.209999999999994 110.874 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -32.85 17.52 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.686 2.257 . . . . 62.340000000000003 112.327 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -80.92 -38.65 27.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 64.510000000000005 110.925 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.601 ' HB3' ' HB2' ' A' ' 71' ' ' ASN . . . -60.99 -43.32 99.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 60.119999999999997 111.149 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.478 ' HB1' ' HB ' ' A' ' 80' ' ' VAL . . . -51.76 -67.27 0.27 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 74.409999999999997 111.136 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.1 ttm-85 -51.19 -34.07 30.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.259 -0.428 . . . . 73.420000000000002 110.886 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.43 -40.19 90.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 74.519999999999996 110.867 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -98.89 26.68 5.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 65.120000000000005 110.867 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 49.85 75.44 0.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 53.32 110.919 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.478 ' HB ' ' HB1' ' A' ' 75' ' ' ALA . 90.9 t -116.45 90.55 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 62.310000000000002 111.134 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 61.1 t -84.4 -42.61 17.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 63.030000000000001 111.111 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.6 m -96.75 152.73 18.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 75.040000000000006 110.866 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.531 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.3 mt -63.9 -57.64 17.94 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.598 0.713 . . . . 74.150000000000006 111.112 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 54.0 Cg_endo -69.74 75.43 1.21 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.743 2.295 . . . . 62.109999999999999 112.336 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 84.8 m -117.17 100.89 8.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 72.209999999999994 111.159 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 22.5 ttp -100.76 112.08 24.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 70.430000000000007 110.883 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 25.2 mt -101.33 118.0 47.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 64.150000000000006 111.165 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.656 HD12 HD13 ' A' ' 111' ' ' ILE . 1.9 tt -81.15 110.3 16.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 71.219999999999999 110.923 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -97.47 170.27 9.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.477 . . . . 74.230000000000004 110.88 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -167.3 97.95 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 75.329999999999998 110.903 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.68 38.43 10.63 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.719 -0.753 . . . . 75.299999999999997 112.509 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.508 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 65.76 37.12 93.13 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.702 -0.761 . . . . 65.209999999999994 112.458 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.456 HG23 ' HD2' ' A' ' 94' ' ' PRO . 86.6 m -158.43 133.89 5.85 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.584 0.707 . . . . 70.010000000000005 111.147 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.456 ' HD2' HG23 ' A' ' 93' ' ' THR . 53.4 Cg_endo -69.75 112.64 3.13 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.697 2.265 . . . . 72.219999999999999 112.322 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.6 m -99.63 -33.51 3.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.443 . . . . 64.209999999999994 111.115 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.5 mmtt -140.88 169.66 17.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 71.400000000000006 110.864 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -153.93 111.87 3.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 75.430000000000007 110.875 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.426 ' N ' HD12 ' A' ' 98' ' ' ILE . 4.6 mp -112.75 127.95 69.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 62.219999999999999 111.164 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.0 p -141.69 144.7 25.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 62.100000000000001 111.155 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 139.58 -28.65 2.53 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.786 -0.721 . . . . 54.409999999999997 112.518 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 64.5 96.57 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.822 0.344 . . . . 71.530000000000001 111.101 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.15 -179.25 5.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 74.129999999999995 110.884 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.29 176.76 2.68 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.745 -0.74 . . . . 41.539999999999999 112.508 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.16 -44.57 71.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.799 0.333 . . . . 72.230000000000004 110.896 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.58 -32.9 70.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 55.200000000000003 111.12 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.446 ' HA ' ' HG2' ' A' ' 109' ' ' ARG . . . -85.43 -58.39 2.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 74.329999999999998 111.082 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.627 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.6 OUTLIER -51.12 -35.51 35.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 64.349999999999994 110.93 -179.96 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.596 HD23 ' N ' ' A' ' 109' ' ' ARG . 5.7 tt -68.83 -59.44 3.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 73.030000000000001 110.91 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.596 ' N ' HD23 ' A' ' 108' ' ' LEU . 15.8 ptm180 -56.91 -32.81 66.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 64.510000000000005 110.867 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -51.9 -25.46 8.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 71.319999999999993 110.878 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.656 HD13 HD12 ' A' ' 88' ' ' LEU . 3.8 mt -85.56 -69.03 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 72.310000000000002 111.148 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -51.56 -49.88 61.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 64.019999999999996 110.92 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -54.12 -34.68 60.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 72.230000000000004 110.84 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.17 -34.95 66.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 75.349999999999994 111.1 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.9 mt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 54.539999999999999 110.889 -179.951 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.2 p . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.836 0.35 . . . . 62.210000000000001 111.109 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.6 m -154.53 -179.85 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 75.140000000000001 111.16 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.3 t -72.64 151.16 42.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 63.450000000000003 111.149 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.489 HG22 ' CG2' ' A' ' 19' ' ' THR . 9.1 p -119.26 151.87 21.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 75.540000000000006 111.144 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.639 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -63.37 162.06 13.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 45.119999999999997 111.109 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -77.4 -52.33 9.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 73.439999999999998 110.821 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.9 t -57.76 -36.37 72.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 64.329999999999998 110.859 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.639 HG22 ' HB ' ' A' ' 16' ' ' THR . 5.0 t -84.65 -17.83 37.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 75.219999999999999 111.137 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.714 ' CE2' HG21 ' A' ' 24' ' ' VAL . 24.6 t80 -49.92 -31.49 12.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 75.540000000000006 110.924 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.405 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -70.95 -34.46 71.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 72.200000000000003 110.869 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.5 m -91.01 -15.2 30.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 75.209999999999994 111.157 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.42 -70.61 0.69 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.231 -0.441 . . . . 73.0 110.862 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 1.035 HG13 HG21 ' A' ' 31' ' ' VAL . 17.3 t -72.06 -70.38 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 75.099999999999994 111.137 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.652 HD23 ' HA3' ' A' ' 92' ' ' GLY . 7.5 mt -40.41 -57.7 1.72 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.156 -0.475 . . . . 71.239999999999995 110.911 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -51.28 -60.04 3.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 74.140000000000001 110.852 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 55.5 p -51.67 139.47 20.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 64.239999999999995 110.838 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -88.82 -41.77 12.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 73.129999999999995 110.872 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.468 HG22 ' HD2' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -51.54 158.76 1.39 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.582 0.706 . . . . 70.340000000000003 111.18 -179.911 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.468 ' HD2' HG22 ' A' ' 29' ' ' THR . 54.0 Cg_endo -69.73 129.8 18.27 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.703 2.269 . . . . 72.230000000000004 112.324 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 1.035 HG21 HG13 ' A' ' 24' ' ' VAL . 92.4 t -97.1 126.6 49.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.437 . . . . 75.340000000000003 111.135 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.8 mp -110.12 121.07 44.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 74.409999999999997 110.937 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.717 HG12 ' HB3' ' A' ' 64' ' ' ALA . 11.7 m -132.81 149.9 32.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 75.540000000000006 111.104 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.28 99.63 5.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 72.239999999999995 110.832 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.47 ' CE2' HD22 ' A' ' 66' ' ' LEU . 5.8 m-85 -73.59 96.81 2.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 65.400000000000006 110.893 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -142.83 -168.6 2.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.168 -0.469 . . . . 74.439999999999998 110.914 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.49 -162.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 54.240000000000002 111.133 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.484 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 4.1 t70 -77.96 13.72 1.32 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.268 -0.424 . . . . 51.32 110.876 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.484 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 0.5 OUTLIER 74.95 94.34 0.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.204 -0.453 . . . . 72.450000000000003 110.887 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 35.0 t -174.79 -50.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 72.349999999999994 110.885 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.24 -69.55 1.39 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.724 -0.75 . . . . 73.319999999999993 112.459 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 -28.47 24.96 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.684 2.256 . . . . 71.129999999999995 112.351 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.655 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 1.9 p -53.95 -25.53 21.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 75.450000000000003 110.95 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.2 pttt -77.96 -31.48 50.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 73.400000000000006 110.847 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 16.1 mtt -85.82 -35.4 20.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 74.549999999999997 110.886 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.552 ' HA ' HG22 ' A' ' 49' ' ' VAL . 2.8 t -100.36 22.07 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.246 -0.434 . . . . 75.129999999999995 111.122 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.814 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -74.36 -61.21 1.23 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.556 0.693 . . . . 74.25 111.091 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.814 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.7 Cg_endo -69.73 -50.66 0.45 Allowed 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.732 2.288 . . . . 52.520000000000003 112.359 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.572 ' O ' HD12 ' A' ' 53' ' ' ILE . 4.1 m -52.09 -29.98 12.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.459 . . . . 33.140000000000001 111.132 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.6 tp -75.04 -41.96 58.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 64.540000000000006 110.888 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -67.45 -34.34 76.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 70.319999999999993 110.872 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -52.84 -62.09 1.87 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 74.120000000000005 110.876 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.572 HD12 ' O ' ' A' ' 49' ' ' VAL . 3.1 mt -51.21 -39.51 20.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 74.049999999999997 111.118 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 74.319999999999993 111.116 179.771 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.3 pp . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.854 0.359 . . . . 63.210000000000001 110.945 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.8 tttp -86.78 147.64 25.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.443 . . . . 64.400000000000006 110.888 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.4 t -140.74 106.56 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.421 . . . . 61.439999999999998 111.124 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.717 ' HB3' HG12 ' A' ' 33' ' ' VAL . . . -113.62 110.08 19.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 31.140000000000001 111.07 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.0 pttm -97.23 128.98 44.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 61.130000000000003 110.911 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.47 HD22 ' CE2' ' A' ' 35' ' ' PHE . 6.2 tp -105.15 146.08 29.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 74.420000000000002 110.909 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.636 ' OD2' ' HB3' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -108.86 97.37 7.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 70.230000000000004 110.86 179.858 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.1 m -49.08 -32.2 4.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 44.100000000000001 111.155 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -50.14 -32.5 16.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 72.340000000000003 110.904 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.636 ' HB3' ' OD2' ' A' ' 67' ' ' ASP . . . -105.99 -28.5 10.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 64.349999999999994 111.098 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.82 72.22 2.02 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.631 0.729 . . . . 75.150000000000006 110.9 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -30.99 21.2 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.661 2.24 . . . . 74.409999999999997 112.337 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -70.6 -42.88 70.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 73.349999999999994 110.895 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.24 -48.35 62.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 75.040000000000006 111.081 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.593 ' HB1' ' CG1' ' A' ' 80' ' ' VAL . . . -53.76 -67.31 0.27 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 74.340000000000003 111.157 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.1 ttp85 -51.87 -31.4 27.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 72.140000000000001 110.868 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -51.64 -37.96 52.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 63.539999999999999 110.87 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -105.24 21.44 17.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 74.329999999999998 110.888 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 65.3 mm-40 46.61 82.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.115 -0.493 . . . . 72.510000000000005 110.917 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.593 ' CG1' ' HB1' ' A' ' 75' ' ' ALA . 7.0 p -122.09 132.77 70.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 75.230000000000004 111.149 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.8 t -120.46 45.81 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 74.230000000000004 111.13 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.454 ' H ' HG22 ' A' ' 80' ' ' VAL . 0.3 OUTLIER -174.05 144.91 1.03 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 52.240000000000002 110.847 -179.813 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.53 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 4.3 mt -66.44 -58.04 11.16 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.571 0.7 . . . . 75.549999999999997 111.116 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.72 ' HB2' ' HB2' ' A' ' 101' ' ' ALA . 53.2 Cg_endo -69.79 73.96 1.34 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.699 2.266 . . . . 52.439999999999998 112.336 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.634 HG23 ' HB ' ' A' ' 99' ' ' VAL . 97.6 m -117.77 129.57 55.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 71.439999999999998 111.145 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -120.78 144.02 48.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.443 . . . . 71.120000000000005 110.874 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 17.5 mt -131.7 122.89 50.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 64.299999999999997 111.129 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.28 105.4 17.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.149 -0.478 . . . . 73.299999999999997 110.889 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -89.45 169.84 11.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 60.310000000000002 110.933 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.12 91.16 0.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 73.340000000000003 110.886 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.33 33.13 12.14 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.706 -0.759 . . . . 74.120000000000005 112.49 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.652 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 74.99 38.83 39.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.761 -0.733 . . . . 63.229999999999997 112.477 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.44 HG23 ' HD2' ' A' ' 94' ' ' PRO . 85.5 m -161.26 133.8 4.41 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.577 0.704 . . . . 65.219999999999999 111.128 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.44 ' HD2' HG23 ' A' ' 93' ' ' THR . 54.0 Cg_endo -69.78 98.13 0.67 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.651 2.234 . . . . 62.140000000000001 112.352 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.6 m -87.65 -31.8 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 72.310000000000002 111.131 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.9 mmtm -132.42 166.0 22.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 73.299999999999997 110.915 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -159.76 115.0 2.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 70.109999999999999 110.866 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.428 ' N ' HD12 ' A' ' 98' ' ' ILE . 4.5 mp -125.36 118.01 51.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 74.120000000000005 111.105 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.634 ' HB ' HG23 ' A' ' 85' ' ' THR . 2.2 p -128.18 145.14 35.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 70.140000000000001 111.146 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 136.68 -28.31 2.87 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.796 -0.716 . . . . 75.329999999999998 112.475 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.72 ' HB2' ' HB2' ' A' ' 84' ' ' PRO . . . 64.49 106.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.821 0.344 . . . . 64.530000000000001 111.075 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.454 ' HG2' HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -147.46 175.61 10.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 74.019999999999996 110.901 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.51 166.66 8.88 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.735 -0.745 . . . . 75.519999999999996 112.538 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.68 -36.51 84.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.766 0.317 . . . . 70.150000000000006 110.932 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.34 -31.33 72.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 75.439999999999998 111.102 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.46 -58.84 2.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 64.5 111.105 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.454 HD23 ' HG2' ' A' ' 102' ' ' LYS . 0.3 OUTLIER -48.22 -47.53 35.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 74.530000000000001 110.929 180.0 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.439 HD23 ' C ' ' A' ' 108' ' ' LEU . 4.0 tt -47.98 -41.53 25.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 71.340000000000003 110.905 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 44.4 mtp180 -76.51 -35.8 58.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 73.430000000000007 110.878 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -51.02 -24.68 3.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.229 -0.441 . . . . 74.439999999999998 110.862 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.0 mt -87.78 -68.94 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 70.329999999999998 111.143 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.461 ' HA ' HD23 ' A' ' 115' ' ' LEU . 0.7 OUTLIER -53.88 -52.92 58.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 74.439999999999998 110.885 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -54.14 -34.47 60.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 71.310000000000002 110.858 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.87 -34.67 71.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 75.420000000000002 111.066 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 112' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 74.219999999999999 110.951 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.2 ttm . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.777 0.322 . . . . 73.030000000000001 110.828 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.44 124.98 36.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 72.239999999999995 111.114 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -99.99 -65.9 0.94 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 73.340000000000003 110.831 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -52.06 149.44 5.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 55.0 110.864 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -143.26 165.93 26.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 73.150000000000006 110.866 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -119.99 30.76 6.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 61.030000000000001 110.859 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -95.64 -36.47 11.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 61.43 110.814 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -52.26 -36.06 51.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.253 -0.431 . . . . 72.209999999999994 110.9 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 13.3 mtt -52.19 -37.32 54.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 70.340000000000003 110.887 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.8 t -53.91 127.89 28.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.433 . . . . 62.32 110.897 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.08 -97.84 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.741 -0.742 . . . . 71.319999999999993 112.499 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.2 p -63.4 115.68 4.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.824 0.345 . . . . 73.230000000000004 111.112 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.2 t -147.09 145.4 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 75.219999999999999 111.086 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.8 t -77.7 127.93 33.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 71.450000000000003 111.109 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.537 ' CG1' HG23 ' A' ' 19' ' ' THR . 43.9 t -97.66 120.79 47.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 75.140000000000001 111.11 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.451 HG22 ' H ' ' A' ' 17' ' ' ASP . 0.2 OUTLIER -59.92 173.58 0.59 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 64.140000000000001 111.185 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.451 ' H ' HG22 ' A' ' 16' ' ' THR . 38.0 t0 -77.87 -41.64 36.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 74.099999999999994 110.878 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.3 m -69.6 -33.73 73.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 71.530000000000001 110.881 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.537 HG23 ' CG1' ' A' ' 15' ' ' VAL . 13.2 t -85.55 -18.19 34.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 74.349999999999994 111.178 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.804 ' CZ ' HG21 ' A' ' 24' ' ' VAL . 7.3 t80 -51.05 -52.68 40.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 73.120000000000005 110.886 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.719 ' CB ' HD12 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -64.6 -14.67 58.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 72.239999999999995 110.864 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.6 m -92.99 -33.17 14.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.294 -0.412 . . . . 73.400000000000006 111.16 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -96.96 -71.56 0.67 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 54.130000000000003 110.878 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.804 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 38.4 t -51.48 -71.81 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 55.450000000000003 111.117 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.719 HD12 ' CB ' ' A' ' 21' ' ' LYS . 12.1 mt -41.71 -58.95 1.8 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 65.109999999999999 110.921 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -49.71 -64.81 0.7 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 73.430000000000007 110.857 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.6 t -55.49 145.88 21.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 70.299999999999997 110.848 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -107.36 35.92 2.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.487 . . . . 71.349999999999994 110.858 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.25 160.3 38.07 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 121.571 0.7 . . . . 74.450000000000003 111.123 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 106.42 1.67 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.695 2.263 . . . . 74.430000000000007 112.343 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.747 HG21 HG13 ' A' ' 24' ' ' VAL . 70.5 t -87.64 118.28 33.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 60.140000000000001 111.135 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.84 99.52 11.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.477 . . . . 70.030000000000001 110.919 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 87' ' ' ILE . 5.6 p -100.16 138.99 22.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 74.200000000000003 111.116 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -125.3 121.83 35.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 61.539999999999999 110.851 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.613 ' CD2' HD22 ' A' ' 66' ' ' LEU . 35.6 m-85 -101.1 89.83 3.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 74.510000000000005 110.845 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -133.3 -167.73 1.97 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.132 -0.486 . . . . 72.219999999999999 110.945 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.05 -166.32 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 65.25 111.069 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.445 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 3.6 m-20 -78.89 12.63 2.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 72.420000000000002 110.919 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.457 ' N ' ' CD1' ' A' ' 39' ' ' TRP . 1.4 m0 77.01 94.62 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 74.340000000000003 110.895 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -174.69 -57.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 53.100000000000001 110.84 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.09 -70.06 1.36 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.788 -0.72 . . . . 72.329999999999998 112.488 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 -44.01 2.31 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.681 2.254 . . . . 63.030000000000001 112.29 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.536 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 42.4 t -52.08 -34.73 45.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.433 . . . . 74.349999999999994 110.894 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.6 -34.14 77.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 73.219999999999999 110.845 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 11.3 mtt -85.25 -38.34 19.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 71.510000000000005 110.88 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.506 ' HA ' HG22 ' A' ' 49' ' ' VAL . 3.0 t -94.1 21.48 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 62.240000000000002 111.141 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.786 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -77.18 -60.84 0.73 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.579 0.704 . . . . 70.400000000000006 111.112 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.786 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.7 Cg_endo -69.71 -49.65 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.681 2.254 . . . . 72.040000000000006 112.38 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.506 HG22 ' HA ' ' A' ' 46' ' ' VAL . 4.4 m -50.49 -30.16 7.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 61.340000000000003 111.127 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.4 tt -84.01 -39.69 19.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.202 -0.454 . . . . 72.439999999999998 110.91 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -61.43 -35.57 77.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 72.230000000000004 110.879 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -55.1 -60.56 3.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 74.439999999999998 110.936 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.432 HD12 ' O ' ' A' ' 49' ' ' VAL . 3.0 mt -51.43 -38.18 20.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 63.439999999999998 111.13 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.33 -43.37 77.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 61.149999999999999 111.123 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -40.55 94.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 72.25 110.849 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -77.64 -37.21 50.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 73.230000000000004 110.846 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.2 mmmt -59.41 -75.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 72.450000000000003 110.898 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -178.13 177.41 1.02 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 40.439999999999998 110.825 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -113.22 34.03 5.27 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.692 -0.766 . . . . 71.519999999999996 112.478 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 70.4 p -122.03 -39.04 2.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.795 0.331 . . . . 54.310000000000002 111.13 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.645 ' C ' HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -51.13 169.25 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.203 -0.453 . . . . 73.540000000000006 110.902 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.538 ' N ' HD22 ' A' ' 61' ' ' LEU . 1.7 ttmp? -128.96 141.97 51.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 72.140000000000001 110.884 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.82 112.93 42.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 73.120000000000005 111.16 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -105.55 147.26 28.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 74.340000000000003 111.112 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.41 156.62 46.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.436 . . . . 72.129999999999995 110.896 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.681 HD21 ' HB2' ' A' ' 71' ' ' ASN . 0.4 OUTLIER -144.42 137.62 27.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.452 . . . . 65.319999999999993 110.927 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.58 106.92 13.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.45 . . . . 73.549999999999997 110.87 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 78.8 t -55.54 -39.11 52.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 62.109999999999999 111.16 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.02 -36.02 62.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 72.319999999999993 110.849 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.8 -35.46 14.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 74.010000000000005 111.15 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.681 ' HB2' HD21 ' A' ' 66' ' ' LEU . 1.7 m-80 -117.87 68.04 6.23 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.627 0.727 . . . . 71.439999999999998 110.894 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -33.3 16.86 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.684 2.256 . . . . 65.349999999999994 112.29 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -62.42 -36.8 83.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 72.109999999999999 110.877 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.15 -34.99 79.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 63.409999999999997 111.051 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.583 ' HB1' ' HB ' ' A' ' 80' ' ' VAL . . . -58.88 -67.52 0.36 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 63.32 111.088 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -53.41 -38.73 63.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 74.299999999999997 110.895 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -51.41 -37.82 50.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 74.019999999999996 110.919 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -110.08 29.93 7.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 74.439999999999998 110.845 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 49.35 82.02 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 71.439999999999998 110.924 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.583 ' HB ' ' HB1' ' A' ' 75' ' ' ALA . 87.4 t -126.89 103.35 10.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 70.209999999999994 111.138 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 60.3 t -98.29 -34.49 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 63.509999999999998 111.143 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.5 m -97.61 151.67 19.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 70.109999999999999 110.855 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.53 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.1 mt -66.66 -57.76 11.31 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.565 0.697 . . . . 73.219999999999999 111.148 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.4 Cg_endo -69.77 70.17 1.6 Allowed 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.694 2.263 . . . . 61.229999999999997 112.332 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 59.1 m -110.49 148.09 32.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 73.120000000000005 111.115 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 5.3 ttp -147.89 147.61 29.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 71.329999999999998 110.883 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.416 ' O ' HG12 ' A' ' 33' ' ' VAL . 10.5 mt -133.43 115.32 22.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 74.099999999999994 111.15 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.429 HD23 ' HB2' ' A' ' 96' ' ' LYS . 10.9 tp -81.3 101.78 9.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 73.430000000000007 110.875 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -89.98 170.33 10.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 73.209999999999994 110.874 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -164.91 96.31 0.72 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 70.439999999999998 110.919 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.97 35.87 23.32 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.763 -0.732 . . . . 52.450000000000003 112.469 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.652 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 71.23 40.89 60.63 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.731 -0.747 . . . . 73.400000000000006 112.499 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.419 HG23 ' HD2' ' A' ' 94' ' ' PRO . 46.6 m -160.65 133.46 4.56 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.596 0.712 . . . . 74.430000000000007 111.158 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.419 ' HD2' HG23 ' A' ' 93' ' ' THR . 53.2 Cg_endo -69.79 87.76 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.67 2.247 . . . . 64.129999999999995 112.318 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 26.9 m -78.54 -34.96 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 72.129999999999995 111.097 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.429 ' HB2' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -141.43 163.71 32.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 73.530000000000001 110.904 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.404 ' C ' HD12 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -150.54 133.47 16.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 75.549999999999997 110.858 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.44 HG23 ' HB3' ' A' ' 110' ' ' GLU . 5.3 mp -137.19 135.44 47.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 72.530000000000001 111.139 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -135.32 139.64 46.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 71.200000000000003 111.149 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 129.02 134.49 3.8 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.767 -0.73 . . . . 34.5 112.454 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.34 86.38 7.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.833 0.349 . . . . 53.329999999999998 111.116 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.529 ' HG2' HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -124.41 172.46 9.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 73.400000000000006 110.847 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.26 171.0 8.42 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.739 -0.743 . . . . 73.230000000000004 112.448 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.06 -43.59 86.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.791 0.329 . . . . 74.5 110.916 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.96 -65.39 0.59 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 54.43 111.093 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.89 -56.91 13.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 73.129999999999995 111.084 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.529 HD23 ' HG2' ' A' ' 102' ' ' LYS . 0.3 OUTLIER -49.82 -36.27 25.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 72.549999999999997 110.918 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.419 HD23 ' C ' ' A' ' 108' ' ' LEU . 10.3 tt -70.15 -37.41 75.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 75.140000000000001 110.925 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 10.0 mtp85 -66.71 -41.52 87.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 71.230000000000004 110.845 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.44 ' HB3' HG23 ' A' ' 98' ' ' ILE . 42.9 mm-40 -52.19 -25.46 9.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 73.400000000000006 110.905 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.3 mt -84.82 -67.99 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 65.340000000000003 111.155 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -52.4 -48.8 65.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 62.439999999999998 110.913 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -58.0 -34.79 70.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.496 . . . . 62.439999999999998 110.886 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.81 -35.04 57.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 73.030000000000001 111.129 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.1 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 62.020000000000003 110.923 -179.984 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 mmt . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.743 0.306 . . . . 72.329999999999998 110.926 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.23 173.31 11.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 71.239999999999995 111.088 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -50.21 -51.94 39.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.203 -0.453 . . . . 63.130000000000003 110.843 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 59.6 m170 49.79 34.63 7.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 73.530000000000001 110.89 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -56.61 167.45 0.73 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 73.209999999999994 110.838 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -119.75 30.85 6.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 63.030000000000001 110.887 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 41.5 t60 -68.34 -36.12 78.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 73.109999999999999 110.896 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -58.57 -42.75 88.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.45 . . . . 73.329999999999998 110.921 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 32.1 mtt -69.3 -36.09 76.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 63.0 110.883 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.6 t -70.21 120.13 15.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 65.420000000000002 110.834 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -93.84 -91.06 1.61 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.763 -0.732 . . . . 62.450000000000003 112.475 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.573 HG22 ' HB ' ' A' ' 63' ' ' VAL . 58.6 p -67.78 118.51 11.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.789 0.328 . . . . 62.240000000000002 111.131 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.06 150.09 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 75.319999999999993 111.143 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.4 t -72.71 131.1 41.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 53.409999999999997 111.143 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.4 t -92.56 121.21 42.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 72.140000000000001 111.148 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.577 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.89 163.67 4.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.122 -0.49 . . . . 61.130000000000003 111.113 -179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -67.02 -39.86 87.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 74.400000000000006 110.82 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.7 t -75.86 -57.67 3.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 75.120000000000005 110.898 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.577 HG22 ' HB ' ' A' ' 16' ' ' THR . 10.5 t -55.79 -24.22 34.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 75.319999999999993 111.144 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.538 ' CE2' HG21 ' A' ' 24' ' ' VAL . 16.6 t80 -51.71 -30.88 23.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 73.140000000000001 110.837 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.562 ' HA ' HD12 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -71.45 -33.37 69.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 71.099999999999994 110.9 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.9 m -92.69 -17.67 23.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 75.310000000000002 111.151 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -93.57 -72.05 0.63 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 64.519999999999996 110.849 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.538 HG21 ' CE2' ' A' ' 20' ' ' PHE . 58.2 t -69.4 -71.29 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 64.140000000000001 111.106 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.562 HD12 ' HA ' ' A' ' 21' ' ' LYS . 12.5 mt -40.18 -60.31 1.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 74.349999999999994 110.861 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -50.31 -56.62 10.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.242 -0.435 . . . . 73.129999999999995 110.863 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.1 t -51.84 158.47 1.0 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 64.109999999999999 110.859 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -119.44 35.76 4.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 71.549999999999997 110.844 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.452 HG22 ' HD2' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -132.4 159.96 70.13 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.523 0.678 . . . . 74.150000000000006 111.175 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.452 ' HD2' HG22 ' A' ' 29' ' ' THR . 53.4 Cg_endo -69.76 122.14 8.83 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.682 2.254 . . . . 53.119999999999997 112.344 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.503 HG22 ' HD2' ' A' ' 62' ' ' LYS . 90.1 t -100.93 122.93 53.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.449 . . . . 73.439999999999998 111.121 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -94.86 99.93 11.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 71.340000000000003 110.901 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 87' ' ' ILE . 7.9 p -100.38 142.62 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 63.229999999999997 111.17 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -135.75 119.84 17.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 74.120000000000005 110.895 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.6 ' HE2' ' HB1' ' A' ' 74' ' ' ALA . 47.1 m-85 -99.74 93.5 5.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 54.340000000000003 110.936 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -136.77 -167.72 2.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.126 -0.488 . . . . 72.200000000000003 110.958 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.57 -165.22 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.433 . . . . 73.010000000000005 111.085 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.446 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 34.7 p-10 -77.69 12.07 1.83 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 73.400000000000006 110.844 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.479 ' N ' ' CD1' ' A' ' 39' ' ' TRP . 1.7 m0 77.62 92.91 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.158 -0.474 . . . . 65.519999999999996 110.908 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -175.89 -53.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 62.409999999999997 110.881 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.26 -70.99 1.3 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.74 -0.743 . . . . 62.210000000000001 112.509 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -32.62 18.17 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.646 2.23 . . . . 71.010000000000005 112.351 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.534 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -59.42 -33.45 71.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 72.230000000000004 110.884 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.53 -28.81 70.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 64.319999999999993 110.898 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 4.6 mmt -87.21 -41.55 13.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 64.430000000000007 110.867 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.522 ' HA ' HG22 ' A' ' 49' ' ' VAL . 2.9 t -94.13 22.16 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 72.420000000000002 111.115 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.78 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -76.75 -61.08 0.77 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.561 0.696 . . . . 70.310000000000002 111.08 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.78 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.9 Cg_endo -69.76 -49.91 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.711 2.274 . . . . 63.329999999999998 112.326 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.612 ' O ' HD12 ' A' ' 53' ' ' ILE . 4.3 m -51.02 -30.42 9.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 72.25 111.112 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.555 HD23 ' O ' ' A' ' 50' ' ' LEU . 7.3 tt -82.95 -36.83 24.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.16 -0.473 . . . . 71.109999999999999 110.945 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -58.9 -35.29 72.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 74.439999999999998 110.907 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -61.82 -67.88 0.37 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 74.099999999999994 110.891 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.612 HD12 ' O ' ' A' ' 49' ' ' VAL . 3.0 mt -51.38 -37.32 18.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 72.439999999999998 111.12 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.82 -41.38 87.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 61.049999999999997 111.072 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.97 -47.24 78.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 72.409999999999997 110.896 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -69.99 -37.37 75.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 73.310000000000002 110.874 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.0 mmtt -55.6 -66.5 0.41 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 70.310000000000002 110.899 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.26 173.9 15.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 52.240000000000002 110.808 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.94 -41.19 41.75 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.74 -0.743 . . . . 44.0 112.52 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.6 p -149.81 53.86 0.93 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.791 0.329 . . . . 54.240000000000002 111.155 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.8 pp -58.33 -175.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 73.010000000000005 110.951 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.503 ' HD2' HG22 ' A' ' 31' ' ' VAL . 32.0 mttp -85.63 124.71 32.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 71.230000000000004 110.938 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.573 ' HB ' HG22 ' A' ' 12' ' ' THR . 57.3 t -131.74 105.35 9.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 53.409999999999997 111.134 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -118.04 139.19 51.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 64.5 111.112 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -134.94 158.75 43.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 75.319999999999993 110.912 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.582 HD22 ' CD2' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -139.71 142.66 36.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.435 . . . . 70.329999999999998 110.974 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.88 107.28 19.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.201 -0.454 . . . . 44.009999999999998 110.871 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 69.4 t -57.47 -36.01 51.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 74.120000000000005 111.162 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.87 -36.38 48.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 71.319999999999993 110.908 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.29 -35.18 10.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 64.219999999999999 111.081 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.485 ' HB2' HD21 ' A' ' 66' ' ' LEU . 2.1 m-80 -115.72 73.59 4.46 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.63 0.728 . . . . 44.109999999999999 110.89 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -30.87 21.41 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.672 2.248 . . . . 44.350000000000001 112.319 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -64.9 -38.96 92.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.429 . . . . 73.120000000000005 110.898 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.6 ' HB1' ' HE2' ' A' ' 35' ' ' PHE . . . -54.48 -48.88 71.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.492 . . . . 63.210000000000001 111.094 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.615 ' HB1' ' HB ' ' A' ' 80' ' ' VAL . . . -53.37 -64.05 0.95 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 73.239999999999995 111.102 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.5 ttp180 -51.23 -34.01 30.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 73.230000000000004 110.899 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -51.73 -40.04 59.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 74.420000000000002 110.892 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -106.65 28.45 7.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 73.030000000000001 110.891 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 50.33 52.88 13.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 74.030000000000001 110.877 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.615 ' HB ' ' HB1' ' A' ' 75' ' ' ALA . 87.7 t -89.63 109.19 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 60.409999999999997 111.135 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.9 t -96.18 -35.74 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 74.099999999999994 111.112 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.5 t -103.12 146.0 29.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 70.010000000000005 110.838 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.54 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 1.1 mp -56.9 -57.43 24.37 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.594 0.711 . . . . 64.010000000000005 111.136 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.647 ' CB ' ' HB2' ' A' ' 101' ' ' ALA . 53.7 Cg_endo -69.76 78.34 1.01 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.668 2.245 . . . . 63.240000000000002 112.329 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.676 HG23 ' CG1' ' A' ' 99' ' ' VAL . 77.0 m -116.72 111.64 20.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.26 -0.427 . . . . 73.549999999999997 111.138 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 10.4 ttp -113.48 122.96 48.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 65.540000000000006 110.896 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.427 ' O ' HG12 ' A' ' 33' ' ' VAL . 20.9 mt -115.53 122.22 68.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 73.340000000000003 111.114 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 16.3 tp -88.16 105.7 17.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.485 . . . . 74.549999999999997 110.895 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -90.18 170.33 10.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 70.420000000000002 110.871 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -168.46 94.64 0.36 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.484 . . . . 63.049999999999997 110.88 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.89 35.85 10.91 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.775 -0.726 . . . . 31.399999999999999 112.48 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.402 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 70.84 37.94 65.76 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.75 -0.738 . . . . 43.420000000000002 112.494 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.459 HG23 ' HD2' ' A' ' 94' ' ' PRO . 85.1 m -161.13 134.16 4.63 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.572 0.701 . . . . 74.420000000000002 111.133 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.459 ' HD2' HG23 ' A' ' 93' ' ' THR . 54.0 Cg_endo -69.73 82.56 0.74 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.646 2.231 . . . . 70.430000000000007 112.37 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.7 m -64.76 -35.02 73.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 70.329999999999998 111.092 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.415 ' HE2' ' HB1' ' A' ' 114' ' ' ALA . 0.0 OUTLIER -140.95 170.02 16.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 73.099999999999994 110.927 179.919 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.476 ' C ' HD12 ' A' ' 98' ' ' ILE . 66.2 ttt180 -158.31 125.5 4.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 73.349999999999994 110.839 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.476 HD12 ' C ' ' A' ' 97' ' ' ARG . 4.8 mp -134.12 125.41 48.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 64.540000000000006 111.12 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.676 ' CG1' HG23 ' A' ' 85' ' ' THR . 10.6 m -132.77 150.96 33.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 71.129999999999995 111.096 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 140.99 -29.81 2.3 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.711 -0.757 . . . . 72.0 112.491 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.647 ' HB2' ' CB ' ' A' ' 84' ' ' PRO . . . 63.27 73.73 0.44 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.841 0.353 . . . . 72.540000000000006 111.07 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.41 -177.23 3.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 70.0 110.873 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.65 166.74 9.13 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.786 -0.721 . . . . 72.040000000000006 112.495 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.5 ptmt -55.71 -46.43 77.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.796 0.332 . . . . 55.509999999999998 110.93 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.23 -62.24 1.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 71.409999999999997 111.088 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.69 -56.57 18.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 70.340000000000003 111.108 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.547 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.8 OUTLIER -51.14 -41.97 60.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 73.510000000000005 110.912 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.437 HD23 ' C ' ' A' ' 108' ' ' LEU . 10.4 tt -63.98 -59.34 4.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 74.25 110.881 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -53.0 -38.77 62.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 73.540000000000006 110.865 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -51.1 -27.03 7.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 74.019999999999996 110.906 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.4 mt -82.87 -68.31 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 62.420000000000002 111.12 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -51.96 -47.86 64.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 45.450000000000003 110.866 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -57.81 -34.97 70.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.474 . . . . 73.310000000000002 110.837 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.415 ' HB1' ' HE2' ' A' ' 96' ' ' LYS . . . -76.36 -35.68 58.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 65.209999999999994 111.112 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.2 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 74.200000000000003 110.895 -179.931 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.1 ptm . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.79 0.328 . . . . 71.109999999999999 110.884 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.95 93.86 4.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 45.039999999999999 111.112 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -98.29 -45.52 6.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.45 . . . . 65.530000000000001 110.86 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 43.9 t-80 -68.16 132.85 47.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 75.230000000000004 110.87 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -98.03 170.01 9.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 71.329999999999998 110.854 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 29.6 p80 -119.55 30.75 6.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 65.120000000000005 110.86 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 43.6 p-80 -74.4 -36.15 63.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 72.209999999999994 110.815 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -95.97 11.25 34.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 75.420000000000002 110.867 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 5.5 ttt -53.81 -36.63 62.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 73.340000000000003 110.861 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.7 t -52.53 117.53 2.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.247 -0.433 . . . . 52.450000000000003 110.86 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 123.17 169.85 13.35 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.758 -0.734 . . . . 55.020000000000003 112.486 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.532 HG22 ' HB ' ' A' ' 63' ' ' VAL . 81.7 p -61.71 100.02 0.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.82 0.343 . . . . 64.409999999999997 111.133 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.1 t -147.18 146.41 18.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 53.100000000000001 111.138 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.4 t -73.88 152.52 40.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.167 -0.47 . . . . 50.549999999999997 111.178 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.509 HG22 ' CG2' ' A' ' 19' ' ' THR . 5.3 p -112.38 147.82 15.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 61.130000000000003 111.099 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.55 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.74 158.94 9.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 55.100000000000001 111.148 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.96 -50.48 16.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 74.099999999999994 110.861 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.8 t -58.96 -36.08 74.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 73.340000000000003 110.873 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.55 HG22 ' HB ' ' A' ' 16' ' ' THR . 6.1 t -85.42 -18.25 34.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 72.439999999999998 111.133 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.721 ' CE2' HG21 ' A' ' 24' ' ' VAL . 23.5 t80 -50.41 -31.78 15.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 74.340000000000003 110.857 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.406 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -71.1 -33.59 70.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 61.149999999999999 110.876 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.1 m -91.18 -15.95 28.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.237 -0.438 . . . . 73.200000000000003 111.145 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -93.18 -70.86 0.68 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.233 -0.44 . . . . 65.030000000000001 110.861 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 1.029 HG13 HG21 ' A' ' 31' ' ' VAL . 15.6 t -71.14 -70.49 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 75.019999999999996 111.113 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.624 HD23 ' HA3' ' A' ' 92' ' ' GLY . 7.1 mt -40.54 -60.08 1.2 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.122 -0.49 . . . . 73.349999999999994 110.877 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -50.44 -59.39 4.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 73.510000000000005 110.848 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.8 t -51.78 149.06 5.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 62.409999999999997 110.84 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -111.66 35.31 3.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 70.030000000000001 110.885 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.426 HG22 ' HD2' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -123.19 160.41 50.07 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.544 0.688 . . . . 61.299999999999997 111.144 -179.839 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.426 ' HD2' HG22 ' A' ' 29' ' ' THR . 53.6 Cg_endo -69.78 124.67 11.3 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.679 2.253 . . . . 71.200000000000003 112.339 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 1.029 HG21 HG13 ' A' ' 24' ' ' VAL . 95.0 t -103.57 122.37 56.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 32.5 111.137 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.573 HD22 HD23 ' A' ' 88' ' ' LEU . 4.0 mm? -93.72 100.08 12.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 44.020000000000003 110.87 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 87' ' ' ILE . 7.1 p -99.63 145.27 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 51.039999999999999 111.135 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.51 118.57 19.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 74.400000000000006 110.808 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -103.08 97.49 7.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 73.409999999999997 110.916 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.5 ' HH2' HD11 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -148.32 -167.83 2.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.146 -0.479 . . . . 71.409999999999997 110.902 -179.914 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.572 ' HA ' HG22 ' A' ' 68' ' ' VAL . . . -56.09 -166.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 60.409999999999997 111.097 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.432 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 18.0 t0 -78.51 12.46 1.99 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.434 . . . . 61.420000000000002 110.823 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.463 ' CD1' ' N ' ' A' ' 39' ' ' TRP . 1.6 m0 77.27 94.04 0.06 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.243 -0.435 . . . . 71.0 110.867 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 2.4 t -167.34 -54.18 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 74.319999999999993 110.872 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.01 -69.88 1.37 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.778 -0.725 . . . . 74.340000000000003 112.439 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -32.94 17.83 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.67 2.246 . . . . 73.230000000000004 112.355 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.546 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 45.5 t -52.02 -34.71 44.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 72.209999999999994 110.895 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -64.63 -34.63 78.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 71.439999999999998 110.883 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 42.1 mtt -84.11 -38.84 20.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.271 -0.422 . . . . 65.219999999999999 110.854 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.521 ' HA ' HG22 ' A' ' 49' ' ' VAL . 3.0 t -94.41 21.76 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.434 . . . . 74.209999999999994 111.108 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.791 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -76.89 -60.83 0.77 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.634 0.731 . . . . 75.340000000000003 111.073 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.791 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.7 Cg_endo -69.72 -49.58 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.697 2.265 . . . . 42.32 112.341 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.618 ' O ' HD12 ' A' ' 53' ' ' ILE . 4.4 m -51.04 -30.23 9.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 75.340000000000003 111.132 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.515 ' HG ' HG12 ' A' ' 46' ' ' VAL . 4.4 mt -69.67 -38.2 76.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.123 -0.489 . . . . 34.539999999999999 110.934 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 8.3 mm-40 -71.93 -35.07 69.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 74.549999999999997 110.889 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -51.27 -66.42 0.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.495 . . . . 74.430000000000007 110.849 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.618 HD12 ' O ' ' A' ' 49' ' ' VAL . 2.5 mp -51.23 -33.11 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 73.340000000000003 111.13 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 51' ' ' GLU . . . -63.19 -52.38 62.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 74.319999999999993 111.127 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.81 -35.58 81.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 73.319999999999993 110.846 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -67.92 -36.0 79.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 73.120000000000005 110.908 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -70.02 -69.81 0.33 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 54.340000000000003 110.905 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.0 t 63.23 40.04 9.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 54.219999999999999 110.877 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -122.81 42.16 1.67 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.768 -0.729 . . . . 70.439999999999998 112.468 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.4 p 46.27 48.87 13.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.803 0.335 . . . . 62.340000000000003 111.163 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.5 pp -87.59 141.81 28.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 61.409999999999997 110.911 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.4 tptt -95.5 149.47 21.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.475 . . . . 74.209999999999994 110.914 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.532 ' HB ' HG22 ' A' ' 12' ' ' THR . 22.4 t -126.93 106.96 16.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 71.200000000000003 111.165 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -118.13 126.61 52.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 74.239999999999995 111.088 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -110.4 159.29 17.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 62.049999999999997 110.93 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.511 HD21 ' HB2' ' A' ' 71' ' ' ASN . 11.1 tp -137.1 145.92 44.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.434 . . . . 71.409999999999997 110.891 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -97.6 119.62 36.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 71.540000000000006 110.846 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.572 HG22 ' HA ' ' A' ' 37' ' ' ALA . 28.8 m -61.5 -35.18 65.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 74.400000000000006 111.138 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.13 -35.28 47.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 74.409999999999997 110.843 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.47 -35.24 11.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 44.229999999999997 111.078 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.511 ' HB2' HD21 ' A' ' 66' ' ' LEU . 1.4 m-80 -118.36 68.2 7.36 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.57 0.7 . . . . 65.219999999999999 110.868 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 -33.43 16.67 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.666 2.244 . . . . 54.329999999999998 112.38 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -68.28 -36.26 79.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 73.430000000000007 110.928 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.59 -47.45 79.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 74.510000000000005 111.09 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.666 ' HB1' ' HB ' ' A' ' 80' ' ' VAL . . . -56.31 -56.37 21.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 64.049999999999997 111.1 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -51.27 -34.19 31.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 54.140000000000001 110.854 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -58.05 -35.92 72.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 61.009999999999998 110.869 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -102.29 26.39 7.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 74.329999999999998 110.883 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 50.1 36.43 12.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 62.229999999999997 110.905 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.666 ' HB ' ' HB1' ' A' ' 75' ' ' ALA . 97.6 t -68.87 103.43 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 70.25 111.143 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 67.1 t -92.18 -35.04 6.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 75.400000000000006 111.174 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 t -105.61 151.76 23.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.481 . . . . 72.519999999999996 110.849 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.538 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.4 mt -60.58 -57.69 24.71 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.658 0.742 . . . . 73.239999999999995 111.139 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 54.1 Cg_endo -69.78 74.1 1.33 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.651 2.234 . . . . 71.230000000000004 112.347 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.985 HG23 HG22 ' A' ' 99' ' ' VAL . 84.0 m -108.99 137.99 46.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.223 -0.444 . . . . 73.319999999999993 111.178 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 10.2 ttm -135.17 145.91 48.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 70.109999999999999 110.878 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.48 ' O ' HG12 ' A' ' 33' ' ' VAL . 28.6 mt -143.07 128.85 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 72.310000000000002 111.138 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.573 HD23 HD22 ' A' ' 32' ' ' LEU . 2.2 tm? -95.2 107.94 20.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 74.120000000000005 110.906 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -92.06 170.29 9.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 73.420000000000002 110.909 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -162.49 106.24 1.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.479 . . . . 74.040000000000006 110.872 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.68 34.28 56.86 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.782 -0.723 . . . . 74.120000000000005 112.489 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.624 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 73.08 40.22 51.46 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.778 -0.725 . . . . 40.210000000000001 112.489 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.442 HG23 ' HD2' ' A' ' 94' ' ' PRO . 86.0 m -160.91 133.8 4.59 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.539 0.685 . . . . 53.420000000000002 111.149 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.442 ' HD2' HG23 ' A' ' 93' ' ' THR . 53.8 Cg_endo -69.77 84.77 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.698 2.265 . . . . 72.299999999999997 112.329 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.5 m -72.37 -35.11 50.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 75.230000000000004 111.117 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -136.32 170.05 16.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 64.409999999999997 110.937 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.554 ' C ' HD12 ' A' ' 98' ' ' ILE . 20.2 ttt-85 -155.97 128.55 7.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 61.039999999999999 110.9 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.554 HD12 ' C ' ' A' ' 97' ' ' ARG . 4.5 mp -138.05 111.67 7.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.462 . . . . 61.25 111.141 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.985 HG22 HG23 ' A' ' 85' ' ' THR . 48.9 t -109.62 133.07 56.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 71.0 111.165 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 136.57 137.4 3.65 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.754 -0.736 . . . . 73.519999999999996 112.479 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.47 83.15 4.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.87 0.367 . . . . 50.5 111.054 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.449 ' HG2' HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -120.03 174.07 6.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 65.349999999999994 110.931 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.87 171.89 5.68 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.719 -0.753 . . . . 74.409999999999997 112.463 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.66 -44.88 90.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.81 0.338 . . . . 51.520000000000003 110.923 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.64 -64.14 0.95 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 64.150000000000006 111.143 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.81 -58.34 7.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 71.349999999999994 111.142 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.49 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.2 OUTLIER -50.67 -40.94 54.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 61.100000000000001 110.924 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.509 ' O ' HD12 ' A' ' 108' ' ' LEU . 3.7 tp -64.7 -54.17 35.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 64.200000000000003 110.921 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -51.45 -43.06 61.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 53.210000000000001 110.86 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -51.12 -27.24 7.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 74.430000000000007 110.881 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.3 mt -83.08 -68.99 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 71.120000000000005 111.143 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.423 ' O ' HD23 ' A' ' 115' ' ' LEU . 9.0 pt-20 -50.9 -48.78 60.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 63.119999999999997 110.884 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -52.79 -32.48 44.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.479 . . . . 74.049999999999997 110.9 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.59 -33.77 71.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 71.120000000000005 111.108 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.423 HD23 ' O ' ' A' ' 112' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 71.230000000000004 110.929 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.798 0.332 . . . . 62.219999999999999 110.889 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.24 64.03 5.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 72.230000000000004 111.089 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -95.32 -43.41 8.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 72.219999999999999 110.825 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -81.39 171.22 15.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 71.230000000000004 110.864 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -145.39 155.65 43.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 75.319999999999993 110.841 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -119.71 -40.42 2.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 71.540000000000006 110.851 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 39.6 p-80 -52.02 -36.27 49.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 72.530000000000001 110.846 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -54.5 -47.86 72.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 62.530000000000001 110.824 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -51.99 -36.22 49.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 55.340000000000003 110.853 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.0 t -52.28 129.7 28.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 43.119999999999997 110.846 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.31 171.61 47.43 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.715 -0.755 . . . . 71.230000000000004 112.464 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.422 HG22 ' HB ' ' A' ' 63' ' ' VAL . 44.5 p -61.27 110.73 1.49 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.827 0.346 . . . . 72.400000000000006 111.165 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.7 t -145.95 146.15 19.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 72.239999999999995 111.123 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.0 m -75.75 125.82 29.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 62.240000000000002 111.159 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.5 t -89.93 127.11 42.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 71.430000000000007 111.156 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.492 ' CB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.13 177.22 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 72.200000000000003 111.151 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.463 ' H ' HG22 ' A' ' 16' ' ' THR . 0.6 OUTLIER -80.1 -35.06 37.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.232 -0.44 . . . . 72.040000000000006 110.882 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.8 t -84.62 -51.73 6.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 64.129999999999995 110.85 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.492 HG22 ' CB ' ' A' ' 16' ' ' THR . 6.2 t -58.43 -19.55 37.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 72.230000000000004 111.167 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.72 ' CE2' HG21 ' A' ' 24' ' ' VAL . 25.1 t80 -51.25 -30.27 17.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 62.240000000000002 110.872 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.417 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -72.47 -34.1 67.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 64.239999999999995 110.898 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.8 m -91.26 -15.99 28.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 65.310000000000002 111.145 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -93.55 -71.53 0.65 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 61.020000000000003 110.851 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.916 HG13 HG21 ' A' ' 31' ' ' VAL . 21.2 t -70.15 -70.65 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 71.549999999999997 111.156 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.609 HD23 ' HA3' ' A' ' 92' ' ' GLY . 7.9 mt -40.6 -60.3 1.16 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.113 -0.494 . . . . 73.329999999999998 110.936 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -50.27 -52.8 33.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 61.210000000000001 110.866 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.9 t -57.21 155.06 9.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 74.200000000000003 110.822 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -104.36 -44.27 4.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.483 . . . . 72.25 110.827 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -51.54 160.0 1.11 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.583 0.706 . . . . 54.32 111.114 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 126.83 13.72 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.63 2.22 . . . . 74.109999999999999 112.336 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.916 HG21 HG13 ' A' ' 24' ' ' VAL . 80.1 t -97.69 127.52 49.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 71.310000000000002 111.159 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.47 HD11 HD11 ' A' ' 88' ' ' LEU . 6.3 mp -103.22 100.11 10.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 71.209999999999994 110.924 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.6 p -102.82 138.46 27.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 74.439999999999998 111.092 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.96 118.43 22.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 73.019999999999996 110.906 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -96.16 90.38 5.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 74.519999999999996 110.893 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -135.6 -167.94 2.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.152 -0.476 . . . . 73.549999999999997 110.969 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.42 ' HA ' HG22 ' A' ' 68' ' ' VAL . . . -56.18 -166.34 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.432 . . . . 60.130000000000003 111.092 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.446 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 9.3 p-10 -78.2 12.45 1.87 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 63.219999999999999 110.863 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.462 ' N ' ' CD1' ' A' ' 39' ' ' TRP . 1.3 m0 76.98 92.95 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 72.420000000000002 110.912 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 36.4 t -170.72 -58.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.441 . . . . 73.430000000000007 110.879 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.8 -71.02 1.25 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.778 -0.725 . . . . 65.430000000000007 112.484 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 -32.2 18.79 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.694 2.263 . . . . 72.219999999999999 112.331 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.536 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 36.3 t -60.23 -32.37 71.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 63.439999999999998 110.867 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -30.21 71.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 71.319999999999993 110.938 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 7.3 mmm -88.44 -39.91 13.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 55.109999999999999 110.858 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.564 ' HA ' HG22 ' A' ' 49' ' ' VAL . 3.1 t -94.25 22.34 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 42.310000000000002 111.096 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.803 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -76.04 -61.04 0.9 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.596 0.712 . . . . 73.019999999999996 111.113 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.803 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.6 Cg_endo -69.78 -50.1 0.49 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.739 2.293 . . . . 61.020000000000003 112.349 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.577 ' O ' HD12 ' A' ' 53' ' ' ILE . 4.4 m -52.86 -31.02 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 74.099999999999994 111.172 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.7 tp -70.33 -41.22 73.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 74.109999999999999 110.914 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -69.81 -34.61 73.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 64.239999999999995 110.906 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -56.39 -63.17 1.28 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 65.409999999999997 110.886 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.577 HD12 ' O ' ' A' ' 49' ' ' VAL . 3.8 mt -53.04 -45.09 52.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 73.150000000000006 111.106 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.462 ' HA ' HD21 ' A' ' 61' ' ' LEU . . . -61.41 -23.35 65.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 75.450000000000003 111.113 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.34 -45.38 19.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 71.319999999999993 110.888 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -74.31 -45.51 47.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 52.409999999999997 110.919 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -51.52 -73.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 74.239999999999995 110.918 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.46 -168.81 2.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 74.420000000000002 110.879 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -109.32 116.88 4.71 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.734 -0.746 . . . . 72.0 112.464 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.8 p 49.83 44.28 25.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.833 0.349 . . . . 71.430000000000007 111.107 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.462 HD21 ' HA ' ' A' ' 54' ' ' ALA . 3.6 pp -58.16 -176.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.257 -0.429 . . . . 75.329999999999998 110.963 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -79.78 119.11 22.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.192 -0.458 . . . . 62.299999999999997 110.856 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.422 ' HB ' HG22 ' A' ' 12' ' ' THR . 58.6 t -118.93 100.89 10.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 63.299999999999997 111.132 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -126.22 132.16 51.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 62.420000000000002 111.105 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -129.36 160.02 34.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 72.200000000000003 110.855 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.483 HD21 ' CB ' ' A' ' 71' ' ' ASN . 18.9 tp -136.16 148.91 48.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 75.420000000000002 110.944 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.78 112.36 24.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.176 -0.465 . . . . 71.120000000000005 110.849 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.42 HG22 ' HA ' ' A' ' 37' ' ' ALA . 27.4 m -59.5 -35.6 59.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 74.230000000000004 111.144 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.55 -36.46 61.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 74.439999999999998 110.868 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.47 -35.22 13.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 72.299999999999997 111.091 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.483 ' CB ' HD21 ' A' ' 66' ' ' LEU . 1.7 m-80 -117.27 68.79 5.23 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.62 0.724 . . . . 74.030000000000001 110.884 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 -32.65 18.39 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.725 2.283 . . . . 61.530000000000001 112.384 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -65.23 -36.28 83.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 74.230000000000004 110.891 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.17 -44.81 96.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 75.439999999999998 111.138 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.674 ' HB1' ' HB ' ' A' ' 80' ' ' VAL . . . -52.57 -61.55 2.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 61.25 111.087 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.5 ttp180 -50.97 -34.79 30.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 73.510000000000005 110.9 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -51.89 -35.92 46.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.486 . . . . 72.400000000000006 110.859 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -108.87 27.89 9.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.449 . . . . 73.129999999999995 110.882 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 50.59 55.76 9.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.495 . . . . 61.530000000000001 110.906 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.674 ' HB ' ' HB1' ' A' ' 75' ' ' ALA . 91.0 t -92.24 104.97 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 50.43 111.115 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 57.4 t -96.44 -35.06 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 63.009999999999998 111.124 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.8 m -102.84 146.64 27.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 73.140000000000001 110.89 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.531 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 5.1 mt -58.19 -57.57 25.1 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.621 0.724 . . . . 71.109999999999999 111.144 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.637 ' CB ' ' HB2' ' A' ' 101' ' ' ALA . 53.5 Cg_endo -69.78 76.39 1.15 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.65 2.233 . . . . 74.25 112.33 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.669 HG23 ' CG1' ' A' ' 99' ' ' VAL . 73.6 m -113.99 134.95 54.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 72.329999999999998 111.112 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 14.2 ttt -133.85 126.42 30.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 64.239999999999995 110.883 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.0 mt -116.97 115.19 48.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 72.239999999999995 111.152 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.47 HD11 HD11 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -81.11 106.31 13.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 75.530000000000001 110.92 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -93.34 170.05 9.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 72.439999999999998 110.932 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -165.74 91.43 0.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 73.530000000000001 110.878 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.82 36.91 8.19 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.715 -0.755 . . . . 61.439999999999998 112.497 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.609 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 68.64 39.3 86.52 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.773 -0.727 . . . . 70.430000000000007 112.488 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.456 HG23 ' HD2' ' A' ' 94' ' ' PRO . 88.6 m -160.53 133.99 4.86 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.58 0.705 . . . . 72.209999999999994 111.156 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.456 ' HD2' HG23 ' A' ' 93' ' ' THR . 53.7 Cg_endo -69.79 109.56 2.35 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.661 2.241 . . . . 64.310000000000002 112.374 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.3 m -101.6 -32.99 3.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.46 . . . . 70.439999999999998 111.138 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.464 ' HD2' ' HB3' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -132.73 164.63 26.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.483 . . . . 62.340000000000003 110.906 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.441 ' C ' HD12 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -155.84 117.51 3.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 64.099999999999994 110.852 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.441 ' N ' HD12 ' A' ' 98' ' ' ILE . 4.7 mp -132.56 130.91 59.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 74.439999999999998 111.126 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.669 ' CG1' HG23 ' A' ' 85' ' ' THR . 11.1 m -138.16 145.39 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 73.319999999999993 111.129 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 146.39 -26.88 1.69 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.745 -0.74 . . . . 73.040000000000006 112.522 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.637 ' HB2' ' CB ' ' A' ' 84' ' ' PRO . . . 62.7 68.35 0.65 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.843 0.354 . . . . 74.549999999999997 111.09 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.2 169.1 9.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 74.409999999999997 110.897 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.77 150.16 39.48 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.744 -0.741 . . . . 52.420000000000002 112.47 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.576 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -48.39 -34.99 11.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.809 0.338 . . . . 73.310000000000002 110.88 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.16 -40.39 77.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 42.020000000000003 111.078 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.76 -49.8 6.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 63.32 111.131 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.7 -52.94 16.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 62.520000000000003 110.961 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.576 HD23 ' O ' ' A' ' 104' ' ' LYS . 1.6 pp -48.12 -35.58 11.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.468 . . . . 71.109999999999999 110.911 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 46.1 mtp85 -74.25 -42.24 59.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 75.5 110.865 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -51.48 -25.0 5.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 62.43 110.926 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.4 mt -87.68 -69.29 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 53.539999999999999 111.167 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -51.11 -49.39 60.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 74.129999999999995 110.873 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -58.91 -34.13 71.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 63.32 110.84 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.464 ' HB3' ' HD2' ' A' ' 96' ' ' LYS . . . -75.09 -35.64 61.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 64.219999999999999 111.116 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.4 mt . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 64.409999999999997 110.971 179.954 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.2 ptm . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.777 0.322 . . . . 61.130000000000003 110.897 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.93 91.84 6.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 74.430000000000007 111.107 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.5 t60 -95.43 -40.5 9.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 75.049999999999997 110.889 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -118.24 144.01 46.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 75.140000000000001 110.829 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -58.84 163.3 3.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 74.109999999999999 110.857 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 61.6 m80 -106.46 -38.1 6.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 63.43 110.854 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -82.36 -36.21 27.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.436 . . . . 74.430000000000007 110.838 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -70.7 -39.46 73.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 74.209999999999994 110.87 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 28.8 mtp -100.04 30.84 3.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 72.25 110.867 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.5 m -60.26 121.12 11.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.28 -0.418 . . . . 73.200000000000003 110.856 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.52 174.71 38.09 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.773 -0.727 . . . . 53.229999999999997 112.523 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.625 HG22 ' HB ' ' A' ' 63' ' ' VAL . 82.4 p -74.11 99.77 3.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.863 0.363 . . . . 73.439999999999998 111.121 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 98.6 t -150.16 143.68 17.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.225 -0.443 . . . . 75.409999999999997 111.093 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.8 t -67.71 126.98 31.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 75.430000000000007 111.131 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 74.7 t -94.82 130.44 43.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 72.239999999999995 111.13 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.599 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.72 160.52 7.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 61.229999999999997 111.161 -179.952 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -73.62 -41.52 62.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.255 -0.43 . . . . 74.040000000000006 110.846 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.6 m -70.39 -34.53 72.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 70.319999999999993 110.885 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.599 HG22 ' HB ' ' A' ' 16' ' ' THR . 7.3 t -85.19 -17.97 35.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 72.030000000000001 111.108 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.724 ' CE2' HG21 ' A' ' 24' ' ' VAL . 24.2 t80 -50.64 -31.23 15.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 62.25 110.859 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.436 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -71.74 -33.48 68.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.149 -0.478 . . . . 72.150000000000006 110.885 179.923 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.6 m -91.7 -16.23 27.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 73.129999999999995 111.182 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -93.36 -71.42 0.65 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 63.119999999999997 110.888 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.842 HG13 HG21 ' A' ' 31' ' ' VAL . 17.9 t -70.39 -70.3 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 71.450000000000003 111.165 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.589 HD23 ' HA3' ' A' ' 92' ' ' GLY . 7.6 mt -40.7 -60.21 1.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 75.530000000000001 110.886 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -50.36 -58.73 5.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 74.230000000000004 110.876 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.3 t -54.02 171.33 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 73.219999999999999 110.876 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -117.73 -40.96 2.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 74.140000000000001 110.836 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.655 HG21 ' OG1' ' A' ' 60' ' ' THR . 0.0 OUTLIER -53.05 159.47 1.91 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.59 0.71 . . . . 65.299999999999997 111.128 -179.905 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.478 ' HD2' HG22 ' A' ' 29' ' ' THR . 54.4 Cg_endo -69.7 131.08 20.57 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.715 2.276 . . . . 63.210000000000001 112.369 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.842 HG21 HG13 ' A' ' 24' ' ' VAL . 96.7 t -105.02 125.26 60.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 53.43 111.11 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.694 ' CD1' HD13 ' A' ' 61' ' ' LEU . 4.7 mt -102.23 100.65 10.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 63.43 110.887 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.3 p -98.55 133.57 40.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 64.430000000000007 111.172 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -115.49 99.55 7.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.225 -0.443 . . . . 75.019999999999996 110.839 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -90.47 89.39 7.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 64.430000000000007 110.887 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -145.87 -169.05 3.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.143 -0.48 . . . . 75.010000000000005 110.917 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.37 -156.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 72.109999999999999 111.099 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.476 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 5.3 m-20 -77.61 9.54 3.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.202 -0.453 . . . . 70.400000000000006 110.862 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.476 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 1.0 OUTLIER 41.87 71.08 0.23 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 74.409999999999997 110.935 -179.933 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 44.5 t -132.63 -45.51 0.89 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 73.420000000000002 110.915 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.75 -67.39 1.52 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.722 -0.751 . . . . 62.219999999999999 112.503 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -24.11 30.08 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.713 2.275 . . . . 71.230000000000004 112.326 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 11.9 p -51.92 -27.13 12.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 74.200000000000003 110.877 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? -61.52 -33.72 74.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 63.310000000000002 110.882 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 6.2 mtp -86.48 -36.52 18.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 73.329999999999998 110.889 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.521 ' HA ' HG22 ' A' ' 49' ' ' VAL . 2.9 t -94.04 21.2 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 74.329999999999998 111.126 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.754 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -76.79 -60.8 0.79 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.596 0.712 . . . . 73.019999999999996 111.051 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.754 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.6 Cg_endo -69.73 -49.13 0.59 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.672 2.248 . . . . 72.230000000000004 112.335 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.717 HG12 ' HG3' ' A' ' 104' ' ' LYS . 4.0 m -51.44 -29.18 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 63.229999999999997 111.155 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.4 tp -84.1 -36.02 23.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 63.039999999999999 110.898 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -71.68 -31.98 67.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 74.439999999999998 110.911 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -49.87 -68.2 0.2 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 74.099999999999994 110.895 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.483 ' H ' HD12 ' A' ' 53' ' ' ILE . 4.0 mp -51.45 -36.66 17.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.178 -0.465 . . . . 62.310000000000002 111.12 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.602 ' HA ' HD21 ' A' ' 61' ' ' LEU . . . -63.05 -40.25 97.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 75.329999999999998 111.103 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.77 -39.26 44.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 73.219999999999999 110.871 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -58.95 -41.19 86.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 73.439999999999998 110.921 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.2 mmtp -69.97 -70.33 0.3 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.475 . . . . 75.030000000000001 110.889 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.3 t 62.85 40.29 9.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 42.219999999999999 110.829 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -120.17 53.81 0.67 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.722 -0.752 . . . . 63.420000000000002 112.499 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.655 ' OG1' HG21 ' A' ' 29' ' ' THR . 13.5 p 49.82 41.86 23.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.859 0.361 . . . . 64.239999999999995 111.163 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.694 HD13 ' CD1' ' A' ' 32' ' ' LEU . 2.5 pp -81.99 136.98 35.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 74.340000000000003 110.916 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.1 mtmp? -102.0 139.97 36.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.228 -0.442 . . . . 73.319999999999993 110.877 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.625 ' HB ' HG22 ' A' ' 12' ' ' THR . 21.7 t -120.55 104.33 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 74.349999999999994 111.141 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -104.5 121.47 43.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 55.039999999999999 111.122 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.87 131.42 54.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 64.340000000000003 110.896 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.512 HD21 ' CG ' ' A' ' 71' ' ' ASN . 44.0 tp -123.83 155.47 37.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.227 -0.442 . . . . 74.329999999999998 110.952 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.45 114.85 27.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 74.450000000000003 110.856 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 79.5 t -61.38 -35.27 65.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 71.549999999999997 111.126 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -51.86 -36.88 49.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 74.349999999999994 110.887 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.93 -34.46 13.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 64.209999999999994 111.072 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.512 ' CG ' HD21 ' A' ' 66' ' ' LEU . 3.1 m120 -117.42 69.61 5.91 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.629 0.728 . . . . 72.150000000000006 110.892 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -32.31 18.81 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.744 2.296 . . . . 73.120000000000005 112.335 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -58.72 -37.58 76.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.438 . . . . 73.010000000000005 110.881 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.97 -47.88 67.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 53.109999999999999 111.065 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.56 ' O ' HG23 ' A' ' 80' ' ' VAL . . . -54.02 -63.47 1.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 75.349999999999994 111.047 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.5 ttp85 -51.56 -33.18 31.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 72.140000000000001 110.868 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -50.99 -39.98 56.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 43.399999999999999 110.873 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -104.39 24.15 12.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 64.040000000000006 110.905 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 47.85 66.55 1.01 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 61.549999999999997 110.911 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 75' ' ' ALA . 95.9 t -87.58 106.8 16.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 75.430000000000007 111.136 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.6 t -80.26 -58.39 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 64.230000000000004 111.139 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.3 m -91.65 163.28 14.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.468 . . . . 71.439999999999998 110.835 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.531 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 1.7 mp -65.3 -58.17 12.97 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.639 0.733 . . . . 54.43 111.133 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.7 Cg_endo -69.75 74.86 1.25 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.658 2.238 . . . . 72.420000000000002 112.374 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.507 ' OG1' HG13 ' A' ' 80' ' ' VAL . 99.7 m -113.87 106.0 13.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 74.230000000000004 111.119 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 9.4 ttp -116.16 121.84 43.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 74.310000000000002 110.865 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.0 mp -104.69 119.04 53.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 73.040000000000006 111.102 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.639 ' CD2' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -80.17 104.56 10.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 72.430000000000007 110.857 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -89.77 169.86 10.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 74.329999999999998 110.9 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -167.71 93.67 0.4 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 75.319999999999993 110.908 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.42 38.77 8.73 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.758 -0.734 . . . . 62.399999999999999 112.5 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.589 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 69.37 37.21 79.49 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.783 -0.722 . . . . 74.019999999999996 112.46 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.459 HG23 ' HD2' ' A' ' 94' ' ' PRO . 85.0 m -160.72 133.78 4.67 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.554 0.692 . . . . 74.140000000000001 111.138 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.459 ' HD2' HG23 ' A' ' 93' ' ' THR . 53.6 Cg_endo -69.74 83.01 0.71 Allowed 'Trans proline' 0 C--N 1.34 0.126 0 C-N-CA 122.703 2.269 . . . . 55.140000000000001 112.292 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.8 m -64.98 -33.88 66.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 73.329999999999998 111.133 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.66 170.22 16.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 63.299999999999997 110.91 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -153.35 127.44 9.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 62.210000000000001 110.881 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.472 HG23 ' HB3' ' A' ' 110' ' ' GLU . 5.3 mp -131.0 143.19 41.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.193 -0.458 . . . . 54.450000000000003 111.144 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -142.13 141.05 29.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 61.43 111.164 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 119.08 145.59 7.7 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.767 -0.73 . . . . 44.539999999999999 112.549 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -100.89 89.1 3.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.893 0.378 . . . . 61.25 111.109 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -120.55 179.87 4.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 74.340000000000003 110.866 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.8 175.26 13.07 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.735 -0.745 . . . . 72.310000000000002 112.525 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.717 ' HG3' HG12 ' A' ' 49' ' ' VAL . 1.6 mtpt -58.18 -47.78 82.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.768 0.318 . . . . 72.310000000000002 110.894 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -53.48 -65.83 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.449 . . . . 72.409999999999997 111.093 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.466 ' HB3' ' HB2' ' A' ' 102' ' ' LYS . . . -50.97 -57.66 8.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 61.030000000000001 111.116 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.572 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.4 OUTLIER -50.82 -34.97 29.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 63.530000000000001 110.938 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.455 HD23 ' C ' ' A' ' 108' ' ' LEU . 9.1 tt -69.42 -60.34 2.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 71.340000000000003 110.927 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 45.1 mtp85 -54.47 -34.35 61.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 73.209999999999994 110.87 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.472 ' HB3' HG23 ' A' ' 98' ' ' ILE . 14.0 mm-40 -49.35 -26.74 3.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 64.450000000000003 110.868 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.3 mt -84.12 -69.73 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 73.150000000000006 111.121 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.677 ' HA ' HD23 ' A' ' 115' ' ' LEU . 3.1 pt-20 -52.75 -50.06 64.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 73.099999999999994 110.895 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -55.92 -34.61 65.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.116 -0.493 . . . . 71.25 110.884 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.1 -36.82 69.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 74.109999999999999 111.096 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.677 HD23 ' HA ' ' A' ' 112' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 64.209999999999994 110.92 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.7 mtt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.781 0.324 . . . . 73.099999999999994 110.891 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.62 103.56 0.34 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 74.519999999999996 111.086 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -73.84 -42.06 61.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 61.329999999999998 110.872 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 -120.65 137.28 54.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 63.310000000000002 110.833 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.9 m80 -57.75 157.94 6.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 74.010000000000005 110.837 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -105.39 30.87 5.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 72.25 110.859 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -76.55 -41.0 48.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 73.040000000000006 110.867 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -69.47 -35.94 76.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 73.409999999999997 110.86 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -97.81 30.81 2.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 70.099999999999994 110.87 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.5 m -62.1 116.33 4.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 44.200000000000003 110.818 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.78 -176.25 33.67 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.734 . . . . 31.219999999999999 112.48 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.3 p -77.09 104.79 7.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.84 0.352 . . . . 53.340000000000003 111.152 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 65.5 t -148.63 142.19 18.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 72.219999999999999 111.13 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.3 t -77.04 128.7 34.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 71.310000000000002 111.14 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.423 ' CG1' HG23 ' A' ' 19' ' ' THR . 47.6 t -91.36 126.59 44.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 74.239999999999995 111.109 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.652 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.6 OUTLIER -59.65 165.99 2.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 63.43 111.182 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.41 ' H ' HG22 ' A' ' 16' ' ' THR . 25.1 t0 -68.37 -48.04 65.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 74.430000000000007 110.868 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.0 t -69.1 -52.93 23.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 65.25 110.87 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.652 HG22 ' HB ' ' A' ' 16' ' ' THR . 6.4 t -59.36 -19.01 43.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 62.539999999999999 111.143 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.711 ' CE2' HG21 ' A' ' 24' ' ' VAL . 24.6 t80 -51.03 -30.74 16.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 72.420000000000002 110.84 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.422 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -72.07 -34.13 68.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 65.299999999999997 110.91 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.0 m -91.19 -16.0 28.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 72.340000000000003 111.178 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.39 -71.33 0.66 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 61.219999999999999 110.875 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.711 HG21 ' CE2' ' A' ' 20' ' ' PHE . 18.6 t -70.4 -70.47 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 64.409999999999997 111.149 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.519 HD23 ' HA3' ' A' ' 92' ' ' GLY . 7.4 mt -40.64 -60.49 1.13 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 50.119999999999997 110.869 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -50.32 -63.71 1.03 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 65.439999999999998 110.889 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.3 t -56.11 150.87 13.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 71.239999999999995 110.848 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -98.88 -36.45 9.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 75.040000000000006 110.814 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -52.67 159.84 1.6 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.567 0.699 . . . . 64.109999999999999 111.152 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.84 127.43 14.53 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.629 2.219 . . . . 72.329999999999998 112.355 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.664 HG21 HG13 ' A' ' 24' ' ' VAL . 99.4 t -102.18 124.4 56.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 72.420000000000002 111.157 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.661 HD23 HD13 ' A' ' 61' ' ' LEU . 3.5 mm? -91.41 123.44 34.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 64.439999999999998 110.908 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.409 HG11 ' CE1' ' A' ' 35' ' ' PHE . 12.9 t -118.6 139.54 45.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.206 -0.452 . . . . 73.129999999999995 111.132 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.528 ' OD1' HD11 ' A' ' 50' ' ' LEU . 1.6 m-20 -131.4 99.83 4.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 74.299999999999997 110.893 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.541 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 32.1 m-85 -91.05 89.54 7.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.462 . . . . 74.340000000000003 110.867 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.437 ' O ' HG13 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -148.98 -169.27 3.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 72.519999999999996 110.923 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.594 ' HA ' HG22 ' A' ' 68' ' ' VAL . . . -60.08 -155.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.436 . . . . 64.200000000000003 111.103 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.473 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 18.7 p-10 -77.93 8.64 4.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 62.329999999999998 110.896 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.473 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 1.6 p-90 41.55 65.77 0.79 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.187 -0.46 . . . . 63.409999999999997 110.899 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 35.8 t -122.58 -46.38 2.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.233 -0.439 . . . . 70.140000000000001 110.875 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.7 -67.62 1.53 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.751 -0.738 . . . . 74.120000000000005 112.458 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -25.57 28.28 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.675 2.25 . . . . 64.25 112.359 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 28.9 t -51.49 -31.76 24.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 31.23 110.885 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.59 -33.5 71.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 54.009999999999998 110.895 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 7.0 mtt -88.13 -35.71 17.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 75.340000000000003 110.891 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.447 ' HA ' HG22 ' A' ' 49' ' ' VAL . 3.1 t -93.51 21.18 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 54.149999999999999 111.148 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.792 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -80.14 -61.41 0.44 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.531 0.681 . . . . 74.530000000000001 111.062 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.792 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 54.3 Cg_endo -69.69 -45.55 1.59 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.665 2.243 . . . . 73.219999999999999 112.375 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' A' ' 46' ' ' VAL . 4.4 m -49.37 -31.34 5.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 73.040000000000006 111.13 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.528 HD11 ' OD1' ' A' ' 34' ' ' ASP . 4.7 tt -88.25 -44.83 10.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 70.420000000000002 110.939 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -58.3 -33.8 69.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 73.439999999999998 110.911 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -63.17 -32.28 73.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.169 -0.469 . . . . 73.040000000000006 110.92 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.449 HD13 ' N ' ' A' ' 53' ' ' ILE . 4.3 mm -64.92 -34.53 71.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 75.340000000000003 111.103 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.422 ' HA ' HD21 ' A' ' 61' ' ' LEU . . . -66.99 -43.03 84.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 72.010000000000005 111.09 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.05 -35.7 78.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 72.299999999999997 110.886 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -70.65 -36.11 73.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.147 -0.479 . . . . 73.430000000000007 110.869 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.19 -71.13 0.53 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 51.219999999999999 110.864 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.4 t -173.14 156.05 3.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.428 . . . . 75.510000000000005 110.886 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -96.23 33.22 5.76 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.772 -0.728 . . . . 51.0 112.495 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.8 t -121.47 -33.15 3.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.85 0.357 . . . . 75.040000000000006 111.138 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.661 HD13 HD23 ' A' ' 32' ' ' LEU . 3.6 pp -51.15 159.41 0.63 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 73.409999999999997 110.891 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.1 tptm -102.17 147.21 26.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 73.430000000000007 110.89 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.0 t -125.4 106.93 17.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 65.109999999999999 111.111 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -121.53 136.77 54.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 72.329999999999998 111.136 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -123.87 146.43 48.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 74.109999999999999 110.872 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.488 HD21 ' CB ' ' A' ' 71' ' ' ASN . 16.1 tp -127.03 152.09 47.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 63.25 110.918 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.588 ' OD2' ' HB3' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -103.29 121.23 42.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 70.310000000000002 110.885 179.85 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.594 HG22 ' HA ' ' A' ' 37' ' ' ALA . 33.1 m -62.24 -33.04 56.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 42.119999999999997 111.135 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -50.42 -35.77 30.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 60.219999999999999 110.926 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.588 ' HB3' ' OD2' ' A' ' 67' ' ' ASP . . . -100.26 -34.11 10.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 61.32 111.088 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.488 ' CB ' HD21 ' A' ' 66' ' ' LEU . 0.7 OUTLIER -121.32 68.07 19.14 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.594 0.711 . . . . 64.549999999999997 110.857 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -33.88 15.69 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.677 2.251 . . . . 63.530000000000001 112.334 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -58.41 -43.57 88.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 62.009999999999998 110.904 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.541 ' HB1' ' CE2' ' A' ' 35' ' ' PHE . . . -54.0 -48.6 70.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 72.340000000000003 111.111 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.568 ' O ' HG23 ' A' ' 80' ' ' VAL . . . -51.7 -68.17 0.19 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 65.230000000000004 111.092 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -50.97 -32.87 22.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 64.25 110.909 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -51.41 -34.54 35.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 74.430000000000007 110.847 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -112.03 26.08 10.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 73.439999999999998 110.865 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 69.9 mm-40 48.48 85.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 73.439999999999998 110.934 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.667 HG13 ' OG1' ' A' ' 85' ' ' THR . 95.1 t -105.96 111.43 35.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 75.5 111.117 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 22.1 t -81.9 -59.86 2.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 62.119999999999997 111.145 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 m -91.34 156.25 17.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 74.200000000000003 110.834 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.531 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 4.7 mt -60.15 -58.01 22.51 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.606 0.717 . . . . 73.329999999999998 111.112 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.7 Cg_endo -69.75 69.77 1.61 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.689 2.259 . . . . 52.399999999999999 112.297 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.742 HG23 HG22 ' A' ' 99' ' ' VAL . 43.7 m -103.98 132.53 50.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 72.200000000000003 111.187 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 17.5 ttp -130.82 143.83 51.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 72.519999999999996 110.861 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 63.1 mt -128.98 117.99 45.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 75.030000000000001 111.138 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.436 ' CD1' HG21 ' A' ' 111' ' ' ILE . 1.9 tt -88.24 105.72 17.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.454 . . . . 75.25 110.943 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -90.02 170.14 10.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 72.319999999999993 110.868 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.424 ' HB3' HG11 ' A' ' 95' ' ' VAL . 0.7 OUTLIER -165.53 92.29 0.54 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 62.32 110.862 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.15 41.36 7.09 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.731 -0.747 . . . . 54.109999999999999 112.487 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.519 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 67.89 35.96 85.72 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.709 -0.758 . . . . 42.140000000000001 112.506 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.457 HG23 ' HD2' ' A' ' 94' ' ' PRO . 86.2 m -161.0 133.86 4.57 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.633 0.73 . . . . 74.409999999999997 111.125 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.457 ' HD2' HG23 ' A' ' 93' ' ' THR . 53.9 Cg_endo -69.77 87.83 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.689 2.26 . . . . 74.329999999999998 112.336 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.424 HG11 ' HB3' ' A' ' 90' ' ' LYS . 28.8 m -70.49 -35.61 62.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 72.420000000000002 111.108 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.466 ' HE2' ' HB1' ' A' ' 114' ' ' ALA . 0.0 OUTLIER -140.7 170.19 16.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 75.099999999999994 110.875 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -155.91 122.76 5.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 72.540000000000006 110.877 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.435 ' N ' HD12 ' A' ' 98' ' ' ILE . 4.6 mp -124.93 132.64 71.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 63.030000000000001 111.146 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.742 HG22 HG23 ' A' ' 85' ' ' THR . 98.0 t -131.74 136.6 56.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 70.329999999999998 111.137 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 127.13 138.66 4.79 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 74.340000000000003 112.476 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.21 84.88 4.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.88 0.371 . . . . 75.329999999999998 111.103 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.06 -179.62 3.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 74.329999999999998 110.895 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.49 -169.74 1.42 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.761 -0.733 . . . . 71.5 112.478 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -79.96 -41.74 25.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.776 0.322 . . . . 75.329999999999998 110.884 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.74 -31.95 72.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 71.230000000000004 111.103 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.438 ' HA ' ' HG2' ' A' ' 109' ' ' ARG . . . -84.07 -60.22 2.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 34.530000000000001 111.093 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.657 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -50.67 -34.59 27.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 72.099999999999994 110.913 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.599 HD23 ' N ' ' A' ' 109' ' ' ARG . 5.8 tt -70.52 -60.51 2.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 62.340000000000003 110.947 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.599 ' N ' HD23 ' A' ' 108' ' ' LEU . 12.6 ptp180 -54.9 -33.01 61.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 74.420000000000002 110.842 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -54.07 -24.54 17.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 73.310000000000002 110.859 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.436 HG21 ' CD1' ' A' ' 88' ' ' LEU . 4.6 mt -85.97 -68.19 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 73.439999999999998 111.138 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -51.75 -49.07 63.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 61.109999999999999 110.902 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -56.18 -34.84 66.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 74.439999999999998 110.817 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.466 ' HB1' ' HE2' ' A' ' 96' ' ' LYS . . . -73.57 -34.74 65.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 61.210000000000001 111.086 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.5 mt . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.218 -0.447 . . . . 65.340000000000003 110.861 -179.926 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 tpt . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.824 0.345 . . . . 64.299999999999997 110.888 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.52 141.3 33.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 53.439999999999998 111.16 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -94.31 -43.95 8.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 71.540000000000006 110.852 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -88.08 139.22 30.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 74.310000000000002 110.891 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -167.4 146.56 5.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 63.420000000000002 110.836 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 -119.96 30.8 6.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 64.030000000000001 110.899 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -66.95 -36.25 81.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 74.310000000000002 110.855 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -52.34 -35.92 52.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 74.019999999999996 110.845 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.9 mmt -52.02 -37.23 52.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 74.219999999999999 110.891 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.1 m -58.77 127.11 30.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 54.409999999999997 110.859 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.1 -99.98 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.737 -0.744 . . . . 74.219999999999999 112.46 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.3 p -61.97 108.07 0.97 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.801 0.334 . . . . 65.530000000000001 111.165 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.3 t -146.24 148.26 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 72.219999999999999 111.115 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 t -73.05 127.51 32.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 70.209999999999994 111.124 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 90.7 t -91.84 143.79 10.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 73.420000000000002 111.124 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.661 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.64 171.73 0.82 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 64.430000000000007 111.065 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.454 ' H ' HG22 ' A' ' 16' ' ' THR . 2.8 t70 -80.79 -48.32 12.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 61.439999999999998 110.879 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.0 t -67.9 -53.98 22.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 72.099999999999994 110.886 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.661 HG22 ' HB ' ' A' ' 16' ' ' THR . 5.0 t -58.83 -19.51 42.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.099 -0.501 . . . . 63.310000000000002 111.146 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.705 ' CE2' HG21 ' A' ' 24' ' ' VAL . 24.2 t80 -51.41 -30.85 20.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 73.230000000000004 110.868 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.432 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -71.88 -33.61 68.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.175 -0.466 . . . . 73.420000000000002 110.907 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.9 m -91.6 -16.17 27.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.169 -0.469 . . . . 75.349999999999994 111.12 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.9 -71.39 0.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 72.329999999999998 110.834 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.705 HG21 ' CE2' ' A' ' 20' ' ' PHE . 13.1 t -70.9 -70.11 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 73.109999999999999 111.152 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.666 HD23 ' O ' ' A' ' 91' ' ' GLY . 6.9 mt -40.44 -60.02 1.2 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 64.420000000000002 110.915 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -51.24 -65.19 0.6 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.227 -0.442 . . . . 73.019999999999996 110.887 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 56.7 m -54.52 153.72 5.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 71.510000000000005 110.851 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -97.02 -34.92 11.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.489 . . . . 54.119999999999997 110.874 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.2 t -50.15 141.47 15.37 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.56 0.695 . . . . 61.0 111.15 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 125.86 12.67 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.685 2.257 . . . . 54.240000000000002 112.369 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.538 HG22 ' HB3' ' A' ' 62' ' ' LYS . 91.2 t -97.93 128.39 49.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 60.149999999999999 111.155 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.437 HD11 HD11 ' A' ' 88' ' ' LEU . 6.5 mp -102.4 108.11 19.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 65.230000000000004 110.905 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.523 HG12 ' O ' ' A' ' 87' ' ' ILE . 7.4 p -97.13 145.44 9.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 53.329999999999998 111.121 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.57 112.19 13.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 64.349999999999994 110.838 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.681 ' CD2' HD22 ' A' ' 66' ' ' LEU . 75.5 m-85 -97.6 97.8 9.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 72.230000000000004 110.872 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -150.78 -168.07 3.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 75.109999999999999 110.888 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.8 -164.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 74.140000000000001 111.106 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.444 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 1.8 m-20 -77.92 12.45 1.76 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.259 -0.428 . . . . 75.299999999999997 110.883 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.46 ' CD1' ' N ' ' A' ' 39' ' ' TRP . 1.6 m0 77.66 94.51 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.475 . . . . 72.099999999999994 110.928 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -167.94 -63.74 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 74.549999999999997 110.87 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.38 -70.51 1.33 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.748 -0.739 . . . . 63.140000000000001 112.522 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -8.07 22.67 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.661 2.241 . . . . 73.120000000000005 112.349 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.503 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 31.4 t -90.34 -26.84 19.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 74.030000000000001 110.914 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -60.54 -30.59 69.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 71.129999999999995 110.888 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 9.6 ptp -88.05 -39.93 14.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 74.310000000000002 110.908 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.476 ' HA ' HG22 ' A' ' 49' ' ' VAL . 3.5 t -93.81 23.12 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 62.039999999999999 111.111 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.814 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -79.79 -61.38 0.46 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.576 0.703 . . . . 60.119999999999997 111.064 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.814 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 54.4 Cg_endo -69.69 -48.03 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.673 2.249 . . . . 63.229999999999997 112.366 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.666 ' O ' HD12 ' A' ' 53' ' ' ILE . 4.6 m -49.78 -31.15 6.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 74.129999999999995 111.128 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.49 -40.27 80.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 72.239999999999995 110.906 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -64.33 -36.62 84.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.443 . . . . 71.430000000000007 110.927 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -59.9 -68.06 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 73.219999999999999 110.915 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.666 HD12 ' O ' ' A' ' 49' ' ' VAL . 3.2 mt -50.44 -39.84 17.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 73.5 111.176 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.455 ' O ' HD22 ' A' ' 61' ' ' LEU . . . -53.55 -39.15 64.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 53.43 111.071 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.9 -35.25 22.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 73.230000000000004 110.876 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -64.09 -36.73 84.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 62.530000000000001 110.937 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -67.59 -73.46 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 74.329999999999998 110.855 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.9 -175.59 4.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 70.420000000000002 110.866 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -89.52 -33.91 8.94 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.748 -0.739 . . . . 25.0 112.486 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 45.7 p -138.18 46.77 2.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.807 0.337 . . . . 54.229999999999997 111.133 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.455 HD22 ' O ' ' A' ' 54' ' ' ALA . 2.1 pt? -63.62 175.76 1.01 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.453 . . . . 62.210000000000001 110.921 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.538 ' HB3' HG22 ' A' ' 31' ' ' VAL . 24.0 tttp -99.97 141.74 32.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 71.310000000000002 110.868 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 37.7 t -146.43 131.54 11.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.257 -0.429 . . . . 23.449999999999999 111.144 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -152.91 138.05 17.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 74.219999999999999 111.146 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.3 mttp -114.08 159.93 19.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 61.409999999999997 110.903 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.681 HD22 ' CD2' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -135.85 141.03 44.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 63.43 110.918 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -93.95 113.46 25.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.472 . . . . 70.239999999999995 110.839 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.9 m -60.18 -35.12 59.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 75.299999999999997 111.149 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -53.97 -35.23 61.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 74.129999999999995 110.896 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.11 -35.55 10.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 73.400000000000006 111.095 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.524 ' HB2' HD21 ' A' ' 66' ' ' LEU . 1.4 m-80 -117.94 68.33 6.52 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.607 0.718 . . . . 63.329999999999998 110.85 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -32.16 19.0 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.687 2.258 . . . . 73.349999999999994 112.309 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -65.99 -43.34 88.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.274 -0.421 . . . . 72.239999999999995 110.878 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.35 -54.57 25.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 54.399999999999999 111.086 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.904 ' HB1' HG11 ' A' ' 80' ' ' VAL . . . -55.88 -60.19 3.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 62.130000000000003 111.136 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -51.63 -34.56 38.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 74.400000000000006 110.897 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -55.44 -36.16 66.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 70.140000000000001 110.851 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -99.35 20.84 12.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 74.540000000000006 110.87 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 48.6 mm-40 48.78 80.51 0.06 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 71.049999999999997 110.931 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.904 HG11 ' HB1' ' A' ' 75' ' ' ALA . 14.7 p -105.44 144.02 15.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 63.32 111.118 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 66.1 t -108.82 -72.25 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 61.020000000000003 111.137 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.4 t -79.71 157.86 27.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 71.400000000000006 110.853 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.534 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 4.6 mt -59.91 -58.0 22.64 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.635 0.731 . . . . 70.329999999999998 111.099 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.743 ' HB2' ' HB2' ' A' ' 101' ' ' ALA . 53.4 Cg_endo -69.74 71.75 1.49 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.648 2.232 . . . . 64.549999999999997 112.374 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.703 HG23 ' CG2' ' A' ' 99' ' ' VAL . 23.5 m -110.44 126.62 54.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 52.520000000000003 111.125 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.0 mtm -122.56 158.18 30.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 74.209999999999994 110.838 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.523 ' O ' HG12 ' A' ' 33' ' ' VAL . 34.0 mt -145.27 121.23 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 74.439999999999998 111.16 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.437 HD11 HD11 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -81.95 110.25 17.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 43.299999999999997 110.898 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -98.46 170.2 9.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 73.439999999999998 110.884 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -166.04 107.58 0.73 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 74.209999999999994 110.875 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.666 ' O ' HD23 ' A' ' 25' ' ' LEU . . . 68.37 35.76 82.84 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.738 -0.744 . . . . 71.099999999999994 112.511 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.646 ' H ' HG12 ' A' ' 24' ' ' VAL . . . 72.55 41.46 51.2 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.758 -0.734 . . . . 65.239999999999995 112.491 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.46 HG23 ' HD2' ' A' ' 94' ' ' PRO . 86.4 m -161.04 133.85 4.54 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.549 0.69 . . . . 74.230000000000004 111.182 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.46 ' HD2' HG23 ' A' ' 93' ' ' THR . 53.4 Cg_endo -69.74 103.05 1.1 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.722 2.281 . . . . 74.430000000000007 112.313 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.5 m -91.07 -32.58 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 72.409999999999997 111.147 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.417 ' HD2' ' HB3' ' A' ' 114' ' ' ALA . 1.6 mmtm -138.38 170.13 16.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 63.32 110.949 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.19 118.19 4.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 74.150000000000006 110.878 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.417 ' N ' HD12 ' A' ' 98' ' ' ILE . 4.8 mp -125.5 137.63 57.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 73.299999999999997 111.119 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.703 ' CG2' HG23 ' A' ' 85' ' ' THR . 66.8 t -147.81 136.15 15.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.472 . . . . 63.310000000000002 111.124 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 151.08 -27.58 1.0 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.734 -0.746 . . . . 72.340000000000003 112.475 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.743 ' HB2' ' HB2' ' A' ' 84' ' ' PRO . . . 63.46 72.68 0.47 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.849 0.357 . . . . 75.140000000000001 111.117 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.423 ' HG2' HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -118.88 174.82 6.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 71.140000000000001 110.857 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.66 173.63 4.45 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.729 -0.748 . . . . 54.43 112.483 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.52 -44.13 75.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.791 0.329 . . . . 70.040000000000006 110.898 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.55 -30.2 65.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 63.32 111.107 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.34 -59.55 2.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.268 -0.424 . . . . 61.219999999999999 111.116 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.468 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.3 OUTLIER -48.71 -44.16 37.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 64.140000000000001 110.891 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.456 HD23 ' C ' ' A' ' 108' ' ' LEU . 7.8 tt -50.27 -43.63 53.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 72.540000000000006 110.91 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -72.46 -37.55 68.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 61.299999999999997 110.91 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -49.85 -25.87 3.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 75.209999999999994 110.873 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.8 mt -86.18 -69.61 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 75.430000000000007 111.102 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.474 ' HA ' HD23 ' A' ' 115' ' ' LEU . 0.4 OUTLIER -52.5 -51.18 60.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 71.129999999999995 110.892 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -55.63 -33.87 64.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.157 -0.474 . . . . 61.049999999999997 110.815 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.417 ' HB3' ' HD2' ' A' ' 96' ' ' LYS . . . -71.9 -34.71 69.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 73.150000000000006 111.105 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' A' ' 112' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 63.299999999999997 110.925 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.778 0.323 . . . . 70.510000000000005 110.854 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.72 149.25 25.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 64.219999999999999 111.092 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -92.87 -46.58 7.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 70.019999999999996 110.878 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -110.53 145.39 37.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 75.099999999999994 110.837 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 42.7 p-80 -151.78 118.8 5.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 73.129999999999995 110.857 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -112.95 -36.91 4.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 60.439999999999998 110.891 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -52.02 -59.86 3.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 63.539999999999999 110.855 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -52.05 -35.87 48.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 60.329999999999998 110.844 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 13.1 ttm -51.97 -37.22 52.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 71.310000000000002 110.904 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.7 m -54.99 119.93 6.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 63.539999999999999 110.861 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.09 164.82 18.49 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.723 -0.751 . . . . 72.219999999999999 112.495 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.5 p -60.1 114.75 3.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.791 0.329 . . . . 74.109999999999999 111.141 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 96.1 t -150.08 144.18 17.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.428 . . . . 65.019999999999996 111.118 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 t -84.1 127.53 33.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.459 . . . . 64.430000000000007 111.097 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.417 ' CG1' HG23 ' A' ' 19' ' ' THR . 47.6 t -94.88 126.0 47.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 73.030000000000001 111.109 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.659 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.6 OUTLIER -59.5 166.44 2.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 64.019999999999996 111.13 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.427 ' H ' HG22 ' A' ' 16' ' ' THR . 1.4 p30 -68.52 -48.33 64.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 71.420000000000002 110.844 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.1 m -68.48 -52.98 26.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 73.329999999999998 110.879 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.659 HG22 ' HB ' ' A' ' 16' ' ' THR . 6.8 t -59.66 -19.0 46.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.092 -0.504 . . . . 73.209999999999994 111.162 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.73 ' CE2' HG21 ' A' ' 24' ' ' VAL . 25.6 t80 -51.31 -30.8 19.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 75.150000000000006 110.878 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.462 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -72.69 -32.94 66.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 75.5 110.871 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.0 m -91.33 -17.1 26.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 74.109999999999999 111.098 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.405 ' HB3' HG11 ' A' ' 15' ' ' VAL . 7.6 t70 -93.63 -71.38 0.66 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 71.219999999999999 110.871 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.743 HG13 HG21 ' A' ' 31' ' ' VAL . 20.0 t -70.08 -70.78 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 35.119999999999997 111.136 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.637 HD23 ' HA3' ' A' ' 92' ' ' GLY . 10.6 mt -40.56 -59.8 1.27 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 73.109999999999999 110.933 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -50.86 -64.85 0.68 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 51.219999999999999 110.85 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.0 t -52.12 163.27 0.39 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 73.099999999999994 110.877 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -106.02 -40.85 5.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 70.409999999999997 110.838 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -51.79 159.69 1.28 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.581 0.705 . . . . 71.510000000000005 111.155 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 147.66 63.4 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.683 2.255 . . . . 62.100000000000001 112.372 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.743 HG21 HG13 ' A' ' 24' ' ' VAL . 97.0 t -123.14 115.5 45.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 51.530000000000001 111.149 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.699 HD22 ' HG ' ' A' ' 88' ' ' LEU . 7.5 mt -103.94 106.29 16.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 72.140000000000001 110.911 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 m -108.48 134.71 49.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 62.520000000000003 111.128 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.526 ' OD2' HD11 ' A' ' 50' ' ' LEU . 0.8 OUTLIER -100.22 99.12 9.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 63.329999999999998 110.85 179.915 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.711 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 5.5 m-85 -82.86 89.56 6.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 72.319999999999993 110.881 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -152.52 -169.19 3.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 74.310000000000002 110.915 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.44 -154.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 61.130000000000003 111.097 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.477 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 35.2 p-10 -77.44 8.94 3.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.434 . . . . 62.140000000000001 110.862 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.477 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 1.1 p-90 41.55 63.53 1.25 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 72.299999999999997 110.893 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 41.2 t -125.04 -45.89 1.84 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 63.200000000000003 110.891 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.59 -68.24 1.49 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.751 -0.738 . . . . 61.530000000000001 112.443 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -26.48 27.65 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.663 2.242 . . . . 74.420000000000002 112.317 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 34.8 t -50.49 -30.14 12.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 63.039999999999999 110.905 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.29 -30.3 17.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.148 -0.478 . . . . 73.510000000000005 110.861 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 16.4 mtt -88.75 -36.72 15.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 53.43 110.893 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.434 ' O ' HG12 ' A' ' 46' ' ' VAL . 3.3 t -92.74 21.3 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 64.329999999999998 111.153 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.779 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -68.95 -59.83 4.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.562 0.696 . . . . 71.319999999999993 111.113 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.779 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.5 Cg_endo -69.75 -45.56 1.55 Allowed 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.705 2.27 . . . . 73.439999999999998 112.353 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.82 HG13 ' HA ' ' A' ' 104' ' ' LYS . 26.3 t -55.37 -50.63 63.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 71.510000000000005 111.113 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.526 HD11 ' OD2' ' A' ' 34' ' ' ASP . 50.5 tp -52.94 -32.03 43.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.195 -0.457 . . . . 62.43 110.921 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.475 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 28.0 mm-40 -83.89 -35.27 24.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 61.409999999999997 110.893 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -51.91 -61.41 2.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 72.040000000000006 110.939 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.665 HD12 ' O ' ' A' ' 49' ' ' VAL . 3.0 mp -50.74 -32.83 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.478 . . . . 62.409999999999997 111.15 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.655 ' HA ' HD11 ' A' ' 61' ' ' LEU . . . -62.52 -40.74 97.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.479 . . . . 72.540000000000006 111.048 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.28 -35.44 35.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 73.230000000000004 110.887 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -62.46 -40.16 95.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 73.439999999999998 110.903 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.619 ' HB2' HD13 ' A' ' 61' ' ' LEU . 2.8 mmpt? -67.32 -72.08 0.18 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.111 -0.495 . . . . 73.25 110.895 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.4 t -145.25 -173.85 4.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 74.519999999999996 110.826 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.82 -34.98 6.0 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.737 -0.744 . . . . 42.140000000000001 112.473 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.1 t -123.97 35.15 4.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.831 0.348 . . . . 74.120000000000005 111.165 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.655 HD11 ' HA ' ' A' ' 54' ' ' ALA . 2.3 pt? -62.97 -171.95 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 74.329999999999998 110.916 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.5 mttp -109.64 120.21 41.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 73.040000000000006 110.929 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.8 t -123.71 112.19 32.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 61.240000000000002 111.105 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -131.04 156.07 45.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 64.040000000000006 111.13 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.7 122.51 16.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 62.299999999999997 110.877 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.534 HD21 ' HB2' ' A' ' 71' ' ' ASN . 11.1 tp -103.28 155.46 18.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.246 -0.434 . . . . 72.120000000000005 110.897 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.414 ' OD1' ' HB3' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -112.54 103.14 11.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 72.129999999999995 110.874 179.824 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.702 HG12 ' HB2' ' A' ' 75' ' ' ALA . 30.7 m -51.11 -32.14 11.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 64.549999999999997 111.149 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.77 -35.58 23.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 75.329999999999998 110.862 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.414 ' HB3' ' OD1' ' A' ' 67' ' ' ASP . . . -105.17 -33.31 8.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.448 . . . . 65.310000000000002 111.097 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.534 ' HB2' HD21 ' A' ' 66' ' ' LEU . 0.4 OUTLIER -120.91 71.75 21.26 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.6 0.714 . . . . 64.109999999999999 110.869 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -32.04 19.39 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.664 2.243 . . . . 73.409999999999997 112.341 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -51.71 -34.52 39.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 73.120000000000005 110.893 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.711 ' HB1' ' CE2' ' A' ' 35' ' ' PHE . . . -68.77 -46.47 68.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.479 . . . . 65.129999999999995 111.094 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.838 ' HB1' HG11 ' A' ' 80' ' ' VAL . . . -55.31 -65.93 0.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.437 . . . . 74.439999999999998 111.069 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -51.04 -32.72 22.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 71.319999999999993 110.886 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.62 -42.14 61.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 75.450000000000003 110.896 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -98.53 20.75 12.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 54.030000000000001 110.898 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 62.9 mm-40 47.41 79.55 0.06 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.474 . . . . 72.400000000000006 110.88 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.838 HG11 ' HB1' ' A' ' 75' ' ' ALA . 14.2 p -106.48 140.96 22.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 74.239999999999995 111.135 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.49 -35.49 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 75.510000000000005 111.135 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.7 t -105.85 151.88 23.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 65.310000000000002 110.885 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.531 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 5.3 mt -55.62 -58.04 17.86 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.64 0.733 . . . . 73.349999999999994 111.119 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.5 Cg_endo -69.76 99.17 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.667 2.245 . . . . 73.349999999999994 112.314 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . 1.001 HG23 HG12 ' A' ' 99' ' ' VAL . 43.3 m -142.39 137.05 30.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 62.219999999999999 111.149 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 32.7 ttp -137.33 131.78 32.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 73.420000000000002 110.907 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 10.9 mm -108.2 110.93 33.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 72.340000000000003 111.1 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.699 ' HG ' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -79.59 100.27 7.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.178 -0.464 . . . . 65.420000000000002 110.896 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -89.58 170.32 10.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 75.230000000000004 110.904 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -166.33 89.59 0.4 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 64.230000000000004 110.902 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.86 39.41 8.7 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.758 -0.734 . . . . 62.450000000000003 112.499 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.637 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 68.72 41.63 82.69 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.74 -0.743 . . . . 71.109999999999999 112.484 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.7 m -161.79 131.31 3.25 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.558 0.694 . . . . 74.120000000000005 111.138 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 86.59 0.57 Allowed 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.675 2.25 . . . . 72.140000000000001 112.39 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.9 m -73.37 -32.24 36.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 60.030000000000001 111.116 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.49 ' HD2' ' HB3' ' A' ' 114' ' ' ALA . 10.9 mmtm -143.38 170.17 16.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 71.019999999999996 110.896 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -158.36 103.56 1.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 73.409999999999997 110.825 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.429 ' N ' HD12 ' A' ' 98' ' ' ILE . 4.6 mp -113.75 132.71 61.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 61.530000000000001 111.113 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 1.001 HG12 HG23 ' A' ' 85' ' ' THR . 3.0 m -128.06 141.6 46.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 74.140000000000001 111.141 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 128.06 142.35 5.44 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.741 -0.743 . . . . 73.519999999999996 112.532 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -96.25 89.2 5.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.873 0.368 . . . . 50.450000000000003 111.108 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.51 ' HB2' ' HB3' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -123.03 -175.39 3.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 62.43 110.959 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.23 -174.79 28.44 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.728 -0.748 . . . . 61.210000000000001 112.481 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.82 ' HA ' HG13 ' A' ' 49' ' ' VAL . 0.4 OUTLIER -70.96 -46.47 62.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.761 0.315 . . . . 72.019999999999996 110.876 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.24 -22.24 65.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 73.239999999999995 111.08 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.51 ' HB3' ' HB2' ' A' ' 102' ' ' LYS . . . -91.28 -60.51 1.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 40.25 111.053 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.478 HD23 ' HG2' ' A' ' 102' ' ' LYS . 0.2 OUTLIER -53.7 -31.28 47.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.248 -0.433 . . . . 74.319999999999993 110.883 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.594 HD23 ' N ' ' A' ' 109' ' ' ARG . 5.7 tt -73.32 -59.64 2.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 73.209999999999994 110.9 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.594 ' N ' HD23 ' A' ' 108' ' ' LEU . 15.6 ptm180 -52.85 -34.04 52.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 65.519999999999996 110.845 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.401 ' HG3' ' HE2' ' A' ' 102' ' ' LYS . 49.9 mm-40 -56.8 -25.0 54.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 63.420000000000002 110.847 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.2 mt -84.58 -65.81 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 62.509999999999998 111.129 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -53.12 -48.24 68.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.433 . . . . 70.329999999999998 110.871 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -54.56 -34.46 61.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.476 . . . . 72.409999999999997 110.86 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.49 ' HB3' ' HD2' ' A' ' 96' ' ' LYS . . . -73.07 -34.74 66.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 65.420000000000002 111.096 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.8 mt . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 75.299999999999997 110.865 -179.932 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ttt . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.767 0.318 . . . . 72.019999999999996 110.853 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -127.5 97.56 4.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 75.319999999999993 111.114 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.9 m-70 -97.4 -50.37 4.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.449 . . . . 60.340000000000003 110.888 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.5 p80 -125.84 115.81 20.57 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.219 -0.446 . . . . 73.209999999999994 110.834 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -150.66 179.65 8.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 74.420000000000002 110.865 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -105.26 30.82 5.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 61.049999999999997 110.846 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -55.69 -36.22 66.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 75.540000000000006 110.85 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 48.7 p-80 -62.81 -36.35 82.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 74.420000000000002 110.843 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 6.7 mmm -77.57 -38.93 47.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 72.099999999999994 110.858 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.9 p -55.08 127.54 29.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 65.209999999999994 110.867 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -89.77 -116.09 1.62 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.721 -0.752 . . . . 54.200000000000003 112.47 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.506 HG22 ' HB ' ' A' ' 63' ' ' VAL . 59.5 p -70.4 100.29 1.73 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.841 0.353 . . . . 75.510000000000005 111.117 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.4 m -152.13 163.57 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.251 -0.431 . . . . 74.209999999999994 111.124 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.475 ' OG1' HD13 ' A' ' 66' ' ' LEU . 9.8 t -75.66 127.62 33.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.16 -0.473 . . . . 74.519999999999996 111.172 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.479 HG21 ' OD1' ' A' ' 23' ' ' ASP . 99.8 t -93.18 136.63 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 74.239999999999995 111.146 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.565 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -60.03 176.05 0.35 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 64.129999999999995 111.127 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.42 ' H ' HG22 ' A' ' 16' ' ' THR . 3.8 p-10 -81.06 -49.14 11.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 71.430000000000007 110.835 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.3 t -68.07 -54.27 19.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 44.5 110.872 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.565 HG22 ' HB ' ' A' ' 16' ' ' THR . 5.7 t -58.24 -19.37 33.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.138 -0.483 . . . . 75.340000000000003 111.168 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.724 ' CE2' HG21 ' A' ' 24' ' ' VAL . 24.9 t80 -50.82 -31.19 16.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 74.409999999999997 110.889 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.413 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.7 OUTLIER -71.54 -34.27 69.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.474 . . . . 73.510000000000005 110.898 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.2 m -91.04 -15.55 29.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 72.420000000000002 111.151 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.479 ' OD1' HG21 ' A' ' 15' ' ' VAL . 29.5 t70 -93.56 -71.1 0.67 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 74.400000000000006 110.855 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.841 HG13 HG21 ' A' ' 31' ' ' VAL . 17.9 t -71.04 -70.43 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 53.140000000000001 111.116 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.58 HD23 ' HA3' ' A' ' 92' ' ' GLY . 7.3 mt -40.55 -59.39 1.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 73.209999999999994 110.952 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -51.14 -62.41 1.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.476 . . . . 74.209999999999994 110.843 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.2 p -52.72 152.63 3.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 71.030000000000001 110.883 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -101.6 -37.79 8.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.112 -0.495 . . . . 64.25 110.829 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.94 159.69 1.76 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.589 0.709 . . . . 62.439999999999998 111.121 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 123.98 10.62 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.692 2.261 . . . . 62.109999999999999 112.335 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.841 HG21 HG13 ' A' ' 24' ' ' VAL . 97.8 t -97.39 123.87 50.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 65.230000000000004 111.112 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.468 HD21 HD13 ' A' ' 88' ' ' LEU . 3.3 mm? -103.5 100.0 9.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 72.129999999999995 110.899 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.1 p -95.18 135.09 30.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 61.43 111.137 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.13 99.72 7.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 75.230000000000004 110.876 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -91.41 89.84 7.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.458 . . . . 63.140000000000001 110.887 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.52 ' HH2' HD11 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -147.8 -169.65 3.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.165 -0.471 . . . . 74.430000000000007 110.919 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.52 ' HA ' HG22 ' A' ' 68' ' ' VAL . . . -61.72 -153.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 53.299999999999997 111.085 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.486 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 22.8 t0 -77.16 9.44 3.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 70.329999999999998 110.848 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.486 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 0.9 OUTLIER 42.01 67.02 0.62 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.166 -0.47 . . . . 71.540000000000006 110.911 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 46.8 t -127.74 -44.7 1.49 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.429 . . . . 71.209999999999994 110.935 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.92 -68.03 1.5 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.755 -0.736 . . . . 42.329999999999998 112.519 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -30.84 21.78 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.655 2.237 . . . . 72.329999999999998 112.312 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 42.8 t -56.08 -24.13 38.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.246 -0.434 . . . . 35.310000000000002 110.869 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 50.4 mttt -50.79 -39.5 52.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 75.230000000000004 110.906 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.457 ' HG3' HG23 ' A' ' 46' ' ' VAL . 12.2 ptm -90.12 -29.3 18.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 75.209999999999994 110.886 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.474 ' HA ' HG22 ' A' ' 49' ' ' VAL . 3.4 t -92.55 21.79 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 71.340000000000003 111.11 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.783 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -80.01 -61.08 0.46 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.578 0.704 . . . . 75.530000000000001 111.116 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.783 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.6 Cg_endo -69.76 -46.7 1.13 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.642 2.228 . . . . 52.140000000000001 112.321 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.589 ' O ' HD12 ' A' ' 53' ' ' ILE . 4.3 m -50.5 -30.14 7.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 41.420000000000002 111.109 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.52 HD11 ' HH2' ' A' ' 36' ' ' TRP . 10.8 mt -69.23 -39.08 78.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 73.349999999999994 110.909 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.53 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 4.0 mm-40 -72.77 -32.45 65.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 74.319999999999993 110.858 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -49.74 -58.62 4.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 72.530000000000001 110.882 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.589 HD12 ' O ' ' A' ' 49' ' ' VAL . 3.0 mp -50.38 -32.12 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 74.030000000000001 111.125 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 51' ' ' GLU . . . -62.64 -53.04 60.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 54.420000000000002 111.103 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -65.71 -34.78 79.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.441 . . . . 75.209999999999994 110.893 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -63.53 -34.44 77.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 74.540000000000006 110.874 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -92.8 -74.56 0.52 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 73.549999999999997 110.882 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.0 t -174.48 179.59 1.74 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 65.219999999999999 110.846 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -105.51 34.44 5.77 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.747 -0.739 . . . . 61.299999999999997 112.465 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.3 p -118.65 -35.45 3.72 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.845 0.355 . . . . 72.540000000000006 111.144 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.647 ' C ' HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -51.31 169.38 0.05 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 73.040000000000006 110.901 179.981 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.551 ' N ' HD22 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -123.69 148.68 46.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 63.420000000000002 110.933 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.506 ' HB ' HG22 ' A' ' 12' ' ' THR . 21.5 t -125.49 102.06 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 64.209999999999994 111.17 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -99.98 138.42 37.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 72.340000000000003 111.084 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.1 pttp -135.64 111.2 9.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 71.129999999999995 110.914 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.475 HD13 ' OG1' ' A' ' 14' ' ' THR . 27.9 tp -107.75 160.32 15.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 70.140000000000001 110.88 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.613 ' OD2' ' HB3' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -104.01 119.85 39.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 75.310000000000002 110.891 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.52 HG22 ' HA ' ' A' ' 37' ' ' ALA . 27.0 m -63.1 -33.49 61.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 63.310000000000002 111.129 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -50.59 -36.13 33.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 62.420000000000002 110.852 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.613 ' HB3' ' OD2' ' A' ' 67' ' ' ASP . . . -98.38 -35.39 10.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 72.439999999999998 111.086 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -120.39 67.6 13.42 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.579 0.704 . . . . 74.409999999999997 110.902 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -33.58 16.56 Favored 'Trans proline' 0 C--N 1.34 0.127 0 C-N-CA 122.687 2.258 . . . . 65.120000000000005 112.377 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -52.21 -52.06 54.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 72.299999999999997 110.877 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.44 -46.13 66.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 75.140000000000001 111.081 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.68 ' HB1' HG11 ' A' ' 80' ' ' VAL . . . -51.47 -70.48 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 60.140000000000001 111.115 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 -51.34 -32.11 24.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 72.340000000000003 110.863 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -51.69 -44.4 63.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 73.219999999999999 110.889 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -95.66 18.99 11.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 62.310000000000002 110.896 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 48.25 72.85 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 65.140000000000001 110.898 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.68 HG11 ' HB1' ' A' ' 75' ' ' ALA . 14.6 p -99.3 131.77 45.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 62.119999999999997 111.154 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.1 t -88.89 -74.03 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 73.200000000000003 111.112 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.86 158.75 29.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 60.32 110.828 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.52 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 1.3 mp -65.75 -58.37 11.62 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.635 0.731 . . . . 73.129999999999995 111.159 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.8 Cg_endo -69.77 71.33 1.53 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.709 2.273 . . . . 55.340000000000003 112.355 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 89.1 m -113.73 139.16 49.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 72.129999999999995 111.159 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 37.4 ttp -135.25 112.74 10.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 73.299999999999997 110.903 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.5 mt -90.04 128.08 42.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.429 . . . . 71.230000000000004 111.122 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.468 HD13 HD21 ' A' ' 32' ' ' LEU . 10.0 tp -92.27 105.78 17.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 63.219999999999999 110.97 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -91.86 170.98 9.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 73.329999999999998 110.834 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -165.67 91.9 0.51 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 72.340000000000003 110.915 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.34 36.14 8.32 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.749 -0.739 . . . . 62.210000000000001 112.53 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.58 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 69.48 38.59 79.73 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.752 -0.737 . . . . 63.140000000000001 112.452 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.46 HG23 ' HD2' ' A' ' 94' ' ' PRO . 86.4 m -161.12 133.91 4.53 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.592 0.71 . . . . 73.140000000000001 111.152 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.46 ' HD2' HG23 ' A' ' 93' ' ' THR . 53.3 Cg_endo -69.79 107.26 1.82 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.723 2.282 . . . . 72.150000000000006 112.322 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 16.5 m -94.13 -32.69 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 73.420000000000002 111.153 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.509 ' HE3' ' HB1' ' A' ' 114' ' ' ALA . 23.5 mmtm -152.61 170.38 20.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 73.439999999999998 110.92 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.417 ' C ' HD12 ' A' ' 98' ' ' ILE . 0.2 OUTLIER -154.29 131.72 11.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 71.540000000000006 110.843 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.434 ' N ' HD12 ' A' ' 98' ' ' ILE . 4.1 mp -126.01 141.85 44.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 75.219999999999999 111.131 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.6 p -150.23 143.31 17.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 65.099999999999994 111.132 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.52 -27.32 1.35 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.765 -0.731 . . . . 63.32 112.518 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 61.82 72.5 0.5 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.817 0.341 . . . . 60.32 111.104 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.44 ' HB2' ' HB3' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -119.38 -179.2 3.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 75.230000000000004 110.873 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.72 178.84 2.3 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.724 -0.751 . . . . 52.030000000000001 112.515 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.64 -36.12 73.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.771 0.32 . . . . 63.020000000000003 110.887 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.61 -32.65 74.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 62.210000000000001 111.112 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.44 ' HB3' ' HB2' ' A' ' 102' ' ' LYS . . . -86.57 -56.38 3.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 64.109999999999999 111.113 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.579 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.4 OUTLIER -52.24 -34.16 44.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 74.510000000000005 110.914 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.601 HD23 ' N ' ' A' ' 109' ' ' ARG . 5.2 tt -70.05 -59.26 3.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.231 -0.441 . . . . 73.439999999999998 110.911 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.601 ' N ' HD23 ' A' ' 108' ' ' LEU . 3.0 ptm180 -56.14 -34.5 66.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 73.409999999999997 110.888 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -52.8 -25.63 11.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 72.109999999999999 110.88 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.6 mt -84.72 -68.43 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.483 . . . . 61.409999999999997 111.143 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -51.93 -49.75 62.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 75.310000000000002 110.885 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -53.82 -35.01 60.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 61.549999999999997 110.851 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.509 ' HB1' ' HE3' ' A' ' 96' ' ' LYS . . . -72.98 -35.83 66.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 74.340000000000003 111.071 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.1 mt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 63.420000000000002 110.966 -179.988 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 mtm . . . . . 0 N--CA 1.458 -0.061 0 CA-C-O 120.769 0.319 . . . . 73.340000000000003 110.923 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.518 ' HB3' ' NE2' ' A' ' 5' ' ' HIS . . . -129.07 148.07 50.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 73.140000000000001 111.087 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -83.81 -60.25 2.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 71.209999999999994 110.855 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -59.04 104.75 0.26 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 71.310000000000002 110.85 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.518 ' NE2' ' HB3' ' A' ' 2' ' ' ALA . 23.9 m-70 -157.23 166.19 33.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 75.109999999999999 110.882 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -111.65 30.84 6.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 70.129999999999995 110.889 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -92.99 11.33 27.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.136 -0.484 . . . . 70.310000000000002 110.886 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -79.36 -36.01 40.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 75.239999999999995 110.848 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -58.03 -36.95 73.45 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.207 -0.451 . . . . 64.099999999999994 110.849 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.5 m -52.51 131.42 33.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 64.099999999999994 110.902 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.7 -108.8 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.759 -0.734 . . . . 60.299999999999997 112.452 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.8 p -60.63 113.93 2.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.862 0.363 . . . . 73.519999999999996 111.144 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 91.7 t -149.96 144.49 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 64.299999999999997 111.116 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 t -82.44 127.16 33.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 72.010000000000005 111.129 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.2 t -92.66 131.64 39.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 63.450000000000003 111.103 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.484 ' CB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.7 179.23 0.13 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.112 -0.495 . . . . 45.450000000000003 111.124 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.441 ' H ' HG22 ' A' ' 16' ' ' THR . 1.1 m-20 -81.05 -49.8 10.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 75.120000000000005 110.934 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.0 m -69.3 -52.99 22.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 63.149999999999999 110.835 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.484 HG22 ' CB ' ' A' ' 16' ' ' THR . 5.3 t -58.29 -19.5 35.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 75.099999999999994 111.147 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.724 ' CE2' HG21 ' A' ' 24' ' ' VAL . 27.3 t80 -51.22 -31.85 21.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 74.019999999999996 110.869 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.432 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -72.04 -32.82 67.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 54.399999999999999 110.876 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.4 m -90.94 -16.58 27.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 75.150000000000006 111.144 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -93.96 -70.76 0.69 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 64.030000000000001 110.879 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.724 HG21 ' CE2' ' A' ' 20' ' ' PHE . 18.8 t -70.2 -70.48 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 65.209999999999994 111.092 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.45 HD23 ' O ' ' A' ' 91' ' ' GLY . 8.3 mt -41.09 -60.35 1.24 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 62.119999999999997 110.932 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -49.82 -63.05 1.23 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 73.409999999999997 110.864 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 59.6 m -48.85 -34.68 13.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 72.530000000000001 110.818 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.0 t0 59.51 30.88 20.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 54.299999999999997 110.897 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.24 160.62 36.75 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.552 0.692 . . . . 73.519999999999996 111.188 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 111.8 2.9 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.666 2.244 . . . . 44.149999999999999 112.349 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.404 HG22 ' HB3' ' A' ' 62' ' ' LYS . 89.7 t -102.88 117.42 48.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 62.229999999999997 111.087 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.1 mt -79.89 102.33 9.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 74.310000000000002 110.888 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.509 HG11 ' CE1' ' A' ' 35' ' ' PHE . 43.1 t -89.71 137.37 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 75.150000000000006 111.11 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -122.46 99.23 6.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.485 . . . . 74.129999999999995 110.892 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.509 ' CE1' HG11 ' A' ' 33' ' ' VAL . 15.1 m-85 -96.72 89.82 5.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 71.340000000000003 110.885 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -151.18 -169.13 3.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.092 -0.504 . . . . 74.219999999999999 110.925 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.66 -154.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 53.009999999999998 111.1 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.477 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 23.9 t0 -77.33 8.74 3.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 70.209999999999994 110.909 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.477 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 1.3 p-90 41.5 64.87 0.94 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 44.340000000000003 110.949 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 4.0 p -124.87 -44.5 1.93 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.273 -0.421 . . . . 71.540000000000006 110.868 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.55 -69.33 1.4 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.755 -0.736 . . . . 72.510000000000005 112.473 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -26.33 27.67 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.697 2.265 . . . . 75.209999999999994 112.317 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 26.1 t -49.9 -31.09 11.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 53.340000000000003 110.889 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -51.94 -29.86 22.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 73.049999999999997 110.842 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 51.6 mmm -89.99 -38.2 13.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 62.450000000000003 110.863 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 1.014 HG12 HD23 ' A' ' 50' ' ' LEU . 3.3 t -92.44 22.72 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 74.349999999999994 111.129 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.772 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -79.12 -60.92 0.52 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.584 0.707 . . . . 54.310000000000002 111.064 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.772 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.7 Cg_endo -69.8 -48.45 0.71 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.701 2.268 . . . . 55.439999999999998 112.312 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.676 ' O ' HD12 ' A' ' 53' ' ' ILE . 4.7 m -50.45 -29.91 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.433 . . . . 74.219999999999999 111.129 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.014 HD23 HG12 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -70.74 -39.59 73.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 72.349999999999994 110.951 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -70.99 -34.38 71.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 54.520000000000003 110.847 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -51.55 -68.76 0.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 60.5 110.873 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.676 HD12 ' O ' ' A' ' 49' ' ' VAL . 2.7 mp -50.43 -34.42 11.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 55.049999999999997 111.131 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.795 ' HA ' HD21 ' A' ' 61' ' ' LEU . . . -60.79 -38.58 85.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.176 -0.466 . . . . 34.539999999999999 111.124 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.88 -35.25 24.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 62.310000000000002 110.883 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -65.84 -47.05 76.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.476 . . . . 73.209999999999994 110.908 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 53.7 mmtt -62.6 -72.34 0.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 75.349999999999994 110.864 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -128.64 178.23 6.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 74.120000000000005 110.872 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.61 -52.4 20.99 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.794 -0.717 . . . . 62.350000000000001 112.517 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 60.5 p -143.67 56.98 1.36 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.821 0.343 . . . . 71.430000000000007 111.121 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.795 HD21 ' HA ' ' A' ' 54' ' ' ALA . 3.7 pp -57.94 -178.21 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.238 -0.437 . . . . 70.140000000000001 110.873 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.404 ' HB3' HG22 ' A' ' 31' ' ' VAL . 14.0 tttp -93.34 146.87 23.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 64.219999999999999 110.893 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -141.26 123.76 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 70.540000000000006 111.129 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -134.89 140.56 45.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 71.140000000000001 111.121 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.71 140.61 51.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 72.129999999999995 110.878 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.583 HD21 ' HB2' ' A' ' 71' ' ' ASN . 4.0 tt -123.21 150.73 43.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 64.409999999999997 110.914 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.658 ' OD2' ' HB3' ' A' ' 70' ' ' ALA . 0.5 OUTLIER -105.4 103.78 13.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 73.150000000000006 110.857 179.88 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.65 HG12 ' HB2' ' A' ' 75' ' ' ALA . 13.4 m -51.42 -33.33 14.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 73.209999999999994 111.104 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.85 -35.44 32.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 75.099999999999994 110.88 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.658 ' HB3' ' OD2' ' A' ' 67' ' ' ASP . . . -103.16 -34.26 8.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 64.430000000000007 111.088 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.583 ' HB2' HD21 ' A' ' 66' ' ' LEU . 1.0 OUTLIER -118.92 67.35 8.05 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.657 0.742 . . . . 75.010000000000005 110.907 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -34.19 15.04 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.707 2.272 . . . . 64.120000000000005 112.285 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -52.01 -46.36 64.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 73.409999999999997 110.891 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.24 -42.58 86.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 72.420000000000002 111.122 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.65 ' HB2' HG12 ' A' ' 68' ' ' VAL . . . -55.52 -68.59 0.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 62.140000000000001 111.06 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -51.2 -31.76 21.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 72.030000000000001 110.854 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -51.08 -36.73 41.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 74.519999999999996 110.866 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -108.77 23.85 13.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 74.219999999999999 110.924 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 70.8 mm-40 48.2 67.65 0.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 72.349999999999994 110.871 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 75' ' ' ALA . 99.4 t -87.5 113.34 24.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.478 . . . . 75.230000000000004 111.1 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.1 t -78.79 -66.88 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 74.519999999999996 111.12 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.45 162.58 17.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 74.329999999999998 110.845 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.53 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.4 mt -65.06 -58.12 13.59 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.636 0.731 . . . . 72.140000000000001 111.118 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.8 Cg_endo -69.8 70.28 1.61 Allowed 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.656 2.237 . . . . 61.310000000000002 112.316 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.499 ' OG1' HG13 ' A' ' 80' ' ' VAL . 99.2 m -108.13 100.02 9.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 53.229999999999997 111.125 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.5 ttt -99.75 118.31 35.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 64.510000000000005 110.856 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.462 HD12 ' CD1' ' A' ' 35' ' ' PHE . 51.4 mt -98.17 131.49 45.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 53.130000000000003 111.102 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.629 HD12 HG21 ' A' ' 111' ' ' ILE . 0.4 OUTLIER -96.37 103.98 15.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 61.109999999999999 110.964 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -90.02 167.72 12.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 71.120000000000005 110.86 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -170.37 119.58 0.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 73.239999999999995 110.877 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.45 ' O ' HD23 ' A' ' 25' ' ' LEU . . . 66.33 30.99 77.67 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.735 -0.745 . . . . 64.120000000000005 112.485 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.411 ' H ' HG12 ' A' ' 24' ' ' VAL . . . 73.37 53.57 7.49 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.795 -0.717 . . . . 52.5 112.458 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 178.92 139.35 0.27 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.554 0.692 . . . . 74.519999999999996 111.143 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.84 84.88 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.676 2.251 . . . . 64.450000000000003 112.322 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.9 m -64.14 -33.84 65.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 73.010000000000005 111.138 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -152.84 170.28 20.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 64.0 110.907 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.44 ' C ' HD12 ' A' ' 98' ' ' ILE . 27.4 ttt180 -151.68 130.86 12.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 70.310000000000002 110.926 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.44 HD12 ' C ' ' A' ' 97' ' ' ARG . 4.5 mp -130.08 135.75 60.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 72.510000000000005 111.16 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -125.29 140.6 47.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 73.209999999999994 111.125 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 127.98 131.05 3.4 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.751 -0.738 . . . . 72.420000000000002 112.478 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.09 70.92 10.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.835 0.35 . . . . 71.239999999999995 111.082 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.439 ' HG2' HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -107.47 171.9 7.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 75.140000000000001 110.909 179.945 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.04 173.62 6.15 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.729 -0.748 . . . . 51.119999999999997 112.496 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.88 -44.93 91.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.766 0.317 . . . . 72.030000000000001 110.855 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.93 -64.11 0.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 61.43 111.124 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.44 -57.9 9.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 73.430000000000007 111.144 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.466 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.2 OUTLIER -51.25 -42.49 61.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 72.310000000000002 110.955 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.478 ' O ' HD12 ' A' ' 108' ' ' LEU . 4.1 tp -63.6 -55.42 23.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 50.409999999999997 110.879 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.7 mtm180 -51.71 -42.0 61.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 73.319999999999993 110.888 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -51.86 -26.09 9.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 62.219999999999999 110.9 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.629 HG21 HD12 ' A' ' 88' ' ' LEU . 2.9 mt -85.14 -68.65 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 55.229999999999997 111.084 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.53 -49.17 62.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 74.409999999999997 110.862 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -56.95 -34.92 68.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 51.149999999999999 110.884 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.22 -37.51 66.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 73.0 111.085 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.0 mt . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.437 . . . . 74.310000000000002 110.932 -179.956 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 mmt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.761 0.315 . . . . 73.349999999999994 110.879 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.39 106.1 11.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 71.349999999999994 111.113 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -98.26 -40.42 8.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 75.340000000000003 110.857 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 24.2 t-80 -101.27 156.0 17.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 74.329999999999998 110.846 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -77.26 168.31 20.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 73.219999999999999 110.832 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 61.2 m-70 -118.4 -37.25 3.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 64.340000000000003 110.86 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -53.08 -36.23 60.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 74.109999999999999 110.826 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -54.83 -36.59 65.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 72.420000000000002 110.843 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 10.1 mtt -98.52 30.73 3.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 75.430000000000007 110.883 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.1 t -71.81 127.55 32.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 70.25 110.846 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.704 ' O ' HG22 ' A' ' 13' ' ' VAL . . . 143.66 173.55 15.26 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.738 -0.744 . . . . 54.509999999999998 112.485 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.2 p -59.98 101.14 0.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.83 0.347 . . . . 63.020000000000003 111.152 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.704 HG22 ' O ' ' A' ' 11' ' ' GLY . 4.2 m -153.45 163.67 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 74.430000000000007 111.143 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 t -66.56 126.98 30.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 62.420000000000002 111.135 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.43 HG23 ' CB ' ' A' ' 64' ' ' ALA . 60.6 t -94.76 127.6 46.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.449 . . . . 73.450000000000003 111.106 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.49 ' CB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.51 179.08 0.12 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 73.129999999999995 111.119 -179.927 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.461 ' H ' HG22 ' A' ' 16' ' ' THR . 1.3 p30 -79.98 -48.11 13.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 73.120000000000005 110.871 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.2 m -70.99 -51.56 24.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 73.519999999999996 110.867 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.49 HG22 ' CB ' ' A' ' 16' ' ' THR . 5.9 t -59.57 -19.32 47.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.148 -0.478 . . . . 63.329999999999998 111.144 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.729 ' CE2' HG21 ' A' ' 24' ' ' VAL . 25.1 t80 -51.26 -30.8 18.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 74.519999999999996 110.86 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.41 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -72.1 -33.63 68.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.473 . . . . 74.120000000000005 110.907 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.2 m -91.43 -16.04 27.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 65.109999999999999 111.143 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -93.46 -71.24 0.66 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 63.039999999999999 110.835 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.74 HG13 HG21 ' A' ' 31' ' ' VAL . 18.6 t -70.47 -70.47 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 75.430000000000007 111.146 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.41 ' HB2' ' HA ' ' A' ' 21' ' ' LYS . 7.4 mt -40.66 -60.11 1.22 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 75.299999999999997 110.949 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -50.46 -57.43 8.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 74.299999999999997 110.848 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.8 t -51.84 153.15 2.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 74.340000000000003 110.868 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -102.17 -49.4 3.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 55.539999999999999 110.911 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.706 HG21 ' OG1' ' A' ' 60' ' ' THR . 0.1 OUTLIER -51.87 159.7 1.31 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 121.624 0.726 . . . . 73.409999999999997 111.094 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 120.08 6.93 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.695 2.263 . . . . 64.540000000000006 112.321 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.74 HG21 HG13 ' A' ' 24' ' ' VAL . 97.6 t -83.35 142.74 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 75.549999999999997 111.105 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.468 HD23 HD11 ' A' ' 61' ' ' LEU . 3.8 mm? -111.9 112.64 24.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.467 . . . . 72.200000000000003 110.934 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.46 HG11 ' CE1' ' A' ' 35' ' ' PHE . 70.8 t -100.61 142.78 15.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 71.519999999999996 111.158 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -133.84 99.79 4.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 71.310000000000002 110.826 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.46 ' CE1' HG11 ' A' ' 33' ' ' VAL . 21.0 m-85 -91.72 89.77 7.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 65.400000000000006 110.892 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -141.66 -168.22 2.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 74.140000000000001 110.955 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.68 -164.76 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 63.240000000000002 111.091 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.456 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 1.5 t70 -77.67 11.98 1.86 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 71.519999999999996 110.87 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.482 ' N ' ' CD1' ' A' ' 39' ' ' TRP . 1.2 m0 76.35 94.76 0.07 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.194 -0.457 . . . . 74.319999999999993 110.886 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -169.68 -65.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 60.030000000000001 110.904 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -70.73 -70.28 1.22 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.761 -0.733 . . . . 73.140000000000001 112.491 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.47 ' O ' HG23 ' A' ' 46' ' ' VAL . 53.2 Cg_endo -69.81 -41.37 4.27 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.73 2.287 . . . . 70.549999999999997 112.278 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.55 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 31.7 t -51.94 -32.57 33.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.445 . . . . 53.350000000000001 110.859 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 18.5 mtpt -62.4 -34.79 77.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 75.5 110.925 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 34.6 mtm -90.13 -36.13 15.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 75.329999999999998 110.893 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.489 ' HA ' HG22 ' A' ' 49' ' ' VAL . 2.2 t -94.35 23.11 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 62.219999999999999 111.1 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.781 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -76.63 -60.62 0.85 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.603 0.716 . . . . 70.150000000000006 111.122 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.781 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.9 Cg_endo -69.73 -48.7 0.67 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.696 2.264 . . . . 73.430000000000007 112.317 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.489 HG22 ' HA ' ' A' ' 46' ' ' VAL . 4.5 m -49.94 -30.2 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 72.409999999999997 111.143 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.458 ' O ' HD13 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -86.13 -45.52 11.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 71.239999999999995 110.886 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -60.96 -32.45 71.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 74.349999999999994 110.846 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -51.31 -63.58 1.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 74.040000000000006 110.892 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.402 HD12 ' O ' ' A' ' 49' ' ' VAL . 2.7 mp -50.75 -41.02 20.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 71.140000000000001 111.142 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.22 -43.75 74.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 71.329999999999998 111.136 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.91 -36.22 42.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 70.129999999999995 110.884 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -60.64 -36.23 78.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 43.520000000000003 110.902 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.3 mmmt -75.64 -75.36 0.18 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.485 . . . . 74.450000000000003 110.951 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.36 -176.85 0.29 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.248 -0.433 . . . . 75.239999999999995 110.872 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.44 -39.88 55.81 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.769 -0.729 . . . . 64.25 112.473 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.706 ' OG1' HG21 ' A' ' 29' ' ' THR . 34.6 p -52.84 -29.05 25.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.804 0.335 . . . . 60.32 111.132 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.468 HD11 HD23 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -49.01 123.88 7.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 60.109999999999999 110.938 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.8 tttp -111.95 148.98 32.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 61.420000000000002 110.867 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.3 t -124.2 104.5 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 62.530000000000001 111.126 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.43 ' CB ' HG23 ' A' ' 15' ' ' VAL . . . -108.59 109.75 21.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 55.43 111.071 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.98 160.68 19.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 72.510000000000005 110.892 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 50.1 tp -148.29 147.56 29.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.439 . . . . 73.239999999999995 110.936 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -79.4 120.99 24.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 61.530000000000001 110.878 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.1 m -48.71 -36.57 7.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 74.329999999999998 111.11 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.36 -32.88 57.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 74.319999999999993 110.838 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.02 -35.03 29.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 70.040000000000006 111.107 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.686 ' HB2' ' HB3' ' A' ' 74' ' ' ALA . 4.5 p30 -118.15 67.14 6.39 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.627 0.727 . . . . 73.409999999999997 110.888 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -32.43 18.33 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.706 2.271 . . . . 62.399999999999999 112.36 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -83.94 -40.8 18.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 42.200000000000003 110.907 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.686 ' HB3' ' HB2' ' A' ' 71' ' ' ASN . . . -59.06 -46.63 87.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 62.039999999999999 111.091 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.497 ' O ' HG23 ' A' ' 80' ' ' VAL . . . -51.0 -63.24 1.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 74.150000000000006 111.141 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.7 ttp180 -51.25 -37.11 45.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 73.310000000000002 110.886 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -55.01 -36.17 65.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 70.120000000000005 110.857 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -98.35 21.77 10.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 75.120000000000005 110.874 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 50.23 80.22 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 63.340000000000003 110.926 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 75' ' ' ALA . 96.5 t -108.55 97.17 5.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.148 -0.478 . . . . 70.310000000000002 111.099 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 81' ' ' VAL . 3.4 t -99.57 34.21 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 72.340000000000003 111.102 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -176.04 140.28 0.41 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.467 . . . . 75.409999999999997 110.887 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.523 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 4.2 mt -57.84 -57.83 22.83 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.668 0.747 . . . . 74.200000000000003 111.09 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.6 Cg_endo -69.74 74.72 1.26 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.714 2.276 . . . . 70.349999999999994 112.359 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.846 HG23 HG12 ' A' ' 99' ' ' VAL . 53.6 m -109.26 143.35 38.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 60.450000000000003 111.142 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 10.9 ttp -141.3 128.79 21.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 75.150000000000006 110.9 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 17.2 mt -115.94 119.72 62.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 65.030000000000001 111.17 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.802 HD12 HG21 ' A' ' 111' ' ' ILE . 0.5 OUTLIER -86.55 111.51 20.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 71.010000000000005 110.915 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -99.42 170.36 8.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 72.140000000000001 110.885 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -163.6 92.53 0.71 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.486 . . . . 74.409999999999997 110.872 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.45 32.21 28.58 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.745 -0.741 . . . . 31.239999999999998 112.503 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.401 ' H ' HG12 ' A' ' 24' ' ' VAL . . . 78.12 38.93 24.88 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.757 -0.735 . . . . 73.230000000000004 112.498 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.1 m -160.32 132.39 4.24 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.589 0.709 . . . . 72.120000000000005 111.11 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 91.73 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.688 2.259 . . . . 62.539999999999999 112.361 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.9 m -70.95 -32.71 49.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 75.209999999999994 111.115 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.1 mmtm -155.25 170.07 22.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 75.109999999999999 110.918 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.614 ' C ' HD12 ' A' ' 98' ' ' ILE . 0.9 OUTLIER -148.01 128.01 13.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 72.219999999999999 110.896 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.614 HD12 ' C ' ' A' ' 97' ' ' ARG . 4.0 mp -136.06 123.75 35.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 63.119999999999997 111.091 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.846 HG12 HG23 ' A' ' 85' ' ' THR . 7.1 m -118.81 159.68 19.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 74.340000000000003 111.116 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 115.57 142.15 7.57 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.713 -0.756 . . . . 74.120000000000005 112.454 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.04 71.24 7.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.835 0.35 . . . . 34.100000000000001 111.12 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.523 ' HB2' ' HB3' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -107.1 164.98 11.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.19 -0.459 . . . . 55.340000000000003 110.909 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.78 -176.36 0.73 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.734 -0.746 . . . . 33.130000000000003 112.459 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.79 -43.77 65.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.737 0.303 . . . . 75.239999999999995 110.889 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.72 -26.14 66.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 33.329999999999998 111.099 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.523 ' HB3' ' HB2' ' A' ' 102' ' ' LYS . . . -90.55 -36.25 14.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 74.519999999999996 111.106 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.688 HD13 ' O ' ' A' ' 107' ' ' LEU . 2.5 tm? -77.22 -36.13 55.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 73.409999999999997 110.896 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.628 ' C ' HD12 ' A' ' 108' ' ' LEU . 1.2 pp -74.65 -39.05 62.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 75.319999999999993 110.906 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.465 ' N ' HD12 ' A' ' 108' ' ' LEU . 16.0 ptm180 -66.88 -35.94 81.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 53.32 110.859 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -57.77 -23.1 50.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 54.32 110.887 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.802 HG21 HD12 ' A' ' 88' ' ' LEU . 3.1 mt -86.48 -66.23 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 72.450000000000003 111.108 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.476 ' HA ' HD12 ' A' ' 115' ' ' LEU . 9.9 pt-20 -52.59 -48.82 66.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 74.230000000000004 110.85 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -59.75 -33.76 72.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 74.219999999999999 110.907 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.0 -35.62 59.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 75.409999999999997 111.122 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.476 HD12 ' HA ' ' A' ' 112' ' ' GLU . 10.0 mt . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 72.439999999999998 110.874 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.799 0.333 . . . . 43.109999999999999 110.888 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.496 ' HB2' HG21 ' A' ' 22' ' ' THR . . . -72.09 106.19 4.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 64.010000000000005 111.097 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 45.1 p-80 -81.14 -36.13 30.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 72.209999999999994 110.889 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -120.93 175.62 5.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 75.120000000000005 110.861 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -114.98 146.23 41.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 71.120000000000005 110.862 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -115.72 30.79 7.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 64.549999999999997 110.875 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 26.3 t60 -88.95 -36.28 15.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 75.530000000000001 110.9 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 28.1 m170 -79.06 -39.92 32.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 72.239999999999995 110.854 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 36.5 mtm -96.01 30.8 2.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 73.349999999999994 110.87 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.9 t -59.15 113.14 1.98 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 63.140000000000001 110.841 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -160.59 173.47 37.14 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.722 -0.752 . . . . 53.200000000000003 112.502 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.9 p -82.79 99.79 9.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.849 0.357 . . . . 72.409999999999997 111.121 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.1 m -153.76 173.19 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.475 . . . . 64.129999999999995 111.095 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.473 ' HA ' ' HB1' ' A' ' 64' ' ' ALA . 0.2 OUTLIER -73.74 152.35 40.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 74.329999999999998 111.122 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.494 HG22 HG23 ' A' ' 19' ' ' THR . 8.6 p -127.44 145.52 34.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 71.329999999999998 111.111 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.649 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.87 162.28 5.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 74.109999999999999 111.125 -179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.42 -50.28 13.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 65.0 110.881 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.1 m -59.69 -35.89 75.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.468 . . . . 53.140000000000001 110.821 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.649 HG22 ' HB ' ' A' ' 16' ' ' THR . 5.3 t -85.43 -17.55 36.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 74.510000000000005 111.178 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.71 ' CE2' HG21 ' A' ' 24' ' ' VAL . 24.7 t80 -49.37 -31.86 10.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 53.340000000000003 110.856 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.411 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -70.09 -36.15 74.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.48 . . . . 72.329999999999998 110.918 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.496 HG21 ' HB2' ' A' ' 2' ' ' ALA . 24.8 m -89.94 -15.09 32.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.436 . . . . 64.040000000000006 111.135 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -92.92 -70.97 0.67 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 73.019999999999996 110.888 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 1.046 HG13 HG21 ' A' ' 31' ' ' VAL . 16.4 t -72.35 -70.31 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 75.420000000000002 111.142 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.639 HD23 ' HA3' ' A' ' 92' ' ' GLY . 7.1 mt -39.9 -56.22 1.84 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 75.120000000000005 110.947 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -55.67 -52.52 63.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 75.540000000000006 110.854 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.5 t -51.89 159.88 0.78 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 61.340000000000003 110.836 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -106.89 -44.76 4.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.143 -0.48 . . . . 73.340000000000003 110.867 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -54.49 159.49 3.28 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.601 0.715 . . . . 74.340000000000003 111.122 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 131.02 20.34 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.695 2.264 . . . . 72.530000000000001 112.322 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 1.046 HG21 HG13 ' A' ' 24' ' ' VAL . 88.2 t -102.25 129.45 53.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 75.109999999999999 111.159 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.813 HD11 HD11 ' A' ' 61' ' ' LEU . 10.7 mt -104.93 106.04 16.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 70.019999999999996 110.917 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.442 HG21 ' CE1' ' A' ' 35' ' ' PHE . 3.8 p -105.12 131.0 55.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 75.430000000000007 111.164 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -116.41 99.61 7.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 74.140000000000001 110.818 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.442 ' CE1' HG21 ' A' ' 33' ' ' VAL . 23.0 m-85 -87.37 89.48 8.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 65.040000000000006 110.897 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.458 ' HZ3' HG11 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -143.61 -169.4 3.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.486 . . . . 74.209999999999994 110.91 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.84 -157.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 73.099999999999994 111.093 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.476 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 15.3 t0 -76.85 9.39 2.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 72.219999999999999 110.876 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.476 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 1.2 p-90 41.69 67.51 0.55 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 72.219999999999999 110.91 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 18.1 t -127.09 -47.7 1.48 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.272 -0.422 . . . . 73.310000000000002 110.839 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.56 -67.91 1.51 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.712 -0.756 . . . . 72.319999999999993 112.525 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -24.82 29.39 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.696 2.264 . . . . 70.319999999999993 112.351 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 36.3 t -49.9 -31.5 12.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 21.129999999999999 110.903 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 11.7 mttp -52.27 -35.14 49.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 72.219999999999999 110.866 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 8.9 mtt -90.44 -32.46 16.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 64.310000000000002 110.875 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.472 ' HA ' ' CG1' ' A' ' 49' ' ' VAL . 3.0 t -92.85 22.89 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 74.219999999999999 111.113 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.79 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -80.87 -60.67 0.43 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.559 0.695 . . . . 62.219999999999999 111.113 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.79 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.9 Cg_endo -69.78 -56.72 0.13 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.702 2.268 . . . . 73.230000000000004 112.326 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.81 HG23 ' HA ' ' A' ' 104' ' ' LYS . 3.0 p -48.76 -33.93 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 62.32 111.119 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.3 tp -69.46 -41.44 76.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 74.209999999999994 110.915 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.466 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 6.4 mm-40 -73.29 -33.24 65.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.461 . . . . 64.439999999999998 110.881 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -50.33 -66.49 0.38 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 74.329999999999998 110.874 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.595 HD12 ' O ' ' A' ' 49' ' ' VAL . 2.6 mt -50.07 -33.07 9.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 62.310000000000002 111.106 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.689 ' HB1' HD21 ' A' ' 61' ' ' LEU . . . -62.81 -45.04 94.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 72.319999999999993 111.122 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.3 -35.27 66.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 72.129999999999995 110.893 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -71.04 -35.84 72.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 64.230000000000004 110.912 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.6 mmtt -61.88 -62.84 1.51 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 54.140000000000001 110.87 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 t -151.58 -169.04 3.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 51.030000000000001 110.854 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 60' ' ' THR . . . -92.05 123.53 7.27 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.762 -0.732 . . . . 43.43 112.491 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.406 ' C ' ' O ' ' A' ' 59' ' ' GLY . 9.9 t 37.57 43.41 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.785 0.326 . . . . 41.340000000000003 111.159 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.813 HD11 HD11 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -58.42 -174.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.264 -0.425 . . . . 74.129999999999995 110.868 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -97.96 140.55 32.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 55.539999999999999 110.903 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.2 t -141.95 118.15 6.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.253 -0.431 . . . . 73.400000000000006 111.138 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.473 ' HB1' ' HA ' ' A' ' 14' ' ' THR . . . -115.48 147.09 41.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 60.450000000000003 111.09 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.2 pttp -138.97 131.38 28.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 75.310000000000002 110.892 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.429 HD21 ' CG ' ' A' ' 71' ' ' ASN . 32.1 tp -122.47 159.48 27.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 74.340000000000003 110.888 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -103.07 118.08 36.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 74.400000000000006 110.838 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.418 HG22 ' HB2' ' A' ' 75' ' ' ALA . 73.9 t -61.62 -35.7 68.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 73.409999999999997 111.141 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -51.41 -35.3 38.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 63.240000000000002 110.898 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.14 -35.06 11.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 64.219999999999999 111.055 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.429 ' CG ' HD21 ' A' ' 66' ' ' LEU . 2.7 m120 -117.79 72.5 8.29 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.619 0.723 . . . . 51.25 110.878 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -31.16 20.84 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.686 2.257 . . . . 72.109999999999999 112.343 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -61.34 -43.33 99.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.243 -0.435 . . . . 64.129999999999995 110.892 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.417 ' HB1' ' CE2' ' A' ' 35' ' ' PHE . . . -60.69 -48.08 83.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 61.030000000000001 111.079 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.548 ' O ' HG23 ' A' ' 80' ' ' VAL . . . -52.16 -66.21 0.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 74.400000000000006 111.089 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.2 ttp85 -51.14 -33.15 25.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 60.299999999999997 110.895 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -51.28 -36.22 41.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 74.010000000000005 110.915 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -108.7 24.97 12.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 74.219999999999999 110.874 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 59.9 mm-40 48.2 67.1 0.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 74.329999999999998 110.858 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 75' ' ' ALA . 98.9 t -91.2 106.2 17.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 72.519999999999996 111.113 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.5 t -80.12 -62.28 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 73.319999999999993 111.099 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 56.1 m -89.83 160.68 16.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.467 . . . . 71.409999999999997 110.858 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.53 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.8 mt -60.2 -58.18 21.27 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.624 0.726 . . . . 60.219999999999999 111.098 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.3 Cg_endo -69.79 77.43 1.08 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.683 2.255 . . . . 71.540000000000006 112.351 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.57 ' HA ' HG12 ' A' ' 99' ' ' VAL . 99.7 m -117.39 109.62 17.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.439 . . . . 43.200000000000003 111.116 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 31.0 ttp -113.77 145.95 40.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 72.219999999999999 110.891 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.6 mt -129.68 117.86 43.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 71.239999999999995 111.138 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.468 ' HG ' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -80.82 102.59 10.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 72.219999999999999 110.924 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -89.52 167.68 12.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 73.219999999999999 110.894 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -161.85 94.86 0.96 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 54.539999999999999 110.909 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.28 32.72 22.12 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.737 -0.744 . . . . 71.209999999999994 112.502 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.639 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 73.49 41.1 45.64 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.716 -0.754 . . . . 73.109999999999999 112.516 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.451 HG23 ' HD2' ' A' ' 94' ' ' PRO . 85.4 m -160.15 133.69 4.91 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.597 0.713 . . . . 73.430000000000007 111.143 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.451 ' HD2' HG23 ' A' ' 93' ' ' THR . 53.8 Cg_endo -69.76 93.78 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.692 2.261 . . . . 71.409999999999997 112.349 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.5 m -88.29 -32.37 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 71.030000000000001 111.133 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -132.12 166.22 22.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 71.450000000000003 110.911 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.408 ' C ' HD12 ' A' ' 98' ' ' ILE . 6.4 ttp180 -160.09 116.74 2.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 73.239999999999995 110.867 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.411 ' N ' HD12 ' A' ' 98' ' ' ILE . 5.0 mp -133.95 139.6 48.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 61.219999999999999 111.128 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.57 HG12 ' HA ' ' A' ' 85' ' ' THR . 4.8 m -132.26 154.82 40.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 72.140000000000001 111.107 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 115.34 137.92 6.4 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.719 -0.753 . . . . 73.129999999999995 112.503 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.43 77.11 6.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.883 0.373 . . . . 62.509999999999998 111.083 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.77 176.76 4.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 75.120000000000005 110.898 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -76.65 166.6 54.21 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.685 -0.769 . . . . 71.319999999999993 112.468 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.81 ' HA ' HG23 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -58.13 -41.01 82.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.755 0.312 . . . . 63.100000000000001 110.854 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.47 -32.19 66.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 64.340000000000003 111.1 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.53 -61.87 1.58 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 72.200000000000003 111.128 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.512 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.3 OUTLIER -45.93 -43.1 13.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 63.240000000000002 110.942 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.581 ' O ' HD12 ' A' ' 108' ' ' LEU . 4.3 tp -49.49 -47.87 48.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 73.310000000000002 110.937 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 50.7 mtm180 -65.7 -40.59 92.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 75.150000000000006 110.838 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -49.79 -25.15 2.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 71.430000000000007 110.896 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.414 ' CD1' HG21 ' A' ' 53' ' ' ILE . 4.2 mt -90.37 -70.09 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 65.230000000000004 111.15 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -51.86 -51.05 59.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 71.450000000000003 110.849 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -57.2 -34.22 68.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.47 . . . . 74.230000000000004 110.895 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.17 -34.02 65.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 43.020000000000003 111.081 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 115' ' ' LEU . 8.5 mt . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 71.200000000000003 110.939 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.1 ptm . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.804 0.335 . . . . 74.099999999999994 110.916 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -113.67 85.45 2.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 73.420000000000002 111.067 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -85.64 -38.19 18.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.258 -0.428 . . . . 64.450000000000003 110.85 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -68.45 126.08 28.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 74.230000000000004 110.822 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -92.08 132.11 36.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 63.439999999999998 110.85 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -119.98 -36.95 3.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 62.140000000000001 110.855 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 21.4 m170 -98.83 -36.13 9.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 75.140000000000001 110.84 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -97.64 11.33 37.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 53.240000000000002 110.889 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 4.4 ptm -61.41 -40.53 94.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 71.120000000000005 110.876 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.9 t -54.58 113.62 1.37 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 64.510000000000005 110.851 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.649 ' O ' HG22 ' A' ' 13' ' ' VAL . . . 133.93 155.03 7.49 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.804 -0.712 . . . . 72.349999999999994 112.523 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.6 p -60.74 105.09 0.41 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.788 0.328 . . . . 50.119999999999997 111.145 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.649 HG22 ' O ' ' A' ' 11' ' ' GLY . 4.6 m -153.31 172.19 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 72.140000000000001 111.163 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.1 t -74.04 127.94 34.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 74.030000000000001 111.192 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.4 t -91.28 137.04 22.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 74.140000000000001 111.095 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.605 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.71 174.73 0.43 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.16 -0.473 . . . . 73.310000000000002 111.144 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.453 ' H ' HG22 ' A' ' 16' ' ' THR . 10.1 t0 -80.49 -48.97 12.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 61.219999999999999 110.888 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.6 m -68.07 -53.44 25.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 72.329999999999998 110.853 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.605 HG22 ' HB ' ' A' ' 16' ' ' THR . 5.6 t -59.06 -19.28 42.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 73.219999999999999 111.158 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.719 ' CE2' HG21 ' A' ' 24' ' ' VAL . 25.0 t80 -51.08 -31.12 17.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 62.210000000000001 110.879 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.402 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -71.82 -33.45 68.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 74.019999999999996 110.902 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.6 m -91.51 -15.97 27.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.199 -0.455 . . . . 60.420000000000002 111.153 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -93.48 -71.23 0.66 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 72.409999999999997 110.888 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 1.005 HG13 HG21 ' A' ' 31' ' ' VAL . 19.1 t -70.5 -70.47 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 71.099999999999994 111.142 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.623 HD23 ' HA3' ' A' ' 92' ' ' GLY . 7.6 mt -40.72 -59.94 1.27 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 75.409999999999997 110.87 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -50.57 -60.68 2.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 73.540000000000006 110.868 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.0 t -51.32 162.06 0.38 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.45 . . . . 74.349999999999994 110.869 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -112.33 -40.28 4.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 74.540000000000006 110.828 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.452 HG22 ' HD2' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -51.94 158.88 1.56 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.563 0.697 . . . . 73.239999999999995 111.172 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.452 ' HD2' HG22 ' A' ' 29' ' ' THR . 53.7 Cg_endo -69.74 116.08 4.39 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.726 2.284 . . . . 73.450000000000003 112.323 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 1.005 HG21 HG13 ' A' ' 24' ' ' VAL . 98.0 t -82.35 141.53 14.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 72.409999999999997 111.111 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.1 mt -112.04 104.89 13.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 74.0 110.912 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 87' ' ' ILE . 8.6 p -113.37 146.86 17.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 75.120000000000005 111.123 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -139.49 117.85 12.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 74.219999999999999 110.9 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.557 ' HE2' ' HB1' ' A' ' 74' ' ' ALA . 20.2 m-85 -95.17 97.05 9.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 73.420000000000002 110.926 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.621 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -146.13 -167.32 2.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 73.329999999999998 110.935 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.09 -167.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 63.130000000000003 111.118 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.447 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 5.7 m-20 -78.77 12.69 1.99 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 73.450000000000003 110.855 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.449 ' CD1' ' N ' ' A' ' 39' ' ' TRP . 0.8 OUTLIER 75.37 85.57 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 75.25 110.91 -179.963 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 2.0 p -164.44 -47.08 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 63.310000000000002 110.88 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.88 -70.72 1.34 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.794 -0.717 . . . . 73.319999999999993 112.463 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -31.22 21.05 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.688 2.259 . . . . 65.120000000000005 112.339 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.548 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 43.7 t -51.24 -29.16 13.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 54.210000000000001 110.852 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -63.66 -49.34 73.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 74.409999999999997 110.902 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.547 ' HG3' HG23 ' A' ' 46' ' ' VAL . 10.9 ptp -77.54 -34.52 53.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 75.219999999999999 110.909 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.547 HG23 ' HG3' ' A' ' 45' ' ' MET . 3.4 t -93.8 21.98 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 72.140000000000001 111.163 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.812 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -76.52 -61.28 0.79 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.606 0.717 . . . . 73.549999999999997 111.142 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.812 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.3 Cg_endo -69.81 -49.83 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.651 2.234 . . . . 64.239999999999995 112.348 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.684 ' O ' HD12 ' A' ' 53' ' ' ILE . 4.1 m -51.04 -30.35 9.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 71.549999999999997 111.144 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.2 tp -76.17 -41.51 49.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.121 -0.49 . . . . 73.510000000000005 110.911 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -71.12 -33.94 70.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 75.299999999999997 110.895 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -51.49 -69.53 0.11 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 63.409999999999997 110.864 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.684 HD12 ' O ' ' A' ' 49' ' ' VAL . 2.8 mp -50.99 -37.29 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 62.520000000000003 111.14 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.75 -48.78 80.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 73.310000000000002 111.108 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.69 -35.99 75.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 71.540000000000006 110.863 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -66.01 -36.67 83.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 74.450000000000003 110.903 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.9 mmtt -75.97 -71.82 0.36 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 73.129999999999995 110.866 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -178.82 -169.03 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 74.239999999999995 110.817 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -113.3 -31.14 2.48 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.77 -0.728 . . . . 71.310000000000002 112.502 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 29.4 p -57.31 -32.54 66.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.842 0.353 . . . . 44.409999999999997 111.158 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.661 ' C ' HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -50.71 168.8 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 75.150000000000006 110.903 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.546 ' N ' HD22 ' A' ' 61' ' ' LEU . 1.3 mptm? -122.28 141.97 50.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 72.519999999999996 110.855 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 23.8 t -120.58 99.81 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 24.23 111.143 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -108.88 142.69 39.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 64.310000000000002 111.108 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.5 mtpt -130.93 159.51 37.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 62.009999999999998 110.91 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.526 HD21 ' CB ' ' A' ' 71' ' ' ASN . 10.4 tp -140.56 144.83 36.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 63.140000000000001 110.924 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.03 119.34 33.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 75.25 110.843 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 36' ' ' TRP . 21.1 t -62.4 -34.58 65.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.486 . . . . 62.340000000000003 111.105 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.56 -35.54 41.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 71.540000000000006 110.867 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.36 -34.09 11.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 51.200000000000003 111.06 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.526 ' CB ' HD21 ' A' ' 66' ' ' LEU . 1.8 m-80 -118.3 68.46 7.35 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.602 0.715 . . . . 75.349999999999994 110.878 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -32.81 17.8 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.692 2.261 . . . . 64.109999999999999 112.328 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -67.99 -35.19 77.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 73.230000000000004 110.859 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.557 ' HB1' ' HE2' ' A' ' 35' ' ' PHE . . . -56.96 -44.13 82.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 55.039999999999999 111.104 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.52 ' O ' HG23 ' A' ' 80' ' ' VAL . . . -59.83 -64.38 0.97 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 70.129999999999995 111.097 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.6 ttp180 -50.51 -35.11 27.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 74.010000000000005 110.898 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.85 -35.79 64.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 71.140000000000001 110.835 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -107.6 28.7 7.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 72.239999999999995 110.896 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 50.96 84.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 75.439999999999998 110.942 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 75' ' ' ALA . 96.9 t -120.78 140.06 46.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.443 . . . . 65.129999999999995 111.131 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.6 m -127.59 -37.69 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 73.340000000000003 111.154 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.2 t -100.96 148.28 25.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 74.5 110.871 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.535 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.1 mt -59.64 -57.69 24.97 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.599 0.714 . . . . 71.010000000000005 111.128 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.8 Cg_endo -69.76 71.56 1.51 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.687 2.258 . . . . 75.430000000000007 112.345 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.982 HG23 HG22 ' A' ' 99' ' ' VAL . 54.8 m -106.39 135.37 47.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 73.430000000000007 111.137 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 5.0 ttt -134.66 146.31 49.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 65.439999999999998 110.898 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.423 ' O ' HG12 ' A' ' 33' ' ' VAL . 22.3 mt -141.86 118.03 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 75.420000000000002 111.156 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.39 101.42 9.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 71.409999999999997 110.948 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -89.91 170.92 9.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 62.299999999999997 110.865 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.74 119.11 0.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 70.439999999999998 110.901 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.37 34.41 88.14 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.707 -0.759 . . . . 61.43 112.501 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.623 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 71.56 42.34 55.5 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.714 -0.755 . . . . 65.25 112.538 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.448 HG23 ' HD2' ' A' ' 94' ' ' PRO . 84.9 m -161.05 133.94 4.57 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.613 0.721 . . . . 51.329999999999998 111.109 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.448 ' HD2' HG23 ' A' ' 93' ' ' THR . 54.0 Cg_endo -69.75 81.35 0.82 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.657 2.238 . . . . 74.219999999999999 112.345 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.3 m -68.2 -32.36 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 52.140000000000001 111.11 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.3 mmtm -142.75 160.19 40.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 75.239999999999995 110.879 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.59 ' C ' HD12 ' A' ' 98' ' ' ILE . 2.4 tmt_? -149.37 124.63 10.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 75.439999999999998 110.871 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.59 HD12 ' C ' ' A' ' 97' ' ' ARG . 4.6 mp -139.35 116.56 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 75.0 111.11 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.982 HG22 HG23 ' A' ' 85' ' ' THR . 61.0 t -111.76 134.24 54.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 73.109999999999999 111.132 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 133.99 140.26 4.29 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.735 -0.745 . . . . 52.149999999999999 112.46 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.32 85.58 4.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.83 0.348 . . . . 44.329999999999998 111.139 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.36 165.92 15.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 63.130000000000003 110.908 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.22 149.76 49.65 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.755 -0.736 . . . . 71.219999999999999 112.523 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.475 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -47.17 -36.98 9.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.822 0.344 . . . . 73.439999999999998 110.869 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.82 -47.03 74.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 75.25 111.114 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -83.18 -49.6 9.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 64.510000000000005 111.094 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.428 ' C ' HD13 ' A' ' 107' ' ' LEU . 2.0 tm? -47.87 -51.87 21.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.237 -0.438 . . . . 64.439999999999998 110.872 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.475 HD23 ' O ' ' A' ' 104' ' ' LYS . 1.7 pp -50.69 -35.89 33.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 73.099999999999994 110.893 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -68.65 -44.69 73.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 60.329999999999998 110.898 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -51.4 -25.61 6.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.49 . . . . 70.129999999999995 110.909 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.401 ' HA ' HD11 ' A' ' 98' ' ' ILE . 3.7 mt -84.72 -68.08 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 71.409999999999997 111.167 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.43 ' O ' HD23 ' A' ' 115' ' ' LEU . 10.1 pt-20 -52.32 -49.38 64.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 70.420000000000002 110.891 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -52.49 -33.82 46.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.481 . . . . 75.400000000000006 110.836 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.01 -34.68 73.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 74.109999999999999 111.081 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.43 HD23 ' O ' ' A' ' 112' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 75.099999999999994 110.919 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.0 mtm . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.802 0.334 . . . . 63.439999999999998 110.895 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.59 -175.82 5.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.447 . . . . 70.439999999999998 111.06 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.7 m170 -77.68 -57.7 3.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.467 . . . . 74.409999999999997 110.847 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -105.65 -175.69 2.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 72.519999999999996 110.847 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.4 m-70 -146.03 120.1 9.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.442 . . . . 74.409999999999997 110.88 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 27.8 m170 -113.99 30.76 7.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 60.43 110.875 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -97.28 11.25 37.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 72.030000000000001 110.885 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.8 t-160 -62.22 -37.84 86.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 75.409999999999997 110.873 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 83.0 mtp -57.77 -44.64 86.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 75.209999999999994 110.888 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.1 m -57.57 124.79 20.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 75.439999999999998 110.884 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -55.9 -84.26 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.678 -0.773 . . . . 71.310000000000002 112.483 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.3 p -71.27 120.76 17.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.856 0.36 . . . . 71.340000000000003 111.162 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.4 t -135.15 140.69 44.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 74.140000000000001 111.121 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 t -92.71 133.38 36.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 74.129999999999995 111.16 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.7 t -89.81 120.73 39.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 72.030000000000001 111.107 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.528 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.92 -179.52 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 62.229999999999997 111.144 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.42 ' H ' HG22 ' A' ' 16' ' ' THR . 4.4 m-20 -79.71 -45.59 18.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 63.409999999999997 110.833 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.7 m -68.98 -54.86 13.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 35.140000000000001 110.864 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.528 HG22 ' HB ' ' A' ' 16' ' ' THR . 10.3 t -57.74 -21.9 43.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 62.240000000000002 111.159 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.629 ' CE2' HG21 ' A' ' 24' ' ' VAL . 20.6 t80 -48.77 -30.5 5.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 73.439999999999998 110.913 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.523 ' HA ' HD12 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -67.61 -41.97 83.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 75.239999999999995 110.876 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.426 HG22 ' O ' ' A' ' 22' ' ' THR . 25.5 m -91.45 -9.69 43.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.228 -0.442 . . . . 63.420000000000002 111.153 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.57 -70.24 0.71 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 52.130000000000003 110.885 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.772 HG22 HG21 ' A' ' 31' ' ' VAL . 11.1 t -83.99 -66.87 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 62.539999999999999 111.145 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.681 HD23 ' HA3' ' A' ' 92' ' ' GLY . 77.8 mt -45.79 -32.77 2.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 71.319999999999993 110.898 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -48.8 -32.05 8.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.157 -0.474 . . . . 74.219999999999999 110.882 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.9 t 65.9 62.97 0.6 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 52.340000000000003 110.851 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -120.23 -32.38 4.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 73.120000000000005 110.886 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.487 HG21 ' O ' ' A' ' 60' ' ' THR . 0.1 OUTLIER -157.16 159.67 30.97 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.557 0.694 . . . . 63.439999999999998 111.139 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.403 ' HD2' HG22 ' A' ' 29' ' ' THR . 53.3 Cg_endo -69.77 126.7 13.6 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.645 2.23 . . . . 72.319999999999993 112.356 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.772 HG21 HG22 ' A' ' 24' ' ' VAL . 91.6 t -98.18 119.17 45.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 53.420000000000002 111.113 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.0 mp -108.0 99.9 9.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 64.230000000000004 110.886 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.4 m -107.44 146.21 13.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 74.109999999999999 111.125 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -123.47 100.21 6.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 73.25 110.897 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -72.15 100.22 2.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 72.319999999999993 110.877 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.467 ' HH2' HD22 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -147.47 -168.3 3.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.153 -0.476 . . . . 64.430000000000007 110.908 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.47 -164.96 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 64.439999999999998 111.128 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.475 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 4.6 m-20 -79.25 13.66 1.8 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.446 . . . . 73.400000000000006 110.903 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.475 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 0.6 OUTLIER 75.19 94.76 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 72.019999999999996 110.925 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -172.13 -57.92 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.444 . . . . 62.439999999999998 110.91 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.26 -70.98 1.28 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.798 -0.715 . . . . 73.430000000000007 112.479 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.404 ' HG3' HG21 ' A' ' 83' ' ' ILE . 54.3 Cg_endo -69.68 -31.04 21.65 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.693 2.262 . . . . 53.520000000000003 112.356 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.556 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 20.4 t -58.46 -35.4 72.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 74.319999999999993 110.87 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.5 ptmm? -65.02 -29.42 70.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 53.409999999999997 110.904 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 9.0 mtm -86.88 -41.54 13.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 74.519999999999996 110.883 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.54 ' HA ' HG22 ' A' ' 49' ' ' VAL . 3.1 t -94.24 22.3 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 51.229999999999997 111.176 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.796 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -75.85 -61.1 0.93 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.512 0.672 . . . . 72.519999999999996 111.129 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.796 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 54.0 Cg_endo -69.72 -50.3 0.48 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.687 2.258 . . . . 72.0 112.354 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.54 HG22 ' HA ' ' A' ' 46' ' ' VAL . 4.2 m -52.66 -29.07 13.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 70.239999999999995 111.163 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.467 HD22 ' HH2' ' A' ' 36' ' ' TRP . 14.0 tp -86.16 -44.31 12.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.146 -0.479 . . . . 72.299999999999997 110.908 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -62.66 -34.4 77.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 72.530000000000001 110.899 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -51.76 -55.41 19.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 74.209999999999994 110.917 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 mt -50.57 -37.99 15.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.085 -0.507 . . . . 74.400000000000006 111.13 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.43 -42.44 62.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 72.120000000000005 111.097 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.0 -40.92 97.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 52.409999999999997 110.881 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -73.57 -36.09 65.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 64.329999999999998 110.862 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.3 -69.36 0.2 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 62.520000000000003 110.901 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.3 t 63.04 39.1 10.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 71.430000000000007 110.826 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -111.06 -117.09 3.7 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.749 -0.739 . . . . 74.329999999999998 112.533 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.487 ' O ' HG21 ' A' ' 29' ' ' THR . 14.8 p -140.31 34.35 1.88 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.788 0.328 . . . . 75.340000000000003 111.152 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.5 pp -81.46 144.8 31.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 43.450000000000003 110.907 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.3 mttm -98.55 126.19 44.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.448 . . . . 71.25 110.891 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 44.5 t -100.34 101.53 12.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 74.239999999999995 111.137 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -117.01 152.45 34.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 60.409999999999997 111.104 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.26 136.88 42.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 72.109999999999999 110.923 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.5 tp -117.04 150.88 37.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 75.140000000000001 110.914 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -106.98 118.57 37.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 71.400000000000006 110.816 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 99.9 t -57.77 -40.35 75.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.469 . . . . 65.409999999999997 111.11 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -51.7 -36.19 45.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.142 -0.481 . . . . 64.420000000000002 110.869 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.34 -33.89 15.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 60.420000000000002 111.111 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -118.76 67.81 7.98 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.604 0.716 . . . . 74.140000000000001 110.866 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -33.58 16.32 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.64 2.227 . . . . 75.109999999999999 112.359 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -74.46 -36.7 63.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 64.319999999999993 110.895 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.26 -48.24 74.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 74.219999999999999 111.111 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.537 ' O ' HG23 ' A' ' 80' ' ' VAL . . . -56.25 -61.41 2.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 71.140000000000001 111.12 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.58 -34.05 35.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 72.549999999999997 110.891 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.17 -34.69 73.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 64.019999999999996 110.873 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -103.88 26.91 8.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 54.219999999999999 110.853 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 49.85 82.5 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.485 . . . . 75.430000000000007 110.904 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 75' ' ' ALA . 85.4 t -117.11 144.58 24.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.229 -0.442 . . . . 75.549999999999997 111.181 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.7 m -135.42 -40.22 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 74.299999999999997 111.096 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.2 m -97.65 146.71 25.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 72.230000000000004 110.861 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.541 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.9 mt -57.94 -57.75 23.52 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.586 0.707 . . . . 72.340000000000003 111.108 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 54.1 Cg_endo -69.79 74.94 1.26 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.696 2.264 . . . . 74.049999999999997 112.343 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.757 HG23 HG12 ' A' ' 99' ' ' VAL . 52.3 m -112.3 143.34 43.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 72.209999999999994 111.129 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 4.2 tmm? -140.34 139.1 35.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 74.319999999999993 110.843 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.1 mt -130.38 113.19 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 73.310000000000002 111.08 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.459 HD12 HD13 ' A' ' 111' ' ' ILE . 1.6 tt -80.53 111.32 16.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 65.030000000000001 110.93 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -98.91 168.75 9.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 74.150000000000006 110.88 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -170.68 93.33 0.19 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.171 -0.468 . . . . 73.140000000000001 110.915 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.77 44.66 6.32 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.727 -0.749 . . . . 73.319999999999993 112.449 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.681 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 63.71 38.41 96.17 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.739 -0.743 . . . . 52.350000000000001 112.5 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.5 m -162.93 128.62 2.22 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.573 0.701 . . . . 60.229999999999997 111.134 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 86.94 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.679 2.253 . . . . 43.530000000000001 112.384 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.5 m -57.56 -35.74 51.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.425 . . . . 63.109999999999999 111.146 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 45.8 mmtt -152.82 170.19 20.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 45.130000000000003 110.896 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.452 ' C ' HD12 ' A' ' 98' ' ' ILE . 11.2 ttt180 -149.73 123.65 9.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 73.329999999999998 110.901 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.452 HD12 ' C ' ' A' ' 97' ' ' ARG . 4.2 mp -127.11 128.97 70.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 74.25 111.131 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.757 HG12 HG23 ' A' ' 85' ' ' THR . 4.8 m -124.55 160.22 29.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.467 . . . . 64.310000000000002 111.136 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 109.51 138.63 8.21 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.727 -0.749 . . . . 41.43 112.487 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -91.87 80.41 5.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.863 0.363 . . . . 74.430000000000007 111.139 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.401 ' HG2' HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -110.84 178.58 4.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.435 . . . . 63.210000000000001 110.855 -179.958 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.75 -169.71 1.07 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.783 -0.723 . . . . 64.0 112.47 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.17 -54.19 6.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.805 0.336 . . . . 54.100000000000001 110.905 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -53.63 -34.03 57.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 74.219999999999999 111.116 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.06 -64.4 1.17 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 54.43 111.094 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.647 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.7 OUTLIER -50.27 -33.65 20.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 73.239999999999995 110.947 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.658 HD23 ' N ' ' A' ' 109' ' ' ARG . 4.1 tt -71.71 -59.29 2.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 53.210000000000001 110.88 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.658 ' N ' HD23 ' A' ' 108' ' ' LEU . 13.0 ptp180 -56.39 -31.74 64.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 63.32 110.875 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -51.75 -24.88 6.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.159 -0.473 . . . . 71.25 110.93 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.459 HD13 HD12 ' A' ' 88' ' ' LEU . 4.7 mt -86.0 -68.7 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.487 . . . . 73.010000000000005 111.123 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -52.42 -49.62 64.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 74.420000000000002 110.842 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -53.72 -35.2 60.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.146 -0.479 . . . . 71.200000000000003 110.888 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.19 -36.37 69.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 71.420000000000002 111.112 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.1 mt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 75.230000000000004 110.93 179.995 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.7 mtt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.709 0.29 . . . . 74.409999999999997 110.902 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.1 59.09 0.65 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.269 -0.423 . . . . 74.510000000000005 111.067 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 15.2 t60 -88.1 -44.65 10.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 72.099999999999994 110.856 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -79.07 -176.01 4.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 72.519999999999996 110.837 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -124.86 174.23 8.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 70.109999999999999 110.813 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 -100.28 30.85 3.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 73.230000000000004 110.871 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -93.62 11.32 29.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 74.349999999999994 110.841 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -108.15 -36.01 6.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 75.540000000000006 110.839 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 49.4 mtt -95.91 30.82 2.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 73.409999999999997 110.859 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.5 m -74.41 110.12 8.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.446 . . . . 63.509999999999998 110.803 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 157.72 175.97 29.25 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.751 -0.737 . . . . 60.130000000000003 112.495 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.9 p -74.48 100.33 3.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.845 0.355 . . . . 73.0 111.133 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.8 m -152.43 160.97 3.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 72.450000000000003 111.125 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.61 ' HA ' ' HB1' ' A' ' 64' ' ' ALA . 8.7 t -68.52 157.17 36.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 72.25 111.17 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.461 HG22 ' CG2' ' A' ' 19' ' ' THR . 8.3 p -124.16 155.01 31.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 71.519999999999996 111.127 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.686 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.57 167.79 1.87 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 53.229999999999997 111.146 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.3 -47.98 13.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.224 -0.444 . . . . 74.439999999999998 110.891 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.9 t -66.59 -53.29 36.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.202 -0.454 . . . . 71.349999999999994 110.901 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.686 HG22 ' HB ' ' A' ' 16' ' ' THR . 3.8 t -61.51 -17.7 55.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 71.25 111.119 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.698 ' CE2' HG21 ' A' ' 24' ' ' VAL . 25.5 t80 -49.71 -32.45 13.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 73.109999999999999 110.907 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.441 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -70.69 -33.18 70.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 72.230000000000004 110.893 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.0 m -90.93 -16.47 28.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 72.030000000000001 111.133 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -93.16 -70.68 0.69 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.446 . . . . 63.450000000000003 110.86 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 1.111 HG13 HG21 ' A' ' 31' ' ' VAL . 17.0 t -71.48 -70.32 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.243 -0.435 . . . . 65.409999999999997 111.113 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.705 HD23 ' HA3' ' A' ' 92' ' ' GLY . 8.5 mt -40.46 -59.99 1.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 73.430000000000007 110.921 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -50.77 -62.11 1.8 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 50.340000000000003 110.874 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 86.2 p -51.79 137.65 25.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 72.319999999999993 110.858 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -88.49 -35.96 16.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.09 -0.505 . . . . 62.32 110.875 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -51.98 159.53 1.4 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.614 0.721 . . . . 74.0 111.174 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 126.5 13.35 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.676 2.25 . . . . 71.340000000000003 112.312 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 1.111 HG21 HG13 ' A' ' 24' ' ' VAL . 95.9 t -99.49 128.02 51.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 71.519999999999996 111.157 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.457 HD11 HD11 ' A' ' 88' ' ' LEU . 7.7 mp -99.8 121.65 41.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 74.329999999999998 110.938 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.6 p -127.43 126.15 66.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 71.129999999999995 111.105 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -110.76 100.07 8.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 64.420000000000002 110.874 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.441 ' HE2' ' HB1' ' A' ' 74' ' ' ALA . 25.8 m-85 -84.29 89.42 7.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 74.209999999999994 110.914 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.402 ' HH2' HD12 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -147.83 -169.17 3.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.124 -0.489 . . . . 73.519999999999996 110.901 -179.933 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.469 ' HA ' HG22 ' A' ' 68' ' ' VAL . . . -60.7 -154.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 60.43 111.114 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.475 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 14.2 p-10 -77.31 8.8 3.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 72.409999999999997 110.875 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.475 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 1.4 p-90 41.49 63.85 1.17 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 71.230000000000004 110.939 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 35.9 t -130.22 -45.94 1.11 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 74.420000000000002 110.924 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.74 -68.75 1.44 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.753 -0.736 . . . . 72.439999999999998 112.485 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -30.8 21.88 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.759 2.306 . . . . 62.140000000000001 112.335 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 53.3 t -58.18 -20.43 41.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.245 -0.434 . . . . 71.329999999999998 110.883 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -49.74 -36.24 24.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 73.030000000000001 110.868 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.496 ' HG3' HG23 ' A' ' 46' ' ' VAL . 6.5 ptp -90.83 -30.92 16.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 71.129999999999995 110.859 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.496 HG23 ' HG3' ' A' ' 45' ' ' MET . 3.3 t -92.73 21.96 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.284 -0.416 . . . . 74.030000000000001 111.141 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.783 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -79.07 -60.98 0.52 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.595 0.712 . . . . 72.109999999999999 111.084 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.783 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.5 Cg_endo -69.75 -48.53 0.7 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.63 2.22 . . . . 64.200000000000003 112.38 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.627 ' O ' HD12 ' A' ' 53' ' ' ILE . 4.6 m -50.01 -30.71 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 75.019999999999996 111.116 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.402 HD12 ' HH2' ' A' ' 36' ' ' TRP . 6.1 tt -71.57 -40.24 70.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 74.430000000000007 110.902 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -73.03 -33.5 65.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 72.140000000000001 110.87 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -52.22 -67.66 0.23 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 71.150000000000006 110.907 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.627 HD12 ' O ' ' A' ' 49' ' ' VAL . 2.8 mt -51.28 -34.34 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 74.310000000000002 111.094 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.3 -40.29 86.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 70.209999999999994 111.076 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.34 -47.61 75.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.443 . . . . 74.150000000000006 110.856 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.445 ' OE1' HD11 ' A' ' 108' ' ' LEU . 13.2 pt-20 -71.11 -36.18 72.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 72.239999999999995 110.892 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.74 -75.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 71.319999999999993 110.867 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.4 -38.49 0.84 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 63.039999999999999 110.891 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 100.28 -27.39 20.6 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.718 -0.754 . . . . 71.400000000000006 112.449 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 79.5 p -137.31 64.43 1.53 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.853 0.358 . . . . 63.340000000000003 111.139 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.608 HD13 ' N ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -116.13 -177.4 3.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 64.239999999999995 110.964 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.02 138.77 35.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.435 . . . . 74.019999999999996 110.934 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.427 HG23 HD23 ' A' ' 61' ' ' LEU . 48.5 t -142.05 99.81 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.266 -0.425 . . . . 63.32 111.125 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.61 ' HB1' ' HA ' ' A' ' 14' ' ' THR . . . -101.75 146.77 27.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 62.340000000000003 111.117 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.24 151.03 49.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 73.019999999999996 110.906 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.49 HD21 ' HB2' ' A' ' 71' ' ' ASN . 13.6 tp -139.94 150.57 44.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 71.400000000000006 110.931 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -103.08 115.45 30.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 62.109999999999999 110.897 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.594 HG12 ' HB2' ' A' ' 75' ' ' ALA . 27.0 m -57.89 -34.66 49.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.46 . . . . 74.239999999999995 111.107 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.48 -36.15 43.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 62.340000000000003 110.868 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.14 -34.62 11.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 73.319999999999993 111.126 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.49 ' HB2' HD21 ' A' ' 66' ' ' LEU . 0.9 OUTLIER -118.82 70.18 9.58 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.625 0.726 . . . . 73.420000000000002 110.883 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.75 -32.65 18.21 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.718 2.278 . . . . 73.540000000000006 112.361 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -59.17 -44.6 92.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 55.109999999999999 110.898 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.441 ' HB1' ' HE2' ' A' ' 35' ' ' PHE . . . -57.07 -54.65 44.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 42.039999999999999 111.073 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.827 ' HB1' HG11 ' A' ' 80' ' ' VAL . . . -54.79 -60.3 3.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 74.349999999999994 111.148 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.85 -33.27 23.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 65.530000000000001 110.888 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -56.01 -38.77 70.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 72.120000000000005 110.881 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -94.63 19.22 10.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 74.299999999999997 110.884 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 47.76 77.84 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 72.150000000000006 110.903 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.827 HG11 ' HB1' ' A' ' 75' ' ' ALA . 6.6 p -120.04 142.47 35.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 70.25 111.121 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.5 m -119.58 -37.66 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 73.219999999999999 111.124 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 39.3 m -89.97 140.22 29.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 71.230000000000004 110.9 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.532 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.0 mt -55.82 -58.02 18.31 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.596 0.712 . . . . 63.520000000000003 111.09 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.5 Cg_endo -69.79 79.21 0.97 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.649 2.232 . . . . 74.409999999999997 112.342 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.714 HG23 HG12 ' A' ' 99' ' ' VAL . 85.6 m -123.37 108.05 12.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.226 -0.443 . . . . 64.340000000000003 111.147 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 18.8 ttp -109.97 142.1 41.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 63.25 110.903 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.2 mt -127.42 129.49 70.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 75.450000000000003 111.135 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.457 HD11 HD11 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -94.42 106.3 18.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 52.310000000000002 110.908 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -89.7 169.99 10.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 72.120000000000005 110.882 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -163.01 92.5 0.76 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 61.149999999999999 110.894 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.52 37.06 9.91 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.777 -0.725 . . . . 71.420000000000002 112.478 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.705 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 71.12 38.3 63.55 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.722 -0.752 . . . . 33.200000000000003 112.503 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.462 HG23 ' HD2' ' A' ' 94' ' ' PRO . 85.2 m -161.02 133.94 4.59 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.579 0.704 . . . . 75.439999999999998 111.171 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.462 ' HD2' HG23 ' A' ' 93' ' ' THR . 54.2 Cg_endo -69.72 107.32 1.82 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.706 2.271 . . . . 64.049999999999997 112.367 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.7 m -98.55 -33.17 4.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 73.099999999999994 111.118 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.9 mmtm -130.28 163.52 26.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 63.409999999999997 110.928 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.417 ' C ' HD12 ' A' ' 98' ' ' ILE . 9.1 ttp180 -155.12 114.12 3.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 73.409999999999997 110.885 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.443 ' N ' HD12 ' A' ' 98' ' ' ILE . 4.7 mp -129.83 129.88 66.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 75.400000000000006 111.134 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.714 HG12 HG23 ' A' ' 85' ' ' THR . 4.2 m -128.49 141.69 45.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 51.340000000000003 111.135 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 132.59 130.92 3.15 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.765 -0.731 . . . . 65.239999999999995 112.482 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.37 59.1 3.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.845 0.355 . . . . 64.400000000000006 111.111 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.25 171.75 8.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 72.209999999999994 110.92 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -67.99 -178.67 14.62 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.771 -0.728 . . . . 74.409999999999997 112.492 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -44.14 72.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.821 0.343 . . . . 75.120000000000005 110.898 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.88 -34.46 65.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 73.209999999999994 111.058 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.437 ' HA ' ' HG2' ' A' ' 109' ' ' ARG . . . -87.97 -56.18 3.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 72.109999999999999 111.113 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.664 HD13 ' O ' ' A' ' 107' ' ' LEU . 1.0 OUTLIER -51.42 -35.19 38.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.448 . . . . 62.43 110.906 -179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.561 HD23 ' N ' ' A' ' 109' ' ' ARG . 6.7 tt -68.98 -60.53 2.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 63.350000000000001 110.904 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.561 ' N ' HD23 ' A' ' 108' ' ' LEU . 14.6 ptp180 -54.59 -35.12 63.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 71.040000000000006 110.864 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -53.24 -24.62 11.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 74.200000000000003 110.878 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.5 mt -84.75 -67.93 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 74.230000000000004 111.153 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.687 ' HA ' HD23 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -52.34 -46.86 66.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 54.020000000000003 110.892 179.901 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -55.42 -34.47 64.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 73.519999999999996 110.85 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.28 -37.1 69.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 41.119999999999997 111.122 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.687 HD23 ' HA ' ' A' ' 112' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 72.340000000000003 110.905 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.765 0.317 . . . . 75.400000000000006 110.885 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.07 109.05 4.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 63.350000000000001 111.1 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.6 m-70 -98.87 -59.87 1.65 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 71.150000000000006 110.827 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -172.27 -179.68 2.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 72.209999999999994 110.882 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 -62.72 168.19 3.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.449 . . . . 55.200000000000003 110.847 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 23.6 p80 -101.19 30.76 3.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 54.149999999999999 110.852 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -57.72 -36.1 71.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 73.209999999999994 110.866 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -96.83 -35.93 10.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.198 -0.456 . . . . 60.32 110.843 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 4.3 tpt -52.14 -36.07 50.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 75.140000000000001 110.921 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.3 t -58.33 114.41 2.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.437 . . . . 61.100000000000001 110.839 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 120.86 177.54 15.75 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 63.340000000000003 112.441 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.463 HG22 ' HB ' ' A' ' 63' ' ' VAL . 20.9 p -61.47 105.71 0.55 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.804 0.335 . . . . 63.25 111.146 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 72.8 t -149.66 144.3 17.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.428 . . . . 65.349999999999994 111.124 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 t -69.13 127.24 32.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 71.430000000000007 111.162 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.9 t -92.9 132.41 37.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 61.140000000000001 111.126 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.499 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.72 177.71 0.2 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 72.109999999999999 111.141 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.455 ' H ' HG22 ' A' ' 16' ' ' THR . 0.6 OUTLIER -80.53 -48.35 12.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 70.120000000000005 110.842 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.6 t -71.16 -52.05 21.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 72.349999999999994 110.865 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.499 HG22 ' HB ' ' A' ' 16' ' ' THR . 4.8 t -58.54 -19.71 40.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 71.409999999999997 111.16 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.709 ' CE2' HG21 ' A' ' 24' ' ' VAL . 24.5 t80 -51.51 -30.71 21.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 74.150000000000006 110.855 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.415 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -72.33 -33.16 67.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 74.129999999999995 110.882 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.4 m -91.67 -16.09 27.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 74.040000000000006 111.162 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -93.48 -71.35 0.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 72.420000000000002 110.832 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.969 HG13 HG21 ' A' ' 31' ' ' VAL . 18.2 t -70.34 -70.42 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 72.239999999999995 111.114 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.617 HD23 ' HA3' ' A' ' 92' ' ' GLY . 7.6 mt -40.72 -60.42 1.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 74.140000000000001 110.919 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -50.05 -57.85 6.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 71.140000000000001 110.893 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.4 m -52.49 147.02 8.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 52.030000000000001 110.86 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -95.34 -45.67 7.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 75.230000000000004 110.839 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -51.11 160.56 0.84 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.53 0.681 . . . . 71.329999999999998 111.137 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 132.08 22.48 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.686 2.257 . . . . 71.409999999999997 112.318 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.969 HG21 HG13 ' A' ' 24' ' ' VAL . 62.8 t -102.3 134.24 43.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 74.409999999999997 111.107 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.851 HD23 HG22 ' A' ' 63' ' ' VAL . 0.3 OUTLIER -101.77 116.41 32.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 64.430000000000007 110.948 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.4 t -94.07 143.51 11.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 74.420000000000002 111.115 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.76 99.85 5.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 62.43 110.881 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -100.96 95.88 6.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 73.310000000000002 110.867 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.683 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -152.05 -167.73 2.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.45 . . . . 72.430000000000007 110.92 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.13 -165.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 52.109999999999999 111.065 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.435 ' O ' ' CB ' ' A' ' 39' ' ' TRP . 4.9 m-20 -77.66 12.6 1.59 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.237 -0.438 . . . . 75.409999999999997 110.888 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.436 ' N ' ' CD1' ' A' ' 39' ' ' TRP . 1.9 m0 78.25 90.32 0.06 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 73.5 110.91 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -174.84 -56.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 72.340000000000003 110.878 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.05 -70.89 1.3 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.72 -0.752 . . . . 52.310000000000002 112.528 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.78 -29.18 24.2 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.714 2.276 . . . . 74.140000000000001 112.365 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.535 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -61.54 -32.17 72.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 72.140000000000001 110.899 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -63.74 -30.68 71.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 72.040000000000006 110.905 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 2.0 mtt -83.78 -43.29 15.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 64.030000000000001 110.836 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.565 ' HA ' HG22 ' A' ' 49' ' ' VAL . 2.8 t -93.93 22.49 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 74.430000000000007 111.121 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.777 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -74.75 -60.73 1.21 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.617 0.723 . . . . 40.310000000000002 111.135 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.777 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.4 Cg_endo -69.79 -49.99 0.5 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.677 2.251 . . . . 73.340000000000003 112.307 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.68 ' O ' HD12 ' A' ' 53' ' ' ILE . 4.1 m -53.6 -29.68 17.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 73.319999999999993 111.128 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.9 tp -72.18 -42.07 66.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.476 . . . . 64.400000000000006 110.972 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -64.28 -36.38 83.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 74.420000000000002 110.898 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -55.82 -69.56 0.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 74.340000000000003 110.862 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.68 HD12 ' O ' ' A' ' 49' ' ' VAL . 2.7 mt -54.83 -36.94 39.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 35.030000000000001 111.128 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.74 -38.24 84.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 54.409999999999997 111.096 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.91 -40.5 22.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 54.43 110.908 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -63.66 -49.12 74.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 73.140000000000001 110.832 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.1 mmtp -55.05 -61.81 2.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 64.200000000000003 110.913 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.514 ' CB ' HD12 ' A' ' 61' ' ' LEU . 0.5 OUTLIER -152.32 -179.65 7.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 62.509999999999998 110.859 -179.921 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -114.28 -21.05 5.68 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.758 -0.734 . . . . 74.439999999999998 112.458 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.2 t -129.01 61.5 1.52 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.858 0.361 . . . . 64.510000000000005 111.161 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.636 ' H ' HD13 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -105.41 172.97 6.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 73.549999999999997 110.87 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.15 122.27 46.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 74.219999999999999 110.928 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.851 HG22 HD23 ' A' ' 32' ' ' LEU . 21.9 t -121.6 112.57 35.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 63.350000000000001 111.147 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -121.94 129.88 52.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 72.200000000000003 111.095 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.78 154.55 26.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 72.200000000000003 110.937 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.451 HD11 ' CG ' ' A' ' 71' ' ' ASN . 4.7 tp -140.41 137.09 33.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 35.399999999999999 110.925 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.25 149.26 30.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 52.409999999999997 110.884 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 36' ' ' TRP . 6.9 t -90.74 -36.17 7.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 75.010000000000005 111.117 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.1 -35.24 64.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 45.119999999999997 110.853 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.33 -32.56 13.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 73.340000000000003 111.116 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.451 ' CG ' HD11 ' A' ' 66' ' ' LEU . 3.7 m-80 -117.01 68.36 4.5 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.611 0.72 . . . . 72.310000000000002 110.883 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -33.09 17.37 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.692 2.261 . . . . 61.399999999999999 112.348 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -67.37 -36.42 81.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 70.430000000000007 110.884 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.78 -49.58 76.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 64.040000000000006 111.078 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.652 ' HB1' ' HB ' ' A' ' 80' ' ' VAL . . . -53.62 -60.86 2.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 75.230000000000004 111.136 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 14.0 ttp85 -51.22 -34.71 33.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 72.430000000000007 110.828 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -51.93 -38.23 55.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.244 -0.435 . . . . 61.219999999999999 110.858 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -106.53 28.06 8.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 65.040000000000006 110.858 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 49.72 61.14 3.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 70.400000000000006 110.903 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.652 ' HB ' ' HB1' ' A' ' 75' ' ' ALA . 85.2 t -96.44 136.56 26.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 74.299999999999997 111.117 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.9 m -127.47 -36.48 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 54.439999999999998 111.137 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.7 t -97.06 143.84 27.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 75.129999999999995 110.825 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.527 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.9 mt -56.86 -57.59 23.18 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.624 0.726 . . . . 55.520000000000003 111.153 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.616 ' CB ' ' HB2' ' A' ' 101' ' ' ALA . 54.4 Cg_endo -69.71 76.88 1.09 Allowed 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.704 2.269 . . . . 64.310000000000002 112.35 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.666 HG23 ' CG1' ' A' ' 99' ' ' VAL . 68.8 m -116.67 127.59 54.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 72.109999999999999 111.11 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.3 tpp -128.35 140.73 51.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 71.310000000000002 110.838 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 19.2 mt -127.82 129.54 69.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 74.129999999999995 111.151 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.15 104.83 16.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 73.519999999999996 110.943 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -90.01 170.14 10.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 73.340000000000003 110.899 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -164.35 91.55 0.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 64.530000000000001 110.922 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.2 32.61 16.53 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.715 -0.755 . . . . 62.009999999999998 112.476 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.617 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 75.14 39.48 37.03 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.763 -0.732 . . . . 64.230000000000004 112.501 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.42 HG23 ' HD2' ' A' ' 94' ' ' PRO . 46.0 m -160.36 133.66 4.79 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.572 0.701 . . . . 71.129999999999995 111.118 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.42 ' HD2' HG23 ' A' ' 93' ' ' THR . 54.3 Cg_endo -69.7 94.52 0.53 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.721 2.28 . . . . 73.239999999999995 112.362 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.2 m -85.11 -30.32 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 63.32 111.083 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.91 164.43 30.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 72.430000000000007 110.886 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.409 ' C ' HD12 ' A' ' 98' ' ' ILE . 22.7 ttt180 -159.29 118.26 2.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 71.409999999999997 110.907 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.452 ' N ' HD12 ' A' ' 98' ' ' ILE . 4.5 mp -128.15 139.89 50.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 73.340000000000003 111.129 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.666 ' CG1' HG23 ' A' ' 85' ' ' THR . 10.0 m -143.37 154.33 16.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 75.120000000000005 111.106 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 136.75 -30.04 2.7 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.743 -0.742 . . . . 33.210000000000001 112.457 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.616 ' HB2' ' CB ' ' A' ' 84' ' ' PRO . . . 63.59 83.04 0.17 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.863 0.363 . . . . 40.409999999999997 111.119 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.98 179.15 6.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 75.099999999999994 110.874 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.24 149.25 39.27 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.727 -0.749 . . . . 71.420000000000002 112.476 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.53 -42.73 44.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.775 0.322 . . . . 74.340000000000003 110.898 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.57 -38.5 72.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 54.420000000000002 111.131 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.93 -59.15 2.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 53.329999999999998 111.122 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.542 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.6 OUTLIER -47.83 -41.01 22.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 74.299999999999997 110.881 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.4 tt -56.46 -41.99 77.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 62.299999999999997 110.872 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -63.75 -42.35 97.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 71.430000000000007 110.868 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -52.38 -25.15 9.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.19 -0.459 . . . . 50.450000000000003 110.887 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.7 mt -85.49 -67.87 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 73.120000000000005 111.112 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.765 ' HA ' HD23 ' A' ' 115' ' ' LEU . 1.9 pp20? -52.3 -48.92 65.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 71.519999999999996 110.867 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -58.88 -33.71 70.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 64.340000000000003 110.871 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.76 -36.5 59.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 62.200000000000003 111.135 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.765 HD23 ' HA ' ' A' ' 112' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 61.420000000000002 110.916 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 ptm . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.825 0.345 . . . . 73.230000000000004 110.925 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -114.38 -177.14 3.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 63.520000000000003 111.131 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -88.67 -36.98 15.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 73.230000000000004 110.851 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -69.71 169.36 13.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 52.020000000000003 110.873 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 72.7 m-70 -82.59 165.61 19.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 75.420000000000002 110.835 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -119.34 31.06 6.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 65.349999999999994 110.848 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 8.7 m170 -93.1 -37.7 12.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 73.299999999999997 110.837 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -52.3 -39.32 60.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 55.32 110.897 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.0 mtt -95.99 30.88 2.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 73.540000000000006 110.899 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.9 m -58.68 128.66 38.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.242 -0.436 . . . . 71.25 110.863 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 154.32 -163.79 31.23 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.748 -0.739 . . . . 64.430000000000007 112.488 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.514 HG22 ' HB ' ' A' ' 63' ' ' VAL . 21.3 p -68.82 117.85 11.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.816 0.341 . . . . 74.349999999999994 111.125 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.1 p -160.23 155.59 3.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 74.329999999999998 111.122 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.5 t -68.29 156.9 36.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 73.400000000000006 111.154 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.552 ' CG1' HG23 ' A' ' 19' ' ' THR . 41.9 t -118.99 127.48 75.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 73.239999999999995 111.155 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.485 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.23 162.88 4.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 73.140000000000001 111.201 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -72.93 -35.68 67.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 71.109999999999999 110.826 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.3 t -75.51 -34.42 60.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 44.530000000000001 110.87 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.552 HG23 ' CG1' ' A' ' 15' ' ' VAL . 7.6 t -86.52 -18.43 31.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.075 -0.512 . . . . 74.420000000000002 111.151 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.735 ' CE2' HG21 ' A' ' 24' ' ' VAL . 24.2 t80 -51.07 -30.68 16.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 75.510000000000005 110.858 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.428 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.8 OUTLIER -72.52 -34.02 67.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 73.400000000000006 110.89 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.1 m -91.51 -16.49 27.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 63.229999999999997 111.138 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.48 -71.33 0.66 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 64.340000000000003 110.845 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.806 HG13 HG21 ' A' ' 31' ' ' VAL . 24.9 t -70.26 -70.67 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 74.109999999999999 111.166 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.428 ' HB2' ' HA ' ' A' ' 21' ' ' LYS . 7.8 mt -40.55 -60.31 1.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 52.420000000000002 110.884 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -50.09 -57.87 6.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 62.229999999999997 110.87 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.8 m -53.33 156.83 2.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 64.209999999999994 110.836 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -98.73 -46.57 5.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.484 . . . . 73.310000000000002 110.861 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.832 HG21 HG23 ' A' ' 60' ' ' THR . 0.6 OUTLIER -57.8 159.83 9.28 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.593 0.711 . . . . 73.530000000000001 111.125 -179.889 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 149.44 67.23 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.669 2.246 . . . . 73.329999999999998 112.332 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.806 HG21 HG13 ' A' ' 24' ' ' VAL . 84.1 t -112.65 127.63 69.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 71.219999999999999 111.149 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.712 HD22 ' CD2' ' A' ' 88' ' ' LEU . 3.7 mt -114.81 99.81 7.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 73.420000000000002 110.93 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 87' ' ' ILE . 8.6 p -97.39 146.17 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 75.439999999999998 111.142 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -133.88 108.67 8.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.462 . . . . 73.310000000000002 110.86 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.566 ' HE2' ' HB1' ' A' ' 74' ' ' ALA . 51.4 m-85 -92.11 94.84 9.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 73.420000000000002 110.868 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -138.18 -167.72 2.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.101 -0.5 . . . . 74.299999999999997 110.918 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.03 -166.62 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 24.34 111.101 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.444 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 9.6 p-10 -78.17 12.27 1.94 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.231 -0.441 . . . . 54.219999999999999 110.87 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.455 ' N ' ' CD1' ' A' ' 39' ' ' TRP . 1.6 m0 77.0 93.32 0.07 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.233 -0.44 . . . . 71.299999999999997 110.916 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 9.5 t -174.06 -56.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.432 . . . . 64.25 110.861 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.75 -69.29 1.41 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.787 -0.72 . . . . 75.129999999999995 112.499 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -43.58 2.57 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.717 2.278 . . . . 71.120000000000005 112.335 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.543 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 33.9 t -52.66 -34.63 52.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.44 . . . . 73.209999999999994 110.883 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -64.44 -35.2 80.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.452 . . . . 72.209999999999994 110.885 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 88.2 mmm -84.59 -36.66 21.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 64.239999999999995 110.867 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.545 ' HA ' HG22 ' A' ' 49' ' ' VAL . 3.3 t -95.29 21.33 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.243 -0.435 . . . . 72.120000000000005 111.15 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.795 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -78.76 -61.39 0.52 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.6 0.715 . . . . 42.030000000000001 111.089 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.795 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.6 Cg_endo -69.74 -49.84 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.717 2.278 . . . . 70.340000000000003 112.307 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.545 HG22 ' HA ' ' A' ' 46' ' ' VAL . 4.4 m -52.23 -30.64 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.236 -0.438 . . . . 63.520000000000003 111.114 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.528 HD23 ' O ' ' A' ' 50' ' ' LEU . 7.5 tt -84.29 -35.16 23.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 52.130000000000003 110.915 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -58.94 -35.47 73.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 74.230000000000004 110.9 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -51.28 -58.25 6.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 71.25 110.885 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.7 mp -51.56 -34.86 16.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 65.310000000000002 111.134 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.62 -39.92 66.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 62.210000000000001 111.109 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.97 -38.47 91.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 64.310000000000002 110.884 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -77.15 -36.46 55.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 74.430000000000007 110.861 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -74.22 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 64.140000000000001 110.868 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.9 t 62.41 35.59 14.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 75.530000000000001 110.824 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -119.77 50.87 0.79 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.759 -0.734 . . . . 60.530000000000001 112.521 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.832 HG23 HG21 ' A' ' 29' ' ' THR . 9.7 t 37.49 43.18 0.4 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.827 0.346 . . . . 63.350000000000001 111.137 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.617 HD13 HD12 ' A' ' 32' ' ' LEU . 3.6 pp -69.69 139.94 53.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 72.239999999999995 110.922 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -84.41 147.49 27.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 74.120000000000005 110.857 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.514 ' HB ' HG22 ' A' ' 12' ' ' THR . 19.8 t -130.47 103.41 8.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 75.230000000000004 111.088 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.6 129.76 50.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 54.210000000000001 111.112 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -129.87 142.49 50.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 71.510000000000005 110.915 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.617 HD21 ' HB2' ' A' ' 71' ' ' ASN . 7.7 tp -137.67 141.17 41.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 61.109999999999999 110.877 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.51 108.99 18.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 73.019999999999996 110.834 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 70.0 t -60.06 -35.78 63.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 41.329999999999998 111.145 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -51.36 -35.07 36.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 74.019999999999996 110.838 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.89 -35.2 10.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 61.439999999999998 111.07 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.617 ' HB2' HD21 ' A' ' 66' ' ' LEU . 1.8 m-80 -116.09 70.56 4.0 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.667 0.746 . . . . 73.219999999999999 110.882 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -31.73 19.92 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.686 2.257 . . . . 43.25 112.33 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -64.1 -35.74 81.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 72.549999999999997 110.933 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.566 ' HB1' ' HE2' ' A' ' 35' ' ' PHE . . . -57.23 -48.8 77.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 45.520000000000003 111.135 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.541 ' O ' HG23 ' A' ' 80' ' ' VAL . . . -53.63 -61.16 2.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 65.299999999999997 111.084 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.7 ttp85 -51.3 -34.05 31.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 62.229999999999997 110.867 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -51.71 -39.65 58.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 55.219999999999999 110.867 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -104.29 26.43 8.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 72.450000000000003 110.892 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 51.0 mm-40 49.78 65.57 1.38 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 74.540000000000006 110.916 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 75' ' ' ALA . 91.7 t -96.82 143.63 12.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.239 -0.437 . . . . 54.439999999999998 111.127 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.7 m -123.64 -38.71 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 73.230000000000004 111.066 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.72 156.82 17.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 63.200000000000003 110.866 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.527 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 2.3 mm -64.6 -57.84 15.48 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.588 0.709 . . . . 73.430000000000007 111.095 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.5 Cg_endo -69.78 70.6 1.58 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.673 2.249 . . . . 65.230000000000004 112.329 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.43 ' OG1' HG13 ' A' ' 80' ' ' VAL . 96.9 m -104.81 137.97 41.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.232 -0.44 . . . . 52.520000000000003 111.143 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -139.04 127.99 23.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 74.549999999999997 110.905 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.403 ' O ' HG12 ' A' ' 33' ' ' VAL . 2.3 mp -114.36 112.76 41.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 63.350000000000001 111.122 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.712 ' CD2' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -79.53 105.71 11.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.47 . . . . 70.200000000000003 110.934 179.891 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -93.13 166.5 12.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 62.350000000000001 110.883 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -170.61 97.1 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 65.340000000000003 110.9 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.98 38.99 9.68 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.713 -0.756 . . . . 70.299999999999997 112.489 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.49 45.02 88.7 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.736 -0.745 . . . . 62.240000000000002 112.444 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.3 m -170.25 134.67 1.14 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.555 0.693 . . . . 74.019999999999996 111.161 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 82.49 0.75 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.667 2.245 . . . . 75.230000000000004 112.336 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.0 m -60.17 -34.08 55.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 74.219999999999999 111.141 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -147.87 170.1 18.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 54.310000000000002 110.911 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.458 ' C ' HD12 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -154.37 123.77 6.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 75.239999999999995 110.847 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.458 HD12 ' C ' ' A' ' 97' ' ' ARG . 4.5 mp -130.26 128.84 64.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 65.230000000000004 111.118 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.4 p -128.42 141.74 45.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 71.409999999999997 111.163 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 122.64 140.23 5.7 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.749 -0.739 . . . . 53.039999999999999 112.502 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.53 93.9 9.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.811 0.339 . . . . 71.019999999999996 111.126 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.577 ' HB2' ' HB3' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -116.77 -176.05 2.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 73.040000000000006 110.859 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.18 163.62 54.52 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.739 -0.744 . . . . 63.43 112.489 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.79 -36.15 57.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.748 0.308 . . . . 73.530000000000001 110.897 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.5 -54.6 10.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 62.240000000000002 111.084 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.577 ' HB3' ' HB2' ' A' ' 102' ' ' LYS . . . -55.76 -53.99 49.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 71.310000000000002 111.125 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.61 HD13 ' O ' ' A' ' 107' ' ' LEU . 1.0 OUTLIER -50.78 -39.48 52.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 74.200000000000003 110.957 179.974 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.436 HD23 ' HG2' ' A' ' 112' ' ' GLU . 0.3 OUTLIER -66.82 -52.77 39.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 70.310000000000002 110.883 179.885 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.51 -40.59 83.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 74.310000000000002 110.918 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -47.12 -28.65 1.86 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 63.020000000000003 110.933 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.6 mt -93.09 -69.52 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 61.229999999999997 111.163 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.436 ' HG2' HD23 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -54.07 -59.96 3.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 63.509999999999998 110.953 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -49.51 -35.9 21.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 72.420000000000002 110.835 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.56 -35.77 63.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 70.450000000000003 111.066 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 74.219999999999999 110.923 -179.964 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 mtt . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.827 0.346 . . . . 72.420000000000002 110.907 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.02 -44.97 13.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 21.149999999999999 111.092 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -81.84 -36.13 28.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 64.349999999999994 110.834 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -91.13 149.22 21.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 74.430000000000007 110.821 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -145.43 154.65 42.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 74.340000000000003 110.86 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -119.97 30.78 6.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 72.400000000000006 110.862 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -68.22 -35.67 78.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 50.299999999999997 110.847 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 48.8 p-80 -88.43 -35.52 17.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 61.509999999999998 110.893 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 13.6 mmt -51.79 -35.61 44.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 63.229999999999997 110.872 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.3 t -51.73 110.18 0.44 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 54.409999999999997 110.857 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 129.11 -147.2 17.61 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.793 -0.718 . . . . 63.43 112.494 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.1 p -72.72 120.0 17.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.81 0.338 . . . . 71.200000000000003 111.162 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 t -132.67 150.41 33.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 74.150000000000006 111.12 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.6 t -86.86 130.6 34.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 75.329999999999998 111.122 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.6 t -89.97 125.72 42.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 73.230000000000004 111.102 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.545 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.5 173.88 0.49 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 55.0 111.131 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.466 ' H ' HG22 ' A' ' 16' ' ' THR . 11.3 t70 -74.96 -47.39 29.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 72.109999999999999 110.848 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.1 m -71.62 -51.64 22.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 62.240000000000002 110.861 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.545 HG22 ' HB ' ' A' ' 16' ' ' THR . 6.3 t -59.28 -19.12 43.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 64.200000000000003 111.18 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.711 ' CE2' HG21 ' A' ' 24' ' ' VAL . 25.2 t80 -51.24 -30.26 16.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 70.109999999999999 110.898 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.409 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -72.55 -33.65 66.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 74.340000000000003 110.869 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.0 m -91.56 -16.08 27.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.196 -0.456 . . . . 73.25 111.181 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.44 -71.32 0.66 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 72.340000000000003 110.864 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.869 HG13 HG21 ' A' ' 31' ' ' VAL . 20.4 t -70.39 -70.5 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.476 . . . . 73.420000000000002 111.109 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.571 HD23 ' HA3' ' A' ' 92' ' ' GLY . 7.6 mt -40.57 -59.99 1.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 70.430000000000007 110.925 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -50.57 -52.64 37.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.458 . . . . 61.100000000000001 110.853 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.1 t -65.31 148.61 51.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 73.519999999999996 110.839 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -102.32 -38.2 7.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.131 -0.486 . . . . 75.129999999999995 110.895 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -52.05 160.23 1.24 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.527 0.68 . . . . 74.329999999999998 111.143 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 127.46 14.62 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.651 2.234 . . . . 73.109999999999999 112.385 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.869 HG21 HG13 ' A' ' 24' ' ' VAL . 41.1 t -93.25 132.0 38.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 64.519999999999996 111.132 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.422 ' CD1' HD21 ' A' ' 88' ' ' LEU . 1.5 mm? -102.85 99.8 9.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 74.409999999999997 110.917 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.555 HG13 HG12 ' A' ' 31' ' ' VAL . 10.2 m -121.46 150.2 24.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 72.510000000000005 111.137 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.01 123.97 31.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 64.319999999999993 110.902 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -89.71 88.78 7.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 71.510000000000005 110.87 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -142.59 -169.19 2.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.477 . . . . 74.200000000000003 110.952 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.87 -163.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.43 . . . . 61.509999999999998 111.116 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.471 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 2.6 m-20 -77.88 12.88 1.55 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 71.25 110.877 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.497 ' N ' ' CD1' ' A' ' 39' ' ' TRP . 0.6 OUTLIER 74.95 96.18 0.07 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 64.400000000000006 110.954 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -170.1 -53.76 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 51.020000000000003 110.875 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.29 -70.72 1.32 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.762 -0.732 . . . . 74.209999999999994 112.474 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.67 -34.18 15.41 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.694 2.263 . . . . 74.519999999999996 112.347 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.562 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 38.4 t -51.8 -33.73 36.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 73.219999999999999 110.883 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.4 mtmt -65.43 -35.3 80.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 75.340000000000003 110.952 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 15.1 mtp -83.49 -39.95 19.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 72.530000000000001 110.883 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.564 ' HA ' HG22 ' A' ' 49' ' ' VAL . 2.9 t -94.54 22.93 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 70.129999999999995 111.152 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.808 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -75.13 -61.16 1.05 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.558 0.694 . . . . 50.43 111.077 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.808 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 52.9 Cg_endo -69.8 -50.65 0.44 Allowed 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.671 2.248 . . . . 42.439999999999998 112.322 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.679 ' O ' HD12 ' A' ' 53' ' ' ILE . 4.3 m -52.53 -30.04 14.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 73.010000000000005 111.141 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.0 tp -74.5 -42.57 58.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 72.530000000000001 110.881 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -57.8 -36.72 72.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 62.299999999999997 110.87 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -57.74 -67.79 0.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 51.210000000000001 110.884 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.679 HD12 ' O ' ' A' ' 49' ' ' VAL . 2.7 mp -50.94 -34.84 14.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 72.219999999999999 111.118 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.48 -34.55 72.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 74.209999999999994 111.119 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.28 -35.37 15.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 53.420000000000002 110.895 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -66.66 -48.5 69.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 74.109999999999999 110.875 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.2 mmpt? -50.68 -69.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 75.409999999999997 110.916 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -141.32 -178.08 5.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 71.299999999999997 110.889 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 60' ' ' THR . . . -81.44 115.78 4.08 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.748 -0.739 . . . . 71.230000000000004 112.466 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.41 ' C ' ' O ' ' A' ' 59' ' ' GLY . 9.8 t 36.95 45.32 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.817 0.341 . . . . 74.150000000000006 111.183 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.408 ' C ' HD12 ' A' ' 61' ' ' LEU . 4.1 pp -56.46 -178.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 75.019999999999996 110.895 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -79.9 118.96 22.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 71.239999999999995 110.924 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.6 t -111.9 107.16 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 53.340000000000003 111.108 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -126.65 170.9 11.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 61.43 111.093 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 31.1 mttt -145.29 148.13 33.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.448 . . . . 72.340000000000003 110.845 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.537 HD11 ' CG ' ' A' ' 71' ' ' ASN . 4.0 tp -125.62 140.55 52.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 73.319999999999993 110.879 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -87.79 119.76 28.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 74.150000000000006 110.831 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.71 -28.08 44.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 61.219999999999999 111.152 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -68.94 -34.98 76.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.178 -0.465 . . . . 74.329999999999998 110.875 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.32 -28.7 23.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 74.450000000000003 111.087 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.537 ' CG ' HD11 ' A' ' 66' ' ' LEU . 5.5 m-80 -115.43 69.37 2.85 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.564 0.697 . . . . 71.510000000000005 110.896 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 -32.06 19.01 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.647 2.231 . . . . 73.439999999999998 112.331 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -74.83 -35.1 62.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 73.310000000000002 110.883 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.04 -40.87 91.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 44.109999999999999 111.111 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.494 ' HB1' ' HB ' ' A' ' 80' ' ' VAL . . . -57.96 -64.85 0.76 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 62.210000000000001 111.086 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -51.15 -34.88 33.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 72.409999999999997 110.879 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.82 -36.33 80.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 44.420000000000002 110.883 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -98.45 24.69 7.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 75.340000000000003 110.88 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 49.09 54.05 11.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 73.549999999999997 110.945 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.494 ' HB ' ' HB1' ' A' ' 75' ' ' ALA . 97.6 t -90.15 136.66 23.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 64.450000000000003 111.164 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.8 m -131.58 -39.07 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 70.420000000000002 111.132 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.1 t -97.04 155.16 16.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 71.409999999999997 110.888 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.52 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 2.3 mm -66.47 -57.96 11.28 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.601 0.715 . . . . 73.439999999999998 111.124 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.4 Cg_endo -69.71 70.07 1.58 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.669 2.246 . . . . 44.520000000000003 112.355 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.645 HG23 ' HB ' ' A' ' 99' ' ' VAL . 62.0 m -109.39 149.39 29.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 64.340000000000003 111.127 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 26.6 ttm -138.63 150.35 46.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 64.109999999999999 110.843 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.9 mt -142.76 109.92 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 73.230000000000004 111.139 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.422 HD21 ' CD1' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -79.68 105.85 11.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.47 . . . . 75.129999999999995 110.926 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -90.29 169.79 10.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 61.32 110.855 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -165.44 95.34 0.64 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 73.540000000000006 110.863 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.67 37.72 13.31 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.753 -0.737 . . . . 74.239999999999995 112.474 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.571 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 68.38 41.01 86.69 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.71 -0.757 . . . . 33.329999999999998 112.494 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.446 HG23 ' HD2' ' A' ' 94' ' ' PRO . 85.4 m -160.76 134.05 4.77 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.643 0.735 . . . . 74.420000000000002 111.088 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.446 ' HD2' HG23 ' A' ' 93' ' ' THR . 53.7 Cg_endo -69.79 86.94 0.57 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.703 2.269 . . . . 71.340000000000003 112.327 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.0 m -76.66 -34.58 23.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 60.32 111.173 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.92 164.12 26.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 62.539999999999999 110.897 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.546 ' C ' HD12 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -155.61 119.83 4.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 74.219999999999999 110.895 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.546 HD12 ' C ' ' A' ' 97' ' ' ARG . 4.8 mp -138.31 130.12 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 75.420000000000002 111.133 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.645 ' HB ' HG23 ' A' ' 85' ' ' THR . 1.6 p -126.11 143.44 39.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 64.430000000000007 111.104 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 128.83 132.61 3.54 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.771 -0.728 . . . . 62.140000000000001 112.486 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.19 75.05 9.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.854 0.359 . . . . 74.140000000000001 111.138 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.432 ' HG2' HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -113.39 171.63 7.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 53.140000000000001 110.896 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.57 171.6 5.45 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.696 -0.764 . . . . 72.239999999999995 112.496 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -60.1 -44.39 94.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.784 0.326 . . . . 73.329999999999998 110.888 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -52.49 -66.29 0.41 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 74.5 111.09 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.71 -59.36 4.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 71.209999999999994 111.095 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.637 HD13 ' O ' ' A' ' 107' ' ' LEU . 1.0 OUTLIER -47.31 -35.48 8.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 73.030000000000001 110.933 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.598 ' O ' HD12 ' A' ' 108' ' ' LEU . 4.2 tp -71.19 -43.92 66.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 74.439999999999998 110.91 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 10.6 mtp85 -59.46 -41.82 90.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 74.400000000000006 110.876 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -53.03 -25.33 12.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 55.219999999999999 110.933 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.7 mt -86.04 -68.59 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 75.120000000000005 111.16 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -51.15 -49.57 60.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.151 -0.477 . . . . 71.219999999999999 110.894 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -58.53 -34.23 70.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 52.329999999999998 110.918 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.1 -36.33 61.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 53.25 111.124 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 mt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 71.430000000000007 110.902 -179.979 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.5 mtt . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.785 0.326 . . . . 54.240000000000002 110.86 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.66 174.07 11.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 53.340000000000003 111.03 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -84.5 -51.17 7.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 74.030000000000001 110.862 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 56.54 54.01 7.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 73.230000000000004 110.865 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 62.0 m170 -77.58 137.46 38.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 71.409999999999997 110.882 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -119.85 30.77 6.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 73.519999999999996 110.887 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -76.6 -40.43 49.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 74.109999999999999 110.811 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 49.1 m-70 -74.28 -36.63 63.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 74.25 110.818 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 37.4 mtp -53.68 -40.52 66.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.444 . . . . 72.219999999999999 110.919 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.3 t -55.0 128.95 35.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 72.310000000000002 110.851 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.682 ' O ' HG22 ' A' ' 13' ' ' VAL . . . 130.11 163.58 11.12 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.727 -0.749 . . . . 42.119999999999997 112.49 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.717 HG22 ' H ' ' A' ' 63' ' ' VAL . 37.1 p -60.27 99.85 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.832 0.348 . . . . 73.319999999999993 111.112 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.682 HG22 ' O ' ' A' ' 11' ' ' GLY . 5.3 m -153.14 174.78 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 72.150000000000006 111.147 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.1 t -75.69 127.21 32.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 52.229999999999997 111.174 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 49.1 t -94.77 125.91 47.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 63.119999999999997 111.136 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.55 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.27 174.0 0.44 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 62.439999999999998 111.152 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.473 ' H ' HG22 ' A' ' 16' ' ' THR . 16.6 t0 -75.1 -47.37 29.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 74.299999999999997 110.81 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.5 t -72.1 -51.52 21.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 75.310000000000002 110.847 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.55 HG22 ' HB ' ' A' ' 16' ' ' THR . 5.8 t -59.12 -19.2 42.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.478 . . . . 73.409999999999997 111.124 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.718 ' CE2' HG21 ' A' ' 24' ' ' VAL . 24.9 t80 -50.88 -30.96 16.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 70.25 110.868 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.43 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -71.78 -34.13 69.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 63.119999999999997 110.92 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.0 m -91.13 -15.91 28.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 71.239999999999995 111.15 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.34 -71.41 0.65 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.441 . . . . 65.230000000000004 110.907 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.718 HG21 ' CE2' ' A' ' 20' ' ' PHE . 17.3 t -70.71 -70.34 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.239 -0.437 . . . . 75.150000000000006 111.127 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.508 HD23 ' HA3' ' A' ' 92' ' ' GLY . 7.4 mt -40.55 -60.31 1.15 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 64.030000000000001 110.921 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -50.36 -61.21 2.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.439 . . . . 74.409999999999997 110.874 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.7 t -56.55 161.33 2.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 73.400000000000006 110.821 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -109.92 -35.98 6.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.104 -0.498 . . . . 71.120000000000005 110.884 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -53.44 158.88 2.57 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.585 0.707 . . . . 72.349999999999994 111.103 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 125.66 12.42 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.631 2.221 . . . . 72.150000000000006 112.387 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.552 HG21 HG13 ' A' ' 24' ' ' VAL . 94.6 t -102.1 115.88 44.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 73.140000000000001 111.148 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.9 mp -94.58 99.73 11.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 73.310000000000002 110.874 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.3 p -98.59 140.88 17.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.14 -0.482 . . . . 70.230000000000004 111.075 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -124.8 102.08 7.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 73.549999999999997 110.84 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -83.4 89.57 7.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 73.340000000000003 110.889 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.739 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -135.6 -168.58 2.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.148 -0.478 . . . . 72.209999999999994 110.903 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.54 -164.48 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 75.530000000000001 111.096 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.45 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 9.5 p-10 -78.68 12.71 1.94 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 74.340000000000003 110.861 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.476 ' N ' ' CD1' ' A' ' 39' ' ' TRP . 1.0 OUTLIER 76.03 95.15 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 71.540000000000006 110.935 -179.94 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 46.1 t -172.25 -56.22 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 41.439999999999998 110.849 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.51 -70.71 1.32 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.721 -0.752 . . . . 71.310000000000002 112.478 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.449 ' HG3' HG21 ' A' ' 83' ' ' ILE . 53.7 Cg_endo -69.72 -32.63 18.36 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.639 2.226 . . . . 65.430000000000007 112.324 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.558 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 35.8 t -54.74 -40.69 69.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.436 . . . . 74.239999999999995 110.907 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.8 pttp -64.34 -26.46 68.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 60.350000000000001 110.861 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 5.3 mtp -87.15 -42.85 12.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.276 -0.42 . . . . 65.450000000000003 110.871 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.522 ' HA ' HG22 ' A' ' 49' ' ' VAL . 3.1 t -94.31 21.44 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 73.209999999999994 111.147 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.778 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -76.75 -61.17 0.76 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.562 0.696 . . . . 54.43 111.088 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.778 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.7 Cg_endo -69.81 -49.77 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.678 2.252 . . . . 63.149999999999999 112.344 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.596 ' O ' HD12 ' A' ' 53' ' ' ILE . 4.3 m -51.24 -30.85 10.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 71.450000000000003 111.105 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.4 tp -90.16 -35.89 15.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 62.140000000000001 110.886 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -68.26 -24.16 64.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 72.099999999999994 110.925 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -65.97 -60.71 2.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.478 . . . . 52.140000000000001 110.873 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.596 HD12 ' O ' ' A' ' 49' ' ' VAL . 2.6 mp -61.52 -33.02 55.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 64.299999999999997 111.118 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.98 -20.04 50.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 73.150000000000006 111.101 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -41.01 92.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 73.409999999999997 110.873 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -91.08 -41.25 11.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 75.430000000000007 110.876 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.676 ' HB3' HD23 ' A' ' 61' ' ' LEU . 0.8 OUTLIER -64.91 -27.83 69.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 75.239999999999995 110.91 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.8 t -42.91 135.42 3.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 64.439999999999998 110.899 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 127.08 -27.99 4.69 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.788 -0.72 . . . . 74.519999999999996 112.484 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -129.34 -37.39 1.64 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.863 0.363 . . . . 73.439999999999998 111.148 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.676 HD23 ' HB3' ' A' ' 57' ' ' LYS . 0.3 OUTLIER -88.89 144.5 26.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 72.310000000000002 110.918 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.486 ' N ' HD12 ' A' ' 61' ' ' LEU . 12.4 ttpp -107.62 141.39 39.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 65.5 110.93 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.717 ' H ' HG22 ' A' ' 12' ' ' THR . 50.4 t -101.71 108.67 24.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.22 -0.446 . . . . 62.130000000000003 111.182 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -122.27 128.91 51.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 73.450000000000003 111.103 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.8 pttt -125.99 157.61 37.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 74.140000000000001 110.882 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 31.3 tp -147.95 146.45 28.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 54.25 110.882 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -82.96 119.88 24.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 62.340000000000003 110.925 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 36' ' ' TRP . 84.7 t -48.14 -39.52 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 75.450000000000003 111.086 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.02 -33.31 56.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 72.230000000000004 110.862 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.82 -34.68 45.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 75.25 111.043 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.601 ' HB2' ' HB3' ' A' ' 74' ' ' ALA . 5.2 p30 -118.39 66.91 6.76 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.627 0.727 . . . . 74.209999999999994 110.874 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -32.85 17.52 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.686 2.257 . . . . 62.340000000000003 112.327 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -80.92 -38.65 27.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 64.510000000000005 110.925 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.601 ' HB3' ' HB2' ' A' ' 71' ' ' ASN . . . -60.99 -43.32 99.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 60.119999999999997 111.149 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.478 ' HB1' ' HB ' ' A' ' 80' ' ' VAL . . . -51.76 -67.27 0.27 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 74.409999999999997 111.136 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.1 ttm-85 -51.19 -34.07 30.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.259 -0.428 . . . . 73.420000000000002 110.886 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.43 -40.19 90.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 74.519999999999996 110.867 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -98.89 26.68 5.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 65.120000000000005 110.867 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 49.85 75.44 0.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 53.32 110.919 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.478 ' HB ' ' HB1' ' A' ' 75' ' ' ALA . 90.9 t -116.45 90.55 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 62.310000000000002 111.134 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 61.1 t -84.4 -42.61 17.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 63.030000000000001 111.111 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.6 m -96.75 152.73 18.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 75.040000000000006 110.866 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.531 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.3 mt -63.9 -57.64 17.94 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.598 0.713 . . . . 74.150000000000006 111.112 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 54.0 Cg_endo -69.74 75.43 1.21 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.743 2.295 . . . . 62.109999999999999 112.336 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 84.8 m -117.17 100.89 8.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 72.209999999999994 111.159 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 22.5 ttp -100.76 112.08 24.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 70.430000000000007 110.883 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 25.2 mt -101.33 118.0 47.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 64.150000000000006 111.165 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.656 HD12 HD13 ' A' ' 111' ' ' ILE . 1.9 tt -81.15 110.3 16.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 71.219999999999999 110.923 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -97.47 170.27 9.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.477 . . . . 74.230000000000004 110.88 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -167.3 97.95 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 75.329999999999998 110.903 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.68 38.43 10.63 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.719 -0.753 . . . . 75.299999999999997 112.509 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.508 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 65.76 37.12 93.13 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.702 -0.761 . . . . 65.209999999999994 112.458 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.456 HG23 ' HD2' ' A' ' 94' ' ' PRO . 86.6 m -158.43 133.89 5.85 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.584 0.707 . . . . 70.010000000000005 111.147 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.456 ' HD2' HG23 ' A' ' 93' ' ' THR . 53.4 Cg_endo -69.75 112.64 3.13 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.697 2.265 . . . . 72.219999999999999 112.322 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.6 m -99.63 -33.51 3.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.443 . . . . 64.209999999999994 111.115 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.5 mmtt -140.88 169.66 17.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 71.400000000000006 110.864 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -153.93 111.87 3.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 75.430000000000007 110.875 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.426 ' N ' HD12 ' A' ' 98' ' ' ILE . 4.6 mp -112.75 127.95 69.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 62.219999999999999 111.164 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.0 p -141.69 144.7 25.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 62.100000000000001 111.155 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 139.58 -28.65 2.53 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.786 -0.721 . . . . 54.409999999999997 112.518 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 64.5 96.57 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.822 0.344 . . . . 71.530000000000001 111.101 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.15 -179.25 5.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 74.129999999999995 110.884 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.29 176.76 2.68 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.745 -0.74 . . . . 41.539999999999999 112.508 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.16 -44.57 71.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.799 0.333 . . . . 72.230000000000004 110.896 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.58 -32.9 70.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 55.200000000000003 111.12 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.446 ' HA ' ' HG2' ' A' ' 109' ' ' ARG . . . -85.43 -58.39 2.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 74.329999999999998 111.082 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.627 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.6 OUTLIER -51.12 -35.51 35.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 64.349999999999994 110.93 -179.96 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.596 HD23 ' N ' ' A' ' 109' ' ' ARG . 5.7 tt -68.83 -59.44 3.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 73.030000000000001 110.91 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.596 ' N ' HD23 ' A' ' 108' ' ' LEU . 15.8 ptm180 -56.91 -32.81 66.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 64.510000000000005 110.867 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -51.9 -25.46 8.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 71.319999999999993 110.878 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.656 HD13 HD12 ' A' ' 88' ' ' LEU . 3.8 mt -85.56 -69.03 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 72.310000000000002 111.148 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -51.56 -49.88 61.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 64.019999999999996 110.92 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -54.12 -34.68 60.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 72.230000000000004 110.84 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.17 -34.95 66.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 75.349999999999994 111.1 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.9 mt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 54.539999999999999 110.889 -179.951 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 mmt . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.79 0.328 . . . . 73.200000000000003 110.906 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.24 81.32 1.93 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 74.519999999999996 111.133 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -99.88 -37.59 8.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 65.109999999999999 110.884 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.8 m170 -75.85 -179.84 5.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 74.439999999999998 110.827 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -116.91 167.02 11.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 71.299999999999997 110.888 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -119.71 30.84 6.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.456 . . . . 73.120000000000005 110.858 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -70.89 -63.8 1.03 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 55.329999999999998 110.82 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -52.17 -35.1 47.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.191 -0.459 . . . . 71.040000000000006 110.862 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 10.9 mtp -51.47 -34.89 37.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 75.530000000000001 110.883 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.6 p -51.62 129.88 26.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 74.329999999999998 110.847 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 135.97 152.92 6.47 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.745 -0.74 . . . . 61.210000000000001 112.495 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.2 p -73.94 99.55 3.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.836 0.35 . . . . 62.210000000000001 111.109 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.6 m -154.53 -179.85 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 75.140000000000001 111.16 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.3 t -72.64 151.16 42.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 63.450000000000003 111.149 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.489 HG22 ' CG2' ' A' ' 19' ' ' THR . 9.1 p -119.26 151.87 21.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 75.540000000000006 111.144 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.639 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -63.37 162.06 13.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 45.119999999999997 111.109 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -77.4 -52.33 9.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 73.439999999999998 110.821 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.9 t -57.76 -36.37 72.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 64.329999999999998 110.859 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.639 HG22 ' HB ' ' A' ' 16' ' ' THR . 5.0 t -84.65 -17.83 37.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 75.219999999999999 111.137 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.714 ' CE2' HG21 ' A' ' 24' ' ' VAL . 24.6 t80 -49.92 -31.49 12.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 75.540000000000006 110.924 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.405 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -70.95 -34.46 71.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 72.200000000000003 110.869 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.5 m -91.01 -15.2 30.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 75.209999999999994 111.157 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.42 -70.61 0.69 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.231 -0.441 . . . . 73.0 110.862 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 1.035 HG13 HG21 ' A' ' 31' ' ' VAL . 17.3 t -72.06 -70.38 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 75.099999999999994 111.137 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.652 HD23 ' HA3' ' A' ' 92' ' ' GLY . 7.5 mt -40.41 -57.7 1.72 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.156 -0.475 . . . . 71.239999999999995 110.911 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -51.28 -60.04 3.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 74.140000000000001 110.852 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 55.5 p -51.67 139.47 20.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 64.239999999999995 110.838 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -88.82 -41.77 12.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 73.129999999999995 110.872 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.468 HG22 ' HD2' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -51.54 158.76 1.39 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.582 0.706 . . . . 70.340000000000003 111.18 -179.911 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.468 ' HD2' HG22 ' A' ' 29' ' ' THR . 54.0 Cg_endo -69.73 129.8 18.27 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.703 2.269 . . . . 72.230000000000004 112.324 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 1.035 HG21 HG13 ' A' ' 24' ' ' VAL . 92.4 t -97.1 126.6 49.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.437 . . . . 75.340000000000003 111.135 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.8 mp -110.12 121.07 44.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 74.409999999999997 110.937 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.717 HG12 ' HB3' ' A' ' 64' ' ' ALA . 11.7 m -132.81 149.9 32.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 75.540000000000006 111.104 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.28 99.63 5.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 72.239999999999995 110.832 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.47 ' CE2' HD22 ' A' ' 66' ' ' LEU . 5.8 m-85 -73.59 96.81 2.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 65.400000000000006 110.893 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -142.83 -168.6 2.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.168 -0.469 . . . . 74.439999999999998 110.914 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.49 -162.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 54.240000000000002 111.133 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.484 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 4.1 t70 -77.96 13.72 1.32 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.268 -0.424 . . . . 51.32 110.876 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.484 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 0.5 OUTLIER 74.95 94.34 0.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.204 -0.453 . . . . 72.450000000000003 110.887 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 35.0 t -174.79 -50.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 72.349999999999994 110.885 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.24 -69.55 1.39 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.724 -0.75 . . . . 73.319999999999993 112.459 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 -28.47 24.96 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.684 2.256 . . . . 71.129999999999995 112.351 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.655 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 1.9 p -53.95 -25.53 21.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 75.450000000000003 110.95 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.2 pttt -77.96 -31.48 50.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 73.400000000000006 110.847 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 16.1 mtt -85.82 -35.4 20.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 74.549999999999997 110.886 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.552 ' HA ' HG22 ' A' ' 49' ' ' VAL . 2.8 t -100.36 22.07 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.246 -0.434 . . . . 75.129999999999995 111.122 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.814 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -74.36 -61.21 1.23 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.556 0.693 . . . . 74.25 111.091 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.814 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.7 Cg_endo -69.73 -50.66 0.45 Allowed 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.732 2.288 . . . . 52.520000000000003 112.359 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.572 ' O ' HD12 ' A' ' 53' ' ' ILE . 4.1 m -52.09 -29.98 12.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.459 . . . . 33.140000000000001 111.132 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.6 tp -75.04 -41.96 58.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 64.540000000000006 110.888 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -67.45 -34.34 76.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 70.319999999999993 110.872 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -52.84 -62.09 1.87 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 74.120000000000005 110.876 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.572 HD12 ' O ' ' A' ' 49' ' ' VAL . 3.1 mt -51.21 -39.51 20.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 74.049999999999997 111.118 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.87 -42.43 90.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 74.319999999999993 111.116 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -44.68 96.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 75.109999999999999 110.893 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.24 -35.53 66.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 71.430000000000007 110.828 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.2 mmtm -67.37 -74.63 0.11 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 73.049999999999997 110.872 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.04 -170.93 0.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 63.439999999999998 110.863 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -124.96 32.96 3.84 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.718 -0.753 . . . . 70.239999999999995 112.517 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.0 p -146.07 32.59 1.01 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.833 0.349 . . . . 65.299999999999997 111.154 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.3 pp -101.51 156.34 17.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 63.210000000000001 110.945 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.8 tttp -86.78 147.64 25.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.443 . . . . 64.400000000000006 110.888 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.4 t -140.74 106.56 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.421 . . . . 61.439999999999998 111.124 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.717 ' HB3' HG12 ' A' ' 33' ' ' VAL . . . -113.62 110.08 19.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 31.140000000000001 111.07 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.0 pttm -97.23 128.98 44.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 61.130000000000003 110.911 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.47 HD22 ' CE2' ' A' ' 35' ' ' PHE . 6.2 tp -105.15 146.08 29.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 74.420000000000002 110.909 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.636 ' OD2' ' HB3' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -108.86 97.37 7.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 70.230000000000004 110.86 179.858 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.1 m -49.08 -32.2 4.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 44.100000000000001 111.155 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -50.14 -32.5 16.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 72.340000000000003 110.904 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.636 ' HB3' ' OD2' ' A' ' 67' ' ' ASP . . . -105.99 -28.5 10.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 64.349999999999994 111.098 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.82 72.22 2.02 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.631 0.729 . . . . 75.150000000000006 110.9 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -30.99 21.2 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.661 2.24 . . . . 74.409999999999997 112.337 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -70.6 -42.88 70.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 73.349999999999994 110.895 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.24 -48.35 62.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 75.040000000000006 111.081 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.593 ' HB1' ' CG1' ' A' ' 80' ' ' VAL . . . -53.76 -67.31 0.27 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 74.340000000000003 111.157 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.1 ttp85 -51.87 -31.4 27.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 72.140000000000001 110.868 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -51.64 -37.96 52.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 63.539999999999999 110.87 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -105.24 21.44 17.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 74.329999999999998 110.888 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 65.3 mm-40 46.61 82.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.115 -0.493 . . . . 72.510000000000005 110.917 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.593 ' CG1' ' HB1' ' A' ' 75' ' ' ALA . 7.0 p -122.09 132.77 70.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 75.230000000000004 111.149 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.8 t -120.46 45.81 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 74.230000000000004 111.13 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.454 ' H ' HG22 ' A' ' 80' ' ' VAL . 0.3 OUTLIER -174.05 144.91 1.03 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 52.240000000000002 110.847 -179.813 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.53 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 4.3 mt -66.44 -58.04 11.16 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.571 0.7 . . . . 75.549999999999997 111.116 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.72 ' HB2' ' HB2' ' A' ' 101' ' ' ALA . 53.2 Cg_endo -69.79 73.96 1.34 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.699 2.266 . . . . 52.439999999999998 112.336 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.634 HG23 ' HB ' ' A' ' 99' ' ' VAL . 97.6 m -117.77 129.57 55.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 71.439999999999998 111.145 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -120.78 144.02 48.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.443 . . . . 71.120000000000005 110.874 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 17.5 mt -131.7 122.89 50.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 64.299999999999997 111.129 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.28 105.4 17.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.149 -0.478 . . . . 73.299999999999997 110.889 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -89.45 169.84 11.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 60.310000000000002 110.933 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.12 91.16 0.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 73.340000000000003 110.886 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.33 33.13 12.14 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.706 -0.759 . . . . 74.120000000000005 112.49 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.652 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 74.99 38.83 39.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.761 -0.733 . . . . 63.229999999999997 112.477 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.44 HG23 ' HD2' ' A' ' 94' ' ' PRO . 85.5 m -161.26 133.8 4.41 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.577 0.704 . . . . 65.219999999999999 111.128 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.44 ' HD2' HG23 ' A' ' 93' ' ' THR . 54.0 Cg_endo -69.78 98.13 0.67 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.651 2.234 . . . . 62.140000000000001 112.352 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.6 m -87.65 -31.8 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 72.310000000000002 111.131 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.9 mmtm -132.42 166.0 22.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 73.299999999999997 110.915 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -159.76 115.0 2.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 70.109999999999999 110.866 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.428 ' N ' HD12 ' A' ' 98' ' ' ILE . 4.5 mp -125.36 118.01 51.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 74.120000000000005 111.105 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.634 ' HB ' HG23 ' A' ' 85' ' ' THR . 2.2 p -128.18 145.14 35.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 70.140000000000001 111.146 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 136.68 -28.31 2.87 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.796 -0.716 . . . . 75.329999999999998 112.475 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.72 ' HB2' ' HB2' ' A' ' 84' ' ' PRO . . . 64.49 106.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.821 0.344 . . . . 64.530000000000001 111.075 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.454 ' HG2' HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -147.46 175.61 10.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 74.019999999999996 110.901 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.51 166.66 8.88 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.735 -0.745 . . . . 75.519999999999996 112.538 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.68 -36.51 84.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.766 0.317 . . . . 70.150000000000006 110.932 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.34 -31.33 72.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 75.439999999999998 111.102 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.46 -58.84 2.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 64.5 111.105 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.454 HD23 ' HG2' ' A' ' 102' ' ' LYS . 0.3 OUTLIER -48.22 -47.53 35.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 74.530000000000001 110.929 180.0 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.439 HD23 ' C ' ' A' ' 108' ' ' LEU . 4.0 tt -47.98 -41.53 25.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 71.340000000000003 110.905 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 44.4 mtp180 -76.51 -35.8 58.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 73.430000000000007 110.878 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -51.02 -24.68 3.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.229 -0.441 . . . . 74.439999999999998 110.862 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.0 mt -87.78 -68.94 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 70.329999999999998 111.143 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.461 ' HA ' HD23 ' A' ' 115' ' ' LEU . 0.7 OUTLIER -53.88 -52.92 58.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 74.439999999999998 110.885 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -54.14 -34.47 60.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 71.310000000000002 110.858 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.87 -34.67 71.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 75.420000000000002 111.066 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 112' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 74.219999999999999 110.951 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.2 p . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.824 0.345 . . . . 73.230000000000004 111.112 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.2 t -147.09 145.4 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 75.219999999999999 111.086 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.8 t -77.7 127.93 33.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 71.450000000000003 111.109 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.537 ' CG1' HG23 ' A' ' 19' ' ' THR . 43.9 t -97.66 120.79 47.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 75.140000000000001 111.11 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.451 HG22 ' H ' ' A' ' 17' ' ' ASP . 0.2 OUTLIER -59.92 173.58 0.59 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 64.140000000000001 111.185 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.451 ' H ' HG22 ' A' ' 16' ' ' THR . 38.0 t0 -77.87 -41.64 36.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 74.099999999999994 110.878 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.3 m -69.6 -33.73 73.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 71.530000000000001 110.881 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.537 HG23 ' CG1' ' A' ' 15' ' ' VAL . 13.2 t -85.55 -18.19 34.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 74.349999999999994 111.178 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.804 ' CZ ' HG21 ' A' ' 24' ' ' VAL . 7.3 t80 -51.05 -52.68 40.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 73.120000000000005 110.886 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.719 ' CB ' HD12 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -64.6 -14.67 58.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 72.239999999999995 110.864 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.6 m -92.99 -33.17 14.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.294 -0.412 . . . . 73.400000000000006 111.16 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -96.96 -71.56 0.67 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 54.130000000000003 110.878 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.804 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 38.4 t -51.48 -71.81 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 55.450000000000003 111.117 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.719 HD12 ' CB ' ' A' ' 21' ' ' LYS . 12.1 mt -41.71 -58.95 1.8 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 65.109999999999999 110.921 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -49.71 -64.81 0.7 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 73.430000000000007 110.857 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.6 t -55.49 145.88 21.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 70.299999999999997 110.848 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -107.36 35.92 2.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.487 . . . . 71.349999999999994 110.858 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.25 160.3 38.07 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 121.571 0.7 . . . . 74.450000000000003 111.123 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 106.42 1.67 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.695 2.263 . . . . 74.430000000000007 112.343 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.747 HG21 HG13 ' A' ' 24' ' ' VAL . 70.5 t -87.64 118.28 33.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 60.140000000000001 111.135 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.84 99.52 11.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.477 . . . . 70.030000000000001 110.919 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 87' ' ' ILE . 5.6 p -100.16 138.99 22.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 74.200000000000003 111.116 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -125.3 121.83 35.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 61.539999999999999 110.851 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.613 ' CD2' HD22 ' A' ' 66' ' ' LEU . 35.6 m-85 -101.1 89.83 3.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 74.510000000000005 110.845 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -133.3 -167.73 1.97 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.132 -0.486 . . . . 72.219999999999999 110.945 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.05 -166.32 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 65.25 111.069 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.445 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 3.6 m-20 -78.89 12.63 2.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 72.420000000000002 110.919 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.457 ' N ' ' CD1' ' A' ' 39' ' ' TRP . 1.4 m0 77.01 94.62 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 74.340000000000003 110.895 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -174.69 -57.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 53.100000000000001 110.84 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.09 -70.06 1.36 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.788 -0.72 . . . . 72.329999999999998 112.488 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 -44.01 2.31 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.681 2.254 . . . . 63.030000000000001 112.29 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.536 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 42.4 t -52.08 -34.73 45.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.433 . . . . 74.349999999999994 110.894 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.6 -34.14 77.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 73.219999999999999 110.845 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 11.3 mtt -85.25 -38.34 19.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 71.510000000000005 110.88 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.506 ' HA ' HG22 ' A' ' 49' ' ' VAL . 3.0 t -94.1 21.48 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 62.240000000000002 111.141 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.786 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -77.18 -60.84 0.73 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.579 0.704 . . . . 70.400000000000006 111.112 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.786 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.7 Cg_endo -69.71 -49.65 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.681 2.254 . . . . 72.040000000000006 112.38 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.506 HG22 ' HA ' ' A' ' 46' ' ' VAL . 4.4 m -50.49 -30.16 7.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 61.340000000000003 111.127 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.4 tt -84.01 -39.69 19.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.202 -0.454 . . . . 72.439999999999998 110.91 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -61.43 -35.57 77.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 72.230000000000004 110.879 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -55.1 -60.56 3.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 74.439999999999998 110.936 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.432 HD12 ' O ' ' A' ' 49' ' ' VAL . 3.0 mt -51.43 -38.18 20.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 63.439999999999998 111.13 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 61.149999999999999 111.123 179.806 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.645 ' C ' HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.898 0.38 . . . . 73.540000000000006 110.902 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.538 ' N ' HD22 ' A' ' 61' ' ' LEU . 1.7 ttmp? -128.96 141.97 51.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 72.140000000000001 110.884 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.82 112.93 42.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 73.120000000000005 111.16 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -105.55 147.26 28.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 74.340000000000003 111.112 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.41 156.62 46.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.436 . . . . 72.129999999999995 110.896 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.681 HD21 ' HB2' ' A' ' 71' ' ' ASN . 0.4 OUTLIER -144.42 137.62 27.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.452 . . . . 65.319999999999993 110.927 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.58 106.92 13.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.45 . . . . 73.549999999999997 110.87 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 78.8 t -55.54 -39.11 52.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 62.109999999999999 111.16 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.02 -36.02 62.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 72.319999999999993 110.849 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.8 -35.46 14.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 74.010000000000005 111.15 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.681 ' HB2' HD21 ' A' ' 66' ' ' LEU . 1.7 m-80 -117.87 68.04 6.23 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.627 0.727 . . . . 71.439999999999998 110.894 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -33.3 16.86 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.684 2.256 . . . . 65.349999999999994 112.29 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -62.42 -36.8 83.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 72.109999999999999 110.877 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.15 -34.99 79.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 63.409999999999997 111.051 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.583 ' HB1' ' HB ' ' A' ' 80' ' ' VAL . . . -58.88 -67.52 0.36 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 63.32 111.088 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -53.41 -38.73 63.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 74.299999999999997 110.895 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -51.41 -37.82 50.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 74.019999999999996 110.919 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -110.08 29.93 7.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 74.439999999999998 110.845 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 49.35 82.02 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 71.439999999999998 110.924 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.583 ' HB ' ' HB1' ' A' ' 75' ' ' ALA . 87.4 t -126.89 103.35 10.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 70.209999999999994 111.138 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 60.3 t -98.29 -34.49 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 63.509999999999998 111.143 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.5 m -97.61 151.67 19.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 70.109999999999999 110.855 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.53 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.1 mt -66.66 -57.76 11.31 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.565 0.697 . . . . 73.219999999999999 111.148 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.4 Cg_endo -69.77 70.17 1.6 Allowed 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.694 2.263 . . . . 61.229999999999997 112.332 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 59.1 m -110.49 148.09 32.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 73.120000000000005 111.115 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 5.3 ttp -147.89 147.61 29.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 71.329999999999998 110.883 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.416 ' O ' HG12 ' A' ' 33' ' ' VAL . 10.5 mt -133.43 115.32 22.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 74.099999999999994 111.15 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.429 HD23 ' HB2' ' A' ' 96' ' ' LYS . 10.9 tp -81.3 101.78 9.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 73.430000000000007 110.875 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -89.98 170.33 10.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 73.209999999999994 110.874 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -164.91 96.31 0.72 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 70.439999999999998 110.919 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.97 35.87 23.32 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.763 -0.732 . . . . 52.450000000000003 112.469 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.652 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 71.23 40.89 60.63 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.731 -0.747 . . . . 73.400000000000006 112.499 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.419 HG23 ' HD2' ' A' ' 94' ' ' PRO . 46.6 m -160.65 133.46 4.56 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.596 0.712 . . . . 74.430000000000007 111.158 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.419 ' HD2' HG23 ' A' ' 93' ' ' THR . 53.2 Cg_endo -69.79 87.76 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.67 2.247 . . . . 64.129999999999995 112.318 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 26.9 m -78.54 -34.96 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 72.129999999999995 111.097 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.429 ' HB2' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -141.43 163.71 32.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 73.530000000000001 110.904 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.404 ' C ' HD12 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -150.54 133.47 16.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 75.549999999999997 110.858 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.44 HG23 ' HB3' ' A' ' 110' ' ' GLU . 5.3 mp -137.19 135.44 47.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 72.530000000000001 111.139 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -135.32 139.64 46.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 71.200000000000003 111.149 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 129.02 134.49 3.8 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.767 -0.73 . . . . 34.5 112.454 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.34 86.38 7.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.833 0.349 . . . . 53.329999999999998 111.116 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.529 ' HG2' HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -124.41 172.46 9.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 73.400000000000006 110.847 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.26 171.0 8.42 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.739 -0.743 . . . . 73.230000000000004 112.448 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.06 -43.59 86.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.791 0.329 . . . . 74.5 110.916 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.96 -65.39 0.59 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 54.43 111.093 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.89 -56.91 13.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 73.129999999999995 111.084 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.529 HD23 ' HG2' ' A' ' 102' ' ' LYS . 0.3 OUTLIER -49.82 -36.27 25.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 72.549999999999997 110.918 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.419 HD23 ' C ' ' A' ' 108' ' ' LEU . 10.3 tt -70.15 -37.41 75.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 75.140000000000001 110.925 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 10.0 mtp85 -66.71 -41.52 87.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 71.230000000000004 110.845 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.44 ' HB3' HG23 ' A' ' 98' ' ' ILE . 42.9 mm-40 -52.19 -25.46 9.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 73.400000000000006 110.905 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.3 mt -84.82 -67.99 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 65.340000000000003 111.155 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -52.4 -48.8 65.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 62.439999999999998 110.913 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -58.0 -34.79 70.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.496 . . . . 62.439999999999998 110.886 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.81 -35.04 57.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 73.030000000000001 111.129 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.1 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 62.020000000000003 110.923 -179.984 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.573 HG22 ' HB ' ' A' ' 63' ' ' VAL . 58.6 p . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.789 0.328 . . . . 62.240000000000002 111.131 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.06 150.09 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 75.319999999999993 111.143 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.4 t -72.71 131.1 41.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 53.409999999999997 111.143 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.4 t -92.56 121.21 42.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 72.140000000000001 111.148 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.577 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.89 163.67 4.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.122 -0.49 . . . . 61.130000000000003 111.113 -179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -67.02 -39.86 87.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 74.400000000000006 110.82 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.7 t -75.86 -57.67 3.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 75.120000000000005 110.898 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.577 HG22 ' HB ' ' A' ' 16' ' ' THR . 10.5 t -55.79 -24.22 34.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 75.319999999999993 111.144 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.538 ' CE2' HG21 ' A' ' 24' ' ' VAL . 16.6 t80 -51.71 -30.88 23.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 73.140000000000001 110.837 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.562 ' HA ' HD12 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -71.45 -33.37 69.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 71.099999999999994 110.9 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.9 m -92.69 -17.67 23.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 75.310000000000002 111.151 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -93.57 -72.05 0.63 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 64.519999999999996 110.849 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.538 HG21 ' CE2' ' A' ' 20' ' ' PHE . 58.2 t -69.4 -71.29 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 64.140000000000001 111.106 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.562 HD12 ' HA ' ' A' ' 21' ' ' LYS . 12.5 mt -40.18 -60.31 1.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 74.349999999999994 110.861 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -50.31 -56.62 10.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.242 -0.435 . . . . 73.129999999999995 110.863 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.1 t -51.84 158.47 1.0 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 64.109999999999999 110.859 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -119.44 35.76 4.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 71.549999999999997 110.844 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.452 HG22 ' HD2' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -132.4 159.96 70.13 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.523 0.678 . . . . 74.150000000000006 111.175 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.452 ' HD2' HG22 ' A' ' 29' ' ' THR . 53.4 Cg_endo -69.76 122.14 8.83 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.682 2.254 . . . . 53.119999999999997 112.344 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.503 HG22 ' HD2' ' A' ' 62' ' ' LYS . 90.1 t -100.93 122.93 53.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.449 . . . . 73.439999999999998 111.121 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -94.86 99.93 11.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 71.340000000000003 110.901 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 87' ' ' ILE . 7.9 p -100.38 142.62 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 63.229999999999997 111.17 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -135.75 119.84 17.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 74.120000000000005 110.895 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.6 ' HE2' ' HB1' ' A' ' 74' ' ' ALA . 47.1 m-85 -99.74 93.5 5.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 54.340000000000003 110.936 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -136.77 -167.72 2.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.126 -0.488 . . . . 72.200000000000003 110.958 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.57 -165.22 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.433 . . . . 73.010000000000005 111.085 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.446 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 34.7 p-10 -77.69 12.07 1.83 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 73.400000000000006 110.844 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.479 ' N ' ' CD1' ' A' ' 39' ' ' TRP . 1.7 m0 77.62 92.91 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.158 -0.474 . . . . 65.519999999999996 110.908 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -175.89 -53.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 62.409999999999997 110.881 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.26 -70.99 1.3 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.74 -0.743 . . . . 62.210000000000001 112.509 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -32.62 18.17 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.646 2.23 . . . . 71.010000000000005 112.351 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.534 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -59.42 -33.45 71.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 72.230000000000004 110.884 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.53 -28.81 70.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 64.319999999999993 110.898 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 4.6 mmt -87.21 -41.55 13.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 64.430000000000007 110.867 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.522 ' HA ' HG22 ' A' ' 49' ' ' VAL . 2.9 t -94.13 22.16 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 72.420000000000002 111.115 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.78 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -76.75 -61.08 0.77 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.561 0.696 . . . . 70.310000000000002 111.08 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.78 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.9 Cg_endo -69.76 -49.91 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.711 2.274 . . . . 63.329999999999998 112.326 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.612 ' O ' HD12 ' A' ' 53' ' ' ILE . 4.3 m -51.02 -30.42 9.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 72.25 111.112 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.555 HD23 ' O ' ' A' ' 50' ' ' LEU . 7.3 tt -82.95 -36.83 24.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.16 -0.473 . . . . 71.109999999999999 110.945 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -58.9 -35.29 72.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 74.439999999999998 110.907 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -61.82 -67.88 0.37 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 74.099999999999994 110.891 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.612 HD12 ' O ' ' A' ' 49' ' ' VAL . 3.0 mt -51.38 -37.32 18.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 72.439999999999998 111.12 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 61.049999999999997 111.072 179.809 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.8 pp . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.862 0.363 . . . . 73.010000000000005 110.951 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.503 ' HD2' HG22 ' A' ' 31' ' ' VAL . 32.0 mttp -85.63 124.71 32.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 71.230000000000004 110.938 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.573 ' HB ' HG22 ' A' ' 12' ' ' THR . 57.3 t -131.74 105.35 9.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 53.409999999999997 111.134 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -118.04 139.19 51.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 64.5 111.112 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -134.94 158.75 43.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 75.319999999999993 110.912 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.582 HD22 ' CD2' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -139.71 142.66 36.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.435 . . . . 70.329999999999998 110.974 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.88 107.28 19.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.201 -0.454 . . . . 44.009999999999998 110.871 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 69.4 t -57.47 -36.01 51.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 74.120000000000005 111.162 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.87 -36.38 48.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 71.319999999999993 110.908 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.29 -35.18 10.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 64.219999999999999 111.081 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.485 ' HB2' HD21 ' A' ' 66' ' ' LEU . 2.1 m-80 -115.72 73.59 4.46 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.63 0.728 . . . . 44.109999999999999 110.89 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -30.87 21.41 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.672 2.248 . . . . 44.350000000000001 112.319 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -64.9 -38.96 92.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.429 . . . . 73.120000000000005 110.898 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.6 ' HB1' ' HE2' ' A' ' 35' ' ' PHE . . . -54.48 -48.88 71.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.492 . . . . 63.210000000000001 111.094 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.615 ' HB1' ' HB ' ' A' ' 80' ' ' VAL . . . -53.37 -64.05 0.95 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 73.239999999999995 111.102 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.5 ttp180 -51.23 -34.01 30.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 73.230000000000004 110.899 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -51.73 -40.04 59.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 74.420000000000002 110.892 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -106.65 28.45 7.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 73.030000000000001 110.891 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 50.33 52.88 13.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 74.030000000000001 110.877 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.615 ' HB ' ' HB1' ' A' ' 75' ' ' ALA . 87.7 t -89.63 109.19 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 60.409999999999997 111.135 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.9 t -96.18 -35.74 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 74.099999999999994 111.112 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.5 t -103.12 146.0 29.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 70.010000000000005 110.838 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.54 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 1.1 mp -56.9 -57.43 24.37 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.594 0.711 . . . . 64.010000000000005 111.136 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.647 ' CB ' ' HB2' ' A' ' 101' ' ' ALA . 53.7 Cg_endo -69.76 78.34 1.01 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.668 2.245 . . . . 63.240000000000002 112.329 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.676 HG23 ' CG1' ' A' ' 99' ' ' VAL . 77.0 m -116.72 111.64 20.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.26 -0.427 . . . . 73.549999999999997 111.138 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 10.4 ttp -113.48 122.96 48.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 65.540000000000006 110.896 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.427 ' O ' HG12 ' A' ' 33' ' ' VAL . 20.9 mt -115.53 122.22 68.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 73.340000000000003 111.114 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 16.3 tp -88.16 105.7 17.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.485 . . . . 74.549999999999997 110.895 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -90.18 170.33 10.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 70.420000000000002 110.871 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -168.46 94.64 0.36 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.484 . . . . 63.049999999999997 110.88 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.89 35.85 10.91 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.775 -0.726 . . . . 31.399999999999999 112.48 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.402 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 70.84 37.94 65.76 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.75 -0.738 . . . . 43.420000000000002 112.494 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.459 HG23 ' HD2' ' A' ' 94' ' ' PRO . 85.1 m -161.13 134.16 4.63 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.572 0.701 . . . . 74.420000000000002 111.133 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.459 ' HD2' HG23 ' A' ' 93' ' ' THR . 54.0 Cg_endo -69.73 82.56 0.74 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.646 2.231 . . . . 70.430000000000007 112.37 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.7 m -64.76 -35.02 73.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 70.329999999999998 111.092 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.415 ' HE2' ' HB1' ' A' ' 114' ' ' ALA . 0.0 OUTLIER -140.95 170.02 16.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 73.099999999999994 110.927 179.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.476 ' C ' HD12 ' A' ' 98' ' ' ILE . 66.2 ttt180 -158.31 125.5 4.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 73.349999999999994 110.839 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.476 HD12 ' C ' ' A' ' 97' ' ' ARG . 4.8 mp -134.12 125.41 48.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 64.540000000000006 111.12 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.676 ' CG1' HG23 ' A' ' 85' ' ' THR . 10.6 m -132.77 150.96 33.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 71.129999999999995 111.096 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 140.99 -29.81 2.3 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.711 -0.757 . . . . 72.0 112.491 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.647 ' HB2' ' CB ' ' A' ' 84' ' ' PRO . . . 63.27 73.73 0.44 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.841 0.353 . . . . 72.540000000000006 111.07 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.41 -177.23 3.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 70.0 110.873 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.65 166.74 9.13 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.786 -0.721 . . . . 72.040000000000006 112.495 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.5 ptmt -55.71 -46.43 77.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.796 0.332 . . . . 55.509999999999998 110.93 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.23 -62.24 1.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 71.409999999999997 111.088 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.69 -56.57 18.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 70.340000000000003 111.108 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.547 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.8 OUTLIER -51.14 -41.97 60.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 73.510000000000005 110.912 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.437 HD23 ' C ' ' A' ' 108' ' ' LEU . 10.4 tt -63.98 -59.34 4.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 74.25 110.881 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -53.0 -38.77 62.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 73.540000000000006 110.865 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -51.1 -27.03 7.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 74.019999999999996 110.906 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.4 mt -82.87 -68.31 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 62.420000000000002 111.12 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -51.96 -47.86 64.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 45.450000000000003 110.866 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -57.81 -34.97 70.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.474 . . . . 73.310000000000002 110.837 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.415 ' HB1' ' HE2' ' A' ' 96' ' ' LYS . . . -76.36 -35.68 58.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 65.209999999999994 111.112 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.2 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 74.200000000000003 110.895 -179.931 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.532 HG22 ' HB ' ' A' ' 63' ' ' VAL . 81.7 p . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.82 0.343 . . . . 64.409999999999997 111.133 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.1 t -147.18 146.41 18.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 53.100000000000001 111.138 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.4 t -73.88 152.52 40.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.167 -0.47 . . . . 50.549999999999997 111.178 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.509 HG22 ' CG2' ' A' ' 19' ' ' THR . 5.3 p -112.38 147.82 15.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 61.130000000000003 111.099 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.55 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.74 158.94 9.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 55.100000000000001 111.148 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.96 -50.48 16.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 74.099999999999994 110.861 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.8 t -58.96 -36.08 74.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 73.340000000000003 110.873 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.55 HG22 ' HB ' ' A' ' 16' ' ' THR . 6.1 t -85.42 -18.25 34.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 72.439999999999998 111.133 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.721 ' CE2' HG21 ' A' ' 24' ' ' VAL . 23.5 t80 -50.41 -31.78 15.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 74.340000000000003 110.857 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.406 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -71.1 -33.59 70.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 61.149999999999999 110.876 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.1 m -91.18 -15.95 28.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.237 -0.438 . . . . 73.200000000000003 111.145 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -93.18 -70.86 0.68 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.233 -0.44 . . . . 65.030000000000001 110.861 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 1.029 HG13 HG21 ' A' ' 31' ' ' VAL . 15.6 t -71.14 -70.49 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 75.019999999999996 111.113 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.624 HD23 ' HA3' ' A' ' 92' ' ' GLY . 7.1 mt -40.54 -60.08 1.2 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.122 -0.49 . . . . 73.349999999999994 110.877 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -50.44 -59.39 4.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 73.510000000000005 110.848 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.8 t -51.78 149.06 5.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 62.409999999999997 110.84 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -111.66 35.31 3.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 70.030000000000001 110.885 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.426 HG22 ' HD2' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -123.19 160.41 50.07 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.544 0.688 . . . . 61.299999999999997 111.144 -179.839 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.426 ' HD2' HG22 ' A' ' 29' ' ' THR . 53.6 Cg_endo -69.78 124.67 11.3 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.679 2.253 . . . . 71.200000000000003 112.339 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 1.029 HG21 HG13 ' A' ' 24' ' ' VAL . 95.0 t -103.57 122.37 56.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 32.5 111.137 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.573 HD22 HD23 ' A' ' 88' ' ' LEU . 4.0 mm? -93.72 100.08 12.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 44.020000000000003 110.87 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 87' ' ' ILE . 7.1 p -99.63 145.27 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 51.039999999999999 111.135 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.51 118.57 19.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 74.400000000000006 110.808 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -103.08 97.49 7.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 73.409999999999997 110.916 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.5 ' HH2' HD11 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -148.32 -167.83 2.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.146 -0.479 . . . . 71.409999999999997 110.902 -179.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.572 ' HA ' HG22 ' A' ' 68' ' ' VAL . . . -56.09 -166.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 60.409999999999997 111.097 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.432 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 18.0 t0 -78.51 12.46 1.99 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.434 . . . . 61.420000000000002 110.823 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.463 ' CD1' ' N ' ' A' ' 39' ' ' TRP . 1.6 m0 77.27 94.04 0.06 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.243 -0.435 . . . . 71.0 110.867 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 2.4 t -167.34 -54.18 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 74.319999999999993 110.872 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.01 -69.88 1.37 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.778 -0.725 . . . . 74.340000000000003 112.439 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -32.94 17.83 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.67 2.246 . . . . 73.230000000000004 112.355 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.546 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 45.5 t -52.02 -34.71 44.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 72.209999999999994 110.895 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -64.63 -34.63 78.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 71.439999999999998 110.883 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 42.1 mtt -84.11 -38.84 20.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.271 -0.422 . . . . 65.219999999999999 110.854 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.521 ' HA ' HG22 ' A' ' 49' ' ' VAL . 3.0 t -94.41 21.76 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.434 . . . . 74.209999999999994 111.108 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.791 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -76.89 -60.83 0.77 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.634 0.731 . . . . 75.340000000000003 111.073 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.791 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.7 Cg_endo -69.72 -49.58 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.697 2.265 . . . . 42.32 112.341 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.618 ' O ' HD12 ' A' ' 53' ' ' ILE . 4.4 m -51.04 -30.23 9.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 75.340000000000003 111.132 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.515 ' HG ' HG12 ' A' ' 46' ' ' VAL . 4.4 mt -69.67 -38.2 76.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.123 -0.489 . . . . 34.539999999999999 110.934 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 8.3 mm-40 -71.93 -35.07 69.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 74.549999999999997 110.889 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -51.27 -66.42 0.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.495 . . . . 74.430000000000007 110.849 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.618 HD12 ' O ' ' A' ' 49' ' ' VAL . 2.5 mp -51.23 -33.11 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 73.340000000000003 111.13 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 51' ' ' GLU . . . . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 74.319999999999993 111.127 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.5 pp . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.947 0.403 . . . . 61.409999999999997 110.911 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.4 tptt -95.5 149.47 21.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.475 . . . . 74.209999999999994 110.914 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.532 ' HB ' HG22 ' A' ' 12' ' ' THR . 22.4 t -126.93 106.96 16.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 71.200000000000003 111.165 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -118.13 126.61 52.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 74.239999999999995 111.088 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -110.4 159.29 17.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 62.049999999999997 110.93 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.511 HD21 ' HB2' ' A' ' 71' ' ' ASN . 11.1 tp -137.1 145.92 44.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.434 . . . . 71.409999999999997 110.891 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -97.6 119.62 36.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 71.540000000000006 110.846 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.572 HG22 ' HA ' ' A' ' 37' ' ' ALA . 28.8 m -61.5 -35.18 65.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 74.400000000000006 111.138 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.13 -35.28 47.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 74.409999999999997 110.843 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.47 -35.24 11.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 44.229999999999997 111.078 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.511 ' HB2' HD21 ' A' ' 66' ' ' LEU . 1.4 m-80 -118.36 68.2 7.36 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.57 0.7 . . . . 65.219999999999999 110.868 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 -33.43 16.67 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.666 2.244 . . . . 54.329999999999998 112.38 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -68.28 -36.26 79.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 73.430000000000007 110.928 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.59 -47.45 79.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 74.510000000000005 111.09 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.666 ' HB1' ' HB ' ' A' ' 80' ' ' VAL . . . -56.31 -56.37 21.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 64.049999999999997 111.1 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -51.27 -34.19 31.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 54.140000000000001 110.854 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -58.05 -35.92 72.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 61.009999999999998 110.869 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -102.29 26.39 7.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 74.329999999999998 110.883 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 50.1 36.43 12.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 62.229999999999997 110.905 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.666 ' HB ' ' HB1' ' A' ' 75' ' ' ALA . 97.6 t -68.87 103.43 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 70.25 111.143 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 67.1 t -92.18 -35.04 6.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 75.400000000000006 111.174 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 t -105.61 151.76 23.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.481 . . . . 72.519999999999996 110.849 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.538 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.4 mt -60.58 -57.69 24.71 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.658 0.742 . . . . 73.239999999999995 111.139 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 54.1 Cg_endo -69.78 74.1 1.33 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.651 2.234 . . . . 71.230000000000004 112.347 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.985 HG23 HG22 ' A' ' 99' ' ' VAL . 84.0 m -108.99 137.99 46.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.223 -0.444 . . . . 73.319999999999993 111.178 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 10.2 ttm -135.17 145.91 48.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 70.109999999999999 110.878 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.48 ' O ' HG12 ' A' ' 33' ' ' VAL . 28.6 mt -143.07 128.85 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 72.310000000000002 111.138 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.573 HD23 HD22 ' A' ' 32' ' ' LEU . 2.2 tm? -95.2 107.94 20.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 74.120000000000005 110.906 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -92.06 170.29 9.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 73.420000000000002 110.909 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -162.49 106.24 1.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.479 . . . . 74.040000000000006 110.872 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.68 34.28 56.86 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.782 -0.723 . . . . 74.120000000000005 112.489 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.624 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 73.08 40.22 51.46 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.778 -0.725 . . . . 40.210000000000001 112.489 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.442 HG23 ' HD2' ' A' ' 94' ' ' PRO . 86.0 m -160.91 133.8 4.59 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.539 0.685 . . . . 53.420000000000002 111.149 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.442 ' HD2' HG23 ' A' ' 93' ' ' THR . 53.8 Cg_endo -69.77 84.77 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.698 2.265 . . . . 72.299999999999997 112.329 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.5 m -72.37 -35.11 50.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 75.230000000000004 111.117 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -136.32 170.05 16.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 64.409999999999997 110.937 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.554 ' C ' HD12 ' A' ' 98' ' ' ILE . 20.2 ttt-85 -155.97 128.55 7.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 61.039999999999999 110.9 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.554 HD12 ' C ' ' A' ' 97' ' ' ARG . 4.5 mp -138.05 111.67 7.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.462 . . . . 61.25 111.141 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.985 HG22 HG23 ' A' ' 85' ' ' THR . 48.9 t -109.62 133.07 56.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 71.0 111.165 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 136.57 137.4 3.65 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.754 -0.736 . . . . 73.519999999999996 112.479 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.47 83.15 4.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.87 0.367 . . . . 50.5 111.054 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.449 ' HG2' HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -120.03 174.07 6.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 65.349999999999994 110.931 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.87 171.89 5.68 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.719 -0.753 . . . . 74.409999999999997 112.463 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.66 -44.88 90.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.81 0.338 . . . . 51.520000000000003 110.923 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.64 -64.14 0.95 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 64.150000000000006 111.143 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.81 -58.34 7.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 71.349999999999994 111.142 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.49 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.2 OUTLIER -50.67 -40.94 54.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 61.100000000000001 110.924 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.509 ' O ' HD12 ' A' ' 108' ' ' LEU . 3.7 tp -64.7 -54.17 35.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 64.200000000000003 110.921 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -51.45 -43.06 61.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 53.210000000000001 110.86 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -51.12 -27.24 7.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 74.430000000000007 110.881 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.3 mt -83.08 -68.99 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 71.120000000000005 111.143 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.423 ' O ' HD23 ' A' ' 115' ' ' LEU . 9.0 pt-20 -50.9 -48.78 60.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 63.119999999999997 110.884 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -52.79 -32.48 44.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.479 . . . . 74.049999999999997 110.9 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.59 -33.77 71.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 71.120000000000005 111.108 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.423 HD23 ' O ' ' A' ' 112' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 71.230000000000004 110.929 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.422 HG22 ' HB ' ' A' ' 63' ' ' VAL . 44.5 p . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.827 0.346 . . . . 72.400000000000006 111.165 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.7 t -145.95 146.15 19.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 72.239999999999995 111.123 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.0 m -75.75 125.82 29.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 62.240000000000002 111.159 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.5 t -89.93 127.11 42.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 71.430000000000007 111.156 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.492 ' CB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.13 177.22 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 72.200000000000003 111.151 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.463 ' H ' HG22 ' A' ' 16' ' ' THR . 0.6 OUTLIER -80.1 -35.06 37.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.232 -0.44 . . . . 72.040000000000006 110.882 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.8 t -84.62 -51.73 6.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 64.129999999999995 110.85 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.492 HG22 ' CB ' ' A' ' 16' ' ' THR . 6.2 t -58.43 -19.55 37.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 72.230000000000004 111.167 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.72 ' CE2' HG21 ' A' ' 24' ' ' VAL . 25.1 t80 -51.25 -30.27 17.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 62.240000000000002 110.872 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.417 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -72.47 -34.1 67.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 64.239999999999995 110.898 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.8 m -91.26 -15.99 28.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 65.310000000000002 111.145 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -93.55 -71.53 0.65 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 61.020000000000003 110.851 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.916 HG13 HG21 ' A' ' 31' ' ' VAL . 21.2 t -70.15 -70.65 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 71.549999999999997 111.156 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.609 HD23 ' HA3' ' A' ' 92' ' ' GLY . 7.9 mt -40.6 -60.3 1.16 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.113 -0.494 . . . . 73.329999999999998 110.936 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -50.27 -52.8 33.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 61.210000000000001 110.866 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.9 t -57.21 155.06 9.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 74.200000000000003 110.822 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -104.36 -44.27 4.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.483 . . . . 72.25 110.827 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -51.54 160.0 1.11 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.583 0.706 . . . . 54.32 111.114 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 126.83 13.72 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.63 2.22 . . . . 74.109999999999999 112.336 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.916 HG21 HG13 ' A' ' 24' ' ' VAL . 80.1 t -97.69 127.52 49.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 71.310000000000002 111.159 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.47 HD11 HD11 ' A' ' 88' ' ' LEU . 6.3 mp -103.22 100.11 10.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 71.209999999999994 110.924 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.6 p -102.82 138.46 27.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 74.439999999999998 111.092 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.96 118.43 22.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 73.019999999999996 110.906 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -96.16 90.38 5.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 74.519999999999996 110.893 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -135.6 -167.94 2.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.152 -0.476 . . . . 73.549999999999997 110.969 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.42 ' HA ' HG22 ' A' ' 68' ' ' VAL . . . -56.18 -166.34 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.432 . . . . 60.130000000000003 111.092 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.446 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 9.3 p-10 -78.2 12.45 1.87 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 63.219999999999999 110.863 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.462 ' N ' ' CD1' ' A' ' 39' ' ' TRP . 1.3 m0 76.98 92.95 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 72.420000000000002 110.912 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 36.4 t -170.72 -58.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.441 . . . . 73.430000000000007 110.879 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.8 -71.02 1.25 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.778 -0.725 . . . . 65.430000000000007 112.484 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 -32.2 18.79 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.694 2.263 . . . . 72.219999999999999 112.331 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.536 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 36.3 t -60.23 -32.37 71.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 63.439999999999998 110.867 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -30.21 71.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 71.319999999999993 110.938 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 7.3 mmm -88.44 -39.91 13.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 55.109999999999999 110.858 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.564 ' HA ' HG22 ' A' ' 49' ' ' VAL . 3.1 t -94.25 22.34 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 42.310000000000002 111.096 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.803 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -76.04 -61.04 0.9 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.596 0.712 . . . . 73.019999999999996 111.113 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.803 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.6 Cg_endo -69.78 -50.1 0.49 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.739 2.293 . . . . 61.020000000000003 112.349 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.577 ' O ' HD12 ' A' ' 53' ' ' ILE . 4.4 m -52.86 -31.02 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 74.099999999999994 111.172 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.7 tp -70.33 -41.22 73.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 74.109999999999999 110.914 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -69.81 -34.61 73.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 64.239999999999995 110.906 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -56.39 -63.17 1.28 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 65.409999999999997 110.886 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.577 HD12 ' O ' ' A' ' 49' ' ' VAL . 3.8 mt -53.04 -45.09 52.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 73.150000000000006 111.106 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.462 ' HA ' HD21 ' A' ' 61' ' ' LEU . . . . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 75.450000000000003 111.113 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.462 HD21 ' HA ' ' A' ' 54' ' ' ALA . 3.6 pp . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.817 0.341 . . . . 75.329999999999998 110.963 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -79.78 119.11 22.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.192 -0.458 . . . . 62.299999999999997 110.856 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.422 ' HB ' HG22 ' A' ' 12' ' ' THR . 58.6 t -118.93 100.89 10.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 63.299999999999997 111.132 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -126.22 132.16 51.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 62.420000000000002 111.105 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -129.36 160.02 34.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 72.200000000000003 110.855 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.483 HD21 ' CB ' ' A' ' 71' ' ' ASN . 18.9 tp -136.16 148.91 48.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 75.420000000000002 110.944 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.78 112.36 24.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.176 -0.465 . . . . 71.120000000000005 110.849 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.42 HG22 ' HA ' ' A' ' 37' ' ' ALA . 27.4 m -59.5 -35.6 59.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 74.230000000000004 111.144 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.55 -36.46 61.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 74.439999999999998 110.868 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.47 -35.22 13.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 72.299999999999997 111.091 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.483 ' CB ' HD21 ' A' ' 66' ' ' LEU . 1.7 m-80 -117.27 68.79 5.23 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.62 0.724 . . . . 74.030000000000001 110.884 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 -32.65 18.39 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.725 2.283 . . . . 61.530000000000001 112.384 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -65.23 -36.28 83.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 74.230000000000004 110.891 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.17 -44.81 96.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 75.439999999999998 111.138 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.674 ' HB1' ' HB ' ' A' ' 80' ' ' VAL . . . -52.57 -61.55 2.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 61.25 111.087 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.5 ttp180 -50.97 -34.79 30.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 73.510000000000005 110.9 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -51.89 -35.92 46.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.486 . . . . 72.400000000000006 110.859 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -108.87 27.89 9.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.449 . . . . 73.129999999999995 110.882 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 50.59 55.76 9.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.495 . . . . 61.530000000000001 110.906 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.674 ' HB ' ' HB1' ' A' ' 75' ' ' ALA . 91.0 t -92.24 104.97 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 50.43 111.115 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 57.4 t -96.44 -35.06 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 63.009999999999998 111.124 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.8 m -102.84 146.64 27.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 73.140000000000001 110.89 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.531 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 5.1 mt -58.19 -57.57 25.1 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.621 0.724 . . . . 71.109999999999999 111.144 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.637 ' CB ' ' HB2' ' A' ' 101' ' ' ALA . 53.5 Cg_endo -69.78 76.39 1.15 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.65 2.233 . . . . 74.25 112.33 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.669 HG23 ' CG1' ' A' ' 99' ' ' VAL . 73.6 m -113.99 134.95 54.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 72.329999999999998 111.112 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 14.2 ttt -133.85 126.42 30.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 64.239999999999995 110.883 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.0 mt -116.97 115.19 48.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 72.239999999999995 111.152 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.47 HD11 HD11 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -81.11 106.31 13.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 75.530000000000001 110.92 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -93.34 170.05 9.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 72.439999999999998 110.932 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -165.74 91.43 0.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 73.530000000000001 110.878 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.82 36.91 8.19 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.715 -0.755 . . . . 61.439999999999998 112.497 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.609 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 68.64 39.3 86.52 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.773 -0.727 . . . . 70.430000000000007 112.488 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.456 HG23 ' HD2' ' A' ' 94' ' ' PRO . 88.6 m -160.53 133.99 4.86 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.58 0.705 . . . . 72.209999999999994 111.156 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.456 ' HD2' HG23 ' A' ' 93' ' ' THR . 53.7 Cg_endo -69.79 109.56 2.35 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.661 2.241 . . . . 64.310000000000002 112.374 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.3 m -101.6 -32.99 3.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.46 . . . . 70.439999999999998 111.138 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.464 ' HD2' ' HB3' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -132.73 164.63 26.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.483 . . . . 62.340000000000003 110.906 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.441 ' C ' HD12 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -155.84 117.51 3.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 64.099999999999994 110.852 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.441 ' N ' HD12 ' A' ' 98' ' ' ILE . 4.7 mp -132.56 130.91 59.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 74.439999999999998 111.126 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.669 ' CG1' HG23 ' A' ' 85' ' ' THR . 11.1 m -138.16 145.39 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 73.319999999999993 111.129 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 146.39 -26.88 1.69 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.745 -0.74 . . . . 73.040000000000006 112.522 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.637 ' HB2' ' CB ' ' A' ' 84' ' ' PRO . . . 62.7 68.35 0.65 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.843 0.354 . . . . 74.549999999999997 111.09 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.2 169.1 9.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 74.409999999999997 110.897 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.77 150.16 39.48 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.744 -0.741 . . . . 52.420000000000002 112.47 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.576 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -48.39 -34.99 11.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.809 0.338 . . . . 73.310000000000002 110.88 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.16 -40.39 77.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 42.020000000000003 111.078 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.76 -49.8 6.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 63.32 111.131 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.7 -52.94 16.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 62.520000000000003 110.961 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.576 HD23 ' O ' ' A' ' 104' ' ' LYS . 1.6 pp -48.12 -35.58 11.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.468 . . . . 71.109999999999999 110.911 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 46.1 mtp85 -74.25 -42.24 59.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 75.5 110.865 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -51.48 -25.0 5.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 62.43 110.926 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.4 mt -87.68 -69.29 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 53.539999999999999 111.167 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -51.11 -49.39 60.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 74.129999999999995 110.873 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -58.91 -34.13 71.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 63.32 110.84 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.464 ' HB3' ' HD2' ' A' ' 96' ' ' LYS . . . -75.09 -35.64 61.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 64.219999999999999 111.116 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.4 mt . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 64.409999999999997 110.971 179.954 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.625 HG22 ' HB ' ' A' ' 63' ' ' VAL . 82.4 p . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.863 0.363 . . . . 73.439999999999998 111.121 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 98.6 t -150.16 143.68 17.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.225 -0.443 . . . . 75.409999999999997 111.093 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.8 t -67.71 126.98 31.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 75.430000000000007 111.131 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 74.7 t -94.82 130.44 43.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 72.239999999999995 111.13 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.599 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.72 160.52 7.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 61.229999999999997 111.161 -179.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -73.62 -41.52 62.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.255 -0.43 . . . . 74.040000000000006 110.846 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.6 m -70.39 -34.53 72.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 70.319999999999993 110.885 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.599 HG22 ' HB ' ' A' ' 16' ' ' THR . 7.3 t -85.19 -17.97 35.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 72.030000000000001 111.108 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.724 ' CE2' HG21 ' A' ' 24' ' ' VAL . 24.2 t80 -50.64 -31.23 15.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 62.25 110.859 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.436 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -71.74 -33.48 68.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.149 -0.478 . . . . 72.150000000000006 110.885 179.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.6 m -91.7 -16.23 27.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 73.129999999999995 111.182 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -93.36 -71.42 0.65 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 63.119999999999997 110.888 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.842 HG13 HG21 ' A' ' 31' ' ' VAL . 17.9 t -70.39 -70.3 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 71.450000000000003 111.165 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.589 HD23 ' HA3' ' A' ' 92' ' ' GLY . 7.6 mt -40.7 -60.21 1.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 75.530000000000001 110.886 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -50.36 -58.73 5.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 74.230000000000004 110.876 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.3 t -54.02 171.33 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 73.219999999999999 110.876 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -117.73 -40.96 2.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 74.140000000000001 110.836 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.478 HG22 ' HD2' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -53.05 159.47 1.91 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.59 0.71 . . . . 65.299999999999997 111.128 -179.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.478 ' HD2' HG22 ' A' ' 29' ' ' THR . 54.4 Cg_endo -69.7 131.08 20.57 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.715 2.276 . . . . 63.210000000000001 112.369 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.842 HG21 HG13 ' A' ' 24' ' ' VAL . 96.7 t -105.02 125.26 60.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 53.43 111.11 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.694 ' CD1' HD13 ' A' ' 61' ' ' LEU . 4.7 mt -102.23 100.65 10.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 63.43 110.887 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.3 p -98.55 133.57 40.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 64.430000000000007 111.172 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -115.49 99.55 7.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.225 -0.443 . . . . 75.019999999999996 110.839 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -90.47 89.39 7.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 64.430000000000007 110.887 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -145.87 -169.05 3.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.143 -0.48 . . . . 75.010000000000005 110.917 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.37 -156.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 72.109999999999999 111.099 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.476 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 5.3 m-20 -77.61 9.54 3.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.202 -0.453 . . . . 70.400000000000006 110.862 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.476 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 1.0 OUTLIER 41.87 71.08 0.23 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 74.409999999999997 110.935 -179.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 44.5 t -132.63 -45.51 0.89 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 73.420000000000002 110.915 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.75 -67.39 1.52 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.722 -0.751 . . . . 62.219999999999999 112.503 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -24.11 30.08 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.713 2.275 . . . . 71.230000000000004 112.326 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 11.9 p -51.92 -27.13 12.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 74.200000000000003 110.877 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? -61.52 -33.72 74.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 63.310000000000002 110.882 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 6.2 mtp -86.48 -36.52 18.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 73.329999999999998 110.889 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.521 ' HA ' HG22 ' A' ' 49' ' ' VAL . 2.9 t -94.04 21.2 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 74.329999999999998 111.126 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.754 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -76.79 -60.8 0.79 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.596 0.712 . . . . 73.019999999999996 111.051 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.754 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.6 Cg_endo -69.73 -49.13 0.59 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.672 2.248 . . . . 72.230000000000004 112.335 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.717 HG12 ' HG3' ' A' ' 104' ' ' LYS . 4.0 m -51.44 -29.18 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 63.229999999999997 111.155 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.4 tp -84.1 -36.02 23.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 63.039999999999999 110.898 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -71.68 -31.98 67.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 74.439999999999998 110.911 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -49.87 -68.2 0.2 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 74.099999999999994 110.895 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.483 ' H ' HD12 ' A' ' 53' ' ' ILE . 4.0 mp -51.45 -36.66 17.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.178 -0.465 . . . . 62.310000000000002 111.12 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.602 ' HA ' HD21 ' A' ' 61' ' ' LEU . . . . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 75.329999999999998 111.103 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.694 HD13 ' CD1' ' A' ' 32' ' ' LEU . 2.5 pp . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.855 0.359 . . . . 74.340000000000003 110.916 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.1 mtmp? -102.0 139.97 36.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.228 -0.442 . . . . 73.319999999999993 110.877 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.625 ' HB ' HG22 ' A' ' 12' ' ' THR . 21.7 t -120.55 104.33 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 74.349999999999994 111.141 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -104.5 121.47 43.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 55.039999999999999 111.122 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.87 131.42 54.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 64.340000000000003 110.896 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.512 HD21 ' CG ' ' A' ' 71' ' ' ASN . 44.0 tp -123.83 155.47 37.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.227 -0.442 . . . . 74.329999999999998 110.952 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.45 114.85 27.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 74.450000000000003 110.856 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 79.5 t -61.38 -35.27 65.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 71.549999999999997 111.126 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -51.86 -36.88 49.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 74.349999999999994 110.887 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.93 -34.46 13.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 64.209999999999994 111.072 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.512 ' CG ' HD21 ' A' ' 66' ' ' LEU . 1.8 m-80 -117.42 69.61 5.91 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.629 0.728 . . . . 72.150000000000006 110.892 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -32.31 18.81 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.744 2.296 . . . . 73.120000000000005 112.335 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -58.72 -37.58 76.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.438 . . . . 73.010000000000005 110.881 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.97 -47.88 67.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 53.109999999999999 111.065 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.56 ' O ' HG23 ' A' ' 80' ' ' VAL . . . -54.02 -63.47 1.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 75.349999999999994 111.047 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.5 ttp85 -51.56 -33.18 31.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 72.140000000000001 110.868 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -50.99 -39.98 56.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 43.399999999999999 110.873 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -104.39 24.15 12.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 64.040000000000006 110.905 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 47.85 66.55 1.01 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 61.549999999999997 110.911 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 75' ' ' ALA . 95.9 t -87.58 106.8 16.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 75.430000000000007 111.136 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.6 t -80.26 -58.39 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 64.230000000000004 111.139 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.3 m -91.65 163.28 14.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.468 . . . . 71.439999999999998 110.835 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.531 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 1.7 mp -65.3 -58.17 12.97 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.639 0.733 . . . . 54.43 111.133 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.7 Cg_endo -69.75 74.86 1.25 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.658 2.238 . . . . 72.420000000000002 112.374 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.507 ' OG1' HG13 ' A' ' 80' ' ' VAL . 99.7 m -113.87 106.0 13.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 74.230000000000004 111.119 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 9.4 ttp -116.16 121.84 43.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 74.310000000000002 110.865 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.0 mp -104.69 119.04 53.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 73.040000000000006 111.102 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.639 ' CD2' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -80.17 104.56 10.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 72.430000000000007 110.857 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -89.77 169.86 10.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 74.329999999999998 110.9 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -167.71 93.67 0.4 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 75.319999999999993 110.908 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.42 38.77 8.73 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.758 -0.734 . . . . 62.399999999999999 112.5 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.589 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 69.37 37.21 79.49 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.783 -0.722 . . . . 74.019999999999996 112.46 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.459 HG23 ' HD2' ' A' ' 94' ' ' PRO . 85.0 m -160.72 133.78 4.67 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.554 0.692 . . . . 74.140000000000001 111.138 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.459 ' HD2' HG23 ' A' ' 93' ' ' THR . 53.6 Cg_endo -69.74 83.01 0.71 Allowed 'Trans proline' 0 C--N 1.34 0.126 0 C-N-CA 122.703 2.269 . . . . 55.140000000000001 112.292 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.8 m -64.98 -33.88 66.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 73.329999999999998 111.133 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.66 170.22 16.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 63.299999999999997 110.91 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -153.35 127.44 9.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 62.210000000000001 110.881 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.472 HG23 ' HB3' ' A' ' 110' ' ' GLU . 5.3 mp -131.0 143.19 41.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.193 -0.458 . . . . 54.450000000000003 111.144 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -142.13 141.05 29.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 61.43 111.164 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 119.08 145.59 7.7 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.767 -0.73 . . . . 44.539999999999999 112.549 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -100.89 89.1 3.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.893 0.378 . . . . 61.25 111.109 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -120.55 179.87 4.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 74.340000000000003 110.866 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.8 175.26 13.07 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.735 -0.745 . . . . 72.310000000000002 112.525 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.717 ' HG3' HG12 ' A' ' 49' ' ' VAL . 1.6 mtpt -58.18 -47.78 82.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.768 0.318 . . . . 72.310000000000002 110.894 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -53.48 -65.83 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.449 . . . . 72.409999999999997 111.093 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.466 ' HB3' ' HB2' ' A' ' 102' ' ' LYS . . . -50.97 -57.66 8.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 61.030000000000001 111.116 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.572 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.4 OUTLIER -50.82 -34.97 29.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 63.530000000000001 110.938 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.455 HD23 ' C ' ' A' ' 108' ' ' LEU . 9.1 tt -69.42 -60.34 2.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 71.340000000000003 110.927 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 45.1 mtp85 -54.47 -34.35 61.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 73.209999999999994 110.87 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.472 ' HB3' HG23 ' A' ' 98' ' ' ILE . 14.0 mm-40 -49.35 -26.74 3.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 64.450000000000003 110.868 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.3 mt -84.12 -69.73 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 73.150000000000006 111.121 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.677 ' HA ' HD23 ' A' ' 115' ' ' LEU . 3.1 pt-20 -52.75 -50.06 64.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 73.099999999999994 110.895 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -55.92 -34.61 65.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.116 -0.493 . . . . 71.25 110.884 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.1 -36.82 69.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 74.109999999999999 111.096 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.677 HD23 ' HA ' ' A' ' 112' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 64.209999999999994 110.92 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.3 p . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.84 0.352 . . . . 53.340000000000003 111.152 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 65.5 t -148.63 142.19 18.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 72.219999999999999 111.13 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.3 t -77.04 128.7 34.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 71.310000000000002 111.14 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.423 ' CG1' HG23 ' A' ' 19' ' ' THR . 47.6 t -91.36 126.59 44.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 74.239999999999995 111.109 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.652 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.6 OUTLIER -59.65 165.99 2.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 63.43 111.182 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.41 ' H ' HG22 ' A' ' 16' ' ' THR . 25.1 t0 -68.37 -48.04 65.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 74.430000000000007 110.868 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.0 t -69.1 -52.93 23.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 65.25 110.87 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.652 HG22 ' HB ' ' A' ' 16' ' ' THR . 6.4 t -59.36 -19.01 43.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 62.539999999999999 111.143 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.711 ' CE2' HG21 ' A' ' 24' ' ' VAL . 24.6 t80 -51.03 -30.74 16.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 72.420000000000002 110.84 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.422 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -72.07 -34.13 68.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 65.299999999999997 110.91 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.0 m -91.19 -16.0 28.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 72.340000000000003 111.178 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.39 -71.33 0.66 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 61.219999999999999 110.875 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.711 HG21 ' CE2' ' A' ' 20' ' ' PHE . 18.6 t -70.4 -70.47 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 64.409999999999997 111.149 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.519 HD23 ' HA3' ' A' ' 92' ' ' GLY . 7.4 mt -40.64 -60.49 1.13 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 50.119999999999997 110.869 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -50.32 -63.71 1.03 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 65.439999999999998 110.889 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.3 t -56.11 150.87 13.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 71.239999999999995 110.848 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -98.88 -36.45 9.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 75.040000000000006 110.814 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -52.67 159.84 1.6 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.567 0.699 . . . . 64.109999999999999 111.152 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.84 127.43 14.53 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.629 2.219 . . . . 72.329999999999998 112.355 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.664 HG21 HG13 ' A' ' 24' ' ' VAL . 99.4 t -102.18 124.4 56.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 72.420000000000002 111.157 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.661 HD23 HD13 ' A' ' 61' ' ' LEU . 3.5 mm? -91.41 123.44 34.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 64.439999999999998 110.908 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.409 HG11 ' CE1' ' A' ' 35' ' ' PHE . 12.9 t -118.6 139.54 45.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.206 -0.452 . . . . 73.129999999999995 111.132 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.528 ' OD1' HD11 ' A' ' 50' ' ' LEU . 1.6 m-20 -131.4 99.83 4.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 74.299999999999997 110.893 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.541 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 32.1 m-85 -91.05 89.54 7.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.462 . . . . 74.340000000000003 110.867 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.437 ' O ' HG13 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -148.98 -169.27 3.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 72.519999999999996 110.923 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.594 ' HA ' HG22 ' A' ' 68' ' ' VAL . . . -60.08 -155.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.436 . . . . 64.200000000000003 111.103 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.473 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 18.7 p-10 -77.93 8.64 4.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 62.329999999999998 110.896 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.473 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 1.6 p-90 41.55 65.77 0.79 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.187 -0.46 . . . . 63.409999999999997 110.899 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 35.8 t -122.58 -46.38 2.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.233 -0.439 . . . . 70.140000000000001 110.875 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.7 -67.62 1.53 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.751 -0.738 . . . . 74.120000000000005 112.458 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -25.57 28.28 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.675 2.25 . . . . 64.25 112.359 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 28.9 t -51.49 -31.76 24.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 31.23 110.885 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.59 -33.5 71.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 54.009999999999998 110.895 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 7.0 mtt -88.13 -35.71 17.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 75.340000000000003 110.891 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.447 ' HA ' HG22 ' A' ' 49' ' ' VAL . 3.1 t -93.51 21.18 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 54.149999999999999 111.148 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.792 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -80.14 -61.41 0.44 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.531 0.681 . . . . 74.530000000000001 111.062 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.792 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 54.3 Cg_endo -69.69 -45.55 1.59 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.665 2.243 . . . . 73.219999999999999 112.375 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' A' ' 46' ' ' VAL . 4.4 m -49.37 -31.34 5.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 73.040000000000006 111.13 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.528 HD11 ' OD1' ' A' ' 34' ' ' ASP . 4.7 tt -88.25 -44.83 10.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 70.420000000000002 110.939 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -58.3 -33.8 69.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 73.439999999999998 110.911 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -63.17 -32.28 73.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.169 -0.469 . . . . 73.040000000000006 110.92 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.449 HD13 ' N ' ' A' ' 53' ' ' ILE . 4.3 mm -64.92 -34.53 71.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 75.340000000000003 111.103 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.422 ' HA ' HD21 ' A' ' 61' ' ' LEU . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 72.010000000000005 111.09 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.661 HD13 HD23 ' A' ' 32' ' ' LEU . 3.6 pp . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.901 0.382 . . . . 73.409999999999997 110.891 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.1 tptm -102.17 147.21 26.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 73.430000000000007 110.89 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.0 t -125.4 106.93 17.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 65.109999999999999 111.111 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -121.53 136.77 54.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 72.329999999999998 111.136 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -123.87 146.43 48.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 74.109999999999999 110.872 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.488 HD21 ' CB ' ' A' ' 71' ' ' ASN . 16.1 tp -127.03 152.09 47.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 63.25 110.918 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.588 ' OD2' ' HB3' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -103.29 121.23 42.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 70.310000000000002 110.885 179.85 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.594 HG22 ' HA ' ' A' ' 37' ' ' ALA . 33.1 m -62.24 -33.04 56.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 42.119999999999997 111.135 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -50.42 -35.77 30.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 60.219999999999999 110.926 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.588 ' HB3' ' OD2' ' A' ' 67' ' ' ASP . . . -100.26 -34.11 10.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 61.32 111.088 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.488 ' CB ' HD21 ' A' ' 66' ' ' LEU . 0.7 OUTLIER -121.32 68.07 19.14 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.594 0.711 . . . . 64.549999999999997 110.857 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -33.88 15.69 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.677 2.251 . . . . 63.530000000000001 112.334 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -58.41 -43.57 88.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 62.009999999999998 110.904 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.541 ' HB1' ' CE2' ' A' ' 35' ' ' PHE . . . -54.0 -48.6 70.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 72.340000000000003 111.111 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.568 ' O ' HG23 ' A' ' 80' ' ' VAL . . . -51.7 -68.17 0.19 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 65.230000000000004 111.092 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -50.97 -32.87 22.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 64.25 110.909 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -51.41 -34.54 35.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 74.430000000000007 110.847 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -112.03 26.08 10.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 73.439999999999998 110.865 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 69.9 mm-40 48.48 85.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 73.439999999999998 110.934 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.667 HG13 ' OG1' ' A' ' 85' ' ' THR . 95.1 t -105.96 111.43 35.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 75.5 111.117 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 22.1 t -81.9 -59.86 2.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 62.119999999999997 111.145 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 m -91.34 156.25 17.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 74.200000000000003 110.834 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.531 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 4.7 mt -60.15 -58.01 22.51 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.606 0.717 . . . . 73.329999999999998 111.112 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.7 Cg_endo -69.75 69.77 1.61 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.689 2.259 . . . . 52.399999999999999 112.297 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.742 HG23 HG22 ' A' ' 99' ' ' VAL . 43.7 m -103.98 132.53 50.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 72.200000000000003 111.187 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 17.5 ttp -130.82 143.83 51.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 72.519999999999996 110.861 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 63.1 mt -128.98 117.99 45.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 75.030000000000001 111.138 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.436 ' CD1' HG21 ' A' ' 111' ' ' ILE . 1.9 tt -88.24 105.72 17.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.454 . . . . 75.25 110.943 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -90.02 170.14 10.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 72.319999999999993 110.868 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.424 ' HB3' HG11 ' A' ' 95' ' ' VAL . 0.7 OUTLIER -165.53 92.29 0.54 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 62.32 110.862 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.15 41.36 7.09 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.731 -0.747 . . . . 54.109999999999999 112.487 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.519 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 67.89 35.96 85.72 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.709 -0.758 . . . . 42.140000000000001 112.506 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.457 HG23 ' HD2' ' A' ' 94' ' ' PRO . 86.2 m -161.0 133.86 4.57 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.633 0.73 . . . . 74.409999999999997 111.125 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.457 ' HD2' HG23 ' A' ' 93' ' ' THR . 53.9 Cg_endo -69.77 87.83 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.689 2.26 . . . . 74.329999999999998 112.336 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.424 HG11 ' HB3' ' A' ' 90' ' ' LYS . 28.8 m -70.49 -35.61 62.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 72.420000000000002 111.108 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.466 ' HE2' ' HB1' ' A' ' 114' ' ' ALA . 0.0 OUTLIER -140.7 170.19 16.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 75.099999999999994 110.875 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -155.91 122.76 5.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 72.540000000000006 110.877 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.435 ' N ' HD12 ' A' ' 98' ' ' ILE . 4.6 mp -124.93 132.64 71.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 63.030000000000001 111.146 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.742 HG22 HG23 ' A' ' 85' ' ' THR . 98.0 t -131.74 136.6 56.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 70.329999999999998 111.137 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 127.13 138.66 4.79 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 74.340000000000003 112.476 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.21 84.88 4.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.88 0.371 . . . . 75.329999999999998 111.103 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.06 -179.62 3.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 74.329999999999998 110.895 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.49 -169.74 1.42 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.761 -0.733 . . . . 71.5 112.478 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -79.96 -41.74 25.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.776 0.322 . . . . 75.329999999999998 110.884 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.74 -31.95 72.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 71.230000000000004 111.103 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.438 ' HA ' ' HG2' ' A' ' 109' ' ' ARG . . . -84.07 -60.22 2.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 34.530000000000001 111.093 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.657 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -50.67 -34.59 27.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 72.099999999999994 110.913 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.599 HD23 ' N ' ' A' ' 109' ' ' ARG . 5.8 tt -70.52 -60.51 2.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 62.340000000000003 110.947 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.599 ' N ' HD23 ' A' ' 108' ' ' LEU . 12.6 ptp180 -54.9 -33.01 61.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 74.420000000000002 110.842 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -54.07 -24.54 17.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 73.310000000000002 110.859 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.436 HG21 ' CD1' ' A' ' 88' ' ' LEU . 4.6 mt -85.97 -68.19 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 73.439999999999998 111.138 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -51.75 -49.07 63.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 61.109999999999999 110.902 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -56.18 -34.84 66.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 74.439999999999998 110.817 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.466 ' HB1' ' HE2' ' A' ' 96' ' ' LYS . . . -73.57 -34.74 65.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 61.210000000000001 111.086 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.5 mt . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.218 -0.447 . . . . 65.340000000000003 110.861 -179.926 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.3 p . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.801 0.334 . . . . 65.530000000000001 111.165 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.3 t -146.24 148.26 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 72.219999999999999 111.115 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 t -73.05 127.51 32.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 70.209999999999994 111.124 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 90.7 t -91.84 143.79 10.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 73.420000000000002 111.124 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.661 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.64 171.73 0.82 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 64.430000000000007 111.065 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.454 ' H ' HG22 ' A' ' 16' ' ' THR . 2.8 t70 -80.79 -48.32 12.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 61.439999999999998 110.879 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.0 t -67.9 -53.98 22.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 72.099999999999994 110.886 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.661 HG22 ' HB ' ' A' ' 16' ' ' THR . 5.0 t -58.83 -19.51 42.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.099 -0.501 . . . . 63.310000000000002 111.146 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.705 ' CE2' HG21 ' A' ' 24' ' ' VAL . 24.2 t80 -51.41 -30.85 20.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 73.230000000000004 110.868 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.432 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -71.88 -33.61 68.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.175 -0.466 . . . . 73.420000000000002 110.907 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.9 m -91.6 -16.17 27.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.169 -0.469 . . . . 75.349999999999994 111.12 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.9 -71.39 0.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 72.329999999999998 110.834 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.705 HG21 ' CE2' ' A' ' 20' ' ' PHE . 13.1 t -70.9 -70.11 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 73.109999999999999 111.152 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.666 HD23 ' O ' ' A' ' 91' ' ' GLY . 6.9 mt -40.44 -60.02 1.2 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 64.420000000000002 110.915 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -51.24 -65.19 0.6 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.227 -0.442 . . . . 73.019999999999996 110.887 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 56.7 m -54.52 153.72 5.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 71.510000000000005 110.851 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -97.02 -34.92 11.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.489 . . . . 54.119999999999997 110.874 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.2 t -50.15 141.47 15.37 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.56 0.695 . . . . 61.0 111.15 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 125.86 12.67 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.685 2.257 . . . . 54.240000000000002 112.369 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.538 HG22 ' HB3' ' A' ' 62' ' ' LYS . 91.2 t -97.93 128.39 49.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 60.149999999999999 111.155 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.437 HD11 HD11 ' A' ' 88' ' ' LEU . 6.5 mp -102.4 108.11 19.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 65.230000000000004 110.905 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.523 HG12 ' O ' ' A' ' 87' ' ' ILE . 7.4 p -97.13 145.44 9.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 53.329999999999998 111.121 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.57 112.19 13.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 64.349999999999994 110.838 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.681 ' CD2' HD22 ' A' ' 66' ' ' LEU . 75.5 m-85 -97.6 97.8 9.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 72.230000000000004 110.872 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -150.78 -168.07 3.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 75.109999999999999 110.888 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.8 -164.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 74.140000000000001 111.106 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.444 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 1.8 m-20 -77.92 12.45 1.76 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.259 -0.428 . . . . 75.299999999999997 110.883 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.46 ' CD1' ' N ' ' A' ' 39' ' ' TRP . 1.6 m0 77.66 94.51 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.475 . . . . 72.099999999999994 110.928 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -167.94 -63.74 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 74.549999999999997 110.87 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.38 -70.51 1.33 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.748 -0.739 . . . . 63.140000000000001 112.522 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -8.07 22.67 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.661 2.241 . . . . 73.120000000000005 112.349 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.503 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 31.4 t -90.34 -26.84 19.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 74.030000000000001 110.914 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -60.54 -30.59 69.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 71.129999999999995 110.888 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 9.6 ptp -88.05 -39.93 14.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 74.310000000000002 110.908 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.476 ' HA ' HG22 ' A' ' 49' ' ' VAL . 3.5 t -93.81 23.12 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 62.039999999999999 111.111 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.814 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -79.79 -61.38 0.46 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.576 0.703 . . . . 60.119999999999997 111.064 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.814 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 54.4 Cg_endo -69.69 -48.03 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.673 2.249 . . . . 63.229999999999997 112.366 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.666 ' O ' HD12 ' A' ' 53' ' ' ILE . 4.6 m -49.78 -31.15 6.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 74.129999999999995 111.128 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.49 -40.27 80.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 72.239999999999995 110.906 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -64.33 -36.62 84.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.443 . . . . 71.430000000000007 110.927 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -59.9 -68.06 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 73.219999999999999 110.915 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.666 HD12 ' O ' ' A' ' 49' ' ' VAL . 3.2 mt -50.44 -39.84 17.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 73.5 111.176 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.455 ' O ' HD22 ' A' ' 61' ' ' LEU . . . . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 53.43 111.071 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.455 HD22 ' O ' ' A' ' 54' ' ' ALA . 2.1 pt? . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.849 0.357 . . . . 62.210000000000001 110.921 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.538 ' HB3' HG22 ' A' ' 31' ' ' VAL . 24.0 tttp -99.97 141.74 32.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 71.310000000000002 110.868 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 37.7 t -146.43 131.54 11.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.257 -0.429 . . . . 23.449999999999999 111.144 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -152.91 138.05 17.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 74.219999999999999 111.146 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.3 mttp -114.08 159.93 19.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 61.409999999999997 110.903 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.681 HD22 ' CD2' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -135.85 141.03 44.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 63.43 110.918 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -93.95 113.46 25.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.472 . . . . 70.239999999999995 110.839 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.9 m -60.18 -35.12 59.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 75.299999999999997 111.149 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -53.97 -35.23 61.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 74.129999999999995 110.896 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.11 -35.55 10.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 73.400000000000006 111.095 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.524 ' HB2' HD21 ' A' ' 66' ' ' LEU . 1.4 m-80 -117.94 68.33 6.52 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.607 0.718 . . . . 63.329999999999998 110.85 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -32.16 19.0 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.687 2.258 . . . . 73.349999999999994 112.309 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -65.99 -43.34 88.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.274 -0.421 . . . . 72.239999999999995 110.878 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.35 -54.57 25.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 54.399999999999999 111.086 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.904 ' HB1' HG11 ' A' ' 80' ' ' VAL . . . -55.88 -60.19 3.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 62.130000000000003 111.136 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -51.63 -34.56 38.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 74.400000000000006 110.897 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -55.44 -36.16 66.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 70.140000000000001 110.851 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -99.35 20.84 12.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 74.540000000000006 110.87 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 48.6 mm-40 48.78 80.51 0.06 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 71.049999999999997 110.931 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.904 HG11 ' HB1' ' A' ' 75' ' ' ALA . 14.7 p -105.44 144.02 15.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 63.32 111.118 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 66.1 t -108.82 -72.25 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 61.020000000000003 111.137 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.4 t -79.71 157.86 27.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 71.400000000000006 110.853 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.534 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 4.6 mt -59.91 -58.0 22.64 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.635 0.731 . . . . 70.329999999999998 111.099 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.743 ' HB2' ' HB2' ' A' ' 101' ' ' ALA . 53.4 Cg_endo -69.74 71.75 1.49 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.648 2.232 . . . . 64.549999999999997 112.374 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.703 HG23 ' CG2' ' A' ' 99' ' ' VAL . 23.5 m -110.44 126.62 54.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 52.520000000000003 111.125 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.0 mtm -122.56 158.18 30.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 74.209999999999994 110.838 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.523 ' O ' HG12 ' A' ' 33' ' ' VAL . 34.0 mt -145.27 121.23 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 74.439999999999998 111.16 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.437 HD11 HD11 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -81.95 110.25 17.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 43.299999999999997 110.898 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -98.46 170.2 9.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 73.439999999999998 110.884 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -166.04 107.58 0.73 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 74.209999999999994 110.875 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.666 ' O ' HD23 ' A' ' 25' ' ' LEU . . . 68.37 35.76 82.84 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.738 -0.744 . . . . 71.099999999999994 112.511 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.646 ' H ' HG12 ' A' ' 24' ' ' VAL . . . 72.55 41.46 51.2 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.758 -0.734 . . . . 65.239999999999995 112.491 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.46 HG23 ' HD2' ' A' ' 94' ' ' PRO . 86.4 m -161.04 133.85 4.54 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.549 0.69 . . . . 74.230000000000004 111.182 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.46 ' HD2' HG23 ' A' ' 93' ' ' THR . 53.4 Cg_endo -69.74 103.05 1.1 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.722 2.281 . . . . 74.430000000000007 112.313 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.5 m -91.07 -32.58 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 72.409999999999997 111.147 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.417 ' HD2' ' HB3' ' A' ' 114' ' ' ALA . 1.6 mmtm -138.38 170.13 16.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 63.32 110.949 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.19 118.19 4.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 74.150000000000006 110.878 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.417 ' N ' HD12 ' A' ' 98' ' ' ILE . 4.8 mp -125.5 137.63 57.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 73.299999999999997 111.119 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.703 ' CG2' HG23 ' A' ' 85' ' ' THR . 66.8 t -147.81 136.15 15.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.472 . . . . 63.310000000000002 111.124 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 151.08 -27.58 1.0 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.734 -0.746 . . . . 72.340000000000003 112.475 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.743 ' HB2' ' HB2' ' A' ' 84' ' ' PRO . . . 63.46 72.68 0.47 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.849 0.357 . . . . 75.140000000000001 111.117 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.423 ' HG2' HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -118.88 174.82 6.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 71.140000000000001 110.857 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.66 173.63 4.45 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.729 -0.748 . . . . 54.43 112.483 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.52 -44.13 75.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.791 0.329 . . . . 70.040000000000006 110.898 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.55 -30.2 65.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 63.32 111.107 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.34 -59.55 2.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.268 -0.424 . . . . 61.219999999999999 111.116 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.468 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.3 OUTLIER -48.71 -44.16 37.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 64.140000000000001 110.891 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.456 HD23 ' C ' ' A' ' 108' ' ' LEU . 7.8 tt -50.27 -43.63 53.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 72.540000000000006 110.91 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -72.46 -37.55 68.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 61.299999999999997 110.91 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -49.85 -25.87 3.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 75.209999999999994 110.873 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.8 mt -86.18 -69.61 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 75.430000000000007 111.102 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.474 ' HA ' HD23 ' A' ' 115' ' ' LEU . 0.4 OUTLIER -52.5 -51.18 60.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 71.129999999999995 110.892 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -55.63 -33.87 64.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.157 -0.474 . . . . 61.049999999999997 110.815 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.417 ' HB3' ' HD2' ' A' ' 96' ' ' LYS . . . -71.9 -34.71 69.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 73.150000000000006 111.105 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' A' ' 112' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 63.299999999999997 110.925 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.5 p . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.791 0.329 . . . . 74.109999999999999 111.141 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 96.1 t -150.08 144.18 17.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.428 . . . . 65.019999999999996 111.118 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 t -84.1 127.53 33.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.459 . . . . 64.430000000000007 111.097 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.417 ' CG1' HG23 ' A' ' 19' ' ' THR . 47.6 t -94.88 126.0 47.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 73.030000000000001 111.109 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.659 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.6 OUTLIER -59.5 166.44 2.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 64.019999999999996 111.13 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.427 ' H ' HG22 ' A' ' 16' ' ' THR . 1.4 p30 -68.52 -48.33 64.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 71.420000000000002 110.844 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.1 m -68.48 -52.98 26.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 73.329999999999998 110.879 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.659 HG22 ' HB ' ' A' ' 16' ' ' THR . 6.8 t -59.66 -19.0 46.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.092 -0.504 . . . . 73.209999999999994 111.162 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.73 ' CE2' HG21 ' A' ' 24' ' ' VAL . 25.6 t80 -51.31 -30.8 19.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 75.150000000000006 110.878 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.462 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -72.69 -32.94 66.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 75.5 110.871 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.0 m -91.33 -17.1 26.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 74.109999999999999 111.098 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.405 ' HB3' HG11 ' A' ' 15' ' ' VAL . 7.6 t70 -93.63 -71.38 0.66 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 71.219999999999999 110.871 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.743 HG13 HG21 ' A' ' 31' ' ' VAL . 20.0 t -70.08 -70.78 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 35.119999999999997 111.136 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.637 HD23 ' HA3' ' A' ' 92' ' ' GLY . 10.6 mt -40.56 -59.8 1.27 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 73.109999999999999 110.933 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -50.86 -64.85 0.68 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 51.219999999999999 110.85 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.0 t -52.12 163.27 0.39 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 73.099999999999994 110.877 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -106.02 -40.85 5.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 70.409999999999997 110.838 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -51.79 159.69 1.28 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.581 0.705 . . . . 71.510000000000005 111.155 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 147.66 63.4 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.683 2.255 . . . . 62.100000000000001 112.372 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.743 HG21 HG13 ' A' ' 24' ' ' VAL . 97.0 t -123.14 115.5 45.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 51.530000000000001 111.149 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.699 HD22 ' HG ' ' A' ' 88' ' ' LEU . 7.5 mt -103.94 106.29 16.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 72.140000000000001 110.911 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 m -108.48 134.71 49.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 62.520000000000003 111.128 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.526 ' OD2' HD11 ' A' ' 50' ' ' LEU . 0.8 OUTLIER -100.22 99.12 9.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 63.329999999999998 110.85 179.915 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.711 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 5.5 m-85 -82.86 89.56 6.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 72.319999999999993 110.881 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -152.52 -169.19 3.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 74.310000000000002 110.915 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.44 -154.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 61.130000000000003 111.097 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.477 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 35.2 p-10 -77.44 8.94 3.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.434 . . . . 62.140000000000001 110.862 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.477 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 1.1 p-90 41.55 63.53 1.25 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 72.299999999999997 110.893 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 41.2 t -125.04 -45.89 1.84 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 63.200000000000003 110.891 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.59 -68.24 1.49 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.751 -0.738 . . . . 61.530000000000001 112.443 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -26.48 27.65 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.663 2.242 . . . . 74.420000000000002 112.317 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 34.8 t -50.49 -30.14 12.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 63.039999999999999 110.905 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.29 -30.3 17.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.148 -0.478 . . . . 73.510000000000005 110.861 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 16.4 mtt -88.75 -36.72 15.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 53.43 110.893 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.434 ' O ' HG12 ' A' ' 46' ' ' VAL . 3.3 t -92.74 21.3 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 64.329999999999998 111.153 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.779 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -68.95 -59.83 4.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.562 0.696 . . . . 71.319999999999993 111.113 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.779 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.5 Cg_endo -69.75 -45.56 1.55 Allowed 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.705 2.27 . . . . 73.439999999999998 112.353 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.82 HG13 ' HA ' ' A' ' 104' ' ' LYS . 26.3 t -55.37 -50.63 63.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 71.510000000000005 111.113 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.526 HD11 ' OD2' ' A' ' 34' ' ' ASP . 50.5 tp -52.94 -32.03 43.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.195 -0.457 . . . . 62.43 110.921 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.475 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 28.0 mm-40 -83.89 -35.27 24.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 61.409999999999997 110.893 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -51.91 -61.41 2.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 72.040000000000006 110.939 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.665 HD12 ' O ' ' A' ' 49' ' ' VAL . 3.0 mp -50.74 -32.83 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.478 . . . . 62.409999999999997 111.15 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.655 ' HA ' HD11 ' A' ' 61' ' ' LEU . . . . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.479 . . . . 72.540000000000006 111.048 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.655 HD11 ' HA ' ' A' ' 54' ' ' ALA . 2.3 pt? . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.853 0.359 . . . . 74.329999999999998 110.916 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.5 mttp -109.64 120.21 41.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 73.040000000000006 110.929 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.8 t -123.71 112.19 32.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 61.240000000000002 111.105 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -131.04 156.07 45.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 64.040000000000006 111.13 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.7 122.51 16.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 62.299999999999997 110.877 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.534 HD21 ' HB2' ' A' ' 71' ' ' ASN . 11.1 tp -103.28 155.46 18.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.246 -0.434 . . . . 72.120000000000005 110.897 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.414 ' OD1' ' HB3' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -112.54 103.14 11.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 72.129999999999995 110.874 179.824 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.702 HG12 ' HB2' ' A' ' 75' ' ' ALA . 30.7 m -51.11 -32.14 11.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 64.549999999999997 111.149 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.77 -35.58 23.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 75.329999999999998 110.862 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.414 ' HB3' ' OD1' ' A' ' 67' ' ' ASP . . . -105.17 -33.31 8.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.448 . . . . 65.310000000000002 111.097 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.534 ' HB2' HD21 ' A' ' 66' ' ' LEU . 0.4 OUTLIER -120.91 71.75 21.26 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.6 0.714 . . . . 64.109999999999999 110.869 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -32.04 19.39 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.664 2.243 . . . . 73.409999999999997 112.341 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -51.71 -34.52 39.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 73.120000000000005 110.893 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.711 ' HB1' ' CE2' ' A' ' 35' ' ' PHE . . . -68.77 -46.47 68.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.479 . . . . 65.129999999999995 111.094 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.838 ' HB1' HG11 ' A' ' 80' ' ' VAL . . . -55.31 -65.93 0.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.437 . . . . 74.439999999999998 111.069 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -51.04 -32.72 22.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 71.319999999999993 110.886 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.62 -42.14 61.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 75.450000000000003 110.896 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -98.53 20.75 12.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 54.030000000000001 110.898 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 62.9 mm-40 47.41 79.55 0.06 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.474 . . . . 72.400000000000006 110.88 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.838 HG11 ' HB1' ' A' ' 75' ' ' ALA . 14.2 p -106.48 140.96 22.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 74.239999999999995 111.135 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.49 -35.49 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 75.510000000000005 111.135 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.7 t -105.85 151.88 23.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 65.310000000000002 110.885 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.531 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 5.3 mt -55.62 -58.04 17.86 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.64 0.733 . . . . 73.349999999999994 111.119 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.5 Cg_endo -69.76 99.17 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.667 2.245 . . . . 73.349999999999994 112.314 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 1.001 HG23 HG12 ' A' ' 99' ' ' VAL . 43.3 m -142.39 137.05 30.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 62.219999999999999 111.149 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 32.7 ttp -137.33 131.78 32.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 73.420000000000002 110.907 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 10.9 mm -108.2 110.93 33.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 72.340000000000003 111.1 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.699 ' HG ' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -79.59 100.27 7.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.178 -0.464 . . . . 65.420000000000002 110.896 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -89.58 170.32 10.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 75.230000000000004 110.904 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -166.33 89.59 0.4 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 64.230000000000004 110.902 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.86 39.41 8.7 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.758 -0.734 . . . . 62.450000000000003 112.499 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.637 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 68.72 41.63 82.69 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.74 -0.743 . . . . 71.109999999999999 112.484 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.7 m -161.79 131.31 3.25 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.558 0.694 . . . . 74.120000000000005 111.138 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 86.59 0.57 Allowed 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.675 2.25 . . . . 72.140000000000001 112.39 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.9 m -73.37 -32.24 36.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 60.030000000000001 111.116 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.49 ' HD2' ' HB3' ' A' ' 114' ' ' ALA . 10.9 mmtm -143.38 170.17 16.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 71.019999999999996 110.896 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -158.36 103.56 1.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 73.409999999999997 110.825 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.429 ' N ' HD12 ' A' ' 98' ' ' ILE . 4.6 mp -113.75 132.71 61.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 61.530000000000001 111.113 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 1.001 HG12 HG23 ' A' ' 85' ' ' THR . 3.0 m -128.06 141.6 46.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 74.140000000000001 111.141 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 128.06 142.35 5.44 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.741 -0.743 . . . . 73.519999999999996 112.532 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -96.25 89.2 5.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.873 0.368 . . . . 50.450000000000003 111.108 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.51 ' HB2' ' HB3' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -123.03 -175.39 3.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 62.43 110.959 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.23 -174.79 28.44 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.728 -0.748 . . . . 61.210000000000001 112.481 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.82 ' HA ' HG13 ' A' ' 49' ' ' VAL . 0.4 OUTLIER -70.96 -46.47 62.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.761 0.315 . . . . 72.019999999999996 110.876 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.24 -22.24 65.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 73.239999999999995 111.08 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.51 ' HB3' ' HB2' ' A' ' 102' ' ' LYS . . . -91.28 -60.51 1.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 40.25 111.053 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.478 HD23 ' HG2' ' A' ' 102' ' ' LYS . 0.2 OUTLIER -53.7 -31.28 47.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.248 -0.433 . . . . 74.319999999999993 110.883 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.594 HD23 ' N ' ' A' ' 109' ' ' ARG . 5.7 tt -73.32 -59.64 2.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 73.209999999999994 110.9 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.594 ' N ' HD23 ' A' ' 108' ' ' LEU . 15.6 ptm180 -52.85 -34.04 52.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 65.519999999999996 110.845 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.401 ' HG3' ' HE2' ' A' ' 102' ' ' LYS . 49.9 mm-40 -56.8 -25.0 54.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 63.420000000000002 110.847 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.2 mt -84.58 -65.81 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 62.509999999999998 111.129 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -53.12 -48.24 68.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.433 . . . . 70.329999999999998 110.871 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -54.56 -34.46 61.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.476 . . . . 72.409999999999997 110.86 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.49 ' HB3' ' HD2' ' A' ' 96' ' ' LYS . . . -73.07 -34.74 66.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 65.420000000000002 111.096 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.8 mt . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 75.299999999999997 110.865 -179.932 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.506 HG22 ' HB ' ' A' ' 63' ' ' VAL . 59.5 p . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.841 0.353 . . . . 75.510000000000005 111.117 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.4 m -152.13 163.57 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.251 -0.431 . . . . 74.209999999999994 111.124 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.475 ' OG1' HD13 ' A' ' 66' ' ' LEU . 9.8 t -75.66 127.62 33.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.16 -0.473 . . . . 74.519999999999996 111.172 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.479 HG21 ' OD1' ' A' ' 23' ' ' ASP . 99.8 t -93.18 136.63 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 74.239999999999995 111.146 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.565 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -60.03 176.05 0.35 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 64.129999999999995 111.127 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.42 ' H ' HG22 ' A' ' 16' ' ' THR . 3.8 p-10 -81.06 -49.14 11.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 71.430000000000007 110.835 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.3 t -68.07 -54.27 19.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 44.5 110.872 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.565 HG22 ' HB ' ' A' ' 16' ' ' THR . 5.7 t -58.24 -19.37 33.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.138 -0.483 . . . . 75.340000000000003 111.168 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.724 ' CE2' HG21 ' A' ' 24' ' ' VAL . 24.9 t80 -50.82 -31.19 16.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 74.409999999999997 110.889 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.413 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.7 OUTLIER -71.54 -34.27 69.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.474 . . . . 73.510000000000005 110.898 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.2 m -91.04 -15.55 29.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 72.420000000000002 111.151 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.479 ' OD1' HG21 ' A' ' 15' ' ' VAL . 29.5 t70 -93.56 -71.1 0.67 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 74.400000000000006 110.855 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.841 HG13 HG21 ' A' ' 31' ' ' VAL . 17.9 t -71.04 -70.43 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 53.140000000000001 111.116 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.58 HD23 ' HA3' ' A' ' 92' ' ' GLY . 7.3 mt -40.55 -59.39 1.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 73.209999999999994 110.952 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -51.14 -62.41 1.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.476 . . . . 74.209999999999994 110.843 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.2 p -52.72 152.63 3.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 71.030000000000001 110.883 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -101.6 -37.79 8.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.112 -0.495 . . . . 64.25 110.829 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.94 159.69 1.76 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.589 0.709 . . . . 62.439999999999998 111.121 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 123.98 10.62 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.692 2.261 . . . . 62.109999999999999 112.335 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.841 HG21 HG13 ' A' ' 24' ' ' VAL . 97.8 t -97.39 123.87 50.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 65.230000000000004 111.112 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.468 HD21 HD13 ' A' ' 88' ' ' LEU . 3.3 mm? -103.5 100.0 9.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 72.129999999999995 110.899 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.1 p -95.18 135.09 30.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 61.43 111.137 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.13 99.72 7.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 75.230000000000004 110.876 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -91.41 89.84 7.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.458 . . . . 63.140000000000001 110.887 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.52 ' HH2' HD11 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -147.8 -169.65 3.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.165 -0.471 . . . . 74.430000000000007 110.919 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.52 ' HA ' HG22 ' A' ' 68' ' ' VAL . . . -61.72 -153.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 53.299999999999997 111.085 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.486 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 22.8 t0 -77.16 9.44 3.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 70.329999999999998 110.848 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.486 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 0.9 OUTLIER 42.01 67.02 0.62 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.166 -0.47 . . . . 71.540000000000006 110.911 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 46.8 t -127.74 -44.7 1.49 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.429 . . . . 71.209999999999994 110.935 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.92 -68.03 1.5 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.755 -0.736 . . . . 42.329999999999998 112.519 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -30.84 21.78 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.655 2.237 . . . . 72.329999999999998 112.312 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 42.8 t -56.08 -24.13 38.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.246 -0.434 . . . . 35.310000000000002 110.869 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 50.4 mttt -50.79 -39.5 52.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 75.230000000000004 110.906 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.457 ' HG3' HG23 ' A' ' 46' ' ' VAL . 12.2 ptm -90.12 -29.3 18.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 75.209999999999994 110.886 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.474 ' HA ' HG22 ' A' ' 49' ' ' VAL . 3.4 t -92.55 21.79 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 71.340000000000003 111.11 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.783 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -80.01 -61.08 0.46 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.578 0.704 . . . . 75.530000000000001 111.116 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.783 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.6 Cg_endo -69.76 -46.7 1.13 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.642 2.228 . . . . 52.140000000000001 112.321 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.589 ' O ' HD12 ' A' ' 53' ' ' ILE . 4.3 m -50.5 -30.14 7.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 41.420000000000002 111.109 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.52 HD11 ' HH2' ' A' ' 36' ' ' TRP . 10.8 mt -69.23 -39.08 78.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 73.349999999999994 110.909 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.53 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 4.0 mm-40 -72.77 -32.45 65.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 74.319999999999993 110.858 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -49.74 -58.62 4.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 72.530000000000001 110.882 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.589 HD12 ' O ' ' A' ' 49' ' ' VAL . 3.0 mp -50.38 -32.12 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 74.030000000000001 111.125 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 51' ' ' GLU . . . . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 54.420000000000002 111.103 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.647 ' C ' HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.913 0.387 . . . . 73.040000000000006 110.901 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.551 ' N ' HD22 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -123.69 148.68 46.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 63.420000000000002 110.933 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.506 ' HB ' HG22 ' A' ' 12' ' ' THR . 21.5 t -125.49 102.06 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 64.209999999999994 111.17 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -99.98 138.42 37.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 72.340000000000003 111.084 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.1 pttp -135.64 111.2 9.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 71.129999999999995 110.914 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.475 HD13 ' OG1' ' A' ' 14' ' ' THR . 27.9 tp -107.75 160.32 15.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 70.140000000000001 110.88 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.613 ' OD2' ' HB3' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -104.01 119.85 39.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 75.310000000000002 110.891 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.52 HG22 ' HA ' ' A' ' 37' ' ' ALA . 27.0 m -63.1 -33.49 61.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 63.310000000000002 111.129 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -50.59 -36.13 33.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 62.420000000000002 110.852 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.613 ' HB3' ' OD2' ' A' ' 67' ' ' ASP . . . -98.38 -35.39 10.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 72.439999999999998 111.086 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -120.39 67.6 13.42 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.579 0.704 . . . . 74.409999999999997 110.902 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -33.58 16.56 Favored 'Trans proline' 0 C--N 1.34 0.127 0 C-N-CA 122.687 2.258 . . . . 65.120000000000005 112.377 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -52.21 -52.06 54.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 72.299999999999997 110.877 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.44 -46.13 66.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 75.140000000000001 111.081 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.68 ' HB1' HG11 ' A' ' 80' ' ' VAL . . . -51.47 -70.48 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 60.140000000000001 111.115 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 -51.34 -32.11 24.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 72.340000000000003 110.863 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -51.69 -44.4 63.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 73.219999999999999 110.889 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -95.66 18.99 11.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 62.310000000000002 110.896 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 48.25 72.85 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 65.140000000000001 110.898 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.68 HG11 ' HB1' ' A' ' 75' ' ' ALA . 14.6 p -99.3 131.77 45.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 62.119999999999997 111.154 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.1 t -88.89 -74.03 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 73.200000000000003 111.112 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.86 158.75 29.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 60.32 110.828 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.52 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 1.3 mp -65.75 -58.37 11.62 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.635 0.731 . . . . 73.129999999999995 111.159 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.8 Cg_endo -69.77 71.33 1.53 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.709 2.273 . . . . 55.340000000000003 112.355 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 89.1 m -113.73 139.16 49.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 72.129999999999995 111.159 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 37.4 ttp -135.25 112.74 10.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 73.299999999999997 110.903 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.5 mt -90.04 128.08 42.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.429 . . . . 71.230000000000004 111.122 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.468 HD13 HD21 ' A' ' 32' ' ' LEU . 10.0 tp -92.27 105.78 17.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 63.219999999999999 110.97 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -91.86 170.98 9.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 73.329999999999998 110.834 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -165.67 91.9 0.51 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 72.340000000000003 110.915 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.34 36.14 8.32 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.749 -0.739 . . . . 62.210000000000001 112.53 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.58 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 69.48 38.59 79.73 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.752 -0.737 . . . . 63.140000000000001 112.452 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.46 HG23 ' HD2' ' A' ' 94' ' ' PRO . 86.4 m -161.12 133.91 4.53 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.592 0.71 . . . . 73.140000000000001 111.152 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.46 ' HD2' HG23 ' A' ' 93' ' ' THR . 53.3 Cg_endo -69.79 107.26 1.82 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.723 2.282 . . . . 72.150000000000006 112.322 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 16.5 m -94.13 -32.69 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 73.420000000000002 111.153 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.509 ' HE3' ' HB1' ' A' ' 114' ' ' ALA . 23.5 mmtm -152.61 170.38 20.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 73.439999999999998 110.92 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.417 ' C ' HD12 ' A' ' 98' ' ' ILE . 0.2 OUTLIER -154.29 131.72 11.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 71.540000000000006 110.843 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.434 ' N ' HD12 ' A' ' 98' ' ' ILE . 4.1 mp -126.01 141.85 44.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 75.219999999999999 111.131 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.6 p -150.23 143.31 17.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 65.099999999999994 111.132 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.52 -27.32 1.35 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.765 -0.731 . . . . 63.32 112.518 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 61.82 72.5 0.5 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.817 0.341 . . . . 60.32 111.104 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.44 ' HB2' ' HB3' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -119.38 -179.2 3.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 75.230000000000004 110.873 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.72 178.84 2.3 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.724 -0.751 . . . . 52.030000000000001 112.515 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.64 -36.12 73.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.771 0.32 . . . . 63.020000000000003 110.887 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.61 -32.65 74.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 62.210000000000001 111.112 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.44 ' HB3' ' HB2' ' A' ' 102' ' ' LYS . . . -86.57 -56.38 3.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 64.109999999999999 111.113 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.579 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.4 OUTLIER -52.24 -34.16 44.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 74.510000000000005 110.914 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.601 HD23 ' N ' ' A' ' 109' ' ' ARG . 5.2 tt -70.05 -59.26 3.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.231 -0.441 . . . . 73.439999999999998 110.911 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.601 ' N ' HD23 ' A' ' 108' ' ' LEU . 3.0 ptm180 -56.14 -34.5 66.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 73.409999999999997 110.888 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -52.8 -25.63 11.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 72.109999999999999 110.88 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.6 mt -84.72 -68.43 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.483 . . . . 61.409999999999997 111.143 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -51.93 -49.75 62.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 75.310000000000002 110.885 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -53.82 -35.01 60.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 61.549999999999997 110.851 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.509 ' HB1' ' HE3' ' A' ' 96' ' ' LYS . . . -72.98 -35.83 66.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 74.340000000000003 111.071 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.1 mt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 63.420000000000002 110.966 -179.988 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.8 p . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.862 0.363 . . . . 73.519999999999996 111.144 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 91.7 t -149.96 144.49 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 64.299999999999997 111.116 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 t -82.44 127.16 33.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 72.010000000000005 111.129 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.2 t -92.66 131.64 39.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 63.450000000000003 111.103 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.484 ' CB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.7 179.23 0.13 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.112 -0.495 . . . . 45.450000000000003 111.124 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.441 ' H ' HG22 ' A' ' 16' ' ' THR . 1.1 m-20 -81.05 -49.8 10.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 75.120000000000005 110.934 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.0 m -69.3 -52.99 22.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 63.149999999999999 110.835 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.484 HG22 ' CB ' ' A' ' 16' ' ' THR . 5.3 t -58.29 -19.5 35.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 75.099999999999994 111.147 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.724 ' CE2' HG21 ' A' ' 24' ' ' VAL . 27.3 t80 -51.22 -31.85 21.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 74.019999999999996 110.869 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.432 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -72.04 -32.82 67.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 54.399999999999999 110.876 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.4 m -90.94 -16.58 27.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 75.150000000000006 111.144 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -93.96 -70.76 0.69 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 64.030000000000001 110.879 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.724 HG21 ' CE2' ' A' ' 20' ' ' PHE . 18.8 t -70.2 -70.48 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 65.209999999999994 111.092 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.45 HD23 ' O ' ' A' ' 91' ' ' GLY . 8.3 mt -41.09 -60.35 1.24 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 62.119999999999997 110.932 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -49.82 -63.05 1.23 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 73.409999999999997 110.864 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 59.6 m -48.85 -34.68 13.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 72.530000000000001 110.818 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.0 t0 59.51 30.88 20.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 54.299999999999997 110.897 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.24 160.62 36.75 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.552 0.692 . . . . 73.519999999999996 111.188 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 111.8 2.9 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.666 2.244 . . . . 44.149999999999999 112.349 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.404 HG22 ' HB3' ' A' ' 62' ' ' LYS . 89.7 t -102.88 117.42 48.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 62.229999999999997 111.087 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.1 mt -79.89 102.33 9.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 74.310000000000002 110.888 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.509 HG11 ' CE1' ' A' ' 35' ' ' PHE . 43.1 t -89.71 137.37 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 75.150000000000006 111.11 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -122.46 99.23 6.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.485 . . . . 74.129999999999995 110.892 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.509 ' CE1' HG11 ' A' ' 33' ' ' VAL . 15.1 m-85 -96.72 89.82 5.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 71.340000000000003 110.885 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -151.18 -169.13 3.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.092 -0.504 . . . . 74.219999999999999 110.925 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.66 -154.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 53.009999999999998 111.1 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.477 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 23.9 t0 -77.33 8.74 3.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 70.209999999999994 110.909 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.477 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 1.3 p-90 41.5 64.87 0.94 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 44.340000000000003 110.949 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 4.0 p -124.87 -44.5 1.93 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.273 -0.421 . . . . 71.540000000000006 110.868 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.55 -69.33 1.4 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.755 -0.736 . . . . 72.510000000000005 112.473 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -26.33 27.67 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.697 2.265 . . . . 75.209999999999994 112.317 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 26.1 t -49.9 -31.09 11.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 53.340000000000003 110.889 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -51.94 -29.86 22.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 73.049999999999997 110.842 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 51.6 mmm -89.99 -38.2 13.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 62.450000000000003 110.863 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 1.014 HG12 HD23 ' A' ' 50' ' ' LEU . 3.3 t -92.44 22.72 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 74.349999999999994 111.129 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.772 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -79.12 -60.92 0.52 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.584 0.707 . . . . 54.310000000000002 111.064 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.772 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.7 Cg_endo -69.8 -48.45 0.71 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.701 2.268 . . . . 55.439999999999998 112.312 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.676 ' O ' HD12 ' A' ' 53' ' ' ILE . 4.7 m -50.45 -29.91 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.433 . . . . 74.219999999999999 111.129 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.014 HD23 HG12 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -70.74 -39.59 73.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 72.349999999999994 110.951 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -70.99 -34.38 71.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 54.520000000000003 110.847 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -51.55 -68.76 0.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 60.5 110.873 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.676 HD12 ' O ' ' A' ' 49' ' ' VAL . 2.7 mp -50.43 -34.42 11.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 55.049999999999997 111.131 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.795 ' HA ' HD21 ' A' ' 61' ' ' LEU . . . . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.176 -0.466 . . . . 34.539999999999999 111.124 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.795 HD21 ' HA ' ' A' ' 54' ' ' ALA . 3.7 pp . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.903 0.382 . . . . 70.140000000000001 110.873 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.404 ' HB3' HG22 ' A' ' 31' ' ' VAL . 14.0 tttp -93.34 146.87 23.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 64.219999999999999 110.893 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -141.26 123.76 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 70.540000000000006 111.129 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -134.89 140.56 45.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 71.140000000000001 111.121 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.71 140.61 51.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 72.129999999999995 110.878 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.583 HD21 ' HB2' ' A' ' 71' ' ' ASN . 4.0 tt -123.21 150.73 43.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 64.409999999999997 110.914 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.658 ' OD2' ' HB3' ' A' ' 70' ' ' ALA . 0.5 OUTLIER -105.4 103.78 13.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 73.150000000000006 110.857 179.88 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.65 HG12 ' HB2' ' A' ' 75' ' ' ALA . 13.4 m -51.42 -33.33 14.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 73.209999999999994 111.104 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.85 -35.44 32.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 75.099999999999994 110.88 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.658 ' HB3' ' OD2' ' A' ' 67' ' ' ASP . . . -103.16 -34.26 8.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 64.430000000000007 111.088 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.583 ' HB2' HD21 ' A' ' 66' ' ' LEU . 0.7 OUTLIER -118.92 67.35 8.05 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.657 0.742 . . . . 75.010000000000005 110.907 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -34.19 15.04 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.707 2.272 . . . . 64.120000000000005 112.285 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -52.01 -46.36 64.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 73.409999999999997 110.891 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.24 -42.58 86.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 72.420000000000002 111.122 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.65 ' HB2' HG12 ' A' ' 68' ' ' VAL . . . -55.52 -68.59 0.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 62.140000000000001 111.06 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -51.2 -31.76 21.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 72.030000000000001 110.854 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -51.08 -36.73 41.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 74.519999999999996 110.866 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -108.77 23.85 13.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 74.219999999999999 110.924 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 70.8 mm-40 48.2 67.65 0.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 72.349999999999994 110.871 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 75' ' ' ALA . 99.4 t -87.5 113.34 24.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.478 . . . . 75.230000000000004 111.1 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.1 t -78.79 -66.88 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 74.519999999999996 111.12 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.45 162.58 17.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 74.329999999999998 110.845 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.53 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.4 mt -65.06 -58.12 13.59 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.636 0.731 . . . . 72.140000000000001 111.118 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.8 Cg_endo -69.8 70.28 1.61 Allowed 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.656 2.237 . . . . 61.310000000000002 112.316 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.499 ' OG1' HG13 ' A' ' 80' ' ' VAL . 99.2 m -108.13 100.02 9.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 53.229999999999997 111.125 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.5 ttt -99.75 118.31 35.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 64.510000000000005 110.856 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.462 HD12 ' CD1' ' A' ' 35' ' ' PHE . 51.4 mt -98.17 131.49 45.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 53.130000000000003 111.102 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.629 HD12 HG21 ' A' ' 111' ' ' ILE . 0.4 OUTLIER -96.37 103.98 15.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 61.109999999999999 110.964 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -90.02 167.72 12.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 71.120000000000005 110.86 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -170.37 119.58 0.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 73.239999999999995 110.877 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.45 ' O ' HD23 ' A' ' 25' ' ' LEU . . . 66.33 30.99 77.67 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.735 -0.745 . . . . 64.120000000000005 112.485 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.411 ' H ' HG12 ' A' ' 24' ' ' VAL . . . 73.37 53.57 7.49 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.795 -0.717 . . . . 52.5 112.458 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 178.92 139.35 0.27 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.554 0.692 . . . . 74.519999999999996 111.143 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.84 84.88 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.676 2.251 . . . . 64.450000000000003 112.322 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.9 m -64.14 -33.84 65.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 73.010000000000005 111.138 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -152.84 170.28 20.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 64.0 110.907 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.44 ' C ' HD12 ' A' ' 98' ' ' ILE . 27.4 ttt180 -151.68 130.86 12.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 70.310000000000002 110.926 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.44 HD12 ' C ' ' A' ' 97' ' ' ARG . 4.5 mp -130.08 135.75 60.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 72.510000000000005 111.16 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -125.29 140.6 47.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 73.209999999999994 111.125 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 127.98 131.05 3.4 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.751 -0.738 . . . . 72.420000000000002 112.478 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.09 70.92 10.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.835 0.35 . . . . 71.239999999999995 111.082 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.439 ' HG2' HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -107.47 171.9 7.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 75.140000000000001 110.909 179.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.04 173.62 6.15 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.729 -0.748 . . . . 51.119999999999997 112.496 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.88 -44.93 91.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.766 0.317 . . . . 72.030000000000001 110.855 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.93 -64.11 0.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 61.43 111.124 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.44 -57.9 9.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 73.430000000000007 111.144 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.466 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.2 OUTLIER -51.25 -42.49 61.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 72.310000000000002 110.955 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.478 ' O ' HD12 ' A' ' 108' ' ' LEU . 4.1 tp -63.6 -55.42 23.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 50.409999999999997 110.879 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.7 mtm180 -51.71 -42.0 61.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 73.319999999999993 110.888 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -51.86 -26.09 9.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 62.219999999999999 110.9 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.629 HG21 HD12 ' A' ' 88' ' ' LEU . 2.9 mt -85.14 -68.65 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 55.229999999999997 111.084 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.53 -49.17 62.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 74.409999999999997 110.862 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -56.95 -34.92 68.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 51.149999999999999 110.884 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.22 -37.51 66.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 73.0 111.085 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.0 mt . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.437 . . . . 74.310000000000002 110.932 -179.956 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.2 p . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.83 0.347 . . . . 63.020000000000003 111.152 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.2 m -153.45 163.67 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 74.430000000000007 111.143 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 t -66.56 126.98 30.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 62.420000000000002 111.135 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.43 HG23 ' CB ' ' A' ' 64' ' ' ALA . 60.6 t -94.76 127.6 46.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.449 . . . . 73.450000000000003 111.106 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.49 ' CB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.51 179.08 0.12 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 73.129999999999995 111.119 -179.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.461 ' H ' HG22 ' A' ' 16' ' ' THR . 1.3 p30 -79.98 -48.11 13.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 73.120000000000005 110.871 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.2 m -70.99 -51.56 24.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 73.519999999999996 110.867 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.49 HG22 ' CB ' ' A' ' 16' ' ' THR . 5.9 t -59.57 -19.32 47.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.148 -0.478 . . . . 63.329999999999998 111.144 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.729 ' CE2' HG21 ' A' ' 24' ' ' VAL . 25.1 t80 -51.26 -30.8 18.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 74.519999999999996 110.86 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.41 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -72.1 -33.63 68.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.473 . . . . 74.120000000000005 110.907 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.2 m -91.43 -16.04 27.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 65.109999999999999 111.143 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -93.46 -71.24 0.66 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 63.039999999999999 110.835 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.74 HG13 HG21 ' A' ' 31' ' ' VAL . 18.6 t -70.47 -70.47 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 75.430000000000007 111.146 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.41 ' HB2' ' HA ' ' A' ' 21' ' ' LYS . 7.4 mt -40.66 -60.11 1.22 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 75.299999999999997 110.949 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -50.46 -57.43 8.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 74.299999999999997 110.848 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.8 t -51.84 153.15 2.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 74.340000000000003 110.868 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -102.17 -49.4 3.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 55.539999999999999 110.911 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -51.87 159.7 1.31 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 121.624 0.726 . . . . 73.409999999999997 111.094 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 120.08 6.93 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.695 2.263 . . . . 64.540000000000006 112.321 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.74 HG21 HG13 ' A' ' 24' ' ' VAL . 97.6 t -83.35 142.74 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 75.549999999999997 111.105 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.468 HD23 HD11 ' A' ' 61' ' ' LEU . 3.8 mm? -111.9 112.64 24.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.467 . . . . 72.200000000000003 110.934 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.46 HG11 ' CE1' ' A' ' 35' ' ' PHE . 70.8 t -100.61 142.78 15.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 71.519999999999996 111.158 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -133.84 99.79 4.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 71.310000000000002 110.826 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.46 ' CE1' HG11 ' A' ' 33' ' ' VAL . 21.0 m-85 -91.72 89.77 7.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 65.400000000000006 110.892 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -141.66 -168.22 2.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 74.140000000000001 110.955 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.68 -164.76 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 63.240000000000002 111.091 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.456 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 1.5 t70 -77.67 11.98 1.86 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 71.519999999999996 110.87 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.482 ' N ' ' CD1' ' A' ' 39' ' ' TRP . 1.2 m0 76.35 94.76 0.07 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.194 -0.457 . . . . 74.319999999999993 110.886 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -169.68 -65.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 60.030000000000001 110.904 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -70.73 -70.28 1.22 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.761 -0.733 . . . . 73.140000000000001 112.491 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.47 ' O ' HG23 ' A' ' 46' ' ' VAL . 53.2 Cg_endo -69.81 -41.37 4.27 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.73 2.287 . . . . 70.549999999999997 112.278 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.55 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 31.7 t -51.94 -32.57 33.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.445 . . . . 53.350000000000001 110.859 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 18.5 mtpt -62.4 -34.79 77.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 75.5 110.925 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 34.6 mtm -90.13 -36.13 15.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 75.329999999999998 110.893 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.489 ' HA ' HG22 ' A' ' 49' ' ' VAL . 2.2 t -94.35 23.11 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 62.219999999999999 111.1 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.781 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -76.63 -60.62 0.85 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.603 0.716 . . . . 70.150000000000006 111.122 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.781 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.9 Cg_endo -69.73 -48.7 0.67 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.696 2.264 . . . . 73.430000000000007 112.317 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.489 HG22 ' HA ' ' A' ' 46' ' ' VAL . 4.5 m -49.94 -30.2 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 72.409999999999997 111.143 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.458 ' O ' HD13 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -86.13 -45.52 11.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 71.239999999999995 110.886 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -60.96 -32.45 71.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 74.349999999999994 110.846 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -51.31 -63.58 1.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 74.040000000000006 110.892 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.402 HD12 ' O ' ' A' ' 49' ' ' VAL . 2.7 mp -50.75 -41.02 20.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 71.140000000000001 111.142 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 71.329999999999998 111.136 179.819 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.468 HD11 HD23 ' A' ' 32' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.871 0.367 . . . . 60.109999999999999 110.938 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.8 tttp -111.95 148.98 32.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 61.420000000000002 110.867 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.3 t -124.2 104.5 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 62.530000000000001 111.126 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.43 ' CB ' HG23 ' A' ' 15' ' ' VAL . . . -108.59 109.75 21.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 55.43 111.071 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.98 160.68 19.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 72.510000000000005 110.892 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 50.1 tp -148.29 147.56 29.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.439 . . . . 73.239999999999995 110.936 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -79.4 120.99 24.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 61.530000000000001 110.878 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.1 m -48.71 -36.57 7.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 74.329999999999998 111.11 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.36 -32.88 57.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 74.319999999999993 110.838 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.02 -35.03 29.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 70.040000000000006 111.107 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.686 ' HB2' ' HB3' ' A' ' 74' ' ' ALA . 4.5 p30 -118.15 67.14 6.39 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.627 0.727 . . . . 73.409999999999997 110.888 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -32.43 18.33 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.706 2.271 . . . . 62.399999999999999 112.36 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -83.94 -40.8 18.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 42.200000000000003 110.907 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.686 ' HB3' ' HB2' ' A' ' 71' ' ' ASN . . . -59.06 -46.63 87.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 62.039999999999999 111.091 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.497 ' O ' HG23 ' A' ' 80' ' ' VAL . . . -51.0 -63.24 1.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 74.150000000000006 111.141 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.7 ttp180 -51.25 -37.11 45.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 73.310000000000002 110.886 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -55.01 -36.17 65.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 70.120000000000005 110.857 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -98.35 21.77 10.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 75.120000000000005 110.874 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 50.23 80.22 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 63.340000000000003 110.926 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 75' ' ' ALA . 96.5 t -108.55 97.17 5.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.148 -0.478 . . . . 70.310000000000002 111.099 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 81' ' ' VAL . 3.4 t -99.57 34.21 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 72.340000000000003 111.102 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -176.04 140.28 0.41 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.467 . . . . 75.409999999999997 110.887 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.523 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 4.2 mt -57.84 -57.83 22.83 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.668 0.747 . . . . 74.200000000000003 111.09 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.6 Cg_endo -69.74 74.72 1.26 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.714 2.276 . . . . 70.349999999999994 112.359 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.846 HG23 HG12 ' A' ' 99' ' ' VAL . 53.6 m -109.26 143.35 38.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 60.450000000000003 111.142 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 10.9 ttp -141.3 128.79 21.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 75.150000000000006 110.9 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 17.2 mt -115.94 119.72 62.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 65.030000000000001 111.17 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.802 HD12 HG21 ' A' ' 111' ' ' ILE . 0.5 OUTLIER -86.55 111.51 20.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 71.010000000000005 110.915 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -99.42 170.36 8.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 72.140000000000001 110.885 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -163.6 92.53 0.71 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.486 . . . . 74.409999999999997 110.872 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.45 32.21 28.58 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.745 -0.741 . . . . 31.239999999999998 112.503 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.401 ' H ' HG12 ' A' ' 24' ' ' VAL . . . 78.12 38.93 24.88 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.757 -0.735 . . . . 73.230000000000004 112.498 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.1 m -160.32 132.39 4.24 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.589 0.709 . . . . 72.120000000000005 111.11 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 91.73 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.688 2.259 . . . . 62.539999999999999 112.361 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.9 m -70.95 -32.71 49.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 75.209999999999994 111.115 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.1 mmtm -155.25 170.07 22.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 75.109999999999999 110.918 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.614 ' C ' HD12 ' A' ' 98' ' ' ILE . 0.9 OUTLIER -148.01 128.01 13.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 72.219999999999999 110.896 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.614 HD12 ' C ' ' A' ' 97' ' ' ARG . 4.0 mp -136.06 123.75 35.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 63.119999999999997 111.091 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.846 HG12 HG23 ' A' ' 85' ' ' THR . 7.1 m -118.81 159.68 19.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 74.340000000000003 111.116 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 115.57 142.15 7.57 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.713 -0.756 . . . . 74.120000000000005 112.454 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.04 71.24 7.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.835 0.35 . . . . 34.100000000000001 111.12 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.523 ' HB2' ' HB3' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -107.1 164.98 11.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.19 -0.459 . . . . 55.340000000000003 110.909 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.78 -176.36 0.73 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.734 -0.746 . . . . 33.130000000000003 112.459 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.79 -43.77 65.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.737 0.303 . . . . 75.239999999999995 110.889 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.72 -26.14 66.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 33.329999999999998 111.099 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.523 ' HB3' ' HB2' ' A' ' 102' ' ' LYS . . . -90.55 -36.25 14.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 74.519999999999996 111.106 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.688 HD13 ' O ' ' A' ' 107' ' ' LEU . 2.5 tm? -77.22 -36.13 55.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 73.409999999999997 110.896 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.628 ' C ' HD12 ' A' ' 108' ' ' LEU . 1.2 pp -74.65 -39.05 62.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 75.319999999999993 110.906 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.465 ' N ' HD12 ' A' ' 108' ' ' LEU . 16.0 ptm180 -66.88 -35.94 81.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 53.32 110.859 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -57.77 -23.1 50.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 54.32 110.887 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.802 HG21 HD12 ' A' ' 88' ' ' LEU . 3.1 mt -86.48 -66.23 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 72.450000000000003 111.108 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.476 ' HA ' HD12 ' A' ' 115' ' ' LEU . 9.9 pt-20 -52.59 -48.82 66.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 74.230000000000004 110.85 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -59.75 -33.76 72.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 74.219999999999999 110.907 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.0 -35.62 59.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 75.409999999999997 111.122 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.476 HD12 ' HA ' ' A' ' 112' ' ' GLU . 10.0 mt . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 72.439999999999998 110.874 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.9 p . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.849 0.357 . . . . 72.409999999999997 111.121 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.1 m -153.76 173.19 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.475 . . . . 64.129999999999995 111.095 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.473 ' HA ' ' HB1' ' A' ' 64' ' ' ALA . 0.2 OUTLIER -73.74 152.35 40.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 74.329999999999998 111.122 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.494 HG22 HG23 ' A' ' 19' ' ' THR . 8.6 p -127.44 145.52 34.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 71.329999999999998 111.111 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.649 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.87 162.28 5.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 74.109999999999999 111.125 -179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.42 -50.28 13.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 65.0 110.881 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.1 m -59.69 -35.89 75.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.468 . . . . 53.140000000000001 110.821 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.649 HG22 ' HB ' ' A' ' 16' ' ' THR . 5.3 t -85.43 -17.55 36.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 74.510000000000005 111.178 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.71 ' CE2' HG21 ' A' ' 24' ' ' VAL . 24.7 t80 -49.37 -31.86 10.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 53.340000000000003 110.856 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.411 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -70.09 -36.15 74.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.48 . . . . 72.329999999999998 110.918 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.8 m -89.94 -15.09 32.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.436 . . . . 64.040000000000006 111.135 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -92.92 -70.97 0.67 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 73.019999999999996 110.888 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 1.046 HG13 HG21 ' A' ' 31' ' ' VAL . 16.4 t -72.35 -70.31 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 75.420000000000002 111.142 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.639 HD23 ' HA3' ' A' ' 92' ' ' GLY . 7.1 mt -39.9 -56.22 1.84 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 75.120000000000005 110.947 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -55.67 -52.52 63.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 75.540000000000006 110.854 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.5 t -51.89 159.88 0.78 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 61.340000000000003 110.836 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -106.89 -44.76 4.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.143 -0.48 . . . . 73.340000000000003 110.867 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -54.49 159.49 3.28 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.601 0.715 . . . . 74.340000000000003 111.122 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 131.02 20.34 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.695 2.264 . . . . 72.530000000000001 112.322 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 1.046 HG21 HG13 ' A' ' 24' ' ' VAL . 88.2 t -102.25 129.45 53.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 75.109999999999999 111.159 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.813 HD11 HD11 ' A' ' 61' ' ' LEU . 10.7 mt -104.93 106.04 16.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 70.019999999999996 110.917 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.442 HG21 ' CE1' ' A' ' 35' ' ' PHE . 3.8 p -105.12 131.0 55.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 75.430000000000007 111.164 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -116.41 99.61 7.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 74.140000000000001 110.818 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.442 ' CE1' HG21 ' A' ' 33' ' ' VAL . 23.0 m-85 -87.37 89.48 8.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 65.040000000000006 110.897 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.458 ' HZ3' HG11 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -143.61 -169.4 3.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.486 . . . . 74.209999999999994 110.91 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.84 -157.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 73.099999999999994 111.093 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.476 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 15.3 t0 -76.85 9.39 2.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 72.219999999999999 110.876 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.476 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 1.2 p-90 41.69 67.51 0.55 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 72.219999999999999 110.91 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 18.1 t -127.09 -47.7 1.48 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.272 -0.422 . . . . 73.310000000000002 110.839 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.56 -67.91 1.51 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.712 -0.756 . . . . 72.319999999999993 112.525 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -24.82 29.39 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.696 2.264 . . . . 70.319999999999993 112.351 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 36.3 t -49.9 -31.5 12.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 21.129999999999999 110.903 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 11.7 mttp -52.27 -35.14 49.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 72.219999999999999 110.866 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 8.9 mtt -90.44 -32.46 16.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 64.310000000000002 110.875 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.472 ' HA ' ' CG1' ' A' ' 49' ' ' VAL . 3.0 t -92.85 22.89 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 74.219999999999999 111.113 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.79 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -80.87 -60.67 0.43 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.559 0.695 . . . . 62.219999999999999 111.113 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.79 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.9 Cg_endo -69.78 -56.72 0.13 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.702 2.268 . . . . 73.230000000000004 112.326 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.81 HG23 ' HA ' ' A' ' 104' ' ' LYS . 3.0 p -48.76 -33.93 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 62.32 111.119 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.3 tp -69.46 -41.44 76.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 74.209999999999994 110.915 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.466 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 6.4 mm-40 -73.29 -33.24 65.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.461 . . . . 64.439999999999998 110.881 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -50.33 -66.49 0.38 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 74.329999999999998 110.874 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.595 HD12 ' O ' ' A' ' 49' ' ' VAL . 2.6 mt -50.07 -33.07 9.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 62.310000000000002 111.106 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.689 ' HB1' HD21 ' A' ' 61' ' ' LEU . . . . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 72.319999999999993 111.122 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.813 HD11 HD11 ' A' ' 32' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.9 0.381 . . . . 74.129999999999995 110.868 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -97.96 140.55 32.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 55.539999999999999 110.903 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.2 t -141.95 118.15 6.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.253 -0.431 . . . . 73.400000000000006 111.138 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.473 ' HB1' ' HA ' ' A' ' 14' ' ' THR . . . -115.48 147.09 41.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 60.450000000000003 111.09 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.2 pttp -138.97 131.38 28.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 75.310000000000002 110.892 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.429 HD21 ' CG ' ' A' ' 71' ' ' ASN . 32.1 tp -122.47 159.48 27.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 74.340000000000003 110.888 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -103.07 118.08 36.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 74.400000000000006 110.838 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.418 HG22 ' HB2' ' A' ' 75' ' ' ALA . 73.9 t -61.62 -35.7 68.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 73.409999999999997 111.141 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -51.41 -35.3 38.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 63.240000000000002 110.898 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.14 -35.06 11.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 64.219999999999999 111.055 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.429 ' CG ' HD21 ' A' ' 66' ' ' LEU . 1.6 m-80 -117.79 72.5 8.29 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.619 0.723 . . . . 51.25 110.878 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -31.16 20.84 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.686 2.257 . . . . 72.109999999999999 112.343 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -61.34 -43.33 99.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.243 -0.435 . . . . 64.129999999999995 110.892 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.417 ' HB1' ' CE2' ' A' ' 35' ' ' PHE . . . -60.69 -48.08 83.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 61.030000000000001 111.079 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.548 ' O ' HG23 ' A' ' 80' ' ' VAL . . . -52.16 -66.21 0.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 74.400000000000006 111.089 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.2 ttp85 -51.14 -33.15 25.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 60.299999999999997 110.895 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -51.28 -36.22 41.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 74.010000000000005 110.915 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -108.7 24.97 12.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 74.219999999999999 110.874 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 59.9 mm-40 48.2 67.1 0.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 74.329999999999998 110.858 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 75' ' ' ALA . 98.9 t -91.2 106.2 17.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 72.519999999999996 111.113 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.5 t -80.12 -62.28 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 73.319999999999993 111.099 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 56.1 m -89.83 160.68 16.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.467 . . . . 71.409999999999997 110.858 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.53 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.8 mt -60.2 -58.18 21.27 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.624 0.726 . . . . 60.219999999999999 111.098 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.3 Cg_endo -69.79 77.43 1.08 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.683 2.255 . . . . 71.540000000000006 112.351 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.57 ' HA ' HG12 ' A' ' 99' ' ' VAL . 99.7 m -117.39 109.62 17.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.439 . . . . 43.200000000000003 111.116 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 31.0 ttp -113.77 145.95 40.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 72.219999999999999 110.891 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.6 mt -129.68 117.86 43.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 71.239999999999995 111.138 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.468 ' HG ' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -80.82 102.59 10.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 72.219999999999999 110.924 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -89.52 167.68 12.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 73.219999999999999 110.894 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -161.85 94.86 0.96 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 54.539999999999999 110.909 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.28 32.72 22.12 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.737 -0.744 . . . . 71.209999999999994 112.502 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.639 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 73.49 41.1 45.64 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.716 -0.754 . . . . 73.109999999999999 112.516 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.451 HG23 ' HD2' ' A' ' 94' ' ' PRO . 85.4 m -160.15 133.69 4.91 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.597 0.713 . . . . 73.430000000000007 111.143 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.451 ' HD2' HG23 ' A' ' 93' ' ' THR . 53.8 Cg_endo -69.76 93.78 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.692 2.261 . . . . 71.409999999999997 112.349 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.5 m -88.29 -32.37 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 71.030000000000001 111.133 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -132.12 166.22 22.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 71.450000000000003 110.911 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.408 ' C ' HD12 ' A' ' 98' ' ' ILE . 6.4 ttp180 -160.09 116.74 2.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 73.239999999999995 110.867 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.411 ' N ' HD12 ' A' ' 98' ' ' ILE . 5.0 mp -133.95 139.6 48.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 61.219999999999999 111.128 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.57 HG12 ' HA ' ' A' ' 85' ' ' THR . 4.8 m -132.26 154.82 40.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 72.140000000000001 111.107 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 115.34 137.92 6.4 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.719 -0.753 . . . . 73.129999999999995 112.503 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.43 77.11 6.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.883 0.373 . . . . 62.509999999999998 111.083 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.77 176.76 4.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 75.120000000000005 110.898 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -76.65 166.6 54.21 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.685 -0.769 . . . . 71.319999999999993 112.468 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.81 ' HA ' HG23 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -58.13 -41.01 82.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.755 0.312 . . . . 63.100000000000001 110.854 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.47 -32.19 66.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 64.340000000000003 111.1 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.53 -61.87 1.58 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 72.200000000000003 111.128 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.512 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.3 OUTLIER -45.93 -43.1 13.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 63.240000000000002 110.942 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.581 ' O ' HD12 ' A' ' 108' ' ' LEU . 4.3 tp -49.49 -47.87 48.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 73.310000000000002 110.937 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 50.7 mtm180 -65.7 -40.59 92.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 75.150000000000006 110.838 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -49.79 -25.15 2.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 71.430000000000007 110.896 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.414 ' CD1' HG21 ' A' ' 53' ' ' ILE . 4.2 mt -90.37 -70.09 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 65.230000000000004 111.15 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -51.86 -51.05 59.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 71.450000000000003 110.849 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -57.2 -34.22 68.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.47 . . . . 74.230000000000004 110.895 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.17 -34.02 65.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 43.020000000000003 111.081 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 115' ' ' LEU . 8.5 mt . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 71.200000000000003 110.939 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.6 p . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.788 0.328 . . . . 50.119999999999997 111.145 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.6 m -153.31 172.19 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 72.140000000000001 111.163 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.1 t -74.04 127.94 34.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 74.030000000000001 111.192 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.4 t -91.28 137.04 22.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 74.140000000000001 111.095 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.605 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.71 174.73 0.43 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.16 -0.473 . . . . 73.310000000000002 111.144 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.453 ' H ' HG22 ' A' ' 16' ' ' THR . 10.1 t0 -80.49 -48.97 12.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 61.219999999999999 110.888 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.6 m -68.07 -53.44 25.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 72.329999999999998 110.853 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.605 HG22 ' HB ' ' A' ' 16' ' ' THR . 5.6 t -59.06 -19.28 42.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 73.219999999999999 111.158 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.719 ' CE2' HG21 ' A' ' 24' ' ' VAL . 25.0 t80 -51.08 -31.12 17.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 62.210000000000001 110.879 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.402 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -71.82 -33.45 68.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 74.019999999999996 110.902 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.6 m -91.51 -15.97 27.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.199 -0.455 . . . . 60.420000000000002 111.153 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -93.48 -71.23 0.66 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 72.409999999999997 110.888 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 1.005 HG13 HG21 ' A' ' 31' ' ' VAL . 19.1 t -70.5 -70.47 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 71.099999999999994 111.142 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.623 HD23 ' HA3' ' A' ' 92' ' ' GLY . 7.6 mt -40.72 -59.94 1.27 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 75.409999999999997 110.87 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -50.57 -60.68 2.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 73.540000000000006 110.868 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.0 t -51.32 162.06 0.38 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.45 . . . . 74.349999999999994 110.869 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -112.33 -40.28 4.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 74.540000000000006 110.828 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.452 HG22 ' HD2' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -51.94 158.88 1.56 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.563 0.697 . . . . 73.239999999999995 111.172 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.452 ' HD2' HG22 ' A' ' 29' ' ' THR . 53.7 Cg_endo -69.74 116.08 4.39 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.726 2.284 . . . . 73.450000000000003 112.323 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 1.005 HG21 HG13 ' A' ' 24' ' ' VAL . 98.0 t -82.35 141.53 14.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 72.409999999999997 111.111 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.1 mt -112.04 104.89 13.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 74.0 110.912 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 87' ' ' ILE . 8.6 p -113.37 146.86 17.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 75.120000000000005 111.123 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -139.49 117.85 12.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 74.219999999999999 110.9 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.557 ' HE2' ' HB1' ' A' ' 74' ' ' ALA . 20.2 m-85 -95.17 97.05 9.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 73.420000000000002 110.926 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.621 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -146.13 -167.32 2.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 73.329999999999998 110.935 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.09 -167.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 63.130000000000003 111.118 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.447 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 5.7 m-20 -78.77 12.69 1.99 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 73.450000000000003 110.855 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.449 ' CD1' ' N ' ' A' ' 39' ' ' TRP . 0.8 OUTLIER 75.37 85.57 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 75.25 110.91 -179.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 2.0 p -164.44 -47.08 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 63.310000000000002 110.88 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.88 -70.72 1.34 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.794 -0.717 . . . . 73.319999999999993 112.463 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -31.22 21.05 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.688 2.259 . . . . 65.120000000000005 112.339 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.548 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 43.7 t -51.24 -29.16 13.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 54.210000000000001 110.852 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -63.66 -49.34 73.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 74.409999999999997 110.902 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.547 ' HG3' HG23 ' A' ' 46' ' ' VAL . 10.9 ptp -77.54 -34.52 53.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 75.219999999999999 110.909 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.547 HG23 ' HG3' ' A' ' 45' ' ' MET . 3.4 t -93.8 21.98 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 72.140000000000001 111.163 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.812 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -76.52 -61.28 0.79 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.606 0.717 . . . . 73.549999999999997 111.142 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.812 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.3 Cg_endo -69.81 -49.83 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.651 2.234 . . . . 64.239999999999995 112.348 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.684 ' O ' HD12 ' A' ' 53' ' ' ILE . 4.1 m -51.04 -30.35 9.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 71.549999999999997 111.144 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.2 tp -76.17 -41.51 49.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.121 -0.49 . . . . 73.510000000000005 110.911 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -71.12 -33.94 70.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 75.299999999999997 110.895 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -51.49 -69.53 0.11 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 63.409999999999997 110.864 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.684 HD12 ' O ' ' A' ' 49' ' ' VAL . 2.8 mp -50.99 -37.29 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 62.520000000000003 111.14 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 73.310000000000002 111.108 179.806 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.661 ' C ' HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.868 0.366 . . . . 75.150000000000006 110.903 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.546 ' N ' HD22 ' A' ' 61' ' ' LEU . 1.3 mptm? -122.28 141.97 50.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 72.519999999999996 110.855 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 23.8 t -120.58 99.81 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 24.23 111.143 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -108.88 142.69 39.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 64.310000000000002 111.108 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.5 mtpt -130.93 159.51 37.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 62.009999999999998 110.91 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.526 HD21 ' CB ' ' A' ' 71' ' ' ASN . 10.4 tp -140.56 144.83 36.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 63.140000000000001 110.924 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.03 119.34 33.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 75.25 110.843 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 36' ' ' TRP . 21.1 t -62.4 -34.58 65.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.486 . . . . 62.340000000000003 111.105 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.56 -35.54 41.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 71.540000000000006 110.867 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.36 -34.09 11.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 51.200000000000003 111.06 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.526 ' CB ' HD21 ' A' ' 66' ' ' LEU . 1.8 m-80 -118.3 68.46 7.35 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.602 0.715 . . . . 75.349999999999994 110.878 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -32.81 17.8 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.692 2.261 . . . . 64.109999999999999 112.328 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -67.99 -35.19 77.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 73.230000000000004 110.859 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.557 ' HB1' ' HE2' ' A' ' 35' ' ' PHE . . . -56.96 -44.13 82.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 55.039999999999999 111.104 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.52 ' O ' HG23 ' A' ' 80' ' ' VAL . . . -59.83 -64.38 0.97 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 70.129999999999995 111.097 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.6 ttp180 -50.51 -35.11 27.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 74.010000000000005 110.898 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.85 -35.79 64.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 71.140000000000001 110.835 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -107.6 28.7 7.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 72.239999999999995 110.896 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 50.96 84.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 75.439999999999998 110.942 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 75' ' ' ALA . 96.9 t -120.78 140.06 46.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.443 . . . . 65.129999999999995 111.131 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.6 m -127.59 -37.69 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 73.340000000000003 111.154 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.2 t -100.96 148.28 25.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 74.5 110.871 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.535 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.1 mt -59.64 -57.69 24.97 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.599 0.714 . . . . 71.010000000000005 111.128 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.8 Cg_endo -69.76 71.56 1.51 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.687 2.258 . . . . 75.430000000000007 112.345 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.982 HG23 HG22 ' A' ' 99' ' ' VAL . 54.8 m -106.39 135.37 47.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 73.430000000000007 111.137 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 5.0 ttt -134.66 146.31 49.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 65.439999999999998 110.898 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.423 ' O ' HG12 ' A' ' 33' ' ' VAL . 22.3 mt -141.86 118.03 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 75.420000000000002 111.156 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.39 101.42 9.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 71.409999999999997 110.948 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -89.91 170.92 9.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 62.299999999999997 110.865 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.74 119.11 0.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 70.439999999999998 110.901 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.37 34.41 88.14 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.707 -0.759 . . . . 61.43 112.501 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.623 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 71.56 42.34 55.5 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.714 -0.755 . . . . 65.25 112.538 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.448 HG23 ' HD2' ' A' ' 94' ' ' PRO . 84.9 m -161.05 133.94 4.57 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.613 0.721 . . . . 51.329999999999998 111.109 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.448 ' HD2' HG23 ' A' ' 93' ' ' THR . 54.0 Cg_endo -69.75 81.35 0.82 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.657 2.238 . . . . 74.219999999999999 112.345 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.3 m -68.2 -32.36 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 52.140000000000001 111.11 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.3 mmtm -142.75 160.19 40.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 75.239999999999995 110.879 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.59 ' C ' HD12 ' A' ' 98' ' ' ILE . 2.4 tmt_? -149.37 124.63 10.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 75.439999999999998 110.871 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.59 HD12 ' C ' ' A' ' 97' ' ' ARG . 4.6 mp -139.35 116.56 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 75.0 111.11 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.982 HG22 HG23 ' A' ' 85' ' ' THR . 61.0 t -111.76 134.24 54.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 73.109999999999999 111.132 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 133.99 140.26 4.29 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.735 -0.745 . . . . 52.149999999999999 112.46 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.32 85.58 4.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.83 0.348 . . . . 44.329999999999998 111.139 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.36 165.92 15.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 63.130000000000003 110.908 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.22 149.76 49.65 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.755 -0.736 . . . . 71.219999999999999 112.523 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.475 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -47.17 -36.98 9.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.822 0.344 . . . . 73.439999999999998 110.869 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.82 -47.03 74.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 75.25 111.114 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -83.18 -49.6 9.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 64.510000000000005 111.094 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.428 ' C ' HD13 ' A' ' 107' ' ' LEU . 2.0 tm? -47.87 -51.87 21.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.237 -0.438 . . . . 64.439999999999998 110.872 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.475 HD23 ' O ' ' A' ' 104' ' ' LYS . 1.7 pp -50.69 -35.89 33.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 73.099999999999994 110.893 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -68.65 -44.69 73.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 60.329999999999998 110.898 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -51.4 -25.61 6.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.49 . . . . 70.129999999999995 110.909 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.401 ' HA ' HD11 ' A' ' 98' ' ' ILE . 3.7 mt -84.72 -68.08 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 71.409999999999997 111.167 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.43 ' O ' HD23 ' A' ' 115' ' ' LEU . 10.1 pt-20 -52.32 -49.38 64.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 70.420000000000002 110.891 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -52.49 -33.82 46.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.481 . . . . 75.400000000000006 110.836 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.01 -34.68 73.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 74.109999999999999 111.081 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.43 HD23 ' O ' ' A' ' 112' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 75.099999999999994 110.919 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.3 p . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.856 0.36 . . . . 71.340000000000003 111.162 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.4 t -135.15 140.69 44.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 74.140000000000001 111.121 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 t -92.71 133.38 36.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 74.129999999999995 111.16 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.7 t -89.81 120.73 39.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 72.030000000000001 111.107 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.528 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.92 -179.52 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 62.229999999999997 111.144 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.42 ' H ' HG22 ' A' ' 16' ' ' THR . 4.4 m-20 -79.71 -45.59 18.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 63.409999999999997 110.833 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.7 m -68.98 -54.86 13.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 35.140000000000001 110.864 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.528 HG22 ' HB ' ' A' ' 16' ' ' THR . 10.3 t -57.74 -21.9 43.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 62.240000000000002 111.159 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.629 ' CE2' HG21 ' A' ' 24' ' ' VAL . 20.6 t80 -48.77 -30.5 5.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 73.439999999999998 110.913 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.523 ' HA ' HD12 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -67.61 -41.97 83.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 75.239999999999995 110.876 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.426 HG22 ' O ' ' A' ' 22' ' ' THR . 25.5 m -91.45 -9.69 43.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.228 -0.442 . . . . 63.420000000000002 111.153 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.57 -70.24 0.71 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 52.130000000000003 110.885 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.772 HG22 HG21 ' A' ' 31' ' ' VAL . 11.1 t -83.99 -66.87 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 62.539999999999999 111.145 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.681 HD23 ' HA3' ' A' ' 92' ' ' GLY . 77.8 mt -45.79 -32.77 2.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 71.319999999999993 110.898 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -48.8 -32.05 8.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.157 -0.474 . . . . 74.219999999999999 110.882 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.9 t 65.9 62.97 0.6 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 52.340000000000003 110.851 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -120.23 -32.38 4.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 73.120000000000005 110.886 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.403 HG22 ' HD2' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -157.16 159.67 30.97 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.557 0.694 . . . . 63.439999999999998 111.139 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.403 ' HD2' HG22 ' A' ' 29' ' ' THR . 53.3 Cg_endo -69.77 126.7 13.6 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.645 2.23 . . . . 72.319999999999993 112.356 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.772 HG21 HG22 ' A' ' 24' ' ' VAL . 91.6 t -98.18 119.17 45.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 53.420000000000002 111.113 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.0 mp -108.0 99.9 9.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 64.230000000000004 110.886 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.4 m -107.44 146.21 13.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 74.109999999999999 111.125 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -123.47 100.21 6.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 73.25 110.897 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -72.15 100.22 2.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 72.319999999999993 110.877 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.467 ' HH2' HD22 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -147.47 -168.3 3.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.153 -0.476 . . . . 64.430000000000007 110.908 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.47 -164.96 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 64.439999999999998 111.128 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.475 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 4.6 m-20 -79.25 13.66 1.8 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.446 . . . . 73.400000000000006 110.903 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.475 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 0.6 OUTLIER 75.19 94.76 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 72.019999999999996 110.925 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -172.13 -57.92 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.444 . . . . 62.439999999999998 110.91 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.26 -70.98 1.28 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.798 -0.715 . . . . 73.430000000000007 112.479 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.404 ' HG3' HG21 ' A' ' 83' ' ' ILE . 54.3 Cg_endo -69.68 -31.04 21.65 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.693 2.262 . . . . 53.520000000000003 112.356 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.556 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 20.4 t -58.46 -35.4 72.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 74.319999999999993 110.87 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.5 ptmm? -65.02 -29.42 70.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 53.409999999999997 110.904 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 9.0 mtm -86.88 -41.54 13.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 74.519999999999996 110.883 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.54 ' HA ' HG22 ' A' ' 49' ' ' VAL . 3.1 t -94.24 22.3 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 51.229999999999997 111.176 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.796 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -75.85 -61.1 0.93 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.512 0.672 . . . . 72.519999999999996 111.129 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.796 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 54.0 Cg_endo -69.72 -50.3 0.48 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.687 2.258 . . . . 72.0 112.354 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.54 HG22 ' HA ' ' A' ' 46' ' ' VAL . 4.2 m -52.66 -29.07 13.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 70.239999999999995 111.163 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.467 HD22 ' HH2' ' A' ' 36' ' ' TRP . 14.0 tp -86.16 -44.31 12.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.146 -0.479 . . . . 72.299999999999997 110.908 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -62.66 -34.4 77.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 72.530000000000001 110.899 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -51.76 -55.41 19.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 74.209999999999994 110.917 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 mt -50.57 -37.99 15.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.085 -0.507 . . . . 74.400000000000006 111.13 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 72.120000000000005 111.097 179.798 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.5 pp . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.847 0.356 . . . . 43.450000000000003 110.907 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.3 mttm -98.55 126.19 44.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.448 . . . . 71.25 110.891 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 44.5 t -100.34 101.53 12.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 74.239999999999995 111.137 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -117.01 152.45 34.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 60.409999999999997 111.104 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.26 136.88 42.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 72.109999999999999 110.923 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.5 tp -117.04 150.88 37.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 75.140000000000001 110.914 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -106.98 118.57 37.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 71.400000000000006 110.816 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 99.9 t -57.77 -40.35 75.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.469 . . . . 65.409999999999997 111.11 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -51.7 -36.19 45.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.142 -0.481 . . . . 64.420000000000002 110.869 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.34 -33.89 15.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 60.420000000000002 111.111 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -118.76 67.81 7.98 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.604 0.716 . . . . 74.140000000000001 110.866 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -33.58 16.32 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.64 2.227 . . . . 75.109999999999999 112.359 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -74.46 -36.7 63.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 64.319999999999993 110.895 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.26 -48.24 74.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 74.219999999999999 111.111 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.537 ' O ' HG23 ' A' ' 80' ' ' VAL . . . -56.25 -61.41 2.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 71.140000000000001 111.12 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.58 -34.05 35.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 72.549999999999997 110.891 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.17 -34.69 73.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 64.019999999999996 110.873 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -103.88 26.91 8.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 54.219999999999999 110.853 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 49.85 82.5 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.485 . . . . 75.430000000000007 110.904 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 75' ' ' ALA . 85.4 t -117.11 144.58 24.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.229 -0.442 . . . . 75.549999999999997 111.181 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.7 m -135.42 -40.22 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 74.299999999999997 111.096 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.2 m -97.65 146.71 25.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 72.230000000000004 110.861 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.541 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.9 mt -57.94 -57.75 23.52 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.586 0.707 . . . . 72.340000000000003 111.108 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 54.1 Cg_endo -69.79 74.94 1.26 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.696 2.264 . . . . 74.049999999999997 112.343 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.757 HG23 HG12 ' A' ' 99' ' ' VAL . 52.3 m -112.3 143.34 43.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 72.209999999999994 111.129 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 4.2 tmm? -140.34 139.1 35.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 74.319999999999993 110.843 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.1 mt -130.38 113.19 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 73.310000000000002 111.08 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.459 HD12 HD13 ' A' ' 111' ' ' ILE . 1.6 tt -80.53 111.32 16.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 65.030000000000001 110.93 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -98.91 168.75 9.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 74.150000000000006 110.88 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -170.68 93.33 0.19 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.171 -0.468 . . . . 73.140000000000001 110.915 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.77 44.66 6.32 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.727 -0.749 . . . . 73.319999999999993 112.449 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.681 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 63.71 38.41 96.17 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.739 -0.743 . . . . 52.350000000000001 112.5 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.5 m -162.93 128.62 2.22 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.573 0.701 . . . . 60.229999999999997 111.134 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 86.94 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.679 2.253 . . . . 43.530000000000001 112.384 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.5 m -57.56 -35.74 51.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.425 . . . . 63.109999999999999 111.146 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 45.8 mmtt -152.82 170.19 20.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 45.130000000000003 110.896 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.452 ' C ' HD12 ' A' ' 98' ' ' ILE . 11.2 ttt180 -149.73 123.65 9.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 73.329999999999998 110.901 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.452 HD12 ' C ' ' A' ' 97' ' ' ARG . 4.2 mp -127.11 128.97 70.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 74.25 111.131 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.757 HG12 HG23 ' A' ' 85' ' ' THR . 4.8 m -124.55 160.22 29.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.467 . . . . 64.310000000000002 111.136 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 109.51 138.63 8.21 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.727 -0.749 . . . . 41.43 112.487 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -91.87 80.41 5.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.863 0.363 . . . . 74.430000000000007 111.139 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.401 ' HG2' HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -110.84 178.58 4.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.435 . . . . 63.210000000000001 110.855 -179.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.75 -169.71 1.07 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.783 -0.723 . . . . 64.0 112.47 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.17 -54.19 6.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.805 0.336 . . . . 54.100000000000001 110.905 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -53.63 -34.03 57.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 74.219999999999999 111.116 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.06 -64.4 1.17 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 54.43 111.094 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.647 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.7 OUTLIER -50.27 -33.65 20.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 73.239999999999995 110.947 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.658 HD23 ' N ' ' A' ' 109' ' ' ARG . 4.1 tt -71.71 -59.29 2.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 53.210000000000001 110.88 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.658 ' N ' HD23 ' A' ' 108' ' ' LEU . 13.0 ptp180 -56.39 -31.74 64.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 63.32 110.875 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -51.75 -24.88 6.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.159 -0.473 . . . . 71.25 110.93 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.459 HD13 HD12 ' A' ' 88' ' ' LEU . 4.7 mt -86.0 -68.7 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.487 . . . . 73.010000000000005 111.123 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -52.42 -49.62 64.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 74.420000000000002 110.842 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -53.72 -35.2 60.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.146 -0.479 . . . . 71.200000000000003 110.888 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.19 -36.37 69.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 71.420000000000002 111.112 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.1 mt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 75.230000000000004 110.93 179.995 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.9 p . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.845 0.355 . . . . 73.0 111.133 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.8 m -152.43 160.97 3.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 72.450000000000003 111.125 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.61 ' HA ' ' HB1' ' A' ' 64' ' ' ALA . 8.7 t -68.52 157.17 36.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 72.25 111.17 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.461 HG22 ' CG2' ' A' ' 19' ' ' THR . 8.3 p -124.16 155.01 31.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 71.519999999999996 111.127 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.686 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.57 167.79 1.87 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 53.229999999999997 111.146 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.3 -47.98 13.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.224 -0.444 . . . . 74.439999999999998 110.891 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.9 t -66.59 -53.29 36.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.202 -0.454 . . . . 71.349999999999994 110.901 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.686 HG22 ' HB ' ' A' ' 16' ' ' THR . 3.8 t -61.51 -17.7 55.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 71.25 111.119 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.698 ' CE2' HG21 ' A' ' 24' ' ' VAL . 25.5 t80 -49.71 -32.45 13.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 73.109999999999999 110.907 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.441 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -70.69 -33.18 70.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 72.230000000000004 110.893 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.0 m -90.93 -16.47 28.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 72.030000000000001 111.133 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -93.16 -70.68 0.69 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.446 . . . . 63.450000000000003 110.86 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 1.111 HG13 HG21 ' A' ' 31' ' ' VAL . 17.0 t -71.48 -70.32 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.243 -0.435 . . . . 65.409999999999997 111.113 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.705 HD23 ' HA3' ' A' ' 92' ' ' GLY . 8.5 mt -40.46 -59.99 1.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 73.430000000000007 110.921 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -50.77 -62.11 1.8 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 50.340000000000003 110.874 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 86.2 p -51.79 137.65 25.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 72.319999999999993 110.858 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -88.49 -35.96 16.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.09 -0.505 . . . . 62.32 110.875 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -51.98 159.53 1.4 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.614 0.721 . . . . 74.0 111.174 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 126.5 13.35 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.676 2.25 . . . . 71.340000000000003 112.312 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 1.111 HG21 HG13 ' A' ' 24' ' ' VAL . 95.9 t -99.49 128.02 51.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 71.519999999999996 111.157 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.457 HD11 HD11 ' A' ' 88' ' ' LEU . 7.7 mp -99.8 121.65 41.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 74.329999999999998 110.938 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.6 p -127.43 126.15 66.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 71.129999999999995 111.105 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -110.76 100.07 8.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 64.420000000000002 110.874 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.441 ' HE2' ' HB1' ' A' ' 74' ' ' ALA . 25.8 m-85 -84.29 89.42 7.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 74.209999999999994 110.914 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.402 ' HH2' HD12 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -147.83 -169.17 3.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.124 -0.489 . . . . 73.519999999999996 110.901 -179.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.469 ' HA ' HG22 ' A' ' 68' ' ' VAL . . . -60.7 -154.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 60.43 111.114 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.475 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 14.2 p-10 -77.31 8.8 3.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 72.409999999999997 110.875 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.475 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 1.4 p-90 41.49 63.85 1.17 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 71.230000000000004 110.939 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 35.9 t -130.22 -45.94 1.11 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 74.420000000000002 110.924 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.74 -68.75 1.44 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.753 -0.736 . . . . 72.439999999999998 112.485 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -30.8 21.88 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.759 2.306 . . . . 62.140000000000001 112.335 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 53.3 t -58.18 -20.43 41.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.245 -0.434 . . . . 71.329999999999998 110.883 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -49.74 -36.24 24.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 73.030000000000001 110.868 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.496 ' HG3' HG23 ' A' ' 46' ' ' VAL . 6.5 ptp -90.83 -30.92 16.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 71.129999999999995 110.859 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.496 HG23 ' HG3' ' A' ' 45' ' ' MET . 3.3 t -92.73 21.96 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.284 -0.416 . . . . 74.030000000000001 111.141 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.783 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -79.07 -60.98 0.52 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.595 0.712 . . . . 72.109999999999999 111.084 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.783 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.5 Cg_endo -69.75 -48.53 0.7 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.63 2.22 . . . . 64.200000000000003 112.38 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.627 ' O ' HD12 ' A' ' 53' ' ' ILE . 4.6 m -50.01 -30.71 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 75.019999999999996 111.116 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.402 HD12 ' HH2' ' A' ' 36' ' ' TRP . 6.1 tt -71.57 -40.24 70.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 74.430000000000007 110.902 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -73.03 -33.5 65.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 72.140000000000001 110.87 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -52.22 -67.66 0.23 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 71.150000000000006 110.907 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.627 HD12 ' O ' ' A' ' 49' ' ' VAL . 2.8 mt -51.28 -34.34 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 74.310000000000002 111.094 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 70.209999999999994 111.076 179.83 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.608 HD13 ' N ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.841 0.353 . . . . 64.239999999999995 110.964 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.02 138.77 35.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.435 . . . . 74.019999999999996 110.934 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.427 HG23 HD23 ' A' ' 61' ' ' LEU . 48.5 t -142.05 99.81 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.266 -0.425 . . . . 63.32 111.125 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.61 ' HB1' ' HA ' ' A' ' 14' ' ' THR . . . -101.75 146.77 27.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 62.340000000000003 111.117 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.24 151.03 49.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 73.019999999999996 110.906 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.49 HD21 ' HB2' ' A' ' 71' ' ' ASN . 13.6 tp -139.94 150.57 44.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 71.400000000000006 110.931 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -103.08 115.45 30.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 62.109999999999999 110.897 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.594 HG12 ' HB2' ' A' ' 75' ' ' ALA . 27.0 m -57.89 -34.66 49.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.46 . . . . 74.239999999999995 111.107 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.48 -36.15 43.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 62.340000000000003 110.868 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.14 -34.62 11.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 73.319999999999993 111.126 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.49 ' HB2' HD21 ' A' ' 66' ' ' LEU . 0.9 OUTLIER -118.82 70.18 9.58 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.625 0.726 . . . . 73.420000000000002 110.883 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.75 -32.65 18.21 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.718 2.278 . . . . 73.540000000000006 112.361 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -59.17 -44.6 92.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 55.109999999999999 110.898 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.441 ' HB1' ' HE2' ' A' ' 35' ' ' PHE . . . -57.07 -54.65 44.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 42.039999999999999 111.073 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.827 ' HB1' HG11 ' A' ' 80' ' ' VAL . . . -54.79 -60.3 3.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 74.349999999999994 111.148 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.85 -33.27 23.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 65.530000000000001 110.888 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -56.01 -38.77 70.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 72.120000000000005 110.881 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -94.63 19.22 10.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 74.299999999999997 110.884 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 47.76 77.84 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 72.150000000000006 110.903 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.827 HG11 ' HB1' ' A' ' 75' ' ' ALA . 6.6 p -120.04 142.47 35.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 70.25 111.121 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.5 m -119.58 -37.66 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 73.219999999999999 111.124 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 39.3 m -89.97 140.22 29.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 71.230000000000004 110.9 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.532 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.0 mt -55.82 -58.02 18.31 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.596 0.712 . . . . 63.520000000000003 111.09 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.5 Cg_endo -69.79 79.21 0.97 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.649 2.232 . . . . 74.409999999999997 112.342 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.714 HG23 HG12 ' A' ' 99' ' ' VAL . 85.6 m -123.37 108.05 12.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.226 -0.443 . . . . 64.340000000000003 111.147 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 18.8 ttp -109.97 142.1 41.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 63.25 110.903 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.2 mt -127.42 129.49 70.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 75.450000000000003 111.135 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.457 HD11 HD11 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -94.42 106.3 18.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 52.310000000000002 110.908 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -89.7 169.99 10.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 72.120000000000005 110.882 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -163.01 92.5 0.76 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 61.149999999999999 110.894 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.52 37.06 9.91 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.777 -0.725 . . . . 71.420000000000002 112.478 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.705 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 71.12 38.3 63.55 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.722 -0.752 . . . . 33.200000000000003 112.503 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.462 HG23 ' HD2' ' A' ' 94' ' ' PRO . 85.2 m -161.02 133.94 4.59 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.579 0.704 . . . . 75.439999999999998 111.171 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.462 ' HD2' HG23 ' A' ' 93' ' ' THR . 54.2 Cg_endo -69.72 107.32 1.82 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.706 2.271 . . . . 64.049999999999997 112.367 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.7 m -98.55 -33.17 4.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 73.099999999999994 111.118 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.9 mmtm -130.28 163.52 26.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 63.409999999999997 110.928 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.417 ' C ' HD12 ' A' ' 98' ' ' ILE . 9.1 ttp180 -155.12 114.12 3.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 73.409999999999997 110.885 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.443 ' N ' HD12 ' A' ' 98' ' ' ILE . 4.7 mp -129.83 129.88 66.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 75.400000000000006 111.134 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.714 HG12 HG23 ' A' ' 85' ' ' THR . 4.2 m -128.49 141.69 45.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 51.340000000000003 111.135 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 132.59 130.92 3.15 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.765 -0.731 . . . . 65.239999999999995 112.482 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.37 59.1 3.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.845 0.355 . . . . 64.400000000000006 111.111 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.25 171.75 8.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 72.209999999999994 110.92 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -67.99 -178.67 14.62 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.771 -0.728 . . . . 74.409999999999997 112.492 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -44.14 72.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.821 0.343 . . . . 75.120000000000005 110.898 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.88 -34.46 65.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 73.209999999999994 111.058 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.437 ' HA ' ' HG2' ' A' ' 109' ' ' ARG . . . -87.97 -56.18 3.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 72.109999999999999 111.113 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.664 HD13 ' O ' ' A' ' 107' ' ' LEU . 1.0 OUTLIER -51.42 -35.19 38.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.448 . . . . 62.43 110.906 -179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.561 HD23 ' N ' ' A' ' 109' ' ' ARG . 6.7 tt -68.98 -60.53 2.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 63.350000000000001 110.904 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.561 ' N ' HD23 ' A' ' 108' ' ' LEU . 14.6 ptp180 -54.59 -35.12 63.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 71.040000000000006 110.864 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -53.24 -24.62 11.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 74.200000000000003 110.878 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.5 mt -84.75 -67.93 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 74.230000000000004 111.153 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.687 ' HA ' HD23 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -52.34 -46.86 66.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 54.020000000000003 110.892 179.901 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -55.42 -34.47 64.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 73.519999999999996 110.85 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.28 -37.1 69.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 41.119999999999997 111.122 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.687 HD23 ' HA ' ' A' ' 112' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 72.340000000000003 110.905 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.463 HG22 ' HB ' ' A' ' 63' ' ' VAL . 20.9 p . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.804 0.335 . . . . 63.25 111.146 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 72.8 t -149.66 144.3 17.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.428 . . . . 65.349999999999994 111.124 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 t -69.13 127.24 32.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 71.430000000000007 111.162 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.9 t -92.9 132.41 37.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 61.140000000000001 111.126 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.499 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.72 177.71 0.2 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 72.109999999999999 111.141 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.455 ' H ' HG22 ' A' ' 16' ' ' THR . 0.6 OUTLIER -80.53 -48.35 12.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 70.120000000000005 110.842 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.6 t -71.16 -52.05 21.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 72.349999999999994 110.865 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.499 HG22 ' HB ' ' A' ' 16' ' ' THR . 4.8 t -58.54 -19.71 40.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 71.409999999999997 111.16 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.709 ' CE2' HG21 ' A' ' 24' ' ' VAL . 24.5 t80 -51.51 -30.71 21.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 74.150000000000006 110.855 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.415 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -72.33 -33.16 67.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 74.129999999999995 110.882 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.4 m -91.67 -16.09 27.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 74.040000000000006 111.162 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -93.48 -71.35 0.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 72.420000000000002 110.832 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.969 HG13 HG21 ' A' ' 31' ' ' VAL . 18.2 t -70.34 -70.42 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 72.239999999999995 111.114 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.617 HD23 ' HA3' ' A' ' 92' ' ' GLY . 7.6 mt -40.72 -60.42 1.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 74.140000000000001 110.919 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -50.05 -57.85 6.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 71.140000000000001 110.893 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.4 m -52.49 147.02 8.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 52.030000000000001 110.86 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -95.34 -45.67 7.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 75.230000000000004 110.839 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -51.11 160.56 0.84 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.53 0.681 . . . . 71.329999999999998 111.137 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 132.08 22.48 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.686 2.257 . . . . 71.409999999999997 112.318 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.969 HG21 HG13 ' A' ' 24' ' ' VAL . 62.8 t -102.3 134.24 43.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 74.409999999999997 111.107 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.851 HD23 HG22 ' A' ' 63' ' ' VAL . 0.3 OUTLIER -101.77 116.41 32.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 64.430000000000007 110.948 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.4 t -94.07 143.51 11.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 74.420000000000002 111.115 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.76 99.85 5.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 62.43 110.881 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -100.96 95.88 6.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 73.310000000000002 110.867 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.683 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -152.05 -167.73 2.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.45 . . . . 72.430000000000007 110.92 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.13 -165.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 52.109999999999999 111.065 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.435 ' O ' ' CB ' ' A' ' 39' ' ' TRP . 4.9 m-20 -77.66 12.6 1.59 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.237 -0.438 . . . . 75.409999999999997 110.888 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.436 ' N ' ' CD1' ' A' ' 39' ' ' TRP . 1.9 m0 78.25 90.32 0.06 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 73.5 110.91 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -174.84 -56.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 72.340000000000003 110.878 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.05 -70.89 1.3 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.72 -0.752 . . . . 52.310000000000002 112.528 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.78 -29.18 24.2 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.714 2.276 . . . . 74.140000000000001 112.365 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.535 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -61.54 -32.17 72.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 72.140000000000001 110.899 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -63.74 -30.68 71.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 72.040000000000006 110.905 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 2.0 mtt -83.78 -43.29 15.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 64.030000000000001 110.836 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.565 ' HA ' HG22 ' A' ' 49' ' ' VAL . 2.8 t -93.93 22.49 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 74.430000000000007 111.121 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.777 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -74.75 -60.73 1.21 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.617 0.723 . . . . 40.310000000000002 111.135 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.777 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.4 Cg_endo -69.79 -49.99 0.5 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.677 2.251 . . . . 73.340000000000003 112.307 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.68 ' O ' HD12 ' A' ' 53' ' ' ILE . 4.1 m -53.6 -29.68 17.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 73.319999999999993 111.128 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.9 tp -72.18 -42.07 66.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.476 . . . . 64.400000000000006 110.972 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -64.28 -36.38 83.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 74.420000000000002 110.898 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -55.82 -69.56 0.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 74.340000000000003 110.862 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.68 HD12 ' O ' ' A' ' 49' ' ' VAL . 2.7 mt -54.83 -36.94 39.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 35.030000000000001 111.128 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 54.409999999999997 111.096 179.82 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.53 HD23 HG23 ' A' ' 63' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.939 0.399 . . . . 73.549999999999997 110.87 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.15 122.27 46.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 74.219999999999999 110.928 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.851 HG22 HD23 ' A' ' 32' ' ' LEU . 21.9 t -121.6 112.57 35.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 63.350000000000001 111.147 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -121.94 129.88 52.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 72.200000000000003 111.095 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.78 154.55 26.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 72.200000000000003 110.937 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.451 HD11 ' CG ' ' A' ' 71' ' ' ASN . 4.7 tp -140.41 137.09 33.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 35.399999999999999 110.925 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.25 149.26 30.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 52.409999999999997 110.884 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 36' ' ' TRP . 6.9 t -90.74 -36.17 7.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 75.010000000000005 111.117 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.1 -35.24 64.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 45.119999999999997 110.853 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.33 -32.56 13.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 73.340000000000003 111.116 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.451 ' CG ' HD11 ' A' ' 66' ' ' LEU . 3.7 m-80 -117.01 68.36 4.5 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.611 0.72 . . . . 72.310000000000002 110.883 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -33.09 17.37 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.692 2.261 . . . . 61.399999999999999 112.348 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -67.37 -36.42 81.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 70.430000000000007 110.884 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.78 -49.58 76.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 64.040000000000006 111.078 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.652 ' HB1' ' HB ' ' A' ' 80' ' ' VAL . . . -53.62 -60.86 2.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 75.230000000000004 111.136 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 14.0 ttp85 -51.22 -34.71 33.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 72.430000000000007 110.828 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -51.93 -38.23 55.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.244 -0.435 . . . . 61.219999999999999 110.858 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -106.53 28.06 8.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 65.040000000000006 110.858 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 49.72 61.14 3.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 70.400000000000006 110.903 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.652 ' HB ' ' HB1' ' A' ' 75' ' ' ALA . 85.2 t -96.44 136.56 26.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 74.299999999999997 111.117 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.9 m -127.47 -36.48 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 54.439999999999998 111.137 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.7 t -97.06 143.84 27.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 75.129999999999995 110.825 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.527 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.9 mt -56.86 -57.59 23.18 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.624 0.726 . . . . 55.520000000000003 111.153 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.616 ' CB ' ' HB2' ' A' ' 101' ' ' ALA . 54.4 Cg_endo -69.71 76.88 1.09 Allowed 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.704 2.269 . . . . 64.310000000000002 112.35 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.666 HG23 ' CG1' ' A' ' 99' ' ' VAL . 68.8 m -116.67 127.59 54.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 72.109999999999999 111.11 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.3 tpp -128.35 140.73 51.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 71.310000000000002 110.838 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 19.2 mt -127.82 129.54 69.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 74.129999999999995 111.151 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.15 104.83 16.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 73.519999999999996 110.943 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -90.01 170.14 10.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 73.340000000000003 110.899 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -164.35 91.55 0.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 64.530000000000001 110.922 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.2 32.61 16.53 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.715 -0.755 . . . . 62.009999999999998 112.476 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.617 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 75.14 39.48 37.03 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.763 -0.732 . . . . 64.230000000000004 112.501 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.42 HG23 ' HD2' ' A' ' 94' ' ' PRO . 46.0 m -160.36 133.66 4.79 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.572 0.701 . . . . 71.129999999999995 111.118 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.42 ' HD2' HG23 ' A' ' 93' ' ' THR . 54.3 Cg_endo -69.7 94.52 0.53 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.721 2.28 . . . . 73.239999999999995 112.362 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.2 m -85.11 -30.32 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 63.32 111.083 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.91 164.43 30.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 72.430000000000007 110.886 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.409 ' C ' HD12 ' A' ' 98' ' ' ILE . 22.7 ttt180 -159.29 118.26 2.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 71.409999999999997 110.907 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.452 ' N ' HD12 ' A' ' 98' ' ' ILE . 4.5 mp -128.15 139.89 50.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 73.340000000000003 111.129 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.666 ' CG1' HG23 ' A' ' 85' ' ' THR . 10.0 m -143.37 154.33 16.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 75.120000000000005 111.106 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 136.75 -30.04 2.7 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.743 -0.742 . . . . 33.210000000000001 112.457 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.616 ' HB2' ' CB ' ' A' ' 84' ' ' PRO . . . 63.59 83.04 0.17 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.863 0.363 . . . . 40.409999999999997 111.119 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.98 179.15 6.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 75.099999999999994 110.874 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.24 149.25 39.27 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.727 -0.749 . . . . 71.420000000000002 112.476 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.53 -42.73 44.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.775 0.322 . . . . 74.340000000000003 110.898 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.57 -38.5 72.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 54.420000000000002 111.131 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.93 -59.15 2.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 53.329999999999998 111.122 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.542 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.6 OUTLIER -47.83 -41.01 22.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 74.299999999999997 110.881 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.4 tt -56.46 -41.99 77.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 62.299999999999997 110.872 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -63.75 -42.35 97.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 71.430000000000007 110.868 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -52.38 -25.15 9.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.19 -0.459 . . . . 50.450000000000003 110.887 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.7 mt -85.49 -67.87 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 73.120000000000005 111.112 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.765 ' HA ' HD23 ' A' ' 115' ' ' LEU . 1.9 pp20? -52.3 -48.92 65.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 71.519999999999996 110.867 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -58.88 -33.71 70.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 64.340000000000003 110.871 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.76 -36.5 59.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 62.200000000000003 111.135 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.765 HD23 ' HA ' ' A' ' 112' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 61.420000000000002 110.916 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.514 HG22 ' HB ' ' A' ' 63' ' ' VAL . 21.3 p . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.816 0.341 . . . . 74.349999999999994 111.125 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.1 p -160.23 155.59 3.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 74.329999999999998 111.122 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.5 t -68.29 156.9 36.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 73.400000000000006 111.154 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.552 ' CG1' HG23 ' A' ' 19' ' ' THR . 41.9 t -118.99 127.48 75.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 73.239999999999995 111.155 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.485 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.23 162.88 4.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 73.140000000000001 111.201 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -72.93 -35.68 67.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 71.109999999999999 110.826 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.3 t -75.51 -34.42 60.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 44.530000000000001 110.87 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.552 HG23 ' CG1' ' A' ' 15' ' ' VAL . 7.6 t -86.52 -18.43 31.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.075 -0.512 . . . . 74.420000000000002 111.151 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.735 ' CE2' HG21 ' A' ' 24' ' ' VAL . 24.2 t80 -51.07 -30.68 16.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 75.510000000000005 110.858 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.428 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.8 OUTLIER -72.52 -34.02 67.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 73.400000000000006 110.89 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.1 m -91.51 -16.49 27.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 63.229999999999997 111.138 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.48 -71.33 0.66 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 64.340000000000003 110.845 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.806 HG13 HG21 ' A' ' 31' ' ' VAL . 24.9 t -70.26 -70.67 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 74.109999999999999 111.166 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.428 ' HB2' ' HA ' ' A' ' 21' ' ' LYS . 7.8 mt -40.55 -60.31 1.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 52.420000000000002 110.884 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -50.09 -57.87 6.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 62.229999999999997 110.87 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.8 m -53.33 156.83 2.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 64.209999999999994 110.836 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -98.73 -46.57 5.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.484 . . . . 73.310000000000002 110.861 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.8 159.83 9.28 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.593 0.711 . . . . 73.530000000000001 111.125 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 149.44 67.23 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.669 2.246 . . . . 73.329999999999998 112.332 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.806 HG21 HG13 ' A' ' 24' ' ' VAL . 84.1 t -112.65 127.63 69.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 71.219999999999999 111.149 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.712 HD22 ' CD2' ' A' ' 88' ' ' LEU . 3.7 mt -114.81 99.81 7.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 73.420000000000002 110.93 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 87' ' ' ILE . 8.6 p -97.39 146.17 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 75.439999999999998 111.142 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -133.88 108.67 8.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.462 . . . . 73.310000000000002 110.86 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.566 ' HE2' ' HB1' ' A' ' 74' ' ' ALA . 51.4 m-85 -92.11 94.84 9.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 73.420000000000002 110.868 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -138.18 -167.72 2.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.101 -0.5 . . . . 74.299999999999997 110.918 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.03 -166.62 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 24.34 111.101 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.444 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 9.6 p-10 -78.17 12.27 1.94 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.231 -0.441 . . . . 54.219999999999999 110.87 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.455 ' N ' ' CD1' ' A' ' 39' ' ' TRP . 1.6 m0 77.0 93.32 0.07 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.233 -0.44 . . . . 71.299999999999997 110.916 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 9.5 t -174.06 -56.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.432 . . . . 64.25 110.861 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.75 -69.29 1.41 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.787 -0.72 . . . . 75.129999999999995 112.499 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -43.58 2.57 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.717 2.278 . . . . 71.120000000000005 112.335 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.543 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 33.9 t -52.66 -34.63 52.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.44 . . . . 73.209999999999994 110.883 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -64.44 -35.2 80.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.452 . . . . 72.209999999999994 110.885 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 88.2 mmm -84.59 -36.66 21.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 64.239999999999995 110.867 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.545 ' HA ' HG22 ' A' ' 49' ' ' VAL . 3.3 t -95.29 21.33 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.243 -0.435 . . . . 72.120000000000005 111.15 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.795 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -78.76 -61.39 0.52 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.6 0.715 . . . . 42.030000000000001 111.089 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.795 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.6 Cg_endo -69.74 -49.84 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.717 2.278 . . . . 70.340000000000003 112.307 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.545 HG22 ' HA ' ' A' ' 46' ' ' VAL . 4.4 m -52.23 -30.64 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.236 -0.438 . . . . 63.520000000000003 111.114 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.528 HD23 ' O ' ' A' ' 50' ' ' LEU . 7.5 tt -84.29 -35.16 23.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 52.130000000000003 110.915 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -58.94 -35.47 73.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 74.230000000000004 110.9 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -51.28 -58.25 6.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 71.25 110.885 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.7 mp -51.56 -34.86 16.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 65.310000000000002 111.134 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 62.210000000000001 111.109 179.779 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.617 HD13 HD12 ' A' ' 32' ' ' LEU . 3.6 pp . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.885 0.374 . . . . 72.239999999999995 110.922 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -84.41 147.49 27.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 74.120000000000005 110.857 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.514 ' HB ' HG22 ' A' ' 12' ' ' THR . 19.8 t -130.47 103.41 8.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 75.230000000000004 111.088 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.6 129.76 50.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 54.210000000000001 111.112 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -129.87 142.49 50.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 71.510000000000005 110.915 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.617 HD21 ' HB2' ' A' ' 71' ' ' ASN . 7.7 tp -137.67 141.17 41.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 61.109999999999999 110.877 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.51 108.99 18.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 73.019999999999996 110.834 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 70.0 t -60.06 -35.78 63.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 41.329999999999998 111.145 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -51.36 -35.07 36.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 74.019999999999996 110.838 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.89 -35.2 10.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 61.439999999999998 111.07 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.617 ' HB2' HD21 ' A' ' 66' ' ' LEU . 1.8 m-80 -116.09 70.56 4.0 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.667 0.746 . . . . 73.219999999999999 110.882 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -31.73 19.92 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.686 2.257 . . . . 43.25 112.33 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -64.1 -35.74 81.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 72.549999999999997 110.933 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.566 ' HB1' ' HE2' ' A' ' 35' ' ' PHE . . . -57.23 -48.8 77.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 45.520000000000003 111.135 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.541 ' O ' HG23 ' A' ' 80' ' ' VAL . . . -53.63 -61.16 2.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 65.299999999999997 111.084 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.7 ttp85 -51.3 -34.05 31.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 62.229999999999997 110.867 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -51.71 -39.65 58.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 55.219999999999999 110.867 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -104.29 26.43 8.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 72.450000000000003 110.892 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 51.0 mm-40 49.78 65.57 1.38 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 74.540000000000006 110.916 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 75' ' ' ALA . 91.7 t -96.82 143.63 12.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.239 -0.437 . . . . 54.439999999999998 111.127 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.7 m -123.64 -38.71 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 73.230000000000004 111.066 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.72 156.82 17.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 63.200000000000003 110.866 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.527 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 2.3 mm -64.6 -57.84 15.48 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.588 0.709 . . . . 73.430000000000007 111.095 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.5 Cg_endo -69.78 70.6 1.58 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.673 2.249 . . . . 65.230000000000004 112.329 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.43 ' OG1' HG13 ' A' ' 80' ' ' VAL . 96.9 m -104.81 137.97 41.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.232 -0.44 . . . . 52.520000000000003 111.143 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -139.04 127.99 23.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 74.549999999999997 110.905 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.403 ' O ' HG12 ' A' ' 33' ' ' VAL . 2.3 mp -114.36 112.76 41.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 63.350000000000001 111.122 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.712 ' CD2' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -79.53 105.71 11.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.47 . . . . 70.200000000000003 110.934 179.891 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -93.13 166.5 12.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 62.350000000000001 110.883 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -170.61 97.1 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 65.340000000000003 110.9 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.98 38.99 9.68 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.713 -0.756 . . . . 70.299999999999997 112.489 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.49 45.02 88.7 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.736 -0.745 . . . . 62.240000000000002 112.444 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.3 m -170.25 134.67 1.14 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.555 0.693 . . . . 74.019999999999996 111.161 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 82.49 0.75 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.667 2.245 . . . . 75.230000000000004 112.336 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.0 m -60.17 -34.08 55.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 74.219999999999999 111.141 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -147.87 170.1 18.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 54.310000000000002 110.911 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.458 ' C ' HD12 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -154.37 123.77 6.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 75.239999999999995 110.847 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.458 HD12 ' C ' ' A' ' 97' ' ' ARG . 4.5 mp -130.26 128.84 64.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 65.230000000000004 111.118 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.4 p -128.42 141.74 45.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 71.409999999999997 111.163 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 122.64 140.23 5.7 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.749 -0.739 . . . . 53.039999999999999 112.502 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.53 93.9 9.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.811 0.339 . . . . 71.019999999999996 111.126 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.577 ' HB2' ' HB3' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -116.77 -176.05 2.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 73.040000000000006 110.859 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.18 163.62 54.52 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.739 -0.744 . . . . 63.43 112.489 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.79 -36.15 57.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.748 0.308 . . . . 73.530000000000001 110.897 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.5 -54.6 10.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 62.240000000000002 111.084 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.577 ' HB3' ' HB2' ' A' ' 102' ' ' LYS . . . -55.76 -53.99 49.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 71.310000000000002 111.125 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.61 HD13 ' O ' ' A' ' 107' ' ' LEU . 1.0 OUTLIER -50.78 -39.48 52.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 74.200000000000003 110.957 179.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.436 HD23 ' HG2' ' A' ' 112' ' ' GLU . 0.3 OUTLIER -66.82 -52.77 39.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 70.310000000000002 110.883 179.885 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.51 -40.59 83.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 74.310000000000002 110.918 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -47.12 -28.65 1.86 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 63.020000000000003 110.933 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.6 mt -93.09 -69.52 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 61.229999999999997 111.163 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.436 ' HG2' HD23 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -54.07 -59.96 3.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 63.509999999999998 110.953 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -49.51 -35.9 21.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 72.420000000000002 110.835 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.56 -35.77 63.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 70.450000000000003 111.066 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 74.219999999999999 110.923 -179.964 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.1 p . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.81 0.338 . . . . 71.200000000000003 111.162 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 t -132.67 150.41 33.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 74.150000000000006 111.12 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.6 t -86.86 130.6 34.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 75.329999999999998 111.122 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.6 t -89.97 125.72 42.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 73.230000000000004 111.102 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.545 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.5 173.88 0.49 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 55.0 111.131 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.466 ' H ' HG22 ' A' ' 16' ' ' THR . 11.3 t70 -74.96 -47.39 29.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 72.109999999999999 110.848 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.1 m -71.62 -51.64 22.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 62.240000000000002 110.861 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.545 HG22 ' HB ' ' A' ' 16' ' ' THR . 6.3 t -59.28 -19.12 43.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 64.200000000000003 111.18 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.711 ' CE2' HG21 ' A' ' 24' ' ' VAL . 25.2 t80 -51.24 -30.26 16.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 70.109999999999999 110.898 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.409 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -72.55 -33.65 66.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 74.340000000000003 110.869 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.0 m -91.56 -16.08 27.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.196 -0.456 . . . . 73.25 111.181 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.44 -71.32 0.66 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 72.340000000000003 110.864 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.869 HG13 HG21 ' A' ' 31' ' ' VAL . 20.4 t -70.39 -70.5 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.476 . . . . 73.420000000000002 111.109 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.571 HD23 ' HA3' ' A' ' 92' ' ' GLY . 7.6 mt -40.57 -59.99 1.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 70.430000000000007 110.925 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -50.57 -52.64 37.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.458 . . . . 61.100000000000001 110.853 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.1 t -65.31 148.61 51.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 73.519999999999996 110.839 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -102.32 -38.2 7.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.131 -0.486 . . . . 75.129999999999995 110.895 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -52.05 160.23 1.24 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.527 0.68 . . . . 74.329999999999998 111.143 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 127.46 14.62 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.651 2.234 . . . . 73.109999999999999 112.385 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.869 HG21 HG13 ' A' ' 24' ' ' VAL . 41.1 t -93.25 132.0 38.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 64.519999999999996 111.132 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.422 ' CD1' HD21 ' A' ' 88' ' ' LEU . 1.5 mm? -102.85 99.8 9.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 74.409999999999997 110.917 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.555 HG13 HG12 ' A' ' 31' ' ' VAL . 10.2 m -121.46 150.2 24.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 72.510000000000005 111.137 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.01 123.97 31.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 64.319999999999993 110.902 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -89.71 88.78 7.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 71.510000000000005 110.87 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -142.59 -169.19 2.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.477 . . . . 74.200000000000003 110.952 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.87 -163.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.43 . . . . 61.509999999999998 111.116 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.471 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 2.6 m-20 -77.88 12.88 1.55 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 71.25 110.877 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.497 ' N ' ' CD1' ' A' ' 39' ' ' TRP . 0.6 OUTLIER 74.95 96.18 0.07 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 64.400000000000006 110.954 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -170.1 -53.76 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 51.020000000000003 110.875 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.29 -70.72 1.32 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.762 -0.732 . . . . 74.209999999999994 112.474 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.67 -34.18 15.41 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.694 2.263 . . . . 74.519999999999996 112.347 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.562 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 38.4 t -51.8 -33.73 36.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 73.219999999999999 110.883 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.4 mtmt -65.43 -35.3 80.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 75.340000000000003 110.952 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 15.1 mtp -83.49 -39.95 19.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 72.530000000000001 110.883 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.564 ' HA ' HG22 ' A' ' 49' ' ' VAL . 2.9 t -94.54 22.93 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 70.129999999999995 111.152 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.808 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -75.13 -61.16 1.05 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.558 0.694 . . . . 50.43 111.077 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.808 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 52.9 Cg_endo -69.8 -50.65 0.44 Allowed 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.671 2.248 . . . . 42.439999999999998 112.322 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.679 ' O ' HD12 ' A' ' 53' ' ' ILE . 4.3 m -52.53 -30.04 14.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 73.010000000000005 111.141 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.0 tp -74.5 -42.57 58.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 72.530000000000001 110.881 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -57.8 -36.72 72.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 62.299999999999997 110.87 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -57.74 -67.79 0.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 51.210000000000001 110.884 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.679 HD12 ' O ' ' A' ' 49' ' ' VAL . 2.7 mp -50.94 -34.84 14.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 72.219999999999999 111.118 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 74.209999999999994 111.119 179.831 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.408 ' C ' HD12 ' A' ' 61' ' ' LEU . 4.1 pp . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.904 0.383 . . . . 75.019999999999996 110.895 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -79.9 118.96 22.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 71.239999999999995 110.924 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.6 t -111.9 107.16 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 53.340000000000003 111.108 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -126.65 170.9 11.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 61.43 111.093 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 31.1 mttt -145.29 148.13 33.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.448 . . . . 72.340000000000003 110.845 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.537 HD11 ' CG ' ' A' ' 71' ' ' ASN . 4.0 tp -125.62 140.55 52.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 73.319999999999993 110.879 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -87.79 119.76 28.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 74.150000000000006 110.831 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.71 -28.08 44.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 61.219999999999999 111.152 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -68.94 -34.98 76.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.178 -0.465 . . . . 74.329999999999998 110.875 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.32 -28.7 23.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 74.450000000000003 111.087 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.537 ' CG ' HD11 ' A' ' 66' ' ' LEU . 5.5 m-80 -115.43 69.37 2.85 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.564 0.697 . . . . 71.510000000000005 110.896 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 -32.06 19.01 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.647 2.231 . . . . 73.439999999999998 112.331 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -74.83 -35.1 62.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 73.310000000000002 110.883 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.04 -40.87 91.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 44.109999999999999 111.111 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.494 ' HB1' ' HB ' ' A' ' 80' ' ' VAL . . . -57.96 -64.85 0.76 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 62.210000000000001 111.086 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -51.15 -34.88 33.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 72.409999999999997 110.879 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.82 -36.33 80.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 44.420000000000002 110.883 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -98.45 24.69 7.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 75.340000000000003 110.88 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 49.09 54.05 11.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 73.549999999999997 110.945 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.494 ' HB ' ' HB1' ' A' ' 75' ' ' ALA . 97.6 t -90.15 136.66 23.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 64.450000000000003 111.164 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.8 m -131.58 -39.07 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 70.420000000000002 111.132 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.1 t -97.04 155.16 16.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 71.409999999999997 110.888 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.52 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 2.3 mm -66.47 -57.96 11.28 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.601 0.715 . . . . 73.439999999999998 111.124 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.4 Cg_endo -69.71 70.07 1.58 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.669 2.246 . . . . 44.520000000000003 112.355 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.645 HG23 ' HB ' ' A' ' 99' ' ' VAL . 62.0 m -109.39 149.39 29.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 64.340000000000003 111.127 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 26.6 ttm -138.63 150.35 46.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 64.109999999999999 110.843 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.9 mt -142.76 109.92 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 73.230000000000004 111.139 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.422 HD21 ' CD1' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -79.68 105.85 11.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.47 . . . . 75.129999999999995 110.926 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -90.29 169.79 10.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 61.32 110.855 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -165.44 95.34 0.64 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 73.540000000000006 110.863 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.67 37.72 13.31 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.753 -0.737 . . . . 74.239999999999995 112.474 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.571 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 68.38 41.01 86.69 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.71 -0.757 . . . . 33.329999999999998 112.494 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.446 HG23 ' HD2' ' A' ' 94' ' ' PRO . 85.4 m -160.76 134.05 4.77 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.643 0.735 . . . . 74.420000000000002 111.088 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.446 ' HD2' HG23 ' A' ' 93' ' ' THR . 53.7 Cg_endo -69.79 86.94 0.57 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.703 2.269 . . . . 71.340000000000003 112.327 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.0 m -76.66 -34.58 23.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 60.32 111.173 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.92 164.12 26.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 62.539999999999999 110.897 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.546 ' C ' HD12 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -155.61 119.83 4.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 74.219999999999999 110.895 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.546 HD12 ' C ' ' A' ' 97' ' ' ARG . 4.8 mp -138.31 130.12 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 75.420000000000002 111.133 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.645 ' HB ' HG23 ' A' ' 85' ' ' THR . 1.6 p -126.11 143.44 39.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 64.430000000000007 111.104 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 128.83 132.61 3.54 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.771 -0.728 . . . . 62.140000000000001 112.486 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.19 75.05 9.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.854 0.359 . . . . 74.140000000000001 111.138 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.432 ' HG2' HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -113.39 171.63 7.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 53.140000000000001 110.896 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.57 171.6 5.45 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.696 -0.764 . . . . 72.239999999999995 112.496 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -60.1 -44.39 94.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.784 0.326 . . . . 73.329999999999998 110.888 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -52.49 -66.29 0.41 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 74.5 111.09 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.71 -59.36 4.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 71.209999999999994 111.095 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.637 HD13 ' O ' ' A' ' 107' ' ' LEU . 1.0 OUTLIER -47.31 -35.48 8.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 73.030000000000001 110.933 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.598 ' O ' HD12 ' A' ' 108' ' ' LEU . 4.2 tp -71.19 -43.92 66.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 74.439999999999998 110.91 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 10.6 mtp85 -59.46 -41.82 90.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 74.400000000000006 110.876 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -53.03 -25.33 12.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 55.219999999999999 110.933 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.7 mt -86.04 -68.59 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 75.120000000000005 111.16 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -51.15 -49.57 60.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.151 -0.477 . . . . 71.219999999999999 110.894 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -58.53 -34.23 70.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 52.329999999999998 110.918 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.1 -36.33 61.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 53.25 111.124 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 mt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 71.430000000000007 110.902 -179.979 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.717 HG22 ' H ' ' A' ' 63' ' ' VAL . 37.1 p . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.832 0.348 . . . . 73.319999999999993 111.112 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.3 m -153.14 174.78 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 72.150000000000006 111.147 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.1 t -75.69 127.21 32.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 52.229999999999997 111.174 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 49.1 t -94.77 125.91 47.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 63.119999999999997 111.136 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.55 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.27 174.0 0.44 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 62.439999999999998 111.152 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.473 ' H ' HG22 ' A' ' 16' ' ' THR . 16.6 t0 -75.1 -47.37 29.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 74.299999999999997 110.81 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.5 t -72.1 -51.52 21.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 75.310000000000002 110.847 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.55 HG22 ' HB ' ' A' ' 16' ' ' THR . 5.8 t -59.12 -19.2 42.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.478 . . . . 73.409999999999997 111.124 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.718 ' CE2' HG21 ' A' ' 24' ' ' VAL . 24.9 t80 -50.88 -30.96 16.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 70.25 110.868 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.43 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -71.78 -34.13 69.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 63.119999999999997 110.92 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.0 m -91.13 -15.91 28.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 71.239999999999995 111.15 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.34 -71.41 0.65 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.441 . . . . 65.230000000000004 110.907 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.718 HG21 ' CE2' ' A' ' 20' ' ' PHE . 17.3 t -70.71 -70.34 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.239 -0.437 . . . . 75.150000000000006 111.127 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.508 HD23 ' HA3' ' A' ' 92' ' ' GLY . 7.4 mt -40.55 -60.31 1.15 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 64.030000000000001 110.921 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -50.36 -61.21 2.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.439 . . . . 74.409999999999997 110.874 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.7 t -56.55 161.33 2.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 73.400000000000006 110.821 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -109.92 -35.98 6.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.104 -0.498 . . . . 71.120000000000005 110.884 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -53.44 158.88 2.57 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.585 0.707 . . . . 72.349999999999994 111.103 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 125.66 12.42 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.631 2.221 . . . . 72.150000000000006 112.387 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.552 HG21 HG13 ' A' ' 24' ' ' VAL . 94.6 t -102.1 115.88 44.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 73.140000000000001 111.148 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.9 mp -94.58 99.73 11.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 73.310000000000002 110.874 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.3 p -98.59 140.88 17.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.14 -0.482 . . . . 70.230000000000004 111.075 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -124.8 102.08 7.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 73.549999999999997 110.84 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -83.4 89.57 7.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 73.340000000000003 110.889 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.739 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -135.6 -168.58 2.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.148 -0.478 . . . . 72.209999999999994 110.903 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.54 -164.48 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 75.530000000000001 111.096 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.45 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 9.5 p-10 -78.68 12.71 1.94 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 74.340000000000003 110.861 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.476 ' N ' ' CD1' ' A' ' 39' ' ' TRP . 1.0 OUTLIER 76.03 95.15 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 71.540000000000006 110.935 -179.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 46.1 t -172.25 -56.22 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 41.439999999999998 110.849 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.51 -70.71 1.32 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.721 -0.752 . . . . 71.310000000000002 112.478 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.449 ' HG3' HG21 ' A' ' 83' ' ' ILE . 53.7 Cg_endo -69.72 -32.63 18.36 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.639 2.226 . . . . 65.430000000000007 112.324 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.558 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 35.8 t -54.74 -40.69 69.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.436 . . . . 74.239999999999995 110.907 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.8 pttp -64.34 -26.46 68.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 60.350000000000001 110.861 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 5.3 mtp -87.15 -42.85 12.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.276 -0.42 . . . . 65.450000000000003 110.871 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.522 ' HA ' HG22 ' A' ' 49' ' ' VAL . 3.1 t -94.31 21.44 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 73.209999999999994 111.147 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.778 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -76.75 -61.17 0.76 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.562 0.696 . . . . 54.43 111.088 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.778 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.7 Cg_endo -69.81 -49.77 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.678 2.252 . . . . 63.149999999999999 112.344 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.596 ' O ' HD12 ' A' ' 53' ' ' ILE . 4.3 m -51.24 -30.85 10.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 71.450000000000003 111.105 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.4 tp -90.16 -35.89 15.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 62.140000000000001 110.886 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -68.26 -24.16 64.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 72.099999999999994 110.925 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -65.97 -60.71 2.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.478 . . . . 52.140000000000001 110.873 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.596 HD12 ' O ' ' A' ' 49' ' ' VAL . 2.6 mp -61.52 -33.02 55.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 64.299999999999997 111.118 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 73.150000000000006 111.101 179.823 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.486 HD12 ' N ' ' A' ' 62' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.863 0.363 . . . . 72.310000000000002 110.918 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.486 ' N ' HD12 ' A' ' 61' ' ' LEU . 12.4 ttpp -107.62 141.39 39.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 65.5 110.93 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.717 ' H ' HG22 ' A' ' 12' ' ' THR . 50.4 t -101.71 108.67 24.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.22 -0.446 . . . . 62.130000000000003 111.182 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -122.27 128.91 51.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 73.450000000000003 111.103 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.8 pttt -125.99 157.61 37.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 74.140000000000001 110.882 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 31.3 tp -147.95 146.45 28.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 54.25 110.882 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -82.96 119.88 24.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 62.340000000000003 110.925 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 36' ' ' TRP . 84.7 t -48.14 -39.52 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 75.450000000000003 111.086 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.02 -33.31 56.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 72.230000000000004 110.862 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.82 -34.68 45.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 75.25 111.043 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.601 ' HB2' ' HB3' ' A' ' 74' ' ' ALA . 5.2 p30 -118.39 66.91 6.76 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.627 0.727 . . . . 74.209999999999994 110.874 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -32.85 17.52 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.686 2.257 . . . . 62.340000000000003 112.327 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -80.92 -38.65 27.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 64.510000000000005 110.925 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.601 ' HB3' ' HB2' ' A' ' 71' ' ' ASN . . . -60.99 -43.32 99.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 60.119999999999997 111.149 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.478 ' HB1' ' HB ' ' A' ' 80' ' ' VAL . . . -51.76 -67.27 0.27 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 74.409999999999997 111.136 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.1 ttm-85 -51.19 -34.07 30.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.259 -0.428 . . . . 73.420000000000002 110.886 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.43 -40.19 90.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 74.519999999999996 110.867 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -98.89 26.68 5.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 65.120000000000005 110.867 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 49.85 75.44 0.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 53.32 110.919 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.478 ' HB ' ' HB1' ' A' ' 75' ' ' ALA . 90.9 t -116.45 90.55 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 62.310000000000002 111.134 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 61.1 t -84.4 -42.61 17.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 63.030000000000001 111.111 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.6 m -96.75 152.73 18.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 75.040000000000006 110.866 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.531 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.3 mt -63.9 -57.64 17.94 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.598 0.713 . . . . 74.150000000000006 111.112 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 54.0 Cg_endo -69.74 75.43 1.21 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.743 2.295 . . . . 62.109999999999999 112.336 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 84.8 m -117.17 100.89 8.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 72.209999999999994 111.159 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 22.5 ttp -100.76 112.08 24.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 70.430000000000007 110.883 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 25.2 mt -101.33 118.0 47.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 64.150000000000006 111.165 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.656 HD12 HD13 ' A' ' 111' ' ' ILE . 1.9 tt -81.15 110.3 16.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 71.219999999999999 110.923 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -97.47 170.27 9.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.477 . . . . 74.230000000000004 110.88 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -167.3 97.95 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 75.329999999999998 110.903 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.68 38.43 10.63 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.719 -0.753 . . . . 75.299999999999997 112.509 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.508 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 65.76 37.12 93.13 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.702 -0.761 . . . . 65.209999999999994 112.458 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.456 HG23 ' HD2' ' A' ' 94' ' ' PRO . 86.6 m -158.43 133.89 5.85 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.584 0.707 . . . . 70.010000000000005 111.147 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.456 ' HD2' HG23 ' A' ' 93' ' ' THR . 53.4 Cg_endo -69.75 112.64 3.13 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.697 2.265 . . . . 72.219999999999999 112.322 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.6 m -99.63 -33.51 3.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.443 . . . . 64.209999999999994 111.115 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.5 mmtt -140.88 169.66 17.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 71.400000000000006 110.864 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -153.93 111.87 3.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 75.430000000000007 110.875 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.426 ' N ' HD12 ' A' ' 98' ' ' ILE . 4.6 mp -112.75 127.95 69.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 62.219999999999999 111.164 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.0 p -141.69 144.7 25.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 62.100000000000001 111.155 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 139.58 -28.65 2.53 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.786 -0.721 . . . . 54.409999999999997 112.518 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 64.5 96.57 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.822 0.344 . . . . 71.530000000000001 111.101 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.15 -179.25 5.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 74.129999999999995 110.884 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.29 176.76 2.68 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.745 -0.74 . . . . 41.539999999999999 112.508 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.16 -44.57 71.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.799 0.333 . . . . 72.230000000000004 110.896 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.58 -32.9 70.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 55.200000000000003 111.12 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.446 ' HA ' ' HG2' ' A' ' 109' ' ' ARG . . . -85.43 -58.39 2.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 74.329999999999998 111.082 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.627 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.6 OUTLIER -51.12 -35.51 35.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 64.349999999999994 110.93 -179.96 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.596 HD23 ' N ' ' A' ' 109' ' ' ARG . 5.7 tt -68.83 -59.44 3.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 73.030000000000001 110.91 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.596 ' N ' HD23 ' A' ' 108' ' ' LEU . 15.8 ptm180 -56.91 -32.81 66.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 64.510000000000005 110.867 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -51.9 -25.46 8.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 71.319999999999993 110.878 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.656 HD13 HD12 ' A' ' 88' ' ' LEU . 3.8 mt -85.56 -69.03 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 72.310000000000002 111.148 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -51.56 -49.88 61.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 64.019999999999996 110.92 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -54.12 -34.68 60.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 72.230000000000004 110.84 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.17 -34.95 66.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 75.349999999999994 111.1 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.9 mt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 54.539999999999999 110.889 -179.951 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.2 p . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.836 0.35 . . . . 62.210000000000001 111.109 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.6 m -154.53 -179.85 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 75.140000000000001 111.16 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.3 t -72.64 151.16 42.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 63.450000000000003 111.149 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.489 HG22 ' CG2' ' A' ' 19' ' ' THR . 9.1 p -119.26 151.87 21.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 75.540000000000006 111.144 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.639 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -63.37 162.06 13.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 45.119999999999997 111.109 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -77.4 -52.33 9.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 73.439999999999998 110.821 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.9 t -57.76 -36.37 72.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 64.329999999999998 110.859 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.639 HG22 ' HB ' ' A' ' 16' ' ' THR . 5.0 t -84.65 -17.83 37.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 75.219999999999999 111.137 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.714 ' CE2' HG21 ' A' ' 24' ' ' VAL . 24.6 t80 -49.92 -31.49 12.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 75.540000000000006 110.924 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.405 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -70.95 -34.46 71.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 72.200000000000003 110.869 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.5 m -91.01 -15.2 30.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 75.209999999999994 111.157 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.42 -70.61 0.69 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.231 -0.441 . . . . 73.0 110.862 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 1.035 HG13 HG21 ' A' ' 31' ' ' VAL . 17.3 t -72.06 -70.38 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 75.099999999999994 111.137 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.652 HD23 ' HA3' ' A' ' 92' ' ' GLY . 7.5 mt -40.41 -57.7 1.72 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.156 -0.475 . . . . 71.239999999999995 110.911 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -51.28 -60.04 3.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 74.140000000000001 110.852 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 55.5 p -51.67 139.47 20.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 64.239999999999995 110.838 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -88.82 -41.77 12.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 73.129999999999995 110.872 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.468 HG22 ' HD2' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -51.54 158.76 1.39 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.582 0.706 . . . . 70.340000000000003 111.18 -179.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.468 ' HD2' HG22 ' A' ' 29' ' ' THR . 54.0 Cg_endo -69.73 129.8 18.27 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.703 2.269 . . . . 72.230000000000004 112.324 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 1.035 HG21 HG13 ' A' ' 24' ' ' VAL . 92.4 t -97.1 126.6 49.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.437 . . . . 75.340000000000003 111.135 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.8 mp -110.12 121.07 44.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 74.409999999999997 110.937 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.717 HG12 ' HB3' ' A' ' 64' ' ' ALA . 11.7 m -132.81 149.9 32.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 75.540000000000006 111.104 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.28 99.63 5.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 72.239999999999995 110.832 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.47 ' CE2' HD22 ' A' ' 66' ' ' LEU . 5.8 m-85 -73.59 96.81 2.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 65.400000000000006 110.893 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -142.83 -168.6 2.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.168 -0.469 . . . . 74.439999999999998 110.914 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.49 -162.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 54.240000000000002 111.133 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.484 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 4.1 t70 -77.96 13.72 1.32 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.268 -0.424 . . . . 51.32 110.876 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.484 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 0.5 OUTLIER 74.95 94.34 0.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.204 -0.453 . . . . 72.450000000000003 110.887 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 35.0 t -174.79 -50.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 72.349999999999994 110.885 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.24 -69.55 1.39 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.724 -0.75 . . . . 73.319999999999993 112.459 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 -28.47 24.96 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.684 2.256 . . . . 71.129999999999995 112.351 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.655 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 1.9 p -53.95 -25.53 21.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 75.450000000000003 110.95 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.2 pttt -77.96 -31.48 50.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 73.400000000000006 110.847 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 16.1 mtt -85.82 -35.4 20.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 74.549999999999997 110.886 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.552 ' HA ' HG22 ' A' ' 49' ' ' VAL . 2.8 t -100.36 22.07 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.246 -0.434 . . . . 75.129999999999995 111.122 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.814 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -74.36 -61.21 1.23 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.556 0.693 . . . . 74.25 111.091 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.814 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.7 Cg_endo -69.73 -50.66 0.45 Allowed 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.732 2.288 . . . . 52.520000000000003 112.359 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.572 ' O ' HD12 ' A' ' 53' ' ' ILE . 4.1 m -52.09 -29.98 12.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.459 . . . . 33.140000000000001 111.132 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.6 tp -75.04 -41.96 58.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 64.540000000000006 110.888 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -67.45 -34.34 76.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 70.319999999999993 110.872 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -52.84 -62.09 1.87 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 74.120000000000005 110.876 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.572 HD12 ' O ' ' A' ' 49' ' ' VAL . 3.1 mt -51.21 -39.51 20.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 74.049999999999997 111.118 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 74.319999999999993 111.116 179.771 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.3 pp . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.854 0.359 . . . . 63.210000000000001 110.945 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.8 tttp -86.78 147.64 25.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.443 . . . . 64.400000000000006 110.888 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.4 t -140.74 106.56 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.421 . . . . 61.439999999999998 111.124 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.717 ' HB3' HG12 ' A' ' 33' ' ' VAL . . . -113.62 110.08 19.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 31.140000000000001 111.07 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.0 pttm -97.23 128.98 44.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 61.130000000000003 110.911 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.47 HD22 ' CE2' ' A' ' 35' ' ' PHE . 6.2 tp -105.15 146.08 29.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 74.420000000000002 110.909 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.636 ' OD2' ' HB3' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -108.86 97.37 7.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 70.230000000000004 110.86 179.858 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.1 m -49.08 -32.2 4.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 44.100000000000001 111.155 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -50.14 -32.5 16.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 72.340000000000003 110.904 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.636 ' HB3' ' OD2' ' A' ' 67' ' ' ASP . . . -105.99 -28.5 10.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 64.349999999999994 111.098 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.82 72.22 2.02 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.631 0.729 . . . . 75.150000000000006 110.9 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -30.99 21.2 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.661 2.24 . . . . 74.409999999999997 112.337 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -70.6 -42.88 70.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 73.349999999999994 110.895 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.24 -48.35 62.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 75.040000000000006 111.081 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.593 ' HB1' ' CG1' ' A' ' 80' ' ' VAL . . . -53.76 -67.31 0.27 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 74.340000000000003 111.157 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.1 ttp85 -51.87 -31.4 27.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 72.140000000000001 110.868 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -51.64 -37.96 52.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 63.539999999999999 110.87 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -105.24 21.44 17.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 74.329999999999998 110.888 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 65.3 mm-40 46.61 82.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.115 -0.493 . . . . 72.510000000000005 110.917 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.593 ' CG1' ' HB1' ' A' ' 75' ' ' ALA . 7.0 p -122.09 132.77 70.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 75.230000000000004 111.149 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.8 t -120.46 45.81 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 74.230000000000004 111.13 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.454 ' H ' HG22 ' A' ' 80' ' ' VAL . 0.3 OUTLIER -174.05 144.91 1.03 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 52.240000000000002 110.847 -179.813 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.53 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 4.3 mt -66.44 -58.04 11.16 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.571 0.7 . . . . 75.549999999999997 111.116 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.72 ' HB2' ' HB2' ' A' ' 101' ' ' ALA . 53.2 Cg_endo -69.79 73.96 1.34 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.699 2.266 . . . . 52.439999999999998 112.336 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.634 HG23 ' HB ' ' A' ' 99' ' ' VAL . 97.6 m -117.77 129.57 55.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 71.439999999999998 111.145 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -120.78 144.02 48.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.443 . . . . 71.120000000000005 110.874 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 17.5 mt -131.7 122.89 50.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 64.299999999999997 111.129 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.28 105.4 17.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.149 -0.478 . . . . 73.299999999999997 110.889 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -89.45 169.84 11.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 60.310000000000002 110.933 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.12 91.16 0.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 73.340000000000003 110.886 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.33 33.13 12.14 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.706 -0.759 . . . . 74.120000000000005 112.49 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.652 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 74.99 38.83 39.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.761 -0.733 . . . . 63.229999999999997 112.477 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.44 HG23 ' HD2' ' A' ' 94' ' ' PRO . 85.5 m -161.26 133.8 4.41 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.577 0.704 . . . . 65.219999999999999 111.128 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.44 ' HD2' HG23 ' A' ' 93' ' ' THR . 54.0 Cg_endo -69.78 98.13 0.67 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.651 2.234 . . . . 62.140000000000001 112.352 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.6 m -87.65 -31.8 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 72.310000000000002 111.131 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.9 mmtm -132.42 166.0 22.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 73.299999999999997 110.915 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -159.76 115.0 2.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 70.109999999999999 110.866 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.428 ' N ' HD12 ' A' ' 98' ' ' ILE . 4.5 mp -125.36 118.01 51.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 74.120000000000005 111.105 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.634 ' HB ' HG23 ' A' ' 85' ' ' THR . 2.2 p -128.18 145.14 35.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 70.140000000000001 111.146 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 136.68 -28.31 2.87 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.796 -0.716 . . . . 75.329999999999998 112.475 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.72 ' HB2' ' HB2' ' A' ' 84' ' ' PRO . . . 64.49 106.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.821 0.344 . . . . 64.530000000000001 111.075 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.454 ' HG2' HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -147.46 175.61 10.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 74.019999999999996 110.901 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.51 166.66 8.88 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.735 -0.745 . . . . 75.519999999999996 112.538 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.68 -36.51 84.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.766 0.317 . . . . 70.150000000000006 110.932 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.34 -31.33 72.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 75.439999999999998 111.102 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.46 -58.84 2.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 64.5 111.105 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.454 HD23 ' HG2' ' A' ' 102' ' ' LYS . 0.3 OUTLIER -48.22 -47.53 35.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 74.530000000000001 110.929 180.0 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.439 HD23 ' C ' ' A' ' 108' ' ' LEU . 4.0 tt -47.98 -41.53 25.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 71.340000000000003 110.905 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 44.4 mtp180 -76.51 -35.8 58.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 73.430000000000007 110.878 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -51.02 -24.68 3.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.229 -0.441 . . . . 74.439999999999998 110.862 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.0 mt -87.78 -68.94 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 70.329999999999998 111.143 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.461 ' HA ' HD23 ' A' ' 115' ' ' LEU . 0.7 OUTLIER -53.88 -52.92 58.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 74.439999999999998 110.885 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -54.14 -34.47 60.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 71.310000000000002 110.858 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.87 -34.67 71.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 75.420000000000002 111.066 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 112' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 74.219999999999999 110.951 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.2 ttm . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.777 0.322 . . . . 73.030000000000001 110.828 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.44 124.98 36.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 72.239999999999995 111.114 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -99.99 -65.9 0.94 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 73.340000000000003 110.831 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -52.06 149.44 5.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 55.0 110.864 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -143.26 165.93 26.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 73.150000000000006 110.866 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -119.99 30.76 6.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 61.030000000000001 110.859 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.7 t-80 -95.64 -36.47 11.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 61.43 110.814 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -52.26 -36.06 51.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.253 -0.431 . . . . 72.209999999999994 110.9 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 13.3 mtt -52.19 -37.32 54.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 70.340000000000003 110.887 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.8 t -53.91 127.89 28.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.433 . . . . 62.32 110.897 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.08 -97.84 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.741 -0.742 . . . . 71.319999999999993 112.499 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.2 p -63.4 115.68 4.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.824 0.345 . . . . 73.230000000000004 111.112 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.2 t -147.09 145.4 19.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 75.219999999999999 111.086 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.8 t -77.7 127.93 33.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 71.450000000000003 111.109 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.537 ' CG1' HG23 ' A' ' 19' ' ' THR . 43.9 t -97.66 120.79 47.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 75.140000000000001 111.11 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.451 HG22 ' H ' ' A' ' 17' ' ' ASP . 0.2 OUTLIER -59.92 173.58 0.59 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 64.140000000000001 111.185 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.451 ' H ' HG22 ' A' ' 16' ' ' THR . 38.0 t0 -77.87 -41.64 36.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 74.099999999999994 110.878 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.3 m -69.6 -33.73 73.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 71.530000000000001 110.881 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.537 HG23 ' CG1' ' A' ' 15' ' ' VAL . 13.2 t -85.55 -18.19 34.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 74.349999999999994 111.178 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.804 ' CZ ' HG21 ' A' ' 24' ' ' VAL . 7.3 t80 -51.05 -52.68 40.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 73.120000000000005 110.886 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.719 ' CB ' HD12 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -64.6 -14.67 58.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 72.239999999999995 110.864 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.6 m -92.99 -33.17 14.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.294 -0.412 . . . . 73.400000000000006 111.16 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -96.96 -71.56 0.67 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 54.130000000000003 110.878 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.804 HG21 ' CZ ' ' A' ' 20' ' ' PHE . 38.4 t -51.48 -71.81 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 55.450000000000003 111.117 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.719 HD12 ' CB ' ' A' ' 21' ' ' LYS . 12.1 mt -41.71 -58.95 1.8 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 65.109999999999999 110.921 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -49.71 -64.81 0.7 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 73.430000000000007 110.857 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.6 t -55.49 145.88 21.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 70.299999999999997 110.848 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -107.36 35.92 2.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.487 . . . . 71.349999999999994 110.858 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.25 160.3 38.07 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 121.571 0.7 . . . . 74.450000000000003 111.123 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 106.42 1.67 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.695 2.263 . . . . 74.430000000000007 112.343 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.747 HG21 HG13 ' A' ' 24' ' ' VAL . 70.5 t -87.64 118.28 33.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 60.140000000000001 111.135 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.84 99.52 11.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.477 . . . . 70.030000000000001 110.919 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 87' ' ' ILE . 5.6 p -100.16 138.99 22.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 74.200000000000003 111.116 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -125.3 121.83 35.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 61.539999999999999 110.851 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.613 ' CD2' HD22 ' A' ' 66' ' ' LEU . 35.6 m-85 -101.1 89.83 3.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 74.510000000000005 110.845 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -133.3 -167.73 1.97 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.132 -0.486 . . . . 72.219999999999999 110.945 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.05 -166.32 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 65.25 111.069 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.445 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 3.6 m-20 -78.89 12.63 2.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 72.420000000000002 110.919 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.457 ' N ' ' CD1' ' A' ' 39' ' ' TRP . 1.4 m0 77.01 94.62 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 74.340000000000003 110.895 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -174.69 -57.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 53.100000000000001 110.84 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.09 -70.06 1.36 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.788 -0.72 . . . . 72.329999999999998 112.488 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 -44.01 2.31 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.681 2.254 . . . . 63.030000000000001 112.29 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.536 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 42.4 t -52.08 -34.73 45.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.433 . . . . 74.349999999999994 110.894 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.6 -34.14 77.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 73.219999999999999 110.845 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 11.3 mtt -85.25 -38.34 19.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.434 . . . . 71.510000000000005 110.88 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.506 ' HA ' HG22 ' A' ' 49' ' ' VAL . 3.0 t -94.1 21.48 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 62.240000000000002 111.141 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.786 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -77.18 -60.84 0.73 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.579 0.704 . . . . 70.400000000000006 111.112 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.786 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.7 Cg_endo -69.71 -49.65 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.681 2.254 . . . . 72.040000000000006 112.38 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.506 HG22 ' HA ' ' A' ' 46' ' ' VAL . 4.4 m -50.49 -30.16 7.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 61.340000000000003 111.127 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.4 tt -84.01 -39.69 19.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.202 -0.454 . . . . 72.439999999999998 110.91 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -61.43 -35.57 77.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 72.230000000000004 110.879 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -55.1 -60.56 3.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 74.439999999999998 110.936 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.432 HD12 ' O ' ' A' ' 49' ' ' VAL . 3.0 mt -51.43 -38.18 20.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.49 . . . . 63.439999999999998 111.13 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.33 -43.37 77.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 61.149999999999999 111.123 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -40.55 94.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 72.25 110.849 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -77.64 -37.21 50.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 73.230000000000004 110.846 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 12.2 mmmt -59.41 -75.0 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 72.450000000000003 110.898 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -178.13 177.41 1.02 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 40.439999999999998 110.825 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -113.22 34.03 5.27 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.692 -0.766 . . . . 71.519999999999996 112.478 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 70.4 p -122.03 -39.04 2.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.795 0.331 . . . . 54.310000000000002 111.13 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.645 ' C ' HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -51.13 169.25 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.203 -0.453 . . . . 73.540000000000006 110.902 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.538 ' N ' HD22 ' A' ' 61' ' ' LEU . 1.7 ttmp? -128.96 141.97 51.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 72.140000000000001 110.884 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.82 112.93 42.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 73.120000000000005 111.16 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -105.55 147.26 28.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 74.340000000000003 111.112 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.41 156.62 46.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.436 . . . . 72.129999999999995 110.896 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.681 HD21 ' HB2' ' A' ' 71' ' ' ASN . 0.4 OUTLIER -144.42 137.62 27.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.452 . . . . 65.319999999999993 110.927 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.58 106.92 13.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.45 . . . . 73.549999999999997 110.87 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 78.8 t -55.54 -39.11 52.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 62.109999999999999 111.16 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.02 -36.02 62.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 72.319999999999993 110.849 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.8 -35.46 14.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 74.010000000000005 111.15 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.681 ' HB2' HD21 ' A' ' 66' ' ' LEU . 1.7 m-80 -117.87 68.04 6.23 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.627 0.727 . . . . 71.439999999999998 110.894 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -33.3 16.86 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.684 2.256 . . . . 65.349999999999994 112.29 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -62.42 -36.8 83.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 72.109999999999999 110.877 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.15 -34.99 79.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 63.409999999999997 111.051 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.583 ' HB1' ' HB ' ' A' ' 80' ' ' VAL . . . -58.88 -67.52 0.36 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 63.32 111.088 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -53.41 -38.73 63.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 74.299999999999997 110.895 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -51.41 -37.82 50.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 74.019999999999996 110.919 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -110.08 29.93 7.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 74.439999999999998 110.845 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 49.35 82.02 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 71.439999999999998 110.924 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.583 ' HB ' ' HB1' ' A' ' 75' ' ' ALA . 87.4 t -126.89 103.35 10.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 70.209999999999994 111.138 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 60.3 t -98.29 -34.49 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 63.509999999999998 111.143 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.5 m -97.61 151.67 19.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 70.109999999999999 110.855 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.53 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.1 mt -66.66 -57.76 11.31 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.565 0.697 . . . . 73.219999999999999 111.148 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.4 Cg_endo -69.77 70.17 1.6 Allowed 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.694 2.263 . . . . 61.229999999999997 112.332 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 59.1 m -110.49 148.09 32.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 73.120000000000005 111.115 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 5.3 ttp -147.89 147.61 29.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 71.329999999999998 110.883 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.416 ' O ' HG12 ' A' ' 33' ' ' VAL . 10.5 mt -133.43 115.32 22.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 74.099999999999994 111.15 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.429 HD23 ' HB2' ' A' ' 96' ' ' LYS . 10.9 tp -81.3 101.78 9.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 73.430000000000007 110.875 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -89.98 170.33 10.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 73.209999999999994 110.874 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -164.91 96.31 0.72 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 70.439999999999998 110.919 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.97 35.87 23.32 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.763 -0.732 . . . . 52.450000000000003 112.469 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.652 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 71.23 40.89 60.63 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.731 -0.747 . . . . 73.400000000000006 112.499 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.419 HG23 ' HD2' ' A' ' 94' ' ' PRO . 46.6 m -160.65 133.46 4.56 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.596 0.712 . . . . 74.430000000000007 111.158 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.419 ' HD2' HG23 ' A' ' 93' ' ' THR . 53.2 Cg_endo -69.79 87.76 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.67 2.247 . . . . 64.129999999999995 112.318 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 26.9 m -78.54 -34.96 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 72.129999999999995 111.097 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.429 ' HB2' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -141.43 163.71 32.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 73.530000000000001 110.904 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.404 ' C ' HD12 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -150.54 133.47 16.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 75.549999999999997 110.858 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.44 HG23 ' HB3' ' A' ' 110' ' ' GLU . 5.3 mp -137.19 135.44 47.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 72.530000000000001 111.139 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -135.32 139.64 46.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 71.200000000000003 111.149 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 129.02 134.49 3.8 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.767 -0.73 . . . . 34.5 112.454 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.34 86.38 7.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.833 0.349 . . . . 53.329999999999998 111.116 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.529 ' HG2' HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -124.41 172.46 9.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 73.400000000000006 110.847 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.26 171.0 8.42 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.739 -0.743 . . . . 73.230000000000004 112.448 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.06 -43.59 86.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.791 0.329 . . . . 74.5 110.916 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.96 -65.39 0.59 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.26 -0.427 . . . . 54.43 111.093 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.89 -56.91 13.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 73.129999999999995 111.084 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.529 HD23 ' HG2' ' A' ' 102' ' ' LYS . 0.3 OUTLIER -49.82 -36.27 25.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 72.549999999999997 110.918 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.419 HD23 ' C ' ' A' ' 108' ' ' LEU . 10.3 tt -70.15 -37.41 75.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 75.140000000000001 110.925 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 10.0 mtp85 -66.71 -41.52 87.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 71.230000000000004 110.845 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.44 ' HB3' HG23 ' A' ' 98' ' ' ILE . 42.9 mm-40 -52.19 -25.46 9.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 73.400000000000006 110.905 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.3 mt -84.82 -67.99 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 65.340000000000003 111.155 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -52.4 -48.8 65.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 62.439999999999998 110.913 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -58.0 -34.79 70.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.496 . . . . 62.439999999999998 110.886 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.81 -35.04 57.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 73.030000000000001 111.129 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.1 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 62.020000000000003 110.923 -179.984 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 mmt . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.743 0.306 . . . . 72.329999999999998 110.926 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.23 173.31 11.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 71.239999999999995 111.088 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -50.21 -51.94 39.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.203 -0.453 . . . . 63.130000000000003 110.843 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 59.6 m170 49.79 34.63 7.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 73.530000000000001 110.89 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -56.61 167.45 0.73 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 73.209999999999994 110.838 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -119.75 30.85 6.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 63.030000000000001 110.887 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 41.5 t60 -68.34 -36.12 78.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 73.109999999999999 110.896 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -58.57 -42.75 88.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.45 . . . . 73.329999999999998 110.921 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 32.1 mtt -69.3 -36.09 76.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 63.0 110.883 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.6 t -70.21 120.13 15.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 65.420000000000002 110.834 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -93.84 -91.06 1.61 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.763 -0.732 . . . . 62.450000000000003 112.475 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.573 HG22 ' HB ' ' A' ' 63' ' ' VAL . 58.6 p -67.78 118.51 11.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.789 0.328 . . . . 62.240000000000002 111.131 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.06 150.09 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 75.319999999999993 111.143 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.4 t -72.71 131.1 41.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 53.409999999999997 111.143 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.4 t -92.56 121.21 42.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 72.140000000000001 111.148 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.577 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.89 163.67 4.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.122 -0.49 . . . . 61.130000000000003 111.113 -179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -67.02 -39.86 87.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 74.400000000000006 110.82 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.7 t -75.86 -57.67 3.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 75.120000000000005 110.898 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.577 HG22 ' HB ' ' A' ' 16' ' ' THR . 10.5 t -55.79 -24.22 34.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 75.319999999999993 111.144 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.538 ' CE2' HG21 ' A' ' 24' ' ' VAL . 16.6 t80 -51.71 -30.88 23.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 73.140000000000001 110.837 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.562 ' HA ' HD12 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -71.45 -33.37 69.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.202 -0.454 . . . . 71.099999999999994 110.9 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.9 m -92.69 -17.67 23.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 75.310000000000002 111.151 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -93.57 -72.05 0.63 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 64.519999999999996 110.849 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.538 HG21 ' CE2' ' A' ' 20' ' ' PHE . 58.2 t -69.4 -71.29 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 64.140000000000001 111.106 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.562 HD12 ' HA ' ' A' ' 21' ' ' LYS . 12.5 mt -40.18 -60.31 1.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 74.349999999999994 110.861 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -50.31 -56.62 10.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.242 -0.435 . . . . 73.129999999999995 110.863 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.1 t -51.84 158.47 1.0 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 64.109999999999999 110.859 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -119.44 35.76 4.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 71.549999999999997 110.844 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.452 HG22 ' HD2' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -132.4 159.96 70.13 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.523 0.678 . . . . 74.150000000000006 111.175 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.452 ' HD2' HG22 ' A' ' 29' ' ' THR . 53.4 Cg_endo -69.76 122.14 8.83 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.682 2.254 . . . . 53.119999999999997 112.344 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.503 HG22 ' HD2' ' A' ' 62' ' ' LYS . 90.1 t -100.93 122.93 53.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.449 . . . . 73.439999999999998 111.121 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -94.86 99.93 11.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 71.340000000000003 110.901 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 87' ' ' ILE . 7.9 p -100.38 142.62 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 63.229999999999997 111.17 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -135.75 119.84 17.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 74.120000000000005 110.895 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.6 ' HE2' ' HB1' ' A' ' 74' ' ' ALA . 47.1 m-85 -99.74 93.5 5.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 54.340000000000003 110.936 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -136.77 -167.72 2.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.126 -0.488 . . . . 72.200000000000003 110.958 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.57 -165.22 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.433 . . . . 73.010000000000005 111.085 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.446 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 34.7 p-10 -77.69 12.07 1.83 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 73.400000000000006 110.844 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.479 ' N ' ' CD1' ' A' ' 39' ' ' TRP . 1.7 m0 77.62 92.91 0.06 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.158 -0.474 . . . . 65.519999999999996 110.908 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -175.89 -53.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 62.409999999999997 110.881 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.26 -70.99 1.3 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.74 -0.743 . . . . 62.210000000000001 112.509 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -32.62 18.17 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.646 2.23 . . . . 71.010000000000005 112.351 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.534 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -59.42 -33.45 71.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 72.230000000000004 110.884 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.53 -28.81 70.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 64.319999999999993 110.898 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 4.6 mmt -87.21 -41.55 13.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 64.430000000000007 110.867 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.522 ' HA ' HG22 ' A' ' 49' ' ' VAL . 2.9 t -94.13 22.16 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 72.420000000000002 111.115 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.78 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -76.75 -61.08 0.77 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.561 0.696 . . . . 70.310000000000002 111.08 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.78 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.9 Cg_endo -69.76 -49.91 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.711 2.274 . . . . 63.329999999999998 112.326 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.612 ' O ' HD12 ' A' ' 53' ' ' ILE . 4.3 m -51.02 -30.42 9.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.242 -0.435 . . . . 72.25 111.112 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.555 HD23 ' O ' ' A' ' 50' ' ' LEU . 7.3 tt -82.95 -36.83 24.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.16 -0.473 . . . . 71.109999999999999 110.945 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -58.9 -35.29 72.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 74.439999999999998 110.907 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -61.82 -67.88 0.37 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 74.099999999999994 110.891 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.612 HD12 ' O ' ' A' ' 49' ' ' VAL . 3.0 mt -51.38 -37.32 18.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 72.439999999999998 111.12 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.82 -41.38 87.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 61.049999999999997 111.072 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.97 -47.24 78.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 72.409999999999997 110.896 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -69.99 -37.37 75.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 73.310000000000002 110.874 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.0 mmtt -55.6 -66.5 0.41 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 70.310000000000002 110.899 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.26 173.9 15.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 52.240000000000002 110.808 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.94 -41.19 41.75 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.74 -0.743 . . . . 44.0 112.52 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.6 p -149.81 53.86 0.93 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.791 0.329 . . . . 54.240000000000002 111.155 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.8 pp -58.33 -175.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 73.010000000000005 110.951 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.503 ' HD2' HG22 ' A' ' 31' ' ' VAL . 32.0 mttp -85.63 124.71 32.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.265 -0.425 . . . . 71.230000000000004 110.938 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.573 ' HB ' HG22 ' A' ' 12' ' ' THR . 57.3 t -131.74 105.35 9.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 53.409999999999997 111.134 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -118.04 139.19 51.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 64.5 111.112 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -134.94 158.75 43.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 75.319999999999993 110.912 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.582 HD22 ' CD2' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -139.71 142.66 36.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.435 . . . . 70.329999999999998 110.974 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.88 107.28 19.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.201 -0.454 . . . . 44.009999999999998 110.871 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 69.4 t -57.47 -36.01 51.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.448 . . . . 74.120000000000005 111.162 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.87 -36.38 48.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 71.319999999999993 110.908 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.29 -35.18 10.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 64.219999999999999 111.081 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.485 ' HB2' HD21 ' A' ' 66' ' ' LEU . 2.1 m-80 -115.72 73.59 4.46 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.63 0.728 . . . . 44.109999999999999 110.89 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -30.87 21.41 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.672 2.248 . . . . 44.350000000000001 112.319 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -64.9 -38.96 92.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.429 . . . . 73.120000000000005 110.898 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.6 ' HB1' ' HE2' ' A' ' 35' ' ' PHE . . . -54.48 -48.88 71.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.119 -0.492 . . . . 63.210000000000001 111.094 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.615 ' HB1' ' HB ' ' A' ' 80' ' ' VAL . . . -53.37 -64.05 0.95 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 73.239999999999995 111.102 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.5 ttp180 -51.23 -34.01 30.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 73.230000000000004 110.899 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -51.73 -40.04 59.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 74.420000000000002 110.892 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -106.65 28.45 7.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 73.030000000000001 110.891 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 50.33 52.88 13.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 74.030000000000001 110.877 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.615 ' HB ' ' HB1' ' A' ' 75' ' ' ALA . 87.7 t -89.63 109.19 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 60.409999999999997 111.135 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.9 t -96.18 -35.74 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 74.099999999999994 111.112 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.5 t -103.12 146.0 29.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 70.010000000000005 110.838 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.54 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 1.1 mp -56.9 -57.43 24.37 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.594 0.711 . . . . 64.010000000000005 111.136 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.647 ' CB ' ' HB2' ' A' ' 101' ' ' ALA . 53.7 Cg_endo -69.76 78.34 1.01 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.668 2.245 . . . . 63.240000000000002 112.329 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.676 HG23 ' CG1' ' A' ' 99' ' ' VAL . 77.0 m -116.72 111.64 20.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.26 -0.427 . . . . 73.549999999999997 111.138 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 10.4 ttp -113.48 122.96 48.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 65.540000000000006 110.896 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.427 ' O ' HG12 ' A' ' 33' ' ' VAL . 20.9 mt -115.53 122.22 68.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 73.340000000000003 111.114 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 16.3 tp -88.16 105.7 17.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.134 -0.485 . . . . 74.549999999999997 110.895 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -90.18 170.33 10.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 70.420000000000002 110.871 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -168.46 94.64 0.36 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.484 . . . . 63.049999999999997 110.88 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.89 35.85 10.91 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.775 -0.726 . . . . 31.399999999999999 112.48 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.402 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 70.84 37.94 65.76 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.75 -0.738 . . . . 43.420000000000002 112.494 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.459 HG23 ' HD2' ' A' ' 94' ' ' PRO . 85.1 m -161.13 134.16 4.63 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.572 0.701 . . . . 74.420000000000002 111.133 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.459 ' HD2' HG23 ' A' ' 93' ' ' THR . 54.0 Cg_endo -69.73 82.56 0.74 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.646 2.231 . . . . 70.430000000000007 112.37 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.7 m -64.76 -35.02 73.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 70.329999999999998 111.092 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.415 ' HE2' ' HB1' ' A' ' 114' ' ' ALA . 0.0 OUTLIER -140.95 170.02 16.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 73.099999999999994 110.927 179.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.476 ' C ' HD12 ' A' ' 98' ' ' ILE . 66.2 ttt180 -158.31 125.5 4.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 73.349999999999994 110.839 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.476 HD12 ' C ' ' A' ' 97' ' ' ARG . 4.8 mp -134.12 125.41 48.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.229 -0.441 . . . . 64.540000000000006 111.12 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.676 ' CG1' HG23 ' A' ' 85' ' ' THR . 10.6 m -132.77 150.96 33.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 71.129999999999995 111.096 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 140.99 -29.81 2.3 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.711 -0.757 . . . . 72.0 112.491 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.647 ' HB2' ' CB ' ' A' ' 84' ' ' PRO . . . 63.27 73.73 0.44 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.841 0.353 . . . . 72.540000000000006 111.07 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.41 -177.23 3.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 70.0 110.873 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.65 166.74 9.13 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.786 -0.721 . . . . 72.040000000000006 112.495 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.5 ptmt -55.71 -46.43 77.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.796 0.332 . . . . 55.509999999999998 110.93 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.23 -62.24 1.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 71.409999999999997 111.088 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.69 -56.57 18.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 70.340000000000003 111.108 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.547 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.8 OUTLIER -51.14 -41.97 60.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 73.510000000000005 110.912 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.437 HD23 ' C ' ' A' ' 108' ' ' LEU . 10.4 tt -63.98 -59.34 4.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 74.25 110.881 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -53.0 -38.77 62.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.168 -0.469 . . . . 73.540000000000006 110.865 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -51.1 -27.03 7.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 74.019999999999996 110.906 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.4 mt -82.87 -68.31 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 62.420000000000002 111.12 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -51.96 -47.86 64.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 45.450000000000003 110.866 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -57.81 -34.97 70.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.156 -0.474 . . . . 73.310000000000002 110.837 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.415 ' HB1' ' HE2' ' A' ' 96' ' ' LYS . . . -76.36 -35.68 58.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 65.209999999999994 111.112 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.2 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 74.200000000000003 110.895 -179.931 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.1 ptm . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.79 0.328 . . . . 71.109999999999999 110.884 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.95 93.86 4.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 45.039999999999999 111.112 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -98.29 -45.52 6.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.45 . . . . 65.530000000000001 110.86 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 43.9 t-80 -68.16 132.85 47.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 75.230000000000004 110.87 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -98.03 170.01 9.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 71.329999999999998 110.854 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 29.6 p80 -119.55 30.75 6.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 65.120000000000005 110.86 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -74.4 -36.15 63.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.229 -0.441 . . . . 72.209999999999994 110.815 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.6 t60 -95.97 11.25 34.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 75.420000000000002 110.867 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 5.5 ttt -53.81 -36.63 62.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 73.340000000000003 110.861 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.7 t -52.53 117.53 2.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.247 -0.433 . . . . 52.450000000000003 110.86 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 123.17 169.85 13.35 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.758 -0.734 . . . . 55.020000000000003 112.486 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.532 HG22 ' HB ' ' A' ' 63' ' ' VAL . 81.7 p -61.71 100.02 0.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.82 0.343 . . . . 64.409999999999997 111.133 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.1 t -147.18 146.41 18.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 53.100000000000001 111.138 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.4 t -73.88 152.52 40.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.167 -0.47 . . . . 50.549999999999997 111.178 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.509 HG22 ' CG2' ' A' ' 19' ' ' THR . 5.3 p -112.38 147.82 15.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 61.130000000000003 111.099 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.55 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.74 158.94 9.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 55.100000000000001 111.148 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.96 -50.48 16.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 74.099999999999994 110.861 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.8 t -58.96 -36.08 74.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 73.340000000000003 110.873 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.55 HG22 ' HB ' ' A' ' 16' ' ' THR . 6.1 t -85.42 -18.25 34.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 72.439999999999998 111.133 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.721 ' CE2' HG21 ' A' ' 24' ' ' VAL . 23.5 t80 -50.41 -31.78 15.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.436 . . . . 74.340000000000003 110.857 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.406 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -71.1 -33.59 70.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 61.149999999999999 110.876 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.1 m -91.18 -15.95 28.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.237 -0.438 . . . . 73.200000000000003 111.145 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -93.18 -70.86 0.68 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.233 -0.44 . . . . 65.030000000000001 110.861 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 1.029 HG13 HG21 ' A' ' 31' ' ' VAL . 15.6 t -71.14 -70.49 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 75.019999999999996 111.113 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.624 HD23 ' HA3' ' A' ' 92' ' ' GLY . 7.1 mt -40.54 -60.08 1.2 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.122 -0.49 . . . . 73.349999999999994 110.877 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -50.44 -59.39 4.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 73.510000000000005 110.848 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.8 t -51.78 149.06 5.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 62.409999999999997 110.84 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -111.66 35.31 3.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 70.030000000000001 110.885 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.426 HG22 ' HD2' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -123.19 160.41 50.07 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.544 0.688 . . . . 61.299999999999997 111.144 -179.839 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.426 ' HD2' HG22 ' A' ' 29' ' ' THR . 53.6 Cg_endo -69.78 124.67 11.3 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.679 2.253 . . . . 71.200000000000003 112.339 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 1.029 HG21 HG13 ' A' ' 24' ' ' VAL . 95.0 t -103.57 122.37 56.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 32.5 111.137 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.573 HD22 HD23 ' A' ' 88' ' ' LEU . 4.0 mm? -93.72 100.08 12.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 44.020000000000003 110.87 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 87' ' ' ILE . 7.1 p -99.63 145.27 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 51.039999999999999 111.135 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.51 118.57 19.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 74.400000000000006 110.808 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -103.08 97.49 7.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 73.409999999999997 110.916 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.5 ' HH2' HD11 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -148.32 -167.83 2.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.146 -0.479 . . . . 71.409999999999997 110.902 -179.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.572 ' HA ' HG22 ' A' ' 68' ' ' VAL . . . -56.09 -166.11 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 60.409999999999997 111.097 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.432 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 18.0 t0 -78.51 12.46 1.99 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.434 . . . . 61.420000000000002 110.823 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.463 ' CD1' ' N ' ' A' ' 39' ' ' TRP . 1.6 m0 77.27 94.04 0.06 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.243 -0.435 . . . . 71.0 110.867 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 2.4 t -167.34 -54.18 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 74.319999999999993 110.872 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.01 -69.88 1.37 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.778 -0.725 . . . . 74.340000000000003 112.439 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -32.94 17.83 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.67 2.246 . . . . 73.230000000000004 112.355 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.546 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 45.5 t -52.02 -34.71 44.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 72.209999999999994 110.895 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -64.63 -34.63 78.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 71.439999999999998 110.883 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 42.1 mtt -84.11 -38.84 20.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.271 -0.422 . . . . 65.219999999999999 110.854 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.521 ' HA ' HG22 ' A' ' 49' ' ' VAL . 3.0 t -94.41 21.76 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.434 . . . . 74.209999999999994 111.108 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.791 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -76.89 -60.83 0.77 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.634 0.731 . . . . 75.340000000000003 111.073 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.791 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.7 Cg_endo -69.72 -49.58 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.697 2.265 . . . . 42.32 112.341 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.618 ' O ' HD12 ' A' ' 53' ' ' ILE . 4.4 m -51.04 -30.23 9.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 75.340000000000003 111.132 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.515 ' HG ' HG12 ' A' ' 46' ' ' VAL . 4.4 mt -69.67 -38.2 76.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.123 -0.489 . . . . 34.539999999999999 110.934 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 8.3 mm-40 -71.93 -35.07 69.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 74.549999999999997 110.889 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -51.27 -66.42 0.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.11 -0.495 . . . . 74.430000000000007 110.849 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.618 HD12 ' O ' ' A' ' 49' ' ' VAL . 2.5 mp -51.23 -33.11 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 73.340000000000003 111.13 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 51' ' ' GLU . . . -63.19 -52.38 62.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 74.319999999999993 111.127 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.81 -35.58 81.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 73.319999999999993 110.846 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -67.92 -36.0 79.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 73.120000000000005 110.908 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -70.02 -69.81 0.33 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 54.340000000000003 110.905 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.0 t 63.23 40.04 9.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 54.219999999999999 110.877 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -122.81 42.16 1.67 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.768 -0.729 . . . . 70.439999999999998 112.468 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.4 p 46.27 48.87 13.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.803 0.335 . . . . 62.340000000000003 111.163 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.5 pp -87.59 141.81 28.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 61.409999999999997 110.911 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.4 tptt -95.5 149.47 21.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.475 . . . . 74.209999999999994 110.914 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.532 ' HB ' HG22 ' A' ' 12' ' ' THR . 22.4 t -126.93 106.96 16.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 71.200000000000003 111.165 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -118.13 126.61 52.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 74.239999999999995 111.088 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -110.4 159.29 17.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 62.049999999999997 110.93 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.511 HD21 ' HB2' ' A' ' 71' ' ' ASN . 11.1 tp -137.1 145.92 44.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.434 . . . . 71.409999999999997 110.891 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -97.6 119.62 36.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 71.540000000000006 110.846 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.572 HG22 ' HA ' ' A' ' 37' ' ' ALA . 28.8 m -61.5 -35.18 65.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 74.400000000000006 111.138 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.13 -35.28 47.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 74.409999999999997 110.843 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.47 -35.24 11.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 44.229999999999997 111.078 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.511 ' HB2' HD21 ' A' ' 66' ' ' LEU . 1.4 m-80 -118.36 68.2 7.36 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.57 0.7 . . . . 65.219999999999999 110.868 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.74 -33.43 16.67 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.666 2.244 . . . . 54.329999999999998 112.38 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -68.28 -36.26 79.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 73.430000000000007 110.928 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.59 -47.45 79.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 74.510000000000005 111.09 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.666 ' HB1' ' HB ' ' A' ' 80' ' ' VAL . . . -56.31 -56.37 21.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 64.049999999999997 111.1 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -51.27 -34.19 31.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 54.140000000000001 110.854 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -58.05 -35.92 72.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 61.009999999999998 110.869 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -102.29 26.39 7.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 74.329999999999998 110.883 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 50.1 36.43 12.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 62.229999999999997 110.905 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.666 ' HB ' ' HB1' ' A' ' 75' ' ' ALA . 97.6 t -68.87 103.43 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 70.25 111.143 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 67.1 t -92.18 -35.04 6.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 75.400000000000006 111.174 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.8 t -105.61 151.76 23.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.481 . . . . 72.519999999999996 110.849 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.538 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.4 mt -60.58 -57.69 24.71 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.658 0.742 . . . . 73.239999999999995 111.139 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 54.1 Cg_endo -69.78 74.1 1.33 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.651 2.234 . . . . 71.230000000000004 112.347 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.985 HG23 HG22 ' A' ' 99' ' ' VAL . 84.0 m -108.99 137.99 46.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.223 -0.444 . . . . 73.319999999999993 111.178 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 10.2 ttm -135.17 145.91 48.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 70.109999999999999 110.878 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.48 ' O ' HG12 ' A' ' 33' ' ' VAL . 28.6 mt -143.07 128.85 16.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 72.310000000000002 111.138 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.573 HD23 HD22 ' A' ' 32' ' ' LEU . 2.2 tm? -95.2 107.94 20.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 74.120000000000005 110.906 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -92.06 170.29 9.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 73.420000000000002 110.909 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -162.49 106.24 1.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.479 . . . . 74.040000000000006 110.872 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.68 34.28 56.86 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.782 -0.723 . . . . 74.120000000000005 112.489 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.624 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 73.08 40.22 51.46 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.778 -0.725 . . . . 40.210000000000001 112.489 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.442 HG23 ' HD2' ' A' ' 94' ' ' PRO . 86.0 m -160.91 133.8 4.59 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.539 0.685 . . . . 53.420000000000002 111.149 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.442 ' HD2' HG23 ' A' ' 93' ' ' THR . 53.8 Cg_endo -69.77 84.77 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.698 2.265 . . . . 72.299999999999997 112.329 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.5 m -72.37 -35.11 50.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 75.230000000000004 111.117 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -136.32 170.05 16.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 64.409999999999997 110.937 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.554 ' C ' HD12 ' A' ' 98' ' ' ILE . 20.2 ttt-85 -155.97 128.55 7.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 61.039999999999999 110.9 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.554 HD12 ' C ' ' A' ' 97' ' ' ARG . 4.5 mp -138.05 111.67 7.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.462 . . . . 61.25 111.141 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.985 HG22 HG23 ' A' ' 85' ' ' THR . 48.9 t -109.62 133.07 56.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 71.0 111.165 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 136.57 137.4 3.65 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.754 -0.736 . . . . 73.519999999999996 112.479 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.47 83.15 4.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.87 0.367 . . . . 50.5 111.054 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.449 ' HG2' HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -120.03 174.07 6.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 65.349999999999994 110.931 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.87 171.89 5.68 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.719 -0.753 . . . . 74.409999999999997 112.463 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.66 -44.88 90.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.81 0.338 . . . . 51.520000000000003 110.923 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.64 -64.14 0.95 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 64.150000000000006 111.143 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.81 -58.34 7.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 71.349999999999994 111.142 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.49 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.2 OUTLIER -50.67 -40.94 54.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 61.100000000000001 110.924 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.509 ' O ' HD12 ' A' ' 108' ' ' LEU . 3.7 tp -64.7 -54.17 35.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 64.200000000000003 110.921 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -51.45 -43.06 61.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 53.210000000000001 110.86 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -51.12 -27.24 7.94 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 74.430000000000007 110.881 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.3 mt -83.08 -68.99 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 71.120000000000005 111.143 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.423 ' O ' HD23 ' A' ' 115' ' ' LEU . 9.0 pt-20 -50.9 -48.78 60.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 63.119999999999997 110.884 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -52.79 -32.48 44.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.479 . . . . 74.049999999999997 110.9 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.59 -33.77 71.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 71.120000000000005 111.108 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.423 HD23 ' O ' ' A' ' 112' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 71.230000000000004 110.929 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.798 0.332 . . . . 62.219999999999999 110.889 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.24 64.03 5.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 72.230000000000004 111.089 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -95.32 -43.41 8.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 72.219999999999999 110.825 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -81.39 171.22 15.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 71.230000000000004 110.864 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -145.39 155.65 43.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 75.319999999999993 110.841 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -119.71 -40.42 2.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 71.540000000000006 110.851 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 39.6 p-80 -52.02 -36.27 49.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 72.530000000000001 110.846 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -54.5 -47.86 72.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 62.530000000000001 110.824 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -51.99 -36.22 49.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 55.340000000000003 110.853 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.0 t -52.28 129.7 28.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 43.119999999999997 110.846 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.31 171.61 47.43 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.715 -0.755 . . . . 71.230000000000004 112.464 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.422 HG22 ' HB ' ' A' ' 63' ' ' VAL . 44.5 p -61.27 110.73 1.49 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.827 0.346 . . . . 72.400000000000006 111.165 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.7 t -145.95 146.15 19.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 72.239999999999995 111.123 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.0 m -75.75 125.82 29.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 62.240000000000002 111.159 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.5 t -89.93 127.11 42.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 71.430000000000007 111.156 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.492 ' CB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.13 177.22 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 72.200000000000003 111.151 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.463 ' H ' HG22 ' A' ' 16' ' ' THR . 0.6 OUTLIER -80.1 -35.06 37.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.232 -0.44 . . . . 72.040000000000006 110.882 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.8 t -84.62 -51.73 6.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 64.129999999999995 110.85 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.492 HG22 ' CB ' ' A' ' 16' ' ' THR . 6.2 t -58.43 -19.55 37.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 72.230000000000004 111.167 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.72 ' CE2' HG21 ' A' ' 24' ' ' VAL . 25.1 t80 -51.25 -30.27 17.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 62.240000000000002 110.872 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.417 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -72.47 -34.1 67.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 64.239999999999995 110.898 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.8 m -91.26 -15.99 28.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 65.310000000000002 111.145 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -93.55 -71.53 0.65 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 61.020000000000003 110.851 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.916 HG13 HG21 ' A' ' 31' ' ' VAL . 21.2 t -70.15 -70.65 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 71.549999999999997 111.156 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.609 HD23 ' HA3' ' A' ' 92' ' ' GLY . 7.9 mt -40.6 -60.3 1.16 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.113 -0.494 . . . . 73.329999999999998 110.936 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -50.27 -52.8 33.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 61.210000000000001 110.866 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.9 t -57.21 155.06 9.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 74.200000000000003 110.822 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -104.36 -44.27 4.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.483 . . . . 72.25 110.827 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -51.54 160.0 1.11 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.583 0.706 . . . . 54.32 111.114 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 126.83 13.72 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.63 2.22 . . . . 74.109999999999999 112.336 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.916 HG21 HG13 ' A' ' 24' ' ' VAL . 80.1 t -97.69 127.52 49.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 71.310000000000002 111.159 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.47 HD11 HD11 ' A' ' 88' ' ' LEU . 6.3 mp -103.22 100.11 10.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 71.209999999999994 110.924 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.6 p -102.82 138.46 27.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 74.439999999999998 111.092 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.96 118.43 22.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 73.019999999999996 110.906 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -96.16 90.38 5.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 74.519999999999996 110.893 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -135.6 -167.94 2.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.152 -0.476 . . . . 73.549999999999997 110.969 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.42 ' HA ' HG22 ' A' ' 68' ' ' VAL . . . -56.18 -166.34 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.432 . . . . 60.130000000000003 111.092 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.446 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 9.3 p-10 -78.2 12.45 1.87 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 63.219999999999999 110.863 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.462 ' N ' ' CD1' ' A' ' 39' ' ' TRP . 1.3 m0 76.98 92.95 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 72.420000000000002 110.912 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 36.4 t -170.72 -58.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.441 . . . . 73.430000000000007 110.879 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.8 -71.02 1.25 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.778 -0.725 . . . . 65.430000000000007 112.484 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 -32.2 18.79 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.694 2.263 . . . . 72.219999999999999 112.331 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.536 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 36.3 t -60.23 -32.37 71.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 63.439999999999998 110.867 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -30.21 71.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 71.319999999999993 110.938 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 7.3 mmm -88.44 -39.91 13.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 55.109999999999999 110.858 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.564 ' HA ' HG22 ' A' ' 49' ' ' VAL . 3.1 t -94.25 22.34 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 42.310000000000002 111.096 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.803 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -76.04 -61.04 0.9 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.596 0.712 . . . . 73.019999999999996 111.113 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.803 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.6 Cg_endo -69.78 -50.1 0.49 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.739 2.293 . . . . 61.020000000000003 112.349 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.577 ' O ' HD12 ' A' ' 53' ' ' ILE . 4.4 m -52.86 -31.02 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 74.099999999999994 111.172 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.7 tp -70.33 -41.22 73.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 74.109999999999999 110.914 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -69.81 -34.61 73.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 64.239999999999995 110.906 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -56.39 -63.17 1.28 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 65.409999999999997 110.886 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.577 HD12 ' O ' ' A' ' 49' ' ' VAL . 3.8 mt -53.04 -45.09 52.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 73.150000000000006 111.106 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.462 ' HA ' HD21 ' A' ' 61' ' ' LEU . . . -61.41 -23.35 65.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 75.450000000000003 111.113 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.34 -45.38 19.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 71.319999999999993 110.888 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -74.31 -45.51 47.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 52.409999999999997 110.919 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -51.52 -73.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.491 . . . . 74.239999999999995 110.918 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.46 -168.81 2.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 74.420000000000002 110.879 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -109.32 116.88 4.71 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.734 -0.746 . . . . 72.0 112.464 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.8 p 49.83 44.28 25.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.833 0.349 . . . . 71.430000000000007 111.107 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.462 HD21 ' HA ' ' A' ' 54' ' ' ALA . 3.6 pp -58.16 -176.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.257 -0.429 . . . . 75.329999999999998 110.963 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -79.78 119.11 22.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.192 -0.458 . . . . 62.299999999999997 110.856 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.422 ' HB ' HG22 ' A' ' 12' ' ' THR . 58.6 t -118.93 100.89 10.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 63.299999999999997 111.132 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -126.22 132.16 51.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 62.420000000000002 111.105 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -129.36 160.02 34.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 72.200000000000003 110.855 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.483 HD21 ' CB ' ' A' ' 71' ' ' ASN . 18.9 tp -136.16 148.91 48.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 75.420000000000002 110.944 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.78 112.36 24.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.176 -0.465 . . . . 71.120000000000005 110.849 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.42 HG22 ' HA ' ' A' ' 37' ' ' ALA . 27.4 m -59.5 -35.6 59.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 74.230000000000004 111.144 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.55 -36.46 61.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 74.439999999999998 110.868 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.47 -35.22 13.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 72.299999999999997 111.091 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.483 ' CB ' HD21 ' A' ' 66' ' ' LEU . 1.7 m-80 -117.27 68.79 5.23 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.62 0.724 . . . . 74.030000000000001 110.884 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 -32.65 18.39 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.725 2.283 . . . . 61.530000000000001 112.384 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -65.23 -36.28 83.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 74.230000000000004 110.891 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.17 -44.81 96.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 75.439999999999998 111.138 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.674 ' HB1' ' HB ' ' A' ' 80' ' ' VAL . . . -52.57 -61.55 2.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 61.25 111.087 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.5 ttp180 -50.97 -34.79 30.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 73.510000000000005 110.9 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -51.89 -35.92 46.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.486 . . . . 72.400000000000006 110.859 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -108.87 27.89 9.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.449 . . . . 73.129999999999995 110.882 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 50.59 55.76 9.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.495 . . . . 61.530000000000001 110.906 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.674 ' HB ' ' HB1' ' A' ' 75' ' ' ALA . 91.0 t -92.24 104.97 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 50.43 111.115 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 57.4 t -96.44 -35.06 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 63.009999999999998 111.124 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 49.8 m -102.84 146.64 27.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 73.140000000000001 110.89 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.531 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 5.1 mt -58.19 -57.57 25.1 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.621 0.724 . . . . 71.109999999999999 111.144 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.637 ' CB ' ' HB2' ' A' ' 101' ' ' ALA . 53.5 Cg_endo -69.78 76.39 1.15 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.65 2.233 . . . . 74.25 112.33 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.669 HG23 ' CG1' ' A' ' 99' ' ' VAL . 73.6 m -113.99 134.95 54.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 72.329999999999998 111.112 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 14.2 ttt -133.85 126.42 30.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 64.239999999999995 110.883 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.0 mt -116.97 115.19 48.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 72.239999999999995 111.152 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.47 HD11 HD11 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -81.11 106.31 13.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 75.530000000000001 110.92 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -93.34 170.05 9.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 72.439999999999998 110.932 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -165.74 91.43 0.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 73.530000000000001 110.878 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.82 36.91 8.19 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.715 -0.755 . . . . 61.439999999999998 112.497 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.609 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 68.64 39.3 86.52 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.773 -0.727 . . . . 70.430000000000007 112.488 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.456 HG23 ' HD2' ' A' ' 94' ' ' PRO . 88.6 m -160.53 133.99 4.86 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.58 0.705 . . . . 72.209999999999994 111.156 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.456 ' HD2' HG23 ' A' ' 93' ' ' THR . 53.7 Cg_endo -69.79 109.56 2.35 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.661 2.241 . . . . 64.310000000000002 112.374 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.3 m -101.6 -32.99 3.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.46 . . . . 70.439999999999998 111.138 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.464 ' HD2' ' HB3' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -132.73 164.63 26.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.483 . . . . 62.340000000000003 110.906 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.441 ' C ' HD12 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -155.84 117.51 3.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 64.099999999999994 110.852 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.441 ' N ' HD12 ' A' ' 98' ' ' ILE . 4.7 mp -132.56 130.91 59.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 74.439999999999998 111.126 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.669 ' CG1' HG23 ' A' ' 85' ' ' THR . 11.1 m -138.16 145.39 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 73.319999999999993 111.129 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 146.39 -26.88 1.69 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.745 -0.74 . . . . 73.040000000000006 112.522 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.637 ' HB2' ' CB ' ' A' ' 84' ' ' PRO . . . 62.7 68.35 0.65 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.843 0.354 . . . . 74.549999999999997 111.09 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.2 169.1 9.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 74.409999999999997 110.897 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.77 150.16 39.48 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.744 -0.741 . . . . 52.420000000000002 112.47 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.576 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -48.39 -34.99 11.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.809 0.338 . . . . 73.310000000000002 110.88 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.16 -40.39 77.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 42.020000000000003 111.078 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.76 -49.8 6.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 63.32 111.131 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.7 -52.94 16.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 62.520000000000003 110.961 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.576 HD23 ' O ' ' A' ' 104' ' ' LYS . 1.6 pp -48.12 -35.58 11.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.468 . . . . 71.109999999999999 110.911 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 46.1 mtp85 -74.25 -42.24 59.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 75.5 110.865 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -51.48 -25.0 5.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 62.43 110.926 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.4 mt -87.68 -69.29 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 53.539999999999999 111.167 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -51.11 -49.39 60.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 74.129999999999995 110.873 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -58.91 -34.13 71.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 63.32 110.84 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.464 ' HB3' ' HD2' ' A' ' 96' ' ' LYS . . . -75.09 -35.64 61.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 64.219999999999999 111.116 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.4 mt . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 64.409999999999997 110.971 179.954 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.2 ptm . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.777 0.322 . . . . 61.130000000000003 110.897 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.93 91.84 6.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.205 -0.452 . . . . 74.430000000000007 111.107 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.5 t60 -95.43 -40.5 9.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 75.049999999999997 110.889 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -118.24 144.01 46.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 75.140000000000001 110.829 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -58.84 163.3 3.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 74.109999999999999 110.857 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 61.6 m80 -106.46 -38.1 6.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 63.43 110.854 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -82.36 -36.21 27.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.436 . . . . 74.430000000000007 110.838 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -70.7 -39.46 73.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 74.209999999999994 110.87 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 28.8 mtp -100.04 30.84 3.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.441 . . . . 72.25 110.867 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.5 m -60.26 121.12 11.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.28 -0.418 . . . . 73.200000000000003 110.856 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.52 174.71 38.09 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.773 -0.727 . . . . 53.229999999999997 112.523 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.625 HG22 ' HB ' ' A' ' 63' ' ' VAL . 82.4 p -74.11 99.77 3.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.863 0.363 . . . . 73.439999999999998 111.121 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 98.6 t -150.16 143.68 17.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.225 -0.443 . . . . 75.409999999999997 111.093 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.8 t -67.71 126.98 31.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 75.430000000000007 111.131 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 74.7 t -94.82 130.44 43.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 72.239999999999995 111.13 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.599 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.72 160.52 7.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 61.229999999999997 111.161 -179.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -73.62 -41.52 62.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.255 -0.43 . . . . 74.040000000000006 110.846 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.6 m -70.39 -34.53 72.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 70.319999999999993 110.885 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.599 HG22 ' HB ' ' A' ' 16' ' ' THR . 7.3 t -85.19 -17.97 35.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.093 -0.503 . . . . 72.030000000000001 111.108 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.724 ' CE2' HG21 ' A' ' 24' ' ' VAL . 24.2 t80 -50.64 -31.23 15.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 62.25 110.859 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.436 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -71.74 -33.48 68.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.149 -0.478 . . . . 72.150000000000006 110.885 179.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.6 m -91.7 -16.23 27.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 73.129999999999995 111.182 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -93.36 -71.42 0.65 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 63.119999999999997 110.888 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.842 HG13 HG21 ' A' ' 31' ' ' VAL . 17.9 t -70.39 -70.3 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 71.450000000000003 111.165 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.589 HD23 ' HA3' ' A' ' 92' ' ' GLY . 7.6 mt -40.7 -60.21 1.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 75.530000000000001 110.886 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -50.36 -58.73 5.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 74.230000000000004 110.876 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.3 t -54.02 171.33 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 73.219999999999999 110.876 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -117.73 -40.96 2.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 74.140000000000001 110.836 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.655 HG21 ' OG1' ' A' ' 60' ' ' THR . 0.0 OUTLIER -53.05 159.47 1.91 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.59 0.71 . . . . 65.299999999999997 111.128 -179.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.478 ' HD2' HG22 ' A' ' 29' ' ' THR . 54.4 Cg_endo -69.7 131.08 20.57 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.715 2.276 . . . . 63.210000000000001 112.369 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.842 HG21 HG13 ' A' ' 24' ' ' VAL . 96.7 t -105.02 125.26 60.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 53.43 111.11 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.694 ' CD1' HD13 ' A' ' 61' ' ' LEU . 4.7 mt -102.23 100.65 10.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 63.43 110.887 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.3 p -98.55 133.57 40.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 64.430000000000007 111.172 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -115.49 99.55 7.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.225 -0.443 . . . . 75.019999999999996 110.839 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -90.47 89.39 7.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 64.430000000000007 110.887 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -145.87 -169.05 3.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.143 -0.48 . . . . 75.010000000000005 110.917 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.37 -156.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 72.109999999999999 111.099 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.476 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 5.3 m-20 -77.61 9.54 3.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.202 -0.453 . . . . 70.400000000000006 110.862 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.476 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 1.0 OUTLIER 41.87 71.08 0.23 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 74.409999999999997 110.935 -179.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 44.5 t -132.63 -45.51 0.89 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 73.420000000000002 110.915 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.75 -67.39 1.52 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.722 -0.751 . . . . 62.219999999999999 112.503 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -24.11 30.08 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.713 2.275 . . . . 71.230000000000004 112.326 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 11.9 p -51.92 -27.13 12.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 74.200000000000003 110.877 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 11.5 ptmm? -61.52 -33.72 74.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 63.310000000000002 110.882 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 6.2 mtp -86.48 -36.52 18.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 73.329999999999998 110.889 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.521 ' HA ' HG22 ' A' ' 49' ' ' VAL . 2.9 t -94.04 21.2 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 74.329999999999998 111.126 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.754 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -76.79 -60.8 0.79 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.596 0.712 . . . . 73.019999999999996 111.051 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.754 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.6 Cg_endo -69.73 -49.13 0.59 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.672 2.248 . . . . 72.230000000000004 112.335 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.717 HG12 ' HG3' ' A' ' 104' ' ' LYS . 4.0 m -51.44 -29.18 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 63.229999999999997 111.155 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.4 tp -84.1 -36.02 23.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 63.039999999999999 110.898 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -71.68 -31.98 67.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 74.439999999999998 110.911 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -49.87 -68.2 0.2 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 74.099999999999994 110.895 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.483 ' H ' HD12 ' A' ' 53' ' ' ILE . 4.0 mp -51.45 -36.66 17.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.178 -0.465 . . . . 62.310000000000002 111.12 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.602 ' HA ' HD21 ' A' ' 61' ' ' LEU . . . -63.05 -40.25 97.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 75.329999999999998 111.103 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -77.77 -39.26 44.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 73.219999999999999 110.871 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -58.95 -41.19 86.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 73.439999999999998 110.921 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.2 mmtp -69.97 -70.33 0.3 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.475 . . . . 75.030000000000001 110.889 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.3 t 62.85 40.29 9.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 42.219999999999999 110.829 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -120.17 53.81 0.67 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.722 -0.752 . . . . 63.420000000000002 112.499 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.655 ' OG1' HG21 ' A' ' 29' ' ' THR . 13.5 p 49.82 41.86 23.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.859 0.361 . . . . 64.239999999999995 111.163 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.694 HD13 ' CD1' ' A' ' 32' ' ' LEU . 2.5 pp -81.99 136.98 35.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 74.340000000000003 110.916 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.1 mtmp? -102.0 139.97 36.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.228 -0.442 . . . . 73.319999999999993 110.877 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.625 ' HB ' HG22 ' A' ' 12' ' ' THR . 21.7 t -120.55 104.33 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 74.349999999999994 111.141 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -104.5 121.47 43.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 55.039999999999999 111.122 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.87 131.42 54.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 64.340000000000003 110.896 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.512 HD21 ' CG ' ' A' ' 71' ' ' ASN . 44.0 tp -123.83 155.47 37.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.227 -0.442 . . . . 74.329999999999998 110.952 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.45 114.85 27.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 74.450000000000003 110.856 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 79.5 t -61.38 -35.27 65.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 71.549999999999997 111.126 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -51.86 -36.88 49.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 74.349999999999994 110.887 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.93 -34.46 13.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 64.209999999999994 111.072 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.512 ' CG ' HD21 ' A' ' 66' ' ' LEU . 1.8 m-80 -117.42 69.61 5.91 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.629 0.728 . . . . 72.150000000000006 110.892 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -32.31 18.81 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.744 2.296 . . . . 73.120000000000005 112.335 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -58.72 -37.58 76.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.438 . . . . 73.010000000000005 110.881 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.97 -47.88 67.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 53.109999999999999 111.065 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.56 ' O ' HG23 ' A' ' 80' ' ' VAL . . . -54.02 -63.47 1.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 75.349999999999994 111.047 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.5 ttp85 -51.56 -33.18 31.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 72.140000000000001 110.868 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -50.99 -39.98 56.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 43.399999999999999 110.873 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -104.39 24.15 12.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 64.040000000000006 110.905 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 47.85 66.55 1.01 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 61.549999999999997 110.911 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 75' ' ' ALA . 95.9 t -87.58 106.8 16.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 75.430000000000007 111.136 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.6 t -80.26 -58.39 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 64.230000000000004 111.139 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.3 m -91.65 163.28 14.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.468 . . . . 71.439999999999998 110.835 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.531 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 1.7 mp -65.3 -58.17 12.97 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.639 0.733 . . . . 54.43 111.133 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.7 Cg_endo -69.75 74.86 1.25 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.658 2.238 . . . . 72.420000000000002 112.374 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.507 ' OG1' HG13 ' A' ' 80' ' ' VAL . 99.7 m -113.87 106.0 13.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 74.230000000000004 111.119 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 9.4 ttp -116.16 121.84 43.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 74.310000000000002 110.865 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.0 mp -104.69 119.04 53.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 73.040000000000006 111.102 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.639 ' CD2' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -80.17 104.56 10.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 72.430000000000007 110.857 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -89.77 169.86 10.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 74.329999999999998 110.9 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -167.71 93.67 0.4 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 75.319999999999993 110.908 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.42 38.77 8.73 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.758 -0.734 . . . . 62.399999999999999 112.5 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.589 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 69.37 37.21 79.49 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.783 -0.722 . . . . 74.019999999999996 112.46 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.459 HG23 ' HD2' ' A' ' 94' ' ' PRO . 85.0 m -160.72 133.78 4.67 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.554 0.692 . . . . 74.140000000000001 111.138 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.459 ' HD2' HG23 ' A' ' 93' ' ' THR . 53.6 Cg_endo -69.74 83.01 0.71 Allowed 'Trans proline' 0 C--N 1.34 0.126 0 C-N-CA 122.703 2.269 . . . . 55.140000000000001 112.292 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.8 m -64.98 -33.88 66.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 73.329999999999998 111.133 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.66 170.22 16.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 63.299999999999997 110.91 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -153.35 127.44 9.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 62.210000000000001 110.881 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.472 HG23 ' HB3' ' A' ' 110' ' ' GLU . 5.3 mp -131.0 143.19 41.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.193 -0.458 . . . . 54.450000000000003 111.144 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -142.13 141.05 29.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 61.43 111.164 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 119.08 145.59 7.7 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.767 -0.73 . . . . 44.539999999999999 112.549 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -100.89 89.1 3.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.893 0.378 . . . . 61.25 111.109 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -120.55 179.87 4.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 74.340000000000003 110.866 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.8 175.26 13.07 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.735 -0.745 . . . . 72.310000000000002 112.525 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.717 ' HG3' HG12 ' A' ' 49' ' ' VAL . 1.6 mtpt -58.18 -47.78 82.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.768 0.318 . . . . 72.310000000000002 110.894 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -53.48 -65.83 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.449 . . . . 72.409999999999997 111.093 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.466 ' HB3' ' HB2' ' A' ' 102' ' ' LYS . . . -50.97 -57.66 8.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 61.030000000000001 111.116 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.572 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.4 OUTLIER -50.82 -34.97 29.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 63.530000000000001 110.938 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.455 HD23 ' C ' ' A' ' 108' ' ' LEU . 9.1 tt -69.42 -60.34 2.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 71.340000000000003 110.927 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 45.1 mtp85 -54.47 -34.35 61.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.466 . . . . 73.209999999999994 110.87 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.472 ' HB3' HG23 ' A' ' 98' ' ' ILE . 14.0 mm-40 -49.35 -26.74 3.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 64.450000000000003 110.868 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.3 mt -84.12 -69.73 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 73.150000000000006 111.121 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.677 ' HA ' HD23 ' A' ' 115' ' ' LEU . 3.1 pt-20 -52.75 -50.06 64.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 73.099999999999994 110.895 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -55.92 -34.61 65.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.116 -0.493 . . . . 71.25 110.884 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.1 -36.82 69.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 74.109999999999999 111.096 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.677 HD23 ' HA ' ' A' ' 112' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.239 -0.437 . . . . 64.209999999999994 110.92 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.7 mtt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.781 0.324 . . . . 73.099999999999994 110.891 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.62 103.56 0.34 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.23 -0.441 . . . . 74.519999999999996 111.086 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -73.84 -42.06 61.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 61.329999999999998 110.872 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 -120.65 137.28 54.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 63.310000000000002 110.833 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.9 m80 -57.75 157.94 6.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 74.010000000000005 110.837 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -105.39 30.87 5.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 72.25 110.859 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -76.55 -41.0 48.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 73.040000000000006 110.867 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -69.47 -35.94 76.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 73.409999999999997 110.86 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -97.81 30.81 2.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 70.099999999999994 110.87 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.5 m -62.1 116.33 4.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 44.200000000000003 110.818 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.78 -176.25 33.67 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.734 . . . . 31.219999999999999 112.48 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.3 p -77.09 104.79 7.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.84 0.352 . . . . 53.340000000000003 111.152 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 65.5 t -148.63 142.19 18.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 72.219999999999999 111.13 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.3 t -77.04 128.7 34.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 71.310000000000002 111.14 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.423 ' CG1' HG23 ' A' ' 19' ' ' THR . 47.6 t -91.36 126.59 44.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 74.239999999999995 111.109 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.652 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.6 OUTLIER -59.65 165.99 2.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 63.43 111.182 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.41 ' H ' HG22 ' A' ' 16' ' ' THR . 25.1 t0 -68.37 -48.04 65.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 74.430000000000007 110.868 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.0 t -69.1 -52.93 23.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 65.25 110.87 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.652 HG22 ' HB ' ' A' ' 16' ' ' THR . 6.4 t -59.36 -19.01 43.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 62.539999999999999 111.143 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.711 ' CE2' HG21 ' A' ' 24' ' ' VAL . 24.6 t80 -51.03 -30.74 16.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 72.420000000000002 110.84 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.422 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -72.07 -34.13 68.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 65.299999999999997 110.91 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.0 m -91.19 -16.0 28.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 72.340000000000003 111.178 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.39 -71.33 0.66 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 61.219999999999999 110.875 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.711 HG21 ' CE2' ' A' ' 20' ' ' PHE . 18.6 t -70.4 -70.47 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.451 . . . . 64.409999999999997 111.149 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.519 HD23 ' HA3' ' A' ' 92' ' ' GLY . 7.4 mt -40.64 -60.49 1.13 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 50.119999999999997 110.869 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -50.32 -63.71 1.03 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 65.439999999999998 110.889 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 9.3 t -56.11 150.87 13.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 71.239999999999995 110.848 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -98.88 -36.45 9.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 75.040000000000006 110.814 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -52.67 159.84 1.6 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.567 0.699 . . . . 64.109999999999999 111.152 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.84 127.43 14.53 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.629 2.219 . . . . 72.329999999999998 112.355 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.664 HG21 HG13 ' A' ' 24' ' ' VAL . 99.4 t -102.18 124.4 56.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 72.420000000000002 111.157 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.661 HD23 HD13 ' A' ' 61' ' ' LEU . 3.5 mm? -91.41 123.44 34.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 64.439999999999998 110.908 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.409 HG11 ' CE1' ' A' ' 35' ' ' PHE . 12.9 t -118.6 139.54 45.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.206 -0.452 . . . . 73.129999999999995 111.132 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.528 ' OD1' HD11 ' A' ' 50' ' ' LEU . 1.6 m-20 -131.4 99.83 4.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 74.299999999999997 110.893 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.541 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 32.1 m-85 -91.05 89.54 7.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.462 . . . . 74.340000000000003 110.867 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.437 ' O ' HG13 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -148.98 -169.27 3.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 72.519999999999996 110.923 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.594 ' HA ' HG22 ' A' ' 68' ' ' VAL . . . -60.08 -155.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.436 . . . . 64.200000000000003 111.103 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.473 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 18.7 p-10 -77.93 8.64 4.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 62.329999999999998 110.896 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.473 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 1.6 p-90 41.55 65.77 0.79 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.187 -0.46 . . . . 63.409999999999997 110.899 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 35.8 t -122.58 -46.38 2.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.233 -0.439 . . . . 70.140000000000001 110.875 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.7 -67.62 1.53 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.751 -0.738 . . . . 74.120000000000005 112.458 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -25.57 28.28 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.675 2.25 . . . . 64.25 112.359 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 28.9 t -51.49 -31.76 24.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 31.23 110.885 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.59 -33.5 71.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 54.009999999999998 110.895 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 7.0 mtt -88.13 -35.71 17.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 75.340000000000003 110.891 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.447 ' HA ' HG22 ' A' ' 49' ' ' VAL . 3.1 t -93.51 21.18 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 54.149999999999999 111.148 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.792 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -80.14 -61.41 0.44 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.531 0.681 . . . . 74.530000000000001 111.062 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.792 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 54.3 Cg_endo -69.69 -45.55 1.59 Allowed 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.665 2.243 . . . . 73.219999999999999 112.375 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' A' ' 46' ' ' VAL . 4.4 m -49.37 -31.34 5.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 73.040000000000006 111.13 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.528 HD11 ' OD1' ' A' ' 34' ' ' ASP . 4.7 tt -88.25 -44.83 10.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 70.420000000000002 110.939 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -58.3 -33.8 69.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 73.439999999999998 110.911 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -63.17 -32.28 73.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.169 -0.469 . . . . 73.040000000000006 110.92 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.449 HD13 ' N ' ' A' ' 53' ' ' ILE . 4.3 mm -64.92 -34.53 71.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 75.340000000000003 111.103 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.422 ' HA ' HD21 ' A' ' 61' ' ' LEU . . . -66.99 -43.03 84.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 72.010000000000005 111.09 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -35.7 78.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 72.299999999999997 110.886 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -70.65 -36.11 73.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.147 -0.479 . . . . 73.430000000000007 110.869 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.19 -71.13 0.53 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 51.219999999999999 110.864 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.4 t -173.14 156.05 3.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.428 . . . . 75.510000000000005 110.886 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -96.23 33.22 5.76 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.772 -0.728 . . . . 51.0 112.495 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.8 t -121.47 -33.15 3.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.85 0.357 . . . . 75.040000000000006 111.138 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.661 HD13 HD23 ' A' ' 32' ' ' LEU . 3.6 pp -51.15 159.41 0.63 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 73.409999999999997 110.891 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.1 tptm -102.17 147.21 26.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 73.430000000000007 110.89 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.0 t -125.4 106.93 17.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 65.109999999999999 111.111 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -121.53 136.77 54.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 72.329999999999998 111.136 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -123.87 146.43 48.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 74.109999999999999 110.872 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.488 HD21 ' CB ' ' A' ' 71' ' ' ASN . 16.1 tp -127.03 152.09 47.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 63.25 110.918 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.588 ' OD2' ' HB3' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -103.29 121.23 42.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 70.310000000000002 110.885 179.85 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.594 HG22 ' HA ' ' A' ' 37' ' ' ALA . 33.1 m -62.24 -33.04 56.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 42.119999999999997 111.135 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -50.42 -35.77 30.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 60.219999999999999 110.926 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.588 ' HB3' ' OD2' ' A' ' 67' ' ' ASP . . . -100.26 -34.11 10.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 61.32 111.088 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.488 ' CB ' HD21 ' A' ' 66' ' ' LEU . 0.7 OUTLIER -121.32 68.07 19.14 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.594 0.711 . . . . 64.549999999999997 110.857 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -33.88 15.69 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.677 2.251 . . . . 63.530000000000001 112.334 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -58.41 -43.57 88.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 62.009999999999998 110.904 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.541 ' HB1' ' CE2' ' A' ' 35' ' ' PHE . . . -54.0 -48.6 70.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 72.340000000000003 111.111 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.568 ' O ' HG23 ' A' ' 80' ' ' VAL . . . -51.7 -68.17 0.19 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 65.230000000000004 111.092 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -50.97 -32.87 22.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.44 . . . . 64.25 110.909 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -51.41 -34.54 35.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 74.430000000000007 110.847 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -112.03 26.08 10.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 73.439999999999998 110.865 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 69.9 mm-40 48.48 85.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 73.439999999999998 110.934 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.667 HG13 ' OG1' ' A' ' 85' ' ' THR . 95.1 t -105.96 111.43 35.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 75.5 111.117 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 22.1 t -81.9 -59.86 2.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 62.119999999999997 111.145 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.4 m -91.34 156.25 17.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 74.200000000000003 110.834 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.531 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 4.7 mt -60.15 -58.01 22.51 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.606 0.717 . . . . 73.329999999999998 111.112 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.7 Cg_endo -69.75 69.77 1.61 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.689 2.259 . . . . 52.399999999999999 112.297 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.742 HG23 HG22 ' A' ' 99' ' ' VAL . 43.7 m -103.98 132.53 50.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 72.200000000000003 111.187 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 17.5 ttp -130.82 143.83 51.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.252 -0.431 . . . . 72.519999999999996 110.861 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 63.1 mt -128.98 117.99 45.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 75.030000000000001 111.138 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.436 ' CD1' HG21 ' A' ' 111' ' ' ILE . 1.9 tt -88.24 105.72 17.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.202 -0.454 . . . . 75.25 110.943 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -90.02 170.14 10.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 72.319999999999993 110.868 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.424 ' HB3' HG11 ' A' ' 95' ' ' VAL . 0.7 OUTLIER -165.53 92.29 0.54 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 62.32 110.862 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.15 41.36 7.09 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.731 -0.747 . . . . 54.109999999999999 112.487 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.519 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 67.89 35.96 85.72 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.709 -0.758 . . . . 42.140000000000001 112.506 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.457 HG23 ' HD2' ' A' ' 94' ' ' PRO . 86.2 m -161.0 133.86 4.57 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.633 0.73 . . . . 74.409999999999997 111.125 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.457 ' HD2' HG23 ' A' ' 93' ' ' THR . 53.9 Cg_endo -69.77 87.83 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.689 2.26 . . . . 74.329999999999998 112.336 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.424 HG11 ' HB3' ' A' ' 90' ' ' LYS . 28.8 m -70.49 -35.61 62.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 72.420000000000002 111.108 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.466 ' HE2' ' HB1' ' A' ' 114' ' ' ALA . 0.0 OUTLIER -140.7 170.19 16.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 75.099999999999994 110.875 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -155.91 122.76 5.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 72.540000000000006 110.877 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.435 ' N ' HD12 ' A' ' 98' ' ' ILE . 4.6 mp -124.93 132.64 71.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 63.030000000000001 111.146 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.742 HG22 HG23 ' A' ' 85' ' ' THR . 98.0 t -131.74 136.6 56.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 70.329999999999998 111.137 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 127.13 138.66 4.79 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 74.340000000000003 112.476 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.21 84.88 4.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.88 0.371 . . . . 75.329999999999998 111.103 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.06 -179.62 3.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 74.329999999999998 110.895 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.49 -169.74 1.42 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.761 -0.733 . . . . 71.5 112.478 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -79.96 -41.74 25.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.776 0.322 . . . . 75.329999999999998 110.884 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.74 -31.95 72.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 71.230000000000004 111.103 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.438 ' HA ' ' HG2' ' A' ' 109' ' ' ARG . . . -84.07 -60.22 2.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 34.530000000000001 111.093 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.657 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -50.67 -34.59 27.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 72.099999999999994 110.913 -179.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.599 HD23 ' N ' ' A' ' 109' ' ' ARG . 5.8 tt -70.52 -60.51 2.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 62.340000000000003 110.947 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.599 ' N ' HD23 ' A' ' 108' ' ' LEU . 12.6 ptp180 -54.9 -33.01 61.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 74.420000000000002 110.842 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -54.07 -24.54 17.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 73.310000000000002 110.859 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.436 HG21 ' CD1' ' A' ' 88' ' ' LEU . 4.6 mt -85.97 -68.19 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.47 . . . . 73.439999999999998 111.138 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -51.75 -49.07 63.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 61.109999999999999 110.902 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -56.18 -34.84 66.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 74.439999999999998 110.817 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.466 ' HB1' ' HE2' ' A' ' 96' ' ' LYS . . . -73.57 -34.74 65.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 61.210000000000001 111.086 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.5 mt . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.218 -0.447 . . . . 65.340000000000003 110.861 -179.926 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 tpt . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.824 0.345 . . . . 64.299999999999997 110.888 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.52 141.3 33.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 53.439999999999998 111.16 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -94.31 -43.95 8.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 71.540000000000006 110.852 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -88.08 139.22 30.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 74.310000000000002 110.891 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -167.4 146.56 5.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 63.420000000000002 110.836 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 -119.96 30.8 6.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 64.030000000000001 110.899 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -66.95 -36.25 81.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 74.310000000000002 110.855 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -52.34 -35.92 52.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 74.019999999999996 110.845 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.9 mmt -52.02 -37.23 52.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 74.219999999999999 110.891 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.1 m -58.77 127.11 30.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 54.409999999999997 110.859 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.1 -99.98 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.737 -0.744 . . . . 74.219999999999999 112.46 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.3 p -61.97 108.07 0.97 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.801 0.334 . . . . 65.530000000000001 111.165 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.3 t -146.24 148.26 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 72.219999999999999 111.115 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 t -73.05 127.51 32.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 70.209999999999994 111.124 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 90.7 t -91.84 143.79 10.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 73.420000000000002 111.124 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.661 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.64 171.73 0.82 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 64.430000000000007 111.065 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.454 ' H ' HG22 ' A' ' 16' ' ' THR . 2.8 t70 -80.79 -48.32 12.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 61.439999999999998 110.879 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.0 t -67.9 -53.98 22.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 72.099999999999994 110.886 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.661 HG22 ' HB ' ' A' ' 16' ' ' THR . 5.0 t -58.83 -19.51 42.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.099 -0.501 . . . . 63.310000000000002 111.146 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.705 ' CE2' HG21 ' A' ' 24' ' ' VAL . 24.2 t80 -51.41 -30.85 20.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 73.230000000000004 110.868 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.432 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -71.88 -33.61 68.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.175 -0.466 . . . . 73.420000000000002 110.907 179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.9 m -91.6 -16.17 27.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.169 -0.469 . . . . 75.349999999999994 111.12 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.9 -71.39 0.65 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 72.329999999999998 110.834 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.705 HG21 ' CE2' ' A' ' 20' ' ' PHE . 13.1 t -70.9 -70.11 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 73.109999999999999 111.152 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.666 HD23 ' O ' ' A' ' 91' ' ' GLY . 6.9 mt -40.44 -60.02 1.2 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 64.420000000000002 110.915 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -51.24 -65.19 0.6 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.227 -0.442 . . . . 73.019999999999996 110.887 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 56.7 m -54.52 153.72 5.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 71.510000000000005 110.851 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -97.02 -34.92 11.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.489 . . . . 54.119999999999997 110.874 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.2 t -50.15 141.47 15.37 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.56 0.695 . . . . 61.0 111.15 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 125.86 12.67 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.685 2.257 . . . . 54.240000000000002 112.369 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.538 HG22 ' HB3' ' A' ' 62' ' ' LYS . 91.2 t -97.93 128.39 49.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 60.149999999999999 111.155 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.437 HD11 HD11 ' A' ' 88' ' ' LEU . 6.5 mp -102.4 108.11 19.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 65.230000000000004 110.905 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.523 HG12 ' O ' ' A' ' 87' ' ' ILE . 7.4 p -97.13 145.44 9.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 53.329999999999998 111.121 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.57 112.19 13.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 64.349999999999994 110.838 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.681 ' CD2' HD22 ' A' ' 66' ' ' LEU . 75.5 m-85 -97.6 97.8 9.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 72.230000000000004 110.872 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -150.78 -168.07 3.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 75.109999999999999 110.888 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.8 -164.58 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 74.140000000000001 111.106 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.444 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 1.8 m-20 -77.92 12.45 1.76 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.259 -0.428 . . . . 75.299999999999997 110.883 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.46 ' CD1' ' N ' ' A' ' 39' ' ' TRP . 1.6 m0 77.66 94.51 0.06 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.475 . . . . 72.099999999999994 110.928 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -167.94 -63.74 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 74.549999999999997 110.87 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.38 -70.51 1.33 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.748 -0.739 . . . . 63.140000000000001 112.522 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -8.07 22.67 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.661 2.241 . . . . 73.120000000000005 112.349 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.503 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 31.4 t -90.34 -26.84 19.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 74.030000000000001 110.914 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -60.54 -30.59 69.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 71.129999999999995 110.888 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 9.6 ptp -88.05 -39.93 14.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 74.310000000000002 110.908 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.476 ' HA ' HG22 ' A' ' 49' ' ' VAL . 3.5 t -93.81 23.12 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 62.039999999999999 111.111 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.814 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -79.79 -61.38 0.46 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.576 0.703 . . . . 60.119999999999997 111.064 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.814 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 54.4 Cg_endo -69.69 -48.03 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.673 2.249 . . . . 63.229999999999997 112.366 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.666 ' O ' HD12 ' A' ' 53' ' ' ILE . 4.6 m -49.78 -31.15 6.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 74.129999999999995 111.128 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.49 -40.27 80.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 72.239999999999995 110.906 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -64.33 -36.62 84.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.443 . . . . 71.430000000000007 110.927 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -59.9 -68.06 0.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 73.219999999999999 110.915 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.666 HD12 ' O ' ' A' ' 49' ' ' VAL . 3.2 mt -50.44 -39.84 17.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 73.5 111.176 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.455 ' O ' HD22 ' A' ' 61' ' ' LEU . . . -53.55 -39.15 64.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 53.43 111.071 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.9 -35.25 22.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 73.230000000000004 110.876 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -64.09 -36.73 84.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 62.530000000000001 110.937 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -67.59 -73.46 0.14 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 74.329999999999998 110.855 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.9 -175.59 4.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 70.420000000000002 110.866 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -89.52 -33.91 8.94 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.748 -0.739 . . . . 25.0 112.486 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 45.7 p -138.18 46.77 2.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.807 0.337 . . . . 54.229999999999997 111.133 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.455 HD22 ' O ' ' A' ' 54' ' ' ALA . 2.1 pt? -63.62 175.76 1.01 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.453 . . . . 62.210000000000001 110.921 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.538 ' HB3' HG22 ' A' ' 31' ' ' VAL . 24.0 tttp -99.97 141.74 32.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 71.310000000000002 110.868 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 37.7 t -146.43 131.54 11.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.257 -0.429 . . . . 23.449999999999999 111.144 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -152.91 138.05 17.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 74.219999999999999 111.146 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.3 mttp -114.08 159.93 19.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 61.409999999999997 110.903 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.681 HD22 ' CD2' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -135.85 141.03 44.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 63.43 110.918 179.922 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -93.95 113.46 25.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.472 . . . . 70.239999999999995 110.839 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.9 m -60.18 -35.12 59.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 75.299999999999997 111.149 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -53.97 -35.23 61.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 74.129999999999995 110.896 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.11 -35.55 10.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 73.400000000000006 111.095 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.524 ' HB2' HD21 ' A' ' 66' ' ' LEU . 1.4 m-80 -117.94 68.33 6.52 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.607 0.718 . . . . 63.329999999999998 110.85 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -32.16 19.0 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.687 2.258 . . . . 73.349999999999994 112.309 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -65.99 -43.34 88.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.274 -0.421 . . . . 72.239999999999995 110.878 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.35 -54.57 25.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 54.399999999999999 111.086 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.904 ' HB1' HG11 ' A' ' 80' ' ' VAL . . . -55.88 -60.19 3.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 62.130000000000003 111.136 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.3 ttt180 -51.63 -34.56 38.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 74.400000000000006 110.897 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -55.44 -36.16 66.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 70.140000000000001 110.851 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -99.35 20.84 12.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 74.540000000000006 110.87 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 48.6 mm-40 48.78 80.51 0.06 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.44 . . . . 71.049999999999997 110.931 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.904 HG11 ' HB1' ' A' ' 75' ' ' ALA . 14.7 p -105.44 144.02 15.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 63.32 111.118 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 66.1 t -108.82 -72.25 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 61.020000000000003 111.137 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.4 t -79.71 157.86 27.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 71.400000000000006 110.853 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.534 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 4.6 mt -59.91 -58.0 22.64 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.635 0.731 . . . . 70.329999999999998 111.099 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.743 ' HB2' ' HB2' ' A' ' 101' ' ' ALA . 53.4 Cg_endo -69.74 71.75 1.49 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.648 2.232 . . . . 64.549999999999997 112.374 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.703 HG23 ' CG2' ' A' ' 99' ' ' VAL . 23.5 m -110.44 126.62 54.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 52.520000000000003 111.125 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.0 mtm -122.56 158.18 30.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 74.209999999999994 110.838 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.523 ' O ' HG12 ' A' ' 33' ' ' VAL . 34.0 mt -145.27 121.23 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 74.439999999999998 111.16 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.437 HD11 HD11 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -81.95 110.25 17.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 43.299999999999997 110.898 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -98.46 170.2 9.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 73.439999999999998 110.884 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -166.04 107.58 0.73 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 74.209999999999994 110.875 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.666 ' O ' HD23 ' A' ' 25' ' ' LEU . . . 68.37 35.76 82.84 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.738 -0.744 . . . . 71.099999999999994 112.511 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.646 ' H ' HG12 ' A' ' 24' ' ' VAL . . . 72.55 41.46 51.2 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.758 -0.734 . . . . 65.239999999999995 112.491 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.46 HG23 ' HD2' ' A' ' 94' ' ' PRO . 86.4 m -161.04 133.85 4.54 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.549 0.69 . . . . 74.230000000000004 111.182 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.46 ' HD2' HG23 ' A' ' 93' ' ' THR . 53.4 Cg_endo -69.74 103.05 1.1 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.722 2.281 . . . . 74.430000000000007 112.313 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.5 m -91.07 -32.58 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 72.409999999999997 111.147 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.417 ' HD2' ' HB3' ' A' ' 114' ' ' ALA . 1.6 mmtm -138.38 170.13 16.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 63.32 110.949 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.19 118.19 4.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 74.150000000000006 110.878 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.417 ' N ' HD12 ' A' ' 98' ' ' ILE . 4.8 mp -125.5 137.63 57.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 73.299999999999997 111.119 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.703 ' CG2' HG23 ' A' ' 85' ' ' THR . 66.8 t -147.81 136.15 15.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.472 . . . . 63.310000000000002 111.124 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 151.08 -27.58 1.0 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.734 -0.746 . . . . 72.340000000000003 112.475 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.743 ' HB2' ' HB2' ' A' ' 84' ' ' PRO . . . 63.46 72.68 0.47 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.849 0.357 . . . . 75.140000000000001 111.117 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.423 ' HG2' HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -118.88 174.82 6.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 71.140000000000001 110.857 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.66 173.63 4.45 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.729 -0.748 . . . . 54.43 112.483 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.52 -44.13 75.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.791 0.329 . . . . 70.040000000000006 110.898 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.55 -30.2 65.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 63.32 111.107 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.34 -59.55 2.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.268 -0.424 . . . . 61.219999999999999 111.116 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.468 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.3 OUTLIER -48.71 -44.16 37.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 64.140000000000001 110.891 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.456 HD23 ' C ' ' A' ' 108' ' ' LEU . 7.8 tt -50.27 -43.63 53.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 72.540000000000006 110.91 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -72.46 -37.55 68.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 61.299999999999997 110.91 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -49.85 -25.87 3.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 75.209999999999994 110.873 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.8 mt -86.18 -69.61 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 75.430000000000007 111.102 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.474 ' HA ' HD23 ' A' ' 115' ' ' LEU . 0.4 OUTLIER -52.5 -51.18 60.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 71.129999999999995 110.892 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -55.63 -33.87 64.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.157 -0.474 . . . . 61.049999999999997 110.815 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.417 ' HB3' ' HD2' ' A' ' 96' ' ' LYS . . . -71.9 -34.71 69.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 73.150000000000006 111.105 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' A' ' 112' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.23 -0.441 . . . . 63.299999999999997 110.925 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.778 0.323 . . . . 70.510000000000005 110.854 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.72 149.25 25.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 64.219999999999999 111.092 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -92.87 -46.58 7.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 70.019999999999996 110.878 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -110.53 145.39 37.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 75.099999999999994 110.837 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 42.7 p-80 -151.78 118.8 5.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 73.129999999999995 110.857 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -112.95 -36.91 4.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 60.439999999999998 110.891 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -52.02 -59.86 3.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 63.539999999999999 110.855 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -52.05 -35.87 48.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 60.329999999999998 110.844 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 13.1 ttm -51.97 -37.22 52.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 71.310000000000002 110.904 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.7 m -54.99 119.93 6.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 63.539999999999999 110.861 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.09 164.82 18.49 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.723 -0.751 . . . . 72.219999999999999 112.495 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.5 p -60.1 114.75 3.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.791 0.329 . . . . 74.109999999999999 111.141 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 96.1 t -150.08 144.18 17.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.428 . . . . 65.019999999999996 111.118 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 t -84.1 127.53 33.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.459 . . . . 64.430000000000007 111.097 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.417 ' CG1' HG23 ' A' ' 19' ' ' THR . 47.6 t -94.88 126.0 47.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 73.030000000000001 111.109 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.659 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.6 OUTLIER -59.5 166.44 2.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 64.019999999999996 111.13 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.427 ' H ' HG22 ' A' ' 16' ' ' THR . 1.4 p30 -68.52 -48.33 64.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 71.420000000000002 110.844 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 3.1 m -68.48 -52.98 26.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 73.329999999999998 110.879 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.659 HG22 ' HB ' ' A' ' 16' ' ' THR . 6.8 t -59.66 -19.0 46.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.092 -0.504 . . . . 73.209999999999994 111.162 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.73 ' CE2' HG21 ' A' ' 24' ' ' VAL . 25.6 t80 -51.31 -30.8 19.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 75.150000000000006 110.878 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.462 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -72.69 -32.94 66.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 75.5 110.871 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.0 m -91.33 -17.1 26.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 74.109999999999999 111.098 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.405 ' HB3' HG11 ' A' ' 15' ' ' VAL . 7.6 t70 -93.63 -71.38 0.66 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 71.219999999999999 110.871 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.743 HG13 HG21 ' A' ' 31' ' ' VAL . 20.0 t -70.08 -70.78 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 35.119999999999997 111.136 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.637 HD23 ' HA3' ' A' ' 92' ' ' GLY . 10.6 mt -40.56 -59.8 1.27 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 73.109999999999999 110.933 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -50.86 -64.85 0.68 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 51.219999999999999 110.85 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.0 t -52.12 163.27 0.39 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 73.099999999999994 110.877 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -106.02 -40.85 5.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 70.409999999999997 110.838 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -51.79 159.69 1.28 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.581 0.705 . . . . 71.510000000000005 111.155 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 147.66 63.4 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.683 2.255 . . . . 62.100000000000001 112.372 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.743 HG21 HG13 ' A' ' 24' ' ' VAL . 97.0 t -123.14 115.5 45.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 51.530000000000001 111.149 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.699 HD22 ' HG ' ' A' ' 88' ' ' LEU . 7.5 mt -103.94 106.29 16.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 72.140000000000001 110.911 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 m -108.48 134.71 49.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 62.520000000000003 111.128 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.526 ' OD2' HD11 ' A' ' 50' ' ' LEU . 0.8 OUTLIER -100.22 99.12 9.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 63.329999999999998 110.85 179.915 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.711 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 5.5 m-85 -82.86 89.56 6.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 72.319999999999993 110.881 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -152.52 -169.19 3.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.157 -0.474 . . . . 74.310000000000002 110.915 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.44 -154.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 61.130000000000003 111.097 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.477 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 35.2 p-10 -77.44 8.94 3.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.244 -0.434 . . . . 62.140000000000001 110.862 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.477 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 1.1 p-90 41.55 63.53 1.25 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 72.299999999999997 110.893 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 41.2 t -125.04 -45.89 1.84 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 63.200000000000003 110.891 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.59 -68.24 1.49 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.751 -0.738 . . . . 61.530000000000001 112.443 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -26.48 27.65 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.663 2.242 . . . . 74.420000000000002 112.317 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 34.8 t -50.49 -30.14 12.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.199 -0.455 . . . . 63.039999999999999 110.905 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.29 -30.3 17.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.148 -0.478 . . . . 73.510000000000005 110.861 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 16.4 mtt -88.75 -36.72 15.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 53.43 110.893 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.434 ' O ' HG12 ' A' ' 46' ' ' VAL . 3.3 t -92.74 21.3 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 64.329999999999998 111.153 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.779 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -68.95 -59.83 4.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.562 0.696 . . . . 71.319999999999993 111.113 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.779 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.5 Cg_endo -69.75 -45.56 1.55 Allowed 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.705 2.27 . . . . 73.439999999999998 112.353 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.82 HG13 ' HA ' ' A' ' 104' ' ' LYS . 26.3 t -55.37 -50.63 63.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 71.510000000000005 111.113 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.526 HD11 ' OD2' ' A' ' 34' ' ' ASP . 50.5 tp -52.94 -32.03 43.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.195 -0.457 . . . . 62.43 110.921 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.475 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 28.0 mm-40 -83.89 -35.27 24.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 61.409999999999997 110.893 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -51.91 -61.41 2.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 72.040000000000006 110.939 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.665 HD12 ' O ' ' A' ' 49' ' ' VAL . 3.0 mp -50.74 -32.83 11.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.478 . . . . 62.409999999999997 111.15 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.655 ' HA ' HD11 ' A' ' 61' ' ' LEU . . . -62.52 -40.74 97.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.479 . . . . 72.540000000000006 111.048 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.28 -35.44 35.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 73.230000000000004 110.887 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -62.46 -40.16 95.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.162 -0.472 . . . . 73.439999999999998 110.903 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.619 ' HB2' HD13 ' A' ' 61' ' ' LEU . 2.8 mmpt? -67.32 -72.08 0.18 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.111 -0.495 . . . . 73.25 110.895 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.4 t -145.25 -173.85 4.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.44 . . . . 74.519999999999996 110.826 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -94.82 -34.98 6.0 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.737 -0.744 . . . . 42.140000000000001 112.473 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.1 t -123.97 35.15 4.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.831 0.348 . . . . 74.120000000000005 111.165 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.655 HD11 ' HA ' ' A' ' 54' ' ' ALA . 2.3 pt? -62.97 -171.95 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 74.329999999999998 110.916 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.5 mttp -109.64 120.21 41.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.171 -0.468 . . . . 73.040000000000006 110.929 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.8 t -123.71 112.19 32.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 61.240000000000002 111.105 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -131.04 156.07 45.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 64.040000000000006 111.13 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.7 122.51 16.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 62.299999999999997 110.877 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.534 HD21 ' HB2' ' A' ' 71' ' ' ASN . 11.1 tp -103.28 155.46 18.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.246 -0.434 . . . . 72.120000000000005 110.897 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.414 ' OD1' ' HB3' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -112.54 103.14 11.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 72.129999999999995 110.874 179.824 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.702 HG12 ' HB2' ' A' ' 75' ' ' ALA . 30.7 m -51.11 -32.14 11.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 64.549999999999997 111.149 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.77 -35.58 23.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 75.329999999999998 110.862 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.414 ' HB3' ' OD1' ' A' ' 67' ' ' ASP . . . -105.17 -33.31 8.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.448 . . . . 65.310000000000002 111.097 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.534 ' HB2' HD21 ' A' ' 66' ' ' LEU . 0.4 OUTLIER -120.91 71.75 21.26 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.6 0.714 . . . . 64.109999999999999 110.869 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -32.04 19.39 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.664 2.243 . . . . 73.409999999999997 112.341 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -51.71 -34.52 39.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 73.120000000000005 110.893 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.711 ' HB1' ' CE2' ' A' ' 35' ' ' PHE . . . -68.77 -46.47 68.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.479 . . . . 65.129999999999995 111.094 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.838 ' HB1' HG11 ' A' ' 80' ' ' VAL . . . -55.31 -65.93 0.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.437 . . . . 74.439999999999998 111.069 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -51.04 -32.72 22.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 71.319999999999993 110.886 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.62 -42.14 61.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 75.450000000000003 110.896 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -98.53 20.75 12.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 54.030000000000001 110.898 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 62.9 mm-40 47.41 79.55 0.06 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.474 . . . . 72.400000000000006 110.88 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.838 HG11 ' HB1' ' A' ' 75' ' ' ALA . 14.2 p -106.48 140.96 22.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 74.239999999999995 111.135 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.8 t -114.49 -35.49 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 75.510000000000005 111.135 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 6.7 t -105.85 151.88 23.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 65.310000000000002 110.885 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.531 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 5.3 mt -55.62 -58.04 17.86 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.64 0.733 . . . . 73.349999999999994 111.119 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.5 Cg_endo -69.76 99.17 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.667 2.245 . . . . 73.349999999999994 112.314 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 1.001 HG23 HG12 ' A' ' 99' ' ' VAL . 43.3 m -142.39 137.05 30.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 62.219999999999999 111.149 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 32.7 ttp -137.33 131.78 32.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 73.420000000000002 110.907 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 10.9 mm -108.2 110.93 33.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 72.340000000000003 111.1 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.699 ' HG ' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -79.59 100.27 7.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.178 -0.464 . . . . 65.420000000000002 110.896 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -89.58 170.32 10.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 75.230000000000004 110.904 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -166.33 89.59 0.4 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 64.230000000000004 110.902 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.86 39.41 8.7 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.758 -0.734 . . . . 62.450000000000003 112.499 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.637 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 68.72 41.63 82.69 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.74 -0.743 . . . . 71.109999999999999 112.484 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.7 m -161.79 131.31 3.25 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.558 0.694 . . . . 74.120000000000005 111.138 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 86.59 0.57 Allowed 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.675 2.25 . . . . 72.140000000000001 112.39 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.9 m -73.37 -32.24 36.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 60.030000000000001 111.116 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.49 ' HD2' ' HB3' ' A' ' 114' ' ' ALA . 10.9 mmtm -143.38 170.17 16.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 71.019999999999996 110.896 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -158.36 103.56 1.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 73.409999999999997 110.825 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.429 ' N ' HD12 ' A' ' 98' ' ' ILE . 4.6 mp -113.75 132.71 61.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 61.530000000000001 111.113 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 1.001 HG12 HG23 ' A' ' 85' ' ' THR . 3.0 m -128.06 141.6 46.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 74.140000000000001 111.141 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 128.06 142.35 5.44 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.741 -0.743 . . . . 73.519999999999996 112.532 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -96.25 89.2 5.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.873 0.368 . . . . 50.450000000000003 111.108 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.51 ' HB2' ' HB3' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -123.03 -175.39 3.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 62.43 110.959 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.23 -174.79 28.44 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.728 -0.748 . . . . 61.210000000000001 112.481 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.82 ' HA ' HG13 ' A' ' 49' ' ' VAL . 0.4 OUTLIER -70.96 -46.47 62.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.761 0.315 . . . . 72.019999999999996 110.876 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.24 -22.24 65.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.266 -0.425 . . . . 73.239999999999995 111.08 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.51 ' HB3' ' HB2' ' A' ' 102' ' ' LYS . . . -91.28 -60.51 1.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 40.25 111.053 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.478 HD23 ' HG2' ' A' ' 102' ' ' LYS . 0.2 OUTLIER -53.7 -31.28 47.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.248 -0.433 . . . . 74.319999999999993 110.883 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.594 HD23 ' N ' ' A' ' 109' ' ' ARG . 5.7 tt -73.32 -59.64 2.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 73.209999999999994 110.9 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.594 ' N ' HD23 ' A' ' 108' ' ' LEU . 15.6 ptm180 -52.85 -34.04 52.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 65.519999999999996 110.845 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.401 ' HG3' ' HE2' ' A' ' 102' ' ' LYS . 49.9 mm-40 -56.8 -25.0 54.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 63.420000000000002 110.847 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.2 mt -84.58 -65.81 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 62.509999999999998 111.129 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -53.12 -48.24 68.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.433 . . . . 70.329999999999998 110.871 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -54.56 -34.46 61.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.476 . . . . 72.409999999999997 110.86 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.49 ' HB3' ' HD2' ' A' ' 96' ' ' LYS . . . -73.07 -34.74 66.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 65.420000000000002 111.096 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.8 mt . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 75.299999999999997 110.865 -179.932 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ttt . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.767 0.318 . . . . 72.019999999999996 110.853 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -127.5 97.56 4.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.254 -0.43 . . . . 75.319999999999993 111.114 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.9 m-70 -97.4 -50.37 4.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.211 -0.449 . . . . 60.340000000000003 110.888 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.5 p80 -125.84 115.81 20.57 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.219 -0.446 . . . . 73.209999999999994 110.834 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -150.66 179.65 8.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 74.420000000000002 110.865 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -105.26 30.82 5.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 61.049999999999997 110.846 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -55.69 -36.22 66.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 75.540000000000006 110.85 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -62.81 -36.35 82.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 74.420000000000002 110.843 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 6.7 mmm -77.57 -38.93 47.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 72.099999999999994 110.858 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.9 p -55.08 127.54 29.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 65.209999999999994 110.867 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -89.77 -116.09 1.62 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.721 -0.752 . . . . 54.200000000000003 112.47 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.506 HG22 ' HB ' ' A' ' 63' ' ' VAL . 59.5 p -70.4 100.29 1.73 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.841 0.353 . . . . 75.510000000000005 111.117 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.4 m -152.13 163.57 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.251 -0.431 . . . . 74.209999999999994 111.124 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.475 ' OG1' HD13 ' A' ' 66' ' ' LEU . 9.8 t -75.66 127.62 33.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.16 -0.473 . . . . 74.519999999999996 111.172 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.479 HG21 ' OD1' ' A' ' 23' ' ' ASP . 99.8 t -93.18 136.63 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.243 -0.435 . . . . 74.239999999999995 111.146 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.565 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -60.03 176.05 0.35 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 64.129999999999995 111.127 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.42 ' H ' HG22 ' A' ' 16' ' ' THR . 3.8 p-10 -81.06 -49.14 11.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 71.430000000000007 110.835 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.3 t -68.07 -54.27 19.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 44.5 110.872 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.565 HG22 ' HB ' ' A' ' 16' ' ' THR . 5.7 t -58.24 -19.37 33.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.138 -0.483 . . . . 75.340000000000003 111.168 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.724 ' CE2' HG21 ' A' ' 24' ' ' VAL . 24.9 t80 -50.82 -31.19 16.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 74.409999999999997 110.889 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.413 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.7 OUTLIER -71.54 -34.27 69.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.474 . . . . 73.510000000000005 110.898 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.2 m -91.04 -15.55 29.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 72.420000000000002 111.151 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.479 ' OD1' HG21 ' A' ' 15' ' ' VAL . 29.5 t70 -93.56 -71.1 0.67 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 74.400000000000006 110.855 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.841 HG13 HG21 ' A' ' 31' ' ' VAL . 17.9 t -71.04 -70.43 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 53.140000000000001 111.116 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.58 HD23 ' HA3' ' A' ' 92' ' ' GLY . 7.3 mt -40.55 -59.39 1.36 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 73.209999999999994 110.952 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -51.14 -62.41 1.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.476 . . . . 74.209999999999994 110.843 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.2 p -52.72 152.63 3.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 71.030000000000001 110.883 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -101.6 -37.79 8.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.112 -0.495 . . . . 64.25 110.829 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.94 159.69 1.76 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.589 0.709 . . . . 62.439999999999998 111.121 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 123.98 10.62 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.692 2.261 . . . . 62.109999999999999 112.335 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.841 HG21 HG13 ' A' ' 24' ' ' VAL . 97.8 t -97.39 123.87 50.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 65.230000000000004 111.112 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.468 HD21 HD13 ' A' ' 88' ' ' LEU . 3.3 mm? -103.5 100.0 9.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 72.129999999999995 110.899 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.1 p -95.18 135.09 30.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 61.43 111.137 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.13 99.72 7.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 75.230000000000004 110.876 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -91.41 89.84 7.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.458 . . . . 63.140000000000001 110.887 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.52 ' HH2' HD11 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -147.8 -169.65 3.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.165 -0.471 . . . . 74.430000000000007 110.919 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.52 ' HA ' HG22 ' A' ' 68' ' ' VAL . . . -61.72 -153.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 53.299999999999997 111.085 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.486 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 22.8 t0 -77.16 9.44 3.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 70.329999999999998 110.848 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.486 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 0.9 OUTLIER 42.01 67.02 0.62 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.166 -0.47 . . . . 71.540000000000006 110.911 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 46.8 t -127.74 -44.7 1.49 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.429 . . . . 71.209999999999994 110.935 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.92 -68.03 1.5 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.755 -0.736 . . . . 42.329999999999998 112.519 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -30.84 21.78 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.655 2.237 . . . . 72.329999999999998 112.312 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 42.8 t -56.08 -24.13 38.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.246 -0.434 . . . . 35.310000000000002 110.869 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 50.4 mttt -50.79 -39.5 52.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 75.230000000000004 110.906 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.457 ' HG3' HG23 ' A' ' 46' ' ' VAL . 12.2 ptm -90.12 -29.3 18.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 75.209999999999994 110.886 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.474 ' HA ' HG22 ' A' ' 49' ' ' VAL . 3.4 t -92.55 21.79 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 71.340000000000003 111.11 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.783 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -80.01 -61.08 0.46 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.578 0.704 . . . . 75.530000000000001 111.116 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.783 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.6 Cg_endo -69.76 -46.7 1.13 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.642 2.228 . . . . 52.140000000000001 112.321 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.589 ' O ' HD12 ' A' ' 53' ' ' ILE . 4.3 m -50.5 -30.14 7.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 41.420000000000002 111.109 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.52 HD11 ' HH2' ' A' ' 36' ' ' TRP . 10.8 mt -69.23 -39.08 78.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 73.349999999999994 110.909 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.53 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 4.0 mm-40 -72.77 -32.45 65.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 74.319999999999993 110.858 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -49.74 -58.62 4.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.484 . . . . 72.530000000000001 110.882 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.589 HD12 ' O ' ' A' ' 49' ' ' VAL . 3.0 mp -50.38 -32.12 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 74.030000000000001 111.125 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 51' ' ' GLU . . . -62.64 -53.04 60.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 54.420000000000002 111.103 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -65.71 -34.78 79.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.441 . . . . 75.209999999999994 110.893 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -63.53 -34.44 77.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 74.540000000000006 110.874 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -92.8 -74.56 0.52 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 73.549999999999997 110.882 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.0 t -174.48 179.59 1.74 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 65.219999999999999 110.846 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -105.51 34.44 5.77 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.747 -0.739 . . . . 61.299999999999997 112.465 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.3 p -118.65 -35.45 3.72 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.845 0.355 . . . . 72.540000000000006 111.144 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.647 ' C ' HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -51.31 169.38 0.05 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 73.040000000000006 110.901 179.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.551 ' N ' HD22 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -123.69 148.68 46.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 63.420000000000002 110.933 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.506 ' HB ' HG22 ' A' ' 12' ' ' THR . 21.5 t -125.49 102.06 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 64.209999999999994 111.17 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -99.98 138.42 37.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 72.340000000000003 111.084 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.1 pttp -135.64 111.2 9.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 71.129999999999995 110.914 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.475 HD13 ' OG1' ' A' ' 14' ' ' THR . 27.9 tp -107.75 160.32 15.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 70.140000000000001 110.88 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.613 ' OD2' ' HB3' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -104.01 119.85 39.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 75.310000000000002 110.891 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.52 HG22 ' HA ' ' A' ' 37' ' ' ALA . 27.0 m -63.1 -33.49 61.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 63.310000000000002 111.129 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -50.59 -36.13 33.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 62.420000000000002 110.852 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.613 ' HB3' ' OD2' ' A' ' 67' ' ' ASP . . . -98.38 -35.39 10.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 72.439999999999998 111.086 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -120.39 67.6 13.42 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.579 0.704 . . . . 74.409999999999997 110.902 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -33.58 16.56 Favored 'Trans proline' 0 C--N 1.34 0.127 0 C-N-CA 122.687 2.258 . . . . 65.120000000000005 112.377 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -52.21 -52.06 54.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 72.299999999999997 110.877 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -52.44 -46.13 66.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 75.140000000000001 111.081 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.68 ' HB1' HG11 ' A' ' 80' ' ' VAL . . . -51.47 -70.48 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 60.140000000000001 111.115 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 -51.34 -32.11 24.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 72.340000000000003 110.863 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -51.69 -44.4 63.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 73.219999999999999 110.889 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -95.66 18.99 11.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 62.310000000000002 110.896 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 54.8 mm-40 48.25 72.85 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 65.140000000000001 110.898 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.68 HG11 ' HB1' ' A' ' 75' ' ' ALA . 14.6 p -99.3 131.77 45.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 62.119999999999997 111.154 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 85.1 t -88.89 -74.03 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 73.200000000000003 111.112 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.86 158.75 29.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 60.32 110.828 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.52 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 1.3 mp -65.75 -58.37 11.62 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.635 0.731 . . . . 73.129999999999995 111.159 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.8 Cg_endo -69.77 71.33 1.53 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.709 2.273 . . . . 55.340000000000003 112.355 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 89.1 m -113.73 139.16 49.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 72.129999999999995 111.159 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 37.4 ttp -135.25 112.74 10.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 73.299999999999997 110.903 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 27.5 mt -90.04 128.08 42.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.429 . . . . 71.230000000000004 111.122 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.468 HD13 HD21 ' A' ' 32' ' ' LEU . 10.0 tp -92.27 105.78 17.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 63.219999999999999 110.97 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -91.86 170.98 9.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 73.329999999999998 110.834 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.5 tttt -165.67 91.9 0.51 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 72.340000000000003 110.915 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.34 36.14 8.32 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.749 -0.739 . . . . 62.210000000000001 112.53 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.58 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 69.48 38.59 79.73 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.752 -0.737 . . . . 63.140000000000001 112.452 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.46 HG23 ' HD2' ' A' ' 94' ' ' PRO . 86.4 m -161.12 133.91 4.53 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.592 0.71 . . . . 73.140000000000001 111.152 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.46 ' HD2' HG23 ' A' ' 93' ' ' THR . 53.3 Cg_endo -69.79 107.26 1.82 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.723 2.282 . . . . 72.150000000000006 112.322 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 16.5 m -94.13 -32.69 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 73.420000000000002 111.153 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.509 ' HE3' ' HB1' ' A' ' 114' ' ' ALA . 23.5 mmtm -152.61 170.38 20.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 73.439999999999998 110.92 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.417 ' C ' HD12 ' A' ' 98' ' ' ILE . 0.2 OUTLIER -154.29 131.72 11.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 71.540000000000006 110.843 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.434 ' N ' HD12 ' A' ' 98' ' ' ILE . 4.1 mp -126.01 141.85 44.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 75.219999999999999 111.131 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.6 p -150.23 143.31 17.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 65.099999999999994 111.132 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.52 -27.32 1.35 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.765 -0.731 . . . . 63.32 112.518 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 61.82 72.5 0.5 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.817 0.341 . . . . 60.32 111.104 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.44 ' HB2' ' HB3' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -119.38 -179.2 3.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 75.230000000000004 110.873 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.72 178.84 2.3 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.724 -0.751 . . . . 52.030000000000001 112.515 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.64 -36.12 73.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.771 0.32 . . . . 63.020000000000003 110.887 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.61 -32.65 74.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 62.210000000000001 111.112 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.44 ' HB3' ' HB2' ' A' ' 102' ' ' LYS . . . -86.57 -56.38 3.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 64.109999999999999 111.113 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.579 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.4 OUTLIER -52.24 -34.16 44.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 74.510000000000005 110.914 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.601 HD23 ' N ' ' A' ' 109' ' ' ARG . 5.2 tt -70.05 -59.26 3.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.231 -0.441 . . . . 73.439999999999998 110.911 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.601 ' N ' HD23 ' A' ' 108' ' ' LEU . 3.0 ptm180 -56.14 -34.5 66.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 73.409999999999997 110.888 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -52.8 -25.63 11.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 72.109999999999999 110.88 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.6 mt -84.72 -68.43 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.483 . . . . 61.409999999999997 111.143 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -51.93 -49.75 62.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 75.310000000000002 110.885 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -53.82 -35.01 60.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 61.549999999999997 110.851 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.509 ' HB1' ' HE3' ' A' ' 96' ' ' LYS . . . -72.98 -35.83 66.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 74.340000000000003 111.071 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.1 mt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 63.420000000000002 110.966 -179.988 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 mtm . . . . . 0 N--CA 1.458 -0.061 0 CA-C-O 120.769 0.319 . . . . 73.340000000000003 110.923 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.518 ' HB3' ' NE2' ' A' ' 5' ' ' HIS . . . -129.07 148.07 50.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 73.140000000000001 111.087 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -83.81 -60.25 2.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 71.209999999999994 110.855 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -59.04 104.75 0.26 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 71.310000000000002 110.85 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.518 ' NE2' ' HB3' ' A' ' 2' ' ' ALA . 23.9 m-70 -157.23 166.19 33.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 75.109999999999999 110.882 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -111.65 30.84 6.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 70.129999999999995 110.889 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -92.99 11.33 27.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.136 -0.484 . . . . 70.310000000000002 110.886 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -79.36 -36.01 40.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 75.239999999999995 110.848 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -58.03 -36.95 73.45 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.207 -0.451 . . . . 64.099999999999994 110.849 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.5 m -52.51 131.42 33.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 64.099999999999994 110.902 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.7 -108.8 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.759 -0.734 . . . . 60.299999999999997 112.452 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.8 p -60.63 113.93 2.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.862 0.363 . . . . 73.519999999999996 111.144 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 91.7 t -149.96 144.49 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 64.299999999999997 111.116 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 t -82.44 127.16 33.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 72.010000000000005 111.129 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.2 t -92.66 131.64 39.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 63.450000000000003 111.103 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.484 ' CB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.7 179.23 0.13 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.112 -0.495 . . . . 45.450000000000003 111.124 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.441 ' H ' HG22 ' A' ' 16' ' ' THR . 1.1 m-20 -81.05 -49.8 10.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 75.120000000000005 110.934 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.0 m -69.3 -52.99 22.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 63.149999999999999 110.835 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.484 HG22 ' CB ' ' A' ' 16' ' ' THR . 5.3 t -58.29 -19.5 35.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 75.099999999999994 111.147 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.724 ' CE2' HG21 ' A' ' 24' ' ' VAL . 27.3 t80 -51.22 -31.85 21.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 74.019999999999996 110.869 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.432 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -72.04 -32.82 67.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 54.399999999999999 110.876 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.4 m -90.94 -16.58 27.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 75.150000000000006 111.144 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -93.96 -70.76 0.69 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 64.030000000000001 110.879 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.724 HG21 ' CE2' ' A' ' 20' ' ' PHE . 18.8 t -70.2 -70.48 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 65.209999999999994 111.092 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.45 HD23 ' O ' ' A' ' 91' ' ' GLY . 8.3 mt -41.09 -60.35 1.24 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 62.119999999999997 110.932 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -49.82 -63.05 1.23 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 73.409999999999997 110.864 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 59.6 m -48.85 -34.68 13.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 72.530000000000001 110.818 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.0 t0 59.51 30.88 20.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.196 -0.456 . . . . 54.299999999999997 110.897 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.24 160.62 36.75 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.552 0.692 . . . . 73.519999999999996 111.188 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 111.8 2.9 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.666 2.244 . . . . 44.149999999999999 112.349 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.404 HG22 ' HB3' ' A' ' 62' ' ' LYS . 89.7 t -102.88 117.42 48.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 62.229999999999997 111.087 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.1 mt -79.89 102.33 9.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 74.310000000000002 110.888 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.509 HG11 ' CE1' ' A' ' 35' ' ' PHE . 43.1 t -89.71 137.37 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 75.150000000000006 111.11 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -122.46 99.23 6.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.485 . . . . 74.129999999999995 110.892 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.509 ' CE1' HG11 ' A' ' 33' ' ' VAL . 15.1 m-85 -96.72 89.82 5.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 71.340000000000003 110.885 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -151.18 -169.13 3.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.092 -0.504 . . . . 74.219999999999999 110.925 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.66 -154.51 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 53.009999999999998 111.1 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.477 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 23.9 t0 -77.33 8.74 3.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 70.209999999999994 110.909 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.477 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 1.3 p-90 41.5 64.87 0.94 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 44.340000000000003 110.949 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 4.0 p -124.87 -44.5 1.93 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.273 -0.421 . . . . 71.540000000000006 110.868 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.55 -69.33 1.4 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.755 -0.736 . . . . 72.510000000000005 112.473 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -26.33 27.67 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.697 2.265 . . . . 75.209999999999994 112.317 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 26.1 t -49.9 -31.09 11.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 53.340000000000003 110.889 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -51.94 -29.86 22.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 73.049999999999997 110.842 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 51.6 mmm -89.99 -38.2 13.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 62.450000000000003 110.863 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 1.014 HG12 HD23 ' A' ' 50' ' ' LEU . 3.3 t -92.44 22.72 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 74.349999999999994 111.129 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.772 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -79.12 -60.92 0.52 Allowed Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.584 0.707 . . . . 54.310000000000002 111.064 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.772 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.7 Cg_endo -69.8 -48.45 0.71 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.701 2.268 . . . . 55.439999999999998 112.312 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.676 ' O ' HD12 ' A' ' 53' ' ' ILE . 4.7 m -50.45 -29.91 7.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.433 . . . . 74.219999999999999 111.129 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.014 HD23 HG12 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -70.74 -39.59 73.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 72.349999999999994 110.951 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -70.99 -34.38 71.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 54.520000000000003 110.847 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -51.55 -68.76 0.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 60.5 110.873 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.676 HD12 ' O ' ' A' ' 49' ' ' VAL . 2.7 mp -50.43 -34.42 11.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 55.049999999999997 111.131 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.795 ' HA ' HD21 ' A' ' 61' ' ' LEU . . . -60.79 -38.58 85.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.176 -0.466 . . . . 34.539999999999999 111.124 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.88 -35.25 24.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 62.310000000000002 110.883 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -65.84 -47.05 76.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.476 . . . . 73.209999999999994 110.908 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 53.7 mmtt -62.6 -72.34 0.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 75.349999999999994 110.864 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -128.64 178.23 6.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.253 -0.431 . . . . 74.120000000000005 110.872 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.61 -52.4 20.99 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.794 -0.717 . . . . 62.350000000000001 112.517 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 60.5 p -143.67 56.98 1.36 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.821 0.343 . . . . 71.430000000000007 111.121 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.795 HD21 ' HA ' ' A' ' 54' ' ' ALA . 3.7 pp -57.94 -178.21 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.238 -0.437 . . . . 70.140000000000001 110.873 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.404 ' HB3' HG22 ' A' ' 31' ' ' VAL . 14.0 tttp -93.34 146.87 23.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 64.219999999999999 110.893 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -141.26 123.76 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 70.540000000000006 111.129 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -134.89 140.56 45.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 71.140000000000001 111.121 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.71 140.61 51.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 72.129999999999995 110.878 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.583 HD21 ' HB2' ' A' ' 71' ' ' ASN . 4.0 tt -123.21 150.73 43.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 64.409999999999997 110.914 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.658 ' OD2' ' HB3' ' A' ' 70' ' ' ALA . 0.5 OUTLIER -105.4 103.78 13.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 73.150000000000006 110.857 179.88 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.65 HG12 ' HB2' ' A' ' 75' ' ' ALA . 13.4 m -51.42 -33.33 14.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 73.209999999999994 111.104 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.85 -35.44 32.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 75.099999999999994 110.88 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.658 ' HB3' ' OD2' ' A' ' 67' ' ' ASP . . . -103.16 -34.26 8.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 64.430000000000007 111.088 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.583 ' HB2' HD21 ' A' ' 66' ' ' LEU . 0.7 OUTLIER -118.92 67.35 8.05 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.657 0.742 . . . . 75.010000000000005 110.907 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -34.19 15.04 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.707 2.272 . . . . 64.120000000000005 112.285 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -52.01 -46.36 64.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 73.409999999999997 110.891 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.24 -42.58 86.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 72.420000000000002 111.122 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.65 ' HB2' HG12 ' A' ' 68' ' ' VAL . . . -55.52 -68.59 0.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 62.140000000000001 111.06 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -51.2 -31.76 21.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 72.030000000000001 110.854 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -51.08 -36.73 41.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 74.519999999999996 110.866 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -108.77 23.85 13.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 74.219999999999999 110.924 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 70.8 mm-40 48.2 67.65 0.8 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 72.349999999999994 110.871 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 75' ' ' ALA . 99.4 t -87.5 113.34 24.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.478 . . . . 75.230000000000004 111.1 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.1 t -78.79 -66.88 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 74.519999999999996 111.12 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.45 162.58 17.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 74.329999999999998 110.845 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.53 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.4 mt -65.06 -58.12 13.59 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.636 0.731 . . . . 72.140000000000001 111.118 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.8 Cg_endo -69.8 70.28 1.61 Allowed 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.656 2.237 . . . . 61.310000000000002 112.316 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.499 ' OG1' HG13 ' A' ' 80' ' ' VAL . 99.2 m -108.13 100.02 9.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 53.229999999999997 111.125 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.5 ttt -99.75 118.31 35.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 64.510000000000005 110.856 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.462 HD12 ' CD1' ' A' ' 35' ' ' PHE . 51.4 mt -98.17 131.49 45.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 53.130000000000003 111.102 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.629 HD12 HG21 ' A' ' 111' ' ' ILE . 0.4 OUTLIER -96.37 103.98 15.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.177 -0.465 . . . . 61.109999999999999 110.964 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -90.02 167.72 12.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 71.120000000000005 110.86 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -170.37 119.58 0.58 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 73.239999999999995 110.877 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.45 ' O ' HD23 ' A' ' 25' ' ' LEU . . . 66.33 30.99 77.67 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.735 -0.745 . . . . 64.120000000000005 112.485 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.411 ' H ' HG12 ' A' ' 24' ' ' VAL . . . 73.37 53.57 7.49 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.795 -0.717 . . . . 52.5 112.458 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 178.92 139.35 0.27 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.554 0.692 . . . . 74.519999999999996 111.143 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.84 84.88 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.676 2.251 . . . . 64.450000000000003 112.322 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.9 m -64.14 -33.84 65.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 73.010000000000005 111.138 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.0 mmtt -152.84 170.28 20.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 64.0 110.907 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.44 ' C ' HD12 ' A' ' 98' ' ' ILE . 27.4 ttt180 -151.68 130.86 12.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 70.310000000000002 110.926 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.44 HD12 ' C ' ' A' ' 97' ' ' ARG . 4.5 mp -130.08 135.75 60.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 72.510000000000005 111.16 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -125.29 140.6 47.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 73.209999999999994 111.125 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 127.98 131.05 3.4 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.751 -0.738 . . . . 72.420000000000002 112.478 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.09 70.92 10.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.835 0.35 . . . . 71.239999999999995 111.082 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.439 ' HG2' HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -107.47 171.9 7.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 75.140000000000001 110.909 179.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -61.04 173.62 6.15 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.729 -0.748 . . . . 51.119999999999997 112.496 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.88 -44.93 91.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.766 0.317 . . . . 72.030000000000001 110.855 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.93 -64.11 0.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 61.43 111.124 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.44 -57.9 9.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 73.430000000000007 111.144 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.466 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.2 OUTLIER -51.25 -42.49 61.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 72.310000000000002 110.955 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.478 ' O ' HD12 ' A' ' 108' ' ' LEU . 4.1 tp -63.6 -55.42 23.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 50.409999999999997 110.879 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.7 mtm180 -51.71 -42.0 61.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 73.319999999999993 110.888 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -51.86 -26.09 9.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 62.219999999999999 110.9 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.629 HG21 HD12 ' A' ' 88' ' ' LEU . 2.9 mt -85.14 -68.65 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 55.229999999999997 111.084 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.53 -49.17 62.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 74.409999999999997 110.862 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -56.95 -34.92 68.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 51.149999999999999 110.884 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.22 -37.51 66.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 73.0 111.085 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.0 mt . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.437 . . . . 74.310000000000002 110.932 -179.956 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 mmt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.761 0.315 . . . . 73.349999999999994 110.879 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.39 106.1 11.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 71.349999999999994 111.113 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -98.26 -40.42 8.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 75.340000000000003 110.857 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 24.2 t-80 -101.27 156.0 17.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 74.329999999999998 110.846 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -77.26 168.31 20.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 73.219999999999999 110.832 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 61.2 m-70 -118.4 -37.25 3.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 64.340000000000003 110.86 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -53.08 -36.23 60.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 74.109999999999999 110.826 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -54.83 -36.59 65.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 72.420000000000002 110.843 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 10.1 mtt -98.52 30.73 3.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 75.430000000000007 110.883 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.1 t -71.81 127.55 32.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 70.25 110.846 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.704 ' O ' HG22 ' A' ' 13' ' ' VAL . . . 143.66 173.55 15.26 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.738 -0.744 . . . . 54.509999999999998 112.485 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.2 p -59.98 101.14 0.11 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.83 0.347 . . . . 63.020000000000003 111.152 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.704 HG22 ' O ' ' A' ' 11' ' ' GLY . 4.2 m -153.45 163.67 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 74.430000000000007 111.143 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 t -66.56 126.98 30.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 62.420000000000002 111.135 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.43 HG23 ' CB ' ' A' ' 64' ' ' ALA . 60.6 t -94.76 127.6 46.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.449 . . . . 73.450000000000003 111.106 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.49 ' CB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.51 179.08 0.12 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 73.129999999999995 111.119 -179.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.461 ' H ' HG22 ' A' ' 16' ' ' THR . 1.3 p30 -79.98 -48.11 13.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 73.120000000000005 110.871 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.2 m -70.99 -51.56 24.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 73.519999999999996 110.867 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.49 HG22 ' CB ' ' A' ' 16' ' ' THR . 5.9 t -59.57 -19.32 47.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.148 -0.478 . . . . 63.329999999999998 111.144 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.729 ' CE2' HG21 ' A' ' 24' ' ' VAL . 25.1 t80 -51.26 -30.8 18.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 74.519999999999996 110.86 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.41 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -72.1 -33.63 68.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.473 . . . . 74.120000000000005 110.907 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.2 m -91.43 -16.04 27.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 65.109999999999999 111.143 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -93.46 -71.24 0.66 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 63.039999999999999 110.835 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.74 HG13 HG21 ' A' ' 31' ' ' VAL . 18.6 t -70.47 -70.47 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 75.430000000000007 111.146 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.41 ' HB2' ' HA ' ' A' ' 21' ' ' LYS . 7.4 mt -40.66 -60.11 1.22 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 75.299999999999997 110.949 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -50.46 -57.43 8.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 74.299999999999997 110.848 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.8 t -51.84 153.15 2.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 74.340000000000003 110.868 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -102.17 -49.4 3.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 55.539999999999999 110.911 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.706 HG21 ' OG1' ' A' ' 60' ' ' THR . 0.1 OUTLIER -51.87 159.7 1.31 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 121.624 0.726 . . . . 73.409999999999997 111.094 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 120.08 6.93 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.695 2.263 . . . . 64.540000000000006 112.321 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.74 HG21 HG13 ' A' ' 24' ' ' VAL . 97.6 t -83.35 142.74 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 75.549999999999997 111.105 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.468 HD23 HD11 ' A' ' 61' ' ' LEU . 3.8 mm? -111.9 112.64 24.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.467 . . . . 72.200000000000003 110.934 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.46 HG11 ' CE1' ' A' ' 35' ' ' PHE . 70.8 t -100.61 142.78 15.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 71.519999999999996 111.158 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -133.84 99.79 4.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 71.310000000000002 110.826 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.46 ' CE1' HG11 ' A' ' 33' ' ' VAL . 21.0 m-85 -91.72 89.77 7.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 65.400000000000006 110.892 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -141.66 -168.22 2.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 74.140000000000001 110.955 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.68 -164.76 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 63.240000000000002 111.091 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.456 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 1.5 t70 -77.67 11.98 1.86 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 71.519999999999996 110.87 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.482 ' N ' ' CD1' ' A' ' 39' ' ' TRP . 1.2 m0 76.35 94.76 0.07 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.194 -0.457 . . . . 74.319999999999993 110.886 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -169.68 -65.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 60.030000000000001 110.904 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -70.73 -70.28 1.22 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.761 -0.733 . . . . 73.140000000000001 112.491 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.47 ' O ' HG23 ' A' ' 46' ' ' VAL . 53.2 Cg_endo -69.81 -41.37 4.27 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.73 2.287 . . . . 70.549999999999997 112.278 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.55 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 31.7 t -51.94 -32.57 33.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.445 . . . . 53.350000000000001 110.859 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 18.5 mtpt -62.4 -34.79 77.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 75.5 110.925 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 34.6 mtm -90.13 -36.13 15.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 75.329999999999998 110.893 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.489 ' HA ' HG22 ' A' ' 49' ' ' VAL . 2.2 t -94.35 23.11 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 62.219999999999999 111.1 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.781 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -76.63 -60.62 0.85 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.603 0.716 . . . . 70.150000000000006 111.122 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.781 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.9 Cg_endo -69.73 -48.7 0.67 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.696 2.264 . . . . 73.430000000000007 112.317 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.489 HG22 ' HA ' ' A' ' 46' ' ' VAL . 4.5 m -49.94 -30.2 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 72.409999999999997 111.143 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.458 ' O ' HD13 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -86.13 -45.52 11.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 71.239999999999995 110.886 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -60.96 -32.45 71.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 74.349999999999994 110.846 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -51.31 -63.58 1.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 74.040000000000006 110.892 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.402 HD12 ' O ' ' A' ' 49' ' ' VAL . 2.7 mp -50.75 -41.02 20.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 71.140000000000001 111.142 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.22 -43.75 74.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 71.329999999999998 111.136 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.91 -36.22 42.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 70.129999999999995 110.884 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -60.64 -36.23 78.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 43.520000000000003 110.902 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.3 mmmt -75.64 -75.36 0.18 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.134 -0.485 . . . . 74.450000000000003 110.951 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.36 -176.85 0.29 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.248 -0.433 . . . . 75.239999999999995 110.872 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -72.44 -39.88 55.81 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.769 -0.729 . . . . 64.25 112.473 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.706 ' OG1' HG21 ' A' ' 29' ' ' THR . 34.6 p -52.84 -29.05 25.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.804 0.335 . . . . 60.32 111.132 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.468 HD11 HD23 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -49.01 123.88 7.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 60.109999999999999 110.938 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.8 tttp -111.95 148.98 32.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 61.420000000000002 110.867 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.3 t -124.2 104.5 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 62.530000000000001 111.126 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.43 ' CB ' HG23 ' A' ' 15' ' ' VAL . . . -108.59 109.75 21.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 55.43 111.071 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.98 160.68 19.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 72.510000000000005 110.892 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 50.1 tp -148.29 147.56 29.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.439 . . . . 73.239999999999995 110.936 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -79.4 120.99 24.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 61.530000000000001 110.878 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.1 m -48.71 -36.57 7.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 74.329999999999998 111.11 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.36 -32.88 57.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.158 -0.474 . . . . 74.319999999999993 110.838 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.02 -35.03 29.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 70.040000000000006 111.107 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.686 ' HB2' ' HB3' ' A' ' 74' ' ' ALA . 4.5 p30 -118.15 67.14 6.39 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.627 0.727 . . . . 73.409999999999997 110.888 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -32.43 18.33 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.706 2.271 . . . . 62.399999999999999 112.36 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -83.94 -40.8 18.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 42.200000000000003 110.907 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.686 ' HB3' ' HB2' ' A' ' 71' ' ' ASN . . . -59.06 -46.63 87.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 62.039999999999999 111.091 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.497 ' O ' HG23 ' A' ' 80' ' ' VAL . . . -51.0 -63.24 1.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 74.150000000000006 111.141 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.7 ttp180 -51.25 -37.11 45.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 73.310000000000002 110.886 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -55.01 -36.17 65.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 70.120000000000005 110.857 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -98.35 21.77 10.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 75.120000000000005 110.874 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 50.23 80.22 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 63.340000000000003 110.926 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 75' ' ' ALA . 96.5 t -108.55 97.17 5.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.148 -0.478 . . . . 70.310000000000002 111.099 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 81' ' ' VAL . 3.4 t -99.57 34.21 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 72.340000000000003 111.102 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -176.04 140.28 0.41 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.467 . . . . 75.409999999999997 110.887 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.523 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 4.2 mt -57.84 -57.83 22.83 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.668 0.747 . . . . 74.200000000000003 111.09 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.6 Cg_endo -69.74 74.72 1.26 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.714 2.276 . . . . 70.349999999999994 112.359 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.846 HG23 HG12 ' A' ' 99' ' ' VAL . 53.6 m -109.26 143.35 38.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 60.450000000000003 111.142 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 10.9 ttp -141.3 128.79 21.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 75.150000000000006 110.9 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 17.2 mt -115.94 119.72 62.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 65.030000000000001 111.17 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.802 HD12 HG21 ' A' ' 111' ' ' ILE . 0.5 OUTLIER -86.55 111.51 20.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 71.010000000000005 110.915 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -99.42 170.36 8.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 72.140000000000001 110.885 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -163.6 92.53 0.71 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.486 . . . . 74.409999999999997 110.872 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.45 32.21 28.58 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.745 -0.741 . . . . 31.239999999999998 112.503 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.401 ' H ' HG12 ' A' ' 24' ' ' VAL . . . 78.12 38.93 24.88 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.757 -0.735 . . . . 73.230000000000004 112.498 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.1 m -160.32 132.39 4.24 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.589 0.709 . . . . 72.120000000000005 111.11 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 91.73 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.688 2.259 . . . . 62.539999999999999 112.361 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.9 m -70.95 -32.71 49.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 75.209999999999994 111.115 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.1 mmtm -155.25 170.07 22.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 75.109999999999999 110.918 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.614 ' C ' HD12 ' A' ' 98' ' ' ILE . 0.9 OUTLIER -148.01 128.01 13.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 72.219999999999999 110.896 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.614 HD12 ' C ' ' A' ' 97' ' ' ARG . 4.0 mp -136.06 123.75 35.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 63.119999999999997 111.091 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.846 HG12 HG23 ' A' ' 85' ' ' THR . 7.1 m -118.81 159.68 19.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 74.340000000000003 111.116 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 115.57 142.15 7.57 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.713 -0.756 . . . . 74.120000000000005 112.454 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.04 71.24 7.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.835 0.35 . . . . 34.100000000000001 111.12 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.523 ' HB2' ' HB3' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -107.1 164.98 11.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.19 -0.459 . . . . 55.340000000000003 110.909 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -58.78 -176.36 0.73 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.734 -0.746 . . . . 33.130000000000003 112.459 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.79 -43.77 65.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.737 0.303 . . . . 75.239999999999995 110.889 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.72 -26.14 66.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 33.329999999999998 111.099 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.523 ' HB3' ' HB2' ' A' ' 102' ' ' LYS . . . -90.55 -36.25 14.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 74.519999999999996 111.106 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.688 HD13 ' O ' ' A' ' 107' ' ' LEU . 2.5 tm? -77.22 -36.13 55.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 73.409999999999997 110.896 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.628 ' C ' HD12 ' A' ' 108' ' ' LEU . 1.2 pp -74.65 -39.05 62.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 75.319999999999993 110.906 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.465 ' N ' HD12 ' A' ' 108' ' ' LEU . 16.0 ptm180 -66.88 -35.94 81.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 53.32 110.859 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -57.77 -23.1 50.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 54.32 110.887 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.802 HG21 HD12 ' A' ' 88' ' ' LEU . 3.1 mt -86.48 -66.23 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 72.450000000000003 111.108 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.476 ' HA ' HD12 ' A' ' 115' ' ' LEU . 9.9 pt-20 -52.59 -48.82 66.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 74.230000000000004 110.85 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -59.75 -33.76 72.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 74.219999999999999 110.907 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.0 -35.62 59.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 75.409999999999997 111.122 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.476 HD12 ' HA ' ' A' ' 112' ' ' GLU . 10.0 mt . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 72.439999999999998 110.874 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.799 0.333 . . . . 43.109999999999999 110.888 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.496 ' HB2' HG21 ' A' ' 22' ' ' THR . . . -72.09 106.19 4.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 64.010000000000005 111.097 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 45.1 p-80 -81.14 -36.13 30.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 72.209999999999994 110.889 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -120.93 175.62 5.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 75.120000000000005 110.861 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -114.98 146.23 41.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 71.120000000000005 110.862 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -115.72 30.79 7.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 64.549999999999997 110.875 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 26.3 t60 -88.95 -36.28 15.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 75.530000000000001 110.9 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 28.1 m170 -79.06 -39.92 32.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 72.239999999999995 110.854 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 36.5 mtm -96.01 30.8 2.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 73.349999999999994 110.87 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.9 t -59.15 113.14 1.98 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 63.140000000000001 110.841 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -160.59 173.47 37.14 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.722 -0.752 . . . . 53.200000000000003 112.502 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.9 p -82.79 99.79 9.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.849 0.357 . . . . 72.409999999999997 111.121 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.1 m -153.76 173.19 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.475 . . . . 64.129999999999995 111.095 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.473 ' HA ' ' HB1' ' A' ' 64' ' ' ALA . 0.2 OUTLIER -73.74 152.35 40.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 74.329999999999998 111.122 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.494 HG22 HG23 ' A' ' 19' ' ' THR . 8.6 p -127.44 145.52 34.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 71.329999999999998 111.111 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.649 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.87 162.28 5.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 74.109999999999999 111.125 -179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.42 -50.28 13.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 65.0 110.881 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.1 m -59.69 -35.89 75.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.169 -0.468 . . . . 53.140000000000001 110.821 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.649 HG22 ' HB ' ' A' ' 16' ' ' THR . 5.3 t -85.43 -17.55 36.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 74.510000000000005 111.178 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.71 ' CE2' HG21 ' A' ' 24' ' ' VAL . 24.7 t80 -49.37 -31.86 10.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 53.340000000000003 110.856 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.411 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -70.09 -36.15 74.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.48 . . . . 72.329999999999998 110.918 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.496 HG21 ' HB2' ' A' ' 2' ' ' ALA . 24.8 m -89.94 -15.09 32.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.436 . . . . 64.040000000000006 111.135 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -92.92 -70.97 0.67 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 73.019999999999996 110.888 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 1.046 HG13 HG21 ' A' ' 31' ' ' VAL . 16.4 t -72.35 -70.31 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 75.420000000000002 111.142 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.639 HD23 ' HA3' ' A' ' 92' ' ' GLY . 7.1 mt -39.9 -56.22 1.84 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 75.120000000000005 110.947 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -55.67 -52.52 63.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 75.540000000000006 110.854 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.5 t -51.89 159.88 0.78 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 61.340000000000003 110.836 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -106.89 -44.76 4.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.143 -0.48 . . . . 73.340000000000003 110.867 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -54.49 159.49 3.28 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.601 0.715 . . . . 74.340000000000003 111.122 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 131.02 20.34 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.695 2.264 . . . . 72.530000000000001 112.322 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 1.046 HG21 HG13 ' A' ' 24' ' ' VAL . 88.2 t -102.25 129.45 53.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 75.109999999999999 111.159 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.813 HD11 HD11 ' A' ' 61' ' ' LEU . 10.7 mt -104.93 106.04 16.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 70.019999999999996 110.917 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.442 HG21 ' CE1' ' A' ' 35' ' ' PHE . 3.8 p -105.12 131.0 55.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 75.430000000000007 111.164 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -116.41 99.61 7.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 74.140000000000001 110.818 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.442 ' CE1' HG21 ' A' ' 33' ' ' VAL . 23.0 m-85 -87.37 89.48 8.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 65.040000000000006 110.897 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.458 ' HZ3' HG11 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -143.61 -169.4 3.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.132 -0.486 . . . . 74.209999999999994 110.91 -179.937 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.84 -157.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 73.099999999999994 111.093 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.476 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 15.3 t0 -76.85 9.39 2.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 72.219999999999999 110.876 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.476 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 1.2 p-90 41.69 67.51 0.55 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 72.219999999999999 110.91 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 18.1 t -127.09 -47.7 1.48 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.272 -0.422 . . . . 73.310000000000002 110.839 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.56 -67.91 1.51 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.712 -0.756 . . . . 72.319999999999993 112.525 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -24.82 29.39 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.696 2.264 . . . . 70.319999999999993 112.351 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 36.3 t -49.9 -31.5 12.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 21.129999999999999 110.903 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 11.7 mttp -52.27 -35.14 49.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 72.219999999999999 110.866 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 8.9 mtt -90.44 -32.46 16.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 64.310000000000002 110.875 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.472 ' HA ' ' CG1' ' A' ' 49' ' ' VAL . 3.0 t -92.85 22.89 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 74.219999999999999 111.113 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.79 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -80.87 -60.67 0.43 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.559 0.695 . . . . 62.219999999999999 111.113 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.79 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.9 Cg_endo -69.78 -56.72 0.13 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.702 2.268 . . . . 73.230000000000004 112.326 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.81 HG23 ' HA ' ' A' ' 104' ' ' LYS . 3.0 p -48.76 -33.93 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 62.32 111.119 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.3 tp -69.46 -41.44 76.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 74.209999999999994 110.915 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.466 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 6.4 mm-40 -73.29 -33.24 65.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.461 . . . . 64.439999999999998 110.881 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -50.33 -66.49 0.38 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.155 -0.475 . . . . 74.329999999999998 110.874 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.595 HD12 ' O ' ' A' ' 49' ' ' VAL . 2.6 mt -50.07 -33.07 9.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 62.310000000000002 111.106 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.689 ' HB1' HD21 ' A' ' 61' ' ' LEU . . . -62.81 -45.04 94.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 72.319999999999993 111.122 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.3 -35.27 66.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 72.129999999999995 110.893 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -71.04 -35.84 72.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 64.230000000000004 110.912 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.6 mmtt -61.88 -62.84 1.51 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 54.140000000000001 110.87 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.3 t -151.58 -169.04 3.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.436 . . . . 51.030000000000001 110.854 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 60' ' ' THR . . . -92.05 123.53 7.27 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.762 -0.732 . . . . 43.43 112.491 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.406 ' C ' ' O ' ' A' ' 59' ' ' GLY . 9.9 t 37.57 43.41 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.785 0.326 . . . . 41.340000000000003 111.159 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.813 HD11 HD11 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -58.42 -174.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.264 -0.425 . . . . 74.129999999999995 110.868 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -97.96 140.55 32.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 55.539999999999999 110.903 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.2 t -141.95 118.15 6.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.253 -0.431 . . . . 73.400000000000006 111.138 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.473 ' HB1' ' HA ' ' A' ' 14' ' ' THR . . . -115.48 147.09 41.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 60.450000000000003 111.09 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.2 pttp -138.97 131.38 28.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 75.310000000000002 110.892 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.429 HD21 ' CG ' ' A' ' 71' ' ' ASN . 32.1 tp -122.47 159.48 27.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 74.340000000000003 110.888 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -103.07 118.08 36.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 74.400000000000006 110.838 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.418 HG22 ' HB2' ' A' ' 75' ' ' ALA . 73.9 t -61.62 -35.7 68.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 73.409999999999997 111.141 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -51.41 -35.3 38.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 63.240000000000002 110.898 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.14 -35.06 11.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 64.219999999999999 111.055 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.429 ' CG ' HD21 ' A' ' 66' ' ' LEU . 1.6 m-80 -117.79 72.5 8.29 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.619 0.723 . . . . 51.25 110.878 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -31.16 20.84 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.686 2.257 . . . . 72.109999999999999 112.343 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -61.34 -43.33 99.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.243 -0.435 . . . . 64.129999999999995 110.892 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.417 ' HB1' ' CE2' ' A' ' 35' ' ' PHE . . . -60.69 -48.08 83.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 61.030000000000001 111.079 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.548 ' O ' HG23 ' A' ' 80' ' ' VAL . . . -52.16 -66.21 0.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 74.400000000000006 111.089 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.2 ttp85 -51.14 -33.15 25.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 60.299999999999997 110.895 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -51.28 -36.22 41.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 74.010000000000005 110.915 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -108.7 24.97 12.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 74.219999999999999 110.874 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 59.9 mm-40 48.2 67.1 0.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.106 -0.497 . . . . 74.329999999999998 110.858 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 75' ' ' ALA . 98.9 t -91.2 106.2 17.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 72.519999999999996 111.113 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.5 t -80.12 -62.28 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 73.319999999999993 111.099 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 56.1 m -89.83 160.68 16.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.467 . . . . 71.409999999999997 110.858 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.53 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.8 mt -60.2 -58.18 21.27 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.624 0.726 . . . . 60.219999999999999 111.098 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.3 Cg_endo -69.79 77.43 1.08 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.683 2.255 . . . . 71.540000000000006 112.351 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.57 ' HA ' HG12 ' A' ' 99' ' ' VAL . 99.7 m -117.39 109.62 17.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.439 . . . . 43.200000000000003 111.116 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 31.0 ttp -113.77 145.95 40.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 72.219999999999999 110.891 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.6 mt -129.68 117.86 43.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 71.239999999999995 111.138 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.468 ' HG ' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -80.82 102.59 10.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 72.219999999999999 110.924 179.903 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -89.52 167.68 12.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 73.219999999999999 110.894 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -161.85 94.86 0.96 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 54.539999999999999 110.909 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.28 32.72 22.12 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.737 -0.744 . . . . 71.209999999999994 112.502 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.639 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 73.49 41.1 45.64 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.716 -0.754 . . . . 73.109999999999999 112.516 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.451 HG23 ' HD2' ' A' ' 94' ' ' PRO . 85.4 m -160.15 133.69 4.91 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.597 0.713 . . . . 73.430000000000007 111.143 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.451 ' HD2' HG23 ' A' ' 93' ' ' THR . 53.8 Cg_endo -69.76 93.78 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.692 2.261 . . . . 71.409999999999997 112.349 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.5 m -88.29 -32.37 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 71.030000000000001 111.133 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -132.12 166.22 22.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 71.450000000000003 110.911 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.408 ' C ' HD12 ' A' ' 98' ' ' ILE . 6.4 ttp180 -160.09 116.74 2.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 73.239999999999995 110.867 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.411 ' N ' HD12 ' A' ' 98' ' ' ILE . 5.0 mp -133.95 139.6 48.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 61.219999999999999 111.128 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.57 HG12 ' HA ' ' A' ' 85' ' ' THR . 4.8 m -132.26 154.82 40.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 72.140000000000001 111.107 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 115.34 137.92 6.4 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.719 -0.753 . . . . 73.129999999999995 112.503 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.43 77.11 6.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.883 0.373 . . . . 62.509999999999998 111.083 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.77 176.76 4.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 75.120000000000005 110.898 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -76.65 166.6 54.21 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.685 -0.769 . . . . 71.319999999999993 112.468 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.81 ' HA ' HG23 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -58.13 -41.01 82.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.755 0.312 . . . . 63.100000000000001 110.854 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.47 -32.19 66.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 64.340000000000003 111.1 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.53 -61.87 1.58 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 72.200000000000003 111.128 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.512 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.3 OUTLIER -45.93 -43.1 13.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 63.240000000000002 110.942 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.581 ' O ' HD12 ' A' ' 108' ' ' LEU . 4.3 tp -49.49 -47.87 48.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 73.310000000000002 110.937 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 50.7 mtm180 -65.7 -40.59 92.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 75.150000000000006 110.838 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -49.79 -25.15 2.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 71.430000000000007 110.896 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.414 ' CD1' HG21 ' A' ' 53' ' ' ILE . 4.2 mt -90.37 -70.09 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.125 -0.489 . . . . 65.230000000000004 111.15 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -51.86 -51.05 59.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 71.450000000000003 110.849 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -57.2 -34.22 68.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.47 . . . . 74.230000000000004 110.895 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.17 -34.02 65.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 43.020000000000003 111.081 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 115' ' ' LEU . 8.5 mt . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 71.200000000000003 110.939 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.1 ptm . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.804 0.335 . . . . 74.099999999999994 110.916 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -113.67 85.45 2.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 73.420000000000002 111.067 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -85.64 -38.19 18.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.258 -0.428 . . . . 64.450000000000003 110.85 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -68.45 126.08 28.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 74.230000000000004 110.822 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -92.08 132.11 36.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 63.439999999999998 110.85 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -119.98 -36.95 3.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 62.140000000000001 110.855 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 21.4 m170 -98.83 -36.13 9.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 75.140000000000001 110.84 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -97.64 11.33 37.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 53.240000000000002 110.889 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 4.4 ptm -61.41 -40.53 94.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 71.120000000000005 110.876 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.9 t -54.58 113.62 1.37 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 64.510000000000005 110.851 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.649 ' O ' HG22 ' A' ' 13' ' ' VAL . . . 133.93 155.03 7.49 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.804 -0.712 . . . . 72.349999999999994 112.523 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.6 p -60.74 105.09 0.41 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.788 0.328 . . . . 50.119999999999997 111.145 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.649 HG22 ' O ' ' A' ' 11' ' ' GLY . 4.6 m -153.31 172.19 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 72.140000000000001 111.163 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.1 t -74.04 127.94 34.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 74.030000000000001 111.192 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.4 t -91.28 137.04 22.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 74.140000000000001 111.095 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.605 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.71 174.73 0.43 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.16 -0.473 . . . . 73.310000000000002 111.144 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.453 ' H ' HG22 ' A' ' 16' ' ' THR . 10.1 t0 -80.49 -48.97 12.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 61.219999999999999 110.888 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.6 m -68.07 -53.44 25.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 72.329999999999998 110.853 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.605 HG22 ' HB ' ' A' ' 16' ' ' THR . 5.6 t -59.06 -19.28 42.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 73.219999999999999 111.158 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.719 ' CE2' HG21 ' A' ' 24' ' ' VAL . 25.0 t80 -51.08 -31.12 17.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 62.210000000000001 110.879 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.402 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -71.82 -33.45 68.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 74.019999999999996 110.902 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.6 m -91.51 -15.97 27.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.199 -0.455 . . . . 60.420000000000002 111.153 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -93.48 -71.23 0.66 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 72.409999999999997 110.888 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 1.005 HG13 HG21 ' A' ' 31' ' ' VAL . 19.1 t -70.5 -70.47 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 71.099999999999994 111.142 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.623 HD23 ' HA3' ' A' ' 92' ' ' GLY . 7.6 mt -40.72 -59.94 1.27 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 75.409999999999997 110.87 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -50.57 -60.68 2.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 73.540000000000006 110.868 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.0 t -51.32 162.06 0.38 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.45 . . . . 74.349999999999994 110.869 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -112.33 -40.28 4.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 74.540000000000006 110.828 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.452 HG22 ' HD2' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -51.94 158.88 1.56 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.563 0.697 . . . . 73.239999999999995 111.172 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.452 ' HD2' HG22 ' A' ' 29' ' ' THR . 53.7 Cg_endo -69.74 116.08 4.39 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.726 2.284 . . . . 73.450000000000003 112.323 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 1.005 HG21 HG13 ' A' ' 24' ' ' VAL . 98.0 t -82.35 141.53 14.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 72.409999999999997 111.111 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.1 mt -112.04 104.89 13.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 74.0 110.912 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 87' ' ' ILE . 8.6 p -113.37 146.86 17.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 75.120000000000005 111.123 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -139.49 117.85 12.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 74.219999999999999 110.9 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.557 ' HE2' ' HB1' ' A' ' 74' ' ' ALA . 20.2 m-85 -95.17 97.05 9.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 73.420000000000002 110.926 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.621 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -146.13 -167.32 2.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 73.329999999999998 110.935 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.09 -167.78 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 63.130000000000003 111.118 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.447 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 5.7 m-20 -78.77 12.69 1.99 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 73.450000000000003 110.855 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.449 ' CD1' ' N ' ' A' ' 39' ' ' TRP . 0.8 OUTLIER 75.37 85.57 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 75.25 110.91 -179.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 2.0 p -164.44 -47.08 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 63.310000000000002 110.88 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.88 -70.72 1.34 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.794 -0.717 . . . . 73.319999999999993 112.463 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -31.22 21.05 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.688 2.259 . . . . 65.120000000000005 112.339 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.548 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 43.7 t -51.24 -29.16 13.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 54.210000000000001 110.852 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -63.66 -49.34 73.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 74.409999999999997 110.902 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.547 ' HG3' HG23 ' A' ' 46' ' ' VAL . 10.9 ptp -77.54 -34.52 53.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 75.219999999999999 110.909 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.547 HG23 ' HG3' ' A' ' 45' ' ' MET . 3.4 t -93.8 21.98 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 72.140000000000001 111.163 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.812 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -76.52 -61.28 0.79 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.606 0.717 . . . . 73.549999999999997 111.142 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.812 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.3 Cg_endo -69.81 -49.83 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.651 2.234 . . . . 64.239999999999995 112.348 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.684 ' O ' HD12 ' A' ' 53' ' ' ILE . 4.1 m -51.04 -30.35 9.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 71.549999999999997 111.144 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.2 tp -76.17 -41.51 49.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.121 -0.49 . . . . 73.510000000000005 110.911 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -71.12 -33.94 70.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 75.299999999999997 110.895 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -51.49 -69.53 0.11 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 63.409999999999997 110.864 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.684 HD12 ' O ' ' A' ' 49' ' ' VAL . 2.8 mp -50.99 -37.29 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 62.520000000000003 111.14 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.75 -48.78 80.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 73.310000000000002 111.108 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.69 -35.99 75.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 71.540000000000006 110.863 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -66.01 -36.67 83.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 74.450000000000003 110.903 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.9 mmtt -75.97 -71.82 0.36 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 73.129999999999995 110.866 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -178.82 -169.03 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 74.239999999999995 110.817 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -113.3 -31.14 2.48 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.77 -0.728 . . . . 71.310000000000002 112.502 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 29.4 p -57.31 -32.54 66.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.842 0.353 . . . . 44.409999999999997 111.158 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.661 ' C ' HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -50.71 168.8 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 75.150000000000006 110.903 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.546 ' N ' HD22 ' A' ' 61' ' ' LEU . 1.3 mptm? -122.28 141.97 50.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 72.519999999999996 110.855 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 23.8 t -120.58 99.81 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.435 . . . . 24.23 111.143 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -108.88 142.69 39.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 64.310000000000002 111.108 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.5 mtpt -130.93 159.51 37.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 62.009999999999998 110.91 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.526 HD21 ' CB ' ' A' ' 71' ' ' ASN . 10.4 tp -140.56 144.83 36.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 63.140000000000001 110.924 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.03 119.34 33.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 75.25 110.843 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 36' ' ' TRP . 21.1 t -62.4 -34.58 65.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.486 . . . . 62.340000000000003 111.105 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.56 -35.54 41.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 71.540000000000006 110.867 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.36 -34.09 11.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 51.200000000000003 111.06 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.526 ' CB ' HD21 ' A' ' 66' ' ' LEU . 1.8 m-80 -118.3 68.46 7.35 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.602 0.715 . . . . 75.349999999999994 110.878 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -32.81 17.8 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.692 2.261 . . . . 64.109999999999999 112.328 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -67.99 -35.19 77.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 73.230000000000004 110.859 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.557 ' HB1' ' HE2' ' A' ' 35' ' ' PHE . . . -56.96 -44.13 82.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 55.039999999999999 111.104 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.52 ' O ' HG23 ' A' ' 80' ' ' VAL . . . -59.83 -64.38 0.97 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 70.129999999999995 111.097 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.6 ttp180 -50.51 -35.11 27.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 74.010000000000005 110.898 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.85 -35.79 64.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.465 . . . . 71.140000000000001 110.835 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -107.6 28.7 7.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 72.239999999999995 110.896 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 50.96 84.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 75.439999999999998 110.942 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 75' ' ' ALA . 96.9 t -120.78 140.06 46.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.443 . . . . 65.129999999999995 111.131 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.6 m -127.59 -37.69 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 73.340000000000003 111.154 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.2 t -100.96 148.28 25.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 74.5 110.871 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.535 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.1 mt -59.64 -57.69 24.97 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.599 0.714 . . . . 71.010000000000005 111.128 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.8 Cg_endo -69.76 71.56 1.51 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.687 2.258 . . . . 75.430000000000007 112.345 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.982 HG23 HG22 ' A' ' 99' ' ' VAL . 54.8 m -106.39 135.37 47.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 73.430000000000007 111.137 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 5.0 ttt -134.66 146.31 49.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 65.439999999999998 110.898 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.423 ' O ' HG12 ' A' ' 33' ' ' VAL . 22.3 mt -141.86 118.03 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 75.420000000000002 111.156 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.39 101.42 9.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 71.409999999999997 110.948 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -89.91 170.92 9.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 62.299999999999997 110.865 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.74 119.11 0.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 70.439999999999998 110.901 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.37 34.41 88.14 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.707 -0.759 . . . . 61.43 112.501 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.623 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 71.56 42.34 55.5 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.714 -0.755 . . . . 65.25 112.538 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.448 HG23 ' HD2' ' A' ' 94' ' ' PRO . 84.9 m -161.05 133.94 4.57 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.613 0.721 . . . . 51.329999999999998 111.109 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.448 ' HD2' HG23 ' A' ' 93' ' ' THR . 54.0 Cg_endo -69.75 81.35 0.82 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.657 2.238 . . . . 74.219999999999999 112.345 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.3 m -68.2 -32.36 55.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 52.140000000000001 111.11 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.3 mmtm -142.75 160.19 40.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 75.239999999999995 110.879 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.59 ' C ' HD12 ' A' ' 98' ' ' ILE . 2.4 tmt_? -149.37 124.63 10.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 75.439999999999998 110.871 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.59 HD12 ' C ' ' A' ' 97' ' ' ARG . 4.6 mp -139.35 116.56 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 75.0 111.11 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.982 HG22 HG23 ' A' ' 85' ' ' THR . 61.0 t -111.76 134.24 54.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 73.109999999999999 111.132 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 133.99 140.26 4.29 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.735 -0.745 . . . . 52.149999999999999 112.46 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.32 85.58 4.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.83 0.348 . . . . 44.329999999999998 111.139 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.36 165.92 15.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 63.130000000000003 110.908 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -63.22 149.76 49.65 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.755 -0.736 . . . . 71.219999999999999 112.523 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.475 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -47.17 -36.98 9.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.822 0.344 . . . . 73.439999999999998 110.869 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.82 -47.03 74.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 75.25 111.114 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -83.18 -49.6 9.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 64.510000000000005 111.094 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.428 ' C ' HD13 ' A' ' 107' ' ' LEU . 2.0 tm? -47.87 -51.87 21.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.237 -0.438 . . . . 64.439999999999998 110.872 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.475 HD23 ' O ' ' A' ' 104' ' ' LYS . 1.7 pp -50.69 -35.89 33.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 73.099999999999994 110.893 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -68.65 -44.69 73.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 60.329999999999998 110.898 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -51.4 -25.61 6.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.49 . . . . 70.129999999999995 110.909 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.401 ' HA ' HD11 ' A' ' 98' ' ' ILE . 3.7 mt -84.72 -68.08 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 71.409999999999997 111.167 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.43 ' O ' HD23 ' A' ' 115' ' ' LEU . 10.1 pt-20 -52.32 -49.38 64.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 70.420000000000002 110.891 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -52.49 -33.82 46.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.481 . . . . 75.400000000000006 110.836 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.01 -34.68 73.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 74.109999999999999 111.081 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.43 HD23 ' O ' ' A' ' 112' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 75.099999999999994 110.919 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.0 mtm . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.802 0.334 . . . . 63.439999999999998 110.895 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.59 -175.82 5.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.447 . . . . 70.439999999999998 111.06 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.7 m170 -77.68 -57.7 3.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.467 . . . . 74.409999999999997 110.847 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -105.65 -175.69 2.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 72.519999999999996 110.847 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.4 m-70 -146.03 120.1 9.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.442 . . . . 74.409999999999997 110.88 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 27.8 m170 -113.99 30.76 7.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 60.43 110.875 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -97.28 11.25 37.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 72.030000000000001 110.885 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.8 t-160 -62.22 -37.84 86.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 75.409999999999997 110.873 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 83.0 mtp -57.77 -44.64 86.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 75.209999999999994 110.888 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.1 m -57.57 124.79 20.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 75.439999999999998 110.884 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -55.9 -84.26 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.678 -0.773 . . . . 71.310000000000002 112.483 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.3 p -71.27 120.76 17.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.856 0.36 . . . . 71.340000000000003 111.162 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.4 t -135.15 140.69 44.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 74.140000000000001 111.121 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 t -92.71 133.38 36.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 74.129999999999995 111.16 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.7 t -89.81 120.73 39.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 72.030000000000001 111.107 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.528 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.92 -179.52 0.1 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 62.229999999999997 111.144 179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.42 ' H ' HG22 ' A' ' 16' ' ' THR . 4.4 m-20 -79.71 -45.59 18.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 63.409999999999997 110.833 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.7 m -68.98 -54.86 13.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 35.140000000000001 110.864 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.528 HG22 ' HB ' ' A' ' 16' ' ' THR . 10.3 t -57.74 -21.9 43.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 62.240000000000002 111.159 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.629 ' CE2' HG21 ' A' ' 24' ' ' VAL . 20.6 t80 -48.77 -30.5 5.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 73.439999999999998 110.913 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.523 ' HA ' HD12 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -67.61 -41.97 83.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 75.239999999999995 110.876 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.426 HG22 ' O ' ' A' ' 22' ' ' THR . 25.5 m -91.45 -9.69 43.65 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.228 -0.442 . . . . 63.420000000000002 111.153 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.57 -70.24 0.71 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 52.130000000000003 110.885 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.772 HG22 HG21 ' A' ' 31' ' ' VAL . 11.1 t -83.99 -66.87 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 62.539999999999999 111.145 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.681 HD23 ' HA3' ' A' ' 92' ' ' GLY . 77.8 mt -45.79 -32.77 2.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 71.319999999999993 110.898 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -48.8 -32.05 8.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.157 -0.474 . . . . 74.219999999999999 110.882 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.9 t 65.9 62.97 0.6 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 52.340000000000003 110.851 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -120.23 -32.38 4.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 73.120000000000005 110.886 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.487 HG21 ' O ' ' A' ' 60' ' ' THR . 0.1 OUTLIER -157.16 159.67 30.97 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.557 0.694 . . . . 63.439999999999998 111.139 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.403 ' HD2' HG22 ' A' ' 29' ' ' THR . 53.3 Cg_endo -69.77 126.7 13.6 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.645 2.23 . . . . 72.319999999999993 112.356 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.772 HG21 HG22 ' A' ' 24' ' ' VAL . 91.6 t -98.18 119.17 45.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 53.420000000000002 111.113 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.0 mp -108.0 99.9 9.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 64.230000000000004 110.886 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.4 m -107.44 146.21 13.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 74.109999999999999 111.125 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -123.47 100.21 6.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 73.25 110.897 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -72.15 100.22 2.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.166 -0.47 . . . . 72.319999999999993 110.877 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.467 ' HH2' HD22 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -147.47 -168.3 3.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.153 -0.476 . . . . 64.430000000000007 110.908 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.47 -164.96 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 64.439999999999998 111.128 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.475 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 4.6 m-20 -79.25 13.66 1.8 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.446 . . . . 73.400000000000006 110.903 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.475 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 0.6 OUTLIER 75.19 94.76 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 72.019999999999996 110.925 -179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -172.13 -57.92 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.444 . . . . 62.439999999999998 110.91 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.26 -70.98 1.28 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.798 -0.715 . . . . 73.430000000000007 112.479 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.404 ' HG3' HG21 ' A' ' 83' ' ' ILE . 54.3 Cg_endo -69.68 -31.04 21.65 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.693 2.262 . . . . 53.520000000000003 112.356 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.556 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 20.4 t -58.46 -35.4 72.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 74.319999999999993 110.87 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.5 ptmm? -65.02 -29.42 70.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 53.409999999999997 110.904 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 9.0 mtm -86.88 -41.54 13.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 74.519999999999996 110.883 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.54 ' HA ' HG22 ' A' ' 49' ' ' VAL . 3.1 t -94.24 22.3 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 51.229999999999997 111.176 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.796 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -75.85 -61.1 0.93 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.512 0.672 . . . . 72.519999999999996 111.129 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.796 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 54.0 Cg_endo -69.72 -50.3 0.48 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.687 2.258 . . . . 72.0 112.354 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.54 HG22 ' HA ' ' A' ' 46' ' ' VAL . 4.2 m -52.66 -29.07 13.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 70.239999999999995 111.163 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.467 HD22 ' HH2' ' A' ' 36' ' ' TRP . 14.0 tp -86.16 -44.31 12.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.146 -0.479 . . . . 72.299999999999997 110.908 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -62.66 -34.4 77.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 72.530000000000001 110.899 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -51.76 -55.41 19.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 74.209999999999994 110.917 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 mt -50.57 -37.99 15.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.085 -0.507 . . . . 74.400000000000006 111.13 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.43 -42.44 62.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 72.120000000000005 111.097 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.0 -40.92 97.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 52.409999999999997 110.881 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -73.57 -36.09 65.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 64.329999999999998 110.862 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.3 -69.36 0.2 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 62.520000000000003 110.901 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.3 t 63.04 39.1 10.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 71.430000000000007 110.826 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -111.06 -117.09 3.7 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.749 -0.739 . . . . 74.329999999999998 112.533 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.487 ' O ' HG21 ' A' ' 29' ' ' THR . 14.8 p -140.31 34.35 1.88 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.788 0.328 . . . . 75.340000000000003 111.152 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.5 pp -81.46 144.8 31.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 43.450000000000003 110.907 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 33.3 mttm -98.55 126.19 44.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.448 . . . . 71.25 110.891 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 44.5 t -100.34 101.53 12.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.204 -0.453 . . . . 74.239999999999995 111.137 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -117.01 152.45 34.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 60.409999999999997 111.104 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.26 136.88 42.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 72.109999999999999 110.923 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 14.5 tp -117.04 150.88 37.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 75.140000000000001 110.914 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -106.98 118.57 37.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.191 -0.459 . . . . 71.400000000000006 110.816 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 99.9 t -57.77 -40.35 75.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.469 . . . . 65.409999999999997 111.11 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -51.7 -36.19 45.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.142 -0.481 . . . . 64.420000000000002 110.869 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -91.34 -33.89 15.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 60.420000000000002 111.111 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -118.76 67.81 7.98 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.604 0.716 . . . . 74.140000000000001 110.866 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -33.58 16.32 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.64 2.227 . . . . 75.109999999999999 112.359 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -74.46 -36.7 63.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 64.319999999999993 110.895 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.26 -48.24 74.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 74.219999999999999 111.111 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.537 ' O ' HG23 ' A' ' 80' ' ' VAL . . . -56.25 -61.41 2.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 71.140000000000001 111.12 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.58 -34.05 35.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 72.549999999999997 110.891 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.17 -34.69 73.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 64.019999999999996 110.873 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -103.88 26.91 8.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 54.219999999999999 110.853 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 77.3 mm-40 49.85 82.5 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.485 . . . . 75.430000000000007 110.904 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 75' ' ' ALA . 85.4 t -117.11 144.58 24.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.229 -0.442 . . . . 75.549999999999997 111.181 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.7 m -135.42 -40.22 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 74.299999999999997 111.096 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.2 m -97.65 146.71 25.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 72.230000000000004 110.861 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.541 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.9 mt -57.94 -57.75 23.52 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.586 0.707 . . . . 72.340000000000003 111.108 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 54.1 Cg_endo -69.79 74.94 1.26 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.696 2.264 . . . . 74.049999999999997 112.343 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.757 HG23 HG12 ' A' ' 99' ' ' VAL . 52.3 m -112.3 143.34 43.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 72.209999999999994 111.129 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 4.2 tmm? -140.34 139.1 35.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 74.319999999999993 110.843 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.1 mt -130.38 113.19 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 73.310000000000002 111.08 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.459 HD12 HD13 ' A' ' 111' ' ' ILE . 1.6 tt -80.53 111.32 16.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 65.030000000000001 110.93 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -98.91 168.75 9.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 74.150000000000006 110.88 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -170.68 93.33 0.19 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.171 -0.468 . . . . 73.140000000000001 110.915 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.77 44.66 6.32 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.727 -0.749 . . . . 73.319999999999993 112.449 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.681 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 63.71 38.41 96.17 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.739 -0.743 . . . . 52.350000000000001 112.5 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.5 m -162.93 128.62 2.22 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.573 0.701 . . . . 60.229999999999997 111.134 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 86.94 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.679 2.253 . . . . 43.530000000000001 112.384 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.5 m -57.56 -35.74 51.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.425 . . . . 63.109999999999999 111.146 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 45.8 mmtt -152.82 170.19 20.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 45.130000000000003 110.896 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.452 ' C ' HD12 ' A' ' 98' ' ' ILE . 11.2 ttt180 -149.73 123.65 9.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 73.329999999999998 110.901 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.452 HD12 ' C ' ' A' ' 97' ' ' ARG . 4.2 mp -127.11 128.97 70.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 74.25 111.131 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.757 HG12 HG23 ' A' ' 85' ' ' THR . 4.8 m -124.55 160.22 29.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.467 . . . . 64.310000000000002 111.136 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 109.51 138.63 8.21 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.727 -0.749 . . . . 41.43 112.487 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -91.87 80.41 5.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.863 0.363 . . . . 74.430000000000007 111.139 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.401 ' HG2' HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -110.84 178.58 4.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.435 . . . . 63.210000000000001 110.855 -179.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -62.75 -169.71 1.07 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.783 -0.723 . . . . 64.0 112.47 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.17 -54.19 6.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.805 0.336 . . . . 54.100000000000001 110.905 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -53.63 -34.03 57.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 74.219999999999999 111.116 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -78.06 -64.4 1.17 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 54.43 111.094 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.647 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.7 OUTLIER -50.27 -33.65 20.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 73.239999999999995 110.947 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.658 HD23 ' N ' ' A' ' 109' ' ' ARG . 4.1 tt -71.71 -59.29 2.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 53.210000000000001 110.88 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.658 ' N ' HD23 ' A' ' 108' ' ' LEU . 13.0 ptp180 -56.39 -31.74 64.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 63.32 110.875 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -51.75 -24.88 6.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.159 -0.473 . . . . 71.25 110.93 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.459 HD13 HD12 ' A' ' 88' ' ' LEU . 4.7 mt -86.0 -68.7 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.487 . . . . 73.010000000000005 111.123 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -52.42 -49.62 64.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 74.420000000000002 110.842 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -53.72 -35.2 60.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.146 -0.479 . . . . 71.200000000000003 110.888 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.19 -36.37 69.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 71.420000000000002 111.112 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.1 mt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 75.230000000000004 110.93 179.995 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.7 mtt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.709 0.29 . . . . 74.409999999999997 110.902 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.1 59.09 0.65 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.269 -0.423 . . . . 74.510000000000005 111.067 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 15.2 t60 -88.1 -44.65 10.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 72.099999999999994 110.856 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -79.07 -176.01 4.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 72.519999999999996 110.837 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -124.86 174.23 8.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 70.109999999999999 110.813 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 -100.28 30.85 3.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 73.230000000000004 110.871 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -93.62 11.32 29.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 74.349999999999994 110.841 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -108.15 -36.01 6.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 75.540000000000006 110.839 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 49.4 mtt -95.91 30.82 2.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 73.409999999999997 110.859 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.5 m -74.41 110.12 8.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.446 . . . . 63.509999999999998 110.803 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 157.72 175.97 29.25 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.751 -0.737 . . . . 60.130000000000003 112.495 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.9 p -74.48 100.33 3.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.845 0.355 . . . . 73.0 111.133 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.8 m -152.43 160.97 3.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 72.450000000000003 111.125 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.61 ' HA ' ' HB1' ' A' ' 64' ' ' ALA . 8.7 t -68.52 157.17 36.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 72.25 111.17 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.461 HG22 ' CG2' ' A' ' 19' ' ' THR . 8.3 p -124.16 155.01 31.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 71.519999999999996 111.127 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.686 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.57 167.79 1.87 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 53.229999999999997 111.146 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.3 -47.98 13.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.224 -0.444 . . . . 74.439999999999998 110.891 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.9 t -66.59 -53.29 36.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.202 -0.454 . . . . 71.349999999999994 110.901 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.686 HG22 ' HB ' ' A' ' 16' ' ' THR . 3.8 t -61.51 -17.7 55.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 71.25 111.119 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.698 ' CE2' HG21 ' A' ' 24' ' ' VAL . 25.5 t80 -49.71 -32.45 13.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 73.109999999999999 110.907 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.441 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -70.69 -33.18 70.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 72.230000000000004 110.893 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.0 m -90.93 -16.47 28.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 72.030000000000001 111.133 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -93.16 -70.68 0.69 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.446 . . . . 63.450000000000003 110.86 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 1.111 HG13 HG21 ' A' ' 31' ' ' VAL . 17.0 t -71.48 -70.32 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.243 -0.435 . . . . 65.409999999999997 111.113 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.705 HD23 ' HA3' ' A' ' 92' ' ' GLY . 8.5 mt -40.46 -59.99 1.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 73.430000000000007 110.921 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -50.77 -62.11 1.8 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 50.340000000000003 110.874 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 86.2 p -51.79 137.65 25.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 72.319999999999993 110.858 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -88.49 -35.96 16.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.09 -0.505 . . . . 62.32 110.875 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -51.98 159.53 1.4 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.614 0.721 . . . . 74.0 111.174 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 126.5 13.35 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.676 2.25 . . . . 71.340000000000003 112.312 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 1.111 HG21 HG13 ' A' ' 24' ' ' VAL . 95.9 t -99.49 128.02 51.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.446 . . . . 71.519999999999996 111.157 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.457 HD11 HD11 ' A' ' 88' ' ' LEU . 7.7 mp -99.8 121.65 41.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 74.329999999999998 110.938 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.6 p -127.43 126.15 66.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 71.129999999999995 111.105 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -110.76 100.07 8.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 64.420000000000002 110.874 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.441 ' HE2' ' HB1' ' A' ' 74' ' ' ALA . 25.8 m-85 -84.29 89.42 7.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 74.209999999999994 110.914 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.402 ' HH2' HD12 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -147.83 -169.17 3.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.124 -0.489 . . . . 73.519999999999996 110.901 -179.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.469 ' HA ' HG22 ' A' ' 68' ' ' VAL . . . -60.7 -154.33 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 60.43 111.114 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.475 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 14.2 p-10 -77.31 8.8 3.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 72.409999999999997 110.875 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.475 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 1.4 p-90 41.49 63.85 1.17 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 71.230000000000004 110.939 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 35.9 t -130.22 -45.94 1.11 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 74.420000000000002 110.924 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.74 -68.75 1.44 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.753 -0.736 . . . . 72.439999999999998 112.485 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -30.8 21.88 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.759 2.306 . . . . 62.140000000000001 112.335 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 53.3 t -58.18 -20.43 41.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.245 -0.434 . . . . 71.329999999999998 110.883 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.1 mttm -49.74 -36.24 24.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 73.030000000000001 110.868 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.496 ' HG3' HG23 ' A' ' 46' ' ' VAL . 6.5 ptp -90.83 -30.92 16.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 71.129999999999995 110.859 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.496 HG23 ' HG3' ' A' ' 45' ' ' MET . 3.3 t -92.73 21.96 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.284 -0.416 . . . . 74.030000000000001 111.141 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.783 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -79.07 -60.98 0.52 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.595 0.712 . . . . 72.109999999999999 111.084 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.783 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.5 Cg_endo -69.75 -48.53 0.7 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.63 2.22 . . . . 64.200000000000003 112.38 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.627 ' O ' HD12 ' A' ' 53' ' ' ILE . 4.6 m -50.01 -30.71 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 75.019999999999996 111.116 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.402 HD12 ' HH2' ' A' ' 36' ' ' TRP . 6.1 tt -71.57 -40.24 70.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 74.430000000000007 110.902 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -73.03 -33.5 65.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 72.140000000000001 110.87 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -52.22 -67.66 0.23 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 71.150000000000006 110.907 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.627 HD12 ' O ' ' A' ' 49' ' ' VAL . 2.8 mt -51.28 -34.34 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 74.310000000000002 111.094 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.3 -40.29 86.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 70.209999999999994 111.076 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.34 -47.61 75.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.443 . . . . 74.150000000000006 110.856 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.445 ' OE1' HD11 ' A' ' 108' ' ' LEU . 13.2 pt-20 -71.11 -36.18 72.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 72.239999999999995 110.892 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.74 -75.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 71.319999999999993 110.867 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.4 -38.49 0.84 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 63.039999999999999 110.891 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 100.28 -27.39 20.6 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.718 -0.754 . . . . 71.400000000000006 112.449 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 79.5 p -137.31 64.43 1.53 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.853 0.358 . . . . 63.340000000000003 111.139 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.608 HD13 ' N ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -116.13 -177.4 3.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.202 -0.454 . . . . 64.239999999999995 110.964 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.02 138.77 35.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.435 . . . . 74.019999999999996 110.934 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.427 HG23 HD23 ' A' ' 61' ' ' LEU . 48.5 t -142.05 99.81 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.266 -0.425 . . . . 63.32 111.125 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.61 ' HB1' ' HA ' ' A' ' 14' ' ' THR . . . -101.75 146.77 27.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 62.340000000000003 111.117 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.24 151.03 49.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 73.019999999999996 110.906 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.49 HD21 ' HB2' ' A' ' 71' ' ' ASN . 13.6 tp -139.94 150.57 44.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 71.400000000000006 110.931 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -103.08 115.45 30.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 62.109999999999999 110.897 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.594 HG12 ' HB2' ' A' ' 75' ' ' ALA . 27.0 m -57.89 -34.66 49.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.46 . . . . 74.239999999999995 111.107 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.48 -36.15 43.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 62.340000000000003 110.868 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.14 -34.62 11.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 73.319999999999993 111.126 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.49 ' HB2' HD21 ' A' ' 66' ' ' LEU . 0.9 OUTLIER -118.82 70.18 9.58 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.625 0.726 . . . . 73.420000000000002 110.883 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.75 -32.65 18.21 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.718 2.278 . . . . 73.540000000000006 112.361 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -59.17 -44.6 92.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 55.109999999999999 110.898 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.441 ' HB1' ' HE2' ' A' ' 35' ' ' PHE . . . -57.07 -54.65 44.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 42.039999999999999 111.073 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.827 ' HB1' HG11 ' A' ' 80' ' ' VAL . . . -54.79 -60.3 3.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 74.349999999999994 111.148 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.85 -33.27 23.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 65.530000000000001 110.888 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -56.01 -38.77 70.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 72.120000000000005 110.881 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -94.63 19.22 10.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 74.299999999999997 110.884 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 47.76 77.84 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.13 -0.486 . . . . 72.150000000000006 110.903 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.827 HG11 ' HB1' ' A' ' 75' ' ' ALA . 6.6 p -120.04 142.47 35.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 70.25 111.121 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.5 m -119.58 -37.66 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 73.219999999999999 111.124 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 39.3 m -89.97 140.22 29.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 71.230000000000004 110.9 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.532 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.0 mt -55.82 -58.02 18.31 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.596 0.712 . . . . 63.520000000000003 111.09 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.5 Cg_endo -69.79 79.21 0.97 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.649 2.232 . . . . 74.409999999999997 112.342 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.714 HG23 HG12 ' A' ' 99' ' ' VAL . 85.6 m -123.37 108.05 12.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.226 -0.443 . . . . 64.340000000000003 111.147 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 18.8 ttp -109.97 142.1 41.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 63.25 110.903 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.2 mt -127.42 129.49 70.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 75.450000000000003 111.135 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.457 HD11 HD11 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -94.42 106.3 18.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 52.310000000000002 110.908 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -89.7 169.99 10.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 72.120000000000005 110.882 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -163.01 92.5 0.76 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 61.149999999999999 110.894 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.52 37.06 9.91 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.777 -0.725 . . . . 71.420000000000002 112.478 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.705 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 71.12 38.3 63.55 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.722 -0.752 . . . . 33.200000000000003 112.503 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.462 HG23 ' HD2' ' A' ' 94' ' ' PRO . 85.2 m -161.02 133.94 4.59 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.579 0.704 . . . . 75.439999999999998 111.171 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.462 ' HD2' HG23 ' A' ' 93' ' ' THR . 54.2 Cg_endo -69.72 107.32 1.82 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.706 2.271 . . . . 64.049999999999997 112.367 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.7 m -98.55 -33.17 4.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 73.099999999999994 111.118 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.9 mmtm -130.28 163.52 26.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 63.409999999999997 110.928 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.417 ' C ' HD12 ' A' ' 98' ' ' ILE . 9.1 ttp180 -155.12 114.12 3.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 73.409999999999997 110.885 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.443 ' N ' HD12 ' A' ' 98' ' ' ILE . 4.7 mp -129.83 129.88 66.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 75.400000000000006 111.134 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.714 HG12 HG23 ' A' ' 85' ' ' THR . 4.2 m -128.49 141.69 45.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 51.340000000000003 111.135 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 132.59 130.92 3.15 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.765 -0.731 . . . . 65.239999999999995 112.482 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.37 59.1 3.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.845 0.355 . . . . 64.400000000000006 111.111 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.25 171.75 8.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 72.209999999999994 110.92 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -67.99 -178.67 14.62 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.771 -0.728 . . . . 74.409999999999997 112.492 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -44.14 72.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.821 0.343 . . . . 75.120000000000005 110.898 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.88 -34.46 65.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 73.209999999999994 111.058 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.437 ' HA ' ' HG2' ' A' ' 109' ' ' ARG . . . -87.97 -56.18 3.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 72.109999999999999 111.113 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.664 HD13 ' O ' ' A' ' 107' ' ' LEU . 1.0 OUTLIER -51.42 -35.19 38.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.448 . . . . 62.43 110.906 -179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.561 HD23 ' N ' ' A' ' 109' ' ' ARG . 6.7 tt -68.98 -60.53 2.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 63.350000000000001 110.904 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.561 ' N ' HD23 ' A' ' 108' ' ' LEU . 14.6 ptp180 -54.59 -35.12 63.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.194 -0.457 . . . . 71.040000000000006 110.864 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -53.24 -24.62 11.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.455 . . . . 74.200000000000003 110.878 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.5 mt -84.75 -67.93 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 74.230000000000004 111.153 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.687 ' HA ' HD23 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -52.34 -46.86 66.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 54.020000000000003 110.892 179.901 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -55.42 -34.47 64.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 73.519999999999996 110.85 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.28 -37.1 69.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 41.119999999999997 111.122 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.687 HD23 ' HA ' ' A' ' 112' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 72.340000000000003 110.905 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.765 0.317 . . . . 75.400000000000006 110.885 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.07 109.05 4.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 63.350000000000001 111.1 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.6 m-70 -98.87 -59.87 1.65 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 71.150000000000006 110.827 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -172.27 -179.68 2.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 72.209999999999994 110.882 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 -62.72 168.19 3.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.449 . . . . 55.200000000000003 110.847 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 23.6 p80 -101.19 30.76 3.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 54.149999999999999 110.852 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -57.72 -36.1 71.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.222 -0.445 . . . . 73.209999999999994 110.866 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -96.83 -35.93 10.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.198 -0.456 . . . . 60.32 110.843 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 4.3 tpt -52.14 -36.07 50.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 75.140000000000001 110.921 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 19.3 t -58.33 114.41 2.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.437 . . . . 61.100000000000001 110.839 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 120.86 177.54 15.75 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 63.340000000000003 112.441 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.463 HG22 ' HB ' ' A' ' 63' ' ' VAL . 20.9 p -61.47 105.71 0.55 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.804 0.335 . . . . 63.25 111.146 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 72.8 t -149.66 144.3 17.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.428 . . . . 65.349999999999994 111.124 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 t -69.13 127.24 32.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 71.430000000000007 111.162 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 58.9 t -92.9 132.41 37.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 61.140000000000001 111.126 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.499 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.72 177.71 0.2 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 72.109999999999999 111.141 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.455 ' H ' HG22 ' A' ' 16' ' ' THR . 0.6 OUTLIER -80.53 -48.35 12.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 70.120000000000005 110.842 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.6 t -71.16 -52.05 21.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 72.349999999999994 110.865 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.499 HG22 ' HB ' ' A' ' 16' ' ' THR . 4.8 t -58.54 -19.71 40.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 71.409999999999997 111.16 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.709 ' CE2' HG21 ' A' ' 24' ' ' VAL . 24.5 t80 -51.51 -30.71 21.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.209 -0.45 . . . . 74.150000000000006 110.855 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.415 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -72.33 -33.16 67.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 74.129999999999995 110.882 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.4 m -91.67 -16.09 27.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 74.040000000000006 111.162 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -93.48 -71.35 0.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 72.420000000000002 110.832 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.969 HG13 HG21 ' A' ' 31' ' ' VAL . 18.2 t -70.34 -70.42 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 72.239999999999995 111.114 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.617 HD23 ' HA3' ' A' ' 92' ' ' GLY . 7.6 mt -40.72 -60.42 1.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 74.140000000000001 110.919 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -50.05 -57.85 6.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 71.140000000000001 110.893 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.4 m -52.49 147.02 8.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 52.030000000000001 110.86 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -95.34 -45.67 7.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 75.230000000000004 110.839 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -51.11 160.56 0.84 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.53 0.681 . . . . 71.329999999999998 111.137 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 132.08 22.48 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.686 2.257 . . . . 71.409999999999997 112.318 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.969 HG21 HG13 ' A' ' 24' ' ' VAL . 62.8 t -102.3 134.24 43.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 74.409999999999997 111.107 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.851 HD23 HG22 ' A' ' 63' ' ' VAL . 0.3 OUTLIER -101.77 116.41 32.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 64.430000000000007 110.948 179.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.4 t -94.07 143.51 11.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 74.420000000000002 111.115 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.76 99.85 5.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.163 -0.471 . . . . 62.43 110.881 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -100.96 95.88 6.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 73.310000000000002 110.867 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.683 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -152.05 -167.73 2.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.45 . . . . 72.430000000000007 110.92 -179.96 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.13 -165.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 52.109999999999999 111.065 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.435 ' O ' ' CB ' ' A' ' 39' ' ' TRP . 4.9 m-20 -77.66 12.6 1.59 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.237 -0.438 . . . . 75.409999999999997 110.888 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.436 ' N ' ' CD1' ' A' ' 39' ' ' TRP . 1.9 m0 78.25 90.32 0.06 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 73.5 110.91 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -174.84 -56.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 72.340000000000003 110.878 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.05 -70.89 1.3 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.72 -0.752 . . . . 52.310000000000002 112.528 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.78 -29.18 24.2 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.714 2.276 . . . . 74.140000000000001 112.365 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.535 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -61.54 -32.17 72.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 72.140000000000001 110.899 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -63.74 -30.68 71.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 72.040000000000006 110.905 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 2.0 mtt -83.78 -43.29 15.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 64.030000000000001 110.836 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.565 ' HA ' HG22 ' A' ' 49' ' ' VAL . 2.8 t -93.93 22.49 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 74.430000000000007 111.121 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.777 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -74.75 -60.73 1.21 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.617 0.723 . . . . 40.310000000000002 111.135 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.777 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.4 Cg_endo -69.79 -49.99 0.5 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.677 2.251 . . . . 73.340000000000003 112.307 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.68 ' O ' HD12 ' A' ' 53' ' ' ILE . 4.1 m -53.6 -29.68 17.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 73.319999999999993 111.128 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.9 tp -72.18 -42.07 66.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.476 . . . . 64.400000000000006 110.972 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -64.28 -36.38 83.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 74.420000000000002 110.898 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -55.82 -69.56 0.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 74.340000000000003 110.862 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.68 HD12 ' O ' ' A' ' 49' ' ' VAL . 2.7 mt -54.83 -36.94 39.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 35.030000000000001 111.128 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.74 -38.24 84.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 54.409999999999997 111.096 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -81.91 -40.5 22.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 54.43 110.908 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -63.66 -49.12 74.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 73.140000000000001 110.832 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.1 mmtp -55.05 -61.81 2.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 64.200000000000003 110.913 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.514 ' CB ' HD12 ' A' ' 61' ' ' LEU . 0.5 OUTLIER -152.32 -179.65 7.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 62.509999999999998 110.859 -179.921 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -114.28 -21.05 5.68 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.758 -0.734 . . . . 74.439999999999998 112.458 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.2 t -129.01 61.5 1.52 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.858 0.361 . . . . 64.510000000000005 111.161 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.636 ' H ' HD13 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -105.41 172.97 6.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 73.549999999999997 110.87 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.15 122.27 46.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 74.219999999999999 110.928 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.851 HG22 HD23 ' A' ' 32' ' ' LEU . 21.9 t -121.6 112.57 35.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 63.350000000000001 111.147 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -121.94 129.88 52.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 72.200000000000003 111.095 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.78 154.55 26.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 72.200000000000003 110.937 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.451 HD11 ' CG ' ' A' ' 71' ' ' ASN . 4.7 tp -140.41 137.09 33.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 35.399999999999999 110.925 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.25 149.26 30.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 52.409999999999997 110.884 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 36' ' ' TRP . 6.9 t -90.74 -36.17 7.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 75.010000000000005 111.117 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.1 -35.24 64.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 45.119999999999997 110.853 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.33 -32.56 13.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 73.340000000000003 111.116 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.451 ' CG ' HD11 ' A' ' 66' ' ' LEU . 3.7 m-80 -117.01 68.36 4.5 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.611 0.72 . . . . 72.310000000000002 110.883 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -33.09 17.37 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.692 2.261 . . . . 61.399999999999999 112.348 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -67.37 -36.42 81.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.224 -0.444 . . . . 70.430000000000007 110.884 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.78 -49.58 76.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 64.040000000000006 111.078 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.652 ' HB1' ' HB ' ' A' ' 80' ' ' VAL . . . -53.62 -60.86 2.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 75.230000000000004 111.136 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 14.0 ttp85 -51.22 -34.71 33.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 72.430000000000007 110.828 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -51.93 -38.23 55.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.244 -0.435 . . . . 61.219999999999999 110.858 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -106.53 28.06 8.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 65.040000000000006 110.858 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 49.72 61.14 3.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 70.400000000000006 110.903 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.652 ' HB ' ' HB1' ' A' ' 75' ' ' ALA . 85.2 t -96.44 136.56 26.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 74.299999999999997 111.117 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.9 m -127.47 -36.48 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 54.439999999999998 111.137 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.7 t -97.06 143.84 27.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 75.129999999999995 110.825 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.527 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.9 mt -56.86 -57.59 23.18 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.624 0.726 . . . . 55.520000000000003 111.153 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.616 ' CB ' ' HB2' ' A' ' 101' ' ' ALA . 54.4 Cg_endo -69.71 76.88 1.09 Allowed 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.704 2.269 . . . . 64.310000000000002 112.35 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.666 HG23 ' CG1' ' A' ' 99' ' ' VAL . 68.8 m -116.67 127.59 54.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 72.109999999999999 111.11 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.3 tpp -128.35 140.73 51.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 71.310000000000002 110.838 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 19.2 mt -127.82 129.54 69.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 74.129999999999995 111.151 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.15 104.83 16.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 73.519999999999996 110.943 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -90.01 170.14 10.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 73.340000000000003 110.899 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -164.35 91.55 0.61 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 64.530000000000001 110.922 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.2 32.61 16.53 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.715 -0.755 . . . . 62.009999999999998 112.476 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.617 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 75.14 39.48 37.03 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.763 -0.732 . . . . 64.230000000000004 112.501 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.42 HG23 ' HD2' ' A' ' 94' ' ' PRO . 46.0 m -160.36 133.66 4.79 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.572 0.701 . . . . 71.129999999999995 111.118 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.42 ' HD2' HG23 ' A' ' 93' ' ' THR . 54.3 Cg_endo -69.7 94.52 0.53 Allowed 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.721 2.28 . . . . 73.239999999999995 112.362 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.2 m -85.11 -30.32 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 63.32 111.083 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.91 164.43 30.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 72.430000000000007 110.886 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.409 ' C ' HD12 ' A' ' 98' ' ' ILE . 22.7 ttt180 -159.29 118.26 2.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 71.409999999999997 110.907 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.452 ' N ' HD12 ' A' ' 98' ' ' ILE . 4.5 mp -128.15 139.89 50.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 73.340000000000003 111.129 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.666 ' CG1' HG23 ' A' ' 85' ' ' THR . 10.0 m -143.37 154.33 16.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 75.120000000000005 111.106 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 136.75 -30.04 2.7 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.743 -0.742 . . . . 33.210000000000001 112.457 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.616 ' HB2' ' CB ' ' A' ' 84' ' ' PRO . . . 63.59 83.04 0.17 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.863 0.363 . . . . 40.409999999999997 111.119 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.98 179.15 6.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 75.099999999999994 110.874 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.24 149.25 39.27 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.727 -0.749 . . . . 71.420000000000002 112.476 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.53 -42.73 44.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.775 0.322 . . . . 74.340000000000003 110.898 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.57 -38.5 72.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 54.420000000000002 111.131 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -82.93 -59.15 2.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 53.329999999999998 111.122 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.542 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.6 OUTLIER -47.83 -41.01 22.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 74.299999999999997 110.881 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.4 tt -56.46 -41.99 77.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 62.299999999999997 110.872 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -63.75 -42.35 97.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 71.430000000000007 110.868 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -52.38 -25.15 9.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.19 -0.459 . . . . 50.450000000000003 110.887 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.7 mt -85.49 -67.87 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 73.120000000000005 111.112 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.765 ' HA ' HD23 ' A' ' 115' ' ' LEU . 1.9 pp20? -52.3 -48.92 65.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 71.519999999999996 110.867 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -58.88 -33.71 70.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 64.340000000000003 110.871 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.76 -36.5 59.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 62.200000000000003 111.135 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.765 HD23 ' HA ' ' A' ' 112' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 61.420000000000002 110.916 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 ptm . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.825 0.345 . . . . 73.230000000000004 110.925 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -114.38 -177.14 3.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 63.520000000000003 111.131 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -88.67 -36.98 15.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 73.230000000000004 110.851 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -69.71 169.36 13.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 52.020000000000003 110.873 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 72.7 m-70 -82.59 165.61 19.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 75.420000000000002 110.835 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -119.34 31.06 6.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 65.349999999999994 110.848 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 8.7 m170 -93.1 -37.7 12.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 73.299999999999997 110.837 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -52.3 -39.32 60.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 55.32 110.897 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.0 mtt -95.99 30.88 2.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 73.540000000000006 110.899 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.9 m -58.68 128.66 38.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.242 -0.436 . . . . 71.25 110.863 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 154.32 -163.79 31.23 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.748 -0.739 . . . . 64.430000000000007 112.488 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.514 HG22 ' HB ' ' A' ' 63' ' ' VAL . 21.3 p -68.82 117.85 11.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.816 0.341 . . . . 74.349999999999994 111.125 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.1 p -160.23 155.59 3.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 74.329999999999998 111.122 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.5 t -68.29 156.9 36.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 73.400000000000006 111.154 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.552 ' CG1' HG23 ' A' ' 19' ' ' THR . 41.9 t -118.99 127.48 75.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 73.239999999999995 111.155 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.485 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.23 162.88 4.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 73.140000000000001 111.201 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -72.93 -35.68 67.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 71.109999999999999 110.826 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 10.3 t -75.51 -34.42 60.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 44.530000000000001 110.87 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.552 HG23 ' CG1' ' A' ' 15' ' ' VAL . 7.6 t -86.52 -18.43 31.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.075 -0.512 . . . . 74.420000000000002 111.151 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.735 ' CE2' HG21 ' A' ' 24' ' ' VAL . 24.2 t80 -51.07 -30.68 16.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 75.510000000000005 110.858 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.428 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.8 OUTLIER -72.52 -34.02 67.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 73.400000000000006 110.89 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.1 m -91.51 -16.49 27.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 63.229999999999997 111.138 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.48 -71.33 0.66 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 64.340000000000003 110.845 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.806 HG13 HG21 ' A' ' 31' ' ' VAL . 24.9 t -70.26 -70.67 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 74.109999999999999 111.166 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.428 ' HB2' ' HA ' ' A' ' 21' ' ' LYS . 7.8 mt -40.55 -60.31 1.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 52.420000000000002 110.884 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -50.09 -57.87 6.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 62.229999999999997 110.87 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.8 m -53.33 156.83 2.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 64.209999999999994 110.836 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -98.73 -46.57 5.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.484 . . . . 73.310000000000002 110.861 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.832 HG21 HG23 ' A' ' 60' ' ' THR . 0.6 OUTLIER -57.8 159.83 9.28 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.593 0.711 . . . . 73.530000000000001 111.125 -179.889 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 149.44 67.23 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.669 2.246 . . . . 73.329999999999998 112.332 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.806 HG21 HG13 ' A' ' 24' ' ' VAL . 84.1 t -112.65 127.63 69.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 71.219999999999999 111.149 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.712 HD22 ' CD2' ' A' ' 88' ' ' LEU . 3.7 mt -114.81 99.81 7.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 73.420000000000002 110.93 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 87' ' ' ILE . 8.6 p -97.39 146.17 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 75.439999999999998 111.142 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -133.88 108.67 8.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.462 . . . . 73.310000000000002 110.86 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.566 ' HE2' ' HB1' ' A' ' 74' ' ' ALA . 51.4 m-85 -92.11 94.84 9.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 73.420000000000002 110.868 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -138.18 -167.72 2.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.101 -0.5 . . . . 74.299999999999997 110.918 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.03 -166.62 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 24.34 111.101 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.444 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 9.6 p-10 -78.17 12.27 1.94 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.231 -0.441 . . . . 54.219999999999999 110.87 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.455 ' N ' ' CD1' ' A' ' 39' ' ' TRP . 1.6 m0 77.0 93.32 0.07 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.233 -0.44 . . . . 71.299999999999997 110.916 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 9.5 t -174.06 -56.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.432 . . . . 64.25 110.861 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -79.75 -69.29 1.41 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.787 -0.72 . . . . 75.129999999999995 112.499 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -43.58 2.57 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.717 2.278 . . . . 71.120000000000005 112.335 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.543 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 33.9 t -52.66 -34.63 52.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.44 . . . . 73.209999999999994 110.883 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -64.44 -35.2 80.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.452 . . . . 72.209999999999994 110.885 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 88.2 mmm -84.59 -36.66 21.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 64.239999999999995 110.867 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.545 ' HA ' HG22 ' A' ' 49' ' ' VAL . 3.3 t -95.29 21.33 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.243 -0.435 . . . . 72.120000000000005 111.15 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.795 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -78.76 -61.39 0.52 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.6 0.715 . . . . 42.030000000000001 111.089 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.795 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.6 Cg_endo -69.74 -49.84 0.52 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.717 2.278 . . . . 70.340000000000003 112.307 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.545 HG22 ' HA ' ' A' ' 46' ' ' VAL . 4.4 m -52.23 -30.64 13.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.236 -0.438 . . . . 63.520000000000003 111.114 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.528 HD23 ' O ' ' A' ' 50' ' ' LEU . 7.5 tt -84.29 -35.16 23.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 52.130000000000003 110.915 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -58.94 -35.47 73.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 74.230000000000004 110.9 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -51.28 -58.25 6.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 71.25 110.885 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.7 mp -51.56 -34.86 16.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 65.310000000000002 111.134 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.62 -39.92 66.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 62.210000000000001 111.109 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.97 -38.47 91.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 64.310000000000002 110.884 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -77.15 -36.46 55.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 74.430000000000007 110.861 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -74.22 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 64.140000000000001 110.868 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.9 t 62.41 35.59 14.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 75.530000000000001 110.824 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -119.77 50.87 0.79 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.759 -0.734 . . . . 60.530000000000001 112.521 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.832 HG23 HG21 ' A' ' 29' ' ' THR . 9.7 t 37.49 43.18 0.4 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.827 0.346 . . . . 63.350000000000001 111.137 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.617 HD13 HD12 ' A' ' 32' ' ' LEU . 3.6 pp -69.69 139.94 53.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 72.239999999999995 110.922 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -84.41 147.49 27.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 74.120000000000005 110.857 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.514 ' HB ' HG22 ' A' ' 12' ' ' THR . 19.8 t -130.47 103.41 8.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 75.230000000000004 111.088 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.6 129.76 50.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 54.210000000000001 111.112 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -129.87 142.49 50.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 71.510000000000005 110.915 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.617 HD21 ' HB2' ' A' ' 71' ' ' ASN . 7.7 tp -137.67 141.17 41.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 61.109999999999999 110.877 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.51 108.99 18.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 73.019999999999996 110.834 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 70.0 t -60.06 -35.78 63.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 41.329999999999998 111.145 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -51.36 -35.07 36.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 74.019999999999996 110.838 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -97.89 -35.2 10.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 61.439999999999998 111.07 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.617 ' HB2' HD21 ' A' ' 66' ' ' LEU . 1.8 m-80 -116.09 70.56 4.0 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.667 0.746 . . . . 73.219999999999999 110.882 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -31.73 19.92 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.686 2.257 . . . . 43.25 112.33 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -64.1 -35.74 81.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 72.549999999999997 110.933 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.566 ' HB1' ' HE2' ' A' ' 35' ' ' PHE . . . -57.23 -48.8 77.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 45.520000000000003 111.135 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.541 ' O ' HG23 ' A' ' 80' ' ' VAL . . . -53.63 -61.16 2.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 65.299999999999997 111.084 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.7 ttp85 -51.3 -34.05 31.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 62.229999999999997 110.867 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -51.71 -39.65 58.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 55.219999999999999 110.867 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -104.29 26.43 8.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 72.450000000000003 110.892 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 51.0 mm-40 49.78 65.57 1.38 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 74.540000000000006 110.916 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 75' ' ' ALA . 91.7 t -96.82 143.63 12.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.239 -0.437 . . . . 54.439999999999998 111.127 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.7 m -123.64 -38.71 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 73.230000000000004 111.066 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.72 156.82 17.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 63.200000000000003 110.866 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.527 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 2.3 mm -64.6 -57.84 15.48 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.588 0.709 . . . . 73.430000000000007 111.095 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.5 Cg_endo -69.78 70.6 1.58 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.673 2.249 . . . . 65.230000000000004 112.329 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.43 ' OG1' HG13 ' A' ' 80' ' ' VAL . 96.9 m -104.81 137.97 41.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.232 -0.44 . . . . 52.520000000000003 111.143 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -139.04 127.99 23.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.217 -0.447 . . . . 74.549999999999997 110.905 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.403 ' O ' HG12 ' A' ' 33' ' ' VAL . 2.3 mp -114.36 112.76 41.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 63.350000000000001 111.122 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.712 ' CD2' HD22 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -79.53 105.71 11.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.47 . . . . 70.200000000000003 110.934 179.891 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -93.13 166.5 12.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 62.350000000000001 110.883 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -170.61 97.1 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 65.340000000000003 110.9 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.98 38.99 9.68 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.713 -0.756 . . . . 70.299999999999997 112.489 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 66.49 45.02 88.7 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.736 -0.745 . . . . 62.240000000000002 112.444 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.3 m -170.25 134.67 1.14 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.555 0.693 . . . . 74.019999999999996 111.161 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 82.49 0.75 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.667 2.245 . . . . 75.230000000000004 112.336 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.0 m -60.17 -34.08 55.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.179 -0.464 . . . . 74.219999999999999 111.141 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -147.87 170.1 18.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 54.310000000000002 110.911 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.458 ' C ' HD12 ' A' ' 98' ' ' ILE . 0.1 OUTLIER -154.37 123.77 6.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 75.239999999999995 110.847 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.458 HD12 ' C ' ' A' ' 97' ' ' ARG . 4.5 mp -130.26 128.84 64.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 65.230000000000004 111.118 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.4 p -128.42 141.74 45.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 71.409999999999997 111.163 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 122.64 140.23 5.7 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.749 -0.739 . . . . 53.039999999999999 112.502 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -90.53 93.9 9.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.811 0.339 . . . . 71.019999999999996 111.126 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.577 ' HB2' ' HB3' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -116.77 -176.05 2.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 73.040000000000006 110.859 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.18 163.62 54.52 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.739 -0.744 . . . . 63.43 112.489 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.79 -36.15 57.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.748 0.308 . . . . 73.530000000000001 110.897 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.5 -54.6 10.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 62.240000000000002 111.084 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.577 ' HB3' ' HB2' ' A' ' 102' ' ' LYS . . . -55.76 -53.99 49.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 71.310000000000002 111.125 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.61 HD13 ' O ' ' A' ' 107' ' ' LEU . 1.0 OUTLIER -50.78 -39.48 52.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 74.200000000000003 110.957 179.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.436 HD23 ' HG2' ' A' ' 112' ' ' GLU . 0.3 OUTLIER -66.82 -52.77 39.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 70.310000000000002 110.883 179.885 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.51 -40.59 83.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 74.310000000000002 110.918 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -47.12 -28.65 1.86 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.464 . . . . 63.020000000000003 110.933 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.6 mt -93.09 -69.52 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 61.229999999999997 111.163 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.436 ' HG2' HD23 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -54.07 -59.96 3.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 63.509999999999998 110.953 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -49.51 -35.9 21.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 72.420000000000002 110.835 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.56 -35.77 63.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 70.450000000000003 111.066 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 74.219999999999999 110.923 -179.964 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 mtt . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.827 0.346 . . . . 72.420000000000002 110.907 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.02 -44.97 13.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 21.149999999999999 111.092 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -81.84 -36.13 28.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 64.349999999999994 110.834 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -91.13 149.22 21.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 74.430000000000007 110.821 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -145.43 154.65 42.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 74.340000000000003 110.86 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -119.97 30.78 6.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 72.400000000000006 110.862 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -68.22 -35.67 78.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 50.299999999999997 110.847 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 48.8 p-80 -88.43 -35.52 17.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 61.509999999999998 110.893 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 13.6 mmt -51.79 -35.61 44.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 63.229999999999997 110.872 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.3 t -51.73 110.18 0.44 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 54.409999999999997 110.857 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 129.11 -147.2 17.61 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.793 -0.718 . . . . 63.43 112.494 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.1 p -72.72 120.0 17.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.81 0.338 . . . . 71.200000000000003 111.162 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.4 t -132.67 150.41 33.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 74.150000000000006 111.12 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.6 t -86.86 130.6 34.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 75.329999999999998 111.122 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.6 t -89.97 125.72 42.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 73.230000000000004 111.102 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.545 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.5 173.88 0.49 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 55.0 111.131 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.466 ' H ' HG22 ' A' ' 16' ' ' THR . 11.3 t70 -74.96 -47.39 29.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 72.109999999999999 110.848 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.1 m -71.62 -51.64 22.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 62.240000000000002 110.861 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.545 HG22 ' HB ' ' A' ' 16' ' ' THR . 6.3 t -59.28 -19.12 43.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 64.200000000000003 111.18 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.711 ' CE2' HG21 ' A' ' 24' ' ' VAL . 25.2 t80 -51.24 -30.26 16.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 70.109999999999999 110.898 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.409 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -72.55 -33.65 66.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 74.340000000000003 110.869 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.0 m -91.56 -16.08 27.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.196 -0.456 . . . . 73.25 111.181 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.44 -71.32 0.66 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 72.340000000000003 110.864 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.869 HG13 HG21 ' A' ' 31' ' ' VAL . 20.4 t -70.39 -70.5 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.476 . . . . 73.420000000000002 111.109 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.571 HD23 ' HA3' ' A' ' 92' ' ' GLY . 7.6 mt -40.57 -59.99 1.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 70.430000000000007 110.925 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -50.57 -52.64 37.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.458 . . . . 61.100000000000001 110.853 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.1 t -65.31 148.61 51.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 73.519999999999996 110.839 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -102.32 -38.2 7.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.131 -0.486 . . . . 75.129999999999995 110.895 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -52.05 160.23 1.24 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.527 0.68 . . . . 74.329999999999998 111.143 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 127.46 14.62 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.651 2.234 . . . . 73.109999999999999 112.385 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.869 HG21 HG13 ' A' ' 24' ' ' VAL . 41.1 t -93.25 132.0 38.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 64.519999999999996 111.132 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.422 ' CD1' HD21 ' A' ' 88' ' ' LEU . 1.5 mm? -102.85 99.8 9.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 74.409999999999997 110.917 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.555 HG13 HG12 ' A' ' 31' ' ' VAL . 10.2 m -121.46 150.2 24.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 72.510000000000005 111.137 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.01 123.97 31.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 64.319999999999993 110.902 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -89.71 88.78 7.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 71.510000000000005 110.87 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -142.59 -169.19 2.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.477 . . . . 74.200000000000003 110.952 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.87 -163.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.43 . . . . 61.509999999999998 111.116 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.471 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 2.6 m-20 -77.88 12.88 1.55 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 71.25 110.877 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.497 ' N ' ' CD1' ' A' ' 39' ' ' TRP . 0.6 OUTLIER 74.95 96.18 0.07 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 64.400000000000006 110.954 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -170.1 -53.76 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 51.020000000000003 110.875 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.29 -70.72 1.32 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.762 -0.732 . . . . 74.209999999999994 112.474 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.67 -34.18 15.41 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.694 2.263 . . . . 74.519999999999996 112.347 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.562 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 38.4 t -51.8 -33.73 36.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 73.219999999999999 110.883 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.4 mtmt -65.43 -35.3 80.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 75.340000000000003 110.952 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 15.1 mtp -83.49 -39.95 19.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 72.530000000000001 110.883 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.564 ' HA ' HG22 ' A' ' 49' ' ' VAL . 2.9 t -94.54 22.93 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 70.129999999999995 111.152 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.808 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -75.13 -61.16 1.05 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.558 0.694 . . . . 50.43 111.077 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.808 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 52.9 Cg_endo -69.8 -50.65 0.44 Allowed 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.671 2.248 . . . . 42.439999999999998 112.322 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.679 ' O ' HD12 ' A' ' 53' ' ' ILE . 4.3 m -52.53 -30.04 14.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 73.010000000000005 111.141 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.0 tp -74.5 -42.57 58.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 72.530000000000001 110.881 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -57.8 -36.72 72.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 62.299999999999997 110.87 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -57.74 -67.79 0.3 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 51.210000000000001 110.884 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.679 HD12 ' O ' ' A' ' 49' ' ' VAL . 2.7 mp -50.94 -34.84 14.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 72.219999999999999 111.118 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.48 -34.55 72.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 74.209999999999994 111.119 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.28 -35.37 15.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 53.420000000000002 110.895 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -66.66 -48.5 69.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 74.109999999999999 110.875 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.2 mmpt? -50.68 -69.38 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 75.409999999999997 110.916 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -141.32 -178.08 5.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 71.299999999999997 110.889 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 60' ' ' THR . . . -81.44 115.78 4.08 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.748 -0.739 . . . . 71.230000000000004 112.466 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.41 ' C ' ' O ' ' A' ' 59' ' ' GLY . 9.8 t 36.95 45.32 0.43 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.817 0.341 . . . . 74.150000000000006 111.183 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.408 ' C ' HD12 ' A' ' 61' ' ' LEU . 4.1 pp -56.46 -178.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 75.019999999999996 110.895 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -79.9 118.96 22.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 71.239999999999995 110.924 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 46.6 t -111.9 107.16 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 53.340000000000003 111.108 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -126.65 170.9 11.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 61.43 111.093 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 31.1 mttt -145.29 148.13 33.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.448 . . . . 72.340000000000003 110.845 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.537 HD11 ' CG ' ' A' ' 71' ' ' ASN . 4.0 tp -125.62 140.55 52.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 73.319999999999993 110.879 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -87.79 119.76 28.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 74.150000000000006 110.831 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.71 -28.08 44.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 61.219999999999999 111.152 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -68.94 -34.98 76.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.178 -0.465 . . . . 74.329999999999998 110.875 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.32 -28.7 23.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 74.450000000000003 111.087 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.537 ' CG ' HD11 ' A' ' 66' ' ' LEU . 5.5 m-80 -115.43 69.37 2.85 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.564 0.697 . . . . 71.510000000000005 110.896 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 -32.06 19.01 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.647 2.231 . . . . 73.439999999999998 112.331 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -74.83 -35.1 62.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 73.310000000000002 110.883 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.04 -40.87 91.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 44.109999999999999 111.111 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.494 ' HB1' ' HB ' ' A' ' 80' ' ' VAL . . . -57.96 -64.85 0.76 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 62.210000000000001 111.086 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -51.15 -34.88 33.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 72.409999999999997 110.879 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.82 -36.33 80.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 44.420000000000002 110.883 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -98.45 24.69 7.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 75.340000000000003 110.88 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 49.09 54.05 11.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 73.549999999999997 110.945 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.494 ' HB ' ' HB1' ' A' ' 75' ' ' ALA . 97.6 t -90.15 136.66 23.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 64.450000000000003 111.164 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.8 m -131.58 -39.07 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 70.420000000000002 111.132 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.1 t -97.04 155.16 16.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 71.409999999999997 110.888 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.52 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 2.3 mm -66.47 -57.96 11.28 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.601 0.715 . . . . 73.439999999999998 111.124 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 53.4 Cg_endo -69.71 70.07 1.58 Allowed 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.669 2.246 . . . . 44.520000000000003 112.355 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.645 HG23 ' HB ' ' A' ' 99' ' ' VAL . 62.0 m -109.39 149.39 29.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 64.340000000000003 111.127 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 26.6 ttm -138.63 150.35 46.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 64.109999999999999 110.843 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.9 mt -142.76 109.92 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 73.230000000000004 111.139 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.422 HD21 ' CD1' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -79.68 105.85 11.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.47 . . . . 75.129999999999995 110.926 179.897 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -90.29 169.79 10.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 61.32 110.855 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -165.44 95.34 0.64 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 73.540000000000006 110.863 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.67 37.72 13.31 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.753 -0.737 . . . . 74.239999999999995 112.474 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.571 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 68.38 41.01 86.69 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.71 -0.757 . . . . 33.329999999999998 112.494 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.446 HG23 ' HD2' ' A' ' 94' ' ' PRO . 85.4 m -160.76 134.05 4.77 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.643 0.735 . . . . 74.420000000000002 111.088 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.446 ' HD2' HG23 ' A' ' 93' ' ' THR . 53.7 Cg_endo -69.79 86.94 0.57 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.703 2.269 . . . . 71.340000000000003 112.327 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.0 m -76.66 -34.58 23.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 60.32 111.173 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.92 164.12 26.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 62.539999999999999 110.897 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.546 ' C ' HD12 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -155.61 119.83 4.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 74.219999999999999 110.895 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.546 HD12 ' C ' ' A' ' 97' ' ' ARG . 4.8 mp -138.31 130.12 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 75.420000000000002 111.133 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.645 ' HB ' HG23 ' A' ' 85' ' ' THR . 1.6 p -126.11 143.44 39.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 64.430000000000007 111.104 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 128.83 132.61 3.54 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.771 -0.728 . . . . 62.140000000000001 112.486 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.19 75.05 9.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.854 0.359 . . . . 74.140000000000001 111.138 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.432 ' HG2' HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -113.39 171.63 7.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 53.140000000000001 110.896 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.57 171.6 5.45 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.696 -0.764 . . . . 72.239999999999995 112.496 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -60.1 -44.39 94.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.784 0.326 . . . . 73.329999999999998 110.888 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -52.49 -66.29 0.41 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 74.5 111.09 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.71 -59.36 4.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 71.209999999999994 111.095 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.637 HD13 ' O ' ' A' ' 107' ' ' LEU . 1.0 OUTLIER -47.31 -35.48 8.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 73.030000000000001 110.933 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.598 ' O ' HD12 ' A' ' 108' ' ' LEU . 4.2 tp -71.19 -43.92 66.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 74.439999999999998 110.91 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 10.6 mtp85 -59.46 -41.82 90.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 74.400000000000006 110.876 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -53.03 -25.33 12.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 55.219999999999999 110.933 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.7 mt -86.04 -68.59 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 75.120000000000005 111.16 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -51.15 -49.57 60.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.151 -0.477 . . . . 71.219999999999999 110.894 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -58.53 -34.23 70.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 52.329999999999998 110.918 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.1 -36.33 61.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 53.25 111.124 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 mt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 71.430000000000007 110.902 -179.979 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.5 mtt . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.785 0.326 . . . . 54.240000000000002 110.86 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.66 174.07 11.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.449 . . . . 53.340000000000003 111.03 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -84.5 -51.17 7.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 74.030000000000001 110.862 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 56.54 54.01 7.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 73.230000000000004 110.865 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 62.0 m170 -77.58 137.46 38.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 71.409999999999997 110.882 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -119.85 30.77 6.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 73.519999999999996 110.887 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -76.6 -40.43 49.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 74.109999999999999 110.811 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 49.1 m-70 -74.28 -36.63 63.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 74.25 110.818 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 37.4 mtp -53.68 -40.52 66.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.444 . . . . 72.219999999999999 110.919 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.3 t -55.0 128.95 35.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 72.310000000000002 110.851 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.682 ' O ' HG22 ' A' ' 13' ' ' VAL . . . 130.11 163.58 11.12 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.727 -0.749 . . . . 42.119999999999997 112.49 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.717 HG22 ' H ' ' A' ' 63' ' ' VAL . 37.1 p -60.27 99.85 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.832 0.348 . . . . 73.319999999999993 111.112 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.682 HG22 ' O ' ' A' ' 11' ' ' GLY . 5.3 m -153.14 174.78 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 72.150000000000006 111.147 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.1 t -75.69 127.21 32.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 52.229999999999997 111.174 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 49.1 t -94.77 125.91 47.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 63.119999999999997 111.136 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.55 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -59.27 174.0 0.44 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 62.439999999999998 111.152 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.473 ' H ' HG22 ' A' ' 16' ' ' THR . 16.6 t0 -75.1 -47.37 29.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 74.299999999999997 110.81 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.5 t -72.1 -51.52 21.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 75.310000000000002 110.847 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.55 HG22 ' HB ' ' A' ' 16' ' ' THR . 5.8 t -59.12 -19.2 42.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.478 . . . . 73.409999999999997 111.124 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.718 ' CE2' HG21 ' A' ' 24' ' ' VAL . 24.9 t80 -50.88 -30.96 16.0 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 70.25 110.868 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.43 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -71.78 -34.13 69.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 63.119999999999997 110.92 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.0 m -91.13 -15.91 28.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 71.239999999999995 111.15 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.34 -71.41 0.65 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.441 . . . . 65.230000000000004 110.907 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.718 HG21 ' CE2' ' A' ' 20' ' ' PHE . 17.3 t -70.71 -70.34 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.239 -0.437 . . . . 75.150000000000006 111.127 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.508 HD23 ' HA3' ' A' ' 92' ' ' GLY . 7.4 mt -40.55 -60.31 1.15 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 64.030000000000001 110.921 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -50.36 -61.21 2.31 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.233 -0.439 . . . . 74.409999999999997 110.874 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.7 t -56.55 161.33 2.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 73.400000000000006 110.821 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -109.92 -35.98 6.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.104 -0.498 . . . . 71.120000000000005 110.884 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -53.44 158.88 2.57 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.585 0.707 . . . . 72.349999999999994 111.103 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 125.66 12.42 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.631 2.221 . . . . 72.150000000000006 112.387 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.552 HG21 HG13 ' A' ' 24' ' ' VAL . 94.6 t -102.1 115.88 44.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 73.140000000000001 111.148 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.9 mp -94.58 99.73 11.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 73.310000000000002 110.874 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.3 p -98.59 140.88 17.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.14 -0.482 . . . . 70.230000000000004 111.075 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -124.8 102.08 7.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 73.549999999999997 110.84 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -83.4 89.57 7.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 73.340000000000003 110.889 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.739 ' O ' HG23 ' A' ' 68' ' ' VAL . 0.1 OUTLIER -135.6 -168.58 2.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.148 -0.478 . . . . 72.209999999999994 110.903 -179.945 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.54 -164.48 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 75.530000000000001 111.096 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.45 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 9.5 p-10 -78.68 12.71 1.94 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.237 -0.438 . . . . 74.340000000000003 110.861 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.476 ' N ' ' CD1' ' A' ' 39' ' ' TRP . 1.0 OUTLIER 76.03 95.15 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 71.540000000000006 110.935 -179.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 46.1 t -172.25 -56.22 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 41.439999999999998 110.849 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -80.51 -70.71 1.32 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.721 -0.752 . . . . 71.310000000000002 112.478 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.449 ' HG3' HG21 ' A' ' 83' ' ' ILE . 53.7 Cg_endo -69.72 -32.63 18.36 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.639 2.226 . . . . 65.430000000000007 112.324 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.558 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 35.8 t -54.74 -40.69 69.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.436 . . . . 74.239999999999995 110.907 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.8 pttp -64.34 -26.46 68.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 60.350000000000001 110.861 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 5.3 mtp -87.15 -42.85 12.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.276 -0.42 . . . . 65.450000000000003 110.871 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.522 ' HA ' HG22 ' A' ' 49' ' ' VAL . 3.1 t -94.31 21.44 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.238 -0.437 . . . . 73.209999999999994 111.147 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.778 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -76.75 -61.17 0.76 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.562 0.696 . . . . 54.43 111.088 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.778 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.7 Cg_endo -69.81 -49.77 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.678 2.252 . . . . 63.149999999999999 112.344 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.596 ' O ' HD12 ' A' ' 53' ' ' ILE . 4.3 m -51.24 -30.85 10.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 71.450000000000003 111.105 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.4 tp -90.16 -35.89 15.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 62.140000000000001 110.886 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -68.26 -24.16 64.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 72.099999999999994 110.925 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -65.97 -60.71 2.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.478 . . . . 52.140000000000001 110.873 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.596 HD12 ' O ' ' A' ' 49' ' ' VAL . 2.6 mp -61.52 -33.02 55.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 64.299999999999997 111.118 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.98 -20.04 50.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 73.150000000000006 111.101 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.26 -41.01 92.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.224 -0.444 . . . . 73.409999999999997 110.873 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -91.08 -41.25 11.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 75.430000000000007 110.876 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.676 ' HB3' HD23 ' A' ' 61' ' ' LEU . 0.8 OUTLIER -64.91 -27.83 69.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 75.239999999999995 110.91 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 7.8 t -42.91 135.42 3.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 64.439999999999998 110.899 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 127.08 -27.99 4.69 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.788 -0.72 . . . . 74.519999999999996 112.484 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -129.34 -37.39 1.64 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.863 0.363 . . . . 73.439999999999998 111.148 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.676 HD23 ' HB3' ' A' ' 57' ' ' LYS . 0.3 OUTLIER -88.89 144.5 26.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 72.310000000000002 110.918 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.486 ' N ' HD12 ' A' ' 61' ' ' LEU . 12.4 ttpp -107.62 141.39 39.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 65.5 110.93 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.717 ' H ' HG22 ' A' ' 12' ' ' THR . 50.4 t -101.71 108.67 24.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.22 -0.446 . . . . 62.130000000000003 111.182 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -122.27 128.91 51.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 73.450000000000003 111.103 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.8 pttt -125.99 157.61 37.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 74.140000000000001 110.882 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 31.3 tp -147.95 146.45 28.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 54.25 110.882 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -82.96 119.88 24.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 62.340000000000003 110.925 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 36' ' ' TRP . 84.7 t -48.14 -39.52 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 75.450000000000003 111.086 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.02 -33.31 56.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 72.230000000000004 110.862 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.82 -34.68 45.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 75.25 111.043 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.601 ' HB2' ' HB3' ' A' ' 74' ' ' ALA . 5.2 p30 -118.39 66.91 6.76 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.627 0.727 . . . . 74.209999999999994 110.874 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -32.85 17.52 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.686 2.257 . . . . 62.340000000000003 112.327 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -80.92 -38.65 27.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 64.510000000000005 110.925 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.601 ' HB3' ' HB2' ' A' ' 71' ' ' ASN . . . -60.99 -43.32 99.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 60.119999999999997 111.149 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.478 ' HB1' ' HB ' ' A' ' 80' ' ' VAL . . . -51.76 -67.27 0.27 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 74.409999999999997 111.136 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.1 ttm-85 -51.19 -34.07 30.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.259 -0.428 . . . . 73.420000000000002 110.886 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.43 -40.19 90.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 74.519999999999996 110.867 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -98.89 26.68 5.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 65.120000000000005 110.867 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 49.85 75.44 0.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 53.32 110.919 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.478 ' HB ' ' HB1' ' A' ' 75' ' ' ALA . 90.9 t -116.45 90.55 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 62.310000000000002 111.134 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 61.1 t -84.4 -42.61 17.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 63.030000000000001 111.111 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.6 m -96.75 152.73 18.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 75.040000000000006 110.866 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.531 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.3 mt -63.9 -57.64 17.94 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.598 0.713 . . . . 74.150000000000006 111.112 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 83' ' ' ILE . 54.0 Cg_endo -69.74 75.43 1.21 Allowed 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.743 2.295 . . . . 62.109999999999999 112.336 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 84.8 m -117.17 100.89 8.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 72.209999999999994 111.159 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 22.5 ttp -100.76 112.08 24.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 70.430000000000007 110.883 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 25.2 mt -101.33 118.0 47.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 64.150000000000006 111.165 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.656 HD12 HD13 ' A' ' 111' ' ' ILE . 1.9 tt -81.15 110.3 16.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 71.219999999999999 110.923 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -97.47 170.27 9.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.477 . . . . 74.230000000000004 110.88 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -167.3 97.95 0.5 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 75.329999999999998 110.903 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.68 38.43 10.63 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.719 -0.753 . . . . 75.299999999999997 112.509 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.508 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 65.76 37.12 93.13 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.702 -0.761 . . . . 65.209999999999994 112.458 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.456 HG23 ' HD2' ' A' ' 94' ' ' PRO . 86.6 m -158.43 133.89 5.85 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.584 0.707 . . . . 70.010000000000005 111.147 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.456 ' HD2' HG23 ' A' ' 93' ' ' THR . 53.4 Cg_endo -69.75 112.64 3.13 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.697 2.265 . . . . 72.219999999999999 112.322 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.6 m -99.63 -33.51 3.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.443 . . . . 64.209999999999994 111.115 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.5 mmtt -140.88 169.66 17.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 71.400000000000006 110.864 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -153.93 111.87 3.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 75.430000000000007 110.875 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.426 ' N ' HD12 ' A' ' 98' ' ' ILE . 4.6 mp -112.75 127.95 69.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 62.219999999999999 111.164 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.0 p -141.69 144.7 25.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 62.100000000000001 111.155 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 139.58 -28.65 2.53 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.786 -0.721 . . . . 54.409999999999997 112.518 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 64.5 96.57 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.822 0.344 . . . . 71.530000000000001 111.101 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.15 -179.25 5.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 74.129999999999995 110.884 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.29 176.76 2.68 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.745 -0.74 . . . . 41.539999999999999 112.508 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.16 -44.57 71.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.799 0.333 . . . . 72.230000000000004 110.896 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.58 -32.9 70.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 55.200000000000003 111.12 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.446 ' HA ' ' HG2' ' A' ' 109' ' ' ARG . . . -85.43 -58.39 2.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 74.329999999999998 111.082 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.627 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.6 OUTLIER -51.12 -35.51 35.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 64.349999999999994 110.93 -179.96 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.596 HD23 ' N ' ' A' ' 109' ' ' ARG . 5.7 tt -68.83 -59.44 3.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 73.030000000000001 110.91 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.596 ' N ' HD23 ' A' ' 108' ' ' LEU . 15.8 ptm180 -56.91 -32.81 66.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 64.510000000000005 110.867 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -51.9 -25.46 8.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 71.319999999999993 110.878 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.656 HD13 HD12 ' A' ' 88' ' ' LEU . 3.8 mt -85.56 -69.03 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 72.310000000000002 111.148 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -51.56 -49.88 61.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 64.019999999999996 110.92 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -54.12 -34.68 60.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 72.230000000000004 110.84 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.17 -34.95 66.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 75.349999999999994 111.1 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.9 mt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 54.539999999999999 110.889 -179.951 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 mmt . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.79 0.328 . . . . 73.200000000000003 110.906 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.24 81.32 1.93 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.44 . . . . 74.519999999999996 111.133 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -99.88 -37.59 8.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 65.109999999999999 110.884 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.8 m170 -75.85 -179.84 5.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 74.439999999999998 110.827 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -116.91 167.02 11.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 71.299999999999997 110.888 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 24.9 m170 -119.71 30.84 6.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.456 . . . . 73.120000000000005 110.858 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -70.89 -63.8 1.03 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 55.329999999999998 110.82 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -52.17 -35.1 47.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.191 -0.459 . . . . 71.040000000000006 110.862 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 10.9 mtp -51.47 -34.89 37.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 75.530000000000001 110.883 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.6 p -51.62 129.88 26.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 74.329999999999998 110.847 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 135.97 152.92 6.47 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.745 -0.74 . . . . 61.210000000000001 112.495 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.2 p -73.94 99.55 3.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.836 0.35 . . . . 62.210000000000001 111.109 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.6 m -154.53 -179.85 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 75.140000000000001 111.16 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.3 t -72.64 151.16 42.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 63.450000000000003 111.149 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.489 HG22 ' CG2' ' A' ' 19' ' ' THR . 9.1 p -119.26 151.87 21.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 75.540000000000006 111.144 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.639 ' HB ' HG22 ' A' ' 19' ' ' THR . 0.2 OUTLIER -63.37 162.06 13.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 45.119999999999997 111.109 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -77.4 -52.33 9.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 73.439999999999998 110.821 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.9 t -57.76 -36.37 72.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 64.329999999999998 110.859 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.639 HG22 ' HB ' ' A' ' 16' ' ' THR . 5.0 t -84.65 -17.83 37.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 75.219999999999999 111.137 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.714 ' CE2' HG21 ' A' ' 24' ' ' VAL . 24.6 t80 -49.92 -31.49 12.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 75.540000000000006 110.924 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.405 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -70.95 -34.46 71.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 72.200000000000003 110.869 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.5 m -91.01 -15.2 30.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 75.209999999999994 111.157 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.42 -70.61 0.69 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.231 -0.441 . . . . 73.0 110.862 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 1.035 HG13 HG21 ' A' ' 31' ' ' VAL . 17.3 t -72.06 -70.38 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 75.099999999999994 111.137 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.652 HD23 ' HA3' ' A' ' 92' ' ' GLY . 7.5 mt -40.41 -57.7 1.72 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.156 -0.475 . . . . 71.239999999999995 110.911 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -51.28 -60.04 3.55 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 74.140000000000001 110.852 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 55.5 p -51.67 139.47 20.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 64.239999999999995 110.838 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -88.82 -41.77 12.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 73.129999999999995 110.872 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.468 HG22 ' HD2' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -51.54 158.76 1.39 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.582 0.706 . . . . 70.340000000000003 111.18 -179.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.468 ' HD2' HG22 ' A' ' 29' ' ' THR . 54.0 Cg_endo -69.73 129.8 18.27 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.703 2.269 . . . . 72.230000000000004 112.324 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 1.035 HG21 HG13 ' A' ' 24' ' ' VAL . 92.4 t -97.1 126.6 49.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.437 . . . . 75.340000000000003 111.135 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.8 mp -110.12 121.07 44.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 74.409999999999997 110.937 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.717 HG12 ' HB3' ' A' ' 64' ' ' ALA . 11.7 m -132.81 149.9 32.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 75.540000000000006 111.104 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.28 99.63 5.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 72.239999999999995 110.832 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.47 ' CE2' HD22 ' A' ' 66' ' ' LEU . 5.8 m-85 -73.59 96.81 2.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 65.400000000000006 110.893 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -142.83 -168.6 2.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.168 -0.469 . . . . 74.439999999999998 110.914 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.49 -162.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 54.240000000000002 111.133 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.484 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 4.1 t70 -77.96 13.72 1.32 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.268 -0.424 . . . . 51.32 110.876 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.484 ' CG ' ' C ' ' A' ' 38' ' ' ASP . 0.5 OUTLIER 74.95 94.34 0.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.204 -0.453 . . . . 72.450000000000003 110.887 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 35.0 t -174.79 -50.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 72.349999999999994 110.885 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.24 -69.55 1.39 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.724 -0.75 . . . . 73.319999999999993 112.459 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 -28.47 24.96 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.684 2.256 . . . . 71.129999999999995 112.351 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.655 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 1.9 p -53.95 -25.53 21.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 75.450000000000003 110.95 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.2 pttt -77.96 -31.48 50.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 73.400000000000006 110.847 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 16.1 mtt -85.82 -35.4 20.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 74.549999999999997 110.886 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.552 ' HA ' HG22 ' A' ' 49' ' ' VAL . 2.8 t -100.36 22.07 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.246 -0.434 . . . . 75.129999999999995 111.122 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.814 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . . . -74.36 -61.21 1.23 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.556 0.693 . . . . 74.25 111.091 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.814 ' HD3' ' HB3' ' A' ' 47' ' ' ALA . 53.7 Cg_endo -69.73 -50.66 0.45 Allowed 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.732 2.288 . . . . 52.520000000000003 112.359 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.572 ' O ' HD12 ' A' ' 53' ' ' ILE . 4.1 m -52.09 -29.98 12.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.459 . . . . 33.140000000000001 111.132 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.6 tp -75.04 -41.96 58.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 64.540000000000006 110.888 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -67.45 -34.34 76.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.232 -0.44 . . . . 70.319999999999993 110.872 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -52.84 -62.09 1.87 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 74.120000000000005 110.876 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.572 HD12 ' O ' ' A' ' 49' ' ' VAL . 3.1 mt -51.21 -39.51 20.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 74.049999999999997 111.118 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.87 -42.43 90.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 74.319999999999993 111.116 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -44.68 96.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 75.109999999999999 110.893 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.24 -35.53 66.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 71.430000000000007 110.828 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.2 mmtm -67.37 -74.63 0.11 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 73.049999999999997 110.872 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.04 -170.93 0.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 63.439999999999998 110.863 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -124.96 32.96 3.84 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.718 -0.753 . . . . 70.239999999999995 112.517 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.0 p -146.07 32.59 1.01 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.833 0.349 . . . . 65.299999999999997 111.154 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.3 pp -101.51 156.34 17.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 63.210000000000001 110.945 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.8 tttp -86.78 147.64 25.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.443 . . . . 64.400000000000006 110.888 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.4 t -140.74 106.56 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.421 . . . . 61.439999999999998 111.124 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.717 ' HB3' HG12 ' A' ' 33' ' ' VAL . . . -113.62 110.08 19.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 31.140000000000001 111.07 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.0 pttm -97.23 128.98 44.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 61.130000000000003 110.911 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.47 HD22 ' CE2' ' A' ' 35' ' ' PHE . 6.2 tp -105.15 146.08 29.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 74.420000000000002 110.909 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.636 ' OD2' ' HB3' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -108.86 97.37 7.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 70.230000000000004 110.86 179.858 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 31.1 m -49.08 -32.2 4.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 44.100000000000001 111.155 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -50.14 -32.5 16.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 72.340000000000003 110.904 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.636 ' HB3' ' OD2' ' A' ' 67' ' ' ASP . . . -105.99 -28.5 10.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 64.349999999999994 111.098 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.82 72.22 2.02 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.631 0.729 . . . . 75.150000000000006 110.9 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -30.99 21.2 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.661 2.24 . . . . 74.409999999999997 112.337 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -70.6 -42.88 70.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 73.349999999999994 110.895 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -51.24 -48.35 62.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.128 -0.487 . . . . 75.040000000000006 111.081 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.593 ' HB1' ' CG1' ' A' ' 80' ' ' VAL . . . -53.76 -67.31 0.27 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 74.340000000000003 111.157 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.1 ttp85 -51.87 -31.4 27.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 72.140000000000001 110.868 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -51.64 -37.96 52.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 63.539999999999999 110.87 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -105.24 21.44 17.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 74.329999999999998 110.888 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 65.3 mm-40 46.61 82.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.115 -0.493 . . . . 72.510000000000005 110.917 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.593 ' CG1' ' HB1' ' A' ' 75' ' ' ALA . 7.0 p -122.09 132.77 70.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 75.230000000000004 111.149 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.8 t -120.46 45.81 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 74.230000000000004 111.13 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.454 ' H ' HG22 ' A' ' 80' ' ' VAL . 0.3 OUTLIER -174.05 144.91 1.03 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 52.240000000000002 110.847 -179.813 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.53 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 4.3 mt -66.44 -58.04 11.16 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.571 0.7 . . . . 75.549999999999997 111.116 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.72 ' HB2' ' HB2' ' A' ' 101' ' ' ALA . 53.2 Cg_endo -69.79 73.96 1.34 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.699 2.266 . . . . 52.439999999999998 112.336 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.634 HG23 ' HB ' ' A' ' 99' ' ' VAL . 97.6 m -117.77 129.57 55.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 71.439999999999998 111.145 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.1 tmm? -120.78 144.02 48.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.443 . . . . 71.120000000000005 110.874 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 17.5 mt -131.7 122.89 50.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 64.299999999999997 111.129 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.28 105.4 17.38 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.149 -0.478 . . . . 73.299999999999997 110.889 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -89.45 169.84 11.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 60.310000000000002 110.933 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.12 91.16 0.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 73.340000000000003 110.886 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.33 33.13 12.14 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.706 -0.759 . . . . 74.120000000000005 112.49 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.652 ' HA3' HD23 ' A' ' 25' ' ' LEU . . . 74.99 38.83 39.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.761 -0.733 . . . . 63.229999999999997 112.477 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.44 HG23 ' HD2' ' A' ' 94' ' ' PRO . 85.5 m -161.26 133.8 4.41 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.577 0.704 . . . . 65.219999999999999 111.128 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.44 ' HD2' HG23 ' A' ' 93' ' ' THR . 54.0 Cg_endo -69.78 98.13 0.67 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.651 2.234 . . . . 62.140000000000001 112.352 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 20.6 m -87.65 -31.8 5.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 72.310000000000002 111.131 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.9 mmtm -132.42 166.0 22.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 73.299999999999997 110.915 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -159.76 115.0 2.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 70.109999999999999 110.866 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.428 ' N ' HD12 ' A' ' 98' ' ' ILE . 4.5 mp -125.36 118.01 51.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 74.120000000000005 111.105 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.634 ' HB ' HG23 ' A' ' 85' ' ' THR . 2.2 p -128.18 145.14 35.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 70.140000000000001 111.146 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 136.68 -28.31 2.87 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.796 -0.716 . . . . 75.329999999999998 112.475 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.72 ' HB2' ' HB2' ' A' ' 84' ' ' PRO . . . 64.49 106.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.821 0.344 . . . . 64.530000000000001 111.075 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.454 ' HG2' HD23 ' A' ' 107' ' ' LEU . 0.0 OUTLIER -147.46 175.61 10.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 74.019999999999996 110.901 179.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -59.51 166.66 8.88 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.735 -0.745 . . . . 75.519999999999996 112.538 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.68 -36.51 84.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.766 0.317 . . . . 70.150000000000006 110.932 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.34 -31.33 72.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 75.439999999999998 111.102 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -90.46 -58.84 2.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 64.5 111.105 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.454 HD23 ' HG2' ' A' ' 102' ' ' LYS . 0.3 OUTLIER -48.22 -47.53 35.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 74.530000000000001 110.929 180.0 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.439 HD23 ' C ' ' A' ' 108' ' ' LEU . 4.0 tt -47.98 -41.53 25.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 71.340000000000003 110.905 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 44.4 mtp180 -76.51 -35.8 58.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 73.430000000000007 110.878 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -51.02 -24.68 3.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.229 -0.441 . . . . 74.439999999999998 110.862 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.0 mt -87.78 -68.94 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 70.329999999999998 111.143 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.461 ' HA ' HD23 ' A' ' 115' ' ' LEU . 0.7 OUTLIER -53.88 -52.92 58.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 74.439999999999998 110.885 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -54.14 -34.47 60.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 71.310000000000002 110.858 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.87 -34.67 71.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 75.420000000000002 111.066 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 112' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.191 -0.459 . . . . 74.219999999999999 110.951 -179.973 . . . . . . . . 2 2 . 1 stop_ save_